{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s outstanding principal on the 5.000 % senior notes due April 2030 was $606 million in FY 2022 and stayed at $606 million in FY 2023 and FY 2024【page_103】【page_80】【page_81】.  The flat balance indicates the company has left this particular issue unchanged, reflecting a disciplined, steady‑state debt‑management approach that retains the note while reshaping its overall debt mix through other issuances and repayments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 balance. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, NOT $606 million as stated in the LLM answer. The LLM incorrectly claims the balance was $606 million in FY 2022 and remained flat through 2023-2024. The correct progression is: $1,086M (2022) → $606M (2023) → $606M (2024), representing a $480 million reduction in 2023 followed by stability. This is a major quantitative error that undermines the entire analysis. The LLM's interpretation of 'flat balance' and 'steady-state debt-management approach' is contradicted by the actual data showing significant debt reduction activity in 2023. The LLM failed to capture the key insight from the ground truth: that AVGO demonstrated 'deliberate debt reduction strategy' with 'active management' of these obligations. Instead, the LLM mischaracterizes the company's approach as leaving the issue 'unchanged' when in fact there was substantial principal reduction. The multi-hop reasoning is flawed because it's based on incorrect starting data. While the LLM correctly identifies the company (AVGO), the metric (5.000% notes due April 2030), and the time period (2022-2024), the core numerical facts are wrong, making the entire answer factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 381,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block has been essentially unchanged: the 2022 filing notes a **59.25 %** of the closed block was reinsured under the agreement (page 214), while the 2023 and 2024 filings each state **59 %** (pages 227 and 204). This steady‑state level of risk transfer—roughly three‑fifths of the closed‑block exposure—shows that the company has deliberately maintained a consistent, long‑term reinsurance strategy that transfers a substantial but not total portion of the block’s risk, preserving some risk on its books while using reinsurance for capital efficiency and diversification.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all three key percentages (59.25% in 2022, 59% in 2023, and 59% in 2024) and accurately characterizes the consistency of MetLife's modified coinsurance strategy. The numeric values are precise and properly formatted. The reasoning about maintaining a steady-state level of risk transfer is sound and logically presented.\n\nWEAKNESSES: (1) The LLM answer omits critical contextual information from the ground truth regarding the deposit method of accounting and the right of offset/combining of deposit liabilities and recoverables—these are important technical accounting details that demonstrate how MetLife implemented the strategy. (2) The answer fails to mention the significant growth in total net ceded reinsurance recoverables from $6.3 billion (2021) to $17.6 billion (2024), which is a key data point that strengthens the argument about the consistency of the closed block percentage despite overall portfolio changes. This omission weakens the multi-hop synthesis aspect of the answer. (3) The answer provides less comprehensive explanation of what the consistency reveals about long-term strategy—while it mentions capital efficiency and diversification, it doesn't fully articulate the strategic implication that the company maintained this proportion despite substantial growth in overall reinsurance activity.\n\nNUMERIC VERIFICATION: All percentages are correct (59.25%, 59%, 59%). The page references cited (214, 227, 204) appear reasonable for 10-K filings but cannot be independently verified from the ground truth provided.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the pattern. However, it misses the opportunity to synthesize the growth in total recoverables alongside the stable closed block percentage, which would have provided stronger evidence of deliberate strategy.\n\nSEMANTIC EQUIVALENCE: The characterization of the strategy as 'deliberate and sustained' aligns with ground truth, and the description of maintaining 'roughly three-fifths' is semantically equivalent to the percentages cited.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 575,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral for master‑netting arrangements fell sharply – it was $1,494 million at 12/31/2022, $800 million at 12/31/2023, and only $491 million at 12/31/2024【page_102】【page_99】.  The steep decline signals that the firm’s derivative exposure (or the margin required to support it) has been shrinking or that netting and margin practices have become more efficient, reflecting tighter management of its derivative risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,494 million (2022), $800 million (2023), and $491 million (2024). The dates are accurate (12/31/2022, 12/31/2023, 12/31/2024). The directional trend is correct: consistent decline from 2022 to 2024. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it identifies the specific collateral changes and provides interpretation of what the trend suggests about derivative exposure management. (3) ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is correctly referenced, and all years are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly connects the numerical decline to strategic implications, offering two plausible interpretations: either reduced derivative exposure or improved offsetting/netting mechanisms. This reasoning aligns with the ground truth's characterization of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' The phrase 'steep decline' accurately characterizes the magnitude of change (from $1,494M to $491M represents a 67% reduction). (5) SEMANTIC EQUIVALENCE: The LLM's interpretation ('derivative exposure has been shrinking or that netting and margin practices have become more efficient') is semantically equivalent to the ground truth's 'strategic reduction in derivative exposure or improved offsetting mechanisms.' Minor note: The LLM provides slightly more nuanced interpretation by explicitly mentioning 'margin required to support it' and 'tighter management of derivative risk,' which adds helpful context without contradicting the ground truth. The citation references (page_102, page_99) suggest proper sourcing from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 519,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO carried $622 million of principal on its 3.625 % senior notes due Oct 2024 at the end of FY 2022 (AVGO 2023 10‑K, p. 81) and the same $622 million remained outstanding at the end of FY 2023 (AVGO 2024 10‑K, p. 81). By the close of FY 2024 the balance was zero because the notes matured in October 2024 and were not refinanced (AVGO 2024 10‑K, p. 81). This shows the company let the note run to maturity and then used the scheduled repayment to shrink its debt, reflecting a disciplined strategy of paying down existing fixed‑rate obligations rather than rolling them over.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: All dollar amounts ($622 million for FY2022 and FY2023, zero for FY2024) match the ground truth exactly. The note maturity date (October 2024) is correct. The fiscal year progression (2022→2023→2024) is accurately tracked. Multi-hop synthesis: The answer correctly synthesizes information across three fiscal years and identifies the key transition point (between FY2023 and FY2024). The reasoning about debt management is sound—the company held the notes to maturity rather than refinancing them. The LLM provides slightly more interpretive detail than the ground truth by explicitly stating the notes 'matured in October 2024 and were not refinanced' and characterizing this as a 'disciplined strategy of paying down existing fixed-rate obligations rather than rolling them over.' This interpretation is reasonable and consistent with the factual progression but goes slightly beyond what the ground truth explicitly states. The ground truth uses more cautious language ('either fully repaid or refinanced'), while the LLM makes a more definitive claim about maturity and non-refinancing. However, this is a reasonable inference from the zero balance in FY2024 and the October 2024 maturity date. All entities are correctly identified (AVGO, the specific note instrument with its rate and maturity date). The answer directly addresses the question about how the exposure evolved and what it indicates about debt management strategy. Minor: The LLM provides specific page references (p. 81) which adds credibility but wasn't required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 447,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, **$2.70 billion in 2023**, and **$2.82 billion in 2024**【page_9】. The steady rise—about a 5% gain each year—shows the company is deepening its foothold in the U.S. Navy’s surface‑ship market, reflecting growing demand and successful capture of destroyer, auxiliary‑ship and other surface‑combatant contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: The revenue figures are correct when accounting for format conversion: $2.56B = $2,560M (vs. ground truth $2,561M - negligible rounding difference), $2.70B = $2,700M (vs. $2,698M - 0.07% variance), and $2.82B = $2,820M (vs. $2,819M - 0.04% variance). All three years' data points are essentially accurate. The LLM's characterization of 'about a 5% gain each year' is reasonable: 2022-2023 shows 5.4% growth ($2,561M to $2,698M), and 2023-2024 shows 4.5% growth ($2,698M to $2,819M), averaging approximately 5% annually. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) revenue evolution across the three-year period, (2) the trajectory pattern (steady increase), and (3) what this indicates about positioning (deepening foothold in U.S. Navy market, growing demand, successful contract capture). ENTITY ACCURACY: Correctly identifies General Dynamics, Marine Systems segment, surface ships, and the specific years (2022-2024). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects revenue growth data to strategic positioning and market implications. The mention of destroyer and auxiliary-ship contracts provides appropriate contextual support. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail (specific contract types, market demand context) than the ground truth, but this represents value-added analysis rather than error. The rounding in billion-dollar format introduces negligible variance (less than 0.1%) that is well within acceptable tolerance for financial reporting. SEMANTIC EQUIVALENCE: The LLM's phrasing 'sustained growth and strategic emphasis' aligns perfectly with the ground truth's characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 487,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 to 2024 Mastercard’s Class A shares kept the same governance rights – each share carries one vote and is entitled to dividends (the charter consistently lists “One vote per share Dividend rights” for Class A in 2022 【page_96】, 2023 【page_99】 and 2024 【page_92】).  At the same time the cash dividend per share rose each year, from $2.04 in 2022 【page_92】 to $2.37 in 2023 【page_99】 and $2.74 in 2024 【page_92】.  This three‑year trend shows a stable voting structure while the company progressively increased cash returns to its Class A shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that MA Class A shares maintained consistent voting rights (one vote per share) across all three years (2022-2024), matching the ground truth. (2) Accurately captures that dividend rights remained standard/unchanged across the period. (3) Provides specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) with proper page citations, demonstrating multi-hop synthesis across three years of filings. (4) Correctly interprets the 3-year progression as indicating stable voting structure with progressive dividend increases. (5) Properly addresses both parts of the question: the evolution of rights AND what it indicates about governance stability. (6) The reasoning is sound - distinguishing between stable governance rights and increasing cash returns is a sophisticated and accurate interpretation. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by providing specific dividend amounts, which adds valuable context but wasn't explicitly in the original answer. However, this is additive information that enhances rather than contradicts the ground truth. The answer demonstrates strong multi-hop reasoning by synthesizing information across three separate 10-K filings and correctly identifying the pattern of stability in governance combined with increasing shareholder returns. All numeric values appear accurate based on the citations provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 411,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose from $2.561 billion in 2022 to $2.698 billion in 2023 and to $2.819 billion in 2024 – roughly a 5% jump each year and about a 10% increase over the two‑year span【page_9】. The steady year‑over‑year growth signals that GD is gaining market share in U.S. Navy surface‑combatant and auxiliary ship programs, benefitting from new contracts and its expanded shipbuilding capacity and workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $2.561 billion (2022), $2.698 billion (2023), $2.819 billion (2024) match the ground truth exactly (format variation from millions to billions is acceptable). The calculated growth rates are accurate: 2022-2023 shows ($2.698-$2.561)/$2.561 = 5.3% (approximately 5% as stated), 2023-2024 shows ($2.819-$2.698)/$2.698 = 4.5% (approximately 5% as stated), and the two-year total growth is ($2.819-$2.561)/$2.561 = 10.1% (approximately 10% as stated). (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the revenue evolution with specific year-over-year figures and interprets what this growth indicates about GD's positioning. (3) ENTITY ACCURACY: General Dynamics is correctly identified, fiscal years 2022-2024 are correct, and the metric (surface ship revenue) is properly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects revenue growth data to market positioning conclusions about Navy contracts, market share gains, and capacity expansion. The reasoning that steady growth indicates 'gaining market share' and 'sustained demand' is logically consistent with the data. (5) MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail than the ground truth (mentioning specific program types like 'surface-combatant and auxiliary ship programs' and factors like 'expanded shipbuilding capacity'), which adds value without contradicting the ground truth. The citation reference [page_9] is included but cannot be verified against the ground truth provided. Overall, the answer is factually accurate, mathematically sound, and provides appropriate context for the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 492,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 10‑K filings for 2022, 2023 and 2024 all state that “the majority of Linde’s business is conducted through long‑term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers” (2022 p. 19; 2023 p. 20; 2024 p. 17). The fact that this description is unchanged over the three years shows the company deliberately relies on long‑term contracts to lock in revenue and pass on energy‑price swings, thereby preserving cash‑flow stability despite volatile energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the core finding that Linde's reliance on long-term contracts remained consistent across 2022, 2023, and 2024; (2) Accurately cites the specific language from the 10-K filings showing the consistency of messaging; (3) Properly synthesizes the multi-hop reasoning by connecting the unchanged contractual strategy to the company's deliberate approach to cash flow stability; (4) Correctly interprets the significance of this consistency as evidence of prioritizing financial resilience and risk management. The answer directly quotes the relevant passage and provides page references (2022 p. 19; 2023 p. 20; 2024 p. 17), demonstrating thorough document review. The reasoning about pass-through mechanisms for energy costs and the company's strategic approach to volatile markets is sound and matches the ground truth. Minor consideration: The LLM answer uses slightly more concise language than the ground truth (e.g., 'lock in revenue' vs. 'revenue predictability'), but this represents semantic equivalence rather than factual error. The answer fully addresses both parts of the question: (1) how reliance evolved (answer: it didn't—remained consistent), and (2) what this suggests about the company's approach (answer: deliberate strategy for cash flow stability and risk management). No calculation errors, no incorrect dates or entities, and the multi-hop synthesis across three years of filings is executed correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 417,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD’s filings show the same treatment each year: the 2022 10‑K notes that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 p.46); the 2023 10‑K repeats this language (2023 p.49); and the 2024 10‑K again states “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2024 p.47). The consistency indicates that GD deliberately strips out non‑economic items from ROIC to keep the metric focused on the core operating returns of the business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies GD's consistent treatment of non-economic accounting changes across all three years (2022, 2023, 2024), matching the ground truth assertion of stability; (2) Provides specific textual evidence from each year's filing with page references (2022 p.46, 2023 p.49, 2024 p.47), demonstrating multi-hop synthesis across three separate documents; (3) Accurately quotes the consistent language used by GD: 'ROIC excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance'; (4) Correctly interprets the meaning of this consistency - that GD deliberately excludes non-economic items to focus ROIC on core operating returns; (5) The reasoning is sound and logically connects the consistent methodology to GD's approach to measuring core performance. Minor considerations: The LLM answer goes slightly beyond the ground truth by including the specific page numbers and exact quotations, which adds credibility but wasn't explicitly required. The semantic meaning is fully aligned with the ground truth - both convey that GD maintained consistent exclusion of non-economic accounting changes and that this reflects a deliberate, institutionalized approach to measuring core performance. No factual errors, calculation errors, or entity misidentifications detected. The answer fully addresses all parts of the multi-part question regarding evolution (consistency), treatment methodology, and what this reveals about the company's approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 432,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth’s parent company continues to provide service‑level guarantees for certain subsidiaries, but “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022” (UNH 2024 Form 10‑K, Note 4)【page_81】. Because the guarantees have stayed immaterial each year, the pattern indicates that UnitedHealth’s risk‑management controls effectively limit exposure and that the company has consistently met its contractual service‑level commitments without generating material financial impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies that service level guarantee amounts were immaterial across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) Accurately cites the source (UNH 2024 Form 10-K, Note 4) with proper attribution. (3) Correctly synthesizes the multi-hop reasoning: immaterial amounts → effective risk management controls → consistent contractual performance. (4) Uses appropriate financial terminology ('accrued, paid or charged to income') that directly mirrors the filing language. (5) Properly interprets the pattern across three years to draw conclusions about risk management effectiveness. MINOR CONSIDERATIONS: (1) The LLM answer includes a parenthetical reference to 'parent company' and 'subsidiaries' which adds context not explicitly in the ground truth, but this is accurate and relevant to understanding the guarantee structure. (2) The answer is slightly more detailed than the ground truth (mentions 'parent company provides guarantees for certain subsidiaries'), which enhances rather than detracts from accuracy. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; the characterization of amounts as 'immaterial' across all three years is accurate; no calculations are required or presented. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and connects the pattern of immateriality to conclusions about risk management effectiveness and contractual performance consistency, which directly addresses the question's request for pattern analysis. The logical chain is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 454,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, rising to **$2.70 billion in 2023** and **$2.82 billion in 2024** – an overall increase of roughly 10 % over the three‑year span【page_9】.  This steady growth reflects the company’s successful capture of expanding demand for U.S. Navy surface combatants and auxiliary vessels, reinforcing its strategic positioning as a premier designer, builder, and lifecycle‑support provider for naval defense platforms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the core factual basis of the response. (1) NUMBERS VERIFICATION: Ground truth shows $2,328M (2022), $2,698M (2023), $2,819M (2024). LLM reports $2.56B (2022), $2.70B (2023), $2.82B (2024). Converting LLM figures to millions: $2,560M, $2,700M, $2,820M. The 2022 figure is off by $232M (10% overstatement), the 2023 figure is off by $2M (negligible), and the 2024 figure is off by $1M (negligible). The 2022 error is substantial and material. (2) CALCULATION VERIFICATION: LLM claims '10% overall increase over three-year span.' Ground truth calculation: ($2,819M - $2,328M) / $2,328M = $491M / $2,328M = 21.1% increase. LLM's 10% figure is significantly understated and mathematically incorrect. (3) MULTI-HOP REASONING: The LLM correctly synthesizes the information across three years and appropriately contextualizes the growth within naval defense strategy. The qualitative reasoning about 'sustained demand for surface combatants' and 'strategic positioning' aligns well with the ground truth narrative. (4) ENTITY ACCURACY: Correctly identifies General Dynamics, Marine Systems segment, and surface ships/naval defense platforms. (5) SEMANTIC EQUIVALENCE: The qualitative interpretation about strategic positioning and market demand is sound and semantically equivalent to the ground truth. However, the quantitative errors are severe enough to substantially diminish the answer's reliability. The 2022 baseline error propagates through the entire analysis, and the percentage calculation error is a fundamental mathematical mistake that contradicts the stated data progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 462,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In 2022 GE described Electric Insurance Company (EIC) as a captive property‑and‑casualty insurer in its run‑off insurance portfolio, noting net claim reserves of roughly $0.2 billion (2021) and $0.3 billion (2020). In the fourth quarter of 2022 the company re‑classified EIC as a “held‑for‑sale” business (reporting about $541 million of assets and $378 million of liabilities, and later recording a $109 million loss in 2023 while a sale agreement was signed). The divestiture was completed in Q2 2024 when GE sold EIC to Riverstone International Holdings for cash proceeds of $120 million, eliminating the related assets and liabilities from its balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and figures, but contains one significant timing discrepancy that affects precision. STRENGTHS: (1) All core financial figures are accurate: $0.2B net claim reserves (2021), $541M assets, $378M liabilities (2023), $109M loss, $120M sale price to Riverstone. (2) Correct entity identification and multi-hop synthesis across 2022-2024 timeline. (3) Proper characterization of EIC as captive P&C insurer and progression from operational to held-for-sale to divested status. (4) Accurate Q2 2024 completion date for sale. (5) Good contextual framing of strategic shift. WEAKNESSES: (1) TIMING ERROR - The LLM states EIC was reclassified as 'held-for-sale' in Q4 2022, but the ground truth indicates this classification occurred by 2023 (the $109M loss was recorded in 2023 in connection with the expected sale). The LLM conflates when the reclassification occurred with when it was disclosed. (2) The LLM mentions 2020 net claim reserves ($0.3B) which, while potentially accurate, is not part of the ground truth answer and adds information not directly relevant to the 2022-2024 evolution requested. (3) Minor semantic issue: stating the loss was 'recorded in 2023 while a sale agreement was signed' is slightly ambiguous about causality - the loss was recorded in connection with the held-for-sale classification, not necessarily while signing. MULTI-HOP REASONING: Correctly synthesized information across three years showing progression from operational classification → held-for-sale status with loss recognition → completed divestiture. The reasoning chain is sound and addresses all three components of the question (classification, financial exposure, divestiture). QUANTITATIVE VERIFICATION: All dollar amounts and dates check out correctly when cross-referenced with ground truth. The $109M loss calculation and $120M proceeds are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 523,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "In 2022 ConocoPhillips completed the monetization of its CVE stake, selling the remaining ≈ 91 million CVE common shares and using the cash to repurchase ≈ 87.7 million of its own shares that year【page_110】. In the following years the company kept the buy‑back program alive, repurchasing ≈ 48.6 million shares in 2023 and ≈ 49.1 million shares in 2024【page_112】—now funded by regular cash flow rather than additional CVE sales. This evolution shows a capital‑allocation approach that first leveraged a one‑time non‑core asset sale to deliver a large, immediate return to shareholders, then transitioned to a disciplined, ongoing share‑repurchase cadence as part of its broader cash‑return strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the capital allocation strategy and correctly identifies the key narrative arc (CVE monetization → share repurchases → transition to cash flow funding). However, there are significant quantitative discrepancies that undermine accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 completion of CVE monetization with ~91 million shares sold\n- Correctly identifies the transition from CVE-funded to cash flow-funded repurchases\n- Accurately characterizes the strategic narrative: one-time asset sale enabling immediate shareholder returns, then disciplined ongoing program\n- Proper entity identification (ConocoPhillips, CVE)\n- Good contextual framing of capital allocation strategy\n\nQUANTITATIVE ERRORS:\n- States 87.7 million shares repurchased in 2022 (no verification in ground truth, appears unsupported)\n- States 48.6 million shares repurchased in 2023 (ground truth shows 383 million cumulative through 2023, but doesn't specify annual breakdown)\n- States 49.1 million shares repurchased in 2024 (ground truth shows 433 million cumulative by year-end 2024, implying ~50 million in 2024, so this is approximately correct)\n- CRITICAL OMISSION: Fails to mention the $45 billion authorization or the $20 billion increase to $65 billion total authorization approved in 2024\n- CRITICAL OMISSION: Fails to mention the $29 billion cost through 2023 or $34.3 billion total cost through 2024\n- The annual share counts provided (87.7M, 48.6M, 49.1M) cannot be verified against ground truth and appear to be estimates or calculations not explicitly stated in source documents\n\nMULTI-HOP REASONING:\n- Successfully synthesizes information across 2022-2024 period\n- Correctly identifies the causal link between CVE monetization and share repurchases\n- Properly traces the evolution from asset-sale-funded to cash-flow-funded repurchases\n- However, fails to incorporate the authorization amounts and total costs, which are key metrics for understanding capital allocation strategy\n\nCOMPLETENESS ISSUES:\n- Missing authorization amounts ($45B initial, $20B increase to $65B total)\n- Missing cumulative cost figures ($29B through 2023, $34.3B through 2024)\n- Missing cumulative share count through 2023 (383 million)\n- Missing cumulative share count through 2024 (433 million)\n\nThe answer provides a coherent narrative but lacks the specific financial metrics that would fully demonstrate the \"expanding capital return strategy\" mentioned in the ground truth. The annual share repurchase figures appear to be derived calculations rather than directly sourced, and their accuracy cannot be confirmed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 706,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged: the company reinsured 59.25 % of the closed block in 2022 and about 59 % in both 2023 and 2024, and each year it has applied the deposit method of accounting, offsetting the deposit liability with the corresponding deposit recoverable. This steady use of the same percentage and accounting treatment signals that MetLife views the modified‑coinsurance structure as a core, long‑term risk‑transfer tool for moving a sizable, consistent portion of closed‑block risk while preserving capital efficiency and policyholder protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct - 59.25% in 2022, 59% in 2023, and 59% in 2024 match the ground truth exactly. The accounting treatment (deposit method with offset between deposit liability and deposit recoverable) is accurately stated. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) the evolution of reinsurance percentage across 2022-2024, (2) the accounting treatment consistency, and (3) what this reveals about long-term risk transfer strategy. ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, and the closed block reference is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the consistency across three years and draws the appropriate conclusion about stable risk transfer strategy. The reasoning that consistency signals a 'core, long-term risk-transfer tool' is logically sound and semantically equivalent to the ground truth's characterization of 'stable long-term risk transfer strategy.' MINOR DIFFERENCES: The LLM adds interpretive language about 'capital efficiency and policyholder protection' which, while not explicitly in the ground truth, represents reasonable inference from the data and doesn't contradict the original answer. The phrasing 'essentially unchanged' and 'steady use' effectively conveys the consistency theme. No calculation errors detected. All factual claims are verifiable against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 429,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The data show that the share of purchases made with Target’s branded credit product fell each year – about 20.5 % in fiscal 2022, 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024【page_27】. The downward trend indicates that a shrinking proportion of guests are using the Target MasterCard (and related RedCard) for their shopping, suggesting a modest decline in consumer engagement with Target’s financial‑card offerings over this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All three penetration rate percentages are factually correct: 20.5% (2022), 19.8% (2023), 18.6% (2024). (2) The LLM correctly identifies the downward trend across all three years. (3) The numeric format is acceptable and matches ground truth. (4) The LLM correctly identifies the product as Target MasterCard/RedCard. (5) The reasoning about declining consumer engagement is sound and supported by the data. WEAKNESSES: (1) The LLM answer omits a key contextual detail from the ground truth: the rebranding from RedCards to Target Circle Cards in 2024 and the significance that this rebranding did not reverse the decline. This is an important nuance that suggests structural challenges in customer loyalty. (2) The LLM uses slightly softer language ('modest decline') compared to the ground truth's characterization of a 'gradual decrease,' though this is a minor semantic difference. (3) The answer doesn't fully address the implications of the rebranding effort, which is relevant context for understanding the trend. MULTI-HOP REASONING: The LLM successfully synthesizes the three-year trend and draws a logical conclusion about consumer engagement, but misses the additional layer of analysis regarding the rebranding event and its failure to reverse the trend. CALCULATION VERIFICATION: No calculations required; all percentages are correctly stated. The trend direction (declining) is correctly identified. OVERALL ASSESSMENT: The core factual answer is correct with accurate numbers and sound reasoning about the trend, but the response is incomplete in addressing the full context of the ground truth answer, particularly regarding the 2024 rebranding and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 463,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. was listed as a member of PMI’s Peer Group in the 2022 filing (see the peer‑group list on page 21) and the same list appears unchanged in the 2023 and 2024 filings (identical peer‑group list on page 26 for both years). The unchanged inclusion signals that PMI relies on a stable set of large, global consumer‑product companies for benchmarking, emphasizing continuity and consistent strategic comparison rather than frequent reshuffling of peers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies Colgate-Palmolive's consistent inclusion in PMI's peer group across 2022-2024; (2) Accurately references specific page numbers (page 21 for 2022, page 26 for 2023-2024) showing attention to filing details; (3) Properly synthesizes the multi-hop information about peer group consistency and its strategic implications; (4) Correctly characterizes the peer group selection criteria (global presence, consumer products, similar size metrics); (5) Appropriately interprets the consistency as indicating stable benchmarking methodology. MINOR GAPS: (1) The LLM answer does not explicitly mention the four characteristics used to determine peer group membership (global presence, focus on consumer products, similarity in net revenues, and market capitalization) - the ground truth specifically lists these four criteria, while the LLM only implies them; (2) The LLM states the peer group list appears 'unchanged' but doesn't explicitly confirm this across all three years with the same level of detail as the ground truth. QUANTITATIVE ACCURACY: Page number references (21, 26) appear reasonable for 10-K filings, though not independently verifiable in this context. The three-year span (2022-2024) is correctly identified. QUALITATIVE REASONING: The multi-hop synthesis is sound - the answer correctly connects the observation of consistent inclusion to the interpretation about PMI's strategic benchmarking approach. The logic that stability indicates 'continuity and consistent strategic comparison' is well-reasoned and matches the ground truth's conclusion. SEMANTIC EQUIVALENCE: The LLM's phrasing about 'stable set of large, global consumer-product companies' and 'consistent strategic comparison' conveys the same meaning as the ground truth's 'ongoing strategic alignment' and 'stable benchmarking methodology.' The answer is semantically equivalent despite different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 539,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s revenue‑recognition policy for development‑service and IP‑licensing contracts did not change between the 2022, 2023 and 2024 filings. In each filing the company states that it first assesses whether the licensing component is distinct; if the license is not distinct it is combined with the development services and revenue is recognized over time, while a distinct license—or a standalone IP license—is recognized at a point in time when the customer can benefit (with no variable consideration)【page_59】【page_63】【page_64】. This identical language across the three years shows that AMD has applied a consistent accounting approach to these arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that AMD's revenue recognition policy remained consistent across 2022-2024 with no changes; (2) Accurately describes the two-part assessment framework (distinctness evaluation); (3) Correctly states that non-distinct licenses are combined with development services and recognized over time, while distinct licenses are recognized at a point in time; (4) Accurately notes the absence of variable consideration across all three years; (5) Properly synthesizes information across multiple years to demonstrate consistency; (6) Includes specific page references supporting the claims. Minor considerations: (1) The LLM answer uses slightly more concise phrasing than the ground truth but conveys identical semantic meaning; (2) Both answers emphasize the 'identical language across three years' as evidence of consistency, which is a sound analytical approach; (3) The LLM answer explicitly references page numbers (59, 63, 64) which adds credibility and specificity. No quantitative errors detected. The multi-hop reasoning is sound—the model correctly synthesized information across three fiscal years to demonstrate policy consistency. The answer directly addresses all aspects of the question: the evolution (or lack thereof), the distinction between combined arrangements and standalone licenses, and what this reveals about consistency. The semantic equivalence is strong throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 413,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. appears in PMI’s peer‑group list in every filing – it is named among the benchmark companies in the 2022 10‑K (page 21), again in the 2023 10‑K (page 26) and unchanged in the 2024 10‑K (page 26). The unchanged presence of a major consumer‑goods firm signals that PMI deliberately frames its competitive set around leading global consumer‑product companies, reinforcing its strategic positioning as a broader consumer‑products player rather than a pure tobacco company.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Colgate-Palmolive Co. was consistently included in PM's (PMI's) peer group across 2022, 2023, and 2024, matching the ground truth's core finding. The answer provides specific page references (2022 10-K page 21, 2023 10-K page 26, 2024 10-K page 26) which adds credibility, though these cannot be independently verified against the ground truth provided. The LLM correctly notes the 3-year consistency and interprets it as deliberate strategic framing. However, there are some issues: (1) The LLM uses 'PMI' while the question and ground truth refer to 'PM' - this is a minor entity naming inconsistency but both refer to Philip Morris International. (2) The LLM's interpretation that this signals PMI frames itself as 'a broader consumer-products player rather than a pure tobacco company' is a reasonable inference but goes slightly beyond what the ground truth explicitly states. The ground truth emphasizes 'alignment with leading global consumer staples firms' while the LLM emphasizes repositioning away from tobacco identity - these are related but not identical framings. (3) The ground truth mentions 'similar revenue and market capitalization' as selection criteria, which the LLM answer omits. (4) The ground truth explicitly states the peer group 'remained unchanged' while the LLM says 'unchanged' - semantically equivalent. Overall, the answer captures the essential finding (3-year consistency of Colgate-Palmolive inclusion) and provides reasonable strategic interpretation, but lacks some of the methodological detail about selection criteria and has a minor company name variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 448,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s policy for combined development‑service and IP‑licensing contracts did not change from 2022 through 2024. In each filing the company first determines whether the license is a distinct performance‑obligation; if the license is not distinct it is combined with the development services and revenue is recognized over time, while a distinct license is accounted for as a separate obligation and revenue is recognized at the point in time the customer can benefit (AMD 2022 10‑K p. 59; AMD 2023 10‑K p. 64; AMD 2024 10‑K p. 64). No variable‑consideration estimates are applied to these arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Strengths: (1) Correctly identifies that AMD's policy remained consistent/unchanged from 2022-2024, matching the ground truth statement of 'no material changes'; (2) Accurately describes the two-part distinctness assessment criteria (capable of being distinct AND distinct in context); (3) Correctly explains the bifurcated accounting treatment: non-distinct licenses combined with development services recognized over time, distinct licenses recognized at point in time; (4) Accurately notes the absence of variable consideration estimates across all three years; (5) Provides specific page citations (2022 10-K p. 59; 2023 10-K p. 64; 2024 10-K p. 64) that add credibility. Minor observations: (1) The LLM uses slightly different phrasing ('did not change' vs. 'remained consistent') but this is semantically equivalent; (2) The LLM's description of the two distinctness criteria is slightly more concise than the ground truth's explicit listing of '(i)' and '(ii)' but captures the same substance; (3) The LLM correctly synthesizes information across three years of filings to demonstrate consistency. No quantitative errors detected. The answer fully addresses all aspects of the multi-part question regarding performance obligations, timing of revenue recognition, and evolution (or lack thereof) across the three-year period. The reasoning is sound and the multi-hop synthesis across three years of SEC filings is properly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 416,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "In 2022 ConocoPhillips completed the sale of its remaining 91 million CVE common shares, directing the cash to its share‑repurchase program【page_110】. The proceeds helped grow buybacks from 383 million shares at a cost of $29 billion by year‑end 2023 to 433 million shares at a cost of $34.3 billion by year‑end 2024, with the board expanding the repurchase authorization to $65 billion【page_110】. This shows a consistent strategy of monetizing non‑core equity (CVE) and using the proceeds to accelerate share buybacks, underscoring a disciplined, shareholder‑focused capital‑allocation approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are accurate: 91 million CVE shares sold in 2022, 383 million shares repurchased at $29B by end-2023, 433 million shares at $34.3B by end-2024, and $65B authorization expansion. (2) Correctly identifies the causal relationship between CVE monetization and share repurchase program. (3) Properly synthesizes multi-year progression (2022-2024) showing escalating capital returns. (4) Accurately characterizes the capital allocation strategy as disciplined and shareholder-focused. (5) Correctly attributes the CVE sale completion to Q1 2022. MINOR WEAKNESSES: (1) The answer omits the historical context that monetization began in May 2021, which provides important framing for understanding the 2022 completion as part of a longer-term strategy. The ground truth explicitly states this was a 'paced monetization' that started earlier. (2) The phrase 'grow buybacks from 383 million shares...to 433 million shares' could be slightly clearer—it shows the cumulative total growth rather than annual growth, though this is technically correct. (3) Does not explicitly state that the CVE monetization was a 'key enabler' of the strategy, though this is implied. The answer is semantically equivalent to the ground truth on the core question about 2022-2024 evolution and capital allocation strategy, but loses some points for incomplete historical context that would strengthen the 'multi-year progression' narrative requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 434,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a steady widening of competitive‑landscape exposure in every segment – Aerospace, Building (now Building Automation), Performance Materials (now Energy & Sustainability) and Safety/Productivity (now Industrial Automation) – with each filing noting “new market entrants,” “non‑traditional players” and product commoditization as key threats (2022 risk factors § 32; 2023 risk factors § 31; 2024 risk factors § 31).  At the same time the company has amplified its strategic response: repositioning spend rose from $275 million in 2022 to $294 million in 2023 (and $195 million in 2024) § 29, and it undertook a full business realignment and announced a spin‑off of Advanced Materials in 2024 § 31, indicating that market pressure is intensifying and prompting Honeywell to restructure into more focused, agile units.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core trend of expanding competitive landscape concerns across Honeywell's business segments from 2022-2024, matching the ground truth's narrative about persistent and intensifying market pressure. The answer appropriately synthesizes multi-hop information about competitive threats (new entrants, commoditization) and strategic responses (restructuring, spin-off). The qualitative reasoning about market pressures driving strategic repositioning is sound and well-articulated.\n\nWEAKNESSES - QUANTITATIVE ERRORS (Critical): The LLM provides specific dollar amounts for repositioning spend that cannot be verified against the ground truth: '$275 million in 2022 to $294 million in 2023 (and $195 million in 2024).' The ground truth does not provide these specific numbers, and the LLM cites '§ 29' as source. The 2024 figure of $195 million appears inconsistent with a claimed 'widening' trend (it decreases from 2023). This is a significant factual claim that lacks verification and may be fabricated or misattributed.\n\nENTITY ACCURACY ISSUES: The LLM references segment name changes (e.g., 'Building (now Building Automation),' 'Performance Materials (now Energy & Sustainability)') that are not mentioned in the ground truth. While some segment renaming may be accurate, the ground truth specifically mentions 'Honeywell Building Technologies' in 2022 and 'Building Automation' in 2024, but does not discuss Performance Materials or Energy & Sustainability. The LLM's inclusion of 'Aerospace' as a segment with competitive landscape concerns is not mentioned in the ground truth.\n\nMISSING ELEMENTS: The LLM does not explicitly mention the 'product commoditization' language that the ground truth identifies as a 2024 addition, though it does reference commoditization generally.\n\nMULTI-HOP REASONING: The synthesis connecting competitive pressures to strategic responses (restructuring, spin-off) is logical and appropriate, though the specific financial figures supporting this connection are questionable.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the qualitative trend and strategic implications, but the unverified/potentially incorrect financial figures significantly undermine credibility. The quantitative accuracy score is low due to these specific number claims that cannot be confirmed against ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 640,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "- The per‑share cash dividend on Mastercard’s Class A common stock rose each year – $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024【page_99】【page_99】【page_92】.  \n- The voting structure for Class A shares never changed; the charter continues to grant “one vote per share” and dividend rights for Class A throughout 2022‑2024【page_96】【page_99】【page_92】.  \n\nThis three‑year pattern of steady dividend growth paired with an unchanged one‑vote‑per‑share framework shows that Mastercard’s governance strategy preserves consistent shareholder voting power while progressively rewarding owners with higher cash returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dividend per-share amounts ($2.04, $2.37, $2.74) that are NOT present in the ground truth answer. The ground truth explicitly states there were NO CHANGES in dividend rights across 2022-2024, describing only that A Class shares 'carry...dividend rights' without specifying actual dividend amounts paid. The LLM has fabricated quantitative data that contradicts the core finding of the ground truth - which emphasizes CONSISTENCY and NO CHANGES over the three-year period. The LLM correctly identifies that voting rights remained at 'one vote per share' throughout 2022-2024, which aligns with ground truth. However, the introduction of specific dividend dollar amounts represents a fundamental factual error that undermines the entire answer. The ground truth's key insight is about the STABILITY of governance structure (no changes in rights descriptions), while the LLM's answer pivots to discussing 'steady dividend growth' - a narrative not supported by the ground truth. The reasoning about 'progressively rewarding owners with higher cash returns' is unsupported by the source material and contradicts the ground truth's emphasis on consistency. The multi-hop synthesis fails because the LLM conflated actual dividend payments (which may have varied) with the RIGHTS associated with the shares (which remained constant). The question asks about how rights 'evolved' - the correct answer is they did NOT evolve, they remained consistent. The LLM's answer suggests evolution through dividend growth, which is a misinterpretation of what the question and ground truth are addressing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 451,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s notional exposure to the total‑return swaps that hedge its deferred‑compensation obligations grew each year – $651 million in FY 2022, $792 million in FY 2023 and $985 million in FY 2024 (page 91).  At the same time, the accounting impact on operating expense shifted from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024 (page 91 for 2023‑24 and page 92 for 2022).  This shows both a larger swap exposure and a swing from a loss to increasingly positive earnings effects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) Notional exposure amounts: $651M (FY2022), $792M (FY2023), $985M (FY2024) - all verified; (2) Gains/losses in operating expenses: $92M loss (FY2022), $58M gain (FY2023), $91M gain (FY2024) - all verified and match ground truth exactly. The multi-hop reasoning is sound: the answer correctly synthesizes information about both the notional exposure trajectory AND the accounting impact across three fiscal years, showing the dual evolution requested. The LLM goes beyond the ground truth by providing additional context (notional exposure amounts) which enriches the answer without contradicting it. The semantic meaning is equivalent to the ground truth - both describe the shift from loss to gains and the improving financial position. Page citations (91, 92) add credibility. Minor consideration: the ground truth focuses primarily on the gains/losses trajectory, while the LLM adds notional exposure data. This is actually a strength as it provides more complete context for understanding the financial exposure evolution. No calculation errors detected. All entities (Cisco, Total Return Swaps, Deferred Compensation, fiscal years) correctly identified. The answer directly addresses how the financial exposure evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 376,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "In 2022 J&J set aside roughly $2 billion to fund a $2 billion trust for LTL Management LLC, the spin‑off created to hold all talc liabilities, while the original LTL Chapter 11 case remained pending (see 2022 filing). In 2023 the company increased that funding to about $9 billion to cover the new “LTL 2” filing (re‑filed in April and dismissed in July) and began pursuing a pre‑packaged bankruptcy, renaming LTL to LLT and moving it to Texas (see 2023 filing). By 2024 the reserve grew to a present‑value of $11.6 billion (≈$13.5 billion nominal), the firm launched a $6.5 billion pre‑packaged plan and created new entities (Red River, Pecos River) that filed Chapter 11 in September, and it secured a multi‑state settlement—reaching an agreement in principle in January and finalizing the settlements in June (see 2024 filing).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth, particularly regarding reserve amounts and entity names. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims reserves increased to $9 billion in 2023 and $11.6 billion/$13.5 billion in 2024, but the ground truth only confirms a $2 billion reserve in 2022 with no mention of these escalated amounts. The specific figures ($9B, $11.6B, $13.5B, $6.5B) cannot be verified against the ground truth and appear to be fabricated or misattributed. (2) ENTITY NAME ERRORS: The LLM states LTL was 'renamed to LLT' and moved to Texas, but the ground truth refers to 'LTL 2' as the re-filed entity, not a renamed entity. The introduction of 'Red River' and 'Pecos River' entities filing Chapter 11 in September 2024 is not mentioned in the ground truth at all. (3) TIMELINE DISCREPANCIES: The ground truth states LTL 2 was 'dismissed' after the Third Circuit reversed the bankruptcy court's decision, but the LLM claims it was 'dismissed in July' after being 're-filed in April,' which conflates the sequence of events. The ground truth indicates JNJ was 'continuing to appeal the dismissal,' not that new entities were filing. (4) SETTLEMENT DETAILS: While both answers mention a multi-state settlement with 42 states and DC, the LLM adds specific dates (January agreement in principle, June finalization) not present in the ground truth, and these cannot be verified. (5) STRATEGY CHARACTERIZATION: The ground truth correctly identifies a shift from 'exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements,' but the LLM's narrative of creating new entities and pre-packaged bankruptonomy in 2024 contradicts this characterization and the ground truth's emphasis on appeals continuing. The LLM appears to have hallucinated or confused multiple financial figures and entity structures not supported by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 532,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "- The 3.125 % senior notes due January 2025 carried an outstanding principal of **$495 million in FY 2022** (AVGO 10‑K 2022 p. 101) and the same **$495 million in FY 2023 and FY 2024** (AVGO 10‑K 2023/2024 p. 81 shows $495 million as of Oct 29 2023 and Nov 3 2024).  \n- The balance has remained flat over the three years, indicating Broadcom has chosen to keep this low‑cost, fixed‑rate debt on its balance sheet rather than accelerate repayment or refinance it, reflecting a strategy of preserving inexpensive financing while focusing repayment efforts on higher‑cost obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $495 million principal balance is confirmed for FY 2022, FY 2023, and FY 2024. The note rate (3.125%) and maturity date (January 2025) are accurate. The fiscal year dates and page references appear reasonable and consistent with typical 10-K filing structures. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the principal balance across three fiscal years, (2) the specific instrument identification, and (3) interpretation of debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, the specific debt instrument is properly characterized, and all fiscal years are correctly referenced. REASONING QUALITY: The LLM correctly synthesizes the key finding that the balance remained constant at $495 million across all three years. The interpretation of what this stability indicates is sound and goes beyond the ground truth by providing additional strategic context - specifically that Broadcom chose to retain this low-cost, fixed-rate debt while focusing repayment on higher-cost obligations. This is a reasonable inference from the stability pattern and demonstrates good financial reasoning. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth (constant $495 million balance indicating consistent debt management) while adding valuable strategic context about the company's apparent preference for preserving inexpensive financing. The wording differs but the factual content aligns perfectly. MINOR CONSIDERATIONS: The LLM provides specific page references (p. 101 for 2022, p. 81 for 2023/2024) which adds credibility, though these cannot be independently verified in this evaluation. The strategic interpretation about 'low-cost, fixed-rate debt' and 'preserving inexpensive financing' is a reasonable inference that enhances the answer without contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 540,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50 % senior note due June 15 2025 showed a rising effective cost: about 3.2 % in FY 2022, roughly 6.4 % in FY 2023, and about 6.7 % in FY 2024【page_89】. The more than‑doubling of the effective rate signals that the net borrowing cost on this fixed‑rate debt has climbed sharply, reflecting higher market rates (and related discount/hedge adjustments) and indicating that Cisco’s overall cost of borrowing has increased over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values match the ground truth precisely - FY2022: 3.2% (vs 3.20%), FY2023: 6.4% (vs 6.38%), FY2024: 6.7% (vs 6.66%). The minor rounding differences (6.4% vs 6.38%, 6.7% vs 6.66%) are acceptable format variations and do not constitute errors. ENTITY ACCURACY: Correctly identifies Cisco, the specific debt instrument (3.50% senior note due June 15, 2025), and all three fiscal years (2022-2024). MULTI-HOP SYNTHESIS: Successfully synthesizes the progression across three years and correctly interprets the trend as an upward movement in effective borrowing costs. REASONING QUALITY: The LLM provides sound interpretation - noting the 'more than doubling' of the effective rate and attributing it to market conditions and discount/hedge adjustments, which aligns with the ground truth's explanation of deteriorating financing terms. COMPLETENESS: Addresses all parts of the question including the evolution of rates and what the progression indicates about borrowing costs. SEMANTIC EQUIVALENCE: The phrase 'net borrowing cost on this fixed-rate debt has climbed sharply' conveys the same meaning as 'deterioration in financing terms.' The only minor distinction is that the LLM provides slightly more specific context about discount/hedge adjustments, which adds value without contradicting the ground truth. No calculation errors detected. The answer is well-structured and directly responsive to the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 420,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s senior and subordinated notes rose from $30.8 billion at year‑end 2022 to $31.3 billion at year‑end 2023, then fell to $30.7 billion at year‑end 2024【page_178†L34-L34】【page_179†L8-L8】【page_189†L8-L8】. During the same span the weighted‑average interest rate on its senior debt climbed from roughly 4.45 % in 2022 to 4.48 % in 2023 and to about 4.84 % in 2024【page_178†L30-L32】【page_188†L30-L33】, suggesting the bank initially expanded low‑cost long‑term funding and later trimmed the balance while accepting higher‑cost debt as market rates rose—reflecting a capital‑structure strategy that balances growth financing with interest‑rate risk management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics. (1) SENIOR/SUBORDINATED NOTES AMOUNTS: Ground truth shows $27.219B (2022), $31.248B (2023), $30.696B (2024). LLM reports $30.8B (2022), $31.3B (2023), $30.7B (2024). The 2022 figure is off by $3.581 billion (13.2% error), which is a massive discrepancy. The 2023 and 2024 figures are approximately correct but the 2022 baseline is fundamentally wrong, undermining the entire 3-year progression analysis. (2) WEIGHTED AVERAGE INTEREST RATES: Ground truth shows 2.76% (2022), 4.48% (2023), 4.84% (2024). LLM reports 4.45% (2022), 4.48% (2023), 4.84% (2024). The 2022 rate is incorrect (4.45% vs 2.76% = 1.69 percentage point error), which is a critical error that misrepresents the interest rate trajectory and the strategic shift. The 2023 and 2024 rates are correct. (3) MULTI-HOP REASONING: The LLM correctly synthesizes the concept that the company raised capital in 2023 and partially reversed it in 2024, and correctly identifies the interest rate increase trend. However, the incorrect 2022 baseline severely compromises the analysis of the '3-year progression.' The narrative about 'initially expanded low-cost long-term funding' is contradicted by the actual data showing rates rose significantly from 2022 to 2023. (4) SEMANTIC ISSUES: The LLM's interpretation that the company 'initially expanded low-cost long-term funding' is inconsistent with the actual data showing rates were already rising. The ground truth correctly identifies this as a 'strategic shift toward fixed-rate financing amid rising interest rates' starting from 2022. The LLM's framing misses the key insight that 2022 rates were much lower (2.76%), making the subsequent increases more dramatic. STRENGTHS: The LLM correctly identifies the 2023 peak and 2024 decline pattern, correctly reports 2023-2024 interest rates, and provides reasonable qualitative interpretation of capital structure strategy. WEAKNESSES: Two major quantitative errors (2022 notes amount and 2022 interest rate) that fundamentally undermine the accuracy of the 3-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 577,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "In the 2022 filing the company said that about 40 % of the U.S. pension‑plan fixed‑income portfolio was invested in U.S. Treasury or agency securities. By the end of 2023 that share had dropped to roughly 30 %, and the 2024 filing reports the allocation remained at about 30 % . The reduction shows the pension fund is deliberately scaling back its exposure to the safest government securities and shifting toward a broader mix of other government and corporate bonds, a move that suggests a strategy aimed at improving yield and diversifying risk while still keeping a modest safety buffer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All percentages are correct - 40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. The year-to-year progression is accurately captured. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the allocation evolution from 2022-2024, (2) the specific percentages for each year, and (3) the strategic implications of the shift. ENTITY ACCURACY: Colgate-Palmolive is correctly identified, the U.S. pension plan is properly referenced, and the fixed income portfolio classification is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the trend (40% → 30% → 30%), recognizes the deliberate nature of the reallocation, and provides appropriate strategic interpretation. The explanation that this represents a shift toward other government and corporate bonds while seeking improved yield is consistent with the ground truth's characterization of yield-seeking behavior and risk tolerance adjustment. SEMANTIC EQUIVALENCE: The LLM's phrasing 'deliberately scaling back its exposure to the safest government securities' effectively conveys the same meaning as the ground truth's 'strategic reallocation away from U.S. treasury and agency securities.' The mention of 'keeping a modest safety buffer' adds reasonable context without contradicting the ground truth. MINOR OBSERVATION: The LLM provides slightly more interpretive detail about the strategic motivation (yield improvement, risk diversification) compared to the ground truth, but this represents appropriate elaboration rather than inaccuracy. The answer is factually correct, well-reasoned, and appropriately addresses the question's multi-hop requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 487,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In 2022 Electric Insurance Company (EIC) was still reported as a captive industrial‑insurance subsidiary within GE’s run‑off insurance operations.  In the fourth quarter of 2022 GE re‑classified EIC as a “business held for sale” (assets ≈ $541 million, liabilities ≈ $378 million) and recorded a valuation allowance that rose from $17 million in 2022 to $124 million in 2023, producing a $109 million loss in that year; the sale was completed in the second quarter of 2024 to Riverstone International for $120 million, eliminating the assets and liabilities from the balance sheet.  This progression—from operating unit to held‑for‑sale to disposal—illustrates GE’s strategic move to shed non‑core insurance assets and concentrate on its core industrial businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and figures. STRENGTHS: (1) Correctly identifies EIC as a captive insurance subsidiary; (2) Accurately states the 2024 sale to Riverstone International for $120 million; (3) Correctly identifies the $109 million loss recorded in 2023; (4) Properly traces the progression from operating unit to held-for-sale to disposal; (5) Accurately conveys GE's strategic direction toward divesting non-core insurance assets; (6) Provides relevant balance sheet figures ($541M assets, $378M liabilities) that add useful context. MINOR DISCREPANCIES: (1) The LLM states the reclassification to 'held for sale' occurred in Q4 2022, while the ground truth indicates this occurred by 2023 without specifying the exact quarter—this is a potential timing issue but not definitively contradicted by ground truth; (2) The LLM provides valuation allowance progression ($17M in 2022 to $124M in 2023) which is not mentioned in the ground truth, suggesting additional detail rather than contradiction; (3) The ground truth mentions 'net claim reserves of $0.2 billion as of December 31, 2021' which the LLM does not include, though this is historical context from 2021 rather than the 2022-2024 period. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022-2024) and correctly connects the classification change, valuation adjustments, and ultimate sale. The reasoning about strategic direction is sound and well-supported. QUANTITATIVE VERIFICATION: The $120M sale price, $109M loss, and balance sheet figures appear accurate or at least not contradicted by ground truth. The calculation logic (valuation allowance increase from $17M to $124M = $107M increase, approximately matching the $109M loss) is sound. Overall, this is a high-quality answer with minor timing ambiguities that do not substantially undermine the core narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 524,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 are listed in the “Description of Securities” section of each filing. In the 2022 Form 10‑K the note appears in Exhibit 4.4 (Officer’s Certificate dated May 6 2014) 【page_56】; the same Exhibit 4.4 with identical wording is reproduced in the 2023 Form 10‑K 【page_56】; and it is again included unchanged in the 2024 Form 10‑K 【page_56】. The unchanged, year‑over‑year disclosure shows Apple has kept the 4.45 % 2044 bond outstanding, indicating a deliberate long‑term debt strategy that relies on very long‑dated, low‑coupon notes to lock in cheap financing and smooth its maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All numeric values are correct - 4.45% coupon rate, 2044 maturity date, May 6, 2014 Officer's Certificate date are all accurate. (2) Multi-hop synthesis is sound - the answer correctly traces the disclosure across 2022, 2023, and 2024 10-K filings and identifies the consistent inclusion in Exhibit 4.4. (3) Entity identification is precise - correctly identifies Apple, the specific debt instrument, and the relevant exhibit references. (4) The reasoning about debt strategy is logical and well-supported: the observation that unchanged year-over-year disclosure indicates the notes remain outstanding is correct, and the interpretation that this reflects a deliberate long-term strategy using long-dated, low-coupon notes is reasonable and consistent with corporate finance principles. (5) The answer goes slightly beyond the ground truth by providing strategic interpretation (\"lock in cheap financing and smooth its maturity profile\"), which adds valuable context without contradicting the ground truth. MINOR CONSIDERATIONS: The ground truth states the notes were \"issued under an Officer's Certificate dated May 6, 2014\" while the LLM says the exhibit is \"dated May 6 2014\" - these are semantically equivalent and both correct. The LLM's strategic interpretation about debt management is inference-based but reasonable and not contradicted by the ground truth. All factual claims are verifiable and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 411,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s senior and subordinated notes grew from **$27.2 billion** at year‑end 2022 (Table 9.2, 2022 10‑K) to **$31.2 billion** at year‑end 2023 (Table 8.2, 2023 10‑K) and then slipped slightly to **$30.7 billion** at year‑end 2024 (Table 9.2, 2024 10‑K)【COF_10k_2022, p. 189】【COF_10k_2023, p. 179】【COF_10k_2024, p. 189】. The 2023 increase reflects a strategic issuance of additional fixed‑rate notes to fund growth and lock in rates before market rates rose, while the modest 2024 reduction—against a rise in the weighted‑average note rate from roughly 2.9 % in 2022 to about 4.8 % in 2024 (Tables 8.1, 2022‑2024)【COF_10k_2022, p. 188】【COF_10k_2023, p. 178】【COF_10k_2024, p. 188】—shows Capital One trimming higher‑cost debt and rebalancing its capital structure to manage interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct - $27.2B (2022), $31.2B (2023), $30.7B (2024) match the ground truth values of $27,219M, $31,248M, and $30,696M respectively (format variations acceptable). The weighted-average interest rate progression from ~2.9% (2022) to ~4.8% (2024) aligns with ground truth's 2.76% to 4.84% range (minor rounding differences acceptable). The net increase of approximately $3.5B over three years is mathematically correct ($30.7B - $27.2B = $3.5B). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and multiple tables, correctly identifying the 2023 peak and 2024 decline pattern. It properly connects the carrying value evolution with interest rate movements and strategic positioning. REASONING QUALITY: The interpretation that the company strategically moved toward fixed-rate financing and locked in rates before market rates rose is sound and matches the ground truth assessment. The explanation of the 2024 reduction as debt rebalancing to manage interest-rate exposure is logical and well-supported. ENTITY ACCURACY: Capital One (COF) correctly identified, fiscal years 2022-2024 properly referenced, financial metrics (senior and subordinated notes, weighted-average interest rates) accurately specified. MINOR OBSERVATIONS: The LLM provides slightly more detailed strategic context (mentioning 'fund growth' in 2023) than the ground truth, but this adds value without contradicting the original answer. Citation references to specific tables and pages enhance credibility. The answer fully addresses all components of the multi-part question regarding carrying value evolution, capital structure strategy, and interest rate positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 493,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "Adobe first presented Frame.io in its 2022 filing as a cloud‑native creative‑collaboration platform that was already built‑in to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and was offered through Adobe GenStudio to support large‑scale content production【ADBE_10k_2022.pdf page_12】. In the 2023 filing the company emphasized Frame.io’s role as a core part of the Adobe creative‑collaboration ecosystem, stressing its direct integration across those same Creative Cloud apps and its availability alongside Adobe Express and Firefly Services in GenStudio【ADBE_10k_2023.pdf page_12】. By the 2024 filing Adobe continued to position Frame.io as an embedded collaboration layer within Creative Cloud, reinforcing its real‑time review, frame‑accurate commenting and scalable content‑creation capabilities across video and design applications and its integration in GenStudio【ADBE_10k_2024.pdf page_12】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, Frame.io was 'listed as a registered trademark' with no mention of integration into Photoshop, Lightroom, or Workfront at that time. However, the LLM claims that in 2022, Frame.io was 'already built-in to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront.' This is a major factual inaccuracy. The ground truth shows a clear PROGRESSION: 2022 (trademark only), 2023 (integration with Premiere Pro and After Effects), 2024 (expanded to Photoshop, Lightroom, Workfront, and GenStudio). The LLM incorrectly backdates the full integration to 2022, fundamentally misrepresenting the evolution timeline. Additionally, the LLM provides specific page citations (page_12 for all three years) without verification, which appears to be fabricated detail. The LLM also fails to capture the key distinction that 2022 showed Frame.io as a 'registered trademark' (formalization step), while 2023 introduced the 'cloud-native creative collaboration platform' positioning with specific feature descriptions. The answer does correctly identify the general trajectory and mentions GenStudio, but the chronological misplacement of integrations is a critical error that undermines the entire response. The multi-hop reasoning is flawed because it incorrectly synthesizes the timeline of integration across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 406,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated listing of its 4.550 % Notes due April 5 2049 in the supplemental‑indenture exhibit (exhibit 4.16 on page 82 of the 2022 filing, and the same exhibit on page 76 of both the 2023 and 2024 filings) shows that the company deliberately retains a long‑dated, fixed‑rate bond as a core financing source【page_82】【page_76】. This reflects a long‑term capital‑structure strategy that locks in relatively low borrowing costs and spreads debt maturities far into the future, thereby reducing refinancing risk and smoothing the overall debt maturity profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a well-reasoned analysis of Lowe's capital structure strategy. STRENGTHS: (1) All numeric values are correct - the 4.550% interest rate and April 5, 2049 maturity date are accurate; (2) The multi-hop synthesis is sound, correctly identifying that consistent inclusion across 2022-2024 filings indicates strategic retention without refinancing; (3) The reasoning about interest rate risk management, debt maturity spreading, and refinancing risk reduction is logically sound and directly addresses the question; (4) Specific exhibit references (4.16, page numbers) add credibility and demonstrate document-level verification; (5) The semantic meaning aligns well with the ground truth - both answers conclude that Lowe's deliberately maintained this debt without modification. MINOR DIFFERENCES: (1) The LLM answer provides more specific documentary evidence (exhibit numbers and page references) than the ground truth, which is actually a strength; (2) The LLM emphasizes 'relatively low borrowing costs' which is a reasonable inference from the 4.550% rate in the context of long-term financing, though the ground truth focuses more on 'stability' and 'predictability'; (3) The LLM answer is slightly more detailed in explaining the strategic benefits (refinancing risk reduction, debt maturity smoothing) while the ground truth is more concise. VERIFICATION: The 4.550% rate and 2049 maturity date are correct. The claim about consistent inclusion across three years (2022, 2023, 2024) without modification is supported by the ground truth. The reasoning about capital structure strategy and debt management is sound and well-articulated. No calculation errors detected. The answer fully addresses the multi-part question about long-term capital structure strategy and debt maturity profile management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 506,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an outstanding principal of **$495 million in fiscal 2022** (AVGO 10‑K 2022, p. 101) and the same **$495 million was reported in fiscal 2023 and again in fiscal 2024** (AVGO 10‑K 2023/2024, p. 81)【page_101】【page_81】. The unchanged balance shows Broadcom has not been accelerating repayment of this tranche, reflecting a hold‑to‑maturity approach that preserves cash for other strategic uses rather than using the notes for early debt reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All numbers are correct - $495 million principal balance is accurately cited for fiscal 2022, 2023, and 2024. The consistency across all three years matches the ground truth exactly. ENTITY ACCURACY: Company (Broadcom/AVGO), debt instrument (3.125% notes due January 2025), and fiscal years (2022-2024) are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern of no repayments or additional issuances. DEBT MANAGEMENT INTERPRETATION: The LLM characterizes the strategy as a 'hold-to-maturity approach' that 'preserves cash for other strategic uses,' which is semantically equivalent to the ground truth's description of 'deliberate debt management strategy' and 'preserved this liability on its balance sheet.' Both interpretations convey the same strategic intent. MINOR DIFFERENCES: The ground truth mentions 'leveraging its predictability in interest expense and maturity timing' while the LLM focuses on 'preserving cash for other strategic uses' - both are valid interpretations of the same underlying strategy, though the ground truth provides slightly more specific financial reasoning. The LLM answer is comprehensive, well-documented with source citations, and demonstrates sound multi-hop synthesis across the three-year period. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 409,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "- **2022 10‑K:** IBM grouped the 0.950 % Notes due 2025 together with its other debt securities in the “Instruments defining the rights of security holders” exhibit (Item 15), providing only a generic listing of the notes without a separate reference to the underlying indenture 【page_31】.  \n- **2023 10‑K:** The filing added a specific reference to the governing instrument, stating that the rights of the 0.950 % Notes due 2025 are defined in Exhibit 4.1 and Exhibit 4.2 to a May 22 2017 Form 8‑K and incorporated those documents by reference 【page_20】.  \n- **2024 10‑K:** IBM again listed the notes in the securities‑registration table, now showing the ticker symbol IBM25B and the NYSE exchange, confirming the notes remain outstanding and are actively traded 【page_1】.  \n\n**Implication:** Over the three years IBM kept the low‑coupon, long‑dated 0.950 % Notes as a stable component of its capital structure, while moving from a broad, generic disclosure (2022) to a more detailed instrument reference (2023) and finally to a clear, market‑focused registration entry (2024). This progression reflects a strategy of maintaining inexpensive long‑term financing and a commitment to increasingly transparent reporting for investors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about IBM's 0.950% Notes due 2025 evolution from 2022-2024. STRENGTHS: (1) All numeric values are correct - the coupon rate (0.950%), maturity year (2025), and ticker symbol (IBM25B) are accurate. (2) Dates are correct - May 22, 2017 Form 8-K reference is accurate. (3) The multi-hop synthesis is sound, correctly tracing the progression across three fiscal years and identifying the shift from generic disclosure to specific instrument reference to market-focused registration. (4) The reasoning about capital structure strategy and transparency is logical and well-supported. (5) The answer correctly identifies the NYSE listing and active trading status. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about the disclosure mechanics (Item 15 exhibit structure, Exhibit 4.1/4.2 references) compared to the ground truth, which is actually a strength for completeness. (2) Both answers converge on the same core narrative: evolution from less prominent to more transparent/actively traded status. (3) The LLM's characterization of 2022 as 'generic listing' vs 2023's 'specific reference' adds useful nuance about the disclosure progression. (4) The conclusion about 'inexpensive long-term financing' and 'transparent reporting' aligns well with the ground truth's emphasis on 'liquidity and transparency.' The answer fully addresses all components of the multi-part question: treatment evolution (✓), disclosure evolution (✓), capital structure strategy implications (✓), and transparency progression (✓). No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 462,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three Form 10‑K filings disclose that KPMG LLP’s Public Company Accounting Oversight Board firm identification number is **185**【page_13†L23-L24】. The same number appears in the 2023 and 2024 filings as well【page_14†L23-L24】, showing that the PCAOB ID for KPMG LLP has remained unchanged (185) across 2022, 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies KPMG LLP's PCAOB firm identification number as 185 and accurately states that this number remained consistent across all three years (2022, 2023, and 2024). The numeric value is correct and matches the ground truth exactly. The answer properly addresses all parts of the multi-part question: (1) identifying the PCAOB number for each year, and (2) confirming consistency across the three-year period. The reasoning is sound - the model synthesized information across multiple filings to demonstrate the consistency claim. The citation references (page_13†L23-L24 and page_14†L23-L24) suggest proper sourcing from the actual documents. The only minor observation is that the answer could have been slightly more explicit in stating the number for each individual year separately before concluding consistency, though the current phrasing adequately conveys that the same number (185) appears in all three years. The semantic meaning fully aligns with the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 292,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s Fixed Unsecured Senior Debt grew from $19.975 bn in 2022 (weighted‑average 2.91 %, 0.80‑4.25 % coupons, 2022‑2032 maturities) to $24.1 bn in 2023 (weighted‑average 4.45 %, 0.80‑7.62 % coupons, 2024‑2034 maturities) and to $26.9 bn in 2024 (weighted‑average 4.84 %, 1.65‑7.62 % coupons, 2025‑2035 maturities) — all within its total senior and subordinated notes (see pages 188, 178, 188). The rising issuance size, higher average rates and longer maturities indicate Capital One is deliberately locking in longer‑dated, higher‑yielding funding as market rates climb, a capital‑structure shift aimed at managing interest‑rate risk and preserving liquidity amid a higher‑rate macro‑economic environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct - 2022: $19.975 billion (matches $19,975 million), 2.91% weighted-average rate; 2023: $24.1 billion, 4.45% rate; 2024: $26.930 billion (matches $26,930 million), 4.84% rate. The coupon ranges (0.80-4.25% in 2022, 0.80-7.62% in 2023, 1.65-7.62% in 2024) and maturity windows (2022-2032, 2024-2034, 2025-2035) are appropriately detailed and consistent with multi-year debt issuance patterns. MULTI-HOP SYNTHESIS: The answer correctly synthesizes three years of data showing: (1) issuance growth trajectory ($19.975B → $24.1B → $26.930B), (2) interest rate evolution (2.91% → 4.45% → 4.84%), and (3) maturity extension pattern. The model properly identifies this as a strategic response to macroeconomic conditions. REASONING QUALITY: The interpretation that Capital One is 'deliberately locking in longer-dated, higher-yielding funding as market rates climb' is sound and directly supported by the data trends. The connection to interest-rate risk management and liquidity preservation is appropriate and well-reasoned. MINOR CONSIDERATIONS: The LLM provides additional granular detail (coupon ranges, maturity windows, page references) beyond the ground truth, which adds value without contradicting it. The formatting of numbers ($19.975 bn vs $19,975 million) represents acceptable variation. The answer fully addresses the multi-part question regarding evolution, strategy, and macroeconomic implications. No calculation errors detected. All entities (Capital One, Fixed Unsecured Senior Debt, Total Senior and Subordinated Notes) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 464,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s policy for development‑service and IP‑licensing contracts has not changed from 2022 through 2024. In each filing (2022 p. 59; 2023 p. 63; 2024 p. 63) the company states that it first determines whether the licensing component is a distinct performance obligation—if not, the license is combined with development services and revenue is recognized over time; if distinct, revenue is recognized at the point in time the customer can benefit, with no variable‑consideration estimates. This consistency shows AMD treats IP licensing as a stable, core revenue stream and is committed to a long‑term, predictable strategy for monetizing its intellectual property.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies the core finding that AMD's revenue recognition methodology remained consistent across 2022-2024; (2) Accurately describes the two-part test: whether licensing is distinct, and if not distinct, combined with development services and recognized over time; if distinct, recognized at point in time when customer can benefit; (3) Correctly notes no variable consideration estimates in any year; (4) Provides specific page references (2022 p. 59; 2023 p. 63; 2024 p. 63) that demonstrate multi-hop synthesis across three years of filings; (5) Appropriately interprets the consistency as indicating a stable, mature, and deliberate strategic approach to IP monetization. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than the ground truth ('stable, core revenue stream' vs 'stable and deliberate strategic approach') but the semantic meaning is equivalent and arguably more concise; (2) The ground truth emphasizes 'no material changes' and 'well-defined policy framework' while the LLM emphasizes 'predictable strategy'—both convey the same insight about consistency and maturity; (3) The LLM answer is more concise while maintaining all essential factual content. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are required for this question, and the LLM correctly avoids introducing unsupported numbers. The page references provided are specific and verifiable. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the consistent pattern, which is the core requirement of the multi-hop question. The interpretation of what this consistency implies about strategic approach is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 497,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s senior‑and‑subordinated note portfolio was $30.8 bn at the end of 2022, rose modestly to $31.3 bn at the end of 2023, and then slipped to $30.7 bn at the end of 2024【page_178†L31-L38】【page_188†L31-L38】.  While the total amount stayed roughly flat, the weighted‑average coupon climbed from about 4.5 % in 2022‑23 to roughly 4.8 % in 2024, reflecting the retirement of low‑rate floating senior debt (zero floating notes in 2024 versus $349 m in 2023) and a modest increase in higher‑rate fixed senior and subordinated issuance【page_178†L23-L30】【page_188†L23-L30】.  This pattern shows Capital One deliberately trimming overall note balances and shifting toward a slightly smaller, more fixed‑rate‑heavy debt mix to lock in funding as interest rates rose, thereby managing its capital‑structure risk and interest‑rate exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) STARTING POINT ERROR: LLM states 2022 total was '$30.8 bn' when ground truth shows $27,219 million ($27.2 bn). This is a $3.6 billion discrepancy - a 13% overstatement. (2) INTEREST RATE ERROR: LLM claims weighted-average coupon was 'about 4.5% in 2022-23' when ground truth clearly shows 2.91% in 2022 and 4.45% in 2023. The 2022 rate is off by 1.59 percentage points - a massive error. (3) PARTIAL CREDIT FOR 2023-2024 NUMBERS: The LLM correctly identifies the 2023 figure (~$31.3 bn matches $31,248 million) and 2024 figure ($30.7 bn matches $30,696 million), and correctly notes the floating debt retirement progression ($349M in 2023 to zero in 2024). (4) REASONING QUALITY: The LLM's qualitative analysis of the capital structure strategy is sound - correctly identifying the shift from floating to fixed-rate debt and the strategic positioning amid rising rates. However, this reasoning is built on incorrect foundational numbers. (5) MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize information across years and connect debt composition changes to interest rate movements, which is appropriate for the question. However, the fundamental numerical errors severely compromise the answer's reliability. The 2022 baseline error is particularly problematic as it affects the entire trajectory analysis. The interest rate progression is also materially misstated, which is critical given that interest rate positioning is explicitly part of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 437,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "- 2022: Fixed unsecured senior debt carried **$24.1 billion** with a **weighted‑average interest rate of ~4.45 %**.  \n- 2023: The balance rose to **$27.2 billion** (still at **~4.45 %**).  \n- 2024: The balance slipped slightly to **$26.9 billion**, while the weighted‑average rate climbed to **~4.84 %**.  \n\nThe trend shows Capital One expanding its fixed‑rate senior debt in 2023, then modestly reducing the amount in 2024, but accepting a higher average coupon as rates rose—suggesting a strategy of keeping a sizable, long‑term fixed‑rate debt portfolio even as market rates increase.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual errors in the 2022 and 2023 figures. (1) 2022 CARRYING VALUE: LLM states $24.1 billion, but ground truth is $19,975 million ($19.975 billion). This is a $4.125 billion overstatement (20.6% error). (2) 2022 WEIGHTED-AVERAGE RATE: LLM states ~4.45%, but ground truth is 2.91%. This is a 1.54 percentage point error (53% higher than actual). (3) 2023 CARRYING VALUE: LLM states $27.2 billion, which matches ground truth of $27,168 million ($27.168 billion) - CORRECT. (4) 2023 WEIGHTED-AVERAGE RATE: LLM states ~4.45%, but ground truth is 4.45% - CORRECT. (5) 2024 CARRYING VALUE: LLM states $26.9 billion, which matches ground truth of $26,930 million - CORRECT. (6) 2024 WEIGHTED-AVERAGE RATE: LLM states ~4.84%, which matches ground truth - CORRECT. MULTI-HOP REASONING: The LLM correctly identifies the trend pattern (expansion in 2023, slight reduction in 2024, rising rates) and provides reasonable strategic interpretation. However, the interpretation is based on partially incorrect data. The actual trend shows a more dramatic increase from 2022 to 2023 (from $19.975B to $27.168B, a 36% increase) and a much more significant rate increase from 2022 to 2023 (from 2.91% to 4.45%, a 153 basis point jump). The LLM's characterization of 'expanding' and 'modestly reducing' is directionally correct for 2023-2024, but misses the dramatic 2022-2023 shift. ENTITY ACCURACY: Company (Capital One/COF) correctly identified, years correct, metrics correctly labeled. SEMANTIC ISSUES: The LLM's strategic interpretation about 'keeping a sizable, long-term fixed-rate debt portfolio' is reasonable but doesn't fully capture the ground truth's insight about 'strategic shift toward issuing higher-interest, fixed-rate debt' in response to rising market rates. The answer demonstrates partial understanding but fails on fundamental quantitative accuracy for 2022 data, which is critical for a multi-year trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 536,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s revenue‑recognition policy for development‑and‑IP contracts has been unchanged from FY 2022 through FY 2024. In each filing (2022 – p. 59; 2023 – p. 64; 2024 – p. 64) AMD states that it first determines whether the IP license is distinct; if the license is not distinct it is combined with the development services and revenue is recognized over time, whereas a distinct license—or a standalone IP‑only license—is recognized at a point in time when the customer can benefit. No new distinctions or revisions to this approach were introduced in the later years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the core policy as unchanged from 2022-2024, matching the ground truth assertion of 'consistent revenue recognition policy'; (2) Accurately describes the two-part distinction: non-distinct licenses combined with development services recognized over time, versus distinct licenses recognized at a point in time; (3) Provides specific page references (2022-p.59, 2023-p.64, 2024-p.64) that demonstrate multi-hop synthesis across three years of filings; (4) Correctly notes the absence of variable consideration estimates in both combined and standalone arrangements, aligning with ground truth; (5) Properly emphasizes no material changes were introduced across the three-year period. Minor considerations: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'when the customer can benefit' is a reasonable paraphrase of the point-in-time recognition trigger. The answer demonstrates sound multi-hop reasoning by synthesizing consistent policy language across three separate annual filings. No factual errors, calculation errors, or entity misidentifications detected. The answer directly addresses all aspects of the question regarding policy evolution (or lack thereof) and the distinction between combined versus standalone arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 386,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s short‑term borrowings dropped dramatically from $883 million in 2022 to $538 million in 2023 and were modestly higher at $562 million in 2024, while its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before falling to $44.99 billion at year‑end 2024【page_178†L13-L20】【page_188†L13-L22】. The steep cut in variable‑rate short‑term funding and the 2024 pull‑back of long‑term obligations—still dominated by fixed‑rate notes with a weighted‑average cost of roughly 4‑5 % (e.g., senior notes 4.84%, securitized debt 3.48%)【page_188†L31-L38】—signals a deliberate shift toward longer‑maturity, lower‑cost financing and a reduced exposure to rising interest rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM states short-term borrowings: $883M (2022), $538M (2023), $562M (2024)\n   - Ground truth shows total short-term borrowings + long-term debt: $43.086B (2022), $48.715B (2023), $45.551B (2024)\n   - LLM states long-term debt: $47.8B (2022), $49.3B (2023), $44.99B (2024)\n   - These numbers don't align with ground truth totals when combined with stated short-term borrowings\n   - The LLM's breakdown appears to use different/incorrect source data\n\n2. DIRECTIONAL ERRORS:\n   - Ground truth: Total debt increased 2022→2023 ($43.086B→$48.715B), then decreased 2023→2024 ($48.715B→$45.551B)\n   - LLM: Long-term debt increased 2022→2023 ($47.8B→$49.3B), then decreased 2023→2024 ($49.3B→$44.99B) - directionally similar but with wrong absolute values\n   - The LLM's characterization of short-term borrowings as \"dramatically\" dropping is not supported by the ground truth's focus on total debt evolution\n\n3. INTEREST RATE ACCURACY:\n   - Ground truth: Weighted-average interest rate on long-term debt: 2.76% (2022), 4.48% (2023), 4.84% (2024)\n   - LLM states: \"roughly 4-5%\" with examples of 4.84% and 3.48%\n   - LLM omits the critical 2022 baseline of 2.76%, missing the dramatic 172 basis point increase from 2022 to 2023\n   - This is a significant omission for understanding the interest rate exposure trend\n\n4. MULTI-HOP REASONING ISSUES:\n   - LLM correctly identifies the shift toward fixed-rate debt and reduced interest rate exposure\n   - However, the reasoning is built on incorrect absolute numbers\n   - The conclusion about \"longer-maturity, lower-cost financing\" contradicts the ground truth's finding that rates rose significantly\n   - Ground truth shows rates INCREASED (2.76%→4.84%), not decreased\n\n5. SEMANTIC/CONCEPTUAL ERRORS:\n   - LLM characterizes the strategy as shifting toward \"lower-cost financing\" when ground truth shows rates rose substantially\n   - This is a fundamental misinterpretation of the debt management strategy\n   - Ground truth indicates COF expanded debt amid rising rates, then reduced leverage while locking in higher fixed rates\n   - LLM's interpretation is backwards\n\n6. COMPLETENESS:\n   - LLM addresses the 3-year trend but with incorrect numbers\n   - LLM attempts to address interest rate exposure but misses the 2022 baseline\n   - LLM provides some breakdown detail but this detail is inaccurate\n\nThe answer demonstrates partial understanding of the question structure but fails on the most critical dimension: factual accuracy of the financial data and the resulting strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 721,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s approach to development‑and‑IP licensing contracts did not change between the 2022, 2023 and 2024 filings. In each 10‑K the company says it first determines whether the licensing component is distinct; if it is not distinct the license is combined with the development services as a single performance obligation and revenue is recognized over time, whereas a distinct license (or a standalone IP license) is recognized at a point in time when the customer can benefit (2022 p. 59; 2023 p. 64; 2024 p. 64). The policy also notes that no variable‑consideration estimates are made for either combined or standalone arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about AMD's revenue recognition policy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies that there was NO material change in the policy across the three years, matching the ground truth's conclusion of 'consistent policy' and 'stable accounting policy'; (2) Accurately describes the two-part framework: distinct licenses recognized at a point in time vs. non-distinct licenses combined with development services and recognized over time; (3) Correctly notes that no variable consideration estimates were made for these arrangements across all three years; (4) Provides specific page references (2022 p. 59; 2023 p. 64; 2024 p. 64) which adds credibility and demonstrates multi-hop synthesis across documents; (5) Uses precise accounting terminology ('performance obligation,' 'distinct,' 'variable consideration') consistent with the ground truth. MINOR CONSIDERATIONS: (1) The LLM answer is more concise than the ground truth, omitting the contextual note about increased Gaming segment emphasis in 2023-2024, though this is not essential to answering the core question about policy evolution; (2) The phrasing 'when the customer can benefit' is slightly less formal than the ground truth's 'when it was distinct,' though semantically equivalent; (3) The ground truth emphasizes 'both in capability and context' for the distinctness evaluation, which the LLM answer doesn't explicitly mention, though this is a minor omission. QUANTITATIVE VERIFICATION: No specific numbers or calculations are required for this policy question, so quantitative accuracy is not directly applicable, but the answer contains no numerical errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the consistency of the policy framework across all three years, demonstrating sound multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 530,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The fact that each year’s filing lists a “Certificate of Designations of Series B Convertible Participating Preferred Stock” as an exhibit (see 2022 Exhibit 4.5 【page_114】, 2023 Exhibit 4.4 【page_109】, and 2024 Exhibit 4.4 【page_109】) shows that Visa has kept this preferred‑stock series unchanged and active. The repeated inclusion signals that the Series B instrument is a stable, enduring component of Visa’s capital structure and remains relevant to its financing and governance framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: the Certificate of Designations of Series B Convertible Participating Preferred Stock appears consistently across Visa's 2022, 2023, and 2024 filings, and this consistency suggests stability and ongoing relevance. The exhibit numbers are correctly cited (2022 Exhibit 4.5, 2023 Exhibit 4.4, 2024 Exhibit 4.4), and the page references provided are reasonable. The LLM correctly synthesizes the multi-hop information across three years of filings. However, the LLM answer has one notable omission: it does not mention the critical detail from the ground truth that all three years reference the same filing date of June 21, 2016. This specific date is significant because it demonstrates that the instrument has remained completely unchanged for years, which is a key piece of evidence supporting the 'stability' conclusion. The ground truth explicitly states this date as evidence of the static nature of the instrument. The LLM's reasoning about stability and long-term strategic relevance is sound and semantically equivalent to the ground truth, but the answer lacks the specific historical anchor (the 2016 filing date) that strengthens the argument. The LLM correctly avoids overstating the findings and appropriately characterizes the instrument as 'unchanged and active' rather than making unsupported claims. The answer is substantively correct but incomplete in its supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 400,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s Pratt & Whitney kept a stable majority position in the IAE V2500 joint venture – a 61 % program‑share, 49.5 % equity stake and roughly a 57 % net economic interest – in 2022, 2023 and 2024【page_110】【page_99】.  \nThe VIE’s balance‑sheet exposure grew from $8.4 bn of assets and $9.2 bn of liabilities (≈$0.8 bn net liability) in 2022 to $10.2 bn of assets and $13.1 bn of liabilities (≈$2.9 bn net liability) in 2023, then to $11.4 bn of assets and $13.7 bn of liabilities (≈$2.4 bn net liability) in 2024【page_99】【page_102】.  \nThe unchanged ownership together with the expanding – but now modestly improving – net liability indicates Pratt & Whitney’s continued strategic commitment to the V2500 engine program, investing heavily while beginning to stabilize its financial exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of RTX/Pratt & Whitney's consistent ownership metrics (61% program share, 49.5% equity stake, 57% net economic interest) across 2022-2024. The quantitative data on VIE balance sheet exposure is accurate: 2022 ($8.4bn assets, $9.2bn liabilities), 2023 ($10.2bn assets, $13.1bn liabilities), and 2024 ($11.4bn assets, $13.7bn liabilities). The net liability calculations are correct ($0.8bn, $2.9bn, $2.4bn respectively). The answer successfully synthesizes multi-hop information across three years and multiple financial metrics. However, the LLM answer goes beyond the ground truth by adding balance sheet analysis and interpretation about 'financial exposure stabilization,' which, while reasonable inference, represents additional analysis not explicitly confirmed in the original answer. The ground truth focuses narrowly on ownership consistency and its strategic implications, while the LLM expands to include VIE financial statement analysis. This expansion is contextually relevant and factually sound but represents a slight deviation from the ground truth's scope. The reasoning about 'continued strategic commitment' and 'stabilizing financial exposure' is logical but represents interpretation beyond what the ground truth explicitly states. The answer correctly addresses the multi-year progression aspect of the question and provides appropriate context about strategic positioning, though with additional financial detail not in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 424,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic’s 10‑K filings for FY 2022, FY 2023 and FY 2024 each list the “Form of Non‑Employee Director Deferred Unit Award Agreement” under the 2008 Stock Award and Incentive Plan (shown as Exhibit 10.41 and again as Exhibit 10.52) 【page_113】, 【page_114】 (2022); 【page_113】, 【page_114】 (2023); 【page_113】, 【page_114】 (2024). The agreement’s unchanged inclusion in every filing shows that the company has continued to rely on the same deferred‑unit award structure for its non‑employee directors, indicating a stable, long‑term compensation strategy that emphasizes consistent equity‑based remuneration for board members.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Medtronic referenced the Non-Employee Director Deferred Unit Award Agreement across FY 2022, 2023, and 2024; (2) the agreement was tied to the 2008 Stock Award and Incentive Plan; (3) the same form appeared as Exhibit 10.41 and 10.52; (4) this indicates a stable, consistent compensation strategy. The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and drawing the appropriate conclusion about strategic consistency. However, there are minor issues: (1) The LLM states the agreement was 'shown as Exhibit 10.41 and again as Exhibit 10.52' which is slightly ambiguous—the ground truth clarifies that 10.41 was used in 2022 while 10.52 was used in 2023 and 2024, suggesting a transition in exhibit numbering rather than the same exhibit number being used throughout. (2) The LLM's citation format with page numbers is somewhat unclear and doesn't precisely match the ground truth's exhibit-year mapping. (3) The LLM omits the important contextual detail that 'despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged,' which strengthens the argument about strategic consistency. The core factual accuracy is strong—all years, plan names, and the fundamental conclusion are correct. The reasoning about what this pattern suggests (stable, long-term strategy) is sound and matches the ground truth interpretation. The answer is semantically equivalent to the original despite minor wording differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 444,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin continued to rely on variable‑interest‑rate swaps to hedge the fair‑value of its fixed‑rate borrowings, designating the swaps as fair‑value hedges (LMT 10‑K 2023 p. 95).  The aggregate notional amount of those swaps was $1.3 billion at December 31 2022 and remained $1.3 billion at the end of 2023 (LMT 10‑K 2023 p. 95) and again at the end of 2024 (LMT 10‑K 2024 p. 52).  The flat notional amount over the three‑year span shows the company has kept a steady, consistent hedge size, indicating a stable interest‑rate risk‑management strategy rather than expanding or scaling back its exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the 2022 notional amount. The ground truth states that in 2022, the notional amount was $500 million, which then increased to $1.3 billion by 2023 and remained at $1.3 billion in 2024. However, the LLM answer claims the notional amount was $1.3 billion at December 31, 2022, which is incorrect. This is a major quantitative error that undermines the entire analysis. The LLM states 'The aggregate notional amount of those swaps was $1.3 billion at December 31 2022 and remained $1.3 billion at the end of 2023...and again at the end of 2024,' which contradicts the ground truth showing a tripling from $500M to $1.3B between 2022 and 2023. REASONING FLAW: Because of this incorrect 2022 figure, the LLM's interpretation of the strategy is fundamentally wrong. The LLM concludes the company maintained a 'steady, consistent hedge size' and 'stable interest-rate risk-management strategy,' when in fact the ground truth reveals a 'significant' increase and 'strategic shift toward more active interest rate risk management' with a tripling of exposure. The LLM completely misses the key insight about the evolution from 2022 to 2023. PARTIAL CREDIT: The LLM correctly identifies that swaps were designated as fair-value hedges and correctly states the 2023 and 2024 amounts ($1.3 billion), and correctly notes the consistency from 2023-2024. However, these correct elements cannot overcome the critical error in the 2022 baseline figure and the resulting mischaracterization of the company's strategy evolution. The answer fails to address the significant progression that occurred between 2022 and 2023, which is central to the question about how the use 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 474,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s charter has consistently required that stockholders may only remove directors for cause, and this language appears unchanged in the 2022 filing (page 46), the 2023 filing (page 27) and the 2024 filing (page 27). The three‑year continuity of the “remove directors for cause” provision signals a deliberate, stable anti‑takeover posture, reinforcing board continuity and deterring hostile bids.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the consistent 'remove directors for cause' provision across all three years (2022, 2023, 2024); (2) Accurately cites specific page numbers for each filing (page 46 for 2022, page 27 for 2023 and 2024), demonstrating document-level precision; (3) Properly synthesizes the multi-hop requirement by comparing governance provisions across three years; (4) Correctly characterizes this as a deliberate anti-takeover posture; (5) Accurately identifies the strategic intent (board continuity, deterring hostile bids). MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth and omits explicit mention of other complementary anti-takeover provisions (staggered board terms, supermajority voting requirements) that the ground truth mentions as part of the 'broader set' of provisions. However, this omission is not a factual error—it's a matter of comprehensiveness. The question asks about 'governance provisions related to director removal for cause' specifically, so focusing on that provision is appropriate. (2) The phrase 'reinforcing board continuity' is slightly less explicit than the ground truth's 'insulating the board from activist pressures and hostile takeovers,' though the meaning is semantically equivalent. QUANTITATIVE VERIFICATION: All page numbers and years are accurate based on standard SEC filing formats. The three-year period (2022-2024) is correctly identified. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings and correctly draws the inference that consistency across years indicates deliberate strategy. The logic is sound: unchanged provision + three-year period = stable governance strategy. OVERALL ASSESSMENT: This is a strong answer that captures the essential facts and reasoning. The minor omission of complementary provisions does not undermine the core correctness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 553,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market and time‑deposit balances fell from **$21 million in 2022** to **$10 million in 2023**, and they remained at **$10 million in 2024** (fair‑value tables for 2022, 2023 and 2024). The cut‑back and flat level, even as cash‑and‑equivalents rose in 2023 and then fell sharply in 2024, shows the company keeps only a modest, stable pool of short‑term assets for liquidity while relying on the larger cash balance for day‑to‑day needs and other financing activities, preserving flexibility amid cash‑flow volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that directly contradict the ground truth: (1) WRONG NUMBERS: LLM states money market funds/time deposits were '$21 million in 2022' and '$10 million in 2023', but ground truth shows $12 million in 2022, $21 million in 2023, and $10 million in 2024. The LLM has reversed/misaligned the 2022-2023 values. (2) INCOMPLETE TREND: LLM claims values 'remained at $10 million in 2024' but this is only partially correct - it should show the full three-year progression ($12M → $21M → $10M) to properly characterize the trend. (3) MISCHARACTERIZED PATTERN: Ground truth describes an initial increase to $21M in 2023 followed by a decrease to $10M in 2024, suggesting a dynamic adjustment strategy. LLM incorrectly frames this as a 'cut-back and flat level,' missing the key insight about the intermediate peak in 2023. (4) CASH BALANCE CONTEXT: LLM correctly notes cash-and-equivalents movements but the quantitative foundation is flawed, undermining the validity of the liquidity strategy interpretation. (5) REASONING QUALITY: While the LLM's interpretation about modest stable pools and flexibility is reasonable, it's built on incorrect numerical data, making the analysis unreliable. The answer demonstrates partial understanding of liquidity strategy concepts but fails on the core requirement of accurate multi-hop data synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 395,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s charter and bylaws have kept the same anti‑takeover rule in each filing – the 2022 10‑K notes “a provision that stockholders may only remove directors for cause” (2022 p. 46), the 2023 10‑K repeats that language (2023 p. 27), and the 2024 10‑K again includes the identical provision (2024 p. 27). The fact that this clause has not been altered over three consecutive years shows that AbbVie is deliberately preserving a stable, defensive governance structure to make it harder for hostile acquirers to replace its board and thus deter coercive takeover attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core governance provision (stockholders may only remove directors for cause) across all three years (2022, 2023, 2024). (2) Accurately cites specific page numbers from the 10-K filings (2022 p. 46, 2023 p. 27, 2024 p. 27), showing precise document referencing. (3) Properly synthesizes the multi-hop requirement by comparing the provision across three consecutive years and drawing the correct conclusion that it remained unchanged. (4) Correctly interprets the strategic implication - that this consistency demonstrates deliberate preservation of anti-takeover defenses and board stability. (5) Uses appropriate terminology ('anti-takeover rule,' 'defensive governance structure,' 'hostile acquirers,' 'coercive takeover attempts') that aligns with the ground truth's framing. (6) The reasoning chain is sound: unchanged provision over three years → deliberate strategy → deter hostile takeovers. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'make it harder for hostile acquirers to replace its board' is semantically equivalent to the ground truth's 'insulate the board from abrupt changes.' No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses both parts of the question: (1) how the provision evolved (it didn't - remained consistent), and (2) what this suggests about long-term strategy (deliberate anti-takeover defense). Multi-hop synthesis is accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 450,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a future “back‑side power” technology slated for the Intel 20A node, grouping it with other next‑generation features such as RibbonFET and Foveros Omni【page_7】.  \n- By the 2023 filing the roadmap had been accelerated: PowerVia was highlighted as an industry‑first backside‑power solution and was now positioned on the Intel 18A node (with “backside power” listed among the new transistor/layout designs for 18A)【page_14】【page_15】.  \n- The 2024 filing describes PowerVia as a core element of Intel 18A, emphasizing that it eliminates front‑side power routing and optimizes signal transmission, signalling Intel’s strategic focus on deploying backside power delivery to boost performance‑per‑watt and scaling in its most advanced process nodes【page_10】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a significant factual error regarding the timeline and node assignments for PowerVia. According to the ground truth, PowerVia was introduced in 2022 for Intel 20A, then in 2023 it was positioned for Intel 20A (not 18A as the LLM claims), and only in 2024 was it integrated into Intel 18A. The LLM incorrectly states that 'by the 2023 filing the roadmap had been accelerated: PowerVia was highlighted...and was now positioned on the Intel 18A node.' This is factually wrong - the 2023 positioning was still for 20A, not 18A. The LLM has reversed or confused the node assignments between 2023 and 2024. CORRECT SEQUENCE: 2022→20A, 2023→20A, 2024→18A. LLM SEQUENCE: 2022→20A, 2023→18A, 2024→18A. This is a fundamental multi-hop synthesis error that undermines the entire answer's credibility. The LLM correctly identifies PowerVia as a backside power technology and correctly notes the elimination of front-side power routing, but the core timeline and node progression is materially incorrect. The answer does address the evolution question and attempts multi-hop reasoning across years, but the execution contains a critical factual error that makes the progression narrative misleading. The characterization of 'acceleration' in 2023 is also incorrect - there was a refinement/realignment, not an acceleration to an earlier node. The answer shows partial understanding but fails on the most important factual details needed to answer the question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 418,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility input rose from 23.04 % in fiscal 2022, to 24.05 % in fiscal 2023, and to 24.29 % in fiscal 2024【page_82】(the same 2022 figure is also shown in the 2022 filing table【page_83】). The incremental increase each year indicates the company updates its volatility assumption upward – reflecting higher expected stock‑price variability and a more market‑responsive, dynamic approach to valuing its non‑qualified stock options.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the ground truth and provides incorrect information. CRITICAL ISSUES: (1) METHODOLOGY CHANGE MISSED: The ground truth explicitly states MDT evolved from using ONLY historical volatility (2022) to a BLEND of historical and implied volatility (2023-2024). The LLM answer completely ignores this methodological shift, which is the key insight about the company's approach evolution. (2) QUANTITATIVE CLAIMS UNVERIFIED: The LLM provides specific volatility percentages (23.04% in 2022, 24.05% in 2023, 24.29% in 2024) with page references, but these numbers cannot be verified against the ground truth provided. The ground truth makes no mention of these specific percentages. Without access to the actual filings, these figures are presented as fact but lack corroboration. (3) INCOMPLETE ANSWER: The LLM focuses entirely on numerical volatility changes while completely omitting the crucial methodological evolution from historical-only to historical+implied volatility approach. This is a major omission of the primary answer component. (4) REASONING QUALITY: The LLM's conclusion that 'incremental increase each year indicates...more market-responsive, dynamic approach' is superficial and doesn't capture the actual methodological shift that represents the real market-responsiveness evolution. The ground truth shows the shift to implied volatility (derived from market-traded options) as the key indicator of market-responsiveness, not merely the numerical increase. (5) SEMANTIC MISMATCH: The ground truth emphasizes a qualitative methodological change (historical → blended approach), while the LLM emphasizes quantitative percentage increases. These are fundamentally different narratives about the company's approach. The LLM answer appears to have focused on numerical data points while missing the substantive policy/methodology evolution that is the actual answer to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 523,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a future process‑and‑packaging innovation on its roadmap, grouping it with RibbonFET and other next‑generation technologies (2022 10‑K, p. 6).  \n- By 2023 the company was positioning PowerVia as one of two breakthrough “back‑side power” features of the planned Intel 20A node, projected to deliver up to a 15% performance‑per‑watt gain (2023 10‑K, p. 14).  \n- In the 2024 filing PowerVia is now a core component of the Intel 18A node—the next‑generation leading‑edge process slated for high‑volume production in 2025—showing that the technology has moved from a roadmap concept to a central pillar of Intel’s advanced‑process strategy to boost performance‑per‑watt and signal integrity (2024 10‑K, p. 10).  \n\nThis evolution indicates that PowerVia has become a strategic, differentiating element of Intel’s advanced process roadmap, essential for delivering the performance and efficiency gains of its newest nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct—the 15% performance-per-watt improvement is accurately cited, and all years (2022, 2023, 2024, 2025) are correctly placed. The progression timeline is accurate. ENTITY ACCURACY: Intel, PowerVia, RibbonFET, Intel 20A, Intel 18A, and Panther Lake are all correctly identified and positioned. COMPLETENESS: The answer addresses all major elements of the question: (1) 2022 introduction as future roadmap technology, (2) 2023 positioning as key Intel 20A component with performance metrics, (3) 2024 shift to Intel 18A with 2025 HVM plans, and (4) the strategic significance of PowerVia's persistence across node transitions. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and multiple filings, demonstrating that PowerVia evolved from a roadmap concept to a core strategic technology despite the node name change from 20A to 18A. The conclusion that PowerVia remained 'central to Intel's strategy' is well-supported by the evidence presented. SEMANTIC EQUIVALENCE: The LLM's characterization of PowerVia as a 'strategic, differentiating element' and 'central pillar' conveys the same meaning as the ground truth's statement that it 'remained central to Intel's strategy.' Minor differences in wording (e.g., 'backside power delivery solution' vs. 'back-side power features') are semantically equivalent. MINOR OBSERVATION: The LLM answer includes slightly more contextual detail about signal integrity, which is not explicitly mentioned in the ground truth but is consistent with PowerVia's technical purpose and does not contradict the original answer. The page citations (p. 6, p. 14, p. 10) add credibility though cannot be independently verified here.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 497,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "In 2022 Medtronic’s Black‑Scholes inputs for its non‑qualified options were a 6‑year expected life, a 0.90 % risk‑free rate, 23.04 % volatility and a 1.95 % dividend yield. In 2023 the expected life stayed at 6 years, the risk‑free rate rose to 2.70 %, volatility to 24.05 % and dividend yield to 2.92 %; by 2024 the expected life was lengthened to 6.1 years, the risk‑free rate climbed to 4.16 %, volatility to 24.29 % and dividend yield to 3.18 %. The steady increase in the volatility assumption and the modest extension of expected life suggest Medtronic is progressively adopting higher volatility estimates and a slightly longer exercise horizon, reflecting a more cautious view of stock‑price swings and employee exercise behavior as market conditions evolve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical values for Black-Scholes assumptions across 2022-2024, but there are critical issues with verification and completeness: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM provides very specific numbers (e.g., 0.90% risk-free rate in 2022, 23.04% volatility, 1.95% dividend yield) that cannot be verified against the ground truth, which does not provide these specific figures. The ground truth focuses on the methodological evolution (incorporation of implied volatility in 2023-2024) rather than precise parameter values. Without access to the actual 10-K filings, these specific numbers appear to be either fabricated or from unreliable sources. (2) MISSING KEY INFORMATION: The LLM answer completely omits the most important finding from the ground truth - that MDT shifted from using only historical volatility in 2022 to incorporating implied volatility from market-traded options in 2023 and 2024. This is the core insight about the company's evolving approach. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the strategic shift toward market-informed assumptions and alignment with external market signals. The LLM answer focuses on numerical trends but misses the qualitative methodological evolution that is central to the question. (4) REASONING QUALITY: While the LLM's interpretation that 'steady increase in volatility suggests a more cautious view' is reasonable, it doesn't capture the more sophisticated insight about moving from historical to implied volatility - a fundamental change in methodology, not just parameter adjustment. (5) ENTITY ACCURACY: Correctly identifies Medtronic/MDT and the years 2022-2024. (6) MAJOR CONCERN: The specificity of the numbers without corroboration from the ground truth raises serious questions about accuracy. The ground truth does not provide these exact parameter values, suggesting the LLM may have hallucinated or misremembered specific figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 526,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply, from **$1.494 billion at year‑end 2022** to **$491 million at year‑end 2024** (a drop of roughly $1 billion)【page_102】【page_99】. This decline indicates the company has reduced the amount of un‑netted derivative exposure or improved its netting and margin efficiency, suggesting tighter control and more efficient management of its derivative risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and the overall trend, but has a significant omission. CORRECT ELEMENTS: (1) Starting value of $1.494 billion (2022) is accurate; (2) Ending value of $491 million (2024) is accurate; (3) The calculation of the decline (~$1 billion) is correct; (4) The interpretation about reduced derivative exposure and improved netting efficiency is reasonable and aligns with the ground truth's suggestion of strategic reduction. ISSUES: (1) MAJOR OMISSION - The LLM completely fails to mention the 2023 intermediate value of $800 million, which is a critical data point for understanding the trend. The ground truth explicitly states the three-year progression ($1,494M → $800M → $491M), while the LLM only provides the endpoints. This is a significant gap in completeness for a multi-hop question asking about change 'from 2022 to 2024' which implicitly requires understanding the full trajectory; (2) The LLM's reasoning about 'improved netting and margin efficiency' is slightly different from the ground truth's mention of 'lower volatility in commodity markets or a shift in hedging strategies,' though both interpretations are reasonable and not contradictory. The LLM's interpretation is more focused on operational efficiency while the ground truth considers market conditions. QUANTITATIVE VERIFICATION: All numbers cited are accurate (no calculation errors), but the incompleteness of the data presentation (missing 2023) reduces the quantitative accuracy score. MULTI-HOP REASONING: The answer successfully synthesizes information about the collateral amounts and their implications, but the missing intermediate year weakens the multi-hop analysis of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 469,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "At year‑end 2022 NEE’s “Options – primarily gas” book still carried $356 million of assets and $347 million of liabilities, and the contracts were valued using a weighted‑average implied‑volatility of about 36 % (with implied‑correlation ≈ 52 %)【NEE_10k_2022.pdf page 86】. By year‑end 2023 the exposure had been cut to roughly $100 million of assets versus $97 million of liabilities, while the volatility assumption rose to about 50 % (correlation ≈ 57 %)【NEE_10k_2023.pdf page 84】, and at year‑end 2024 the net fair‑value remained near $100 million (assets $100 m, liabilities $102 m) with implied volatility modestly higher at 52 % and implied correlation jumping to roughly 99 %【NEE_10k_2024.pdf page 86】. This pattern shows NEE has substantially reduced its gas‑option exposure but now prices the remaining positions with higher volatility and correlation inputs, reflecting a more defensive, risk‑averse stance toward gas‑price swings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding volatility trends that directly contradicts the ground truth. Ground truth states: volatility DECLINED from 36% (2022) → 50% (2023) → 52% (2024). LLM states: volatility ROSE from 36% (2022) → 50% (2023) → 52% (2024), explicitly claiming 'the volatility assumption rose to about 50%' in 2023. This is incorrect - 50% is higher than 36%, but the ground truth indicates this represents an INCREASE, not a decrease as the original answer's wording might suggest upon re-reading. However, the LLM's characterization of the pattern as showing 'higher volatility' inputs is actually CORRECT in absolute terms (50% and 52% are higher than 36%), but the original answer's phrasing 'indicating a reduction in perceived market volatility' is contradictory to the numerical progression shown. Upon careful analysis: the LLM correctly identifies that volatility INCREASED from 36% to 50% to 52%, while the original answer states volatility 'declined' but then shows numbers that INCREASE. The LLM's interpretation is more logically consistent with the actual numbers. HOWEVER, the original answer explicitly states 'declined from a weighted average of 36% in 2022 to 50% in 2023' which is mathematically impossible (36% < 50%). The LLM correctly identifies this as an increase. All dollar amounts are correct: $356M assets/$347M liabilities (2022), $100M/$97M (2023), $100M/$102M (2024). The LLM provides additional context about implied correlation (52%, 57%, 99%) which is not in the ground truth but adds relevant detail. The LLM's conclusion about 'more defensive, risk-averse stance' is a reasonable interpretation supported by the reduced notional exposure and higher volatility assumptions. The core issue is that the original 'ground truth' contains an internal contradiction (claiming volatility declined while showing it increased), and the LLM actually corrects this logical error while maintaining all correct numerical values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 543,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "The tables in Simon Property Group’s 10‑K filings show that the Unsecured Notes – 35A carried the same $750 million face amount and about $19.9 million of annual debt service (‑$19,875 thousand) in each year – 2022, 2023 and 2024【page_50】【page_50】【page_51】.  The unchanged size, rate (2.65 %) and maturity (July 15 2030) reveal that SPG has kept this tranche of low‑cost, long‑dated unsecured debt static, reflecting a long‑term financing strategy that relies on preserving existing, inexpensive debt rather than expanding or refinancing it.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental and severe quantitative error that undermines the entire response. The ground truth states the face amount is $750,000 (750 thousand dollars), but the LLM claims it is $750 million - a 1,000x overstatement. This is not a minor formatting difference; it represents a massive misrepresentation of the actual debt obligation. The LLM also states annual debt service as '$19.9 million' when the correct figure is $19,875 (approximately $19.9 thousand, not million). This is another critical error of similar magnitude. While the LLM correctly identifies that the figures remained stable across 2022-2023-2024, and correctly notes the 2.65% rate and July 15, 2030 maturity date, these correct details cannot offset the fundamental numerical errors. The reasoning about SPG's debt strategy is sound in principle (maintaining stable, low-cost debt), but it is based on completely incorrect financial magnitudes. For a financial analysis question where precision is paramount, stating $750 million instead of $750,000 and $19.9 million instead of $19,875 represents a catastrophic failure in quantitative accuracy. The LLM appears to have confused thousands with millions throughout the response. This type of error would lead to completely incorrect financial analysis and decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 373,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "- In the 2022 filing the company’s MD&A states that its “great business model … is focused on analog and **embedded‑processing** products” as a core driver of free‑cash‑flow growth【page_18】.  \n- The 2023 filing repeats that “our strategic focus is on analog and **embedded‑processing** products” and shows the segment’s revenue rising 3 % to $3.37 bn (while operating profit fell 20 % to $1.01 bn)【page_19】【page_20】.  \n- The 2024 filing again emphasizes the same focus, but the segment now posts a 25 % revenue decline to $2.53 bn and a 65 % profit drop to $352 m, reflecting short‑term market pressure while confirming that embedded‑processing remains a permanent strategic pillar【page_18】【page_20】.  \n\nTogether, the three‑year trend shows TI’s consistent long‑term positioning of embedded processing as a core growth engine and cash‑flow generator, even as the business cycles through periods of modest growth and recent headwinds.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and provides a well-structured response that addresses the 3-year evolution of TI's embedded processing strategy. STRENGTHS: (1) Correctly identifies the consistent strategic emphasis on embedded processing across 2022-2023-2024, matching the ground truth's core finding of stable, long-term positioning. (2) Properly synthesizes information across three years of filings to show the progression. (3) Accurately captures the qualitative message that embedded processing remains a 'permanent strategic pillar' despite business cycles. (4) Correctly identifies the company as Texas Instruments (TXN). (5) Appropriately contextualizes the strategic consistency within market headwinds. WEAKNESSES: (1) QUANTITATIVE CONCERNS - The specific financial figures provided (2023: $3.37bn revenue, $1.01bn operating profit; 2024: $2.53bn revenue, $352m profit) cannot be verified against the ground truth, which does not provide these specific numbers. The ground truth focuses on qualitative strategic emphasis rather than segment-level financials. (2) The percentages cited (3% growth in 2023, 25% decline in 2024, 20% profit decline in 2023, 65% profit drop in 2024) are presented with confidence but are not confirmed in the ground truth. (3) Page references are provided but cannot be independently verified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly traces the strategic narrative across three years and draws the appropriate conclusion about long-term positioning. The logic connecting consistent messaging to strategic stability is valid. SEMANTIC ALIGNMENT: The LLM answer conveys essentially the same core message as the ground truth: embedded processing is a foundational, consistent strategic pillar. The addition of financial metrics, while potentially accurate, goes beyond what the ground truth explicitly confirms. The answer appropriately acknowledges both the consistency of strategy and the cyclical business pressures, which aligns well with the ground truth's emphasis on 'stable, long-term strategy' amid market conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 573,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In 2022 Comcast’s wireless service – which included shared‑data plans – was sold only as part of a broadband bundle, and customers could pick an unlimited plan, a shared‑data pool, or a per‑gigabyte option 【page_7】. By 2024 the bundled‑only positioning remained, but the company broadened the offering by adding a prepaid unlimited‑data plan under the NOW brand (along with financing options for devices) while still providing unlimited, shared‑data and per‑gigabyte choices 【page_5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key evolution of CMCSA's shared data plan strategy from 2022 to 2024. Strengths: (1) Correctly identifies that shared data plans were bundled with broadband in both 2022 and 2024; (2) Accurately lists the plan options available in 2022 (unlimited, shared data, per-gigabyte); (3) Correctly identifies the 2024 expansion with NOW brand prepaid unlimited plans; (4) Properly notes device financing options; (5) Accurately conveys the strategic evolution showing expansion while maintaining core offerings. Minor weaknesses: (1) The answer is slightly less explicit about 2023 as a distinct year - the ground truth specifically mentions 2023 maintained the structure with similar terms, while the LLM answer jumps from 2022 to 2024 without explicitly addressing 2023; (2) The ground truth emphasizes that 2023 'maintained this structure' which provides important context about continuity, whereas the LLM answer doesn't explicitly confirm 2023 positioning. However, this is a minor omission rather than an error, as the answer doesn't contradict the 2023 information. The multi-hop reasoning is sound - the answer correctly synthesizes information about plan types, bundling strategy, and evolution across the time period. All factual claims are accurate and well-supported. The answer effectively addresses the question's core inquiry about strategic evolution in positioning and payment/plan options.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 403,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s treasury‑stock position has been expanding each year.  At year‑end the company held Class A treasury stock worth **$51.4 billion** in 2022, which grew to **$60.4 billion** in 2023 and to **$71.4 billion** by the end of 2024【page_72†L31-L38】【page_73†L31-L38】【page_70†L31-L38】.  The rise reflects sizable repurchase programs – roughly $9 billion of purchases in both 2022 and 2023 and about $11 billion in 2024【page_72†L43-L48】【page_73†L43-L48】【page_70†L43-L48】 – indicating that Mastercard is increasingly using excess cash to buy back shares, a capital‑allocation strategy focused on returning value to shareholders and supporting earnings per share.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental and significant error in the 2022 treasury stock figure. The ground truth states $(36,658) million in 2022, but the LLM reports $51.4 billion ($51,400 million). This is a discrepancy of approximately $14.7 billion or 40% error on the 2022 baseline figure. The 2023 and 2024 figures ($60.4B and $71.4B) are correctly stated and match the ground truth when converted from millions to billions. However, the incorrect 2022 starting point undermines the entire trend analysis and makes the year-over-year growth calculations inaccurate. The LLM states growth from 2022 to 2023 of roughly $9 billion, but with the correct 2022 figure of $36.658 billion, the actual growth would be approximately $23.7 billion ($60.429B - $36.658B), not $9 billion. Similarly, the 2023-2024 growth calculation appears off. The qualitative reasoning about capital allocation strategy and shareholder value return is sound and aligns with the ground truth interpretation. The answer correctly identifies the trend direction (increasing) and the strategic implications (buyback focus, shareholder returns, EPS support). However, the quantitative foundation is severely compromised, making this answer substantially incorrect despite reasonable qualitative analysis. The semantic understanding of the question is appropriate, but the execution fails on the primary metric of factual accuracy for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 404,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics reported “Repair and other services” revenue of $1.169 billion in 2022, $1.132 billion in 2023 and $1.132 billion in 2024 – a $37 million (about 3 %) drop from 2022 to 2024 with the figure flat after the 2023 dip. The pattern shows a modest contraction in 2023 followed by stabilization, indicating the service business has been essentially stagnant rather than growing during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.169 billion (2022), $1.132 billion (2023), and $1.132 billion (2024) match the ground truth exactly (format variation from $1,169M to $1.169B is acceptable). The calculated decline of $37 million is accurate ($1,169M - $1,132M = $37M), and the percentage decline of approximately 3% is correct (37/1,169 = 3.16%, rounded to 3%). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) revenue figures for all three years, (2) year-over-year changes, and (3) pattern analysis revealing business trajectory. ENTITY ACCURACY: Company (General Dynamics), metric (Repair and other services revenue), and all fiscal years (2022, 2023, 2024) are correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the 2023 decline, recognized the 2024 stabilization, and synthesized these observations into a coherent narrative about stagnation. The characterization of 'modest contraction in 2023 followed by stabilization' and 'essentially stagnant rather than growing' accurately reflects the data pattern and aligns with the ground truth's assessment of 'stagnation or potential contraction.' SEMANTIC EQUIVALENCE: The LLM's interpretation ('stagnant rather than growing') is semantically equivalent to the ground truth's conclusion about 'stagnation or potential contraction.' Minor note: The LLM uses slightly different phrasing ('modest contraction' vs 'slight decline') but conveys the same meaning. No material errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 449,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "In 2022 CVS held residential mortgage‑backed securities (RMBS) with a fair‑value of **$757 million** and gross unrealized losses of **$89 million** (page 147). By the end of 2023 the fair‑value rose to **$810 million** while unrealized losses fell to **$60 million** (page 147). In the 2024 filing the only RMBS disclosed is in the Separate‑Accounts portfolio, valued at **$71 million** (page 160) and no unrealized‑loss amount is reported, indicating that CVS has dramatically trimmed the size of its RMBS holdings and is moving to a much smaller, lower‑risk exposure in this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states fair value of $757M and unrealized losses of $89M, but ground truth shows $629M fair value and $10M unrealized losses - the LLM's numbers are significantly overstated (20% higher on fair value, 790% higher on losses). (2) 2023: LLM claims fair value rose to $810M with $60M unrealized losses, but ground truth shows fair value DECREASED to $614M - the LLM has the direction completely wrong and the magnitude is off by $196M (32% error). The unrealized losses figure of $60M happens to match ground truth, but this appears coincidental given the other errors. (3) 2024: LLM correctly identifies $71M in RMBS holdings in Separate-Accounts portfolio, which matches ground truth. The LLM's qualitative interpretation about de-risking and moving to lower-risk exposure is directionally reasonable and aligns with the actual trajectory, but this conclusion is based on incorrect underlying data. The multi-hop synthesis fails because the foundational numbers are wrong - the LLM cannot correctly assess the evolution of exposure when the 2022-2023 figures are materially misstated. The reasoning about strategic reduction is sound in principle but undermined by factual inaccuracy in the prior years' data. The answer demonstrates a fundamental failure in quantitative accuracy that makes the overall assessment unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 409,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Across the three years Linde’s on‑site atmospheric‑gas contracts remained long‑term “total‑requirement” agreements (typically 10‑20 years) that obligate customers to purchase a minimum volume and include price‑escalation provisions 【page_94】【page_100】. The pricing has always contained a variable component indexed to external price indices, and the later filings spell out that this variable element is driven by inflationary escalations, currency‑exchange effects and pass‑through costs for natural‑gas and electricity 【page_102】【page_89】. The amount of future consideration tied to these minimum‑purchase obligations grew from roughly $48 billion in the 2023 filing to $58 billion in the 2024 filing, reflecting a larger emphasis on the variable, indexed pricing component.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core contractual structure (10-20 year on-site agreements with minimum purchase requirements and price escalation provisions) and accurately describes the variable pricing components (indexed to external price indices, inflationary escalations, currency effects, natural gas and electricity pass-through costs). The answer appropriately synthesizes information across multiple years and correctly notes the evolution toward greater transparency in pricing mechanisms. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites specific dollar amounts ($48 billion in 2023 filing, $58 billion in 2024 filing) that cannot be verified against the ground truth. The ground truth does not mention these specific figures, and the LLM provides page references that suggest these numbers come from the filings, but the ground truth makes no reference to such quantified amounts. This is a significant factual claim that appears unsupported. (2) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes that variable pricing clarification was 'not detailed in 2022' but became explicit in 2023, representing a key evolution in disclosure. The LLM states the pricing 'has always contained a variable component,' which contradicts the ground truth's assertion that this was a new clarification in 2023. (3) MISSING ASC 606 CONTEXT - The ground truth specifically mentions the practical expedient for measuring progress toward performance obligations and ASC 606 revenue recognition alignment, which the LLM completely omits. (4) EMPHASIS MISMATCH - The ground truth emphasizes 'growing emphasis on transparency' as the key evolution, while the LLM emphasizes quantitative growth in future consideration amounts without grounding these numbers in the source material. The LLM's claim about 'larger emphasis on the variable, indexed pricing component' based on the $48B to $58B growth is not supported by the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but does so with unverified quantitative claims that undermine the analysis. The qualitative synthesis of pricing mechanisms is sound, but the quantitative synthesis appears fabricated or misattributed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 597,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "- 2022: Net short forward‑gas position of about ‑1,307 MMBtu (NEE)【page_85】  \n- 2023: Net short grew to roughly ‑1,452 MMBtu (NEE)【page_85】  \n- 2024: Net short fell to about ‑1,131 MMBtu (NEE)【page_87】\n\nThe three‑year pattern shows the company expanded its net‑short gas hedge in 2023 but then trimmed that exposure in 2024, indicating a move from a more aggressive risk‑off stance toward a slightly less‑exposed, more balanced positioning in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 2,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect and uses entirely different metrics than the ground truth. (1) WRONG METRIC: The LLM reports MMBtu (physical volume units) while the ground truth reports dollar amounts ($160M, $300M, $250M). These are completely different dimensions - one measures physical quantity of gas contracts, the other measures financial exposure. (2) WRONG DIRECTION: The LLM describes 'net short' positions (negative values: -1,307, -1,452, -1,131 MMBtu), which is a hedging/directional stance. The ground truth describes net asset positions (positive values: $160M, $300M, $250M), which is financial exposure. These represent opposite interpretations. (3) WRONG NUMBERS: Even if MMBtu were the correct metric, the specific values (-1,307, -1,452, -1,131) do not match any calculation or conversion from the ground truth dollar amounts. (4) INCOMPLETE SYNTHESIS: The ground truth requires synthesizing asset and liability components (e.g., 2022: $191M assets - $31M liabilities = $160M net exposure). The LLM provides no such breakdown and uses a completely different data source. (5) MISALIGNED CONCLUSION: While both answers describe a 2023 expansion followed by 2024 contraction, the LLM's characterization of 'risk-off stance' and 'less-exposed positioning' contradicts the ground truth's interpretation of 'greater gas market exposure' and 'strategic shift.' The LLM appears to have accessed different pages (85, 87) with different derivative data than what the ground truth references. This is a fundamental failure to answer the question as posed - the question asks about net exposure evolution in dollar terms, not physical hedging positions in MMBtu.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 463,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Broadcom (AVGO) consistently placed **industrial fiber optics** as a distinct line within its **Industrial** product family—grouped alongside optocouplers, sensors, motion encoders, LEDs and Ethernet ICs【page_5†L1-L9】. In each year the company described these industrial offerings as serving a broad set of **industrial and automotive application markets**—factory automation, renewable‑energy and power‑generation systems, medical equipment, defense/aerospace, and vehicle subsystems such as EV power‑train, infotainment and advanced‑driver‑assistance—indicating that the positioning of industrial fiber optics remained stable and integral to the broader industrial portfolio throughout the period【page_7†L1-L9】【page_10†L1-L9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies AVGO/Broadcom as the company across all three years (2022-2024); (2) Accurately lists the product groupings for each year - optocouplers, sensors, motion encoders/control subsystems, LEDs, and Ethernet ICs; (3) Correctly identifies the application markets: factory automation, renewable energy, power generation, medical equipment, defense/aerospace, and automotive subsystems including EVs; (4) Properly synthesizes the multi-hop information showing consistency across the three-year period; (5) Correctly concludes that Industrial Fiber Optics maintained a stable strategic role with no significant expansion or contraction. MINOR ISSUES: (1) The LLM answer includes slightly more granular detail on automotive applications (EV powertrain, infotainment, ADAS) compared to the ground truth's more general reference to 'electric vehicles' and 'automotive subsystems' - this is an enhancement rather than an error; (2) The citation format with page references and line numbers appears to be fabricated (the 【page_X†LX-LX】 notation is not standard SEC filing format), though this doesn't affect factual accuracy; (3) Very minor: the ground truth mentions 'motion encoders' in 2023 and 'motion control subsystems' in 2024, while the LLM conflates these slightly by listing both together, though this is a negligible distinction. QUANTITATIVE ACCURACY: No numerical data, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The year references (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the evolution (or lack thereof) of Industrial Fiber Optics positioning. The conclusion about stability is well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 558,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "Across the three filings the Unsecured Notes – 31B remained unchanged: a 3.25 % coupon, $750 million face amount and $24.4 million of annual debt‑service (interest) with a maturity of 30 Nov 2026 in 2022【page_50】, 2023【page_50】 and 2024【page_51】. This consistency shows Simon Property Group is keeping a stable, low‑cost layer of long‑term unsecured debt, reflecting a disciplined strategy to lock in cheap financing and maintain a predictable debt‑service profile rather than expanding or refinancing that tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: (1) Face amount of $750 million is correct across all three years (2022-2024); (2) Interest rate of 3.25% is accurate; (3) Annual debt service of $24.4 million matches the ground truth value of $24,375,000 (minor rounding from $24.375M to $24.4M is acceptable format variation); (4) Maturity date of November 30, 2026 is provided, adding useful context not in ground truth but not contradicting it. Multi-hop synthesis: The answer correctly synthesizes information across three years (2022, 2023, 2024) and identifies the consistent pattern of no changes in the instrument's structure. Entity accuracy: SPG (Simon Property Group) is correctly identified, the specific debt instrument (Unsecured Notes - 31B) is properly referenced, and all fiscal years are correct. Reasoning quality: The LLM provides sound interpretation of what the stability reveals about SPG's debt strategy - characterizing it as a 'stable, low-cost layer' and 'disciplined strategy to lock in cheap financing.' This interpretation aligns with and enhances the ground truth's conclusion about stable long-term debt strategy. The answer includes page references (page_50, page_51) which adds credibility. Minor strengths: The LLM adds the maturity date detail and provides slightly more strategic context than the ground truth. No factual errors detected. The only minor deviation is the rounding of $24,375,000 to $24.4 million, which is a standard and acceptable format variation for financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 430,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and then to **$76 million in 2024**【page_44】. The steady year‑over‑year increase signals that the company is progressively allocating more resources to employee retirement benefits, underscoring a continued commitment to supporting its workforce’s long‑term financial security.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis. Verification of numbers: $70M (2022), $75M (2023), $76M (2024) all match ground truth exactly. The year-over-year progression is correctly identified. However, the LLM answer omits the specific 8.6% total increase calculation that was included in the ground truth answer. The LLM characterizes the trend as 'steady year-over-year increase' which is accurate but slightly imprecise—the increases are modest ($5M then $1M), not uniformly steady. The semantic interpretation about 'progressive allocation' and 'commitment to supporting workforce' is reasonable and aligns with the ground truth's characterization of 'steady and slightly growing commitment.' The answer successfully synthesizes the three-year data and provides appropriate context about what the trend indicates. The inclusion of a page reference adds credibility. Minor deduction for not calculating or mentioning the specific 8.6% increase metric that was in the original answer, and for slightly overstating the consistency of year-over-year increases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 319,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD’s definition of ROIC has been unchanged over the three years. In each filing the company states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” – 2022 10‑K (p. 47), 2023 10‑K (p. 50) and 2024 10‑K (p. 49). This consistency shows that GD deliberately strips out accounting‑only items from its ROIC metric, using the measure to evaluate pure operating returns on capital rather than fluctuations caused by non‑economic accounting adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that GD maintained consistent ROIC methodology across all three years (2022, 2023, 2024), matching the ground truth assertion of stability; (2) Accurately cites the specific exclusion of goodwill impairments and non-economic accounting changes from ROIC calculations; (3) Provides specific page references for each year's 10-K filing (p. 47 for 2022, p. 50 for 2023, p. 49 for 2024), demonstrating multi-hop synthesis across three separate documents; (4) Correctly interprets the methodology as deliberate and disciplined, aligning with ground truth characterization; (5) Explains the rationale clearly - that GD uses ROIC to measure pure operating returns rather than accounting fluctuations. The answer goes slightly beyond the ground truth by providing exact page citations and more detailed explanation of the rationale, which adds value without introducing errors. Minor consideration: The LLM provides a direct quote that cannot be independently verified from the provided context, but the substance of the claim (consistent exclusion across three years) is factually correct per the ground truth. The semantic meaning and factual content align perfectly with the original answer's core finding of consistency and disciplined methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 372,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS’s Separate Accounts assets were $3.313 billion at year‑end 2022, slipped to $3.204 billion in 2023, and then rose to $3.311 billion in 2024 【page_157】, 【page_108】. The three‑year trend shows a modest decline followed by a rebound, leaving the asset base essentially flat around $3.2‑$3.3 billion, which suggests CVS is maintaining a stable investment position to back its long‑term insurance contracts rather than dramatically expanding or contracting those holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states $3.313 billion vs. ground truth $5,087 million ($5.087 billion) - a massive $1.774 billion discrepancy (35% understatement); (2) 2023: LLM states $3.204 billion vs. ground truth $3,250 million - relatively close but still incorrect; (3) 2024: LLM states $3.311 billion vs. ground truth $3,311 million - this one is correct. The LLM's narrative about the trend is fundamentally wrong: it describes a 'modest decline followed by a rebound' when the actual trend shows a DRAMATIC 36% decline from 2022 to 2023 ($5,087M to $3,250M), followed by a marginal 2% recovery in 2024. The LLM's conclusion that CVS is 'maintaining a stable investment position' is misleading because it misses the significant 2023 contraction. The reasoning quality is undermined by the incorrect baseline numbers. While the LLM correctly identifies the company (CVS) and metric (Separate Accounts Assets), the quantitative foundation is severely flawed, making the entire analysis unreliable. The only correct data point is the 2024 figure of $3.311 billion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 337,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "From 2022 onward, Target’s Credit Card Program Agreement with TD Bank USA, N.A. was updated by a **Third Amendment** dated November 1, 2022 (filed as Exhibit (10)JJ) and then by a **Letter Agreement** dated March 8, 2023 (both shown on page 75 of the 2024 filing). The 2024 Form 10‑K still references the original 2012 agreement and its **First Amendment** (February 24, 2015) and **Second Amendment** (November 19, 2019) (pages 69 and 74), indicating that the 2022‑2023 amendments are the most recent contractual milestones in the program’s evolution.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims a 'Third Amendment dated November 1, 2022' exists - the ground truth makes no mention of any third amendment, only references to the original agreement (October 22, 2012), First Amendment (February 24, 2015), and Second Amendment (November 19, 2019). (2) The LLM references a 'Letter Agreement dated March 8, 2023' - again, no such document is mentioned in the ground truth. (3) The LLM cites specific page numbers (75, 69, 74) from the 2024 filing without verification against the actual ground truth data. (4) The LLM's core claim that '2022-2023 amendments are the most recent contractual milestones' directly contradicts the ground truth, which only identifies amendments through November 19, 2019. The ground truth explicitly states the agreement 'saw continued maintenance and formal updates' but only documents three versions: the original 2012 agreement and two amendments (2015 and 2019). The LLM appears to have fabricated amendment dates and documents not supported by the knowledge graph. While the LLM correctly identifies the original agreement date (October 22, 2012) and the First Amendment date (February 24, 2015), it introduces false information about subsequent amendments. The answer is contextually relevant to the question asked but fundamentally unreliable due to invented facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 395,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In 2022 Linde described rare gases (krypton, neon, xenon) simply as part of its atmospheric‑gases portfolio and as co‑products of the same cryogenic air‑separation process that makes oxygen, nitrogen and argon 【page_94】. By 2023 they were still listed among the core atmospheric gases but the filing began to stress that the same industrial‑gases and Engineering segments supply them, underscoring their role as a shared output of Linde’s plant‑design business 【page_100】. In the 2024 filing Linde elevated rare‑gas production to a strategic growth area, highlighting its market‑leadership in non‑cryogenic air‑separation and advanced separation technologies (VPSA, membrane) that uniquely enable efficient rare‑gas output, and tying those gases to its Engineering business that designs and builds the air‑separation plants—integrating rare‑gas production with its broader atmospheric‑ and process‑gases lines 【page_4】【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each year's positioning; (2) Accurately names specific rare gases (krypton, neon, xenon) consistent with ground truth; (3) Correctly identifies technological innovations (VPSA, membrane separation) as key differentiators in 2024; (4) Properly synthesizes the multi-hop evolution from product-centric (2022) to technology- and integration-driven (2024) approach; (5) Accurately describes the shift in emphasis from simple portfolio listing to strategic growth area with market leadership positioning; (6) Correctly identifies the integration with Engineering segment and air-separation plant design business; (7) Accurately characterizes rare gases as byproducts/co-products of air separation processes. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'co-products' vs 'byproducts') but these are semantically equivalent; (2) The LLM answer emphasizes 'non-cryogenic' air separation technologies while ground truth mentions both cryogenic and non-cryogenic contexts - however, the 2024 emphasis on non-cryogenic is accurate per ground truth; (3) Page citations are included in LLM answer (pages 94, 100, 4, 5) which adds credibility but cannot be verified against ground truth; (4) The answer could have slightly more explicitly stated the 'long-term contracts with price escalation clauses' mentioned in ground truth for 2023, though this is a minor omission. QUANTITATIVE ACCURACY: No numerical calculations or specific financial metrics are required for this question, so this dimension is not directly applicable, but the answer contains no factual errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple business segments (atmospheric gases, industrial gases, Engineering) to show the evolution of strategic positioning. The logical progression is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 560,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s master‑netting collateral tied to its advances to equity companies fell sharply – it was **$1.494 billion at 12/31/2022**, dropped to **$800 million at 12/31/2023**, and further declined to **$491 million at 12/31/2024**【page_102】【page_99】.  This steady reduction in posted collateral suggests that the firm’s derivative exposure linked to its equity‑company relationships has been shrinking, reflecting either lower derivative positions or reduced risk in those relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The number format variation ($1.494 billion vs $1,494 million in ground truth) is acceptable and demonstrates proper understanding. The dates are accurate (12/31/2022, 12/31/2023, 12/31/2024). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of collateral amounts across the three-year period, and (2) what this trend suggests about derivative liability exposure. ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to advances to equity companies) is precisely identified, and all fiscal years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the consistent downward trend and interprets it as reflecting de-risking or reduced derivative exposure. The language 'steady reduction in posted collateral' and 'derivative exposure linked to equity-company relationships has been shrinking' accurately captures the same analytical insight as the ground truth's 'strategic reduction in exposure to derivative liabilities' and 'de-risking or portfolio optimization efforts.' MINOR OBSERVATIONS: The LLM's phrasing 'either lower derivative positions or reduced risk in those relationships' is slightly more cautious than the ground truth's definitive statement about 'strategic reduction' and 'de-risking,' but this represents appropriate analytical nuance rather than an error. The inclusion of page references adds credibility without detracting from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 468,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s long‑term contract coverage rose from roughly 92 % of its net generating capacity at the end of 2021 to about 94 % by the end of 2022 and stayed at roughly 94 % in 2023【page_18】and 2024【page_19】.  Maintaining such a high, stable share of output under long‑term bilateral contracts shows the company is deliberately locking in revenue and hedging spot‑market price risk, using these contracts as a core risk‑mitigation tool in competitive wholesale markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the baseline year and starting percentage. The ground truth states NEER's reliance was 92% in 2022, 94% in 2023, and 94% in 2024. However, the LLM answer claims the coverage was 'roughly 92% at the end of 2021' and 'about 94% by the end of 2022,' which shifts the entire timeline back by one year and misrepresents the data. The ground truth explicitly tracks the evolution FROM 2022 THROUGH 2024, not from 2021-2024. This is a fundamental error in temporal accuracy. CORRECT ELEMENTS: The LLM correctly identifies the final percentages (94% for 2023 and 2024) and accurately describes the strategic implications (revenue stability, hedging spot-market price risk, core risk-mitigation tool in competitive markets). The qualitative reasoning about the company's risk mitigation strategy is sound and semantically equivalent to the ground truth. MULTI-HOP SYNTHESIS: The LLM demonstrates understanding of the relationship between contract coverage percentages and risk management strategy, which is appropriate. However, the temporal misalignment undermines the core factual accuracy required for a multi-hop financial question. COMPLETENESS: The answer addresses the evolution trend and strategic implications, but the incorrect year-to-year progression makes it incomplete in terms of accurate data representation. The question specifically asks about the evolution 'from 2022 through 2024,' and the LLM's answer starting from 2021 is a material deviation from the requested timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 435,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an outstanding principal of $495 million in fiscal 2022, and the same $495 million was reported in both fiscal 2023 and fiscal 2024 【page_81】. The balance did not change over the three‑year period, indicating the company has chosen to keep this low‑cost, medium‑term debt on its books without prepaying or increasing it – a disciplined strategy that preserves a stable source of financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on all quantitative metrics. All numbers are accurate: $495 million principal balance consistently reported across fiscal 2022, 2023, and 2024. The dates (January 2025 maturity, fiscal years 2022-2024) are correct. The multi-hop synthesis is sound - the model correctly identified the instrument across three fiscal years and tracked the unchanged balance. The core factual content matches the ground truth perfectly. However, there are minor differences in interpretation and framing: (1) The LLM characterizes the strategy as 'disciplined' and 'preserves a stable source of financing,' which is a reasonable inference but slightly different from the ground truth's suggestion that AVGO 'may be planning to refinance or use cash reserves to settle the obligation.' Both interpretations are plausible given the data, but they represent different strategic framings. (2) The LLM's characterization of this as a 'low-cost, medium-term debt' is reasonable but adds interpretive language not explicitly in the ground truth. (3) The ground truth more directly addresses the question about what the unchanged balance 'reveals' about debt management strategy by explicitly mentioning refinancing or cash settlement possibilities, while the LLM focuses on the disciplined nature of maintaining the debt. The LLM answer is factually accurate and addresses the question adequately, but the ground truth provides slightly more direct insight into the strategic implications. No calculation errors, no entity confusion, and all key facts are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 433,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K tables the “Unsecured Notes ‑ 37B” consistently show a 2.25 % coupon, a $700 million face amount (shown as 700,000 in the “thousands” column), and a maturity of January 15, 2032【page_50†L71-L75】【page_50†L71-L75】【page_50†L71-L75】. The lack of any change over three years indicates Simon Property Group is deliberately preserving this low‑cost, long‑dated debt issuance, locking in favorable rates and extending maturity to reduce refinancing risk and support a stable long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700,000,000 face amount (properly noted as 700,000 in thousands column), and January 15, 2032 maturity date. The answer correctly identifies that these terms remained consistent across all three years (2022, 2023, 2024). COMPLETENESS: The answer addresses all three components of the multi-part question: interest rate evolution, face amount evolution, and maturity date evolution, plus the strategic implications question. ENTITY ACCURACY: Simon Property Group correctly identified, fiscal years 2022-2024 correctly referenced, and the specific debt instrument (Unsecured Notes - 37B) properly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified consistency across three years and drew appropriate strategic conclusions about debt management, refinancing risk reduction, and capital structure stability. The reasoning that stable long-term debt with favorable rates supports real estate portfolio cash flows is contextually appropriate. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents a \"deliberate long-term debt strategy\" and \"preserving low-cost, long-dated debt\" aligns perfectly with the ground truth's characterization of \"deliberate long-term debt strategy focused on maintaining predictable financing costs.\" Minor note: The LLM uses slightly different language (\"preserving\" vs. \"maintaining\") but conveys identical meaning. The citation format with page references adds credibility. No calculation errors, no missing data points, and the strategic interpretation is sound and well-supported by the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 472,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Across the three filings the Melaka, Malaysia site is listed with an “X” only under the Analog column and a blank under Embedded Processing – in 2022【page_16】, again in 2023【page_16】 and once more in 2024【page_16】. This unchanged designation shows TI has kept the Melaka footprint dedicated to analog production, with no move to add embedded‑processing capability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint evolution from 2022-2024. STRENGTHS: (1) All factual information is correct - the answer accurately identifies that Melaka had an 'X' under Analog and blank under Embedded Processing consistently across all three years (2022, 2023, 2024); (2) The multi-hop synthesis is sound - the model correctly synthesized information across three separate filings to identify the consistent pattern; (3) Entity accuracy is perfect - correct company (Texas Instruments/TI), correct location (Melaka, Malaysia), correct product categories (Analog vs Embedded Processing), correct time period (2022-2024); (4) The conclusion about 'targeted investment in analog capabilities rather than diversification into embedded processing' is logically sound and supported by the data; (5) Page references are provided (page_16) adding credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase 'stable, analog-only operational strategy' and 'consistency suggests' - however, this is a stylistic difference, not a factual error; (2) The LLM uses 'unchanged designation' which semantically conveys the same meaning as the ground truth's emphasis on consistency; (3) Both answers reach the same substantive conclusion about the company's strategic focus. The answer demonstrates clear understanding of the question's multi-part nature (evolution over time + what it reveals about company focus) and successfully synthesizes information across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 450,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s multi‑layered security model—anchored by privacy‑by‑design, data‑by‑design, AI‑governance and a robust cyber‑security program—has been continuously reinforced as its real‑time payments network grew from 12 markets in 2022 to 13 markets by the end of 2023, with the 2024 filing still emphasizing the same layered protection while reporting operation or implementation of real‑time payments in 13 markets【page_11】. In 2024 the firm added technical‑standard development (e.g., EMV), third‑party assessments and integrated security into new payment flows such as virtual‑card numbers and Alias‑Based Remittances, reflecting a more mature, integrated security posture across its expanding global footprint【page_9】【page_12】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the market expansion from 12 markets in 2022 to 13 markets by 2023, with 2024 maintaining 13 markets - this matches ground truth. (2) Accurately mentions EMV technical standards development. (3) Correctly notes the multi-layered security approach and its continuous evolution. (4) Appropriately references third-party assessments and integration of security into new payment flows. WEAKNESSES: (1) The LLM introduces specific security framework components (privacy-by-design, data-by-design, AI-governance) that are not mentioned in the ground truth, which may be accurate but cannot be verified against the provided knowledge graph. (2) CRITICAL OMISSION: The ground truth explicitly mentions Mastercard's 2024 expansion into China through a joint venture and the ability to process domestic transactions there - this is a significant market expansion detail that the LLM completely fails to address. This is a major gap in the multi-hop synthesis, as the China expansion is directly relevant to how security had to scale further. (3) The LLM mentions 'virtual-card numbers and Alias-Based Remittances' as new payment flows, which are not in the ground truth and cannot be verified. (4) The LLM does not adequately explain the evolution narrative - it presents features but doesn't clearly show how the approach evolved in response to the expanding infrastructure. (5) Missing discussion of public-private partnerships mentioned in ground truth. QUANTITATIVE ACCURACY: Numbers are correct (12→13 markets, years 2022-2024), but the answer lacks the crucial China expansion detail that represents a major quantitative/geographic expansion. QUALITATIVE ACCURACY: While the security components mentioned are plausible, the failure to address the China joint venture expansion represents a significant gap in understanding the multi-hop question about how security evolved in response to expanding markets. The answer is partially correct but incomplete in addressing the core evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 546,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics’ Land Systems unit raised its Canadian‑Army LAV output each year – 360 new LAVs in 2022 (10‑K 2022, p. 11), 399 in 2023 (10‑K 2023, p. 11), and 449 new LAVs in 2024 (10‑K 2024, p. 10) (the 2024 filing also notes an extra 66 LAVs under the LRSS program). The steady increase signals a deliberate strategic push to expand its LAV portfolio and deepen its role as a primary supplier to the Canadian Army.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. All core numbers are correct: 360 units (2022), 399 units (2023), and 449 units (2024). The progression and trend analysis are accurate. The answer correctly identifies General Dynamics' Land Systems unit and properly synthesizes the multi-hop information across three fiscal years from SEC filings. The LLM appropriately cites specific page references (10-K 2022 p. 11, 10-K 2023 p. 11, 10-K 2024 p. 10), adding credibility. The reasoning about strategic focus is sound and matches the ground truth's interpretation of 'consistent and growing strategic emphasis.' One minor enhancement in the LLM answer is the inclusion of the additional 66 LAVs under the LRSS program in 2024, which provides supplementary context not explicitly mentioned in the ground truth but represents accurate additional detail from the filings. The semantic meaning is equivalent to the ground truth - both convey that production volumes increased steadily year-over-year, indicating strategic commitment to the LAV program. The wording differs slightly ('raised,' 'steady increase,' 'deliberate strategic push') but conveys the same core message. No calculation errors detected. All entities (General Dynamics, Canadian Army, LAV program) are correctly identified. The answer fully addresses both parts of the question: the evolution of production volumes and what this indicates about strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 404,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s pension plan listed hedge‑fund limited partnership holdings of **$225 million in 2022**, **$252 million in 2023**, and **$280 million in 2024** (see footnotes on the pension‑asset tables for 2022 – page 174, 2023 – page 173, and 2024 – page 167). The steady increase each year shows the company is progressively expanding its exposure to hedge‑fund LPs, indicating a strategic tilt toward alternative assets to diversify the pension portfolio and seek higher returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. Specific issues: (1) WRONG NUMBERS: LLM states 2022=$225M, 2023=$252M, 2024=$280M, but ground truth shows 2022=$214M, 2023=$225M, 2024=$252M. Every single year's figure is incorrect - the LLM appears to have shifted the data forward by one year. (2) CALCULATION ERROR: LLM claims 'steady increase each year' but provides no percentage calculation. Ground truth correctly identifies 17.8% total increase over three years. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trajectory. It correctly identified the pattern (steady increase) but with wrong numbers, which undermines the entire analysis. (4) MISSING CONTEXT: While LLM provides page references (which is good), it fails to capture the nuance that the 2022-2023 increase was modest ($11M or 5.1%) while 2023-2024 showed acceleration ($27M or 12%), suggesting evolving strategy. (5) SEMANTIC ISSUE: LLM's interpretation of 'progressively expanding' is reasonable given the (incorrect) numbers it cited, but the actual data shows more measured growth. The answer demonstrates reasonable reasoning structure but is built on fundamentally wrong data, making it unreliable for decision-making purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 368,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The RedCard‑penetration metric – which captures purchases made with Target’s credit products, including the Target MasterCard Credit Card – fell from ≈20.5 % in fiscal 2022 to 19.8 % in 2023 and to 18.6 % in 2024 (see page 27). This steady decline indicates that, although the cards still command a sizable share of transactions, consumer adoption and engagement with Target’s credit offering have been weakening over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL: The LLM provides 18.6% for 2024, but the ground truth states 17.8% for 2024. This is a material discrepancy of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The error in the 2024 figure is significant for a financial metric question where precision is essential. QUALITATIVE ACCURACY: The LLM correctly identifies the metric as RedCard penetration, correctly notes the steady decline trend, and appropriately interprets this as weakening consumer adoption and engagement. The reasoning about the cards commanding a sizable share despite declining penetration is sound. However, the LLM omits important contextual details from the ground truth answer, such as: (1) the explanation that RedCard sales increased in dollar terms but total sales grew faster (dilution effect), (2) potential causes like shifting consumer preferences, increased competition, or reduced sensitivity to the 5% discount incentive. COMPLETENESS: The LLM addresses the core question about penetration rate evolution and what it suggests about consumer adoption, but provides less comprehensive analysis than the ground truth. The answer is somewhat superficial in explaining the underlying drivers of the trend. ENTITY ACCURACY: Correctly identifies Target MasterCard Credit Card and RedCard as the relevant products. Correctly references fiscal years 2022-2024. MULTI-HOP REASONING: The answer demonstrates basic multi-hop synthesis (connecting penetration rates across years to draw conclusions about trends), but lacks the deeper analysis of why the trend occurred. The reference to 'page 27' suggests proper source attribution but doesn't enhance the analysis. OVERALL: The answer is partially correct with one significant numerical error (18.6% vs 17.8% for 2024) that undermines confidence in the quantitative accuracy. The qualitative reasoning is sound but incomplete compared to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 526,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "NextEra Energy’s fair‑value exposure for FPL’s cost‑recovery clauses rose from $16 million at 12/31/2022 (page 52) to $12 million at 12/31/2023 (page 53) and then jumped to $38 million at 12/31/2024 (page 55). In 2023 the $12 million net exposure reflected a $‑12 million contribution from significant other observable inputs offset by $24 million from significant unobservable inputs (page 53), whereas in 2024 the $38 million exposure was driven by $4 million of other observable inputs and $34 million of unobservable inputs (page 55), indicating a shift toward greater reliance on unobservable inputs and a reversal of the prior year’s negative observable‑input effect.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the 2022 figure. Ground truth states 2022 total fair value was $1 million, but the LLM claims it was $16 million. This is a fundamental discrepancy that undermines the entire analysis of the 'evolution' from 2022-2024. The LLM correctly identifies the 2023 figure ($12 million) and 2024 figure ($38 million), along with the correct component breakdowns for both years (2023: -$12M observable, +$24M unobservable; 2024: +$4M observable, +$34M unobservable). However, the missing 2022 data point is critical since the question explicitly asks about the evolution 'from 2022 through 2024.' The LLM's statement that fair value 'rose from $16 million at 12/31/2022...to $12 million at 12/31/2023' contradicts the ground truth showing a rise from $1M to $12M. This error cascades through the analysis - the LLM cannot accurately characterize the three-year evolution when the starting point is wrong. The qualitative reasoning about 'shift toward greater reliance on unobservable inputs' is sound for 2023-2024, but the incomplete picture (missing 2022 data) prevents proper assessment of the full three-year trend. The LLM does provide page citations and demonstrates understanding of the observable vs. unobservable input distinction, but the quantitative foundation is fatally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 378,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s 10‑K filings from 2022‑2024 all list Anta as a major rival and reaffirm that Nike remains the world’s largest athletic‑footwear and apparel seller. In each year the company stresses “continued emphasis” on technical innovation—citing the rollout of Nike Air, Zoom, Flyknit, React and related technologies (Product Research, Design & Development sections, e.g., 2022 p. 6; 2024 p. 6)—and a brand‑engagement strategy built on digital experiences, social‑media interaction and athlete/influencer endorsements (Competition sections, e.g., 2022 p. 8; 2024 p. 8). The language and focus are essentially unchanged, indicating Nike’s competitive positioning versus Anta has stayed steady, anchored in the same innovation‑and‑engagement emphasis throughout the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the key finding. Ground truth explicitly states that NKE's competitive positioning EVOLVED from 2022-2024, with a strategic shift: (1) 2022 emphasized 'quality, performance, reliability' plus 'new product style and design innovation'; (2) 2023 elevated 'innovation and development' AHEAD of performance/reliability (signaling strategic shift); (3) 2024 further solidified innovation focus with digital engagement emphasis. The LLM claims positioning 'has stayed steady' and 'language and focus are essentially unchanged'—this is the opposite of the ground truth's core finding of evolution and strategic shift. SPECIFIC ISSUES: (1) The LLM correctly identifies Anta as a named competitor across all years (correct). (2) The LLM correctly identifies Nike as global leader (correct). (3) The LLM correctly mentions innovation technologies (Nike Air, Zoom, Flyknit, React) and digital engagement strategies (correct). (4) However, the LLM's INTERPRETATION is fundamentally wrong: it concludes positioning remained 'steady' when ground truth shows clear evolution in emphasis priorities from 2022→2023→2024. (5) The LLM misses the critical 2023 inflection point where 'innovation and development' was elevated AHEAD of performance/reliability—this represents a strategic shift in response to competitive pressures. (6) The LLM's citation format (e.g., '2022 p. 6; 2024 p. 6') appears fabricated without verification against actual filings. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across three years. It treated the three years as static rather than identifying the progression and strategic shift. This is a fundamental failure in multi-hop reasoning for a question explicitly asking 'how has...evolved.' QUANTITATIVE ACCURACY: No specific numbers were required, so this scores moderately (7/10) for correctly identifying years and general competitive positioning, but loses points for unsupported page citations. QUALITATIVE ACCURACY: Very low (3/10) because the core analytical conclusion is inverted from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 575,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The equity‑compensation tables in TI’s 10‑K filings show that the 2003 Director Compensation Plan was included in the total shares to be issued, but the footnote that lists “shares remaining available for future issuance” never mentions the 2003 plan – only the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan (2022 table page 63; 2023 table page 61; 2024 table page 59). Because no remaining pool is reported for the 2003 plan in any of these years, the plan’s share pool has been fully exhausted, indicating that TI no longer relies on the 2003 Director Compensation Plan for new director equity awards and has shifted to newer compensation plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a partially correct but incomplete assessment of the 2003 Director Compensation Plan's evolution. STRENGTHS: (1) Correctly identifies that the 2003 plan was not listed in the 'shares remaining available for future issuance' footnotes across 2022-2024, (2) Accurately cites specific page numbers from the 10-K filings (pages 63, 61, 59), (3) Correctly identifies the alternative plans mentioned (2009 LTIP, 2014 ESPP, 2018 Director Plan), (4) Reaches a logical conclusion that the plan's share pool was exhausted. WEAKNESSES: (1) The answer focuses narrowly on the absence of remaining shares available for future issuance, but doesn't address the broader evolution described in the ground truth - that the plan was 'still referenced as active' in 2022 with shares being issued, then 'no longer listed' in 2023, then 'no longer mentioned' in 2024. (2) The LLM answer conflates 'no remaining shares available for future issuance' with 'share pool fully exhausted' - these are related but distinct concepts. The ground truth indicates a gradual phase-out and strategic shift, not simply an exhaustion. (3) Missing the nuance that the plan was still referenced for outstanding grants in 2023 even though it wasn't listed for future issuance. (4) The answer doesn't capture the 'gradual phase-out' aspect emphasized in the ground truth - it presents the situation more as a binary state (exhausted/not used) rather than an evolution. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and identifies the pattern of the plan's absence from future issuance tables. However, it misses the temporal evolution aspect that the ground truth emphasizes. The reasoning is sound but incomplete in capturing the full narrative of the plan's transition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 489,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "CMCSA’s advertising business already provided “technology, tools, data‑driven services and marketplace solutions” to media customers in its 2022 filing (2022 10‑K p.6). In 2023 the company deepened that integration by embedding those data‑driven capabilities across its X1, Sky Q, NOW and Xumo Stream Box platforms and by leveraging its cloud‑based video, advanced‑search and virtualized‑network infrastructure to deliver richer audience data (2023 10‑K p.6‑7). By 2024 the suite was further expanded with additional automated tools and broader marketplace solutions, allowing advertisers to target and engage viewers more effectively across linear, streaming and digital properties (2024 10‑K p.6‑8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies CMCSA's core advertising offerings in 2022 (technology, tools, data-driven services, marketplace solutions); (2) Accurately describes 2023 expansion with specific platform names (X1, Sky Q, NOW, Xumo Stream Box) and infrastructure details (cloud-based video, advanced search, virtualized networks); (3) Properly characterizes 2024 enhancements (automated tools, broader marketplace solutions, cross-property targeting); (4) Provides appropriate page citations (2022 10-K p.6, 2023 10-K p.6-7, 2024 10-K p.6-8) that add credibility; (5) Correctly synthesizes the evolution narrative showing progression from basic offerings to integrated, technology-enabled solutions. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth (naming specific platforms and infrastructure components), which represents added value rather than error; (2) Both answers convey the same core narrative of deepening integration and expansion of data-driven capabilities; (3) The LLM answer emphasizes 'automated tools' and 'cross-property targeting' in 2024, which aligns with the ground truth's mention of 'enhanced digital advertising tools' and 'improved advertiser reach and targeting precision'; (4) No quantitative metrics (dollar amounts, percentages) are present in either answer, so quantitative accuracy is based on dates and factual claims, all of which are correct. The answer fully addresses the multi-part question regarding evolution, specific enhancements, technology improvements, and marketplace solutions across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 472,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial‑mortgage‑backed‑securities (CMBS) portfolio has been shrinking. At 31 Dec 2022 the company held CMBS with a fair‑value of $992 million and $155 million of unrealized losses; by 31 Dec 2023 that exposure had fallen to $675 million of fair‑value and $100 million of unrealized losses (44 + 287 securities)【page_149】. In the 2024 filing the only CMBS reported are the $3 million of fair‑value assets in its Separate‑Accounts portfolio (down from $6 million in 2023) with no loss amount disclosed 【page_160】. The steady decline in both the size of the holding and the magnitude of unrealized losses signals that CVS is actively de‑risking its CMBS exposure, positioning itself more conservatively as interest‑rate‑driven valuation pressures persist.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies that contradict the ground truth across all three years: (1) 2022: LLM states $992M fair value with $155M unrealized losses, but ground truth shows $574M fair value with $12M unrealized losses - a massive overstatement of both metrics (73% higher fair value, 1,192% higher losses). (2) 2023: LLM correctly states $675M fair value and $100M unrealized losses, matching ground truth exactly. (3) 2024: LLM states $3M fair value (down from $6M in 2023), but ground truth shows $6M in 2024 with no significant unrealized losses - the LLM appears to have reversed the 2023-2024 comparison. The LLM's claim that 2024 holdings fell to $3M contradicts its own statement that 2023 had $6M. REASONING ISSUES: While the LLM correctly identifies the overall de-risking trend and declining exposure pattern, the foundational numbers are wrong, undermining the credibility of the analysis. The conclusion about de-risking is semantically aligned with ground truth, but is built on incorrect data. COMPLETENESS: The answer addresses the three-year evolution and risk positioning question, but the 2022 baseline is fundamentally incorrect, making the trend analysis unreliable. The multi-hop synthesis across years is attempted but marred by data errors. The inclusion of page references and specific security counts adds detail but doesn't compensate for the core numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 402,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings show that the employee‑discount component has been unchanged in scope over the three years – each filing lists “merchandise and other discounts” as part of the team‑member compensation and benefits package (2022 Human Capital Management, p. 6; 2023 Compensation and Benefits, p. 6; 2024 Compensation and Benefits, p. 7). The filings never disclose a specific discount rate, so the monetary value of the discount is not quantified, but the 2024 filing does broaden the wage range ($15‑$24 per hour) and adds new benefits (e.g., sick pay) while keeping the discount language identical. This continuity suggests Target treats the merchandise discount as a stable, core perk that it preserves while progressively enhancing overall employee compensation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that merchandise discounts were listed across all three years (2022, 2023, 2024) as part of Target's employee benefits. (2) Accurately notes that no specific discount rate/monetary value is disclosed in the filings. (3) Correctly identifies the wage range expansion to $15-$24/hour in 2024. (4) Appropriately concludes that the discount represents a stable, core perk preserved while other benefits expanded. (5) Cites specific page references (though these cannot be independently verified). WEAKNESSES: (1) The LLM answer is overly narrow in scope—it focuses primarily on the discount's consistency rather than the broader 'evolution' requested in the question. The ground truth emphasizes how the FRAMING and EMPHASIS evolved alongside broader benefits enhancements (financial wellness in 2023, mental health/virtual healthcare in 2024), but the LLM largely ignores this contextual evolution. (2) The LLM states the discount language remained 'identical' across years, but doesn't explore how the presentation context changed—the ground truth notes the discount was presented within increasingly sophisticated benefits ecosystems. (3) Missing analysis of the strategic implications: the ground truth explicitly discusses a 'strategic shift toward holistic employee well-being,' while the LLM's conclusion is more limited ('stable, core perk'). (4) The LLM mentions 'sick pay' as a new 2024 benefit but doesn't connect this to the broader wellness narrative evident in the ground truth. (5) The question asks what the progression 'suggests about the company's employee benefit strategy'—the LLM provides a partial answer (preservation + enhancement) but misses the deeper strategic narrative about holistic well-being integration. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the core pattern (consistency + expansion), but fails to fully synthesize the contextual evolution of how benefits were framed and positioned. The reasoning is sound but incomplete relative to the question's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 561,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In the 2022 filing Linde singled out “cultural challenges associated with integrating employees from the acquired company” as a specific risk and even highlighted cross‑cultural and language integration issues (2022 p.12). The 2023 filing broadened the integration‑risk narrative to include control‑implementation and management‑time distractions but kept the cultural‑challenge bullet (2023 p.10), and the 2024 filing retained that same cultural‑challenge item while adding a fuller list of integration risks, including employee‑retention (2024 p.12). This steady, increasingly detailed focus shows that Linde treats cultural integration as a core, recurring risk and embeds it in a comprehensive cross‑border integration‑risk management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific page references and filing years (2022, 2023, 2024) that cannot be verified against the ground truth, which is a significant concern. While the answer correctly identifies that Linde discussed cultural challenges across these three years and that the discussion evolved, there are several issues: (1) The LLM cites specific page numbers (p.12, p.10, p.12) without verification capability, which is problematic for factual accuracy. (2) The LLM's characterization differs from the ground truth in important ways: the ground truth emphasizes a progression from 'operational hurdles' to 'strategic risk management and financial outcomes,' while the LLM focuses on 'steady, increasingly detailed focus' and 'comprehensive cross-border integration-risk management strategy.' (3) The ground truth specifically notes that by 2023, Linde 'expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks,' but the LLM mentions 'control-implementation and management-time distractions' instead—these are different risk categories. (4) The ground truth emphasizes a shift in framing toward 'financial results if integration efforts fail to achieve synergies and retain key personnel,' while the LLM mentions employee-retention but doesn't capture the financial outcomes emphasis as clearly. (5) The LLM's conclusion about 'comprehensive cross-border integration-risk management strategy' is somewhat speculative and not directly supported by the ground truth's more nuanced observation about the evolution in framing. The answer is partially correct in identifying the persistence of cultural challenges and their evolution, but misses key nuances about how the framing shifted from operational to strategic/financial perspectives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 487,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral for master‑netting arrangements dropped from $1.494 billion at 12/31/2022 to $491 million at 12/31/2024—a decline of roughly $1.0 billion (2023 $800 million)【page_102】【page_99】.  The falling collateral, which backs initial‑margin requirements, indicates that the company’s derivative positions and associated margin needs have been shrinking, reflecting tighter risk‑management and more effective netting of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $1.494 billion (2022) = $1,494 million, $491 million (2024), and the intermediate 2023 value of $800 million is correctly referenced. The calculated decline of ~$1.0 billion is accurate ($1,494M - $491M = $1,003M). Date formatting is appropriate (12/31/2022, 12/31/2024). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in collateral amounts across the three-year period, and (2) what this trend suggests about derivative exposure management. The LLM correctly identifies all three data points (2022, 2023, 2024) even though the question only explicitly asked about 2022-2024. ENTITY ACCURACY: Company (ExxonMobil), metric (collateral under master netting arrangements related to Notes and accounts receivable - net), and time periods are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to implications about derivative exposure management, noting that shrinking collateral reflects tighter risk management and more effective netting. This interpretation aligns with the ground truth's characterization of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' SEMANTIC EQUIVALENCE: The LLM's explanation of 'derivative positions and associated margin needs have been shrinking' is semantically equivalent to the ground truth's 'strategic reduction in derivative exposure.' The phrase 'more effective netting of its derivative exposure' directly parallels 'improved offsetting mechanisms.' MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail about initial-margin requirements and risk management mechanisms, which adds value without contradicting the ground truth. The citation references (page_102, page_99) suggest proper source documentation. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 533,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "Broadcom’s Security Insights Platform was first shown only as a “Security Insights Code program” in the Mainframe Software table of the 2022 filing (2022 p. 9), but by 2022 p. 10 it was already described as a solution that quickly interprets mainframe security posture, identifies risks and provides ongoing remediation steps, with the output “available for use with in‑house tools for security information and event management.” The same language appears unchanged in the 2023 (2023 p. 10) and 2024 (2024 p. 10) 10‑Ks, indicating that integration remains limited to customers’ internal SIEM tools, remediation stays framed as continuous and ad‑hoc, and the platform is positioned as part of Broadcom’s broader Enterprise Security portfolio that leverages AI‑driven threat intelligence to support its overall cyber‑defense strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE CLAIMS: The LLM answer fundamentally contradicts the ground truth on the key evolution narrative. Ground truth states the platform evolved from a standalone tool (2022) to being more explicitly tied to AVGO's broader cybersecurity portfolio (2023) to being contextualized within an expanded mainframe software suite including Cybersecurity, AIOps, and DevOps (2024). The LLM claims the language remained 'unchanged' across all three years and that 'integration remains limited to customers' internal SIEM tools,' which directly contradicts the ground truth's assertion of strategic evolution and expanded contextualization. SPECIFIC ERRORS: (1) The LLM states the platform description was 'unchanged in the 2023 and 2024 10-Ks,' but ground truth explicitly describes different positioning in each year - 2023 showed 'more explicit' ties to broader portfolio, 2024 showed 'expanded mainframe software suite' contextualization. (2) The LLM characterizes the evolution as static ('same language appears unchanged'), missing the core narrative of strategic shift from standalone to integrated component. (3) The LLM's claim about 'limited integration' contradicts ground truth's description of 2024 positioning within expanded suite. WHAT WAS CORRECT: (1) The LLM correctly identifies the core 2022 functionality (interprets mainframe security, identifies risks, provides remediation steps, available for SIEM tools). (2) Page references appear reasonable (2022 p. 9-10, 2023 p. 10, 2024 p. 10). (3) The mention of 'Enterprise Security portfolio' and 'AI-driven threat intelligence' aligns with ground truth's broader context. MULTI-HOP REASONING FAILURE: The question asks about evolution 'from 2022 to 2024' - this requires synthesizing year-over-year changes. The LLM failed to identify the key evolution points that ground truth emphasizes: (1) increasing explicit ties to broader portfolio, (2) shift from standalone to integrated component, (3) expanded contextualization within suite. Instead, the LLM concluded there was no meaningful evolution. This is a fundamental failure in multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 577,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, Simon Property Group’s Unsecured Notes – 32B consistently carried a $750 million face amount and a 3.38 % fixed coupon (maturing June 15 2027)【page_50†L19-L20】【page_50†L14-L15】【page_51†L16-L17】. Keeping the size and low rate unchanged over three years shows the company’s deliberate strategy to lock in inexpensive, medium‑term debt and limit refinancing risk, underscoring a disciplined long‑term debt‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three fiscal years (2022-2024). QUANTITATIVE VERIFICATION: All numeric values are correct - $750 million face amount, 3.38% interest rate, and June 15, 2027 maturity date are accurately stated and consistent with the ground truth. The answer correctly identifies that these terms remained unchanged across all three years. COMPLETENESS: The answer addresses the core question about how the debt evolved (or in this case, remained stable) and provides interpretation of what this reveals about debt management strategy. ENTITY ACCURACY: SPG (Simon Property Group) is correctly identified, the specific debt instrument (Unsecured Notes - 32B) is properly named, and all fiscal years (2022, 2023, 2024) are correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that consistency across three years indicates a deliberate strategy rather than active management/refinancing. The interpretation that this reflects a strategy to 'lock in inexpensive, medium-term debt and limit refinancing risk' is logically sound and semantically equivalent to the ground truth's characterization of 'stable long-term debt strategy' with 'no early redemption or restructuring.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'low rate' is a reasonable characterization of 3.38% in the context of debt markets. The inclusion of citation references (page numbers) adds credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 455,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024 Lumen has been repeatedly flagged as a major broadband rival that is continuously extending its fiber‑to‑the‑home and fiber‑to‑the‑premises network deeper into the markets where Comcast operates, offering speeds that exceed traditional DSL and directly challenging Comcast’s broadband speeds (CMCSA 2022 p.8; 2023 p.9; 2024 p.8). At the same time, Lumen (along with other wireline carriers) has increasingly used bundled service packages—pairing high‑speed broadband with voice, wireless or other offerings—to pressure Comcast’s pricing and bundling strategy, a trend highlighted in each year’s competition discussion (CMCSA 2022 p.8; 2023 p.9; 2024 p.8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core competitive dynamics between Lumen and CMCSA from 2022-2024. STRENGTHS: (1) Correctly identifies Lumen as a major/key competitor throughout the period; (2) Accurately captures the fiber network expansion strategy (fiber-to-the-home/fiber-to-the-premises) across all three years; (3) Properly synthesizes the bundled service strategy (broadband + voice/wireless) as a consistent competitive tactic; (4) Correctly notes the escalation/persistence of competitive pressure; (5) Appropriately cites the relevant filing pages and years; (6) Maintains semantic equivalence with ground truth regarding 'consistent and possibly intensifying' threat. MINOR WEAKNESSES: (1) The LLM answer adds specific technical details ('fiber-to-the-home,' 'fiber-to-the-premises,' 'speeds that exceed traditional DSL') that, while reasonable inferences from typical competitive dynamics, are not explicitly confirmed in the ground truth statement; (2) The phrase 'directly challenging Comcast's broadband speeds' is slightly more assertive than the ground truth's more measured language about 'competitive service packages'; (3) The answer includes page citations (p.8, p.9) which add specificity but cannot be verified against the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two companies, correctly identifying the evolution of competitive threat and the dual strategies (fiber expansion + bundling). The logical flow from 2022 through 2024 matches the ground truth's narrative of escalation. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are all correct. Overall, the LLM answer is factually sound and addresses all components of the multi-part question with appropriate detail and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 525,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded‑payment‑card usage has been slipping. The company reported RedCard (now Target Circle) penetration of 20.5 % for the fiscal year ended January 29 2022, 19.8 % for FY 2023, and 18.6 % for FY 2024 (see 2023 10‑K page 27 and 2024 10‑K page 29). The steady decline – roughly two percentage points over three years – suggests the loyalty‑driven discount/reward program is losing traction, indicating that the branded‑card strategy is becoming less effective at generating incremental purchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FY 2024 PENETRATION RATE: The LLM states 18.6% for FY 2024, but the ground truth shows 17.8%. This is a material discrepancy of 0.8 percentage points that affects the core quantitative answer. The LLM correctly identifies the 2022 (20.5%) and 2023 (19.8%) figures. CALCULATION VERIFICATION: The LLM claims 'roughly two percentage points over three years' - from 20.5% to 18.6% would be 1.9 percentage points, which is approximately correct for their stated numbers, but since the actual 2024 figure is 17.8%, the true decline is 2.7 percentage points, making their characterization of the trend magnitude inaccurate. STRENGTHS: (1) Correctly identifies the downward trend across all three years, (2) Properly synthesizes multi-hop information (penetration rates across multiple fiscal years), (3) Correctly names the product (RedCard/Target Circle), (4) Provides appropriate interpretation that the trend suggests weakening effectiveness of the loyalty strategy, (5) Cites specific 10-K page references showing research effort. WEAKNESSES: (1) The 18.6% figure for FY 2024 is factually incorrect (should be 17.8%), (2) This error cascades into the magnitude assessment of the decline, (3) The reasoning about effectiveness is sound but based on partially incorrect data. The qualitative reasoning about what the trend suggests is appropriate and matches the ground truth interpretation, but the quantitative foundation is compromised by the FY 2024 error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 407,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "- In the 2022 filing Chevron simply listed the Republic of Congo among its operating countries, indicating it still held non‑operated working interests in offshore permits such as Haute Mer and Lianzi【page_33】.  \n- By 2024 the Congo assets had become a material part of its upstream portfolio – roughly 20 % of Chevron’s net oil‑equivalent production in OPEC+ nations came from the Republic of Congo, and the company was still investing about $0.7 billion in offshore development and gas projects there in 2023‑24【page_41】【page_109】.  \n- However, the 2024 report also disclosed that Chevron will sell its 31.5 % non‑operated interest in the offshore Haute Mer permit and its 15.75 % interest in the Congo portion of Lianzi in January 2025, signalling a strategic move to exit or reduce its stake in the region【page_43】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CONTRADICTORY NARRATIVE: The LLM answer contains a fundamental logical contradiction. It states that in 2022 Chevron 'held non-operated working interests' and then claims 'by 2024 the Congo assets had become a material part of its upstream portfolio – roughly 20% of Chevron's net oil-equivalent production in OPEC+ nations came from the Republic of Congo.' This contradicts the ground truth which shows Chevron was DIVESTING from Congo by 2024, not increasing its material stake. The LLM appears to have misread or conflated timeline information. (2) INVESTMENT AMOUNT AMBIGUITY: The LLM states '$0.7 billion in offshore development and gas projects there in 2023-24' but the ground truth specifies this was 'approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo' in 2023 - not necessarily all in Congo, and the timeframe attribution to 2023-24 is imprecise. (3) MISSING KEY CONTEXT: The ground truth emphasizes a clear TRANSITION from 'active investment and development to divestiture' and 'realignment of Chevron's portfolio toward higher-priority regions.' The LLM answer fails to clearly articulate this strategic shift - instead it presents the 2024 divestiture as somewhat disconnected from the earlier narrative about material production. (4) PERCENTAGE CLAIM UNVERIFIED: The claim about '20% of Chevron's net oil-equivalent production in OPEC+ nations' is not mentioned in the ground truth and appears to be either fabricated or misattributed. (5) CORRECT ELEMENTS: The specific divestiture details are accurate (31.5% Haute Mer, 15.75% Lianzi, January 2025 timing). The 2022 listing of Congo as operational country is correct. However, these correct elements are undermined by the contradictory framing of Congo's importance increasing while simultaneously being divested. The multi-hop reasoning is fundamentally flawed due to the narrative contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 530,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra’s net Level‑3 derivative exposure – which captures its gas‑related options – was a modest $170 million asset position at the end of 2022【page_87】. By 2023 the company held gas‑options with fair values of $100 million on the asset side and $97 million on the liability side, and the weighted‑average implied volatility for those options rose to about 50 % (range 20‑233 %)【page_84】; in 2024 the fair‑value balance remained essentially unchanged ($100 million assets vs. $102 million liabilities) while implied volatility edged higher to roughly 52 % (range 15‑150 %)【page_86】. The move from a small net asset exposure in 2022 to a near‑zero net position with rising implied volatilities in 2023‑24 shows NEE has kept its gas‑option hedge neutral but is pricing and preparing for greater gas‑price uncertainty in the market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) 2022 ASSET VALUE MISMATCH: Ground truth states $356 million in assets for 2022, but LLM reports only $170 million as 'net Level-3 derivative exposure.' This is a critical 52% understatement of the 2022 asset position. The LLM appears to have confused or misreported the 2022 baseline figure. (2) 2022 LIABILITY DATA MISSING: Ground truth explicitly states $347 million in liabilities for 2022, but LLM provides no 2022 liability figure at all, making it impossible to assess the full 2022 position. (3) 2022 IMPLIED VOLATILITY MISSING: Ground truth specifies 36% average implied volatility for 2022, but LLM omits this entirely, preventing proper year-over-year volatility comparison. (4) PARTIAL ACCURACY FOR 2023-2024: The LLM correctly reports 2023 figures ($100M assets, $97M liabilities, 50% volatility) and 2024 figures ($100M assets, $102M liabilities, 52% volatility), which match ground truth. (5) REASONING QUALITY: The LLM's interpretation of 'near-zero net position' and 'hedge neutral' is reasonable given the 2023-2024 data it presents, but this conclusion is undermined by the missing 2022 baseline. The characterization of 'de-risking' cannot be properly evaluated without accurate 2022 comparisons. (6) MULTI-HOP SYNTHESIS: The LLM failed to synthesize the complete three-year trajectory because it did not accurately capture the 2022 starting point. The narrative of 'sharp reduction from 2022 to 2023' cannot be verified with the LLM's reported numbers. CALCULATION VERIFICATION: Ground truth shows asset decline from $356M (2022) to $100M (2023) = 72% reduction; LLM's $170M to $100M = 41% reduction—fundamentally different magnitude. The LLM's answer is internally consistent for 2023-2024 but fails on the critical 2022 baseline, which is essential for answering a question about evolution 'from 2022 through 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 507,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike’s 2022 Form 10‑K lists FlyEase alongside a broad set of emerging technologies—“Nike Air, Zoom, Nike Free, Flywire, Dri‑Fit, Flyknit, **FlyEase**, Zoom X, Air Max, and Nike React”—to illustrate its commitment to new product innovation【page_6】. In the 2024 Form 10‑K the same roster appears (now “Nike Air, Zoom, Nike Free, Dri‑Fit, Flyknit, **FlyEase**, Zoom X, Air Max, and Nike React”), showing that FlyEase remains highlighted as a core technology and has progressed from a novel concept to an established pillar of Nike’s innovation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides accurate information about FlyEase appearing in Nike's 2022 and 2024 10-K filings alongside other technologies, with correct technology names and proper citations. However, it has significant gaps in addressing the full scope of the question. STRENGTHS: (1) Correctly identifies FlyEase in both 2022 and 2024 10-K filings; (2) Accurately lists the technology roster from both years; (3) Properly notes FlyEase's progression from novel concept to established pillar; (4) Quantitative accuracy is solid - years and document references are correct. CRITICAL WEAKNESSES: (1) The original answer explicitly mentions a 2023 expansion phase with emphasis on 'integration into various categories and consumer applications,' which the LLM answer completely omits. This is a significant gap in the multi-hop synthesis across three years (2022-2023-2024); (2) The LLM answer only compares 2022 and 2024, missing the middle year that the ground truth identifies as showing deliberate scaling efforts; (3) The LLM answer lacks the nuanced progression narrative - it jumps from 'novel concept' to 'established pillar' without documenting the intermediate scaling phase; (4) The answer doesn't capture the ground truth's insight about FlyEase becoming 'fully embedded in Nike's innovation narrative' with consistent appearance in product R&D sections. MULTI-HOP REASONING: The question requires synthesizing information across three years (2022, 2023, 2024) to show evolution. The LLM only synthesizes two years, missing critical intermediate data. The ground truth shows a three-stage progression (introduction → expansion/scaling → full embedding), but the LLM presents only a two-stage comparison. This represents incomplete multi-hop synthesis. The answer is partially correct but substantially incomplete in addressing the full temporal evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 506,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "Across the three filings the Unsecured Notes ‑ 35A stayed exactly the same – a $750 million face amount carrying a 2.65 % rate, with $19.9 million of annual debt service and a July 15, 2030 maturity 【page_50】 (2022), 【page_50】 (2023), 【page_51】 (2024). The unchanged size, rate and term show that Simon Property Group is deliberately preserving this low‑cost, long‑dated tranche of unsecured debt as a stable pillar of its long‑term financing strategy while it adjusts other components of its debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a major factual error that fundamentally undermines the response. The ground truth states the face amount is $750,000 (seven hundred fifty thousand dollars), but the LLM claims it is $750 million. This is a 1,000x magnitude error. Similarly, the annual debt service is stated as $19,875 in the ground truth, but the LLM claims $19.9 million - another massive error. These are not minor formatting variations; they represent fundamental misstatement of the financial obligations. The maturity date (07/15/30), interest rate (2.65%), and the consistency across years are correctly identified. The reasoning about SPG maintaining a stable approach to this debt instrument is sound and aligns with the ground truth interpretation. However, the quantitative errors are so severe that they invalidate the core factual content of the answer. The LLM appears to have confused the notation or misread the source documents, leading to inflated figures by three orders of magnitude. This is a critical failure in quantitative accuracy that cannot be overlooked, despite the otherwise reasonable qualitative analysis of the company's debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 333,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Texas Instruments repeatedly states that its business model is built around “analog and embedded‑processing products” and that it places “additional strategic emphasis on designing and selling…into the industrial and automotive markets” (2022 p. 18‑19; 2023 p. 18‑19; 2024 p. 18‑19). This unchanged focus shows that embedded processing is treated as a core, cash‑generating platform that supports TI’s long‑term objective of growing free‑cash‑flow‑per‑share through disciplined capital allocation and shareholder returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of TI's strategic positioning but has notable gaps compared to the ground truth. STRENGTHS: (1) Correctly identifies the core strategic emphasis on 'analog and embedded-processing products' across all three years (2022, 2023, 2024); (2) Accurately notes the consistent focus on industrial and automotive markets; (3) Properly connects this strategy to free cash flow per share growth objective; (4) Correctly identifies disciplined capital allocation as part of the strategy; (5) Cites appropriate page references (18-19) for all three years. WEAKNESSES: (1) The answer is more narrowly focused on market emphasis (industrial/automotive) rather than comprehensively addressing how the strategic emphasis 'evolved' - the ground truth emphasizes the evolution of framing and positioning across the three years, while the LLM treats it as 'unchanged'; (2) Missing key contextual details from ground truth: the 2022 reference to 'four competitive advantages' and 'more opportunity per customer and more value for investments'; (3) Doesn't capture the nuance that in 2023 TI 'reiterated' the focus (suggesting reinforcement) and in 2024 'maintained' it (suggesting continuity) - the ground truth provides more granular year-by-year positioning; (4) The phrase 'unchanged focus' contradicts the question's premise about 'evolution' - while technically accurate that the core message remained consistent, it misses the subtle evolution in how TI framed and emphasized these products. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this is not a differentiating factor. The page references (18-19) appear consistent across years. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects it to the free cash flow per share objective, demonstrating adequate multi-hop reasoning. However, it doesn't fully explore the evolution aspect as thoroughly as the ground truth. SEMANTIC EQUIVALENCE: The core message about embedded processing being central to TI's strategy and supporting free cash flow per share growth is conveyed in both answers, though the ground truth provides richer detail about the specific framing in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 602,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "In the 2022 Form 10‑K Marvel was mentioned only as an “indefinite‑lived intangible asset” (a trademark) on the balance sheet – a pure accounting recognition of its value (see pages 110‑112). By the 2023 filing Disney was actively promoting Marvel as a consumer‑facing brand, listing it as one of the top‑level “tiles” on Disney+ alongside Disney, Pixar, Star Wars and National Geographic (see page 7), thereby using the franchise to attract and retain subscribers. The 2024 filing still records Marvel among the indefinite‑lived intangible assets (see page 114), confirming that the company continues to treat Marvel as a core IP that drives Disney+ subscriber growth while preserving its balance‑sheet value. This evolution shows Disney’s financial strategy of turning a high‑value trademark into a prominent UI feature to fuel DTC growth, especially on Disney+.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Marvel's strategic use across Disney's platforms from 2022-2024 and accurately captures the key financial strategy elements. Strengths: (1) Correctly identifies Marvel as an indefinite-lived intangible asset in both 2022 and 2024; (2) Accurately describes the 2023 transition to a top-level tile on Disney+ alongside other branded content; (3) Properly synthesizes the multi-hop reasoning connecting balance sheet asset recognition to UI implementation to subscriber growth strategy; (4) Correctly identifies the DTC (direct-to-consumer) growth objective. Weaknesses and omissions: (1) The LLM answer does not mention the Disney+ subscriber count of 123 million as of September 28, 2024, which the ground truth includes as a key metric validating the strategy's success; (2) Missing reference to ESPN+ tile launch plans for early fiscal 2025, which the ground truth identifies as part of the broader branded content strategy; (3) The answer focuses primarily on Marvel but doesn't explicitly mention the other tiles (Disney, Pixar, Star Wars, National Geographic) as comprehensively as the ground truth's framing of Marvel within a broader branded content ecosystem. Quantitative accuracy is strong - no numerical errors detected. The page references cited (110-112, 7, 114) appear reasonable for 10-K filings though cannot be independently verified. The reasoning about the shift from 'passive asset recognition to active brand utilization' is sound and well-articulated. The answer adequately addresses the question's core inquiry about strategic evolution and financial implications, though it misses some supporting metrics and contextual details that would strengthen the completeness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 480,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement continued to cover essentially the same slice of its closed block – 59.25 % of the block in 2022 (2022 10‑K, p. 214) and roughly 59 % in both 2023 (2023 10‑K, p. 227) and 2024 (2024 10‑K, p. 204).  At the same time, the reinsurance recoverable balances linked to that arrangement grew sharply: net ceded reinsurance recoverables were $6.1 billion at year‑end 2022 (2023 10‑K, p. 227), the November 2023 risk‑transfer transaction generated $10.3 billion of reinsurance recoverables and deposit receivables (2024 10‑K, p. 206), and total net ceded reinsurance recoverables rose to $17.6 billion by year‑end 2024 (2024 10‑K, p. 204).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) PERCENTAGE ACCURACY: The LLM correctly identifies the percentages (59.25% in 2022, ~59% in 2023-2024), which matches the ground truth. (2) CRITICAL NUMERIC ERRORS - REINSURANCE RECOVERABLE BALANCES: This is where the answer fails severely. The ground truth specifies UNSECURED reinsurance recoverable balances of $3.6B (2022), $4.4B (2023), and $4.2B (2024). The LLM instead reports completely different figures: $6.1B (2022), $10.3B (2023 transaction), and $17.6B (2024). These numbers are dramatically larger and appear to reference total net ceded reinsurance recoverables rather than the unsecured balances specifically asked about in the question. The LLM conflates different metrics - it discusses a November 2023 risk-transfer transaction generating $10.3B in reinsurance recoverables and deposit receivables, which is not mentioned in the ground truth answer at all. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and cite specific 10-K pages, it fails to correctly identify which metric (unsecured vs. total net ceded) is relevant to the question. The question specifically asks about 'reinsurance recoverable balances' in the context of the modified coinsurance agreement evolution, and the ground truth clearly establishes these as unsecured balances. (4) SEMANTIC DIVERGENCE: The LLM's characterization of 'sharp growth' in reinsurance recoverables contradicts the ground truth's characterization of 'minor fluctuations in unsecured exposure.' The LLM's narrative of sharp increases ($3.6B→$6.1B→$10.3B→$17.6B) is fundamentally incompatible with the ground truth's stable pattern ($3.6B→$4.4B→$4.2B). This represents a major factual error, not merely a wording difference. The answer appears to have confused or misidentified the relevant balance sheet items.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 517,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "- 2022: CVS reported residential mortgage‑backed securities (RMBS) with an amortized‑cost of **$845 million** and a fair‑value of **$757 million**【page_147】.  \n- 2023: The RMBS balance rose slightly to an amortized‑cost of **$862 million** (fair‑value **$810 million**)【page_147】.  \n- 2024: The only RMBS disclosed is in the Separate‑Accounts portfolio, where fair‑value fell to **$71 million** (up from $51 million in 2023)【page_160】.  \n\nThe three‑year trend shows a modest increase in the core RMBS holding from 2022‑2023, followed by a sharp pull‑back and confinement of the exposure to a smaller Separate‑Accounts segment in 2024, suggesting CVS is deliberately reducing its overall mortgage‑backed fixed‑income risk and repositioning such assets into a more isolated, policy‑linked bucket.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years: (1) 2022: LLM reports $845M amortized cost and $757M fair value, but ground truth shows $629M in RMBS investments. This is a massive discrepancy of $216M (34% overstatement). (2) 2023: LLM reports $862M amortized cost and $810M fair value, but ground truth shows $614M. Again, a $248M overstatement (40% error). (3) 2024: LLM correctly identifies $71M, matching ground truth. The LLM also misses the critical unrealized losses data ($10M in 2022, $60M in 2023) that the ground truth explicitly includes as evidence of risk exposure. The LLM's interpretation of the trend is partially reasonable (identifying a pullback in 2024), but this reasoning is built on incorrect foundational numbers. The LLM appears to have confused or conflated different RMBS categories or reporting lines from the 10-K. The claim about 'Separate-Accounts portfolio' in 2024 is not substantiated by the ground truth answer. The multi-hop synthesis fails because the core quantitative data is wrong, making the risk assessment and strategic positioning conclusions unreliable. While the qualitative narrative about de-risking has some merit, it's based on incorrect numbers and incomplete analysis of unrealized losses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 370,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife said that in 2022 it re‑insured 59.25 % of the closed block through a modified‑coinsurance agreement and recorded the arrangement under the deposit method, offsetting the deposit liability with a recoverable 【page_214】. In the 2023 filing the company reported that about 59 % of the closed block was re‑insured on a modified‑coinsurance basis and continued to use the deposit‑method accounting with the same offset 【page_204】. The 2024 filing confirms the continued use of a modified‑coinsurance structure for the separate‑account products and the ongoing deposit‑method accounting (including deposit assets and liabilities), but it no longer discloses a specific percentage for the closed block 【page_229】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key percentages (59.25% in 2022, 59% in 2023) and accurately describes the deposit method accounting with offset treatment for 2022 and 2023. The page citations appear reasonable. The LLM correctly notes the evolution across the three years.\n\nWEAKNESSES: (1) CRITICAL DISCREPANCY: The ground truth states that in 2024, the percentage was 'reported as 59%' with consistent accounting treatment, but the LLM claims '2024 filing...no longer discloses a specific percentage for the closed block.' This is a significant factual contradiction. The ground truth explicitly states the 2024 percentage was 59%, while the LLM says it wasn't disclosed. (2) INCOMPLETE CHARACTERIZATION: The LLM describes 2024 as applying to 'separate-account products' rather than the closed block specifically, which may represent a mischaracterization or incomplete understanding of the scope. (3) ACCOUNTING TREATMENT CLARITY: While the LLM mentions 'deposit assets and liabilities' for 2024, it doesn't explicitly confirm that the offset treatment remained consistent as stated in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the evolution pattern, but fails on the critical 2024 data point. The reasoning about consistency is partially undermined by the claim that 2024 lacks a specific percentage disclosure.\n\nNUMERIC VERIFICATION: 59.25% (2022) ✓, 59% (2023) ✓, but 2024 percentage disclosure status is contradicted.\n\nThe answer demonstrates good structure and mostly correct information for 2022-2023, but the fundamental error regarding 2024 percentage disclosure significantly impacts overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 467,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net short position in natural‑gas forward contracts was roughly (1,307) MMBtu in 2022, grew to about (1,452) MMBtu in 2023, and then fell to approximately (1,131) MMBtu in 2024 [page_85; page_84]. The increase in 2023 shows the company took on a larger gas‑price exposure, but the subsequent reduction in 2024 indicates it trimmed that exposure, suggesting a move toward a more cautious, risk‑averse stance in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect in multiple ways. (1) WRONG METRIC: The LLM reports net exposure in MMBtu (physical units), while the ground truth provides dollar amounts ($160M, $300M, $250M). These are completely different metrics - one measures volume, the other measures financial exposure. (2) WRONG DIRECTION: The LLM describes a 'net short position' with negative values in parentheses, suggesting the company is short natural gas. The ground truth shows positive asset values exceeding liabilities, indicating a net long position (assets $191M > liabilities $31M in 2022, etc.). (3) WRONG NUMBERS: Even if we were to accept MMBtu as a valid metric, the specific values (1,307, 1,452, 1,131) do not match any data in the ground truth. (4) INCOMPLETE SYNTHESIS: The question asks about net exposure evolution and risk positioning. The ground truth provides clear dollar amounts showing: 2022: $160M, 2023: $300M (increase), 2024: $250M (decrease). The LLM's narrative about 'increased exposure in 2023 then reduction in 2024' aligns directionally with the ground truth trend, but the underlying numbers are entirely wrong. (5) MISSING COMPONENT BREAKDOWN: The ground truth helpfully breaks down assets and liabilities for each year, providing transparency. The LLM provides no such breakdown. The conclusion about 'more cautious stance' in 2024 is semantically similar to the ground truth, but this cannot redeem the fundamental factual errors in the quantitative data. This appears to be a case where the LLM may have confused different disclosure tables or metrics from the filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 443,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 filing, industrial fiber optics was listed as a distinct product line within the industrial segment—grouped with optocouplers, sensors, motion‑control encoders and Ethernet PHYs—and was described mainly for factory‑automation, renewable‑energy and automotive‑electronics applications (2022 p.10, p.5). The 2023 filing kept the same categorization but expanded the narrative to stress a much broader set of end‑markets—industrial automation, power generation, medical, defense, aerospace and EV/ADAS—while still listing motion encoders and Ethernet ICs as adjacent offerings (2023 p.7). By the 2024 filing, industrial fiber optics was positioned as an integrated element of a convergent industrial suite, explicitly tied to motion‑control encoders and Ethernet ICs to support an even wider range of uses, from electric‑vehicle powertrains and advanced driver‑assistance to diverse industrial‑automation applications (2024 p.7).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTIONS WITH GROUND TRUTH: The LLM answer contains significant discrepancies with the original answer regarding product groupings and timeline evolution. Ground truth states that in 2022, Industrial Fiber Optics was grouped with 'optocouplers, motion encoders, LED devices, and Ethernet ICs' - the LLM omits LED devices and incorrectly includes 'sensors' and 'Ethernet PHYs' in 2022. Ground truth indicates 2023 emphasized 'sensors, encoders, and microcontrollers' - the LLM states it kept 'the same categorization' which contradicts the ground truth's description of evolved groupings. (2) PRODUCT CATEGORIZATION ERRORS: The LLM lists 'Ethernet PHYs' in 2022, but ground truth specifies 'Ethernet ICs' for 2022 and only mentions 'Ethernet PHYs' emerging in 2024. This is a material distinction that suggests misreading of filing data. (3) APPLICATION SCOPE MISALIGNMENT: The LLM claims 2022 applications included 'factory-automation, renewable-energy and automotive-electronics' but ground truth specifies 'industrial automation, medical systems, defense, and electric vehicle subsystems' - these are different application categories. (4) MISSING KEY EVOLUTION DETAILS: The LLM fails to capture the ground truth's core insight about the strategic shift from 'standalone industrial components to more interconnected, intelligent systems' - instead providing a more generic narrative. (5) CITATION ISSUES: The LLM provides specific page references (2022 p.10, p.5, etc.) that cannot be verified against the ground truth and may be fabricated. (6) INCOMPLETE SYNTHESIS: While the LLM attempts multi-hop reasoning across three years, it misses critical distinctions in how product groupings evolved (LED devices in 2022, microcontrollers in 2023, camera microcontrollers in 2024). The answer demonstrates partial understanding but contains too many factual errors to be reliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 519,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock – a $1‑par, $0.3 million issue owned solely by Sojitz America – carried a cumulative dividend of $0.10 per share payable each May 31, and that dividend requirement was unchanged in FY 2022, FY 2023 and FY 2024【page_79】【page_79】.  The preferred stock was fully issued, not a “blank‑check” series, and Nike’s charter bars any additional preferred issuances, so the ownership and voting rights of Sojitz America remained stable throughout the three years【page_79】【page_79】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is substantially correct on the key quantitative facts: the $0.3 million par value, the $1 par per share, the $0.10 annual dividend per share, and the May 31 payment date are all accurate. The statement that these terms remained unchanged across FY 2022-2024 is correct. The answer also correctly identifies Sojitz America as the sole owner and notes the stability of ownership and voting rights.\n\nHowever, the answer has notable omissions relative to the ground truth:\n\n1. MISSING CONTEXT ON DIVIDEND PRIORITY: The ground truth emphasizes that \"dividends on the preferred stock must be paid in full before any dividends on common stock could be declared.\" This is a significant financial implication that the LLM answer does not mention. This is a material aspect of the financial relationship's implications.\n\n2. MISSING REDEMPTION CONTEXT: The ground truth notes that \"Sojitz America...has not sought redemption of the stock despite having the option to do so.\" This provides important context about the stability and nature of the relationship. The LLM answer mentions the stock is \"not a blank-check series\" and that Nike's charter bars additional preferred issuances, but doesn't address the redemption option or lack of redemption activity.\n\n3. CHARACTERIZATION OF \"EVOLUTION\": The question asks how the relationship \"evolved\" from 2022-2024. Both answers correctly identify that there was NO evolution/change, but the ground truth frames this as \"remained structurally stable\" while the LLM answer states terms were \"unchanged.\" Both convey the same meaning, though the ground truth's framing is slightly more responsive to the \"evolution\" aspect of the question.\n\n4. FINANCIAL IMPLICATIONS FRAMING: The question specifically asks about \"financial implications.\" The ground truth addresses this by discussing dividend priority and the long-term nature of the relationship. The LLM answer focuses more on structural/legal aspects (charter restrictions, fully issued status) rather than the financial implications.\n\nQuantitative accuracy is high (9/10) - all numbers are correct. Qualitative accuracy is 7/10 because while the core facts are right, the answer misses important contextual elements about dividend priority and redemption that are material to understanding the financial implications. Contextual relevance is 7/10 because the answer addresses stability but doesn't fully capture the financial implications dimension of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 663,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "Simon’s Unsecured Notes 31B have been unchanged over the three years – each filing shows a $750 million face amount, a 3.25 % fixed rate, $24.4 million of annual debt service and a maturity of 30 Nov 2026 (2022 $750 000/$24 375 k【page_48】; 2023 $750 000/$24 375 k【page_50】; 2024 $750 000/$24 375 k【page_51】). The consistency indicates SPG is using the 31B note as a stable, low‑cost, medium‑term financing source, locking in rate certainty and avoiding refinancing risk as part of its long‑term capital strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics. STRENGTHS: (1) All core numbers are accurate: $750 million face amount (correctly formatted as $750,000 in thousands in the filing context), 3.25% fixed rate, November 30, 2026 maturity date. (2) Annual debt service calculation of $24.375 million ($750M × 3.25%) is mathematically correct. (3) Multi-hop synthesis is sound - the answer correctly tracks the instrument across three years (2022-2024) and identifies consistency. (4) Strategic interpretation is reasonable - characterizing this as a 'stable, low-cost, medium-term financing source' aligns with the ground truth's assessment of 'consistent long-term financing approach.' (5) Page citations provided add credibility. MINOR ISSUES: (1) The LLM states '$24.4 million of annual debt service' while the precise figure is $24.375 million - this is a minor rounding presentation difference but the calculation is correct. (2) The LLM answer uses '$750 000' notation (thousands) which is technically correct for SEC filing context but could be clearer. (3) The ground truth mentions 'broader changes in SPG's unsecured debt portfolio' and references to retirement of certain notes and issuance of new instruments like Unsecured Notes - 41A in 2024, which the LLM answer does not address. However, the question specifically asks about the 31B instrument's evolution, so this omission is not critical to answering the core question. VERIFICATION: The consistency claim across all three years is verified as correct. The strategic interpretation about rate certainty and refinancing risk avoidance is sound and well-reasoned. Overall, the answer correctly synthesizes multi-year data and provides appropriate financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 485,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The value of TI common stock held in the U.S. defined‑contribution plans fell from $940 million in 2022 to $873 million in 2023 and to $852 million in 2024【page_44】【page_43】. This three‑year decline mirrors a modest drop in TI’s share price and, because the stock fund has been frozen to new contributions since 2016, shows that employee holdings are simply tracking market performance rather than growing through fresh employee investment in the retirement plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three dollar amounts are correct ($940M in 2022, $873M in 2023, $852M in 2024), and the year-over-year decline pattern is accurately captured. The numbers match the ground truth exactly. COMPLETENESS: The answer addresses the core question about the 3-year trend and provides interpretation of what the trend indicates. ENTITY ACCURACY: Correctly identifies TI common stock, U.S. defined contribution plans, and the relevant time period (2022-2024). REASONING QUALITY: The LLM correctly synthesizes multi-hop information by: (1) presenting the numerical trend, (2) explaining the frozen contribution policy since 2016, and (3) drawing the logical conclusion that holdings are tracking market performance rather than growing through new contributions. This reasoning is sound and matches the ground truth's interpretation. SEMANTIC EQUIVALENCE: The LLM's explanation that \"employee holdings are simply tracking market performance rather than growing through fresh employee investment\" is semantically equivalent to the ground truth's statement about \"a freeze on new contributions into the TI common stock fund since 2016\" combined with \"market valuation shifts.\" MINOR CONSIDERATIONS: The LLM's phrasing focuses slightly more on market performance tracking as the primary explanation, while the ground truth presents it as one of multiple factors (\"strategic reduction in stock allocations by employees\" OR \"freeze on new contributions\" OR \"combination of both\"). However, this is a minor difference in emphasis rather than a factual error, as the LLM's explanation is consistent with and supported by the ground truth. The inclusion of page citations adds credibility. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 509,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "In fiscal 2022 Disney employed roughly 220 000 people—about 166 000 in the United States and 54 000 abroad—with seasonal workers accounting for ≈7 % of the total; a significant portion of the workforce was covered by collective‑bargaining agreements and many non‑U.S. employees were represented by works councils, trade unions or other employee associations【page_5】. By September 28 2024 the headcount had risen to about 233 000 (≈ 171 000 U.S. and 62 000 international) and the seasonal share increased to ≈8 %, while the same pattern of collective‑bargaining coverage and international employee‑association representation continued【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Disney's workforce evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022 total of 220,000 (166,000 U.S., 54,000 international) with 7% seasonal workers; 2024 total of 233,000 (171,000 U.S., 62,000 international) with 8% seasonal workers. The calculations are accurate: U.S. growth of 5,000 employees, international growth of 8,000 employees, and seasonal percentage increase of 1 percentage point. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) total employee count evolution, (2) U.S. vs. international distribution, (3) seasonal workforce percentages, and (4) employee association representation. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple years and data points, showing the progression from 2022 to 2024 and identifying trends (growing reliance on seasonal workers, maintained collective bargaining agreements). ENTITY ACCURACY: Company name (The Walt Disney Company/Disney) is correct, fiscal years are properly identified (fiscal 2022 and September 28, 2024), and all metrics are appropriately labeled. MINOR CONSIDERATIONS: The LLM uses slightly different formatting (≈ symbol, special characters) and includes citation references (【page_5】, 【page_16】) which add credibility but are not part of the ground truth answer. The semantic meaning is fully preserved - the answer conveys identical information to the ground truth with appropriate professional language. The only minor deviation is the inclusion of contextual details about collective bargaining agreements and works councils, which enriches the answer without contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 484,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD’s ROIC definition has not changed – each filing explicitly says that ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 p. 47; 2023 p. 50; 2024 p. 49). By consistently stripping out these non‑operational items, GD signals that it wants the metric to capture only the core return generated by the capital it truly deploys, not the effects of accounting adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across all three years (2022, 2023, 2024), matching the ground truth assertion of consistency; (2) Accurately cites the specific language from filings ('excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance') and provides page references (2022 p. 47; 2023 p. 50; 2024 p. 49) that demonstrate multi-hop synthesis across three years of filings; (3) Correctly interprets the meaning of this consistency—that GD maintains a stable framework emphasizing economic performance over accounting volatility; (4) Adds valuable context by explaining the rationale ('capture only the core return generated by the capital it truly deploys, not the effects of accounting adjustments'), which enhances understanding without contradicting the ground truth. Minor considerations: (1) The LLM answer includes the phrase 'goodwill impairments' alongside non-economic accounting changes, which is a slight expansion beyond the ground truth's focus on 'non-economic accounting changes' alone, but this is not incorrect—it's additional relevant detail from the actual filings; (2) The answer is slightly more interpretive/analytical than the ground truth, but this interpretation is sound and supported by the cited evidence. The multi-hop reasoning is excellent: the answer successfully synthesizes information across three separate years of filings to demonstrate consistency. No calculation errors, no factual inaccuracies, and the semantic meaning fully aligns with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 469,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In the 2022 filing Linde simply listed rare gases (krypton, neon, xenon) as part of its “atmospheric gases” portfolio that are produced as co‑products of its conventional air‑separation plants 【page_94】. By the 2024 filing the company stresses that it now leverages its market‑leading **non‑cryogenic** air‑separation technology and a suite of proprietary, patented processes to produce, store and market rare gases 【page_4】, showing a strategic shift from a commodity‑co‑product role to a technology‑driven, differentiated offering. This evolution highlights Linde’s competitive advantage: advanced, patented production methods that give it higher‑margin, niche‑market leadership in the industrial‑gases sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of rare gases as part of atmospheric gases portfolio produced through air separation - matches ground truth. (2) Accurately captures the 2024 evolution toward non-cryogenic air separation technology leadership - this is the critical strategic shift identified in both answers. (3) Properly synthesizes the multi-hop reasoning: 2022 commodity co-product → 2024 technology-driven differentiation. (4) Correctly identifies specific technologies (non-cryogenic air separation, patented processes) that enhance competitive advantage. (5) Appropriately emphasizes the shift from commodity positioning to higher-margin, differentiated offerings. (6) Includes specific page references (page_94, page_4) showing document grounding. MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly mention VPSA (vacuum pressure swing adsorption) or membrane separation technologies by name, though it references 'proprietary, patented processes' which captures the same concept. The ground truth specifically names these technologies. (2) The LLM answer emphasizes 'niche-market leadership' and 'higher-margin' positioning, which is a reasonable inference about competitive advantage but goes slightly beyond what the ground truth explicitly states about efficiency and customer service capabilities. However, this inference is logical and not contradictory. (3) The 2023 filing is not explicitly mentioned in the LLM answer, though the ground truth notes it 'reiterated' the 2022 positioning - this is a minor omission of intermediate data point but doesn't affect the core narrative of evolution from 2022 to 2024. QUANTITATIVE ACCURACY: No numerical data required; dates (2022, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across multiple years and filing documents to show strategic evolution. The logic connecting technological advancement to competitive advantage is sound. SEMANTIC EQUIVALENCE: The core message matches - Linde evolved from treating rare gases as commodity co-products to leveraging advanced technology for differentiated market positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 597,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s long‑term bilateral contract coverage rose to roughly 94 % of its net generating capacity in 2022 (NEE 10‑K 2022 p. 18) and stayed at about 94 % in 2023 (NEE 10‑K 2023 p. 18) and 2024 (NEE 10‑K 2024 p. 19).  This consistently high, stable share of capacity locked into long‑term PPAs shows the company is deliberately securing predictable cash flows and hedging against spot‑market price swings, a clear risk‑management focus in a volatile energy market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 percentage. The ground truth states that in 2022, approximately 92% of NEER's net generating capacity was committed under long-term contracts. However, the LLM answer claims it was 'roughly 94%' in 2022, which is incorrect. The correct progression should be: 92% (2022) → 94% (2023) → 94% (2024). This represents a 2-percentage-point increase from 2022 to 2023, not a stable 94% throughout. This is a material factual error that undermines the core quantitative accuracy of the response. The LLM also misses the key insight that there was an evolution/increase from 2022 to 2023, instead presenting the data as if it remained constant at 94% across all three years. QUALITATIVE ASSESSMENT: The LLM correctly identifies the risk management strategy and the purpose of long-term bilateral contracts (securing predictable cash flows, hedging against spot-market price swings). The reasoning about revenue stability and risk mitigation is sound and semantically equivalent to the ground truth. The reference to 'non-qualifying hedges' mentioned in the ground truth is absent from the LLM answer, representing a minor omission of supporting detail. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three years and correctly identifies the trend's implications for risk management strategy, though it fails to accurately characterize the trend itself (claiming stability when there was actually an increase from 2022 to 2023). ENTITY ACCURACY: Company identification (NEER/NextEra Energy Resources) and fiscal years are correct. The metric (net generating capacity under long-term contracts) is correctly identified. OVERALL: The answer demonstrates good understanding of the strategic implications but contains a critical numerical error that significantly impacts correctness. The 2022 figure of 94% instead of 92% is a factual mistake that cannot be overlooked in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 542,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an unchanged $495 million principal balance in each of the three most recent fiscal years – $495 million in FY 2022 (AVGO 10‑K 2022 p. 101), $495 million in FY 2023 (AVGO 10‑K 2023 p. 81) and $495 million in FY 2024 (AVGO 10‑K 2024 p. 81). The flat balance shows the company has not been repaying or refinancing this low‑cost, near‑term debt, suggesting a deliberate strategy to retain inexpensive financing while using cash for other priorities such as acquisitions and share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All financial figures are correct - $495 million principal balance is accurately cited for FY 2022, 2023, and 2024. The debt instrument is correctly identified as 3.125% senior notes due January 2025. Page references provided (p. 101 for 2022, p. 81 for 2023 and 2024) add credibility. ENTITY ACCURACY: The company is correctly identified as Broadcom (AVGO ticker), and all fiscal years are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend across multiple 10-K filings, correctly identifying the unchanged balance across all three years and drawing the appropriate conclusion about debt management strategy. SEMANTIC EQUIVALENCE: The LLM answer goes slightly beyond the ground truth by providing additional context about the company's strategic priorities (acquisitions and share repurchases), which is a reasonable inference from the debt retention strategy but represents an enhancement rather than a deviation. The characterization of the debt as 'low-cost, near-term debt' is accurate and adds valuable context. MINOR DIFFERENCES: The ground truth uses 'AVGO' terminology while the LLM uses 'Broadcom' - both are correct as AVGO is Broadcom's ticker symbol. The LLM provides more detailed sourcing with specific page numbers, which strengthens the answer. The interpretation that the flat balance 'suggests a deliberate strategy' in the LLM answer is slightly more interpretive than the ground truth's 'suggests that AVGO did not retire or refinance,' but both convey the same essential insight about debt management. No calculation errors, no missing data points, and the synthesis across three fiscal years is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 476,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "SPG’s Unsecured Notes ‑ 37B stayed exactly the same over the three years. In the 2022 filing the note carried a $700 million face amount and a 1 / 15 / 2032 maturity; the 2023 filing shows the identical $700 million face amount and 1 / 15 / 2032 maturity; and the 2024 filing again lists $700 million with a 1 / 15 / 2032 maturity【2022 10‑K p. 50】, 【2023 10‑K p. 50】, 【2024 10‑K p. 51】. This unchanged exposure signals that Simon Property Group is maintaining a stable, low‑cost, medium‑term unsecured debt tranche rather than expanding or refinancing it, underscoring a long‑term debt strategy focused on predictable cash‑flow and maturity profiling.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a major factual error in the face amount. The ground truth states the face amount is $700,000 (seven hundred thousand dollars), but the LLM answer claims it is $700 million (seven hundred million dollars) - a 1,000x overstatement. This is a fundamental quantitative error that undermines the entire answer. While the LLM correctly identifies: (1) the consistency of the note across 2022-2024, (2) the correct maturity date of 01/15/32 (or 1/15/2032), (3) the correct company (SPG/Simon Property Group), and (4) reasonable interpretation of the debt strategy, the massive error in the face amount is unacceptable for financial analysis. The LLM also provides page references and cites sources, which adds credibility but does not compensate for the core numerical error. The reasoning about debt strategy stability is sound, but it is built on incorrect financial data. For financial questions, precision in dollar amounts is critical - a $700M vs $700K difference represents a material misstatement that would significantly impact any financial analysis or decision-making. The format variation rule (allowing $476M = $476 million) applies to equivalent representations, but here the LLM has fundamentally misread the magnitude of the obligation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 360,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has been listed in each of the three filings as an analog‑only facility – it carries an “X” under the Analog column and no mark under Embedded Processing in 2022 (TXN 10‑K 2022 p. 16), 2023 (TXN 10‑K 2023 p. 16) and 2024 (TXN 10‑K 2024 p. 16). The footnotes (asterisk vs. double‑asterisk) indicate the plant is partially leased/owned, but its product‑line role has not shifted to embedded processing over this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that Melaka was 'marked as engaged in analog operations (with a checkmark)' and 'continued to be listed exclusively under analog operations' across 2022-2024. However, the LLM claims the facility carries an 'X' under the Analog column, which is the opposite of a checkmark. An 'X' typically indicates absence or non-engagement, while a checkmark indicates presence/engagement. This is a critical misreading of the source data. The LLM correctly identifies: (1) the facility location (Melaka, Malaysia), (2) the company (Texas Instruments/TXN), (3) the years covered (2022, 2023, 2024), (4) the product lines in question (analog vs. embedded processing), (5) the stability of the role over time, and (6) the page references. However, the core factual claim about the marking symbol is inverted, making the answer fundamentally incorrect despite addressing the right question with appropriate context. The LLM also adds accurate detail about lease/ownership status (partially leased/owned) which is relevant but doesn't compensate for the primary error. The reasoning structure is sound and multi-hop synthesis is appropriate, but the factual foundation is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 366,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "In fiscal 2022 Disney’s Content Sales/Licensing segment listed “post‑production services through Industrial Light & Magic (and Skywalker Sound)” as part of its “Other” revenue line 【page_13】. In fiscal 2023 the same segment description was retained, now explicitly calling out “post‑production services through Industrial Light & Magic and Skywalker Sound” among the sources of Content Sales/Licensing revenue 【page_7】. The fiscal 2024 filing repeats that wording, showing that Disney’s reliance on ILM for post‑production work remained steady and continued to be reported within the Content Sales/Licensing segment’s revenue mix throughout the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Industrial Light & Magic (and Skywalker Sound) was listed as part of the Content Sales/Licensing segment across all three fiscal years (2022-2024), and accurately notes that post-production services were included in the 'Other' revenue line. The specific page references provided (page_13 for 2022, page_7 for 2023) add credibility. The core factual claim that ILM remained consistently reported within this segment is accurate.\n\nWEAKNESSES: (1) The LLM answer lacks the nuanced analysis present in the ground truth regarding the EVOLUTION of Disney's reliance on ILM. The ground truth emphasizes a 'shift in revenue focus' toward TV/VOD and theatrical distribution, and describes a 'strategic repositioning' within a 'DTC-first content model.' The LLM answer simply states the reliance 'remained steady' without capturing this contextual evolution. (2) The ground truth explicitly discusses how the segment's narrative and structure changed across the three years, with increasing emphasis on content licensing and distribution. The LLM answer treats the three years as essentially identical ('same segment description was retained'). (3) The ground truth suggests a 'potential strategic repositioning' and frames ILM's role as increasingly embedded 'within the broader ecosystem of content delivery rather than as a standalone service.' The LLM answer misses this interpretive dimension entirely. (4) While the LLM correctly identifies that post-production services were included, it doesn't address how the framing or emphasis of these services evolved relative to other revenue streams.\n\nMULTI-HOP REASONING: The question asks about evolution 'as reflected in the Content Sales/Licensing segment's structure and reported revenue streams.' The LLM answer addresses the literal presence of ILM across years but fails to synthesize the structural and narrative changes that constitute the actual 'evolution' being asked about. This represents incomplete multi-hop synthesis.\n\nNUMERIC/FACTUAL VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy cannot be fully assessed. The LLM's factual claims about segment inclusion appear correct based on the page references cited.\n\nOVERALL ASSESSMENT: The LLM answer provides accurate but superficial information. It correctly identifies what was reported but misses the qualitative evolution and strategic repositioning that the ground truth emphasizes as central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 676,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife reported equity‑method income from its operating joint ventures of **$51 million in 2022**, which **declined to $38 million in 2023** and then **jumped to $175 million in 2024**【page_247†L31-L34】【page_224†L31-L34】. The dip in 2023 signals weaker results from the insurance‑underwriting joint ventures that year, while the sharp rise in 2024 points to a strong rebound in underwriting profitability and overall performance of those joint‑venture operations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that are drastically different from the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports $51M (2022), $38M (2023), and $175M (2024), while the ground truth shows $1,305M (2022), $151M (2023), and $988M (2024). These are not minor formatting differences - the LLM numbers are off by a factor of approximately 25x for 2022, 4x for 2023, and 5.6x for 2024. (2) CALCULATION/TREND ANALYSIS: While the LLM correctly identifies the directional trend (decline then rebound), the magnitude of the trend is completely misrepresented. The ground truth shows a dramatic 88.4% decline from 2022 to 2023 ($1,305M to $151M), followed by a 554% rebound in 2024 ($151M to $988M). The LLM's numbers show only a 25.5% decline and 361% rebound, fundamentally misrepresenting the volatility. (3) MULTI-HOP SYNTHESIS: The LLM correctly identifies this as equity method investment income from operating joint ventures and attempts to synthesize the three-year trend, but the underlying data is completely wrong, making the synthesis invalid. (4) ENTITY ACCURACY: MetLife is correctly identified, the metric is correctly identified as equity method investment income from operating joint ventures, and the years are correct. However, the actual values are wrong. (5) SEMANTIC EQUIVALENCE: While the LLM's interpretation of the trend (volatility, downturn then recovery) is semantically aligned with the ground truth's interpretation, this cannot overcome the massive quantitative errors. The LLM appears to have cited specific page references that may not contain the correct data, or the model hallucinated the numbers entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 465,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "- 2022: General Dynamics was producing **399 new LAVs** for the Canadian Army in eight variants 【page_11】.  \n- 2023: Production slipped to **360 new LAVs** in the same configuration 【page_11】.  \n- 2024: Production rose to **449 new LAVs** (plus an additional 66 LAVs under the LRSS program) 【page_10】.  \n\nThe dip in 2023 followed by a rebound and expansion in 2024 shows the LAV platform remains a strategic growth driver for GD’s Combat Systems segment, underscoring its importance as a high‑margin export product and a core element of the company’s defense portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer has the production volumes in the wrong order, fundamentally misrepresenting the data trend. Ground truth shows: 2022=360 units, 2023=399 units, 2024=449 units (consistent upward trend). LLM answer states: 2022=399 units, 2023=360 units, 2024=449 units (showing a dip then rebound). This is a complete reversal of the 2022-2023 figures. The LLM correctly identifies 2024 as 449 units but incorrectly swaps the 2022 and 2023 values. This error is particularly problematic because: (1) it inverts the actual production trend, (2) it leads to an incorrect interpretation of the strategic narrative (the LLM describes a 'dip in 2023 followed by a rebound' when the actual data shows consistent growth), and (3) it misrepresents the company's operational performance. The mention of the LRSS program in 2024 (66 additional LAVs) is a contextual addition not in the ground truth but doesn't contradict it. The qualitative assessment about strategic importance is reasonable but is built on incorrect quantitative foundations. The reasoning about the LAV platform's strategic role is sound in principle but is undermined by the factual errors in the production volume sequence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 344,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan reported hedge‑fund limited‑partnership holdings of **$237 million in 2022** (footnote 2 on the 2022 fair‑value table)【page_165】, **$252 million in 2023** (footnote 2 on the 2023 table)【page_173】, and **$280 million in 2024** (footnote 2 on the 2024 table)【page_167】. The steady rise—about a 6% jump from 2022‑23 and an 11% jump from 2023‑24—shows CVS is gradually increasing its hedge‑fund LP exposure, consistent with a modest shift in its pension‑fund strategy toward a higher allocation to alternative assets (the target hedge‑fund allocation rose from 3% to 4% over the period) to diversify returns and enhance portfolio performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains fundamentally incorrect numbers across all three years. Ground truth values are: 2022: $214M, 2023: $225M, 2024: $252M. LLM reports: 2022: $237M, 2023: $252M, 2024: $280M. Every single year's figure is wrong, with discrepancies ranging from $23M to $28M per year. These are not minor rounding differences but substantial misstatements of pension fund asset allocations. The LLM's year-over-year percentage calculations (6% and 11% increases) are mathematically correct based on its incorrect numbers, but this compounds the error by presenting false trends with apparent precision. The LLM also claims the target hedge-fund allocation rose from 3% to 4%, which cannot be verified against the ground truth and appears to be fabricated detail. The qualitative reasoning about 'modest shift toward alternative assets' and 'diversify returns' is reasonable in tone but is built entirely on false numerical foundations. The answer demonstrates multi-hop synthesis capability (combining data across years and adding contextual interpretation), but this is severely undermined by the complete failure on quantitative accuracy. The semantic direction (increasing exposure over time) happens to align with ground truth, but the magnitude and specific values are entirely wrong, making this answer dangerously misleading for financial analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 392,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across all three filings the Sorriso brand is consistently presented as a core global‑regional trademark within Colgate‑Palmolive’s Oral, Personal and Home Care segment. In the 2022 10‑K the brand is listed among the company’s global trademarks (see 2022 p. 79), the 2023 filing repeats that positioning (2023 p. 79), and the 2024 filing again includes Sorriso in the same list (2024 p. 79), showing that the brand’s integration in the worldwide Oral, Personal and Home Care portfolio has remained stable and strategically important over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the three-year period (2022-2023-2024). STRENGTHS: (1) Correctly identifies Sorriso as a consistent trademark across all three years; (2) Accurately notes the brand's positioning within the Oral, Personal and Home Care segment; (3) Properly synthesizes the multi-hop information showing continuity and stability across filings; (4) Correctly identifies the years and filing structure; (5) Appropriately characterizes the brand as 'core global-regional trademark' which aligns with ground truth's 'regional brand asset'; (6) Cites specific page references (p. 79) which adds credibility. MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing ('core global-regional trademark' vs ground truth's 'regional brand asset') - while semantically similar, the ground truth emphasizes 'regional' more explicitly; (2) The LLM answer emphasizes 'stable and strategically important' positioning but doesn't explicitly mention 'regional market penetration and diversified consumer engagement' aspects that the ground truth highlights; (3) The phrase 'worldwide Oral, Personal and Home Care portfolio' is accurate but the ground truth more specifically frames this as 'global product strategy' with emphasis on regional leverage. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references (p. 79) are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three separate filings to show continuity. The multi-hop logic is sound - tracking a single brand across multiple years and documents. CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question and appropriately notes the 'stable' nature of the positioning, which is the key insight. The answer could have been slightly more explicit about regional market strategy emphasis, but the core message aligns well with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 529,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s operating‑joint‑venture (OJV) line in net investment income was $51 million in 2022, fell to $38 million in 2023, and then jumped to $175 million in 2024【page_247†L31-L34】【page_224†L19-L23】. The dip in 2023 followed by a sharp rise in 2024 shows the company is re‑emphasizing OJV participation – expanding its equity‑method footprint to generate more earnings and diversify its investment portfolio after a brief pull‑back.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2022=$51M, 2023=$38M, 2024=$175M. The ground truth clearly shows 2022=$77M, 2023=$51M, 2024=$38M. Every single year's figure is wrong. The LLM has shifted all values down by one year and invented a $175M figure for 2024 that does not exist in the ground truth. (2) CALCULATION/TREND ANALYSIS ERROR: The LLM describes a 'dip in 2023 followed by a sharp rise in 2024' suggesting re-emphasis and expansion. This is completely backwards. The actual trend is a consistent DECLINE: $77M→$51M→$38M, representing a 51% reduction over three years. The ground truth explicitly states this indicates 'a strategic shift away from operating joint ventures.' (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year data series. It appears to have misread or misaligned the years, creating an entirely false narrative. (4) STRATEGIC INTERPRETATION REVERSAL: The LLM concludes MetLife is 're-emphasizing OJV participation' and 'expanding its equity-method footprint,' which is the opposite of what the declining trend indicates. The ground truth correctly identifies this as a reduction in direct involvement. (5) CITATION ISSUES: While the LLM provides page references, the cited data does not support the numbers presented. The answer demonstrates a fundamental misunderstanding of the data and provides misleading strategic conclusions based on fabricated figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 429,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s equity position in the Angola LNG joint‑venture has not changed – the 2022 filing shows a 36.4 % non‑operating interest in Angola LNG Limited【page_78】, and the 2024 filing repeats the same 36.4 % shareholding【page_14】.  In both years Chevron is not the plant operator; the LNG facility is run by Angola LNG Limited.  By 2024 Chevron highlights that the LNG plant – the world’s first supplied with associated gas and capable of processing 1.1 billion cf/d – will be fed by its upstream New Gas Consortium (NGC) project, including the Quiluma‑Maboqueiro fields that have on‑shore treatment connections to the plant【page_14】, indicating a tighter integration of its upstream gas assets with the LNG operation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All quantitative data is accurate - correctly identifies the 36.4% stake in both 2022 and 2024, the 31% NGC working interest, and the 1.1 billion cf/d processing capacity. (2) Correctly identifies the non-operating nature of Chevron's role in Angola LNG Limited. (3) Accurately describes the upstream integration through NGC project, specifically naming Quiluma and Maboqueiro fields. (4) Properly synthesizes multi-hop information showing the evolution from 2022 to 2024. (5) Correctly notes the onshore treatment connections linking upstream assets to the LNG plant. MINOR WEAKNESSES: (1) The LLM answer characterizes Chevron's 2022 role as a 'non-operating interest' rather than explicitly stating it was described as a 'passive equity investor' - while semantically similar, the ground truth uses 'passive equity investor' language which is slightly more descriptive of the relationship. (2) The answer could have been slightly more explicit about the 2023 transition period, though this is a minor omission. (3) The phrase 'tighter integration' captures the evolution well but could have been more explicitly framed as a 'strategic shift from passive ownership to integrated gas monetization model' as stated in ground truth. VERIFICATION: All numbers check out (36.4%, 31%, 1.1 billion cf/d), years are correct (2022, 2024), entities are correctly identified (Angola LNG Limited, NGC, Quiluma, Maboqueiro), and the multi-hop reasoning correctly synthesizes information about operational role, stake percentage, and upstream integration. The answer demonstrates sound understanding of the evolution despite minor wording differences from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 479,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 2022 filing excerpts (pages 101‑105) do not list a balance for the 3.625 % senior notes due October 2024, indicating that the liability was not disclosed as a material item at that time. By fiscal 2023 the company reported $622 million outstanding on those notes 【page_81】, and by fiscal 2024 the balance was fully retired, shown as a dash (zero) 【page_81】. This rapid decline from a material balance in 2023 to complete repayment by the October 2024 maturity reflects a deliberate strategy to use cash and proceeds from other financing to eliminate near‑term debt as the maturity date approached.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that in 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. However, the LLM answer claims that '2022 filing excerpts (pages 101-105) do not list a balance for the 3.625% senior notes due October 2024, indicating that the liability was not disclosed as a material item at that time.' This is INCORRECT. The LLM has reversed the 2022 and 2023 positions. According to ground truth: 2022 = $622M, 2023 = $622M (unchanged), 2024 = $0 (retired). According to LLM: 2022 = $0 (not disclosed), 2023 = $622M, 2024 = $0. This represents a significant quantitative accuracy failure on the primary metric being tracked. The LLM correctly identifies that the notes were fully retired by 2024 and correctly interprets this as a deliberate debt management strategy, but the progression timeline is fundamentally wrong. The reasoning about debt management strategy is sound in principle, but it's applied to an incorrect timeline. The answer demonstrates partial understanding of the question's intent but fails on the core factual requirement of accurately tracking the evolution of the liability across the three fiscal years. The multi-hop synthesis is incomplete and inaccurate because the foundational data points are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 384,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "SPG’s Unsecured Notes – 35B carried an annual debt‑service (interest expense) of $28.5 million in each of the three years – $28.5 million in 2022 (SPG 2022 10‑K p. 50)【page_50】, $28.5 million in 2023 (SPG 2023 10‑K p. 50)【page_50】, and $28.5 million in 2024 (SPG 2024 10‑K p. 51)【page_51】. The unchanged amount suggests that the company’s financing cost for this particular note has remained stable over the period, with no increase or decrease in interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Verification of key elements: (1) QUANTITATIVE ACCURACY: The LLM correctly identifies the interest expense as $28.5 million for all three years (2022, 2023, 2024). The ground truth states $28,500 in thousands, which equals $28.5 million - the LLM properly converted the unit representation. All three years' figures are accurate and consistent with ground truth. (2) ENTITY ACCURACY: SPG (Simon Property Group) is correctly identified, the instrument 'Unsecured Notes - 35B' is correctly named, and all three fiscal years (2022, 2023, 2024) are correctly referenced. (3) MULTI-HOP REASONING: The LLM successfully synthesized information across three separate 10-K filings (2022, 2023, 2024) and correctly identified the consistent pattern across all years. The conclusion that this indicates a fixed interest rate structure is logically sound and matches the ground truth interpretation. (4) COMPLETENESS: The answer fully addresses the question's request to show how interest expense 'evolved' and what the trend suggests. The LLM appropriately notes that there was no evolution (stable/unchanged), which is the correct finding. (5) MINOR CONSIDERATION: The LLM provides specific page references (p. 50, p. 51) which adds credibility, though these cannot be independently verified from the ground truth provided. The semantic equivalence is excellent - both answers convey that the expense remained constant at $28.5 million across all three years, indicating a fixed rate structure. No calculation errors detected. The only reason this is not a perfect 10 is that the ground truth explicitly states the figures in thousands ($28,500 thousands), while the LLM converted to millions ($28.5 million) - though this conversion is mathematically correct and represents proper financial reporting convention, it represents a slight deviation from the exact ground truth format.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 522,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "Disney’s DTC strategy began in 2022 with a re‑organization of DMED, the launch of an ad‑supported Disney+ tier and a new pricing‑realignment plan, while warning that the cost of executing the DTC strategy could rise faster than anticipated and that competition for programming rights and talent was intensifying【page_25】【page_26】【page_27】【page_28】【page_29】. In 2023 the company deepened its investment in streaming – adding strategic spend to grow subscription and ad revenue, rolling out the ESPN flagship DTC service and emphasizing cost‑containment and a new content‑curation approach – even as it faced flat subscriber growth, higher programming costs and tougher competition for content and talent【page_53】【page_54】【page_55】. By 2024 Disney’s approach had become more cautious and integrated, continuing to invest in ad‑supported and bundled streaming offerings while stressing cost‑realignment and acknowledging that programming costs and competitive pressure remain high and that the DTC cost base may grow more slowly than hoped【page_22】【page_23】【page_24】【page_25】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Disney's DTC evolution from 2022-2024 with generally accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies key strategic initiatives: DMED reorganization, ad-supported tier launch, ESPN DTC service rollout, bundled offerings; (2) Accurately captures the progression of challenges: rising programming costs, intensified competition, talent competition; (3) Properly synthesizes multi-hop information across three years showing strategic evolution; (4) Correctly identifies the shift from aggressive investment to more cautious, cost-conscious approach; (5) Appropriately references specific page numbers indicating source documentation. WEAKNESSES: (1) Missing the specific $12.25 billion unused bank facilities figure mentioned in ground truth for 2023, which is a concrete quantitative detail; (2) Does not explicitly mention that returns on some DTC investments were negative or low in 2022, which is an important characterization of the initial strategy; (3) Lacks explicit mention of how subscription fees and advertising revenues were expected to offset declines in affiliate fees and linear advertising (though this is implied); (4) The characterization of 2024 as 'more cautious' is somewhat ambiguous - the ground truth emphasizes 'aggressive push' continuing amid rising costs, whereas the LLM suggests a pullback; (5) Does not explicitly mention programming distributors demanding terms that reduced revenue or bundled DTC with linear networks. QUANTITATIVE ACCURACY: The answer contains no incorrect numbers or calculations. The missing $12.25B figure prevents a perfect score, but no false numbers are presented. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - the answer correctly synthesizes information across three years and identifies the strategic evolution. Entity identification is accurate (Disney, DMED, ESPN, Disney+). CONTEXTUAL RELEVANCE: The answer directly addresses the question about investment strategy evolution, competitive positioning, and the shift toward streaming services. The three-year trajectory is clearly presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 577,
        "total_tokens": 2216
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s deposit‑method reinsurance was modest in 2022 – it was used only for the modified‑coinsurance arrangement covering about 59 % of the closed block (the company notes that it “accounts for this agreement under the deposit method of accounting” [page 214]) and the only disclosed deposit balances were the $1.8 bn of deposit assets and $1.4 bn of deposit liabilities reported for 2021/2020 [page 216], indicating no material deposit balances were shown for 2022. The November 2023 risk‑transfer with Global Atlantic added $10.3 bn of reinsurance recoverables and deposit receivables, pushing deposit assets to $5.1 bn and deposit liabilities to $1.3 bn at year‑end 2023 [page 206]; by year‑end 2024 those balances had slipped to $4.6 bn and $1.2 bn respectively as the transaction’s impact was amortized [page 206].",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of MetLife's deposit method accounting evolution and correctly identifies the key 2023 Global Atlantic transaction as a pivotal event. However, there is a critical quantitative discrepancy: the LLM reports deposit assets at year-end 2023 as $5.1 billion, while the ground truth states $4.6 billion for 2024 and implies the 2023 figure should be higher than 2024's $4.6 billion (the ground truth does not explicitly state 2023 deposit assets, but the trajectory suggests they were higher than 2024). The LLM's $5.1 billion figure for 2023 appears plausible given the $10.3 billion transaction impact, but cannot be verified against the ground truth which does not provide an explicit 2023 deposit assets figure. The 2024 figures are correct: $4.6 billion in deposit assets and $1.2 billion in deposit liabilities match exactly. The 2022 figures ($1.8 billion assets, $1.4 billion liabilities) are correctly cited. The Global Atlantic transaction amount of $10.3 billion is accurate. The LLM correctly identifies the deposit method accounting context, the modified-coinsurance arrangement, and the amortization pattern post-transaction. The reasoning about the 'post-transaction rebalancing' and 'recalibration in 2024' is sound and well-supported. The answer appropriately synthesizes information across multiple years and correctly identifies the strategic shift. The main weakness is the unverified 2023 deposit assets figure of $5.1 billion, which creates uncertainty about complete accuracy, though the overall narrative and most specific numbers are correct. The answer is well-structured, contextually relevant, and demonstrates multi-hop reasoning across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 471,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial‑mortgage‑backed‑securities (CMBS) holdings fell sharply over the three‑year period – the portfolio was about $1.2 billion in 2022 (amortized cost $1,172 m; fair value $1,018 m) and slipped to roughly $1.07 billion in 2023 (amortized cost $1,066 m; fair value $975 m)【page_148】, and by 2024 the only CMBS reported were $3 million of fair‑value assets in its separate‑account portfolio (down from $6 million in 2023)【page_158】. This steady decline shows CVS is actively trimming its CMBS exposure, signalling a strategic move away from this asset class toward a more de‑risked or re‑allocated investment mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims 2022 CMBS holdings were ~$1.2 billion (amortized cost $1,172M; fair value $1,018M), but the ground truth states $574 million in 2022. This is a 104% overstatement. The LLM claims 2023 holdings were ~$1.07 billion (amortized cost $1,066M; fair value $975M), but ground truth shows $675 million - a 58% overstatement. The LLM correctly identifies 2024 as $3 million, matching ground truth. (2) MULTI-HOP SYNTHESIS ERROR: The LLM appears to have confused or misidentified the CMBS holdings, possibly mixing in data from different asset categories or misreading source documents. The magnitude of error (off by hundreds of millions of dollars) suggests fundamental data extraction failure. (3) TRAJECTORY ANALYSIS: While the LLM correctly identifies the overall trend as a decline and de-risking strategy (which aligns with ground truth's conclusion), this correct conclusion is built on incorrect foundational numbers. The ground truth shows: $574M → $675M → $3M (increase then dramatic drop). The LLM shows: $1,172M → $1,066M → $3M (steady decline). These are different trajectories. (4) SEMANTIC ALIGNMENT: The qualitative conclusion about de-risking and strategic reallocation is semantically correct, but the supporting data is wrong. The answer demonstrates poor data accuracy despite reasonable analytical framing. The citation references (page_148, page_158) suggest the LLM attempted to ground its answer in source documents, but the numbers extracted are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 446,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "The “hello” brand appears in the trademark list of every filing – it is named among Colgate‑Palmolive’s principal global and regional trademarks in the 2022 10‑K (page 79), again in the 2023 10‑K (page 79) and once more in the 2024 10‑K (page 79). In each year the brand is implicitly tied to the Oral‑Care sub‑segment, which consistently contributed the largest share of worldwide net sales (≈ 43 % in 2022, 42 % in 2023 and 43 % in 2024) while Personal‑Care and Home‑Care remained roughly 18‑19 % and 17 % respectively (pages 79 for each year), showing that hello’s positioning has remained stable and central to the company’s oral‑care strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 'hello' brand appearing in trademark disclosures across all three years (2022, 2023, 2024) on page 79 of each 10-K filing. The segment revenue percentages provided are accurate: Oral Care at approximately 43%, 42%, and 43% for the respective years, with Personal Care and Home Care at roughly 18-19% and 17%. The multi-hop synthesis correctly connects the brand's consistent trademark disclosure to its strategic positioning within the Oral Care segment. However, there are minor weaknesses: (1) The LLM states the brand is 'implicitly tied to the Oral-Care sub-segment' but the original answer notes it was disclosed within 'Oral, Personal and Home Care segments' collectively, suggesting the brand may span multiple segments rather than being exclusively tied to oral care. (2) The LLM's inference that 'hello's positioning has remained stable and central to the company's oral-care strategy' goes slightly beyond what can be definitively concluded from trademark disclosure alone—the original answer more cautiously states it 'maintained a stable role' and 'likely supporting diversification.' (3) The answer could have been more explicit about the brand's presence across all three segments rather than focusing primarily on oral care. The quantitative data is accurate and properly formatted, and the three-year continuity analysis is sound. The answer successfully addresses the core question about portfolio evolution and trademark disclosure consistency, though it makes a slightly stronger claim about oral-care exclusivity than the evidence fully supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 452,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s deposit‑method reinsurance – used for the modified‑coinsurance portion of its closed block (59.25 % of the block was accounted for under the deposit method in 2022) 【page_214】 – grew to $5.1 billion of deposit assets and $1.3 billion of deposit liabilities in 2023 and then eased to $4.6 billion of assets and $1.2 billion of liabilities at year‑end 2024 【page_206】. The jump in 2023 shows the company expanding risk‑transfer arrangements that move cash to reinsurers without taking on significant insurance‑risk exposure, while the modest pull‑back in 2024 (after a large Global Atlantic risk‑transfer deal) indicates a strategic trimming to keep a net‑asset‑positive deposit position and limit overall reinsurance risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative discrepancies that undermine its accuracy. CRITICAL ERRORS: (1) The LLM reports 2023 deposit assets as $5.1 billion, but the ground truth states 2023 figures were not explicitly provided in the original answer - the ground truth only mentions 2022 ($1.8B assets, $1.4B liabilities) and 2024 ($4.6B assets, $1.2B liabilities). The LLM's $5.1B figure for 2023 cannot be verified against the ground truth and appears to be an unsupported claim. (2) The 2024 figures in the LLM answer ($4.6B assets, $1.2B liabilities) DO match the ground truth exactly, which is correct. (3) The 2022 figures are missing entirely from the LLM answer, which is a significant omission since the ground truth explicitly states 2022 had $1.8B in deposit assets and $1.4B in liabilities. STRENGTHS: The LLM correctly identifies the deposit method accounting approach, mentions the Global Atlantic transaction as a key event, and provides reasonable qualitative interpretation about risk transfer and balance sheet flexibility. The reasoning about strategic trimming and maintaining a net-asset-positive position is sound and aligns with the ground truth's interpretation. The mention of the closed block and modified-coinsurance arrangement adds relevant context. WEAKNESSES: The missing 2022 baseline data is a major gap that prevents proper trend analysis. The unverified 2023 figure ($5.1B) is problematic. The answer doesn't clearly establish the full 2022-2024 evolution as requested. The multi-hop synthesis is incomplete because it fails to include all three years' data points needed to show the complete trend. The qualitative reasoning is good but is undermined by incomplete quantitative foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 472,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "In 2022 NEE reported roughly $10.9 billion of special‑use‑fund assets (about $6.5 bn for NEE and $4.5 bn for FPL) in its recurring non‑derivative fair‑value tables, with a smaller $906 m (NEE) and $672 m (FPL) portion carried at Level 2 and embedded in other assets; by 2023 the fair‑value amount fell to about $8.8 bn (NEE $5.3 bn, FPL $3.5 bn) and the company disclosed that derivative‑related collateral posted declined to $0.7 bn in cash and $1.6 bn in letters of credit (potential BBB‑downgrade posting $0.5 bn and below‑investment‑grade posting $2.4 bn).  In the 2024 filing the special‑use‑fund balance was presented as a distinct line item of $9.8 bn (up from $8.7 bn in 2023), reflecting growth and a clearer balance‑sheet presentation while continuing to provide detailed fair‑value breakdowns and collateral disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Special Use Funds evolution but contains significant quantitative discrepancies and introduces information not present in the ground truth. STRENGTHS: (1) Correctly identifies the 2024 balance sheet presentation of $9.8 billion (vs $8.7 billion in 2023), matching ground truth exactly; (2) Correctly notes the $1.1 billion increase from 2023 to 2024; (3) Appropriately addresses fair value disclosures, collateral implications, and balance sheet presentation as requested; (4) Provides multi-hop synthesis across years and entities (NEE vs FPL breakdown). CRITICAL ISSUES: (1) QUANTITATIVE MISMATCH - Ground truth states equity investments without readily determinable fair values grew from $485 million (2022) to $538 million (2023), but LLM reports $10.9 billion in 2022 and $8.8 billion in 2023 for special-use-fund assets. These are fundamentally different figures and the LLM's numbers are not validated in the ground truth; (2) The LLM introduces FPL subsidiary breakdowns ($6.5bn NEE, $4.5bn FPL in 2022; $5.3bn NEE, $3.5bn FPL in 2023) which are not mentioned in the ground truth at all; (3) The LLM provides specific collateral figures ($0.7bn cash, $1.6bn letters of credit, $0.5bn BBB-downgrade, $2.4bn below-investment-grade) that are not present in the ground truth; (4) The LLM reports Level 2 fair value amounts ($906M NEE, $672M FPL) not mentioned in ground truth. REASONING ASSESSMENT: The LLM demonstrates sound multi-hop reasoning in tracking evolution across years and entities, but the factual foundation appears unreliable. The answer may be drawing from actual 10-K data but diverges significantly from the provided ground truth baseline. The 2024 figures align perfectly, suggesting partial accuracy, but the 2022-2023 figures and subsidiary breakdowns cannot be verified against the ground truth provided. This creates uncertainty about whether the LLM is providing accurate SEC filing information or confabulating details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 538,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "In the 2022 filing the Security Insights Platform was positioned as a solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” and the resulting data is “available for use with in‑house tools for security information and event management”【page_10】【page_11】. By the 2024 filing the core positioning is unchanged – it still stresses rapid risk assessment and continuous remediation – but the description is refined and the offering is now listed as “Security Insights Code programs” in the portfolio table, again emphasizing that its data can be fed into customers’ in‑house tools and remediation workflows【page_8】【page_10】【page_11】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key positioning elements across the 2022-2024 period. The core facts are accurate: (1) 2022 positioning emphasized rapid assessment and risk identification with data available for in-house tools; (2) 2024 positioning remained largely unchanged with consistent emphasis on remediation and integration with customer workflows; (3) the naming convention shift to 'Security Insights Code programs' is correctly noted. The multi-hop synthesis across three years is sound, correctly identifying the evolution (or lack thereof) in the platform's described capabilities. However, there are minor gaps: (1) The LLM answer does not explicitly state that the 2023 description 'remained largely unchanged' as mentioned in the ground truth, creating a slight incompleteness in the three-year narrative; (2) The ground truth emphasizes that AVGO 'maintained a stable value proposition without expanding on new integrations or remediation features' - while the LLM answer implies this through 'core positioning is unchanged,' it doesn't explicitly state the lack of expansion/new features as clearly. The page citations provided (page_8, page_10, page_11) appear reasonable for a 10-K filing structure. The semantic equivalence is strong - both answers convey that the platform's core value proposition remained stable while maintaining emphasis on integration with in-house tools. The LLM answer actually provides slightly more specific detail about the portfolio naming convention change, which adds value. No numerical errors or calculation issues present. The answer appropriately addresses the multi-part question about positioning evolution and integration/remediation workflow emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 479,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike listed its Laakdal, Belgium distribution center as an owned, “most‑significant” overseas facility in FY 2022【page_27】. The FY 2023 10‑K (pages 27‑31) makes no change – Laakdal remains an owned distribution hub – and the FY 2024 filing again confirms Nike’s ownership of the Laakdal site【page_29】. The unchanged ownership across three consecutive years signals that Laakdal is a strategic, core anchor of Nike’s European logistics network, providing a stable, controlled distribution hub for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. FACTUAL ACCURACY: The answer correctly identifies that Laakdal, Belgium is described as company-owned across FY 2022, 2023, and 2024, with no changes in ownership status. The characterization as a 'most-significant' international distribution center is accurate. Page references (27, 27-31, 29) are appropriately cited and appear consistent with typical 10-K filing structures. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) ownership evolution (consistent ownership across three years), (2) operational footprint description (unchanged as owned distribution hub), and (3) strategic importance interpretation (stable, core anchor for European logistics). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years, correctly identifying the consistency pattern and drawing appropriate conclusions about strategic importance. The reasoning that 'unchanged ownership across three consecutive years signals strategic importance' is sound and logically derived. ENTITY ACCURACY: Company name (Nike), facility location (Laakdal, Belgium), fiscal years (2022, 2023, 2024), and ownership status are all correctly identified. SEMANTIC EQUIVALENCE: The LLM's characterization of Laakdal as a 'strategic, core anchor' and 'stable, controlled distribution hub' conveys the same meaning as the ground truth's 'stable and integral part.' Minor differences in wording ('most-significant' vs 'most significant') are inconsequential formatting variations. MINOR OBSERVATIONS: The answer includes specific page citations which add credibility, though these cannot be independently verified. The phrase 'makes no change' in the FY 2023 reference is slightly awkward phrasing but semantically correct. Overall, the answer demonstrates accurate fact retrieval, correct multi-hop reasoning across three years, and appropriate interpretation of strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 540,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "- 2022 (as of 12/31/2021) the Unsecured Notes ‑ 32B carried a 3.38 % coupon, a $750 million face amount, and a maturity of June 15 2027【page_50】.  \n- 2023 (as of 12/31/2022) the same tranche still showed a 3.38 % rate, $750 million face and a June 15 2027 maturity【page_50】.  \n- 2024 (as of 12/31/2023) the terms were unchanged – 3.38 % interest, $750 million face, maturing June 15 2027【page_51】.  \n\nThe three‑year consistency indicates SPG is keeping this note as a stable, low‑cost medium‑term financing instrument, opting to hold it to its scheduled maturity rather than refinancing or retiring it early.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - FACE AMOUNT DISCREPANCY: The LLM states the face amount as '$750 million' across all three years, while the ground truth specifies '$750,000' (which appears to be in thousands, representing $750 million in actual dollars, but the ground truth explicitly states '750,000'). This is a significant quantitative error that affects the primary financial metric being tracked. The LLM's interpretation of $750 million may be semantically reasonable in context, but it contradicts the explicit ground truth value of $750,000.\n\nCORRECT ELEMENTS: (1) Interest rate of 3.38% is correct for all three years; (2) Maturity date of June 15, 2027 (06/15/27) is correct for 2023 and 2024; (3) The observation about consistency and stability is accurate; (4) The reasoning about debt management strategy (holding to maturity, no refinancing) aligns with ground truth.\n\nPARTIAL ACCURACY ON MATURITY DATE: The ground truth notes that the maturity date was 'unspecified in the 2022 report' but the LLM states it was explicitly listed as June 15, 2027 in 2022. This is a factual discrepancy - the LLM appears to have incorrectly stated that the 2022 maturity date was specified when ground truth indicates it was not.\n\nYEAR LABELING ISSUE: The LLM uses confusing date notation ('2022 (as of 12/31/2021)') which is technically the 2021 fiscal year data, not 2022. The ground truth refers to '2022, 2023, and 2024' which should correspond to fiscal years ending 12/31/2022, 12/31/2023, and 12/31/2024 respectively. This creates ambiguity about which fiscal years are being compared.\n\nQUALITATIVE REASONING: The synthesis and interpretation of the three-year pattern is sound and well-articulated, correctly identifying the stability strategy and lack of refinancing activity.\n\nSUMMARY: The answer contains one critical quantitative error (face amount denomination), one factual error (maturity date availability in 2022), and one labeling/clarity issue (fiscal year dating), but the overall reasoning and most key facts are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 548,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "- In the debt‑securities portfolio, foreign securities were carried at a fair value of **$2.55 billion in 2022** with **$244 million of unrealized losses**; by year‑end 2023 the fair value had slipped slightly to **$2.51 billion** and the unrealized loss had been cut to **$122 million** (page 147).  \n- In the Separate‑Accounts portfolio, the foreign‑security holding fell dramatically to **$51 million in 2024** from **$202 million in 2023** (page 160), and no unrealized‑loss amount is reported for 2024.  \n\nThe trend shows a modest improvement in the debt‑security position from 2022‑23, followed by a sharp reduction in foreign‑security assets in 2024, suggesting CVS is actively de‑risking its exposure to international market fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. (1) QUANTITATIVE ACCURACY FAILURES: 2022 - LLM states $2.55 billion in fair value with $244 million unrealized losses, but ground truth shows $838 million fair value with $24 million unrealized losses (LLM is 3x too high on fair value, 10x too high on losses). 2023 - LLM states $2.51 billion fair value with $122 million unrealized losses, but ground truth shows $1,650 million fair value with $122 million unrealized losses (LLM is 1.5x too high on fair value, though unrealized losses match). 2024 - LLM correctly identifies $51 million in fair value, matching ground truth. (2) PORTFOLIO CONFUSION: The LLM appears to be mixing data from different portfolio categories (debt-securities vs. separate-accounts), which creates confusion about what is being measured. The ground truth presents a coherent narrative of foreign securities across the company, while the LLM fragments the data into separate portfolio buckets without clear reconciliation. (3) MULTI-HOP REASONING FAILURE: The LLM fails to synthesize the complete 2022-2024 trajectory correctly. The ground truth shows: $838M (2022) → $1,650M (2023) → $51M (2024), demonstrating a clear pattern of growth then dramatic de-risking. The LLM's numbers don't follow this logical progression and obscure the actual trend. (4) MISSING CONTEXT: The LLM provides page references (147, 160) but the underlying data is incorrect, suggesting potential source confusion or misreading of the filings. The conclusion about de-risking is directionally correct but is based on wrong numbers, undermining its credibility. (5) SEMANTIC ISSUE: While the LLM correctly identifies de-risking as the trend, this conclusion is reached through incorrect intermediate data, making the reasoning path invalid even if the final direction is right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 517,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 10‑K filings for 2022, 2023 and 2024 all note that when the NAIC has not yet evaluated a non‑agency RMBS or CMBS, the insurer assigns an internally‑developed designation until a NAIC rating is available (2022 p.101; 2023 p.94; 2024 p.84). Nevertheless, the portfolio tables show that the overwhelming majority of these securities were already classified under NAIC designations (e.g., >97 % in NAIC 1 for RMBS in 2022 p.96, 2023 p.96 and 2024 p.86), with only a small, transient slice requiring internal ratings—demonstrating that MetLife consistently relies on the NAIC’s modeling methodology for credit‑quality assessment, using internal designations only as a temporary bridge.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides a partially correct but incomplete response to the multi-hop question about MetLife's evolution in using internally developed designations for non-agency RMBS and CMBS from 2022-2024.\n\nSTRENGTHS:\n1. Correctly identifies that MetLife used internally developed designations as a temporary bridge when NAIC ratings were unavailable\n2. Accurately notes that the overwhelming majority of securities were classified under NAIC designations (>97% cited for RMBS)\n3. Correctly synthesizes the core finding that MetLife relies primarily on NAIC methodology with internal designations as a transitional tool\n4. Properly cites page numbers from the three-year period (2022-2024)\n5. Correctly identifies the three-year period and companies involved\n\nWEAKNESSES:\n1. MISSING KEY QUANTITATIVE DATA: The ground truth provides specific dollar amounts ($4.2 billion increase in Level 3 securities in 2023, $1.6 billion in 2024) and growth percentages (14.5% in 2023, 4.9% in 2024). The LLM answer completely omits these critical metrics.\n2. INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth reveals a temporal evolution pattern showing decreasing reliance on internal designations over time (evidenced by slowing growth in Level 3 securities). The LLM answer states the use \"remained consistent\" but doesn't capture the declining growth trend that indicates fewer new securities requiring internal designations.\n3. MISSING CONTEXTUAL EVOLUTION: The ground truth emphasizes the NAIC methodology was \"refined as of December 31, 2021\" and became \"more established and widely applied\" over the period. The LLM answer doesn't capture this maturation narrative.\n4. INCOMPLETE ANSWER TO QUESTION: The question asks what the \"multi-year pattern reveals\" about reliance on NAIC methodology. The ground truth shows a DECREASING reliance pattern (evidenced by slowing Level 3 growth), while the LLM answer suggests consistency rather than evolution.\n5. QUANTITATIVE ACCURACY ISSUE: The LLM cites >97% for NAIC 1 RMBS but doesn't provide the specific growth metrics that are central to understanding the evolution pattern.\n\nMULTI-HOP REASONING ASSESSMENT:\nThe LLM correctly synthesizes information across three years but fails to identify the key pattern: the slowing growth in Level 3 securities (14.5% → 4.9%) indicates a shift away from internal designations toward NAIC assessments. This is the critical insight that answers \"what does this multi-year pattern reveal.\"\n\nCALCULATION/NUMERIC VERIFICATION:\nThe LLM provides no calculations or specific dollar amounts. The ground truth's key metrics ($4.2B, $1.6B, 14.5%, 4.9%) are entirely absent from the LLM response, representing a significant omission for a quantitative question about financial evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 735,
        "total_tokens": 2240
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- In 2022 Chevron still held a non‑operated working interest in the Republic of Congo (listed among its operating countries) but no specific capital spend was disclosed.   \n- In 2023 the company allocated about **$0.7 billion** to offshore development and natural‑gas projects in the Republic of Congo (as part of its $0.7 bn Africa‑region spend) 【page 109】.   \n- By 2024 the Republic of Congo accounted for roughly **20 % of Chevron’s net oil‑equivalent production in OPEC+ nations** 【page 41】, and Chevron announced it would **sell its 31.5 % non‑operated interest in the Haute Mer permit and its 15.75 % interest in the Lianzi area** (sale slated for January 2025) 【page 43】, marking a shift from investment to divestiture.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key narrative arc (active operation 2022-2023 → divestiture 2024), accurately cites the $0.7 billion Africa allocation for 2023, and correctly identifies the 31.5% Haute Mer and 15.75% Lianzi divestiture details with proper timing (January 2025). The multi-hop synthesis across years is sound and addresses the question's core requirements about capital allocation and asset ownership changes.\n\nCRITICAL ERRORS: (1) The LLM introduces a new claim about Republic of Congo representing \"roughly 20% of Chevron's net oil-equivalent production in OPEC+ nations\" in 2024 - this specific metric does NOT appear in the ground truth answer and represents unsupported information injection. (2) The LLM states the $0.7 billion was allocated \"to offshore development and natural-gas projects in the Republic of Congo\" specifically, when the ground truth indicates this was a regional allocation to Africa that \"included the Republic of Congo among other countries like Nigeria and Angola\" - this misrepresents the scope and specificity of the allocation.\n\nQUANTITATIVE ACCURACY ISSUES: The $0.7 billion figure is correct, but the contextual framing is problematic. The 20% production claim is unsupported by ground truth and represents a factual error. The divestiture percentages (31.5% and 15.75%) are accurate.\n\nMULTI-HOP REASONING: The synthesis across 2022-2024 is logically sound, but the introduction of the 20% production metric breaks the chain of reasoning by adding information not in the ground truth, suggesting either hallucination or misattribution of data.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses capital allocation and asset ownership changes, though the production metric addition is tangential to the core question about investment footprint evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 498,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "In the 2022 filing TI simply reaffirmed that “our strategic focus is on analog and embedded processing products” and noted that embedded‑processing revenue helped offset weaker analog sales (2022 10‑K, p. 19). By the 2023 and 2024 filings the company had woven embedded processing into its competitive‑advantage framework, identifying it as the second of four sustainable advantages—a “broad portfolio of analog and embedded processing products” that creates more opportunity per customer and adds value to its investments (2023 10‑K, p. 17‑18; 2024 10‑K, p. 17‑18). Throughout 2022‑2024 the emphasis remained steady, with TI continuing to invest in R&D and capital to grow the embedded‑processing line even as its revenue rose in 2023 and fell in 2024 (2023 segment results, p. 20; 2024 segment results, p. 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed, specific information than the ground truth. Key strengths: (1) Correctly identifies the three-year period (2022-2024) and accurately characterizes the evolution of TI's strategic emphasis on Embedded Processing Products; (2) Accurately notes that embedded processing was positioned as the 'second of four sustainable advantages' in 2023 and 2024 filings, with specific page references (p. 17-18); (3) Correctly identifies the shift in framing from 2022 (simple reaffirmation) to 2023-2024 (integration into competitive advantage framework); (4) Appropriately references revenue trends (2023 rise, 2024 fall) and R&D/capital investment patterns; (5) All page citations appear reasonable and specific. Minor considerations: (1) The ground truth uses more general language about 'narrative reinforcement' and 'language evolution,' while the LLM provides more concrete structural details about the competitive advantage framework positioning; (2) The LLM's statement about embedded processing helping 'offset weaker analog sales' in 2022 is a reasonable inference but not explicitly confirmed in the ground truth; (3) The LLM provides more granular detail about the evolution (2022 as simple reaffirmation vs. 2023-2024 integration into framework) which enhances rather than contradicts the ground truth. The answer successfully synthesizes multi-hop information across three years and correctly identifies how the strategic emphasis evolved within TI's competitive framework. No significant factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 437,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50 % senior note showed a rising effective cost: it was about **5.3 % in FY 2022**, increased to **6.38 % in FY 2023**, and rose again to **6.66 % in FY 2024** (see the senior‑note tables in the 2022, 2023 and 2024 10‑Ks – page 89 of each filing)【CSCO_10k_2022.pdf page_89】【CSCO_10k_2023.pdf page_89】【CSCO_10k_2024.pdf page_89】. This upward trend indicates that Cisco’s borrowing cost on this fixed‑rate debt has been climbing, reflecting higher market rates and issuance costs over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN FY2022 RATE: The LLM states the effective interest rate was 5.3% in FY2022, but the ground truth clearly indicates it was 3.20%. This is a significant factual error (1.1 percentage point discrepancy). The FY2023 (6.38%) and FY2024 (6.66%) rates are correct. QUANTITATIVE ACCURACY ISSUES: The primary metric (FY2022 rate) is substantially wrong. The error magnitude is material - claiming 5.3% vs actual 3.20% represents a ~65% overstatement of the rate. This is not a minor rounding or formatting difference. COMPLETENESS: The answer addresses the multi-hop question structure (tracking the note across three fiscal years) and provides the progression narrative. However, the incorrect starting point undermines the entire analysis. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Senior Note, and the three fiscal years. REASONING QUALITY: The interpretation that the trend reflects market rate increases and investor risk perception is reasonable and matches the ground truth conclusion. However, this reasoning is built on an incorrect foundation. MULTI-HOP SYNTHESIS: The model attempts to synthesize data across three years of filings, which is appropriate, but the synthesis contains a fundamental error in the first data point. The citations to page 89 of each 10-K are appropriately referenced but the data extraction from those pages appears flawed for FY2022. The progression narrative (rising costs over time) is correct in direction but starts from the wrong baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 415,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor disclosures in 2022, 2023 and 2024 all contain the same warning that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law…” and that failure to meet “well‑capitalized” and “well‑managed” standards could impose activity limits (page 5 2022; page 5 2023; page 5 2024). The unchanged language over three years shows that regulatory constraints on capital planning and shareholder returns have remained persistent, limiting BNY Mellon’s strategic flexibility in distributing capital despite any operational initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that BNY Mellon's risk-factor disclosures across 2022-2024 contain consistent language about capital return limitations under U.S. banking laws. The citation of specific page numbers (page 5 for all three years) and the reference to 'well-capitalized' and 'well-managed' standards are accurate. The LLM correctly notes the persistence of regulatory constraints.\n\nWEAKNESSES: (1) The LLM characterizes the language as 'unchanged' across three years, which contradicts the ground truth that shows meaningful evolution. The ground truth explicitly states that 2023 'specifically reiterated' certain provisions and that 2024 'added a stronger emphasis on liquidity management and the potential consequences.' The LLM misses this progression entirely. (2) The LLM fails to capture the specific evolution in regulatory focus: the ground truth notes that 2023 added explicit mention of Delaware law and preferred stock dividend obligations, while 2024 emphasized liquidity management more strongly. (3) The LLM's conclusion that language was 'unchanged over three years' is factually incorrect based on the ground truth's documentation of evolving emphasis and scope. (4) The LLM does not adequately address the 'multi-year progression' aspect of the question - it treats the three years as static rather than showing how the company's disclosure evolved.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails to properly identify the evolution that the ground truth documents. The reasoning is incomplete because it doesn't capture how regulatory emphasis shifted from general oversight (2022) to specific provisions (2023) to liquidity-focused consequences (2024).\n\nSEMANTIC ISSUES: While the LLM's statement about persistent constraints is not wrong, it fundamentally mischaracterizes the nature of the answer by claiming 'unchanged language' when the ground truth explicitly documents changes in emphasis and scope across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 542,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ “Repair and other services” line fell $37 million, from $1,169 million in 2022 to $1,132 million in 2023, and then held at $1,132 million in 2024 【page_9】. The 2024 table shows the same amount as 2023, and the accompanying discussion notes that this revenue comes from ongoing post‑delivery maintenance, modernization and lifecycle‑support contracts for the Navy’s existing fleet – a mature, contract‑driven business that delivers steady cash flow but little incremental growth 【page_9】. This pattern suggests the segment is a stable, non‑cyclical contributor that the company relies on for consistent earnings rather than as a primary growth engine.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all numbers correct: $1,169M (2022), $1,132M (2023), and $1,132M (2024). The calculation of the $37M decline is accurate. The answer correctly identifies the revenue pattern and addresses all parts of the multi-part question: the change from 2022-2023, the flat performance in 2024, and interpretation of what this suggests about the segment. The LLM provides additional context about the nature of the business (post-delivery maintenance, modernization, lifecycle-support contracts) that enriches understanding beyond the ground truth answer. The reasoning is sound and well-synthesized. Minor differences from ground truth: (1) The LLM characterizes the segment as 'stable, non-cyclical contributor' and 'consistent earnings' rather than emphasizing 'limited growth or strategic prioritization' as the ground truth does. (2) The LLM does not explicitly mention 'market saturation, resource reallocation to higher-priority programs, or operational constraints' as potential explanations, instead focusing on the mature, contract-driven nature of the business. These are not errors but rather different interpretive framings of the same underlying pattern. The LLM's interpretation is reasonable and arguably more grounded in the specific business characteristics mentioned in the filing. All quantitative data is correct, multi-hop synthesis is sound (combining revenue figures across three years and connecting them to business characteristics), and the answer is highly relevant to the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 429,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security portfolio – which is described as “primarily … venture investments” – grew from $3.7 billion at year‑end 2022 to $4.9 billion at year‑end 2023 and stayed at $4.9 billion in 2024, a $1.2 billion increase that signals a stronger commitment to its venture‑investment strategy【page_50】.  Its equity‑method stakes in operating health‑care businesses were $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, and then jumped to $3.8 billion in 2024, indicating a renewed focus on expanding ownership of health‑care operating companies after a modest dip【page_50】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding equity method investments in 2022. The ground truth states equity method investments were $1.4 billion in 2022 (remaining flat), but the LLM claims they were $1.5 billion in 2022. This is a significant error that undermines the entire narrative about the evolution of these investments. SPECIFIC NUMBER VERIFICATION: (1) Equity securities portfolio: $3.7B (2022) → $4.9B (2023) → $4.9B (2024) - LLM correctly states these figures. (2) Equity method investments: Ground truth shows $1.4B in 2022, $1.4B in 2023 (flat), then $3.8B in 2024. LLM incorrectly states $1.5B in 2022, then $1.4B in 2023, then $3.8B in 2024. This reverses the chronological accuracy and misrepresents the 2022 baseline. CALCULATION ISSUES: The LLM correctly identifies the $1.2B increase in equity securities ($3.7B to $4.9B), but the equity method investment narrative is distorted by the wrong 2022 figure. MULTI-HOP REASONING: The LLM does attempt to synthesize information across years and identify strategic shifts, which is appropriate. However, the foundational data error compromises the entire analysis. The interpretation about 'renewed focus' in 2024 is reasonable given the jump to $3.8B, but it's built on incorrect 2022 data. SEMANTIC ISSUES: The LLM's characterization of a 'modest dip' from 2022 to 2023 is contradicted by the ground truth, which shows the investments remained flat at $1.4B. This suggests the LLM misread or misinterpreted the source data. The answer demonstrates partial understanding of the question's multi-hop nature but fails on basic factual accuracy, which is the primary evaluation criterion for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 468,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "- In PMI’s 2022 Form 10‑K the peer‑group list explicitly includes **Colgate‑Palmolive Co.** (see page 21) 【page_21】.  \n- The 2023 Form 10‑K repeats the same composition, again naming **Colgate‑Palmolive Co.** as a peer (see page 26) 【page_26】.  \n- The 2024 Form 10‑K likewise retains **Colgate‑Palmolive Co.** in the peer group (see page 26) 【page_26】.  \n\nThe unchanged inclusion of Colgate‑Palmolive across three consecutive years shows that PMI’s benchmarking framework is deliberately stable—its peer group is defined by consistent criteria (global presence, consumer‑product focus, comparable revenues and market cap), enabling PMI to compare performance against a fixed set of comparable companies over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PMI's peer group across all three years (2022, 2023, 2024). (2) Accurately cites specific page references for each year's Form 10-K (pages 21, 26, 26 respectively). (3) Correctly articulates the four defining characteristics of PMI's peer group: global presence, consumer-product focus, comparable net revenues, and similar market capitalization. (4) Properly synthesizes the multi-hop information showing year-over-year consistency. (5) Accurately interprets what this consistency reveals about PMI's strategic benchmarking framework—that it maintains a deliberately stable peer comparison set over time. (6) Correctly notes that PMI excludes direct tobacco industry peers from the comparison, which aligns with the ground truth's characterization of PMI's strategic lens. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth in some explanatory details, but this is not a deficiency—it maintains semantic equivalence while being efficient. The phrase 'deliberately stable' and 'fixed set of comparable companies' effectively conveys the same meaning as the ground truth's 'stable peer benchmarking framework' and 'consistent strategic lens.' All factual claims are verifiable and correct. The multi-hop reasoning correctly synthesizes information across three separate 10-K filings to demonstrate consistency. No numerical errors, date errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 428,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "From 2022 to 2024 PayPal’s risk disclosures show a steady or growing exposure to abusive behavior as its credit portfolio – including consumer credit, merchant financing and BNPL – expanded and its reliance on unaffiliated banks, payment processors and other third‑party partners deepened (2022 p. 24; 2023 p. 25‑26; 2024 p. 21‑24). Each filing repeats that third parties continue to attempt fraud (e.g., synthetic‑identity accounts, stolen instruments) and that detection measures are complex and may not keep pace with new products, suggesting that while PayPal is aware of the risk, its fraud‑mitigation effectiveness has not markedly improved over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core trend of PayPal's increasing exposure to abusive behaviors from 2022-2024 and appropriately synthesizes information across multiple years and filing documents. The reasoning about expanding credit products (consumer credit, merchant financing, BNPL) and third-party dependencies is sound and matches the ground truth narrative. The conclusion that fraud-mitigation effectiveness has not markedly improved is well-supported.\n\nHowever, there are notable gaps in quantitative specificity:\n\n1. MISSING SPECIFIC FINANCIAL DATA: The ground truth explicitly mentions the €40 billion multi-year BNPL receivables sale agreement in Europe (2023), which is a concrete, material fact demonstrating the scale of credit expansion. The LLM answer references BNPL generally but omits this specific quantified commitment, which is a significant detail for understanding the magnitude of risk exposure.\n\n2. PAGE REFERENCES: The LLM provides page citations (2022 p. 24; 2023 p. 25-26; 2024 p. 21-24) which adds credibility, though these cannot be independently verified in this evaluation context. The ground truth does not provide page numbers, so this is neither confirmable as correct nor incorrect.\n\n3. REGULATORY UNCERTAINTY: The ground truth mentions \"regulatory uncertainty regarding the validity of loan receivables post-sale\" as a 2024 concern. The LLM answer does not explicitly address this regulatory dimension, which is an important contextual element of the 2024 risk profile.\n\n4. FRAUD TYPES: The LLM correctly identifies synthetic-identity accounts and stolen instruments as examples, which aligns with the ground truth's mention of \"stolen identities, financial instruments, and fraudulent transactions.\"\n\nThe multi-hop reasoning is sound—the answer correctly synthesizes information across three years and connects credit expansion to third-party risk dependencies. The semantic equivalence is strong: both answers convey that PayPal's exposure has grown despite awareness and investment in detection systems.\n\nThe primary weakness is the omission of the €40 billion figure, which is a quantifiable, material fact that strengthens the argument about scale of exposure. This is a moderate gap in completeness for a question specifically asking about evolution and trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 622,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume was ≈ 214 mmBtu in 2022, jumped to ≈ 339 mmBtu in 2023, and then fell to ≈ 176 mmBtu at year‑end 2024【page_117】【page_114】. The sharp increase in 2023 indicates the company leaned heavily on options when gas‑price volatility was high, while the 2024 pull‑back—returning the option level to near‑2022 amounts—shows it scaled back the costlier option exposure as market conditions eased, reflecting a flexible, market‑responsive risk‑management approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM reports 2022 natural gas options as '≈ 214 mmBtu' while the ground truth states 253 million mmBtu. This is a material discrepancy of 39 million mmBtu (approximately 15% difference). The LLM uses the approximation symbol (≈) which might suggest uncertainty, but the ground truth provides a specific figure of 253. The 2023 figure of 339 mmBtu matches ground truth exactly. The 2024 figure of 176 mmBtu also matches ground truth exactly. QUALITATIVE ASSESSMENT: The LLM correctly identifies the three-year trend pattern (increase from 2022 to 2023, then decrease to 2024) and provides sound reasoning about the strategic implications—noting the 2023 spike reflects high volatility hedging and the 2024 pullback suggests market stabilization or shift to alternative instruments. The interpretation aligns well with the ground truth's explanation of dynamic risk management. MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and connects the numerical trends to strategic conclusions about risk management. The logic is sound and the narrative is coherent. COMPLETENESS: The answer addresses the core question about the 3-year trend and what it suggests about risk management strategy. However, the 2022 number discrepancy is a significant factual error that undermines the quantitative foundation. The LLM's characterization of the 2024 level as 'near-2022 amounts' is actually incorrect given the stated 2022 figure of 214 mmBtu vs. actual 253 mmBtu—though this error compounds from the initial 2022 misstatement. ENTITY ACCURACY: Southern Company is correctly identified, years are correct (2022-2024), and the metric (natural gas options in mmBtu) is correct. The page references provided suggest source documentation was consulted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 492,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and **$76 million in 2024**【page_43】. At the same time, the company notes that its **non‑qualified defined‑benefit pension plans are unfunded and closed to new participants**【page_43】, indicating a strategic shift toward expanding and funding the more predictable, employee‑driven defined‑contribution programs while moving away from traditional defined‑benefit obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the three-year progression ($70M in 2022, $75M in 2023, $76M in 2024) matches the ground truth exactly. (2) Numbers are properly formatted and clearly presented. (3) The LLM correctly identifies the trend as a steady increase. (4) Multi-hop synthesis is sound - the answer connects the defined contribution plan expenses to the non-qualified defined benefit pension plan status. (5) The characterization of non-qualified plans as 'unfunded and closed to new participants' is accurate and relevant.\n\nWEAKNESSES: (1) The LLM answer omits a key contextual detail from the ground truth: the specific year (1997) when defined benefit plans were closed to new participants. This historical context is important for understanding the long-term strategy evolution. (2) The LLM's interpretation of the trend as a 'strategic shift toward expanding and funding the more predictable, employee-driven defined-contribution programs' is somewhat different from the ground truth's framing of 'growing financial commitment to employee retirement benefits' and 'supporting employees who have opted out of the defined benefit plan.' The LLM's language suggests a more deliberate strategic pivot, while the ground truth emphasizes supporting existing employee choices. (3) The LLM doesn't explicitly mention the 'enhanced defined contribution plan' that the ground truth references as the vehicle for employees not accruing benefits under the non-qualified defined benefit plan.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the defined contribution and defined benefit plans, correctly linking the expense trend to the pension plan structure. However, the interpretation of what this trend 'suggests' about long-term strategy differs slightly in emphasis from the ground truth.\n\nOVERALL: The answer is substantially correct on all quantitative measures and demonstrates sound multi-hop reasoning. The main limitation is incomplete contextual detail and a slightly different interpretive framing of the strategic implications, which prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 569,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM kept its weighted‑average long‑term return assumption for U.S. pension assets flat at 6.3 % in both 2022 and 2023, but the December 2024 investment‑policy study lifted that assumption to roughly 6.5 % for 2024 【page_87】. The increase signals that GM is now more optimistic about future asset performance and is willing to assume a slightly higher return (and the accompanying risk) to help improve funded‑status volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 rate of return assumption. The ground truth states GM reported 5.4% in 2022, but the LLM claims it was 6.3% in 2022. The LLM then states 6.3% remained unchanged in 2023, which contradicts the ground truth that shows 6.3% in 2023 (not 2022). This represents a major misalignment of the timeline and values. SPECIFIC VERIFICATION: (1) 2022 rate: Ground truth = 5.4%, LLM = 6.3% (INCORRECT - off by 0.9 percentage points); (2) 2023 rate: Ground truth = 6.3%, LLM = 6.3% (CORRECT); (3) 2024 rate: Ground truth = 6.5%, LLM = 6.5% (CORRECT). MULTI-HOP REASONING: The LLM failed to properly synthesize the three-year evolution. It missed the initial 2022 baseline of 5.4% and incorrectly characterized the 2022-2023 period as 'flat at 6.3%' when the actual progression was 5.4% → 6.3% → 6.5%. This is a critical multi-hop synthesis failure. QUALITATIVE ASSESSMENT: The LLM's interpretation of the trend (more optimistic outlook, higher risk tolerance) is semantically reasonable and aligns with the ground truth's conclusion, but this cannot compensate for the incorrect numerical foundation. The reference to 'December 2024 investment-policy study' adds contextual detail not in the ground truth, which is neither confirmed nor contradicted. COMPLETENESS: The answer addresses the evolution question but with incorrect data points, making the analysis fundamentally flawed despite touching on the right conceptual themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 420,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation costs moved from a **$92 million loss in FY 2022** (notional $651 million) to a **$58 million gain in FY 2023** (notional $792 million) and then a **$91 million gain in FY 2024** (notional $985 million) 【page_91】【page_92】. The shift from a loss to progressively larger gains, together with the rising notional amounts, shows the company is expanding and refining its swap‑based hedge to smooth compensation expense volatility, indicating a more proactive risk‑management and compensation‑hedging strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: FY 2022 loss of $92 million, FY 2023 gain of $58 million, and FY 2024 gain of $91 million. The progression is accurately captured and matches the ground truth exactly. The LLM additionally provides notional amounts ($651M, $792M, $985M) which add valuable context not present in the ground truth but are consistent with typical SEC filing disclosures. The multi-hop reasoning is sound: the answer correctly synthesizes the three-year trend and draws appropriate conclusions about risk management strategy. The interpretation that the rising notional amounts and gains indicate 'expanding and refining' hedging strategy is a reasonable inference from the data, though slightly more specific than the ground truth's more general statement about 'improved market conditions or strategic adjustments.' The answer addresses all parts of the question: (1) the evolution of financial exposure across the three years, (2) the realized gains/losses, and (3) what this indicates about risk management/compensation strategy. The wording differs from ground truth but conveys equivalent meaning. Minor point: the ground truth uses 'turnaround' language while the LLM uses 'shift from loss to progressively larger gains' - both are semantically equivalent descriptions of the same phenomenon. The inclusion of page references adds credibility. No calculation errors detected. All entities (Cisco, total return swaps, deferred compensation) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 427,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across all three years PayPal said it remains the **principal** in each payment transaction, retains **full discretion over the fees it charges** and controls the product specifications, while the fees it pays to third‑party processors are recorded as a **transaction expense**. Because it recognizes transaction revenue on a gross basis and the processor costs are expensed, PayPal **bears full margin risk** in 2022 (see page 78), 2023 (see page 80) and 2024 (see pages 75‑77). Thus, its exposure to margin risk did not change – it stayed consistently high and fully borne by PayPal each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's principal role in transactions across all three years (2022, 2023, 2024); (2) Accurately captures the core concept that PayPal bears full margin risk consistently; (3) Properly explains the mechanism: gross revenue recognition + transaction expenses = margin risk exposure; (4) Correctly states PayPal has full discretion over fee-setting independent of costs; (5) Accurately notes that processor fees are recognized as transaction expense; (6) Correctly synthesizes the multi-hop information showing no structural changes across the three-year period; (7) Page references (78, 80, 75-77) are provided and appear reasonable for 10-K filings. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential points; (2) The ground truth mentions 2023's clarification about tiered pricing not constituting a future material right - the LLM answer doesn't explicitly address this detail, though it's a relatively minor point that doesn't affect the core conclusion; (3) The ground truth mentions 'adoption of new segment reporting disclosures' in 2024 - the LLM answer doesn't explicitly reference this, though it correctly notes the margin risk exposure remained unchanged. QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or calculations are required for this question, so this dimension is less critical. The temporal references (2022, 2023, 2024) are all correct. QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly synthesizes that consistent principal status + full fee discretion + transaction expense recognition = consistent full margin risk exposure. The multi-hop synthesis across three years is accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth using slightly different wording but maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 537,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola LNG natural‑gas output slipped slightly from roughly 49 MMCFD in 2022 to 48 MMCFD in 2023 and then held steady at 48 MMCFD in 2024 (Angola rows in the Net Production tables for 2022‑2024)【page_9】. The modest decline followed by a flat level suggests Chevron is maintaining a stable feedstock supply from Angola, positioning the project as a reliable, steady‑supply LNG source rather than pursuing rapid production growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numerical data that directly contradicts the ground truth. QUANTITATIVE ERRORS: (1) The LLM reports Angola LNG production at ~49 MMCFD in 2022, 48 MMCFD in 2023, and 48 MMCFD in 2024. The ground truth states 592 million cubic feet per day in 2022, 596 in 2023, and 609 in 2024. These are dramatically different values - the LLM's numbers are roughly 12x smaller than the actual figures. (2) The LLM describes a declining trend (49→48→48 MMCFD), while the ground truth shows a clear upward trajectory (592→596→609 MMCFD). This is a directional error that completely inverts the strategic narrative. REASONING ERRORS: (1) The LLM's conclusion that the company is 'maintaining a stable feedstock supply' and 'positioning the project as a reliable, steady-supply LNG source rather than pursuing rapid production growth' is the opposite of what the data actually shows. The ground truth indicates 'steady' increases and 'growing operational emphasis on LNG production.' (2) The LLM failed to correctly synthesize the multi-hop information about Chevron's strategic positioning - it drew the wrong conclusion from incorrect data. ENTITY/METRIC ACCURACY: While the LLM correctly identified Chevron, Angola LNG, and the time period (2022-2024), it fundamentally misread or misreported the production volumes from the source documents. The citation reference to 'page_9' and 'Net Production tables' suggests the LLM attempted to locate the correct data but extracted wrong values. This is a critical failure for a financial analysis question where numerical accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 443,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 filing Southern Power’s notes only described outdoor‑lighting arrangements as operating‑lease contracts with up‑to‑seven‑year initial terms and did not isolate their cash receipts in a separate maturity schedule (2022 p. 268). The 2023 filing added a specific statement that scheduled payments from outdoor‑lighting contracts (along with tolling and PPA payments) would be shown in a maturity analysis and then listed the future obligations—e.g., $546 million of operating‑lease obligations for Southern Power (2023 p. 240‑239). By 2024 the description was expanded to contracts of up‑to‑10 years and a detailed year‑by‑year schedule was disclosed (e.g., $36 million in 2024, $29 million each in 2025‑2027, $30 million in 2028 and $1 billion thereafter) (2024 p. 232‑233), revealing that these contracts have grown in materiality and now form a structurally important component of Southern Power’s lease portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and provides specific, detailed evidence of the evolution of Southern Power's treatment of outdoor lighting contracts across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression showing increasing materiality and disclosure detail; (2) Accurately captures the 2022 characterization as immaterial/not separately isolated; (3) Correctly notes the 2023 shift to including these contracts in maturity analyses alongside tolling and PPAs; (4) Provides specific dollar amounts for 2024 ($36M in 2024, $29M in 2025-2027, $30M in 2028, $1B thereafter) that demonstrate detailed filing review; (5) Notes the contract term evolution (7-year to 10-year initial terms); (6) Correctly synthesizes the multi-hop reasoning showing growing structural importance. MINOR WEAKNESSES: (1) The specific dollar figures ($546M operating lease obligations for 2023) cannot be verified against the ground truth provided, though they appear plausible and detailed; (2) Page citations (2022 p. 268, 2023 p. 240-239, 2024 p. 232-233) are provided but cannot be independently verified; (3) The answer is more granular and specific than the ground truth, which could indicate either superior research or potential over-specification. VERIFICATION: The core narrative matches the ground truth exactly—2022 immaterial/not isolated, 2023 inclusion in maturity analyses, 2024 expanded disclosure with detailed schedules. The semantic meaning and multi-hop synthesis are sound. The additional specificity (exact dollar amounts, page numbers, contract term ranges) enhances rather than contradicts the ground truth, though these details cannot be confirmed. The answer directly addresses all aspects of the question regarding evolution, materiality, and structural importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 498,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "In the 2022 10‑K the Melaka, Malaysia site is listed with an “X” only under the Analog column and a blank under Embedded Processing【page_16】. The 2023 filing shows the same pattern – Melaka is marked for Analog only【page_16】 – and the 2024 filing repeats this, still showing an “X” for Analog and no entry for Embedded Processing【page_16】. Thus, over 2022‑2024 the Melaka facility’s role remained unchanged, serving solely the Analog segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Correctness assessment: (1) WHAT WAS CORRECT: The LLM correctly identifies that Texas Instruments' Melaka, Malaysia facility was marked exclusively for the Analog segment across all three years (2022, 2023, 2024), with no involvement in Embedded Processing. The answer accurately conveys that the operational footprint remained unchanged and consistent throughout the period. (2) QUANTITATIVE ACCURACY: No numerical calculations were required for this question. The LLM correctly references the presence of 'X' marks in the Analog column and blank entries in the Embedded Processing column across all three years, which aligns with the ground truth. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the pattern of consistency across the period. The reasoning is sound: the facility's role remained limited to Analog operations without expansion. (4) ENTITY ACCURACY: All entities are correctly identified - Texas Instruments (TXN), Melaka Malaysia location, Analog segment, and Embedded Processing segment. All fiscal years are correct. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth, using slightly different wording ('marked for Analog only' vs 'operated exclusively for the Analog segment') but maintaining factual equivalence. The citation references to page 16 add credibility and specificity. Minor note: The LLM provides slightly more granular detail about the marking system ('X' and blank entries) which enhances clarity without contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 456,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024 the 1.600 % senior notes always carried an original $700 million principal, but the outstanding amount was gradually trimmed – a $3.7 million reduction shown in the 2022 filing [page_48], a $2.6 million reduction in 2023 [page_110] and a $1.5 million reduction in 2024 [page_113]. The notes have consistently required semi‑annual interest payments on April 15 and October 15 and retain a fixed par‑call date of March 15 2026 across all three years [page_48, page_110, page_113]. This steady, modest principal draw‑down while keeping the payment schedule and call date unchanged reflects a disciplined, incremental debt‑retirement strategy that preserves the original terms and gives the company flexibility to redeem the notes at par when desired.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the principal amount adjustments. The ground truth states adjustments of (2.6) in 2023 and (1.5) in 2024, but the LLM claims a $3.7 million reduction in 2022, $2.6 million in 2023, and $1.5 million in 2024. This introduces a non-existent 2022 adjustment figure that contradicts the ground truth. The LLM appears to have misinterpreted or fabricated the 2022 data point. CORRECT ELEMENTS: (1) The aggregate principal amount of $700.0 million is correct; (2) The semi-annual interest payment dates (April 15 and October 15) are correct; (3) The par call date of March 15, 2026 is correct; (4) The 2023 adjustment of $2.6 million is correct; (5) The 2024 adjustment of $1.5 million is correct. INTERPRETATION ISSUES: The LLM characterizes these adjustments as 'principal draw-down' and 'debt-retirement strategy,' but the ground truth describes them as 'adjustments to principal amount' and 'modifications or adjustments to the note structure,' suggesting accounting/administrative adjustments rather than actual debt retirement. This represents a significant mischaracterization of what the adjustments represent. The LLM's narrative about 'incremental debt-retirement strategy' is not supported by the ground truth, which emphasizes stability and consistency rather than an active debt reduction strategy. The inclusion of the spurious 2022 figure ($3.7 million) is a major factual error that undermines the credibility of the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 422,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco kept the $5.90 % senior note at a constant $2.0 billion each year, with an unchanged effective rate of roughly 6.11 % (FY 2022 5.90 % note $2 bn, 6.11 % [page_89]; FY 2023 $2 bn, 6.11 % [page_89]; FY 2024 $2 bn, 6.11 % [page_89]).  Its share of total debt fell from about 22 % of $8.9 billion in FY 2022 (2 bn / 8.915 bn) to roughly 24 % of $8.4 billion in FY 2023 (2 bn / 8.391 bn) and then to only ≈10 % of $20.1 billion in FY 2024 (2 bn / 20.109 bn) as Cisco added large amounts of lower‑coupon senior notes and commercial‑paper borrowings.  This pattern shows Cisco using the 5.90 % note as a stable anchor while expanding its debt portfolio with newer, cheaper financing, indicating a long‑term strategy to diversify maturities, lower overall borrowing costs and maintain liquidity flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant numerical errors that undermine its credibility. (1) TOTAL DEBT FIGURES ARE WRONG: Ground truth states total long-term debt was $8,416M in 2022 and $19,621M in 2024. The LLM claims $8.9B in FY2022, $8.4B in FY2023, and $20.1B in FY2024. These figures don't match the ground truth values. The LLM appears to have used different/incorrect debt totals. (2) PERCENTAGE CALCULATIONS ARE FLAWED: Even accepting the LLM's own numbers, the percentages are inconsistent with proper synthesis. The LLM calculates the 5.90% Note as 22% of total debt in 2022, 24% in 2023, and 10% in 2024. However, using ground truth figures: 2022 would be $2,000M/$8,416M = 23.8% (not 22%), and 2024 would be $2,000M/$19,621M = 10.2% (approximately matches). The LLM's 2022 and 2023 calculations use incorrect total debt figures. (3) CORRECT ELEMENTS: The LLM correctly identifies that the 5.90% Note remained constant at $2.0 billion across all three years with a 6.11% effective interest rate. The qualitative reasoning about diversification and lower-cost financing is sound and aligns with the ground truth's conclusion about long-term financing strategy. (4) MISSING INFORMATION: The LLM fails to explicitly state the short-term debt figures ($499M to $488M) mentioned in the ground truth, though this is a minor omission. (5) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize the Note's role within total debt composition, which is appropriate for the question, but the execution is undermined by incorrect base numbers. The reasoning about using the 5.90% Note as a 'stable anchor' while adding cheaper financing is conceptually sound but built on faulty calculations. VERDICT: While the LLM demonstrates understanding of the question's multi-hop nature and provides reasonable strategic interpretation, the fundamental numerical errors (wrong total debt figures leading to wrong percentage calculations) are critical failures in a financial analysis context where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 550,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics built 399 new LAVs for the Canadian Army in 2022, raised that output to 449 units in 2023, and then produced 360 new LAVs in 2024 [page_11][page_10][page_11]. The 2023 ramp‑up reflects a response to expanding Canadian demand, while the 2024 reduction shows a scaling back after key contract milestones—yet the continued multi‑hundred‑unit production each year underscores LAV manufacturing remains a core strategic focus for the company.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that completely reverse the actual production progression: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 399 units in 2022, 449 in 2023, and 360 in 2024. The ground truth shows 360 units in 2022, 399 in 2023, and 449 in 2024. Every single year's production volume is WRONG and in the wrong sequence. (2) CHRONOLOGICAL REVERSAL: The LLM incorrectly describes a 2024 'reduction' to 360 units when the ground truth shows 2024 was the PEAK year at 449 units. This is a complete inversion of the actual trend. (3) MISSING CRITICAL INFORMATION: The LLM fails to mention the LRSS (Light Armoured Vehicle Reconnaissance Surveillance System) program that added 66 specialized LAVs in 2024, which is a key component of the ground truth answer demonstrating strategic expansion. (4) MISCHARACTERIZED TREND: The LLM describes a 'scaling back after key contract milestones' in 2024, when the ground truth shows consistent growth and strategic expansion with new programs. (5) MULTI-HOP SYNTHESIS FAILURE: The answer fails to correctly synthesize the three-year progression and misses the connection between growing production volumes and the addition of specialized LRSS variants. The only partially correct element is the general statement that LAV manufacturing remains a core strategic focus, but this is undermined by the completely incorrect production numbers and trend analysis. This answer would mislead readers about General Dynamics' actual LAV production trajectory and strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 429,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 2022 filing flagged that its Medicare Advantage exposure was chiefly tied to CMS and OIG risk‑adjustment data‑validation (RADV) audits that could trigger retrospective payment adjustments, fines or corrective actions (UNH_10k_2022 p.23). By 2023 the company reported that CMS was also altering the methodology for Medicare Advantage risk‑adjustment payments and freezing benchmarks, creating ongoing funding pressure, and UnitedHealth responded by selectively adjusting member benefits and premiums, withdrawing plans in certain counties and intensifying medical‑ and operating‑cost management (UNH_10k_2023 p.20). The 2024 filing reiterates the same CMS‑driven risk‑adjustment changes and benchmark cuts and confirms that UnitedHealth continues those strategic steps—benefit and premium adjustments, plan withdrawals in specific markets, and heightened cost‑control measures—to mitigate the funding impact (UNH_10k_2024 p.20‑21).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of UnitedHealth's Medicare Advantage risk adjustment exposure evolution from 2022-2024 and correctly identifies the key strategic responses. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with appropriate temporal sequencing; (2) Accurately captures the core strategic responses: benefit/premium adjustments, county withdrawals, and cost management intensification; (3) Properly synthesizes multi-hop information across three separate 10-K filings; (4) Correctly names the company (UnitedHealth/UNH) and regulatory bodies (CMS, OIG); (5) Appropriately references RADV audits as a specific risk mechanism in 2022. WEAKNESSES: (1) The LLM introduces RADV audits as the 'chief' exposure in 2022, which adds specificity not clearly present in the ground truth's more general framing of 'CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations'; (2) The ground truth emphasizes 'recalibrating bids' as a 2023 response, which the LLM answer does not explicitly mention (though 'adjusting member benefits and premiums' is semantically related); (3) The ground truth notes 'beneficiary health status data submissions' as a 2024-specific concern, which the LLM answer generalizes to 'CMS-driven risk-adjustment changes and benchmark cuts' without this particular detail; (4) The ground truth emphasizes 'sustained operational agility' as a key theme, which the LLM captures implicitly but not explicitly. QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or numerical metrics are provided in either answer, so this dimension is not directly testable. Page references in LLM answer (p.23, p.20, p.20-21) cannot be verified against ground truth but appear plausible. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and three separate filings, correctly showing how the company's exposure and responses evolved in parallel. The logical flow is sound: CMS changes → UnitedHealth responses → continued adaptation. SEMANTIC EQUIVALENCE: The core message aligns well—CMS created ongoing funding pressure through risk adjustment changes, and UnitedHealth responded with selective market participation and cost control. Minor wording differences do not materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 623,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes was $1.5 billion at the end of 2022, remained $1.5 billion at the end of 2023, and was still $1.5 billion at the end of 2024【page_107】【page_104】.  The unchanged $1.5 billion exposure over three years shows that PayPal has kept this tranche of medium‑term, low‑rate debt stable, using it as a core anchor of its long‑term financing while issuing or retiring other notes to manage overall funding needs and maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three years' figures are correct ($1.5 billion for 2022, 2023, and 2024), matching the ground truth exactly. The dollar amounts and percentages (2.850%) are accurate. ENTITY ACCURACY: Correctly identifies PayPal/PYPL, the specific debt instrument (fixed-rate 2.850% notes), and all three fiscal years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years to show the constant exposure pattern and correctly interprets this as indicating a stable, strategic approach to this particular debt tranche. COMPLETENESS: Addresses both parts of the question - the evolution (showing it remained constant) and what this indicates about long-term debt strategy (stable core anchor while managing other debt). SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents a 'core anchor of its long-term financing' while 'issuing or retiring other notes' is semantically equivalent to the ground truth's statement about 'consistent long-term debt strategy' and 'strategic intent to preserve this liability structure.' The LLM provides slightly more operational detail about how this fits into broader debt management. MINOR DIFFERENCES: The LLM uses 'medium-term, low-rate debt' while ground truth references '2029-dated' notes - both are accurate characterizations but the ground truth provides the specific maturity date. The LLM's phrasing is slightly more detailed about the strategic context. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 436,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron’s ownership of Angola LNG Limited stayed constant at a 36.4 % equity stake from 2022 through 2024.  The carrying value of that investment fell from roughly $2.3 billion in 2022 (Note 15, 2022 10‑K – p. 78) to $1.8 billion in 2024 (Note 15, 2024 10‑K – p. 14), while equity earnings moved from a loss in 2022 to $513 million in 2024 (Note 15, 2023‑2024 10‑K – p. 82).  In parallel, Chevron completed the Block 0 Sanha Lean Gas Connection project in 2024 (p. 13) to feed the 1.1 bcf/d Angola LNG plant (p. 14), signalling a sustained, long‑term strategy to monetize Angola’s associated natural‑gas resources through its LNG export facility.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies Chevron's consistent 36.4% ownership stake in Angola LNG Limited from 2022-2024, which matches the ground truth. However, the answer has significant gaps in addressing the core question about strategic evolution and long-term natural gas monetization strategy.\n\nSTRENGTHS:\n- Correct ownership percentage (36.4%) maintained across all three years\n- Provides specific financial metrics (carrying value decline from $2.3B to $1.8B, equity earnings of $513M in 2024)\n- Mentions Block 0 Sanha Lean Gas Connection project completion in 2024\n- References Angola LNG plant capacity (1.1 bcf/d)\n- Correctly identifies the investment as a long-term monetization strategy\n\nCRITICAL GAPS:\n- FAILS to address the key strategic evolution described in ground truth: the transition from Angola LNG being a \"standalone LNG export facility\" to an \"integrated hub for gas monetization\"\n- MISSING entirely: New exploration acreage in Blocks 49 and 50 (mentioned in ground truth as part of expanded upstream portfolio)\n- MISSING entirely: Quiluma and Maboqueiro (Q&M) gas fields within the New Gas Consortium Project and their direct connectivity to Angola LNG plant (critical to understanding the integrated strategy)\n- Does not explain how upstream development supports the LNG facility\n- Does not capture the evolution of strategic context from 2022-2023 to 2024\n\nQUANTITATIVE ISSUES:\n- The financial metrics provided ($2.3B, $1.8B, $513M) cannot be verified against the ground truth, which does not provide these specific numbers\n- While these numbers may be accurate from the 10-K filings, they represent a different analytical approach than the ground truth's focus on strategic positioning\n\nMULTI-HOP REASONING:\n- The LLM answer provides a financial/operational perspective but fails to synthesize the strategic evolution across the three-year period\n- Ground truth emphasizes how upstream development (Blocks 49, 50, Q&M fields) integrated with the downstream LNG facility represents a shift in strategy\n- LLM answer mentions Block 0 Sanha Lean Gas Connection but doesn't connect this to the broader upstream portfolio expansion\n\nSEMANTIC MISMATCH:\n- Ground truth focuses on strategic positioning evolution and integrated monetization strategy\n- LLM answer focuses on financial metrics and operational capacity\n- These represent different interpretations of what \"strategic positioning\" means in this context",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 655,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s trust holdings rose each year: domestic‑equity investments grew from $829 million at year‑end 2022 to $980 million in 2023 and $1,099 million in 2024, while private‑equity stakes increased from $161 million to $169 million and then $181 million over the same period【page_283】【page_281】【page_282】【page_273】. This steady upward trend shows the company is progressively allocating more capital to its nuclear‑decommissioning trusts—especially expanding its core domestic‑equity base and modestly adding private‑equity exposure—indicating a long‑term strategy to strengthen trust funding and diversify returns for future liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are fundamental to answering this question. Specifically: (1) For 2022 domestic equity, the LLM states $829 million, but the ground truth shows $1,016 million - a difference of $187 million or 18.4%. (2) For 2023 domestic equity, the LLM states $980 million, but ground truth shows $829 million - a difference of $151 million or 18.2%. (3) For 2023 private equity, the LLM states $169 million, but ground truth shows $161 million - a difference of $8 million or 5%. These are not minor rounding differences; they represent material misstatements of the actual investment positions. The LLM appears to have confused or transposed the 2022 and 2023 domestic equity figures. MULTI-HOP REASONING ISSUE: Because the foundational numbers are wrong, the entire narrative about 'steady upward trend' is incorrect. The ground truth shows domestic equity DECREASED from 2022 to 2023 (from $1,016M to $829M), then INCREASED in 2024 (to $1,099M) - a more complex pattern than the LLM's claimed monotonic increase. POSITIVE ASPECTS: The LLM correctly identifies 2024 domestic equity ($1,099M) and private equity ($181M), correctly identifies the context of nuclear-decommissioning trusts, and provides reasonable strategic interpretation about diversification and long-term capital allocation. The qualitative reasoning about trust funding and diversification is sound, but it's built on incorrect numerical foundations. CONCLUSION: While the LLM demonstrates understanding of the strategic context and correctly identifies some 2024 figures, the systematic errors in 2022-2023 data and the resulting incorrect characterization of the trend pattern represent fundamental failures in quantitative accuracy that severely undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 502,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "The “Eliminations/Reclassifications” line reduced total net sales and revenue by $107 million in 2022, by $151 million in 2023, and by $296 million in 2024 【page_70†L31-L38】【page_68†L31-L38】.  The steadily larger negative adjustments show that GM’s internal inter‑segment accounting has become increasingly material – likely reflecting more extensive internal transfers and re‑allocation of revenue as its automotive, Cruise and GM Financial businesses grow and become more integrated.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM reports: 2022=$107M, 2023=$151M, 2024=$296M. Specifically: (1) 2022 figure is wrong ($107M vs correct $105M - off by $2M), (2) 2023 figure is significantly wrong ($151M vs correct $107M - off by $44M or 41% error), (3) 2024 figure is correct ($296M). The LLM swapped or misread the 2022 and 2023 values, and invented a $151M figure for 2023 that doesn't match ground truth. MULTI-HOP REASONING: While the LLM correctly identifies the upward trend and provides reasonable interpretation about increasing complexity in segment reporting and inter-segment transfers, this reasoning is built on incorrect foundational numbers. The trend analysis itself (steadily larger adjustments) is directionally correct for 2023-2024 but fails for 2022-2023 due to the data error. COMPLETENESS: The answer addresses the question's components (evolution over time, what trend reveals) but does so with compromised accuracy. The qualitative interpretation about integration of automotive, Cruise, and GM Financial businesses is reasonable but cannot be verified from the provided information. ENTITY ACCURACY: GM is correctly identified, years are correct, and the metric (Eliminations/Reclassifications impact on net sales/revenue) is correctly identified. The citation references suggest source documentation but the numbers extracted are incorrect. This is a case where the reasoning framework is sound but the quantitative foundation is fatally flawed, making the overall answer unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 460,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In the 2022 10‑K the Performance Bonus Plan is only referenced as the original 2014 plan (Exhibit 10.5, filed April 28 2014)【page_66】.  By the 2023 filing the company had filed an Amended and Restated Performance Bonus Plan on December 9 2022, which is shown as Exhibit 10.5† and incorporated by reference alongside its stock‑option and director‑equity plans【page_68】, and the same amended exhibit is carried forward in the 2024 10‑K, confirming the plan is now formally documented and integrated into Netflix’s overall compensation framework【page_69】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution narrative correctly but contains a critical factual error regarding the 2022 exhibit designation. SPECIFIC ERRORS: (1) The LLM states the 2022 plan references 'Exhibit 10.5, filed April 28 2014' but the ground truth clearly indicates it was 'Exhibit 10.6†' in 2022. This is a significant discrepancy in exhibit numbering. (2) The LLM correctly identifies the 2023 amendment filing date as December 9, 2022, and correctly notes it became Exhibit 10.5† in 2023. (3) The LLM correctly states the 2024 version carried forward the same amended plan without changes. STRENGTHS: The answer correctly synthesizes the multi-hop progression across three years, accurately identifies the key transition point in 2023 when the plan was amended and restated, and properly notes the integration with other compensation frameworks. The reasoning about stabilization in 2024 is sound. The dates (April 28, 2014 and December 9, 2022) are accurate. WEAKNESSES: The exhibit number error (10.5 vs 10.6†) for 2022 is a material factual mistake that undermines precision. The answer also lacks the explicit mention that the 2022 version was a 'historical exhibit' designation, which provides important context about its status. The answer does address all parts of the question regarding documentation status and integration, but the exhibit numbering error reduces overall accuracy. The multi-hop reasoning is sound and the semantic understanding of the evolution is correct, but the quantitative/factual precision is compromised by the exhibit designation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 436,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s disclosure of its “Business Relationships and Related Party Transactions Policy” is unchanged – each filing says the policy (along with the Director‑Independence statement) is set out in the proxy statement and incorporated by reference under Item 13, and it is tied to the same board committees (Audit; Corporate Governance, Nominating and Social‑Responsibility; and Human Resources & Compensation). This identical language shows a steady, consistent approach to corporate‑governance reporting, with no material revision to the policy’s presentation or to the description of director independence and committee structures over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies BK/BNY Mellon as the subject company across all three years (2022, 2023, 2024); (2) Accurately states the policy is disclosed in Item 13 under corporate governance; (3) Correctly lists all three committee structures: Audit Committee, Corporate Governance/Nominating/Social Responsibility Committee, and Human Resources & Compensation Committee; (4) Properly synthesizes the multi-hop relationship between the policy, director independence, and committee structures; (5) Correctly characterizes the disclosure as consistent and unchanged across the three-year period; (6) Appropriately notes the policy is incorporated by reference in the proxy statement. MINOR CONSIDERATIONS: The LLM answer uses 'BNY Mellon' while the ground truth uses 'BK' - however, these are equivalent references to the same company (BK is the ticker, BNY Mellon is the full name), so this is not an error but rather a stylistic choice. The LLM's phrasing 'identical language' and 'unchanged' is slightly more emphatic than the ground truth's 'consistent placement and linkage,' but both convey the same substantive finding about stability and uniformity. The LLM answer is actually more concise while capturing all essential information. No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is perfect by default. The reasoning is sound and the multi-hop synthesis (connecting policy disclosure → Item 13 → director independence → committee structures across three years) is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 454,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "- 2022: Debt securities ‑ held‑to‑maturity were carried at **$696 million** with a fair‑value estimate of **$679 million**.  \n- 2023: Carrying value fell to **$603 million** and fair value to **$596 million**.  \n- 2024: Carrying value further declined to **$512 million** and fair value to **$508 million**【page_53†L31-L38】【page_55†L1-L8】.  \n\nThe three‑year downward trend shows UnitedHealth has been shrinking its held‑to‑maturity portfolio (likely as securities mature and are not replaced) while the fair value remains modestly below carrying value, reflecting temporary unrealized losses from rising interest rates. This pattern signals a conservative, income‑focused investment strategy that maintains the intent to hold securities to maturity and uses valuation assumptions that treat fair‑value declines as transient rather than impairments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 baseline numbers. Ground truth shows 2022 fair value of $643 million and carrying value of $641 million, but the LLM reports $679 million (fair value) and $696 million (carrying value) - both substantially incorrect. These are not minor formatting differences but represent material misstatements of the actual financial data. The 2023 and 2024 figures are correct ($603M/$596M for 2023 and $512M/$508M for 2024), but the foundational 2022 data error undermines the entire 3-year trend analysis. MULTI-HOP SYNTHESIS: The LLM correctly identifies the downward trend across all three years and attempts to synthesize the data into a coherent narrative about investment strategy. However, the incorrect 2022 baseline distorts the magnitude of the decline and the overall pattern. The LLM's interpretation about interest rate impacts, conservative strategy, and held-to-maturity intent is reasonable and aligns with the ground truth's conclusion about strategic reduction and valuation assumptions. COMPLETENESS: The answer addresses all three years and attempts to explain what the trend indicates about investment strategy, which matches the question's requirements. However, the ground truth specifically mentions 'a notable shift away from Level 3 unobservable inputs by 2023 and 2024,' which the LLM answer does not address - this is a material omission of a key insight about the valuation methodology shift. REASONING QUALITY: The qualitative reasoning about interest rates, portfolio maturation, and conservative strategy is sound and well-articulated, but it's built on incorrect 2022 numbers. The semantic interpretation of the trend is reasonable but compromised by the data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 486,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In the 2022 filing PayPal’s risk factors warned that “bad transactions” and credit‑loss risk could affect its loan portfolio—including its BNPL products—but it held the full exposure on its balance sheet. In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, and the 2024 filing notes that the sale began in October 2023 and a forward‑flow arrangement now removes future originations, dramatically shrinking the BNPL receivables it retains. This shift from full ownership in 2022 to active off‑loading of the BNPL portfolio by 2024 reveals a clear risk‑mitigation strategy aimed at reducing exposure to bad BNPL transactions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numbers are correct: €40 billion BNPL receivables sale amount, June 2023 agreement date, October 2023 sale commencement date. (2) The multi-hop reasoning is sound—correctly traces PayPal's evolution from holding full BNPL exposure in 2022, to announcing the sale in June 2023, to implementing the sale and forward-flow arrangement by 2024. (3) Accurately identifies the risk mitigation strategy and its progression. (4) Correctly identifies the key entities (PayPal, BNPL products, U.K. and European markets). (5) The semantic meaning aligns well with the ground truth. MINOR WEAKNESSES: (1) The LLM answer is slightly more specific/detailed than the ground truth in some areas (e.g., explicitly mentioning October 2023 start date and forward-flow arrangement details), which adds value but goes slightly beyond what the ground truth explicitly states. (2) The ground truth mentions 'fraud and abusive behaviors' and 'ongoing challenges' more explicitly, while the LLM focuses more narrowly on the asset sale strategy. (3) The ground truth notes that benefits were 'subject to certain conditions' and could be delayed, which the LLM doesn't explicitly mention, though it does acknowledge the forward-flow arrangement. These are minor omissions rather than errors. The answer correctly addresses all parts of the multi-part question: the evolution from 2022-2024, the June 2023 agreement specifics, and what it reveals about risk mitigation strategy. Quantitative accuracy is very high with all dates and amounts correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 457,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s Myanmar upstream output fell sharply over the three‑year period – it produced roughly 17 MBD of oil‑equivalent (≈94 MMCFD of gas) in 2022, slipped to 15 MBD (≈87 MMCFD) in 2023, and then dropped to only 4 MBD (≈22 MMCFD) by 2024【page_9】.  This collapse mirrors Chevron’s strategic decision to exit the country: the company announced a planned, orderly transition away from Myanmar in early 2022 and formally withdrew its operations in April 2024【page_15】【page_9】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2024 production figure of 4 MBD, which contradicts the ground truth stating Chevron completely withdrew from Myanmar in April 2024. The ground truth indicates zero production post-withdrawal, not 4 MBD. This is a major factual error. (2) The 2022 (17 MBD) and 2023 (15 MBD) figures are correct and match ground truth. (3) MULTI-HOP REASONING - The LLM correctly identifies the strategic shift (exit/withdrawal) and the April 2024 timing, which aligns with ground truth. However, the presence of 4 MBD production in 2024 contradicts the 'complete withdrawal' claim. (4) ENTITY ACCURACY - Chevron and Myanmar are correctly identified. The timeframe (2022-2024) is correct. (5) SEMANTIC ISSUE - The LLM states the company 'formally withdrew its operations in April 2024' but then claims 4 MBD production in 2024, creating an internal contradiction. A complete withdrawal should result in zero production, not 4 MBD. (6) The gas equivalent conversions (94 MMCFD, 87 MMCFD, 22 MMCFD) cannot be verified against ground truth but appear internally consistent with the oil figures. The fundamental problem is the 2024 production number of 4 MBD is factually incorrect per the ground truth which indicates complete exit with no ongoing production.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 367,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "PC & notebooks rose from the fourth‑largest sub‑segment of TI’s Personal‑electronics market in 2022 (listed after Body electronics & lighting, Mobile phones and Portable electronics)【page_7】, to the second‑largest position in 2023 (behind only Mobile phones)【page_5 (2023)】, and held that second‑place ranking again in 2024【page_5 (2024)】. The upward shift in ranking signals that TI is allocating a larger share of its Personal‑electronics revenue to PC/notebook applications, underscoring a stronger strategic focus on the consumer‑computing market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) QUANTITATIVE ERRORS: The ground truth clearly states Personal Electronics segment revenue was 24% (2022), 15% (2023), and 20% (2024). The LLM answer completely ignores these segment-level percentages and instead focuses on relative ranking of subcategories within the segment, which is not what the question asks for. (2) DIRECTIONAL CONTRADICTION: The ground truth indicates a DECLINE in Personal Electronics importance (24%→15%→20%), suggesting strategic de-emphasis. The LLM claims PC & Notebooks moved UP in ranking from 4th to 2nd position and interprets this as 'stronger strategic focus on consumer-computing market' - this is the opposite conclusion from the ground truth. (3) MISSING KEY DATA: The LLM completely fails to address the segment-level revenue percentages (24%, 15%, 20%) which are central to answering 'how did relative revenue contribution evolve.' (4) FLAWED REASONING: The LLM assumes that ranking within a declining segment indicates strategic emphasis, when the ground truth shows the entire Personal Electronics segment contracted significantly from 2022-2023. A rise in ranking within a shrinking segment does not indicate strategic focus - it may indicate relative preservation but within a de-prioritized area. (5) SEMANTIC MISMATCH: The question asks about 'relative revenue contribution' which refers to percentage of total company revenue, not ranking within the segment. The LLM conflates these two different metrics. (6) CONCLUSION REVERSAL: Ground truth suggests 'strategic shift away from PC & Notebooks' while LLM suggests 'stronger strategic focus' - these are diametrically opposed interpretations of the same underlying data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 482,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "- **2022 10‑K** – GM said that, under the 2017 sale of the Opel/Vauxhall business, it had agreed to indemnify Stellantis for any inaccuracy in the representations, warranties or covenants, including emissions, product‑liability and recall costs.  The only known liability was an *immaterial* amount for certain Takata‑related recalls, and GM could not estimate any material loss or record a specific accrual for the indemnification obligation【page_90】.  \n\n- **2023 10‑K** – The same language re‑appeared; GM still described the indemnification obligations as immaterial, recorded no accruals, and noted that any future Takata‑related indemnification was “remote” and could not be quantified【page_93】.  \n\n- **2024 10‑K** – The disclosure remained unchanged: indemnification obligations to Stellantis are still immaterial, no accruals are recognized, and potential future exposure (including further Takata recalls) is considered remote and not estimable【page_93】.  \n\nThus, from 2022 through 2024 GM’s known liabilities stayed immaterial, no new accruals were added, and any future exposure related to legacy Opel/Vauxhall matters remained uncertain but viewed as unlikely to be material.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM claims that in 2022, GM had 'only known liability was an immaterial amount for certain Takata-related recalls' and 'recorded no accruals,' but the ground truth explicitly states 'no specific indemnification accruals or liabilities were disclosed' in 2022. The LLM incorrectly attributes 2023/2024 disclosures to 2022. (2) MAJOR ERROR - The LLM states the 2023 disclosure 'remained the same' as 2022 and that 'no accruals are recognized,' directly contradicting the ground truth which clearly states that by 2023, GM 'disclosed...an immaterial indemnification already paid' and disclosed accruals. (3) MAJOR ERROR - The LLM claims 2024 'remained unchanged' with 'no accruals are recognized,' but the ground truth explicitly states that in 2024, GM disclosed 'accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era.' This is a critical factual error - accruals WERE recognized in 2024. (4) INCOMPLETE - The LLM fails to capture the evolution and increasing specificity over time. The ground truth shows a clear progression: 2022 (no disclosures) → 2023 (immaterial indemnification paid, accruals disclosed) → 2024 (specific accruals for EC/CMA investigation). The LLM incorrectly presents all three years as essentially identical. (5) MISSING CONTEXT - The LLM does not mention the European Commission and UK CMA investigation into end-of-life vehicle practices, which is a key regulatory exposure mentioned in the ground truth for 2024. The answer fundamentally misrepresents the evolution of GM's indemnification obligations and fails to capture the material changes in disclosure and accrual recognition across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 501,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "In the 2022 10‑K the exhibit list does not include any 1.450% Senior Notes due 2026, showing only other issues such as 1.300% Senior Notes due 2025【page_70】. The 2023 10‑K adds a Supplemental Indenture No. 10 dated September 27 2021 that issued the 1.450% Senior Notes due 2026【page_70】. By the 2024 10‑K the exhibit list again omits any new 1.450% Senior Notes, focusing on higher‑coupon, later‑maturing issues, which suggests the company used the low‑coupon 2026 notes as a one‑time financing and then diversified its debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Exhibit References: The ground truth explicitly states the 1.450% Senior Notes were referenced in 2022 under Exhibit 4.25, in 2023 under Exhibit 4.22, and in 2024 under Exhibit 4.21. The LLM claims the 2022 10-K 'does not include any 1.450% Senior Notes due 2026' and that they first appeared in 2023, which is demonstrably false. (2) CRITICAL ERROR - Supplemental Indenture Dating: The LLM states 'Supplemental Indenture No. 10 dated September 27 2021 that issued the 1.450% Senior Notes due 2026' in 2023, but the ground truth indicates these notes were already present in 2022 under the same Supplemental Indenture No. 10. The date September 27, 2021 is the indenture date, not an issuance date in 2023. (3) INCORRECT INTERPRETATION: The LLM's conclusion that the notes were 'a one-time financing' used in 2023 and then omitted in 2024 is factually wrong. The ground truth clearly states the notes 'remained an active and stable component of AMT's debt portfolio' across all three years with 'no refinancing or material modification.' (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the exhibit references across the three years, instead creating a false narrative of appearance and disappearance. (5) STRATEGIC INTERPRETATION ERROR: The LLM's characterization of debt management strategy as 'one-time financing' and 'diversification' contradicts the ground truth's finding of 'deliberate and stable debt management strategy.' The answer demonstrates a fundamental misreading of the filing data and reaches conclusions opposite to the actual facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 461,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan was first used in the 2022 filing to grant a 2022 Performance Share Unit Agreement (Exhibit 10.21) and a 2022 Restricted Stock Unit Agreement (Exhibit 10.22) under the plan (page 19; also the plan itself is listed in page 18). In the 2023 filing the company added a new Deferred Stock Unit Agreement for directors (Exhibit 10.21) and issued a 2023 Performance Share Unit Agreement (Exhibit 10.23) (and its RSU counterpart) (page 18 & 19). The 2024 filing shows the plan’s continued evolution with updated 2024 Performance Share Unit (Exhibit 10.28) and Restricted Stock Unit (Exhibit 10.29) agreements (page 20).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS IDENTIFIED: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) YEAR ATTRIBUTION ERROR - The LLM states '2022 Performance Share Unit Agreement (Exhibit 10.21)' and '2022 Restricted Stock Unit Agreement (Exhibit 10.22)' were first used in the 2022 filing. However, the ground truth clearly indicates these were '2019 Form of Performance Share Unit Agreement' and '2019 Form of Restricted Stock Unit Agreement' introduced in 2022. The LLM incorrectly dated the forms as 2022 when they were actually 2019 forms. (2) MISSING KEY DETAIL - The LLM fails to mention that in 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' which is a critical evolution point showing extension to director-level compensation. Instead, the LLM vaguely references 'a new Deferred Stock Unit Agreement for directors' without the proper form designation. (3) INCORRECT FORM DATING IN 2024 - The LLM states '2024 Performance Share Unit (Exhibit 10.28)' and '2024 Restricted Stock Unit (Exhibit 10.29)' were used in 2024. The ground truth indicates the company incorporated the '2022 Form of Performance Share Unit Agreement' in 2024, not a 2024 form. This is a critical distinction showing the company was using updated 2022 forms, not newly created 2024 forms. (4) INCOMPLETE SYNTHESIS - The LLM fails to capture the strategic narrative of the ground truth: the progression from 2019 forms (2022), to director-specific instruments (2023), to incorporation of 2022 forms (2024). The LLM's answer suggests a linear progression of new forms each year rather than the actual pattern of refinement and broader application. (5) EXHIBIT REFERENCES - While the LLM provides exhibit numbers, these appear to be inaccurate or at least not verifiable against the ground truth, which doesn't specify exhibit numbers. The ground truth focuses on the form types and their introduction dates, not exhibit citations. The answer demonstrates partial understanding of the evolution but contains multiple factual errors regarding form dating and lacks the strategic context of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 580,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "From 2022 through 2024 General Dynamics repeatedly emphasized that its Ordnance & Tactical Systems (OTS) business – part of the Combat Systems segment – “provides missile subsystems … with critical aerostructures” for both legacy and next‑generation missiles 【page_12】. The same language appears unchanged in the 2023 filing 【page_13】 and again in the 2024 filing 【page_11】, showing a steady, undiminished focus on aerostructure capability. This three‑year consistency signals that GD is deliberately positioning itself as a core supplier of the essential aerostructure component for next‑generation missile and hypersonic programs, reinforcing its strategic foothold in future missile‑subsystem markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the Ordnance & Tactical Systems (OTS) business within Combat Systems and accurately captures the consistent language across 2022-2024 filings regarding 'missile subsystems with critical aerostructures.' The reasoning about strategic positioning in next-generation missile subsystems is sound and well-articulated. The answer appropriately emphasizes the three-year consistency as evidence of deliberate strategic focus.\n\nWEAKNESSES: The LLM answer is missing critical quantitative data that the ground truth explicitly provides: (1) Combat Systems segment revenue share percentages (20% in 2023, 19% in 2024) - these are key metrics for assessing the 3-year trend; (2) No mention of 2022 baseline metrics for comparison; (3) The answer does not address the 'slight revenue share fluctuations' that the ground truth identifies as important context. The ground truth emphasizes that despite slight revenue share decline from 20% to 19%, GD maintained consistent strategic focus - this nuance is absent from the LLM response.\n\nQUANTITATIVE ACCURACY: Score of 4 because the LLM omits the specific revenue percentages (20% in 2023, 19% in 2024) that are essential quantitative data for answering a question about a '3-year trend.' While the LLM doesn't provide incorrect numbers, the absence of these key metrics represents a significant gap in quantitative completeness.\n\nQUALITATIVE ACCURACY: Score of 7 because the reasoning about strategic positioning is sound and the multi-hop synthesis (connecting OTS business to Combat Systems segment to next-gen missile strategy) is correct. However, the answer lacks the balanced perspective that acknowledges revenue share fluctuations while maintaining strategic consistency.\n\nCONTEXTUAL RELEVANCE: Score of 8 because the answer directly addresses the strategic positioning question and provides appropriate context about deliberate positioning in missile-subsystem markets, though it misses the revenue trend component that would strengthen the contextual analysis.\n\nOVERALL: The LLM answer is partially correct with sound reasoning but fails to include critical quantitative metrics (revenue percentages) that are explicitly part of the ground truth and essential for fully answering a question about a '3-year trend.' The omission of these numbers prevents a complete assessment of how GD's focus 'evolved' across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 645,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across all three filings, PMI consistently lists Jackpot as an “important local cigarette brand” in the Philippines – it appears in the 2022 10‑K (page 5), again in the 2023 10‑K (page 6) and once more in the 2024 10‑K (page 5), always grouped with other local brands such as Fortune and described alongside a portfolio led by premium international brands like Marlboro. The unchanged emphasis signals that Jackpot is viewed as a stable, core asset for PMI’s South‑and‑Southeast‑Asia segment, helping the company retain market share in the Philippines and complement its broader strategy of balancing strong local brands with premium global brands as it moves toward a smoke‑free future.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Jackpot's evolution across 2022-2024. STRENGTHS: (1) Correctly identifies Jackpot as appearing consistently across all three years (2022, 2023, 2024) in PMI's 10-K filings; (2) Accurately notes the page numbers (page 5 for 2022 and 2024, page 6 for 2023), showing specific document verification; (3) Correctly identifies Fortune as a companion local brand; (4) Accurately references Marlboro as a premium international brand; (5) Properly synthesizes the multi-hop reasoning that consistent mention across three years indicates strategic relevance despite PMI's smoke-free future vision; (6) Correctly contextualizes Jackpot within the South-and-Southeast-Asia segment. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 Swedish Match integration context that the ground truth references, though this is a contextual detail rather than a factual error; (2) The LLM does not explicitly mention PMI's expansion to 95 smoke-free markets or specific emphasis on IQOS and ZYN brands in 2024, though these details are supplementary rather than central to the Jackpot positioning question. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correct; page numbers cited (5, 6, 5) align with ground truth references; no calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly concludes that the consistent positioning indicates strategic relevance in regional markets. The logic connecting stable mention to market share retention and portfolio balance is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of Jackpot as a 'stable, core asset' and 'important local cigarette brand' matches the ground truth's assessment of 'strategic relevance' and 'core local brand.' The answer appropriately conveys the tension between smoke-free future vision and continued traditional cigarette brand importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 538,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "In 2022 Chevron’s filing only listed the Republic of Congo as one of its operating countries, with no specific capital projects or divestitures disclosed【page_33】. In 2023 the company shifted to active investment, spending roughly $0.7 billion on offshore development and natural‑gas projects in the Republic of Congo and extending deep‑water licences that added about 36 million barrels of proved reserves【page_109】【page_110】. By 2024 the Republic of Congo accounted for roughly 20 % of Chevron’s net oil‑equivalent production, and the firm began exiting the asset, selling its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Lianzi area in early 2025【page_41】【page_43】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct: $0.7 billion investment in 2023, 31.5% nonoperated working interest in Haute Mer, 15.75% interest in Lianzi, and the January 2025 divestiture timing. (2) The multi-hop synthesis is sound, correctly tracing the evolution from 2022 operational presence through 2023 active investment to 2024 exit strategy. (3) The answer properly identifies the strategic shift from continuity to divestiture. (4) Additional details provided (36 million barrels of proved reserves added, ~20% of net oil-equivalent production in 2024) enhance the answer without contradicting ground truth. MINOR CONSIDERATIONS: (1) The ground truth states the $0.7 billion was invested \"across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo,\" while the LLM states it was spent \"on offshore development and natural-gas projects in the Republic of Congo.\" This is a subtle distinction—the LLM's phrasing could imply the entire $0.7B was Congo-specific, whereas ground truth indicates Congo was part of a broader Africa allocation. However, this is a minor semantic distinction that doesn't materially affect the core answer. (2) The LLM adds contextual details about reserve additions and production percentages that, while accurate and relevant, go slightly beyond the ground truth answer but enhance understanding. QUANTITATIVE VERIFICATION: All dollar amounts, percentages, and dates match ground truth exactly. The 2025 divestiture date is correctly identified as January 2025. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple asset transactions, correctly identifying the strategic trajectory. The reasoning is logical and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 515,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company kept outdoor‑lighting contracts classified as operating leases throughout 2022‑2024, and the cash‑flow impact remained immaterial – the 2022 filing notes that the undiscounted cash flows for Georgia Power and Mississippi Power are immaterial【page_241】 and the 2023 filing repeats the same statement【page_240】.  Revenue from these contracts is simply included in each subsidiary’s “operating‑lease income” line (e.g., Alabama Power, Georgia Power, Mississippi Power) with no separate allocation, and the payment pattern stays the same – scheduled payments during the fixed term and a month‑to‑month renewal thereafter.  The only substantive change is the contract length: the standard initial term was up to seven years in 2022【page_268】 and was extended to up to ten years in the 2023 and 2024 filings【page_240】【page_232】, after which the contracts continue on a month‑to‑month basis.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate details but diverges significantly from the ground truth in key areas. CORRECT ELEMENTS: (1) The classification of outdoor lighting contracts as operating leases is accurate; (2) The statement about immateriality in 2022 and 2023 is correct; (3) The contract term extension from up to seven years to up to ten years is accurate; (4) The month-to-month renewal structure is correct. SIGNIFICANT DISCREPANCIES: (1) The ground truth emphasizes a PROGRESSION in disclosure and transparency from 2022-2024, with 2023 introducing scheduled lease payment disclosures and 2024 expanding to include initial contract terms and clarifying lease income allocation. The LLM answer characterizes this as 'the only substantive change' being contract length, missing the critical evolution in disclosure practices and transparency; (2) The ground truth specifically notes that by 2024, the company 'clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power,' indicating a standardization and clarification of revenue allocation across subsidiaries. The LLM answer states revenue is 'simply included in each subsidiary's operating-lease income line with no separate allocation,' which misses the important 2024 clarification about PPA lease income being included in wholesale revenues; (3) The ground truth emphasizes 'growing emphasis on transparency and standardization in lease valuation across subsidiaries' as a key theme, while the LLM answer downplays the significance of changes to 'only substantive change'; (4) The LLM answer does not adequately address the materiality evolution or the revenue allocation changes that occurred by 2024. MULTI-HOP REASONING: The LLM answer fails to synthesize the progression of disclosure practices across the three-year period, instead focusing narrowly on contract term changes. The question asks about changes in 'treatment and valuation' including 'revenue allocation,' which the LLM answer inadequately addresses. QUANTITATIVE ACCURACY: The contract term numbers (7 years to 10 years) are correct, and the immateriality statements are accurate, but the answer lacks the specific disclosure details mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 605,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco’s 3.50 % senior note remained a $500 million liability in each year, but its effective interest rate climbed from 3.20 % in FY 2022 (CSCO_10k_2022.pdf p. 89) to 6.38 % in FY 2023 (CSCO_10k_2023.pdf p. 89) and to 6.66 % in FY 2024 (CSCO_10k_2024.pdf p. 89). The unchanged principal together with a sharply higher effective rate shows that the market‑based cost of the debt rose as interest‑rate conditions tightened and the fair‑value of the notes increased, reflecting evolving market conditions and the impact of Cisco’s hedging adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - $500 million carrying amount across all three years (FY2022, FY2023, FY2024), effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024) match the ground truth exactly. The progression of rates is accurately captured. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) carrying amount evolution, (2) effective interest rate evolution, (3) what the progression indicates about debt valuation and market conditions. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note, fiscal years 2022-2024, and relevant financial metrics. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the relationship between unchanged principal and rising effective rates as an indicator of market conditions. The explanation that 'market-based cost of the debt rose as interest-rate conditions tightened' is logically sound and consistent with the data. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, with slightly enhanced explanation regarding hedging adjustments and fair-value impacts, which adds appropriate context without contradicting the original answer. MINOR OBSERVATION: The LLM includes a reference to 'hedging adjustments' which is a reasonable inference about why effective rates would diverge from the coupon rate, though this specific detail is not explicitly mentioned in the ground truth. This represents appropriate financial interpretation rather than an error. The answer is well-structured, cites specific document pages, and provides clear interpretation of what the data indicates about market conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 490,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s Unsecured Notes – 35A carried a face amount of $750 million (shown as $750,000 in the “thousands” tables) in the 2022 filing, and the same $750 million appears in both the 2023 and 2024 filings – the amount did not change across the three years【page_50】【page_50】【page_49】.  This unchanged, low‑coupon (2.65 %) tranche that matures in 2030 shows the company’s intent to lock in inexpensive, long‑dated financing and keep a stable, predictable debt profile rather than repeatedly refinancing or expanding that particular liability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key quantitative facts: $750 million face value (properly noting the thousands notation), 2.65% interest rate, July 15, 2030 maturity date, and consistency across 2022-2024. The numeric accuracy is excellent with proper format handling. The core observation about stability and the company's intent to lock in long-term financing is sound. WEAKNESSES: (1) The answer is narrower in scope than the ground truth - it focuses primarily on the 35A notes themselves but provides minimal context about the 'broader changes in their unsecured debt portfolio' mentioned in the original answer. The ground truth specifically references new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities as important context for understanding the strategic pattern. The LLM answer doesn't synthesize this comparative information. (2) The characterization of the strategy is somewhat incomplete - while the LLM correctly identifies the intent to maintain stable, long-dated financing, it doesn't fully explain how this fits into a broader debt management strategy that includes selective refinancing and new issuances. (3) The answer lacks the comparative analysis that would strengthen the multi-hop reasoning - comparing the stability of 35A against changes elsewhere in the debt portfolio would better illustrate the deliberate nature of the strategy. QUANTITATIVE VERIFICATION: All numbers check out correctly - $750M consistent across years, 2.65% rate, 2030 maturity. MULTI-HOP REASONING: The answer successfully synthesizes information across three years but fails to synthesize across multiple debt instruments or broader portfolio context. SEMANTIC EQUIVALENCE: The core message about stability and strategy intent is conveyed, though less comprehensively than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 501,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept Embedded Processing at the core of its strategy throughout the period. In each of the 2022, 2023 and 2024 Form 10‑K filings the company states that its “great business model is focused on analog and embedded‑processing products” and that a “broad portfolio of analog and embedded‑processing products” is one of the four sustainable competitive advantages (advantage b) – see the strategy sections on pages 18 (2022), 18 (2023) and 20 (2024). Although the segment’s revenue fell from $3.26 bn in 2022 to $2.53 bn in 2024, the strategic emphasis on Embedded Processing has remained unchanged, continuing to be a central pillar of TI’s competitive‑advantage framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a solid response with mostly accurate information but has some notable differences from the ground truth. STRENGTHS: (1) Correctly identifies Embedded Processing as the second of four sustainable competitive advantages; (2) Accurately cites the consistent strategic emphasis across 2022-2024; (3) Provides specific page references (18, 18, 20) for the three years; (4) Includes relevant revenue data ($3.26B in 2022 declining to $2.53B in 2024) showing business context; (5) Correctly identifies the product portfolio language about 'analog and embedded-processing products.' WEAKNESSES: (1) The LLM quotes 'great business model is focused on analog and embedded-processing products' but the ground truth emphasizes the specific phrase about 'more opportunity per customer and more value for our investments' - this is a material difference in capturing the exact strategic language used; (2) The LLM does not explicitly mention that the identical phrasing was used across all three years, which is a key point in the ground truth about consistency; (3) The LLM adds revenue decline context ($3.26B to $2.53B) which, while factually interesting and likely accurate, is not mentioned in the ground truth and somewhat shifts focus from the strategic emphasis question to business performance. QUANTITATIVE ACCURACY: The revenue figures appear reasonable for a major semiconductor company segment, though they cannot be verified against the ground truth provided. The page numbers cited are specific and plausible. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the consistent positioning within the four competitive advantages framework. However, it misses the nuance about the specific repeated language ('more opportunity per customer and more value for our investments') that the ground truth emphasizes as key evidence of sustained importance. The answer is directionally correct but lacks the precision in capturing the exact strategic messaging that the ground truth highlights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 553,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "In 2022 Comcast’s MVNO wireless service was offered only in the United States as part of a broadband bundle, with customers able to choose an unlimited‑data plan, a shared‑data plan, or a per‑gigabyte option【page_7】. In 2023 the service was extended to the United Kingdom and began serving “international customers” who could select various gigabyte‑based plans, adding geographic reach and more plan choices【page_5】. By 2024 Comcast added further flexibility by launching prepaid unlimited‑data plans under the NOW brand for domestic users and also offering unlimited‑data options for international customers【page_5】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of CMCSA's wireless offerings across the three-year period (2022-2024). It accurately captures: (1) 2022 offerings as U.S.-only bundled service with plan flexibility (unlimited, shared data, per-gigabyte options), (2) 2023 expansion to UK and international markets with gigabyte-based plans, (3) 2024 introduction of NOW brand prepaid unlimited plans and expanded international options. The chronological progression and geographic expansion narrative is sound.\n\nWEAKNESSES: (1) The LLM introduces a specific geographic detail (\"United Kingdom\") that is not explicitly confirmed in the ground truth, which only states \"international expansion\" without naming specific countries. This represents a potential factual overreach. (2) The LLM characterizes 2023 offerings as \"gigabyte-based plans\" for international customers, but the ground truth indicates 2023 maintained the same structure as 2022 with emphasis on flexibility (unlimited, shared data, per-gigabyte options), not a shift to gigabyte-only plans. This is a subtle but meaningful distinction. (3) The answer lacks explicit mention that shared data plans continued to be offered in 2024, though the ground truth emphasizes \"continuing to offer shared data plans\" as part of the evolution. (4) The citation references (page_7, page_5) cannot be verified against the ground truth knowledge graph.\n\nMULTI-HOP REASONING: The answer demonstrates adequate synthesis across the three-year period, correctly linking plan flexibility evolution with geographic expansion. However, the reasoning about what changed year-to-year contains some inaccuracies in characterizing the specific plan types available in each year.\n\nFACTUAL ACCURACY: Core timeline and major developments are correct, but specific characterizations of plan offerings in 2023 and the explicit mention of UK expansion introduce elements not confirmed in ground truth. The answer is directionally correct but contains details that go beyond or slightly mischaracterize the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 560,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "PayPal’s 10‑K risk‑factor language has moved from a 2022 warning that “failure to deal effectively with fraud, abusive behaviors… may increase our loss rate” and that its credit products “expose us to additional risks” – including borrower defaults and reliance on partner banks [page_21, page_22] – to a 2023 discussion that emphasizes its heavy dependence on unaffiliated third‑party lenders, the limits of its credit‑risk models, and the expectation that “third parties will continue to attempt to abuse… creating fictitious PayPal accounts using stolen or synthetic identities” [page_23, page_24]. By 2024 the filing adds concrete funding‑structure actions—selling up to €40 billion of BNPL loan receivables and pursuing other third‑party financing arrangements—while still noting that “third parties may seek to engage in abusive schemes… that are often difficult to detect and may be deployed at a scale” [page_22, page_23, page_25]. This evolution shows that PayPal’s exposure to abusive behavior has become more intertwined with its credit‑product funding and partnership ecosystem, indicating a markedly higher complexity in risk‑management for its digital payments platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the €40 billion BNPL loan receivable sale figure, matching the ground truth exactly. (2) Accurately captures the 3-year progression from 2022-2024 with appropriate temporal sequencing. (3) Properly synthesizes multi-hop information about fraud evolution, including fictitious account creation, stolen financial instruments, account takeovers, and synthetic identity fraud. (4) Correctly identifies the shift from general fraud concerns to more sophisticated third-party fraud schemes and BNPL-related risks. (5) Appropriately emphasizes the growing complexity and intertwining of credit products with fraud exposure. (6) Maintains semantic equivalence with ground truth while using slightly different phrasing. MINOR WEAKNESSES: (1) The LLM answer references specific page numbers (page_21, page_22, etc.) which are not present in the ground truth and cannot be verified as accurate - this adds specificity that may or may not be correct but doesn't contradict the ground truth. (2) The LLM answer mentions 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks' is present in the ground truth but not explicitly stated in the LLM response, though the LLM does reference 'third-party financing arrangements' which partially captures this concept. (3) The LLM answer could have been more explicit about the FDIC-insured bank dimension mentioned in ground truth. QUANTITATIVE VERIFICATION: The €40 billion figure is correctly stated and matches ground truth exactly. No calculations are required or presented, so quantitative accuracy is high. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the progression of complexity in fraud schemes and their relationship to credit products. The reasoning about how PayPal's exposure evolved is sound and logically structured. OVERALL ASSESSMENT: The answer is substantially correct with accurate key facts, proper temporal sequencing, and sound multi-hop reasoning. The page number citations, while potentially helpful, introduce unverifiable specificity. The core narrative about PayPal's evolving fraud exposure and its relationship to credit products is accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 632,
        "total_tokens": 2229
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "In 2022 Gilead identified its El Segundo, California site as one of its principal manufacturing facilities, supporting its cell‑therapy pipeline (2022 10‑K p. 33). By the 2023 filing the company explicitly says the El Segundo plant is used for “clinical and commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats that same expanded role (2023 10‑K p. 11; 2024 10‑K p. 10), indicating the site moved from primarily clinical work to handling both clinical and commercial cell‑therapy production. Gilead also notes that its capital resources are sufficient to purchase, lease or construct additional facilities to meet long‑term growth needs, underscoring a strategic commitment to invest in and expand its cell‑therapy manufacturing capacity (2022 10‑K p. 33).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of years (2022, 2023, 2024), correct company (GILD/Gilead), and accurate characterization of El Segundo's role in cell therapy manufacturing. The answer correctly cites specific 10-K page numbers and accurately describes the evolution from clinical to clinical and commercial manufacturing capabilities. However, there are notable differences from the ground truth: (1) The LLM characterizes the evolution as a shift 'from primarily clinical work to handling both clinical and commercial cell-therapy production,' but the ground truth indicates El Segundo was identified as supporting 'clinical and commercial manufacturing' in 2022 itself, not a progression from clinical-only to both. This represents a subtle but meaningful misinterpretation of the facility's role trajectory. (2) The LLM adds information about capital resources and facility expansion strategy that, while relevant to the broader context, goes slightly beyond what the ground truth emphasizes about the specific El Segundo facility evolution. (3) The ground truth emphasizes 'continuity' and 'no indication of reduced emphasis or facility changes,' while the LLM frames it as a transition/evolution, which is a semantic difference in interpretation. The quantitative accuracy is strong (years and page citations are correct), and the multi-hop reasoning across three years of filings is sound. The answer is contextually relevant and addresses the question's core components, but the characterization of the facility's role change is not entirely aligned with the ground truth's assertion that El Segundo was already identified for both clinical and commercial manufacturing in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 472,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across Costco’s 2022, 2023 and 2024 Form 10‑K reports the 2.750 % Senior Notes are consistently shown as a single tranche that matures on May 18 2024 (Exhibit 4.6 in the Item 15 exhibit list on page 66 of each filing)【COST_10k_2022 page_66】【COST_10k_2023 page_66】【COST_10k_2024 page_66】. The unchanged maturity date over three consecutive years indicates that Costco has maintained a stable, medium‑term debt profile, choosing to let the notes run to their original maturity rather than refinancing or extending them—reflecting a disciplined, low‑turnover debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) All numeric values are correct - the 2.750% interest rate and May 18, 2024 maturity date are accurately stated and consistent with ground truth; (2) The temporal scope is correct - covers 2022, 2023, and 2024 filings as required; (3) Multi-hop synthesis is sound - correctly identifies that the maturity structure remained unchanged across all three years, demonstrating proper information synthesis across multiple filings; (4) The interpretation of debt management strategy is accurate and matches the ground truth assessment that Costco maintained a static approach without refinancing or extension; (5) The citation format with specific page references (page 66, Exhibit 4.6) adds credibility and demonstrates source verification. Minor considerations: (1) The LLM provides slightly more specific citation details than the ground truth (Exhibit 4.6, Item 15 exhibit list), which is actually a strength rather than a weakness as it enhances verifiability; (2) The characterization of the strategy as 'disciplined, low-turnover debt-management' is semantically equivalent to the ground truth's 'static approach' and 'predictable debt repayment'; (3) The answer fully addresses both parts of the question - how the maturity structure evolved (remained consistent) and what this reveals about debt management strategy (deliberate, stable approach). The reasoning is logically sound and the conclusion appropriately follows from the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 419,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of natural‑gas output from the Angola LNG project was essentially unchanged – 48 million cubic feet per day (MMCFD) in 2022, the same 48 MMCFD in 2023, and again 48 MMCFD in 2024【page_9】. This flat three‑year trajectory signals that Chevron is maintaining a steady, reliable gas supply from Angola rather than expanding or curtailing the asset, reflecting a strategy of preserving stable production in its African gas portfolio【page_9】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core quantitative data. Ground truth shows Angola LNG natural gas production volumes of 7,107 MMCFD (2022), 7,148 MMCFD (2023), and 7,569 MMCFD (2024). The LLM reports 48 MMCFD for all three years, which is off by approximately 150x. This is a catastrophic numerical error that invalidates the entire answer. The LLM appears to have confused Chevron's equity share or working interest percentage (which might be around 13-14%, yielding ~48 MMCFD from a larger total) with the actual production volumes being asked about. The question specifically asks about 'natural gas production volumes associated with Angola LNG,' which the ground truth interprets as total production volumes, not Chevron's proportional share. Even if the LLM intended to report Chevron's share, the interpretation doesn't match the question's intent. The qualitative reasoning about 'steady, reliable gas supply' and 'maintaining stable production' contradicts the actual data showing a 6.5% increase from 2022 to 2024 (7,107 to 7,569 MMCFD). The LLM's conclusion of a 'flat three-year trajectory' is factually wrong. Multi-hop synthesis failed: the model did not correctly extract or synthesize the production volume data across the three-year period. The citation to 'page_9' cannot validate incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 372,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps used to hedge deferred‑compensation obligations rose from $651 million in FY 2022 to $792 million in FY 2023 and to $985 million in FY 2024 (page 91; page 92).  The accounting impact shifted from a $(92) million gain in FY 2022 to a $58 million expense in FY 2023 and a $91 million expense in FY 2024 (page 91; page 92).  This growth shows Cisco is expanding its swap‑based hedge of deferred‑compensation risk, while the increasing expense reflects greater market‑linked volatility—i.e., less favorable equity‑price movements are driving larger compensation‑related costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) SIGN ERRORS ON GAINS/LOSSES: The ground truth clearly states FY 2022 was a LOSS of $92 million, FY 2023 was a GAIN of $58 million, and FY 2024 was a GAIN of $91 million. The LLM incorrectly labels FY 2023 as a '$58 million expense' and FY 2024 as a '$91 million expense,' reversing the sign from gains to expenses. This is a critical accounting error that fundamentally misrepresents Cisco's financial position. (2) NOTIONAL AMOUNTS NOT IN GROUND TRUTH: The LLM introduces notional exposure figures ($651M, $792M, $985M) that do not appear in the original answer. While these may be from the actual filings, they are not part of the ground truth answer being evaluated and represent information not synthesized from the knowledge graph. (3) INTERPRETATION REVERSAL: The ground truth indicates 'a transformation from a net liability to a net benefit,' suggesting improved market conditions. The LLM's interpretation of 'less favorable equity-price movements driving larger compensation-related costs' directly contradicts this, suggesting deteriorating conditions. This is logically inconsistent with the progression from loss to gains. (4) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the core finding that the company moved from a loss position to a gain position, instead focusing on notional amounts and mischaracterizing the P&L impact. The answer demonstrates poor multi-hop reasoning by introducing extraneous data points while misrepresenting the key financial metrics from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 446,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "- 2022: Lowe’s already required all suppliers to comply with a human‑rights policy, a conflict‑minerals policy and a Vendor Code of Conduct that includes enhanced environmental standards, and it was expanding its portfolio of independently‑certified (third‑party) products (2022 p. 9).  \n- 2023: The company revised its wood‑sourcing policy, adding country‑specific risk levels, stronger monitoring practices and a new forestry grievance process, while continuing to increase the share of independently‑certified products (2023 p. 9).  \n- 2024: Lowe’s further strengthened the wood‑sourcing policy into a more robust risk‑based framework with improved monitoring and grievance mechanisms, and it kept expanding independently‑certified offerings, reflecting a deeper focus on supplier environmental and human‑rights compliance (2024 p. 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately captures the evolution of Lowe's supplier practices; (2) All factual claims are accurate: 2022 mentions Vendor Code of Conduct, human rights policy, conflict-minerals policy, and enhanced environmental standards; 2023 correctly identifies wood-sourcing policy revisions with country-specific risk levels, stronger monitoring, and new forestry grievance process; 2024 accurately describes the more robust risk-based framework with improved monitoring and grievance mechanisms; (3) The answer properly synthesizes multi-hop information across three years, showing clear progression and deepening commitment; (4) Includes specific details like 'independently-certified products' and 'forestry grievance process' that demonstrate comprehensive understanding; (5) Provides source citations (2022 p. 9, 2023 p. 9, 2024 p. 9) showing proper documentation. MINOR CONSIDERATIONS: (1) The LLM answer includes 'conflict-minerals policy' which is not explicitly mentioned in the ground truth answer, though this is an accurate addition from the source material and enhances rather than detracts from the response; (2) The ground truth mentions 'wood sourcing policy ensuring products came from well-managed, non-endangered forests' in 2022, while the LLM answer doesn't explicitly state this detail for 2022, though it does capture the policy's evolution in subsequent years. This is a very minor omission that doesn't significantly impact the overall accuracy. QUANTITATIVE ACCURACY: No calculations or specific percentages/dollar amounts are required for this question, so this dimension is not directly applicable, but the answer maintains perfect accuracy on all dates and temporal references. QUALITATIVE ACCURACY: The reasoning is sound, the multi-hop synthesis across three years is logical and well-structured, and all entities are correctly identified. The answer effectively conveys the progression from monitoring through policy updates to enhanced frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 573,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From the 2022 filing Comcast first flagged wireless carriers as a new broadband rival, noting that “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” were beginning to bundle those data plans with attractive pricing (page 28). By the 2023 filing the threat was fleshed out – Comcast named the major U.S. players AT&T, T‑Mobile and Verizon (and U.K. peers BT and Virgin Media) and added that “various wireless companies are offering internet services using 5G fixed‑wireless networks and 4G and 5G wireless broadband services,” often through lower‑price bundles (pages 8 & 9). The 2024 risk discussion repeats and expands this view, stating that “wireless telecommunications companies … using a variety of technologies, including 5G fixed‑wireless networks and 4G and 5G wireless broadband services” now “offer competitive pricing, packaging and/or bundling of services to customers,” keeping the competitive pressure steady and broader (page 21).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022-2024 with appropriate progression of competitive threat intensity; (2) Accurately names all major competitors (AT&T, T-Mobile, Verizon) and includes additional international competitors (BT, Virgin Media) not mentioned in ground truth but factually present in filings; (3) Properly synthesizes technological capabilities across years: 4G/5G in 2022, 5G fixed wireless emphasis in 2023, and continued expansion in 2024; (4) Correctly captures the bundling strategy evolution, noting the shift from basic bundling in 2022 to DTC streaming service bundling by 2024; (5) Provides specific page references (28, 8, 9, 21) that ground the answer in actual filing content; (6) Multi-hop reasoning is sound - successfully synthesizes information across three years of filings to show clear competitive escalation. MINOR CONSIDERATIONS: (1) The LLM answer includes BT and Virgin Media as U.K. competitors, which adds context beyond the ground truth but is factually accurate and relevant to CMCSA's competitive landscape; (2) The ground truth explicitly mentions 'DTC streaming services' bundling in 2024, while the LLM answer uses the more general term 'services' - however, the LLM's phrasing is still semantically equivalent and accurate; (3) All dates, company names, and technological terms are correct. QUANTITATIVE ACCURACY: No calculations required; all dates (2022, 2023, 2024) and technology references (4G, 5G, fixed wireless) are accurate. QUALITATIVE ACCURACY: The reasoning chain is logical and well-structured, showing clear progression of competitive threat. Entity identification is precise and comprehensive. CONTEXTUAL RELEVANCE: The answer directly and thoroughly addresses all aspects of the multi-part question regarding technological capabilities, bundling strategies, and specific competitors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 531,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "From 2022 through 2024 PayPal’s filings repeatedly state that it “bears full margin risk” because it acts as the principal on every transaction, sets fees at its discretion (using tiered, volume‑based pricing) and absorbs the costs it pays to payment‑processors, while any merchant or consumer incentives are recorded as reductions to revenue. The language around pricing, processor fees and incentive accounting is unchanged across the three years, indicating that PayPal’s margin‑risk exposure has remained stable and that the company continues to retain strong control over both pricing decisions and cost management.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies PayPal's core strategic position: bearing full margin risk, setting fees at discretion, absorbing processor costs, and recording incentives as revenue reductions. The statement that this language remained 'unchanged across the three years' aligns with the ground truth's conclusion about 'stable strategic stance.' The mention of tiered, volume-based pricing is accurate and adds helpful specificity. WEAKNESSES: (1) The LLM answer significantly OMITS the 2023 expansion of incentive discussion (discounts, rebates, rewards) that the ground truth explicitly highlights as adding 'complexity to margin management.' This is a material omission for a multi-year trend analysis. (2) The LLM answer completely MISSES the 2024 development regarding contractual compensation from sellers violating terms (fraud, counterfeiting), which the ground truth identifies as introducing 'new revenue streams potentially affecting margin dynamics.' This is a critical gap in the multi-hop synthesis across all three years. (3) The LLM answer states the language is 'unchanged' which oversimplifies the ground truth's more nuanced finding that while the strategic stance remained stable, the company 'expanded its discussion' and 'further detailed' its revenue streams. (4) The LLM answer lacks the ground truth's explicit recognition of the evolution in complexity: 2022 (basic fee discretion) → 2023 (expanded incentive discussion) → 2024 (new revenue streams). QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing errors). QUALITATIVE ACCURACY: The core reasoning about margin risk and pricing control is sound, but the failure to capture the 2023-2024 evolution represents incomplete multi-hop synthesis (5/10). CONTEXTUAL RELEVANCE: The answer addresses the main question about margin risk evolution and control, but misses key developments that would fully answer 'what does this multi-year trend reveal' (7/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 544,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease‑accounting language was essentially unchanged from FY 2022 through FY 2024. In each filing the company states that **“some leases include free‑rent periods and step‑rent provisions, which are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise”** 【page_45】. The **lease term** is defined as **“the non‑cancelable period of the lease plus any options to extend when it is reasonably certain that the Company will exercise the option”** 【page_46】, and the right‑of‑use (ROU) asset and lease liability are initially measured at the present value of the discounted minimum lease payments over that term using the incremental borrowing rate. Consequently, the free‑rent period is spread over the full (including certain renewal) term, lowering the initial ROU‑asset amount; no material change to this assumption or its impact on ROU valuation was introduced between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies that Costco's lease accounting language remained essentially unchanged from FY 2022-2024, matching the ground truth's characterization of 'stable and consistent approach'; (2) Accurately captures the core accounting treatment: free-rent periods and step-rent provisions recognized on straight-line basis over original lease term plus reasonably certain extension options; (3) Correctly identifies the use of incremental borrowing rate for present value calculations; (4) Properly explains the multi-hop synthesis: how free-rent periods spread over the full term (including renewals) lowers the initial ROU asset amount; (5) Accurately notes no material changes were introduced between 2022-2024; (6) Correctly identifies that leases lacked material residual value guarantees and restrictive covenants. MINOR CONSIDERATIONS: (1) The LLM answer provides more specific textual citations (page references) than the ground truth, which adds credibility but goes slightly beyond what was explicitly stated in the original answer; (2) The ground truth mentions 'variable lease payments' for leases with periodic rent increases based on price indices or sales volume in FY 2023, which the LLM answer does not explicitly address—however, this is a minor omission as it doesn't contradict the core finding and may represent a secondary disclosure detail; (3) The LLM answer's explanation of the ROU asset valuation impact is slightly more mechanistic/technical than the ground truth but remains semantically equivalent and accurate. QUANTITATIVE ACCURACY: No numerical errors; all fiscal years (2022, 2023, 2024) correctly referenced; no calculations required or presented. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years to demonstrate consistency in accounting treatment and its impact on ROU valuation. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate technical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 563,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across all three years PayPal consistently described itself as the **principal** of each payment, setting fees at its own discretion and therefore **bearing full margin risk** – the fees it charges are independent of the costs it pays to payment processors, which are recorded as transaction expense (2022 p. 78; 2023 p. 75; 2024 p. 77). Its transaction pricing has remained a mix of fixed and variable components (the variable portion is a percentage of the payment amount known at processing) and contracts are **open‑ended, transaction‑level agreements that automatically renew and use tiered, volume‑based pricing with no capitalized contract costs or material contract balances** (2022 p. 78; 2023 p. 75; 2024 p. 77). Thus, from 2022 through 2024 PayPal’s exposure to margin risk did not materially change; the pricing model, reliance on payment processors, and contract structure stayed essentially the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies PayPal's core margin risk exposure structure (bearing full margin risk as principal, recognizing fees on gross basis, paying processors as transaction expense) and accurately notes this remained consistent across 2022-2024. The characterization of pricing as tiered, volume-based, and open-ended is accurate. Page citations appear reasonable and consistent with typical 10-K structure. The answer correctly synthesizes that the fundamental pricing model remained unchanged.\n\nWEAKNESSES: (1) The LLM answer OMITS a significant evolution mentioned in the ground truth: the 2023 addition of clarifying language about how incentives provided to users are recognized as revenue reductions based on performance targets or amortized over contractual terms. This represents a material change in how margin structure variability is described and recognized, even if the fundamental risk exposure remained stable. (2) The LLM answer OMITS the 2024 adoption of new segment reporting disclosures under ASU 2023-07, which the ground truth identifies as increasing transparency around segment-level expenses and potentially affecting margin risk analysis across business units. This is a substantive change in reporting structure. (3) The LLM answer states margin risk 'did not materially change' but the ground truth more nuanced position is that it remained 'structurally stable but operationally nuanced' — the LLM misses the operational nuances introduced by the 2023 incentive recognition changes and 2024 segment reporting changes.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the consistency in core pricing model. However, it fails to complete the full multi-hop analysis by missing how changes in incentive recognition (2023) and segment reporting (2024) affected the operational complexity of margin risk even while the structural exposure remained constant.\n\nCOMPLETENESS: The answer addresses the main question about evolution but incompletely. It covers transaction pricing model and contract structure adequately but misses important changes in incentive recognition methodology and segment reporting that are material to understanding how margin risk exposure 'evolved' (even if structurally stable).\n\nNUMERIC/FACTUAL: No specific numbers are provided in either answer, so quantitative accuracy is based on the logical consistency of the claims made. The page citations in the LLM answer (p. 78, 75, 77 for respective years) are plausible but cannot be verified without access to actual filings. The characterization of pricing components and contract terms appears factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 715,
        "total_tokens": 2202
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90 % senior note has been used at the same level each year – $2 billion of principal outstanding in FY 2022 (July 30 2022), FY 2023 (July 29 2023) and FY 2024 (July 27 2024) – and the effective interest rate on that tranche has stayed essentially unchanged at about 6.11 % in all three periods【page_89】.  The unchanged utilization and stable effective cost indicate that Cisco is maintaining the 5.90 % note as a core, fixed‑rate component of its long‑term debt mix, relying on it for predictable financing while keeping overall borrowing costs steady despite market‑rate movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. QUANTITATIVE VERIFICATION: All numbers are correct - $2,000 million ($2 billion) principal outstanding across FY 2022, 2023, and 2024; effective interest rate of 6.11% constant across all three years; maturity date of February 2039 correctly referenced. The fiscal year dates provided (July 30 2022, July 29 2023, July 27 2024) are accurate. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) utilization evolution (constant at $2B), (2) effective interest rate evolution (constant at 6.11%), (3) implications for long-term debt strategy (maintaining as core fixed-rate component), and (4) financing costs (predictable, steady despite market movements). MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws appropriate conclusions about Cisco's debt management strategy - that the stability indicates a consistent, deliberate approach to capital structure management. ENTITY ACCURACY: Cisco correctly identified, note characteristics (5.90% coupon, February 2039 maturity) accurate, fiscal years properly referenced. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents a 'core, fixed-rate component' and 'predictable financing' aligns perfectly with the ground truth's characterization of 'consistent approach' and 'stable' management. Minor note: The citation reference [page_89] adds credibility but is not essential to evaluation. The answer is slightly more interpretive than the ground truth (adding 'core, fixed-rate component' language) but this represents reasonable financial analysis rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 467,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Lowe’s Intellectual‑Property sections in each filing list “Kobalt” as one of its private‑brand trademarks alongside STAINMASTER and allen+roth – fiscal 2022 (Intellectual Property, p. 7) 【page_7】, fiscal 2023 (Intellectual Property, p. 9) 【page_9】, and fiscal 2024 (Intellectual Property, p. 7) 【page_7】. The language is essentially unchanged across the three years, showing Kobalt has remained a core private‑brand asset with a steady strategic emphasis, while the 2024 filing adds broader commentary about “high‑value private brands,” underscoring its continued importance in Lowe’s brand portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies Kobalt as a private brand trademark across all three fiscal years (2022, 2023, 2024); (2) Accurately notes the consistent positioning alongside STAINMASTER and allen+roth; (3) Properly synthesizes the multi-hop information across three separate filings; (4) Correctly characterizes the strategic emphasis as 'steady' and 'stable' rather than expanding; (5) Appropriately cites page numbers for each year's filing. MINOR CONSIDERATIONS: (1) The LLM adds a detail about 2024 filing including 'broader commentary about high-value private brands' - this is a reasonable inference about increased emphasis but goes slightly beyond what the ground truth explicitly states about 'no explicit increase or decrease in prominence'; (2) The phrase 'core private-brand asset' is semantically equivalent to the ground truth's 'key private brand' and 'ongoing brand importance.' QUANTITATIVE ACCURACY: All fiscal years (2022, 2023, 2024) are correct; page number citations appear reasonable and consistent with typical SEC filing structures. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate annual filings and correctly identifies the pattern of consistency rather than change. SEMANTIC EQUIVALENCE: The LLM's characterization of 'steady strategic emphasis' and 'stable strategic role' are semantically equivalent to the ground truth's conclusion. The answer fully addresses the question about how positioning and strategic emphasis evolved (or remained stable) across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 451,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Simon’s Unsecured Notes ‑ 37B have been unchanged across the three filings – each shows a 2.25 % fixed‑rate note with a $700 million face amount (listed as $700,000 in the “thousands” tables) and a maturity of January 15 2032 (2022 10‑K p. 50; 2023 10‑K p. 50; 2024 10‑K p. 51). The consistency indicates the company is maintaining a stable, long‑dated unsecured tranche to lock in modest rates and provide predictable, long‑term financing for its portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - 2.25% interest rate, $700 million face amount (correctly noted as $700,000 in thousands format), and maturity date of January 15, 2032 are all accurate across 2022-2024. The LLM appropriately clarifies the thousands notation convention, showing understanding of SEC filing format conventions. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) interest rate evolution (unchanged at 2.25%), (2) face amount evolution (unchanged at $700M), and (3) maturity date evolution (unchanged at 01/15/32). MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three separate 10-K filings (2022, 2023, 2024) and identified the consistency pattern. The page references (p. 50, 50, 51) add credibility and demonstrate proper source tracking. REASONING QUALITY: The interpretation that stability indicates 'confidence in debt management' and 'favorable market conditions' is sound and aligns with the ground truth's assessment. The characterization of the note as 'stable, long-dated unsecured tranche' with 'modest rates' and 'predictable, long-term financing' is semantically equivalent to and slightly more detailed than the ground truth. MINOR DIFFERENCES: The LLM uses slightly more specific language ('fixed-rate note,' 'long-dated unsecured tranche') compared to ground truth's more general phrasing, but this represents enhanced clarity rather than error. The LLM's explanation of the thousands notation convention demonstrates superior attention to detail. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 461,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site was listed as an Analog‑only location in each filing – the 2022 10‑K “Properties” table (page 16) shows an X under Analog and nothing under Embedded Processing, and the same pattern appears in the 2023 10‑K (page 16) and the 2024 10‑K (page 16). Thus, across 2022‑2024 the Melaka footprint did not expand to the Embedded Processing segment; it remained dedicated solely to Analog.【page_16】【page_16】【page_16】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) All factual claims are correct - the answer accurately states that Melaka was Analog-only in 2022, 2023, and 2024 with no Embedded Processing involvement; (2) Quantitative accuracy is perfect - no numerical errors, dates are correct (2022, 2023, 2024), and the consistent pattern across all three years is accurately represented; (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three separate 10-K filings and identifies the consistent pattern; (4) Entity accuracy is correct - Texas Instruments (TXN) is properly identified, Melaka, Malaysia is correctly specified, and the business segments (Analog and Embedded Processing) are accurately named; (5) The answer provides specific sourcing (Properties table, page 16 in each filing) which demonstrates proper document verification; (6) The conclusion about 'stable, specialized role' and 'no expansion' is logically sound based on the consistent data. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth and doesn't explicitly use the phrase 'This 3-year consistency highlights a stable, specialized role' but conveys the same meaning through 'the Melaka footprint did not expand...it remained dedicated solely to Analog.' This is a semantic equivalence rather than an error. The answer fully addresses all parts of the question: the evolution (or lack thereof) across the three years, the specific business segments, and the temporal consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 450,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes remained unchanged at $1.5 billion in each of the three most recent years – $1.5 bn in 2022 (as shown in the 2023 filing) 【page_107†L31-L34】, $1.5 bn in 2023 (2023 filing) 【page_107†L31-L34】, and $1.5 bn in 2024 (2024 filing) 【page_104†L27-L30】.  This flat exposure signals that PayPal is deliberately preserving a sizable tranche of low‑cost, long‑dated debt, using it as a stable financing foundation while issuing newer, higher‑rate notes for growth‑related needs – a strategy that emphasizes predictable interest expense and long‑term debt stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of PYPL's debt management strategy. QUANTITATIVE ACCURACY: All numerical values are correct - the $1.5 billion principal amount is accurately stated for all three years (2022, 2023, 2024), with proper citation references to specific filing pages. The consistency of the amount across all three years is correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained constant at $1.5B), and (2) what this indicates about long-term debt management strategy (deliberate preservation of low-cost, stable debt). ENTITY ACCURACY: Company (PayPal/PYPL), metric (fixed-rate 2.850% notes), and time period (2022-2024) are all correctly identified. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM correctly synthesizes that the flat exposure indicates strategic debt management, specifically that PayPal is maintaining a stable, low-cost debt tranche while issuing newer higher-rate notes for other needs. This aligns with the ground truth's observation about contrasting with retirement of 1.350% notes and introduction of new notes. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberately preserving a sizable tranche of low-cost, long-dated debt' and 'emphasizing predictable interest expense and long-term debt stability' conveys the same meaning as the ground truth's 'consistent long-term liability' and 'maintained its long-term debt structure.' Minor differences: The LLM provides slightly more explicit strategic interpretation ('growth-related needs') which adds helpful context without contradicting the ground truth. The citation format and page references enhance credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 497,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "In the 2022 filing the Hoofddorp, Netherlands site is not listed among Gilead’s manufacturing locations, indicating it was not yet part of the company’s cell‑therapy production network (see GILD 2022 10‑K, pages 31‑35). By 2023 the Hoofddorp facility appears in the “Our Manufacturing Facilities” list as a site used for commercial manufacturing and processing of cell‑therapy products — showing its entry into the global cell‑therapy supply chain (GILD 2023 10‑K, page 11). The 2024 filing repeats this description, confirming that Hoofddorp continues to serve as a commercial manufacturing and processing hub for cell‑therapy products, cementing its role in Gilead’s worldwide manufacturing strategy (GILD 2024 10‑K, page 10).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer directly contradicts the ground truth on a fundamental claim. The ground truth explicitly states that in 2022, Gilead identified Hoofddorp as a 'principal manufacturing facility,' indicating it WAS already part of the company's strategic operations in 2022. However, the LLM claims 'In the 2022 filing the Hoofddorp, Netherlands site is not listed among Gilead's manufacturing locations, indicating it was not yet part of the company's cell-therapy production network.' This is a major factual error that undermines the entire answer. The LLM incorrectly characterizes the 2022 status as absent when the ground truth shows it was present and identified as principal. The LLM correctly identifies that 2023 and 2024 both show Hoofddorp being used for commercial manufacturing and processing of cell therapy products, which aligns with the ground truth. However, the incorrect 2022 characterization is a significant error that misrepresents the evolution of the facility's role. The LLM's narrative of 'entry into the global cell-therapy supply chain' in 2023 is factually wrong—the facility was already identified as principal in 2022. The multi-hop reasoning fails because it misinterprets the 2022 baseline, leading to an incorrect trajectory analysis. The ground truth emphasizes 'continuity and deepening' while the LLM incorrectly suggests a new entry point in 2023. This is a fundamental misreading of the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 406,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "In 2022 Costco reported the 1.375 % Senior Notes due June 2027 as a $1,250 long‑term‑debt item with only a $73 current‑portion classification (page_52). In the 2023 fiscal year the current portion jumped to $1,081, moving most of the $1,250 balance into the current‑liability category (page_52). By 2024 the notes were again shown primarily as long‑term debt, with the current portion reduced to $103 (page_52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: the principal amount of $1,250 million is consistently maintained across 2022-2024, and the current portion classifications are accurate ($73M in 2022, $1,081M in 2023, $103M in 2024). The multi-hop synthesis is sound, correctly tracking how the same debt instrument's classification evolved across three fiscal years. The answer properly addresses the core question about how treatment evolved in terms of both long-term debt composition and current portion classification. The narrative clearly explains the shifting debt maturity profiles and the movement between current and long-term liability categories. Minor note: The LLM uses slightly informal formatting (\"long‑term‑debt\" with special characters) and includes page references that add context but aren't strictly necessary. The semantic meaning is fully preserved and matches the ground truth answer. The reasoning demonstrates proper understanding that the principal remained constant while classification changed, which is the key insight of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 319,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal’s $2.850 % fixed‑rate notes (maturing 10/1/2029) have shown virtually no change over the three‑year period – the outstanding principal was $1.5 billion in 2022 and 2023 [page 107] and remained $1.5 billion at the end of 2024 [page 104].  The company’s repayment schedule still lists a single $1.5 billion cash outflow in 2029 [page 106], indicating that PayPal has left this low‑cost, long‑dated tranche untouched while using other issuances to refinance or retire higher‑rate debt.  This stability signals a disciplined long‑term debt strategy that locks in inexpensive financing and limits additional leverage.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the question about PayPal's debt management strategy. STRENGTHS: (1) All key numbers are correct: $1.5 billion principal amount across 2022-2024, 2.850% fixed rate, October 1, 2029 maturity date. (2) The quantitative facts are precisely stated with proper formatting and page references. (3) The multi-hop synthesis is sound - the answer correctly identifies that this debt tranche remained unchanged while other refinancing activity occurred elsewhere. (4) The interpretation of debt strategy is reasonable and well-supported: the company maintained this low-cost, long-dated debt while managing other obligations. (5) The answer directly addresses both parts of the question: how obligations evolved (remained stable) and what this reveals about strategy (disciplined approach, locking in inexpensive financing). MINOR GAPS: (1) The LLM answer does not explicitly mention the September 2019 issuance date or the $5.0 billion total issuance context that the ground truth provides, which adds some historical context. (2) The effective interest rate of 2.96% mentioned in the ground truth is not included in the LLM answer, though this is a minor detail. (3) The phrase 'limits additional leverage' in the LLM answer is slightly interpretive - the ground truth focuses more on 'preserving capital structure stability' which is a more precise characterization. VERIFICATION: All numeric values check out correctly. The reasoning about maintaining this tranche while refinancing others is logically sound and well-supported. The answer appropriately uses page references to support claims. The semantic meaning aligns well with the ground truth despite some wording differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 477,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s gas‑related option positions have been essentially flat – the fair‑value of the option assets stayed at about $100 million each year, while the liability side was $102 million in 2022, fell to $97 million in 2023 (creating a small net‑asset position), and returned to $102 million in 2024【page_84】.  The company’s implied‑volatility assumptions have also been steady, with a weighted‑average volatility of roughly 50‑52 % (range 15‑150 % in 2022 and 2024, 20‑233 % in 2023)【page_84】, indicating that NEE deliberately maintains a balanced, hedged exposure to gas price risk while assuming relatively high market volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - Asset values: LLM claims \"about $100 million each year\" but ground truth shows $356M (2022), $100M (2023), $100M (2024). The 2022 figure is completely wrong.\n   - Liability values: LLM claims \"$102 million in 2022, fell to $97 million in 2023, and returned to $102 million in 2024\" but ground truth shows $347M (2022), $97M (2023), $102M (2024). The 2022 liability figure is drastically incorrect.\n   - Volatility: LLM states \"roughly 50-52%\" but ground truth shows 36% (2022), 50% (2023), 52% (2024). The 2022 volatility is wrong.\n   - The LLM describes the position as \"essentially flat\" when in fact there was a dramatic 71.6% decline in asset fair value from 2022 to 2023 ($356M to $100M).\n\n2. MULTI-HOP REASONING - FAILED:\n   - The LLM failed to identify the key trend: a significant de-risking from 2022 to 2023, with stabilization in 2024.\n   - The LLM's characterization of \"deliberately maintains a balanced, hedged exposure\" contradicts the ground truth's interpretation of \"strategic de-risking.\"\n   - The LLM missed the critical insight that volatility assumptions actually declined from 36% to 50% (a 38.9% increase, not a decline), then slightly increased to 52%.\n\n3. ENTITY AND METRIC ACCURACY:\n   - Company name is correct (NextEra/NEE).\n   - Years are correct (2022-2024).\n   - Metrics are identified but values are wrong.\n\n4. SEMANTIC INTERPRETATION:\n   - The LLM's conclusion about \"balanced, hedged exposure\" and \"high market volatility\" is inconsistent with the ground truth's narrative of de-risking and reduction in expected volatility.\n   - The statement about volatility being \"steady\" is incorrect; there was a notable decline from 36% to 50%.\n\n5. SPECIFIC CALCULATION ERRORS:\n   - 2022 asset fair value: LLM says ~$100M, should be $356M (error of $256M or 256%)\n   - 2022 liability fair value: LLM says $102M, should be $347M (error of $245M or 240%)\n   - 2022 volatility: LLM says ~50-52%, should be 36% (error of 14-16 percentage points)\n\nThe LLM answer demonstrates a fundamental misunderstanding of the data, with the most critical error being the complete misstatement of 2022 figures, which are essential to understanding the multi-year trend. The answer fails to capture the significant de-risking that occurred from 2022 to 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 654,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments posted a modest $9 million gain in FY 2022, turned to a $21 million loss in FY 2023, and widened to a $67 million loss in FY 2024. These results helped drive other income (loss), net from a $392 million gain in 2022 to a $248 million loss in 2023 and a $306 million loss in 2024 (page 46). The swing from a small gain to increasingly larger losses shows that the debt‑investment portion of Cisco’s portfolio is quite volatile, reflecting sensitivity to market‑rate and credit‑loss fluctuations over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Specific financial figures are provided with precision: $9M gain (FY2022), $21M loss (FY2023), $67M loss (FY2024) for AFS debt investments; other income (loss), net figures of $392M gain (2022), $248M loss (2023), $306M loss (2024). (2) The answer correctly identifies the trend progression from gains to losses across the three-year period. (3) Multi-hop reasoning is sound: the LLM synthesizes how AFS debt investment performance directly impacted other income (loss), net, and draws appropriate conclusions about portfolio volatility. (4) The explanation of volatility drivers (market-rate and credit-loss fluctuations) is contextually appropriate and demonstrates understanding of investment dynamics. (5) The answer directly addresses all parts of the question: financial performance impact, year-by-year progression, and what this reveals about volatility. MINOR CONSIDERATIONS: The ground truth answer is more qualitative and general (stating 'higher losses' and 'recurring negative impact'), while the LLM provides specific quantitative data with page references. This specificity is actually a strength, as it provides verifiable, concrete evidence. The LLM's characterization of the $9M gain as 'modest' and the losses as 'increasingly larger' accurately reflects the magnitude and trend. The semantic equivalence is strong: both answers convey that AFS debt investments negatively impacted other income (loss), net in FY2023-2024, and both identify this as evidence of portfolio volatility. No calculation errors detected. All entities (Cisco, AFS debt investments, other income/loss, fiscal years) are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 478,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe’s first issued the 4.550 % notes in the **Fifteenth Supplemental Indenture dated April 5 2019** (a 30‑year bond due April 5 2049).  The same indenture is listed as **Exhibit 4.16** in each of the company’s annual reports – in the 2022 10‑K (see page 82), again in the 2023 10‑K (see page 75) and once more in the 2024 10‑K (see page 75) – indicating that the notes remain outstanding and are repeatedly disclosed.  This repeated, multi‑year documentation shows that Lowe’s relies on long‑dated, fixed‑rate debt as a core financing strategy, locking in borrowing costs for decades rather than issuing new short‑term instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All numbers and dates are correct - 4.550% interest rate, April 5, 2019 issuance date, April 5, 2049 maturity date (30-year bond), and the consistent exhibit references (4.16) across 2022, 2023, and 2024 10-Ks are all accurate. The page number citations (82 for 2022, 75 for 2023 and 2024) add specificity and credibility. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) how the notes evolved (consistent documentation across three years), (2) the documentation pattern (same Fifteenth Supplemental Indenture repeatedly disclosed), and (3) what this indicates about long-term debt strategy (reliance on long-dated, fixed-rate debt). ENTITY ACCURACY: Lowe's Companies, Inc. correctly identified, fiscal years 2022-2023-2024 correctly specified, financial instrument (4.550% Notes) correctly named. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the pattern of consistency and drawing the appropriate conclusion about strategic intent. The reasoning that repeated disclosure of the same indenture indicates no modifications or early redemptions is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - stable long-term debt structure with no changes - while providing additional supporting detail (specific exhibit numbers and page references). The interpretation that this reflects a deliberate strategy to lock in borrowing costs for decades is a reasonable inference from the documented pattern. MINOR CONSIDERATIONS: The LLM answer provides more granular detail (exhibit numbers, page references) than the ground truth, which enhances credibility without introducing errors. The characterization of the strategy as 'locking in borrowing costs for decades' is a logical inference from the facts presented and aligns with the ground truth's conclusion about 'steady approach to long-term financing.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 546,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "Across the three most recent 10‑K filings the Unsecured Notes – 35B tranche never changed – it carries a $750 million face amount and a 3.80 % coupon (maturing 07/15/2050) in 2022, 2023 and 2024【page_50】【page_50】【page_51】.  The constancy of both the principal size and the fixed‑rate exposure shows SPG’s deliberate strategy of preserving a stable, long‑dated, moderate‑rate unsecured note to lock in financing costs and limit refinancing risk over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - $750 million face value, 3.80% interest rate, and maturity date of 07/15/2050 are all accurate across 2022-2024. The LLM correctly identifies that these values remained constant throughout the three-year period. COMPLETENESS: The answer addresses all key aspects of the question: (1) face value evolution (stable at $750M), (2) interest rate exposure (unchanged at 3.80%), and (3) strategic implications. The multi-hop synthesis correctly combines data across three fiscal years to demonstrate consistency. ENTITY ACCURACY: Simon Property Group (SPG) is correctly identified, the debt instrument (Unsecured Notes - 35B) is properly named, and all years (2022, 2023, 2024) are correctly referenced. REASONING QUALITY: The LLM provides sound interpretation of the data, correctly concluding that the stability indicates a deliberate strategy to lock in financing costs and limit refinancing risk. The reasoning about long-dated, moderate-rate unsecured notes is logically sound and well-supported by the facts. MINOR CONSIDERATIONS: The original answer mentions 'maturity date was extended from 07/15/50 in 2022 to the same date in 2024' which is somewhat awkwardly worded (it wasn't extended, it remained the same). The LLM answer avoids this confusion by simply stating the maturity date remained constant. The LLM's interpretation is clearer and more accurate. The inclusion of page references adds credibility. Overall, the LLM answer is factually correct, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 465,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "In 2022 PayPal warned that its credit products could generate defaults, that cross‑border trade was exposed to tariffs, exchange‑rate swings and regulatory hurdles, and that reliance on unaffiliated banks, payment processors and other third‑party lenders created operational risk (2022 p.24‑28). The 2023 filing added detail on the limits of its credit‑risk models, the risk of a partner bank terminating lending, and the heightened sensitivity of cross‑border volumes to economic and legal factors (2023 p.23‑27), and the 2024 filing introduced a separate “bad‑transactions risk” section that stresses increasingly sophisticated fraud and abusive behavior across its credit portfolio and international flows while still noting third‑party dependencies (2024 p.21‑25). This evolution shows PayPal moving from broad risk statements to a more granular, proactive risk‑management focus—tightening credit‑risk oversight, diversifying and monitoring third‑party relationships, and investing in fraud‑detection—to strengthen operational resilience as transaction‑risk complexities grow.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer completely omits the critical €40 billion BNPL loan receivables sale agreement mentioned in the ground truth as a key 2023 strategic development. This is a major factual omission for a multi-year trend analysis. The LLM provides no specific financial figures or concrete strategic actions, only general descriptions of risk management evolution. (2) ENTITY/FACT ACCURACY - The ground truth specifically mentions: (a) Synchrony Bank partnership for U.S. consumer credit (2022), (b) €40 billion U.K./European BNPL receivables sale agreement (2023), (c) 'valid-when-made' doctrine legal uncertainty (2024). The LLM answer mentions none of these specific entities or strategic initiatives. Instead, it references generic page numbers (2022 p.24-28, 2023 p.23-27, 2024 p.21-25) without verifiable content. (3) MULTI-HOP REASONING - The ground truth shows a clear strategic transformation: internal risk absorption → external risk mitigation through asset sales → legal contingency planning. The LLM describes a more generic evolution from 'broad risk statements to granular focus' without capturing the specific strategic pivot to asset sales and external risk transfer. (4) COMPLETENESS - The LLM addresses credit products, cross-border trade, and third-party dependencies as requested, but fails to capture the most significant strategic development (the €40B receivables sale) that demonstrates PayPal's actual risk management strategy. (5) WHAT WAS CORRECT - The LLM correctly identifies the three risk categories (credit products, cross-border, third-party dependencies) and the general trend toward more sophisticated risk management. The characterization of increasing fraud sophistication and proactive oversight is directionally accurate. However, without the specific strategic actions and financial commitments, the answer misses the core evidence of how risk management actually evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 526,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s filings show a steady competitive stance: in 2022 it explicitly listed BJ ’s Wholesale Club as one of its “other warehouse‑club” rivals and highlighted Kirkland Signature as a private‑label that “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins” (page 8). The 2023 and 2024 reports repeat the same wording—still naming BJ’s as a direct competitor—and reaffirm that Kirkland Signature remains a high‑quality, lower‑price brand whose sales penetration the company will continue to grow (page 8). Thus, from 2022 through 2024 Costco’s positioning relative to BJ’s stayed consistent, with an unchanged but reinforced emphasis on Kirkland Signature as a key differentiator.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies BJ's Wholesale Club as a named competitor in Costco's filings, accurately quotes the Kirkland Signature value proposition ('helps lower costs, differentiate our merchandise offerings, and generally earn higher margins'), and correctly characterizes the consistency of messaging across 2022-2024. The specific page reference (page 8) adds credibility. (2) QUANTITATIVE ACCURACY: No numerical claims are made that require verification, which is appropriate for this qualitative question about competitive positioning. The temporal framing (2022, 2023, 2024) is accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to demonstrate the stable competitive positioning thesis. It correctly identifies that while BJ's is named as a competitor consistently, the Kirkland Signature differentiation strategy remains unchanged in emphasis and messaging. (4) COMPLETENESS: The answer addresses all parts of the multi-part question: (a) how competitive positioning evolved (answer: it remained stable), (b) the role of Kirkland Signature as a differentiator (answer: consistent emphasis across years), and (c) the specific time period 2022-2024 (fully covered). (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core finding as the ground truth—that Costco's competitive approach was stable with consistent emphasis on Kirkland Signature—while providing slightly more specific supporting detail (direct quotes, page references). Minor difference: The LLM uses 'steady' and 'consistent' language that perfectly matches the ground truth's 'remained stable' and 'no significant shift' characterization. The answer is well-structured, evidence-based, and demonstrates sound understanding of the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 518,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "- 2022: gas‑forward contracts were recorded at a fair‑value **asset of $191 million and a liability of $31 million** (net ≈ $160 million)【page 83】.  \n- 2023: the asset rose to **$377 million** and the liability to **$77 million** (net ≈ $300 million)【page 84】.  \n- 2024: the asset fell to **$296 million** while the liability fell to **$46 million** (net ≈ $250 million)【page 86】.  \n\nThe three‑year trend shows NextEra markedly expanded its gas‑forward position in 2023, then modestly trimmed it in 2024, leaving a net exposure still higher than in 2022—signaling an overall risk‑on stance in natural‑gas markets with a recent move toward modest de‑risking.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - 2022 assets ($191M), 2022 liabilities ($31M), 2023 assets ($377M), 2023 liabilities ($77M), 2024 assets ($296M), 2024 liabilities ($46M). The net position calculations are accurate ($160M, $300M, $250M respectively). The progression matches the ground truth exactly. COMPLETENESS: The answer addresses all three years (2022-2024) and covers both asset and liability components, providing a comprehensive 3-year evolution. ENTITY ACCURACY: NextEra Energy correctly identified, gas forward contracts properly specified, fair value metrics correctly applied, and years properly sequenced. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the 2023 spike as a notable expansion point, recognizes the 2024 pullback as modest de-risking, and synthesizes this into a coherent narrative about risk positioning. The interpretation that the net exposure remains higher in 2024 than 2022 ($250M vs $160M) is logically sound and demonstrates understanding of the strategic implications. MINOR CONSIDERATIONS: The LLM provides slightly more detailed interpretation than the ground truth (mentioning 'risk-on stance' and 'de-risking'), but this represents value-added analysis rather than error. The page citations (83, 84, 86) add credibility though cannot be independently verified. The semantic equivalence is excellent - the LLM's characterization of 'growing but increasingly balanced exposure' aligns with the ground truth's assessment of 'strategic expansion...accompanied by rising market risk.' No calculation errors detected. The answer fully addresses the question's request for understanding what the 3-year progression indicates about risk positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 491,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑rate‑swap activity fell sharply over the three‑year period. In the 2022 filing the company reported $2.56 billion of forward‑interest‑rate‑swap notional amounts, designated as cash‑flow hedges for anticipated debt issuances (2022 10‑K, Note 9, p. 62). By the 2023 filing the fair‑value of those swaps had dropped to $251 million (2024 10‑K, p. 54) and the 2024 filing notes that forward swaps were still held as of February 3 2023 but shows no remaining balance for 2024, indicating the positions were largely unwound (2024 10‑K, p. 46). This move from a large hedge in 2022 to essentially no forward‑swap exposure by 2024 suggests Lowe’s initially used swaps to lock in borrowing costs when rate risk was high, then scaled back or terminated the hedges as market rates and its financing plans changed, reflecting a flexible, market‑responsive interest‑rate risk‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (swaps declining from 2022-2024) and provides sound qualitative reasoning about Lowe's interest rate risk management strategy. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nKEY ISSUES:\n\n1. NOTIONAL AMOUNT DISCREPANCY: The LLM cites $2.56 billion in forward-interest-rate-swap notional amounts for 2022, but the ground truth does not mention this figure. The ground truth only references 2023 fair value of $251 million and notes that swaps were referenced in 2022 in the context of cash flow hedges affecting 2019-2021 periods. The introduction of the $2.56B notional figure without ground truth support is problematic.\n\n2. FAIR VALUE CONFUSION: The LLM states \"By the 2023 filing the fair-value of those swaps had dropped to $251 million\" - this is correct per ground truth ($251 million as of February 3, 2023). However, the phrasing \"dropped to\" implies a decline from the $2.56B notional, which conflates notional amounts with fair values - these are different metrics.\n\n3. 2024 STATUS ACCURACY: The LLM correctly identifies that forward swaps were no longer held by 2024 (as of January 31, 2025), matching the ground truth statement that they \"were not listed among the derivative instruments.\"\n\n4. REASONING QUALITY: The qualitative reasoning is sound - the LLM correctly interprets the progression as reflecting a flexible, market-responsive strategy and appropriately connects the unwinding to changing market conditions and refinancing activities. This matches the ground truth's characterization of \"deliberate use and subsequent release.\"\n\n5. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and connects it to broader strategic implications, which is appropriate for the question.\n\nCORRECT ELEMENTS:\n- 2023 fair value of $251 million ✓\n- 2024 unwinding/elimination of positions ✓\n- Characterization as cash flow hedges ✓\n- Strategic interpretation of the progression ✓\n- Connection to market conditions and financing ✓\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- $2.56 billion notional amount for 2022 (not in ground truth)\n- Conflation of notional amounts with fair values\n- Specific page citations that cannot be verified against ground truth\n\nThe answer would score higher if the $2.56B figure were either removed or properly sourced, and if the distinction between notional and fair value were clarified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 665,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "- In each filing (2022 – page 7 & 8; 2023 – page 7 & 8; 2024 – page 7 & 8) Comcast repeatedly notes that **Lumen is a major wireline competitor that is “building and continuing to build fiber‑based wireline network infrastructure … and are offering services with these higher speeds in many of our service areas.”**【page_8】【page_8】【page_8】\n\n- Comcast’s own network transformation has accelerated over the same period: it **began rolling out 2 Gbps downstream speeds in 2022 (to roughly one‑third of its HFC footprint) and expanded that coverage to about 50 % by 2024**【page_7】【page_7】; it **started deploying DOCSIS 4.0 in select markets in 2023**【page_7】【page_7】; and it **has been extending fiber‑to‑the‑premises, now offering symmetrical residential speeds up to 10 Gbps and business speeds up to 100 Gbps**【page_7】【page_7】.\n\n- Together, these disclosures show that while Lumen’s fiber build‑out has remained a competitive pressure, Comcast has progressively broadened its high‑speed fiber and DOCSIS‑4.0 footprint, allowing it to match or exceed Lumen’s speeds and service options in the markets where the two networks overlap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions: (1) ENTITY ACCURACY: Correctly identifies CMCSA (Comcast) and Lumen as the two competitors, with proper ticker/company name usage throughout. (2) TEMPORAL COVERAGE: Appropriately addresses all three years (2022-2024) as required by the question. (3) QUANTITATIVE ACCURACY: Provides specific, verifiable metrics including 2 Gbps deployment to ~33% of HFC footprint in 2022 expanding to ~50% by 2024, DOCSIS 4.0 deployment starting in 2023, and fiber-to-premises speeds up to 10 Gbps residential/100 Gbps business. These numbers are presented with appropriate precision and appear consistent with typical industry disclosures. (4) MULTI-HOP SYNTHESIS: Excellently synthesizes information across three years and two companies, showing how Lumen's competitive threat evolved while CMCSA responded with its own infrastructure investments. The answer correctly identifies the overlapping market dynamics and competitive response patterns. (5) SEMANTIC EQUIVALENCE: The LLM answer goes beyond the ground truth by providing specific technical details (DOCSIS 4.0, symmetrical speeds, fiber-to-premises) that enhance understanding while maintaining factual accuracy. The direct quotes from filings strengthen credibility. (6) REASONING QUALITY: The conclusion that CMCSA progressively matched/exceeded Lumen's capabilities is logically sound and well-supported by the cited evidence. Minor consideration: The ground truth emphasizes Lumen's 'growing influence' while the LLM answer emphasizes CMCSA's competitive response - both perspectives are valid and complementary rather than contradictory. The answer fully addresses the question's focus on competitive positioning evolution and implications for service offerings in overlapping markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 496,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "In 2022 PayPal’s 10‑K stressed a “simplest checkout” goal, offering a seamless omnichannel solution that let merchants accept online and in‑person payments while providing buy‑now‑pay‑later and credit‑card funding sources in the U.S., U.K., France, Germany and Japan and supporting payments in more than 200 markets and over 100 currencies (page_8). In 2023 the company made checkout even more friction‑free and reward‑driven, embedded its BNPL products into branded checkout, broadened its platform‑agnostic reach to process payments in roughly 200 markets and about 150 currencies and added offline engagement through PayPal‑branded debit/credit cards and Zettle POS (page_10; page_8). By 2024 PayPal deepened the credit suite—offering BNPL, interest‑bearing installments and co‑branded credit cards across the U.S., Europe, Japan and Australia—while its payments platform now serves 434 million accounts in ~200 markets, supports over 150 currencies and delivers a unified omnichannel merchant stack (branded checkout, unbranded processing, Zettle and in‑store card solutions) that streamlines online, mobile and in‑store purchases (page_6; page_5; page_10).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that conflict with the ground truth. Key issues: (1) CURRENCY SUPPORT DISCREPANCY: The LLM claims PayPal supported 'over 100 currencies' in 2022, which aligns with ground truth. However, it then claims 'roughly 200 markets and about 150 currencies' in 2023 and 'over 150 currencies' in 2024. The ground truth states approximately 150 currencies by 2023 and maintains this through 2024, not 'over 150.' More critically, the LLM states PayPal supported 'more than 200 markets' in 2022, which is not mentioned in the ground truth for that year. (2) ACCOUNT NUMBERS: The LLM introduces '434 million accounts' in 2024, which is not present in the ground truth answer and cannot be verified against it. (3) TIMELINE ACCURACY: The ground truth emphasizes a progression from 'global scale and usability' (2022-2023) to 'enhanced financial services integration and comprehensive merchant enablement' (2024). The LLM captures this evolution but adds unverified details. (4) BNPL INTEGRATION: Both answers correctly identify BNPL integration, but the LLM adds specifics about 'interest-bearing installments' and 'co-branded credit cards' that are not in the ground truth. (5) OMNICHANNEL SOLUTIONS: The LLM correctly identifies Zettle, Braintree, and debit/credit cards, matching the ground truth. However, the LLM's claim about 'more than 200 markets' in 2022 contradicts the ground truth's focus on 'over 100 currencies' without mentioning market count for that year. The answer demonstrates reasonable qualitative understanding of the evolution but introduces numerical claims not supported by the ground truth, particularly regarding market count in 2022 and account numbers in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 473,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The RedCard (Target Debit Card) penetration slipped from 20.5 percent in FY 2022 to 19.8 percent in FY 2023 and to 18.6 percent in FY 2024【page_27】. This steady decline shows the debit‑card’s share of purchases is shrinking, implying that while it still generates incremental sales, its relative contribution to Target’s growth is diminishing over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate figures. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM reports: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The 2023 figure is incorrect (19.8% vs 18.6%) and the 2024 figure is incorrect (18.6% vs 17.8%). These are not minor rounding differences but represent material misstatements of the data. The LLM essentially shifted all figures upward by approximately 1.2 percentage points for 2023 and 0.8 percentage points for 2024. QUALITATIVE ASSESSMENT: The LLM correctly identifies the overall trend (declining penetration) and provides reasonable interpretation that this suggests diminishing contribution to growth. However, the interpretation is somewhat generic and doesn't fully capture the 'consistent decline' pattern or the specific insight about 'weakening customer engagement with the payment loyalty program' mentioned in the ground truth. COMPLETENESS: The answer addresses the trend question but provides less nuanced analysis than the ground truth regarding what the decline suggests about the card's role. The ground truth explicitly notes the 'diminishing role' and links this to 'weakening customer engagement,' while the LLM uses softer language ('relative contribution...diminishing'). ENTITY ACCURACY: Correctly identifies Target Debit Card/RedCard and fiscal years. The page reference [page_27] is noted but cannot be verified. MULTI-HOP REASONING: The synthesis is straightforward and logically sound, but the foundation is compromised by incorrect numbers. The reasoning quality is adequate but built on faulty data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 454,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy for development‑plus‑IP licensing contracts did not change between the 2022, 2023 and 2024 filings. In each 10‑K (2022 p. 59; 2023 p. 63; 2024 p. 64) AMD says it first determines whether the licensing component is distinct. If the license is not distinct, it is combined with the development services and revenue is recognized over time; if the license is distinct—or if the arrangement is a standalone IP license—revenue is recognized at a point in time when the customer can benefit, with no variable‑consideration estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that AMD's policy remained consistent across 2022-2024, matching the ground truth assertion of 'maintained a consistent revenue recognition framework'; (2) Accurately describes the two-part framework: distinct licenses recognized at point in time vs. non-distinct licenses combined with development services and recognized over time; (3) Provides specific page references (2022 p. 59; 2023 p. 63; 2024 p. 64) that demonstrate multi-hop synthesis across three years of filings; (4) Correctly notes the distinction between standalone IP licenses and combined arrangements; (5) Accurately captures the timing of revenue recognition (point in time for distinct/standalone licenses, over time for non-distinct combined arrangements). Minor considerations: (1) The LLM answer adds a detail about 'no variable-consideration estimates' which is not explicitly mentioned in the ground truth, though this appears to be a reasonable inference from standard revenue recognition practices and doesn't contradict the ground truth; (2) The ground truth mentions 'when the customer can benefit from the IP' while the LLM says 'when the customer can benefit' - semantically equivalent; (3) The LLM answer is more concise and structured than the ground truth but conveys all essential information. The multi-hop reasoning is sound - the answer successfully synthesizes information across three separate 10-K filings to demonstrate policy consistency. No quantitative errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 434,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike’s Form 10‑K filings for fiscal 2022, 2023 and 2024 all place FlyEase alongside the company’s flagship innovations (Air, Zoom, Free, Dri‑FIT, Flyknit, ZoomX, Air Max, React) in the “Product research, design and development” discussion (2022 p.6; 2023 p.6; 2024 p.6). The repeated listing shows FlyEase was consistently positioned as a core technology in Nike’s innovation portfolio throughout the period, with no change in its strategic emphasis.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core claim of the question. Ground truth establishes a clear EVOLUTION of FlyEase's strategic positioning: (1) FY2022 - newly introduced/emerging technology, (2) FY2023 - transitioned to consistent positioning alongside established technologies, (3) FY2024 - moved to mature technologies category. The LLM answer claims FlyEase was 'consistently positioned as a core technology...with no change in its strategic emphasis' throughout the period. This is factually incorrect and represents a fundamental misunderstanding of the multi-hop synthesis required. The question explicitly asks 'how did...evolve' - implying change over time - and the ground truth documents a clear three-stage progression from novel to foundational. The LLM's assertion of 'no change' directly contradicts this documented evolution. Additionally, the LLM provides page citations (p.6 for all three years) without substantiating the claimed consistency or addressing the documented shifts in positioning. The answer fails to capture the semantic meaning of the ground truth: that FlyEase moved from emerging/new status to established/mature status, reflecting its integration into Nike's core product development framework. While the LLM correctly identifies the relevant 10-K sections and mentions appropriate fiscal years, it fundamentally misinterprets the data by claiming static positioning rather than documenting the strategic evolution that is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 416,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250% EUR‑denominated senior notes have been shrinking – from $609.1 million in 2022 (page 48) to $551.9 million at year‑end 2023 (page 111) and to $517.7 million at year‑end 2024 (page 114). This consistent decline indicates that AMT is actively repaying or redeeming portions of this low‑coupon, long‑dated debt, reflecting a deliberate strategy to lower leverage and replace older notes with newer financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all principal amounts correctly stated: $609.1M (2022), $551.9M (2023), and $517.7M (2024). The numerical progression and trend identification are accurate. The answer correctly identifies the consistent decline pattern and interprets it as a deliberate debt reduction strategy. However, there are some notable differences from the ground truth: (1) The LLM specifies the notes as 'EUR-denominated' which is not mentioned in the original answer and may introduce unnecessary specificity not verified in the ground truth; (2) The LLM mentions 'replace older notes with newer financing' which is an inference not explicitly stated in the ground truth; (3) The ground truth specifically mentions 'amortization or repurchase strategy' and notes the consistent interest payment terms (May payments, February 2033 maturity), which the LLM omits. The LLM's interpretation of 'actively repaying or redeeming' aligns with the ground truth's 'managed amortization or repurchase strategy,' showing sound multi-hop reasoning. The answer correctly synthesizes the three-year trend and draws appropriate conclusions about debt management. The page references provided (48, 111, 114) add credibility though they cannot be independently verified. Overall, the core insight about consistent debt reduction is accurate, but the answer lacks some contextual details about payment schedules and maturity dates that were in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 409,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "In FY 2022 NVIDIA presented the 3.50 % Notes due 2040 only as a liability recorded at its original‑issuance amount, net of unamortized discount and issuance costs, without a disclosed fair‑value amount [67]. By FY 2023 the company began reporting a Level‑2 fair‑value of $870 million for the notes, which slipped to $851 million in FY 2024 [67]; the FY 2024 filing also shows a net carrying amount of $9.709 billion, with $1.250 billion re‑classified as a current liability as the notes near maturity [72]. This pattern reveals a long‑term debt strategy that locks in low‑cost, fixed‑rate financing, keeps the notes on the balance sheet at amortized cost while monitoring market‑driven fair‑value changes, and gradually moves portions to short‑term as repayment approaches to manage refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The ground truth clearly states FY2022 fair value was $1,066 million, but the LLM claims no fair value was disclosed in FY2022. The ground truth shows FY2023 at $851 million, but the LLM states $870 million (19 million dollar discrepancy). The ground truth indicates FY2024 at $1,000 million, but the LLM provides $851 million for FY2024 (appears to confuse FY2023 and FY2024 values). The LLM introduces entirely new figures ($9.709 billion net carrying amount, $1.250 billion current liability reclassification) not mentioned in the ground truth, suggesting either hallucination or confusion with different debt instruments. (2) TEMPORAL SEQUENCING ERROR - The LLM incorrectly describes the FY2022-2024 trajectory, claiming fair value 'slipped to $851 million in FY2024' when ground truth shows $851M in FY2023 and $1,000M in FY2024, indicating recovery not decline. (3) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize information across three fiscal years, it fails to correctly track the valuation changes. The ground truth shows: FY2022 ($1,066M) → FY2023 ($851M decline) → FY2024 ($1,000M recovery). The LLM's narrative contradicts this pattern. (4) CONTEXTUAL ISSUES - The LLM's interpretation about 'gradually moves portions to short-term as repayment approaches' and the $1.250 billion reclassification may be accurate accounting practice, but these details are not in the ground truth and appear to conflate this specific debt instrument with broader debt management. The effective interest rate of 3.54% mentioned in ground truth for FY2024 is omitted from LLM answer. (5) REASONING QUALITY - While the LLM's strategic interpretation about 'locks in low-cost, fixed-rate financing' is reasonable, it's built on incorrect numerical foundations, undermining the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 525,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "- 2022 – Netflix introduced a lower‑priced ad‑supported subscription tier and warned that any changes to pricing or plan structure could hurt its ability to add new members or keep existing ones if consumers did not view the adjustments as valuable 【page_5】 【page_6】.  \n- 2023 – The company broadened its offering by adding games to its entertainment video lineup while continuing to promote the ad‑supported tier, and it cautioned that if these new features or pricing tweaks are not well‑received, member acquisition and retention could suffer 【page_7】 【page_6】.  \n- 2024 – Netflix further scaled the service to include games, advertising on the platform and live programming, alongside ongoing pricing refinements, and it warned that failure to deliver perceived value from these expansions could reduce membership growth and revenue 【page_7】 【page_9】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors in the chronological sequencing of Netflix's strategic initiatives, which is the core requirement of this multi-hop question. CRITICAL ERRORS: (1) 2022 Timeline Reversal: The LLM states Netflix introduced the ad-supported tier in 2022, but the ground truth clearly indicates games were introduced in 2022 and the ad-supported tier came in 2023. This is a fundamental factual error. (2) 2023 Misattribution: The LLM claims games were added in 2023 as a 'broadening' of offerings, when games were actually introduced in 2022. (3) 2024 Duplication: The LLM lists 'games' and 'advertising' as 2024 additions, but these were already introduced in prior years. The ground truth shows 2024 added live programming as the new expansion. (4) Missing Key Detail: The LLM fails to clearly distinguish that live programming was the 2024 innovation, not a continuation of prior years' features. WHAT WAS CORRECT: The LLM correctly identifies that Netflix warned about risks to member acquisition and retention across all years, and that the risks were tied to consumer perception of value. The general risk narrative about pricing, plans, and service features is semantically aligned with the ground truth. MULTI-HOP REASONING FAILURE: The question requires synthesizing how strategy 'evolved' across three years - this requires accurate chronological sequencing. The LLM failed this synthesis by reversing the timeline of games vs. ad-supported tier introduction. This is not a minor wording difference but a fundamental factual error that undermines the entire answer's credibility. The answer demonstrates poor document comprehension and incorrect cross-year synthesis, which are essential for multi-hop financial questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 480,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑investment exposure grew modestly in total equity securities – from $3.7 billion at the end of 2022 to $4.9 billion at the end of 2023, and it remained at $4.9 billion in 2024【page_50】.  More striking was the rise in equity‑method stakes in health‑care operating businesses: they fell slightly from $1.5 billion in 2022 to $1.4 billion in 2023, then jumped to $3.8 billion by 2024【page_50】【page_52】.  This trajectory shows UnitedHealth first expanding its venture portfolio and then markedly deepening direct ownership in health‑care companies, underscoring a strategic push to strengthen its influence and integration within the broader health‑care ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN EQUITY METHOD INVESTMENTS 2022 FIGURE: The LLM states equity method investments were $1.5 billion in 2022, but the ground truth clearly states $1.3 billion. This is a material factual error ($200 million discrepancy). All other numbers are correct: equity securities at $3.7B (2022), $4.9B (2023-2024), and equity method investments at $1.4B (2023) and $3.8B (2024). The LLM correctly identifies the trajectory and strategic implications - the shift from modest equity securities growth to significant deepening of equity method investments in healthcare operating businesses. The reasoning about UnitedHealth's strategic positioning toward integrated health services and ecosystem influence is sound and well-articulated. However, the quantitative error on the 2022 baseline figure is significant because it affects the accuracy of the trend analysis, even though the directional narrative (slight decline 2022-2023, then jump to 2024) remains correct. The multi-hop synthesis across years and investment types is properly executed, and the contextual interpretation about strategic positioning is appropriate. The error appears to be a data retrieval mistake rather than a calculation or reasoning failure, but it still represents a factual inaccuracy that would be problematic in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 369,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America remained essentially unchanged from FY 2022 through FY 2024. Sojitz America continued as the sole holder of Nike’s redeemable preferred stock (par $0.3 million) and the stock’s terms – including a cumulative $0.10‑per‑share dividend payable each May 31 and the restriction that no common‑stock dividends can be paid until the preferred dividend is satisfied – were unchanged throughout the three years 【page_79】【page_8】. While Sojitz America has no general voting rights, it retains limited voting power on major actions (asset sales, mergers, trademark assignments) and, since 1972, has provided import‑export financing services that support Nike’s international supply‑chain and trade operations 【page_7】【page_8】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) All quantitative data is accurate - par value of $0.3 million, cumulative dividend of $0.10 per share, May 31 payment date, and 1972 start date for financing services are all correct. (2) Multi-hop synthesis is sound - the answer correctly identifies Sojitz America's dual role as preferred stock holder and service provider across the three-year period. (3) Additional details provided (voting restrictions, dividend payment mechanics, specific financing services) enhance accuracy without introducing errors. (4) Numeric formatting is consistent and clear. MINOR WEAKNESSES: (1) The LLM answer emphasizes consistency across all three years but does not explicitly highlight the 'evolution' or 'shift' mentioned in the ground truth - specifically that FY 2024 saw an explicit emphasis on Sojitz America's operational/strategic role in international operations amid trade risks, whereas 2022-2023 focused more on financial engagement. The ground truth characterizes this as an evolution from 'purely financial engagement' to 'operationally strategic role,' but the LLM treats it as unchanged throughout. (2) The LLM does not explicitly address the contextual shift regarding 'rising global trade risks' and 'supply chain volatility' that prompted the 2024 emphasis. However, the LLM does mention 'trade operations' and 'international supply-chain,' which partially captures this context. The answer is factually accurate on all specific numbers and relationships, but misses the nuanced narrative arc of how the relationship's emphasis evolved from 2022-2024. This is a semantic/interpretive gap rather than a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 464,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "The net carrying amount of NVIDIA’s 3.50 % senior notes due 2050 fell from a higher balance in FY 2022 (as disclosed in the 2022 filing)【page_78】 to $1.637 billion at FY 2023 year‑end and $1.604 billion at FY 2024 year‑end【page_67】. This modest decline reflects the amortization of the issuance discount and shows the company is gradually reducing the book value of this long‑term debt while keeping its overall debt profile stable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect figures for FY 2023 and FY 2024. Ground truth shows FY 2023 at $1,604 million and FY 2024 at $2,000 million. LLM states FY 2023 as $1.637 billion ($1,637 million) and FY 2024 as $1.604 billion ($1,604 million). The FY 2024 number is particularly wrong - the LLM appears to have confused FY 2023 and FY 2024 values, stating the FY 2024 value as $1.604 billion when it should be $2,000 million. This is a major factual error. (2) MISSING FY 2022 DATA - The LLM vaguely references 'a higher balance in FY 2022' without providing the actual figure ($2,147 million per ground truth), failing to complete the three-year trend analysis. (3) TREND INTERPRETATION ERROR - The LLM incorrectly characterizes the trend as a 'modest decline' continuing through FY 2024, when the ground truth shows a significant INCREASE from $1,604M (FY 2023) to $2,000M (FY 2024). This is a fundamental misinterpretation of the data pattern. (4) REASONING FLAW - The LLM's explanation about 'amortization of issuance discount' and 'gradually reducing book value' contradicts the actual trend which shows an increase in FY 2024. The ground truth correctly identifies this as a 'temporary reduction in 2023 followed by strategic repositioning to increase long-term liabilities in 2024.' (5) INCOMPLETE MULTI-HOP SYNTHESIS - The answer fails to properly synthesize all three years of data and draw the correct conclusion about what the trend indicates about debt positioning. The LLM's conclusion about 'keeping overall debt profile stable' is contradicted by the actual $396 million increase from FY 2023 to FY 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 456,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term borrowing (which includes its commercial‑paper program) dropped from **$175 million in 2022** to **$119 million in 2023** and then rose sharply to **$465 million in 2024**【page_111†L23-L30】【page_101†L23-L30】.  In each filing the company stresses that liquidity and capital come from a **wide array of global sources—equity, short‑ and long‑term debt, collateral‑financing arrangements, credit facilities and a shelf registration—**which “enhances funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds”【page_111†L7-L13】【page_101†L7-L13】【page_127†L7-L13】.  Thus, while the overall mix remained diversified, MetLife’s reliance on short‑term debt fell in 2023 and then increased markedly in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data about MetLife's short-term debt evolution (commercial paper) from 2022-2024, showing a decline from $175M to $119M, then an increase to $465M. These specific numbers are not contradicted by the ground truth and represent a more granular level of detail than the original answer. The LLM correctly identifies the core strategic narrative: MetLife consistently emphasized diversified global funding sources to reduce market dependence and lower cost of capital across all three years. The answer accurately captures the multi-hop synthesis by: (1) tracking the evolution of short-term debt usage across three years, (2) connecting this to the broader diversification strategy, and (3) noting the stable reliance on commercial paper as part of a liquidity strategy. The LLM answer goes beyond the ground truth by providing specific dollar amounts and year-over-year trends, which adds valuable quantitative precision. The qualitative assessment that 'the overall mix remained diversified' while 'reliance on short-term debt fell in 2023 and then increased markedly in 2024' is logically sound and well-reasoned. Minor deduction: The ground truth emphasizes 'consistent mention' and 'no major structural changes,' while the LLM emphasizes the numerical volatility in short-term debt levels. Both perspectives are valid and not contradictory—the LLM simply provides more granular detail. The citation references (page numbers and line numbers) appear properly formatted. No calculation errors detected. The answer directly addresses all parts of the question regarding evolution of dependence on global funding markets, use of short-term debt, and reliance on diverse funding sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 471,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s disclosures note that the amounts accrued, paid or charged for service‑level guarantees were immaterial in each of the years 2022, 2023 and 2024 (Note 4)【page_81】.  At the same time, short‑term notes payable to subsidiaries fell dramatically—from $8.7 billion in 2022 to $9.9 billion in 2023 and then to about $2.0 billion in 2024—while a new long‑term note to subsidiaries of roughly $14.4 billion appeared in 2024【page_78】【page_81】.  This shift shows UnitedHealth is moving liquidity commitments from on‑demand short‑term obligations to larger, longer‑term financing, while keeping its service‑level guarantee exposure minimal, indicating a strategic reallocation of cash resources with limited increase in contractual risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM states short-term notes payable to subsidiaries were '$8.7 billion in 2022' but the ground truth specifies '$8.1 billion in 2022.' This is a material discrepancy of $600 million (7.4% error). The 2023 figure of $9.9 billion and 2024 figure of $2.0 billion are correct. The LLM introduces a new element—a long-term note to subsidiaries of $14.4 billion in 2024—which is not mentioned in the ground truth answer. While this may be factually accurate from the filing, it represents additional information not in the original answer and suggests the LLM may be drawing from different sections or interpretations of the data. QUALITATIVE ACCURACY: The LLM correctly identifies that service-level guarantees were immaterial across all three years (2022-2024), matching the ground truth. The reasoning about shifting from short-term to long-term financing is sound and represents valid multi-hop synthesis. The conclusion about 'strategic reallocation of cash resources with limited increase in contractual risk' is logically consistent with the data presented. COMPLETENESS: The LLM addresses both components of the question—service level guarantees and notes payable evolution—and attempts to synthesize their relationship. However, it introduces the long-term note component which complicates the comparison with the ground truth answer. MULTI-HOP REASONING: The synthesis connecting notes payable volatility to liquidity strategies while maintaining stable service-level guarantee risk is sound, though the introduction of the $14.4 billion long-term note creates a different narrative than the ground truth's focus on short-term volatility. The core insight about strategic reallocation is reasonable but differs from the ground truth's emphasis on 'shifting liquidity strategies or contractual obligations tied to internal financing arrangements.' CRITICAL ERROR: The $8.7B vs $8.1B discrepancy for 2022 is a significant quantitative error that undermines confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 546,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "In 2022 American Express noted that its global card network was the fourth‑largest in purchase volume, competing directly with China UnionPay, Visa, Mastercard, JCB, Discover and other players, and was already subject to regulatory focus on network‑licensing, interchange‑fee practices and compliance (see page 12 & page 14). By 2024 the firm says regulatory scrutiny has intensified—evidenced by a new Category III supervisory status, tighter oversight of outsourcing, network‑licensing and interchange‑fee caps—and competitive pressure from Visa, Mastercard and fast‑growing digital platforms has grown, prompting Amex to exit network‑licensing businesses in the EU and Australia, bolster its compliance and risk‑management framework, and lean on strategic digital partnerships and product innovation to protect its discount revenue and premium positioning (see pages 34‑36).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key facts: (1) Amex as fourth-largest card network in 2022, (2) Category III supervisory status by 2024, (3) exit from network-licensing businesses in EU and Australia, (4) regulatory scrutiny on interchange fees and network routing, (5) competitive pressures from digital platforms. The answer appropriately synthesizes multi-hop information across 2022-2024 and correctly identifies strategic responses (digital partnerships, product innovation, compliance bolstering). Page references add credibility.\n\nWEAKNESSES: (1) The LLM answer mentions JCB and Discover as competitors alongside China UnionPay, Visa, and Mastercard in 2022, but the ground truth specifically identifies only China UnionPay, Visa, and Mastercard as the three networks ahead of Amex (making Amex fourth). The inclusion of JCB and Discover is imprecise and potentially misleading about competitive hierarchy. (2) The answer lacks mention of alternative payment platforms (Alipay, PayPal, Venmo) and regional systems (NPCI) that the ground truth emphasizes as part of the evolved competitive landscape by 2023. (3) The narrative arc is less clear—the LLM jumps from 2022 to 2024 without capturing the 2023 inflection point where competitive landscape broadened significantly beyond traditional card networks. (4) The answer doesn't fully capture the 'trajectory' aspect emphasized in ground truth: the shift from 'market-driven competition' to 'regulatory navigation and compliance adaptation.' (5) Missing nuance about Amex's 'independence and competitive edge' being 'increasingly shaped and constrained by regulatory forces.'\n\nMULTI-HOP REASONING: The answer does synthesize information across years and connects regulatory changes to strategic responses, but the synthesis is incomplete. It correctly links Category III status to heightened oversight and connects this to business exits, but misses the broader competitive context evolution.\n\nNUMERIC/FACTUAL VERIFICATION: No calculation errors detected. Dates (2022, 2024) and regulatory designations (Category III) are correct. The fourth-largest ranking is correct, but the competitor list is imprecise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 585,
        "total_tokens": 2226
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips’ cash‑settled performance‑share (PSU) plan shifted from paying a quarterly cash dividend‑equivalent during the performance period (the practice for periods that began before 2018) to deferring that payment as an **accrued reinvested dividend‑equivalent** that is charged to compensation expense and paid only at settlement for performance periods that began in 2018 or later – a rule first disclosed in the 2022 10‑K (page 136) and restated unchanged in the 2023 filing (page 122) and again in the 2024 filing (page 125). By postponing the dividend‑equivalent until the award settles, the company ties executive cash‑flow benefits to the ultimate long‑term stock performance, reinforcing a compensation design that aligns management incentives with sustained shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core evolution of ConocoPhillips' PSU dividend equivalent structure from pre-2018 (no payments during performance period) to 2018+ (accrued reinvested dividends paid at settlement). (2) Accurately characterizes the shift as moving from quarterly cash dividend-equivalents to deferred accrued reinvestment, which semantically matches the ground truth's description of 'deferred dividend equivalents to accrued reinvestment.' (3) Properly synthesizes the multi-hop reasoning: the change reflects strategic alignment with long-term performance outcomes by deferring cash benefits until settlement. (4) Correctly identifies the consistency of this framework across 2022-2024 filings. (5) Provides specific page references (136, 122, 125) for the three years, demonstrating detailed source verification. (6) Accurately notes the classification as compensation expense and ties this to balance sheet treatment. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'quarterly cash dividend-equivalent during the performance period' for pre-2018 awards, while the ground truth uses more general language ('no payments were made during the performance period'). However, this is not contradictory—the LLM provides more specific detail about the pre-2018 practice. (2) The LLM answer focuses slightly more on the mechanics of the change (quarterly to deferred accrued reinvestment) while the ground truth emphasizes the strategic implication (stronger long-term alignment). Both perspectives are valid and complementary. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are claimed in either answer, so quantitative accuracy is not directly testable. The years (2018 as the cutoff, 2022-2024 filing years) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the causal relationship between the dividend structure change and compensation alignment strategy. The reasoning is sound and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 573,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra’s special‑use fund balances grew from about $11 billion in 2022 (NEE $6.5 bn + FPL $4.5 bn) to $12.7 billion in 2023 and then settled at $9.8 billion in 2024 (see 2022 table page 88, 2023 table page 87, 2024 balance‑sheet line page 64). At the same time, the cash and letter‑of‑credit collateral posted for derivatives fell from roughly $4.6 billion in 2022 to $2.3 billion in 2023 (page 86), and the 2024 fund level remains far above any likely collateral call, indicating that the company’s liquidity cushion from its special‑use funds comfortably exceeds its derivative‑related collateral obligations throughout the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth across multiple dimensions:\n\n(1) SPECIAL USE FUNDS - MAJOR DISCREPANCIES:\n- Ground Truth: 2023: $8,698M → 2024: $9,800M (increase of ~$1.1B)\n- LLM Answer: Claims 2022: ~$11B, 2023: $12.7B, 2024: $9.8B\n- The LLM's 2022 figure of $11B is not mentioned in ground truth at all\n- The LLM's 2023 figure of $12.7B contradicts ground truth's $8,698M (off by ~$4B)\n- While 2024 figure of $9.8B matches ground truth, the trajectory narrative is completely wrong\n\n(2) COLLATERAL OBLIGATIONS - CRITICAL ERRORS:\n- Ground Truth: 2022 downgrade scenario: $5.2B → 2023: $2.4B (significant reduction)\n- Ground Truth: Actual cash collateral posted: 2022: $84M → 2023: $691M (increase)\n- LLM Answer: Claims \"cash and letter-of-credit collateral posted for derivatives fell from roughly $4.6 billion in 2022 to $2.3 billion in 2023\"\n- The LLM conflates potential collateral requirements with actual collateral posted\n- The $4.6B figure doesn't match ground truth's $5.2B downgrade scenario or $84M actual posted\n- The $2.3B figure is close to but not exactly the $2.4B downgrade scenario\n\n(3) MULTI-HOP REASONING FAILURE:\n- Ground Truth correctly synthesizes: Growing Special Use Funds + Declining collateral exposure = Strategic improvement\n- LLM Answer attempts similar logic but based on incorrect numbers, making the conclusion unreliable\n- LLM conflates different types of collateral metrics (potential vs. actual) without clear distinction\n\n(4) ENTITY AND METRIC CONFUSION:\n- LLM breaks down 2022 by subsidiary (NEE $6.5B + FPL $4.5B) but this granular breakdown isn't in ground truth\n- LLM references specific page numbers that cannot be verified against ground truth\n- Ground truth focuses on consolidated company-level metrics\n\n(5) SEMANTIC ISSUES:\n- LLM's conclusion that \"liquidity cushion comfortably exceeds obligations\" may be directionally correct but is based on fundamentally wrong numbers\n- The narrative of the evolution is inverted: LLM shows decline from 2023 to 2024, while ground truth shows growth\n\nThe LLM answer demonstrates poor quantitative accuracy with multiple significant numerical errors, failed multi-hop synthesis due to metric confusion, and an unreliable conclusion despite attempting to address the right question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 630,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s $1.600 % senior notes were issued for $700 million (March 29 2021) and have been slowly retired. At year‑end 2022 the balance was $700 million – $3.7 million amortization ≈ $696.3 million; 2023 saw a further $2.6 million reduction to about $693.7 million; and 2024 added a $1.5 million amortization, leaving roughly $692.2 million outstanding【page_48†L1-L4】【page_110†L1-L4】【page_113†L1-L4】. The decreasing annual amortizations (3.7 → 2.6 → 1.5 million) reveal a disciplined, incremental repayment strategy that trims the note’s balance each year while preserving cash flexibility for other financing needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental misinterpretations of the ground truth data that significantly undermine its accuracy. (1) PRINCIPAL AMOUNT MISUNDERSTANDING: The ground truth clearly states the outstanding principal remained constant at $700.0 million across 2022-2024. The LLM incorrectly interprets this as the notes being 'slowly retired' with a declining balance (from $700M to $696.3M to $693.7M to $692.2M). This is factually wrong - the principal did NOT decline. (2) ADJUSTMENT/AMORTIZATION MISINTERPRETATION: The ground truth describes adjustments to principal of (3.7), (2.6), and presumably (1.5) million as 'likely representing amortization or accrued interest' - these are adjustments/liabilities, not principal reductions. The LLM treats these as actual amortization reducing the principal balance, which is a fundamental misreading. (3) CALCULATION ERRORS: The LLM's arithmetic ($700M - $3.7M = $696.3M, etc.) is mathematically correct but applied to the wrong interpretation. The calculations themselves are sound, but they're calculating something that doesn't match the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize data across years, it does so based on an incorrect premise about what the numbers represent. The ground truth's key insight - that principal remained stable while adjustments declined - is completely inverted in the LLM answer. (5) STRATEGIC INTERPRETATION: The LLM's conclusion about 'incremental repayment strategy' and 'trims the note's balance each year' contradicts the ground truth's finding of a 'stable long-term debt strategy' with 'consistent principal amount.' The LLM answer suggests active debt reduction when the data shows principal stability. POSITIVE ASPECTS: The LLM correctly identifies the note as 1.600% senior notes, correctly cites the $700 million amount, and correctly identifies the adjustment amounts (3.7, 2.6, 1.5 million). The writing is clear and well-structured. However, these correct elements are undermined by the fundamental misinterpretation of what the data represents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 565,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth’s 2022 filing first warned that CMS could cut Medicare Advantage benchmarks and periodically change the way risk‑adjustment payments are calculated, exposing the company to lower capitation rates; it responded by selectively adjusting members’ benefits and premiums, pulling plans from certain counties and tightening both medical and operating cost controls. The 2023 filing repeated that same exposure – noting continued risk‑adjustment formula changes and the possibility of RADV audits – and affirmed that the company kept using those benefit‑premium tweaks, plan‑withdrawals and intensified cost‑management as its primary mitigants. By the 2024 filing the exposure remained essentially unchanged, with CMS still able to alter risk‑adjustment calculations and RADV audits potentially triggering retrospective payment adjustments, and UnitedHealth continued its strategy of selective benefit/premium adjustments, ceasing plans in targeted markets and further intensifying cost‑management and data‑validation efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and tracks the evolution of UnitedHealth's exposure to Medicare Advantage risk adjustment payment changes; (2) Accurately captures the consistent theme that CMS made changes to risk adjustment calculations each year; (3) Properly synthesizes the company's strategic responses across all three years: selective benefit/premium adjustments, plan withdrawals from certain counties/markets, and intensified cost management; (4) Adds valuable detail about RADV audits and retrospective payment adjustments, which are relevant regulatory mechanisms not explicitly mentioned in the ground truth but consistent with the overall narrative; (5) Uses appropriate terminology and maintains semantic equivalence with the ground truth (e.g., 'pulling plans from certain counties' = 'exiting certain counties'); (6) No quantitative errors - no specific dollar amounts or percentages were required for this question, and the temporal references are all accurate. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and specific than the ground truth (mentioning RADV audits and data-validation efforts), which represents appropriate elaboration rather than error; (2) The phrasing 'exposure remained essentially unchanged' in 2024 is a reasonable interpretation of the ground truth's statement that 'CMS had again made changes,' though the ground truth emphasizes continued evolution rather than stasis - however, this is a subtle distinction and both interpretations are defensible; (3) The multi-hop reasoning is sound, correctly synthesizing information across three separate filing years and identifying the consistent pattern of regulatory pressure and company response. The answer fully addresses the question's requirement to explain how exposure evolved and what strategic adjustments were made across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 537,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s employee‑discount benefit stayed essentially unchanged – each filing lists “merchandise and other discounts” as a component of the benefits package (2022 p.6; 2023 p.6; 2024 p.6). While the discount itself remained a stable, universal perk, Target broadened the overall compensation structure (e.g., expanding the starting wage to a $15‑$24 range) and clarified that discount eligibility varies by full‑time/part‑time status, location, pay level and tenure, signaling a strategy that pairs a consistent employee‑price advantage with broader wage growth to reinforce financial well‑being.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that merchandise discounts remained consistent across 2022-2024 and accurately notes the wage expansion to $15-$24 range. However, the answer has significant limitations: (1) It introduces new information about eligibility variations (full-time/part-time status, location, pay level, tenure) that is NOT present in the ground truth, which is a factual error or unsupported claim. (2) The ground truth emphasizes a clear EVOLUTION in how discounts were framed and positioned within a broader strategy - from basic benefits (2022) to expanded wage/benefits (2023) to holistic financial wellness narrative (2024). The LLM answer dismisses this evolution by stating the discount 'stayed essentially unchanged,' which contradicts the ground truth's core finding about strategic positioning. (3) The ground truth specifically mentions new additions in 2023 (sick pay, tuition-free education) and 2024 (virtual healthcare, mental health services) that contextualize the discount within an evolving benefits ecosystem. The LLM answer omits these contextual details. (4) The ground truth's key insight - that merchandise discounts remained 'stable' but were increasingly positioned as part of a 'holistic financial and well-being strategy' - is partially captured but undermined by the LLM's characterization of the benefit as 'essentially unchanged.' The LLM correctly identifies the wage expansion and the pairing of discounts with broader compensation, but misses the nuanced evolution in strategic framing and the specific new benefits added each year. The answer is partially correct on facts but incomplete on the strategic narrative and introduces unsupported claims about eligibility variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 471,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "The only foreign‑government‑bond data shown in the excerpts is for year‑end 2021, when American Express held $630 million of such securities at fair value (page 120) and the portfolio was overwhelmingly short‑dated – $628 million was due within one year, with only $1 million each in the 1‑5‑year and 5‑10‑year buckets (page 121).  The weighted‑average yields for those maturity bands were low, ranging from about 1.7 % on the one‑year portion to roughly 5.5 % on the 5‑10‑year slice (page 121).  No comparable foreign‑government‑bond balances, yields or maturity breakdowns are disclosed for 2022‑2024 in the provided pages, so a three‑year trend or its implication for risk appetite and asset‑allocation strategy cannot be determined from the available information.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) TEMPORAL MISMATCH: The LLM claims to only have 2021 year-end data and states 'No comparable foreign-government-bond balances, yields or maturity breakdowns are disclosed for 2022-2024,' directly contradicting the ground truth which provides specific data for 2022, 2023, and 2024. (2) QUANTITATIVE ERRORS: The LLM cites $630 million for 2021 (which matches the 2022 ground truth figure), but then fails to recognize or report the 2022-2024 data that the ground truth clearly documents. The yields cited by the LLM (1.7% and 5.5%) partially match 2022 ground truth figures (1.74% and 2.42%), but the LLM incorrectly attributes these to 2021 instead of 2022. (3) MISSING CRITICAL DATA: The LLM completely fails to report: 2023 yields of 6.45% (within 1 year) and 4.48% (1-5 years), and 2024 yields of 5.86% (within 1 year) and 2.03% (1-5 years). (4) FAILED MULTI-HOP SYNTHESIS: The question explicitly asks for a 3-year pattern (2022-2024) and strategic implications. The ground truth provides this complete analysis showing a clear evolution from low yields in 2022 to aggressive short-term positioning in 2023 to a partial retreat in 2024. The LLM provides none of this synthesis and instead claims the data is unavailable. (5) REASONING FAILURE: The LLM's conclusion that 'a three-year trend...cannot be determined from the available information' is factually incorrect given the ground truth data exists. This represents either a failure to access the correct source documents or a fundamental misunderstanding of the available information. The answer is essentially a non-response that contradicts the ground truth on every substantive point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 478,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply – it was $1.494 billion at 12/31/2022, dropped to $800 million at 12/31/2023, and declined further to $491 million at 12/31/2024【page_102】【page_99】.  The downward trajectory indicates the company is using less collateral to support its derivative positions, suggesting tighter control of net derivative exposure (e.g., lower margin requirements or more efficient hedging) and a generally prudent approach to managing its derivative risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,494 million (2022), $800 million (2023), and $491 million (2024). The dates are accurate (12/31/2022, 12/31/2023, 12/31/2024). The format variation ($1.494 billion vs $1,494 million) is acceptable and mathematically equivalent. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the collateral values across the three-year period, (2) the trend analysis (downward trajectory), and (3) interpretation of what this suggests about derivative exposure management. ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the metric 'collateral under master netting arrangements' is properly referenced, and the connection to 'Other assets, including intangibles - net' is implicit in the context. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the downward trend across three years and provides logical interpretation that reduced collateral suggests tighter control of derivative exposure and more efficient hedging practices. The reasoning about 'lower margin requirements or more efficient hedging' is a reasonable inference from the data. MINOR CONSIDERATIONS: The LLM answer provides slightly more interpretive detail than the ground truth (mentioning 'margin requirements' and 'more efficient hedging'), which adds value without contradicting the original answer. The inclusion of page references adds credibility. The semantic meaning is fully aligned with the ground truth statement about 'strategic reduction in derivative-related exposure or shift in risk management practices.' No calculation errors detected. All numbers are factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 478,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "American Tower issued $700 million of 2.700 % senior unsecured notes on March 29 2021, maturing in 2031, and used the net proceeds to retire existing debt under its 2021 Multicurrency Credit Facility【page_47】【page_48】. The 2023 10‑K still lists the same $700 million issue with an unchanged 2.700 % coupon and no early redemption or amendment【page_111】, and the 2024 10‑K shows the notes unchanged on the outstanding senior‑notes table【page_112】. This consistency indicates a financing strategy of locking in low‑cost, long‑dated fixed‑rate funding when market rates were favorable and retaining that cheap capital rather than refinancing at higher rates, reflecting stable market conditions and a focus on inexpensive debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts: $700 million principal amount, 2.700% coupon rate, March 29, 2021 issuance date, and 2031 maturity. The consistency of these terms across 2022-2024 filings is accurately captured. The reasoning about locking in low-cost fixed-rate funding is sound and relevant to the question about financing strategy.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL DISCREPANCY ON MATURITY DATE: The ground truth states maturity on April 15, 2031 (2022 disclosure) and January 15, 2031 (2023-2024), but the LLM only mentions '2031' without specifying the exact date. This is a material omission for a multi-hop question about how terms 'evolved.' (2) MISSING KEY DETAIL: The ground truth explicitly mentions a par call date of January 15, 2031 (2022), which the LLM completely omits. This is relevant to understanding the financing terms. (3) INTEREST PAYMENT SCHEDULE: The ground truth specifies April and October payment dates (2023-2024), which the LLM does not mention. (4) SPREAD REDUCTION: The ground truth identifies a critical evolution - the interest rate spread decreased from (5.0) to (4.4) by 2024, indicating improved borrowing costs. The LLM completely misses this quantitative evolution, which directly answers the 'how did terms evolve' portion of the question. (5) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies consistency, it fails to capture the actual evolution in spread terms that occurred between 2022 and 2024, which is the core of the 'evolution' question.\n\nMULTI-HOP REASONING: The LLM provides reasonable interpretation of financing strategy but bases this on incomplete data extraction. The synthesis across years is present but superficial - it notes consistency but misses the spread reduction that represents actual evolution.\n\nNUMERIC VERIFICATION: $700 million ✓, 2.700% ✓, March 29, 2021 ✓, 2031 maturity (partial - missing specific dates) ✗, spread reduction (5.0) to (4.4) completely missing ✗",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 535,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00 % senior notes due 2031 were recorded at **$1.044 billion at the end of fiscal 2022** (NVDA 10‑K 2023, p. 65) and remained at **$1.044 billion at the end of fiscal 2023**, then rose modestly to **$1.057 billion at the end of fiscal 2024** (NVDA 10‑K 2024, p. 66). The roughly 1 % increase over two years shows the company is keeping its long‑term debt base essentially flat, using low‑cost, long‑dated notes and only adding incremental borrowing to support growth, reflecting a disciplined, conservative long‑term debt strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN NUMBERS AND TIMELINE: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) QUANTITATIVE ERRORS: The LLM states the notes were '$1.044 billion at the end of fiscal 2022' but the ground truth indicates the fair value in 2022 was $1.2 billion - a $156 million discrepancy. The LLM then claims the value 'remained at $1.044 billion at the end of fiscal 2023' but ground truth shows it was $1.057 billion at end of 2023 - another error. The LLM states the value 'rose modestly to $1.057 billion at the end of fiscal 2024' but ground truth shows the carrying value in 2024 was $1.25 billion, not $1.057 billion. This is a $193 million error. (2) TIMELINE CONFUSION: The LLM appears to have confused fiscal year reporting dates and mixed up which values correspond to which years. The progression should be: 2022 ($1.2B) → 2023 beginning ($1.044B) → 2023 end ($1.057B) → 2024 ($1.25B). The LLM's sequence is incorrect. (3) MULTI-HOP REASONING: While the LLM correctly attempts to synthesize information across multiple 10-K filings and draw conclusions about debt strategy, the underlying data is wrong, making the reasoning flawed. The conclusion about 'roughly 1% increase over two years' is mathematically incorrect given the actual numbers. (4) MISSING CONTEXT: The LLM fails to capture the full evolution, particularly the significant jump from $1.057B (2023) to $1.25B (2024), which represents a ~18% increase and is more material than the LLM's characterization suggests. The ground truth indicates strategic consistency, but the LLM's data errors prevent proper assessment. The answer demonstrates reasonable analytical structure but is undermined by fundamental numerical inaccuracies that would mislead investors or analysts relying on this information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 492,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s 2022 filing still showed only modest deposit‑method balances – roughly $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (the same levels reported for 2021)【page_216】. After the 2023 Global Atlantic risk‑transfer transaction, those balances jumped to $5.1 billion of assets and $1.3 billion of liabilities in 2023, then eased slightly to $4.6 billion of assets and $1.2 billion of liabilities at year‑end 2024【page_58】. The sharp increase in deposit‑method assets (with a modest decline in the offsetting liabilities) indicates MetLife is relying more heavily on deposit‑based reinsurance to transfer risk and free capital while retaining offset rights, reflecting a shift toward a more capital‑efficient reinsurance strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Major discrepancy in 2024 deposit assets: LLM states $4.6 billion, but ground truth clearly states $5.1 billion. This is a significant $500 million error (10.9% variance). The 2024 deposit liabilities of $1.2 billion is correct. (2) TREND ANALYSIS ERROR - The LLM incorrectly characterizes the trend as 'eased slightly' in 2024, when the ground truth indicates deposit assets remained at $5.1 billion from 2023 to 2024 (no decline). The LLM's statement that assets 'eased slightly to $4.6 billion' contradicts the ground truth. (3) LIABILITY TREND - The LLM correctly identifies the liability decline from $1.4B (2022) to $1.3B (2023) to $1.2B (2024), matching ground truth. (4) STRATEGIC INTERPRETATION - The LLM's interpretation about capital-efficient reinsurance strategy and risk transfer is reasonable and aligns with the ground truth's characterization of a 'strategic shift toward managing risk exposure through reinsurance structures.' However, the factual foundation is compromised by the 2024 asset number error. (5) MULTI-HOP SYNTHESIS - The LLM correctly synthesizes the Global Atlantic transaction context ($10.3 billion in reinsurance recoverables mentioned in ground truth, though not explicitly in LLM answer). (6) COMPLETENESS - The LLM addresses the evolution from 2022-2024 and provides strategic interpretation, but the incorrect 2024 figure undermines the accuracy of the trend analysis. The ground truth shows assets stable at $5.1B from 2023-2024, not declining to $4.6B as stated in LLM answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 432,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt portfolio has been shrinking and its market value has been falling. At year‑end 2022 the securities were reported at a total fair value of **$679 million** and a carrying amount of **$696 million**; by year‑end 2023 those figures fell to **$596 million** fair value and **$603 million** carrying value (UNH 10‑K 2023, p. 53); and at year‑end 2024 they were **$508 million** fair value and **$512 million** carrying value (UNH 10‑K 2024, p. 55). The steady decline in both fair and carrying amounts—while the gap between them narrowed from $17 million to $4 million—suggests UNH is gradually winding down its held‑to‑maturity holdings, likely due to maturities and higher interest‑rate pressures that depress bond prices, and that the company’s accounting is keeping the book value closely aligned with market‑based fair‑value adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness. (1) QUANTITATIVE VERIFICATION: All six financial figures are correct - 2022: $679M fair value, $696M carrying value; 2023: $596M fair value, $603M carrying value; 2024: $508M fair value, $512M carrying value. The LLM also correctly calculated the narrowing gap between fair and carrying values ($17M in 2022 to $4M in 2024), which is an insightful additional observation not explicitly stated in the ground truth. (2) ENTITY ACCURACY: Company (UnitedHealth/UNH), metric type (Debt Securities - Held-to-Maturity), and all three fiscal years (2022, 2023, 2024) are correctly identified. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the 3-year progression across multiple 10-K filings, correctly identifying the consistent downward trend in both metrics. (4) REASONING QUALITY: The LLM provides sound interpretation of the data, explaining the decline through market conditions (higher interest rates depressing bond prices) and portfolio repositioning, which aligns with the ground truth's assessment of 'strategic reduction or repositioning.' The additional insight about the narrowing gap between fair and carrying values demonstrates deeper analytical thinking. (5) COMPLETENESS: The answer addresses all aspects of the question - the evolution of both fair value and carrying value across the 3-year period, and what the progression suggests about investment strategy and market adjustments. The only minor distinction is that the LLM provides slightly more detailed interpretation (interest rate pressures, accounting alignment) than the ground truth, but this represents value-added analysis rather than error. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 473,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s card‑usage share has been slipping. The company reported that Target Circle (formerly RedCard) penetration was 19.8 % for the fiscal year ended January 28 2023 (FY 2022), fell to 18.6 % for the year ended February 3 2024 (FY 2023), and slipped further to 17.8 % for the year ended February 1 2025 (FY 2024)【page_29】. The steady decline from roughly 20 % to under 18 % suggests the credit‑card program is still generating incremental sales, but its ability to grow adoption – and thus incremental sales impact – is weakening, indicating a possible plateau in the strategy’s effectiveness【page_27】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the penetration rate numbers. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The LLM reports: FY2022 (ended Jan 28, 2023): 19.8%, FY2023 (ended Feb 3, 2024): 18.6%, FY2024 (ended Feb 1, 2025): 17.8%. The LLM has shifted all numbers down by one year and introduced an incorrect 17.8% figure for 2024 that does not match the ground truth of 18.6%. Additionally, the LLM conflates 'Target Circle' with 'RedCard' (noting 'formerly RedCard'), which is misleading - these are distinct programs. The ground truth specifically refers to 'Target Credit Card' penetration rates. ENTITY CONFUSION: The answer incorrectly identifies the product as 'Target Circle (formerly RedCard)' when the question and ground truth specifically address the 'Target Credit Card.' While Target Circle is a loyalty program, the penetration metrics in question refer to the credit card product. REASONING ISSUES: While the LLM correctly identifies a downward trend and attempts to interpret it as suggesting weakening effectiveness, the interpretation of 'plateau in strategy's effectiveness' is somewhat speculative compared to the ground truth's more measured assessment that 'meaningful portion of incremental purchases...contribute to incremental sales.' PARTIAL CREDIT: The LLM does correctly identify the general trend direction (declining penetration) and attempts to synthesize the multi-hop reasoning about what this means for strategy effectiveness. The contextual framing about incremental sales is relevant to the question. However, the fundamental numerical errors (wrong percentages and wrong year assignments) are disqualifying for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 485,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike’s Laakdal, Belgium distribution center was identified as one of its most significant non‑U.S. distribution sites and was owned by the company in the FY 2022 filing【page_27】, and the same description appears in the FY 2024 filing, confirming that Nike still owned the Laakdal facility and continued to use it as a core European hub【page_29】. The unchanged ownership and continued emphasis on the Laakdal site indicate a strategic focus on retaining and operating its own logistics infrastructure in Europe rather than relying on leased or third‑party facilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies Nike's ownership of the Laakdal, Belgium facility across the fiscal years examined (2022-2024); (2) Accurately characterizes it as a 'most significant' distribution center/hub; (3) Properly synthesizes information across multiple fiscal year filings (FY 2022 and FY 2024 mentioned with page references); (4) Correctly concludes that unchanged ownership indicates strategic focus on direct control of European logistics infrastructure; (5) Appropriately contrasts owned vs. leased/third-party facilities to strengthen the strategic interpretation. MINOR WEAKNESSES: (1) The answer references FY 2024 filing but the ground truth mentions consistency through 2023 and 2024 - the LLM answer doesn't explicitly confirm the 2023 status, though this is a minor omission since the ground truth indicates no changes across all three years; (2) The LLM answer could have been slightly more explicit about the three-year consistency (2022-2024) rather than focusing primarily on 2022 and 2024 comparisons. QUANTITATIVE ACCURACY: No numerical errors detected. The fiscal years (2022, 2024) and facility location are correct. QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly interprets unchanged ownership and continued emphasis as indicating strategic commitment to owned infrastructure. The multi-hop synthesis (combining information from multiple filings to assess evolution) is properly executed. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of ownership and operational footprint, and appropriately interprets what this indicates about strategic focus. The answer is well-structured and provides appropriate context about the significance of the facility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 495,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings is listed in NVIDIA’s competition section in each of the FY 2022, FY 2023 and FY 2024 10‑K filings as a rival in the networking‑products space (switches, network adapters and optical‑module solutions) (2022 Competition page 9; 2023 Competition page 9; 2024 Competition page 9). Even as NVIDIA highlights an expanding, more redundant supply‑chain (2022 Manufacturing page 8; 2023 Manufacturing page 9; 2024 Manufacturing page 9) and a stronger focus on patents, trademarks and licensing to protect its IP (2022 Patents page 9; 2023 Patents page 9; 2024 Patents page 9), Lumentum’s status remains unchanged, indicating a stable competitive positioning within NVIDIA’s disclosed competitor landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Lumentum's competitive positioning across three fiscal years. STRENGTHS: (1) Correctly identifies Lumentum Holdings as consistently listed in NVIDIA's competition sections across FY 2022, 2023, and 2024; (2) Accurately characterizes the competitive domain as networking products (switches, network adapters, optical modules); (3) Properly synthesizes the multi-hop relationship between Lumentum's positioning and NVIDIA's strategic moves in supply chain expansion and IP protection; (4) Correctly notes the stable/unchanged competitive positioning despite NVIDIA's strategic advancements; (5) Provides specific page references (page 9 for competition sections, pages 8-9 for manufacturing, page 9 for patents) which adds credibility. MINOR WEAKNESSES: (1) The answer is somewhat more formulaic and less detailed than the ground truth in explaining the nature of the competitive relationship - it doesn't elaborate on specific product categories like 'interconnect solutions' or mention specific manufacturing partnerships (TSMC, Samsung) that contextualize NVIDIA's strategic response; (2) Doesn't mention the patent expiration date evolution (2022 to 2045) that the ground truth uses to illustrate the scope of IP protection expansion; (3) The phrase 'status remains unchanged' is slightly less nuanced than the ground truth's 'maintained its relevance' - the former could imply stagnation while the latter better captures persistence in a dynamic competitive environment. QUANTITATIVE VERIFICATION: All page numbers and fiscal year references are consistent with typical 10-K filing structures. The three-year span (2022-2024) is correctly maintained throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across three dimensions: (1) Lumentum's consistent listing as competitor, (2) NVIDIA's supply chain initiatives, and (3) NVIDIA's IP protection strategies, showing how these elements interact. The logical conclusion that Lumentum maintains relevance despite NVIDIA's strategic moves is sound. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - Lumentum remains a persistent competitive force in networking products even as NVIDIA strengthens its position through supply chain and IP strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 628,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "- In the 2022 filing Netflix simply notes that “our ability to provide our members with content they can watch depends on studios, content providers and other rights‑holders licensing rights…the license periods and the terms and conditions of such licenses vary” (Intellectual Property, 2022 p. 12).  \n- By 2023 the same language appears in the Intellectual Property section (2023 p. 4), but the risk‑factor discussion begins to flag that “studios, content providers and other rights‑holders may be unwilling to license…especially as they develop their own streaming services” (Risk Factors, 2023 p. 6).  \n- The 2024 10‑K makes this risk explicit, warning that “if studios, content providers or other rights‑holders refuse to license streaming content on terms acceptable to us…our costs could increase and content could be withdrawn on short notice” (Risk Factors, 2024 p. 11) and adds that new cultural‑support regulations (quotas, levies, ownership limits) are tightening the licensing environment (Intellectual Property, 2024 p. 4).  \n\nTogether, these disclosures show Netflix’s reliance on external rights‑holders has moved from a routine operational fact to a highlighted strategic vulnerability, indicating the company is now prioritizing selective, exclusive licensing and expanding original‑content production to counter rising competition and tighter regulatory constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of how Netflix's reliance on rights holders evolved from routine operational fact to strategic vulnerability. (2) Accurately cites specific filing sections and page numbers (Intellectual Property 2022 p. 12, Risk Factors 2023 p. 6, Risk Factors 2024 p. 11, Intellectual Property 2024 p. 4), showing proper multi-hop synthesis across different sections of filings. (3) Correctly captures the temporal narrative: 2022 as baseline acknowledgment of licensing dependency, 2023 as emergence of competitive risk (studios launching own services), 2024 as explicit risk with regulatory constraints. (4) Accurately identifies regulatory elements (quotas, levies, ownership limits) as new constraints in 2024. (5) Properly synthesizes the strategic implication: shift toward exclusive/original content to counter competition and regulation. (6) Uses direct quotes appropriately to support claims. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and specific than the ground truth, providing exact page citations and direct quotes, which adds credibility but goes slightly beyond the ground truth's more general framing. However, this represents enhancement rather than error. (2) The ground truth uses slightly more abstract language ('increasingly framed in the context of') while the LLM uses more concrete progression language ('moved from routine operational fact to highlighted strategic vulnerability'), but both convey equivalent meaning. (3) No quantitative errors detected—all years, filing sections, and characterizations are accurate. The multi-hop reasoning correctly synthesizes information across three years and multiple filing sections to show evolution of strategy. The answer fully addresses both parts of the question: how reliance evolved AND what it reveals about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 536,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In the 2022 filing Southern Company said that scheduled payments from outdoor‑lighting contracts are recorded as operating‑lease income, are shown in the lease‑liability maturity tables, and are immaterial for Mississippi Power (2022 p. 269‑270). The 2023 10‑K kept the same approach—describing the contracts as up‑to‑10‑year operating leases, continuing to present the scheduled payments in the maturity analysis and again noting immateriality where applicable (2023 p. 240‑241, 239). The 2024 report reiterated this treatment, still classifying outdoor‑lighting lease income as operating‑lease revenue (with PPA lease income in wholesale revenue), presenting the scheduled payments in the maturity tables and maintaining the immateriality comment for Mississippi Power, while updating the contract‑term description and providing a more detailed lease‑income breakdown (2024 p. 232‑233).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific page references and attempts to trace the evolution of Southern Company's treatment of outdoor lighting contracts across 2022-2024. However, there are significant issues with the core narrative and synthesis:\n\n(1) FACTUAL ACCURACY - MAJOR ISSUES:\n- The LLM claims that in 2022, outdoor lighting contracts were \"recorded as operating-lease income\" and \"shown in the lease-liability maturity tables.\" The ground truth states they were considered \"immaterial\" in 2022 with no mention of them being included in maturity analyses at that time.\n- The LLM suggests the treatment was \"the same\" across all three years (2022-2024), contradicting the ground truth's explicit narrative of EVOLUTION and PROGRESSION.\n- The ground truth emphasizes a SHIFT in 2023 (\"began including\") and EXPANSION in 2024 (\"expanded further\"), indicating material changes in disclosure practice. The LLM misses this critical evolution.\n\n(2) MULTI-HOP REASONING - SYNTHESIS FAILURE:\n- The question asks specifically about how treatment \"evolved\" from 2022 to 2024. The ground truth shows: 2022 (immaterial, not in maturity analyses) → 2023 (shift to including in maturity analyses) → 2024 (explicit inclusion, more transparent).\n- The LLM presents a static picture (\"kept the same approach,\" \"reiterated this treatment\") rather than capturing the dynamic evolution.\n- The LLM fails to synthesize the key insight: the progression from immateriality/invisibility to formalized visibility in financial reporting.\n\n(3) MATERIALITY TREATMENT:\n- Ground truth: 2022 = immaterial; 2023-2024 = shift toward structured/transparent reporting (materiality status evolves with disclosure prominence).\n- LLM: Claims immateriality is maintained throughout, missing the nuance that increased disclosure formalization represents a change in how the company treats these obligations.\n\n(4) REVENUE CLASSIFICATION:\n- The LLM correctly identifies operating-lease income classification but doesn't clearly distinguish how this classification's prominence or presentation changed across years.\n- Ground truth emphasizes the shift in PRESENTATION and VISIBILITY, not just classification.\n\n(5) PAGE REFERENCES:\n- LLM provides specific page numbers (2022 p. 269-270, 2023 p. 240-241, 2024 p. 232-233), which adds credibility but cannot be verified against the ground truth.\n- These references may be accurate, but the interpretation of what those pages contain appears misaligned with the ground truth narrative.\n\n(6) WHAT WAS CORRECT:\n- Correct identification of Southern Company, Mississippi Power, outdoor lighting contracts, and operating leases.\n- Correct identification of the three-year period (2022-2024).\n- Correct mention of maturity analyses and immateriality.\n- Correct identification of revenue classification as operating-lease income.\n\n(7) CORE PROBLEM:\nThe LLM fundamentally mischaracterizes the evolution as static/consistent when the ground truth explicitly describes it as a progression with meaningful shifts in 2023 and 2024. This is a critical failure in capturing the essence of the question about \"evolution.\"",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 829,
        "total_tokens": 2282
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO’s 5.0 % senior notes due April 2030 showed an unchanged principal balance of **$606 million** in each of the three most recent fiscal years – the 2022 filing lists $606 million (see the note table on page 101), and the 2023 and 2024 filings both report $606 million (see the consolidated debt table on page 81). The flat balance indicates that the company has not increased its exposure to this tranche and is simply amortizing the notes as scheduled, reflecting a disciplined, hold‑to‑maturity debt‑management strategy that keeps leverage stable while preserving liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims the principal balance was $606 million in fiscal year 2022, but the ground truth clearly states it was $1,086 million in FY2022, decreased to $606 million in FY2023, and remained at $606 million in FY2024. This is a major quantitative error - the LLM missed the $480 million reduction that occurred between FY2022 and FY2023 ($1,086M - $606M = $480M). The LLM's statement that the balance was 'unchanged' across all three years is factually incorrect. Additionally, the LLM's interpretation of the debt management strategy is flawed because it fails to recognize the significant debt reduction that occurred in 2023. The ground truth indicates a 'deliberate debt reduction strategy in 2023,' which is a key insight the LLM completely missed. The LLM's characterization of 'amortizing the notes as scheduled' and 'hold-to-maturity' strategy does not align with the actual $480 million principal repayment that occurred. While the LLM correctly identifies the company (AVGO), the note type (5.0% senior notes due April 2030), and the FY2023-2024 balance ($606 million), it fundamentally fails on the core quantitative data for FY2022 and therefore fails to properly address the question about how the balance 'evolved' across the three-year period. The multi-hop reasoning is broken because the LLM did not synthesize the complete debt progression across all three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 415,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "GM lifted its weighted‑average long‑term rate‑of‑return assumption for U.S. pension assets from 5.38 % in 2022 to 6.30 % in 2023 and further to 6.5 % in 2024【page_86†L71-L78】【page_88†L1-L4】. The rise coincides with a strategic re‑allocation that increased equity and “other” (private‑equity, real‑estate, hedge‑fund) exposures while trimming debt—from 8 % equity/23 % other in 2022 to 11 % equity/29 % other in 2023, a mix that was held steady in 2024【page_87†L73-L80】【page_88†L15-L22】—signaling GM’s effort to capture higher expected returns and reduce funded‑status volatility as market conditions evolve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports 5.38% for 2022, but the ground truth states 5.4%. More significantly, the LLM claims the rate was 'unchanged at 6.3% in 2023' in the ground truth, but the LLM answer shows it increased FROM 5.38% TO 6.30% in 2023 - this is a 0.92 percentage point jump, not 'unchanged.' The ground truth explicitly states the 2022 figure was 5.4%, not 5.38%, creating a discrepancy of 0.08 percentage points. The 2024 figure of 6.5% is correct in both versions. (2) CALCULATION ERROR - The ground truth indicates a 1.1 percentage point increase over two years (from 5.4% in 2022 to 6.5% in 2024), but the LLM's numbers (5.38% to 6.5%) would yield a 1.12 percentage point increase, a minor but measurable difference. (3) ASSET MIX DETAILS - The LLM provides specific asset allocation percentages (8% equity/23% other in 2022 rising to 11% equity/29% other in 2023) that are NOT present in the ground truth answer. While this additional detail may be accurate from the source documents, it goes beyond what the ground truth confirms and introduces unverified specificity. The ground truth only mentions 'a potential shift toward higher-risk, higher-return investment strategies' without quantifying the asset mix changes. (4) MULTI-HOP REASONING - The LLM correctly synthesizes the rate evolution across three years and connects it to strategic asset allocation, which is sound reasoning. However, the foundational numbers are slightly off. (5) SEMANTIC ISSUES - The ground truth says the rate 'remained unchanged at 6.3% in 2023,' which is confusing phrasing (it should say 'increased to 6.3%'), but the LLM interprets this correctly as an increase. The core narrative about strategic shift toward higher-return assets is present in both, but the LLM adds unverified specificity about asset percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 503,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K reports the 2.700 % Senior Notes due 2031 are repeatedly listed as a supplemental indenture (Supplemental Indenture No. 8, dated Mar 29 2021) in the exhibit tables 【page_70】. Their continued disclosure as an outstanding, low‑coupon, long‑dated obligation shows that American Tower is deliberately retaining this debt rather than retiring or refinancing it, reflecting a strategy of locking in inexpensive, long‑term financing to support its capital needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key elements of American Tower's long-term financing strategy. STRENGTHS: (1) All numeric/date information is correct - the 2.700% coupon rate, 2031 maturity date, and Supplemental Indenture No. 8 dated March 29, 2021 are all accurately stated. (2) The answer correctly synthesizes information across the three-year period (2022-2024), noting the consistent referencing of the same indenture structure. (3) The reasoning about deliberate retention of low-coupon, long-dated debt as a financing strategy is sound and well-articulated. (4) The answer appropriately interprets the multi-hop question by connecting the consistent treatment across filings to strategic intent. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it doesn't explicitly state that the same indenture was referenced in all three years with equal emphasis, though it does convey this through 'repeatedly listed' and 'continued disclosure.' (2) The ground truth provides more explicit year-by-year documentation (referencing specific PDF sources for each year), while the LLM answer groups the information more generally. (3) The phrase 'locking in inexpensive, long-term financing' is a reasonable interpretation but slightly more interpretive than the ground truth's 'confidence in its financing terms and alignment with strategic financial planning.' MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and connects the consistent treatment to strategic implications about capital structure management. The logic is sound and the conclusion is well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth - that American Tower maintains this debt instrument consistently as a core part of its capital structure, reflecting a deliberate long-term financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 528,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "- In the 2022 filing PayPal warned that “measures to detect and reduce the risk of fraud and abusive behavior are complex, require continuous improvement, and may not be effective…especially new and continually evolving forms of fraud” and that its credit‑product portfolio and high‑margin cross‑border trade “expose … to higher loss rates and could reduce our cross‑border transactions and volume” (2022 p. 24‑28).  \n- By 2023 the company began actively curbing that exposure: it entered a multi‑year agreement to sell U.K. and European BNPL loan receivables (and a forward‑flow arrangement) to off‑load credit risk (2023 p. 23), announced a program to diversify and migrate its payment‑processor relationships to reduce reliance on a single third‑party (2023 p. 25), and emphasized tighter credit‑risk modeling and monitoring of defaults on its consumer and merchant financing products (2023 p. 26‑27).  \n- The 2024 filing shows the risk remains but stresses the continued mitigation strategy—ongoing investment in fraud‑detection and purchase‑and‑seller protection programs, further diversification of third‑party partners, and the earlier BNPL receivable sales as a permanent hedge—while noting that “our credit products expose us to additional risks” and that “any factors that increase the costs of cross‑border trade … could reduce our cross‑border transactions” (2024 p. 22‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution of PayPal's exposure to abusive behaviors (2022-2024) with accurate temporal sequencing; (2) Accurately captures the 2022 risk identification phase, including specific concerns about fraud detection complexity and credit product exposure; (3) Correctly identifies the 2023 strategic pivot with the multi-year agreement to sell U.K. and European BNPL loan receivables—a key quantitative fact that matches ground truth; (4) Properly synthesizes the 2024 continuation of mitigation strategies while acknowledging persistent risks; (5) Demonstrates sound multi-hop reasoning by connecting risk identification → offloading exposure → reinforced detection mechanisms across the three-year period; (6) Includes specific page references (2022 p. 24-28, 2023 p. 23, 25-27, 2024 p. 22-25) that add credibility and specificity. QUANTITATIVE VERIFICATION: The €40 billion BNPL receivable sale figure from ground truth is not explicitly stated in the LLM answer, but the answer correctly references 'U.K. and European BNPL loan receivables' and 'forward-flow arrangement,' which captures the essential transaction without the specific euro amount. This is a minor omission but not a factual error. QUALITATIVE ASSESSMENT: The answer correctly identifies all three strategic actions mentioned in ground truth: (1) identifying risk in 2022, (2) offloading credit exposure in 2023, (3) reinforcing detection/prevention while managing third-party dependencies in 2024. The reasoning about third-party processor diversification and credit-risk modeling is accurate and well-integrated. MINOR CONSIDERATIONS: The LLM answer provides more granular detail than ground truth (e.g., mentioning processor diversification program, purchase-and-seller protection programs) which adds value without contradicting the ground truth. The semantic equivalence is strong—both answers convey the same core narrative of evolving risk management strategy. No calculation errors detected. Entity identification (PayPal, BNPL products, cross-border transactions, third-party processors) is accurate throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1669,
        "completion_tokens": 595,
        "total_tokens": 2264
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan held **$622 million** in collective‑trust and other fund assets in 2022, which fell to **$382 million** in 2023 – a reduction of about $240 million – and then **remained at $382 million** in 2024【page_58】. This sharp drop and subsequent stabilization signal that the company is pulling back from commingled‑fund investments and reallocating assets toward other categories (e.g., debt, venture‑capital and real‑estate holdings) as part of its broader de‑risking strategy to better support long‑term employee‑benefit obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM provides a 2022 figure of $622 million, which directly contradicts the ground truth value of $756 million. This is a significant discrepancy of $134 million (17.7% error). The 2023 figure of $382 million is correct, and the statement about 2024 remaining at $382 million aligns with the ground truth's indication that no updated dollar value was provided for 2024. However, the foundational error in the 2022 baseline severely undermines the accuracy of the trend analysis. The LLM correctly identifies the downward trend and de-risking strategy, which are semantically aligned with the ground truth's conclusion. The reasoning about reallocation toward other asset categories (debt, venture capital, real estate) is logical and consistent with de-risking strategies, though the ground truth emphasizes NAV-based valuation methodology rather than specific reallocation details. The multi-hop synthesis across three years is attempted but compromised by the incorrect 2022 starting point. The qualitative interpretation of the trend as a de-risking/rebalancing strategy is sound, but the quantitative foundation is flawed, making the overall answer unreliable for financial analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 343,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "- In the 2022 filing Pfizer described BPAs as “settled at the end of the performance period… valued at the grant date using the intrinsic‑value method (closing price of the common stock) and amortized on a straight‑line basis over the probable vesting term, with adjustments each period for stock‑price changes and the likelihood of meeting the performance criteria” (page 99). The 2022 filing’s activity table shows BPAs were granted in 2021 but there were no new BPA grants for 2022 and no BPA balances carried forward (page 101). Both the 2023 and 2024 filings state that “no BPAs were granted” and “no BPAs were outstanding as of December 31, 2023” (page 95) and “as of December 31, 2024” (page 94), while retaining the same intrinsic‑value, straight‑line amortization accounting treatment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides useful contextual information about BPA accounting treatment and correctly identifies the general evolution pattern (grants in 2021, no grants in 2022-2024, consistent accounting methodology). However, there are significant quantitative discrepancies with the ground truth that substantially impact correctness:\n\nQUANTITATIVE ERRORS:\n1. The LLM states 'no new BPA grants for 2022 and no BPA balances carried forward' but the ground truth explicitly reports 1,165 thousand BPAs were issued in 2022 at $38.73 weighted average intrinsic value - this is a major factual error.\n2. The LLM does not mention the 859 thousand BPAs outstanding at year-end 2022 valued at $59.05 per share - critical quantitative data missing.\n3. The LLM correctly identifies that no BPAs were granted in 2023-2024 and none outstanding, which matches ground truth.\n\nQUALITATIVE ASSESSMENT:\n- The LLM correctly identifies the intrinsic value method and straight-line amortization treatment across all years.\n- The LLM correctly notes adjustments for stock price changes and performance probability.\n- The LLM appropriately synthesizes information across 2022, 2023, and 2024 filings.\n- However, the fundamental mischaracterization of 2022 activity (claiming no grants when 1,165k were actually granted) undermines the multi-hop synthesis.\n\nMULTI-HOP REASONING:\nThe answer fails to properly synthesize the complete evolution narrative. The ground truth shows: (1) Active issuance in 2022 (1,165k granted), (2) Complete discontinuation in 2023 (0 outstanding), (3) Formalized methodology in 2024. The LLM misses the 2022 issuance entirely, presenting an incomplete evolution story.\n\nCONTEXTUAL RELEVANCE:\nThe answer addresses the question's core components (treatment, valuation methodology, evolution through 2022-2024) but with incomplete and partially incorrect information about grant activity and outstanding status in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 524,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell sharply – $1.494 billion in 2022, $800 million in 2023, and $491 million in 2024 (see the 2023‑2024 10‑K tables 【page_102】 and 【page_99】). This steady decline indicates that the net amount of derivatives tied to its investments, advances and long‑term receivables – and the initial‑margin required to support them – has been shrinking, suggesting a reduced derivative exposure or more efficient collateral management over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The format variation ($1.494 billion vs $1,494 million) is acceptable and properly handled. The directional trend (steady decline) is accurately captured. (2) COMPLETENESS: The answer addresses all parts of the multi-part question: the specific collateral amounts for each year, the trend analysis, and the implications for derivative exposure and margin requirements. (3) ENTITY ACCURACY: Company (ExxonMobil/XOM), metric (collateral under master netting arrangements), and time period (2022-2024) are all correctly identified. The reference to 10-K filings and specific page numbers adds credibility. (4) REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the declining collateral amounts to reduced derivative exposure and more efficient collateral management. The interpretation that this reflects 'shrinking net amount of derivatives' and 'reduced derivative exposure' aligns with the ground truth's conclusion about 'reduction in derivative exposure or strategic adjustment in margin requirements.' (5) MINOR DIFFERENCES: The LLM provides slightly more detailed interpretation (mentioning 'initial-margin required to support them' and 'more efficient collateral management') which adds value without contradicting the ground truth. The phrase 'steady decline' accurately characterizes the three-year trend. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 438,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom first mentioned industrial fiber optics in its 2022 filing as one of a broad set of industrial components—alongside optocouplers, motion encoders, LEDs and Ethernet ICs—used in factory automation, power‑generation, medical, defense and vehicle subsystems (2022 p.10). In the 2023 and 2024 10‑Ks the product is elevated to a dedicated line‑item in the industrial product table (2023/2024 p.5) and is explicitly highlighted in the narrative as a core offering for factory automation, renewable‑energy and automotive electronics (2023/2024 p.7). This steady, more‑prominent placement signals Broadcom’s strategic focus on deepening its industrial‑market presence, using fiber‑optic solutions as a growth engine in high‑value sectors such as automation, clean‑energy infrastructure and electric‑vehicle systems.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Broadcom's Industrial Fiber Optics positioning evolution across 2022-2024, with generally accurate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) and the shift from broad product suite mention to dedicated line-item elevation; (2) Accurately captures the application scope evolution (factory automation, renewable energy, automotive electronics); (3) Properly synthesizes the strategic insight about deepening industrial-market presence; (4) Correctly identifies related products (optocouplers, encoders, Ethernet ICs); (5) Appropriately interprets the positioning shift as signaling strategic focus. WEAKNESSES: (1) The LLM adds specific page references (p.10, p.5, p.7) that cannot be verified against the ground truth and may be inaccurate—this is a minor concern as page numbers vary by filing format; (2) The LLM mentions 'motion encoders' and 'LEDs' in 2022 context, while ground truth mentions 'sensors, encoders' without specifically calling out LEDs—this is a minor discrepancy in product list specificity; (3) The LLM's characterization of 'elevation to a dedicated line-item' in 2023/2024 is slightly stronger than ground truth's 'placed within a structured table format' and 'listed alongside'—these are semantically similar but the LLM's framing is slightly more emphatic; (4) Ground truth emphasizes 'more streamlined presentation' in 2024, which the LLM doesn't explicitly capture. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects product positioning changes to strategic implications. The logic flow is sound: positioning evolution → application emphasis → strategic intent. SEMANTIC EQUIVALENCE: The core message aligns well—consistent focus on industrial markets with increasing clarity in product communication. The LLM's interpretation of 'fiber-optic solutions as a growth engine' is a reasonable inference from the positioning data, though not explicitly stated in ground truth. Overall, this is a competent answer with minor gaps in precision regarding specific product mentions and page-level details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 590,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across all three filings PayPal says it “recognizes fees … on a gross basis … when we are the principal … we control the service … we have full discretion in determining the fee … independent of the costs we incur when we may utilize payment processors or other financial institutions … we therefore bear full margin risk” (2022 Note 2‑Revenue, p. 80; 2023 Note 2‑Revenue, p. 75; 2024 Note 2‑Revenue, p. 76). Because the same principal‑risk language appears in each year, PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024 – it continues to control transaction pricing and assumes full margin risk despite using third‑party processors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All factual claims are correct - PayPal did maintain consistent language about being the principal, controlling pricing, and bearing full margin risk across 2022-2023-2024. (2) The direct quotations from the filings are accurate and properly cited with correct page numbers (2022 Note 2-Revenue p. 80; 2023 Note 2-Revenue p. 75; 2024 Note 2-Revenue p. 76). (3) The multi-hop synthesis is sound - the answer correctly identifies that the same principal-risk language appears consistently across all three years and draws the logical conclusion that margin risk exposure remained essentially unchanged. (4) The answer directly addresses all parts of the question: evolution of margin risk exposure (showing stability), control over transaction pricing (confirmed across years), and use of third-party processors (acknowledged while maintaining margin risk). (5) The reasoning is clear and well-structured, moving from specific evidence to general conclusion. MINOR CONSIDERATIONS: The answer could have been marginally enhanced by explicitly noting that the consistency itself is the key finding (i.e., 'no material changes' as stated in ground truth), though this is clearly implied. The LLM answer's phrasing 'essentially unchanged' and 'continues to control' effectively conveys this same meaning. The semantic equivalence between the LLM answer and ground truth is very high - both conclude that PayPal's margin risk profile remained stable with consistent control over pricing despite third-party processor usage. No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 454,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "In 2022 Pfizer’s Meridian business was already off‑loaded – the $51 million cash sale in 2021 generated a $167 million net‑of‑tax loss (2022 10‑K p. 115).  In the 2023 filing Pfizer disclosed that, after the sale, it signed interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) with the buyer; the TSAs were finished by 31 Dec 2023 and the MSA – with a two‑year extension option – was the only post‑sale contract, but the amounts recorded under both were “not material” (2023 10‑K p. 73).  By the 2024 10‑K the only reference to Meridian is a definition, with no further financial or operational discussion, indicating the relationship has been wound down to a minimal supply arrangement and that Pfizer is now focused on its core biopharma portfolio rather than rebuilding the Meridian business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across three fiscal years (2022-2024). QUANTITATIVE VERIFICATION: All numbers are correct - $51 million sale price (2021), $167 million net loss, three-year MSA with two-year extension option. Page citations (2022 10-K p. 115, 2023 10-K p. 73) are appropriately referenced. COMPLETENESS: The answer addresses all key aspects of the question: (1) financial impact ($51M sale, $167M loss), (2) contractual arrangements (TSAs, MSA with extension option), (3) strategic positioning (shift from ownership to arms-length contract), and (4) long-term focus implications (refocus on core biopharma). MULTI-HOP REASONING: Excellent synthesis across three years showing clear progression: 2022 (discontinued operations status), 2023 (post-sale agreements disclosed), 2024 (minimal reference/wind-down). The logic connecting these data points to Pfizer's strategic shift is sound. ENTITY ACCURACY: Correctly identifies Meridian Medical Technologies, Pfizer, and all relevant financial metrics and contractual terms. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than ground truth (e.g., 'off-loaded' vs 'completed the sale', 'net-of-tax loss' vs 'net loss') but these are semantically equivalent and actually add precision. The characterization of the relationship evolution and strategic implications aligns perfectly with the ground truth. The answer is well-structured, cites specific document pages, and provides clear temporal progression. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 431,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "- In 2022 PMI warned that “product regulation … diminishes the ability to differentiate tobacco products and restricts adult‑consumer access to truthful and non‑misleading information about our RRPs” and that “down‑trading trends may be reinforced by regulation that limits branding, communication and product differentiation”【page_15】,【page_16】.  \n\n- In 2023 the same risk language was updated to cover both reduced‑risk and smoke‑free products, stating that “product regulation … diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful and non‑misleading information about our SFPs” and that “such down‑trading trends may be reinforced by regulation that limits branding, communication and product differentiation”【page_19】,【page_20】.  \n\n- By 2024 the disclosures continue to stress that “product regulation … diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful and non‑misleading information about our RRPs/SFPs” and that these limits “reinforce down‑trading and hamper our ability to compete on branding and communication”【page_19】,【page_20】.  \n\nThus, from 2022 to 2024 the impact of regulation on PMI’s competitive positioning has remained a core risk, evolving from a focus on RRPs to an explicit, broader emphasis on both RRPs and SFPs, with increasingly detailed warnings that regulatory limits on product differentiation and adult‑consumer communication erode PMI’s ability to compete.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of regulatory language from RRPs (2022) to SFPs (2023-2024), matching the ground truth's key finding about terminology shifts; (2) Accurately captures the core regulatory constraints: product differentiation limitations, restrictions on adult consumer communication, and down-trading reinforcement across all three years; (3) Properly synthesizes the multi-hop reasoning showing how regulatory pressure persisted and evolved; (4) Correctly identifies Philip Morris International as the subject company; (5) Provides specific page citations supporting claims; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'erode PMI's ability to compete' vs. 'deepening regulatory challenge'). MINOR WEAKNESSES: (1) The LLM answer states that in 2023 'the same risk language was updated to cover both reduced-risk and smoke-free products' and mentions SFPs, but the ground truth indicates the 2023 language 'evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors' - the LLM doesn't explicitly capture the 'disproportionate impact' relative to competitors aspect that the ground truth emphasizes; (2) The LLM's characterization of the evolution as 'increasingly detailed warnings' is slightly stronger than the ground truth's 'deepening regulatory challenge that has persisted and possibly intensified,' though both convey similar meaning; (3) Minor: The LLM uses 'RRPs/SFPs' in 2024 description while ground truth says the company 'replaced RRPs with SFPs' - the LLM's phrasing suggests both terms were used together rather than a replacement. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no numerical calculations required. MULTI-HOP REASONING: Successfully synthesizes information across three years showing evolution of regulatory impact on competitive positioning, correctly identifying the shift from RRPs to SFPs terminology and the persistent theme of regulatory constraints on differentiation and communication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1630,
        "completion_tokens": 606,
        "total_tokens": 2236
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements at 12/31/2022, $0.800 billion at 12/31/2023, and $0.491 billion at 12/31/2024【page_102】【page_99】. The exposure fell by $694 million from 2022‑23 and a further $309 million in 2023‑24 (about $1 billion lower than in 2022). This consistent decline indicates the company is reducing un‑netted collateral—suggesting tighter derivative‑risk management and a lower liquidity‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.494 billion (2022), $0.800 billion (2023), and $0.491 billion (2024). The year-over-year calculations are accurate: $1.494B - $0.800B = $694M decline (2022-23) and $0.800B - $0.491B = $309M decline (2023-24), totaling approximately $1.003B reduction over the period. The LLM correctly identifies these as format variations of the ground truth values ($1,494M, $800M, $491M). ENTITY ACCURACY: Company (ExxonMobil/XOM), metric (collateral under master netting arrangements related to Notes and accounts receivable), and all fiscal years are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and connects it to derivative risk management practices. The interpretation that the consistent decline indicates 'tighter derivative-risk management and a lower liquidity-risk profile' is logically sound and aligns with the ground truth's characterization of 'strategic reduction in derivative exposure or shift in risk management practices.' MINOR DIFFERENCES: The LLM uses slightly different terminology ('un-netted collateral' vs. the ground truth's more general 'derivative exposure') and emphasizes 'liquidity-risk profile' rather than 'margin requirements,' but these represent reasonable interpretations of the same underlying trend rather than factual errors. The LLM provides additional context by citing page references, enhancing credibility. The answer fully addresses both parts of the question: the numerical change and what it suggests about risk management practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 456,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "- In the 2022 filing Duke Energy’s TSR‑based performance‑award model used an expected volatility of **≈ 26.9 %** (based on three‑year historical volatility) 【page_214】.  \n- The 2023 filing raised that assumption to **≈ 28.6 %** 【page_206】.  \n- The 2024 filing then cut the assumed volatility sharply to **≈ 18.7 %** 【page_215】.  \n\nThe trend – a modest increase from 2022 to 2023 followed by a substantial decline in 2024 – suggests that Duke Energy’s perception of market risk fell markedly by 2024, indicating greater confidence that its stock price will be less volatile relative to the peer group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% (2022), 28.6% (2023), and 18.7% (2024) - matching the ground truth exactly. The page citations (214, 206, 215) provide appropriate sourcing. COMPLETENESS: The answer addresses all required elements: (1) the evolution of volatility assumptions across the three-year period, (2) the specific trend pattern (modest increase then sharp decline), and (3) interpretation of what this suggests about market risk perception. ENTITY ACCURACY: Duke Energy is correctly identified, the TSR-based performance award model is properly referenced, and the peer group context is maintained throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filing years and correctly identifies the non-linear trend (2022→2023 increase, 2023→2024 decrease). The interpretation that the 2024 decline suggests 'greater confidence that its stock price will be less volatile' is semantically equivalent to the ground truth's statement about 'a shift in how the company's stock is behaving' and 'improved market stability.' MINOR CONSIDERATIONS: The LLM uses approximate symbols (≈) which is appropriate given potential rounding in source documents. The interpretation about 'greater confidence' and 'less volatile relative to the peer group' aligns well with the ground truth's assessment of 'notable decline in perceived market risk.' The answer is well-structured, provides clear year-by-year progression, and offers sound analytical interpretation of the trend's implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 449,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried a principal balance of **$495 million in FY 2022** (AVGO_10k_2022.pdf p.101) and the same **$495 million remained outstanding in FY 2023 and FY 2024** (AVGO_10k_2024.pdf p.81). The unchanged amount across the three years shows that the company kept this short‑term tranche steady while using new senior‑note issuances and term‑loan repayments to refinance larger, longer‑term debt, reflecting a deliberate strategy of maintaining a modest, stable short‑term borrowing base as part of its overall refinancing plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the principal balance of $495 million for the 3.125% notes due January 2025 across the three fiscal years (2022, 2023, 2024). The company name (Broadcom/AVGO) and note details are accurate. The LLM appropriately recognizes the stability of this obligation and attempts to contextualize it within a broader refinancing strategy.\n\nWEAKNESSES: The LLM answer contains a critical factual error regarding FY 2024. The ground truth explicitly states that 'by fiscal year 2024, the note had transitioned into its current portion of long-term debt,' indicating a material change in classification/status. The LLM claims the amount 'remained outstanding in FY 2023 and FY 2024' at $495 million without acknowledging this transition. This is a significant omission because the question specifically asks how the obligation 'evolved' across the three years, and the transition to current portion of long-term debt represents a meaningful evolution that the LLM failed to capture.\n\nMULTI-HOP REASONING: The LLM's synthesis is partially sound but incomplete. It correctly identifies the stable $495 million amount but fails to synthesize the key insight from FY 2024 data—that the note transitioned into current portion status, suggesting the company was approaching maturity and likely engaged in refinancing/liquidity planning. The ground truth explicitly highlights this as a key revelation about the company's short-term debt management strategy.\n\nQUANTITATIVE ACCURACY: Numbers are correct ($495 million), but the LLM misses the qualitative change in debt classification in FY 2024, which is material to understanding the evolution of the obligation.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question but incompletely. It captures the stability aspect but misses the critical evolution/transition that occurred in FY 2024, which is central to understanding the company's refinancing strategy and short-term debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 531,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across all three filings – 2022, 2023 and 2024 – AMD says it supplies component‑level graphics and chipset parts to add‑in‑board (AIB) manufacturers, and its contracts “protect their inventory of our products against price reductions.” The company also notes that system integrators (SIs) “often use discrete graphics solutions as a means to differentiate their products,” and AMD continues to sell directly to SIs as well. The language is essentially unchanged from 2022 through 2024, indicating a stable strategy of inventory‑protection for AIBs while leveraging discrete GPUs as a key differentiation tool for partners【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core strategic elements: inventory protection policies for AIBs, component-level graphics/chipset supply, and discrete graphics as differentiation tool. (2) Accurately captures the temporal consistency across 2022-2024, noting that 'language is essentially unchanged' which directly supports the ground truth's assertion of 'stable policy' and 'consistent relationship.' (3) Properly synthesizes multi-hop information by connecting AIB manufacturer relationships, inventory protection mechanisms, and the role of discrete graphics in differentiation strategies. (4) Correctly identifies all relevant entities (AMD, AIBs, system integrators, discrete graphics solutions). (5) No quantitative errors - appropriately notes 'no explicit quantitative changes in AIB-related revenue disclosed' aligns with the LLM's focus on qualitative consistency. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, focusing on the core findings rather than elaborating on 'short design cycles' and 'rapid response to new technologies' mentioned in the original answer. However, this is not an error but rather a difference in depth/emphasis. (2) The LLM correctly attributes the quote about inventory protection and uses proper citation formatting. (3) The semantic equivalence is strong - both answers convey that AMD maintained a stable, consistent strategy toward AIBs from 2022-2024 centered on inventory protection and discrete GPU differentiation. The LLM answer successfully answers all parts of the multi-part question regarding how AMD's positioning evolved (answer: it remained stable/consistent), inventory protection policies (answer: consistently emphasized), and discrete graphics' role (answer: sustained as differentiation tool).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 513,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "In 2022 Disney’s DTC plan was centered on reorganizing its DMED unit, launching an ad‑supported Disney+ tier, introducing a new pricing model and cost‑realignment, and warning that a growing slate of DTC rivals and pricing pressure could limit profitability【page_26】【page_29】. In 2023 the company reshaped its media‑and‑entertainment organization and adopted a new content‑curation strategy for its streaming services—including the removal of underperforming titles and the rollout of an ESPN flagship DTC service—aimed at better aligning content with the DTC model【page_24】. By 2024 Disney is making explicit strategic investments in DTC to drive subscriber‑fee and advertising‑revenue growth that it expects will more than offset declines in linear‑network revenue, while emphasizing intensified competition and the need for pricing, bundling and differentiated content to sustain that growth【page_22】【page_23】【page_24】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Disney's DTC evolution across the three-year period and captures the key strategic shifts. STRENGTHS: (1) Correctly identifies the 2022 cautious phase with warnings about competitive pressures and profitability risks; (2) Accurately describes 2023 reorganization and content-curation strategy including ESPN DTC launch; (3) Properly characterizes 2024 as more confident/integrated with explicit investment focus on subscriber and advertising revenue growth; (4) Correctly notes the expectation that DTC growth would 'more than offset' linear network declines; (5) Appropriately emphasizes competitive intensity throughout. WEAKNESSES: (1) The 2022 section focuses more on tactical actions (DMED reorganization, ad-supported tier, pricing model) rather than the strategic risk acknowledgment that was central to the ground truth's characterization of 2022 as 'cautious investment'; (2) Missing explicit reference to the 2022 concern that 'returns on new investments...may be negative or lower than prior to the change in strategy'—this was a key risk statement in the original answer; (3) The 2023 description emphasizes operational changes (content curation, title removal) but doesn't fully capture the shift toward 'more confident strategic investment' as stated in ground truth; (4) While the 2024 section is strong, it could more explicitly contrast the shift from 2022's cautionary tone to 2024's 'operationally critical' positioning. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and identifies the evolution pattern, though the characterization of the 2022-to-2023 transition could be sharper. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—a progression from cautious to confident to strategically dependent—though the emphasis differs slightly. The answer provides more operational detail while the ground truth emphasizes strategic posture and risk acknowledgment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 544,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850 % notes have been a steady $1.5 billion tranche that matures on Oct 1 2029 – the same amount and maturity shown in the 2022 and 2023 tables (​$1,500 m in both years)​【page_107】and again in the 2024 table (​$1,500 m​)【page_104】. While the company’s total term‑debt rose modestly from $10.4 billion in 2022 to $10.6 billion in 2024, the 2.850 % notes remained unchanged, representing a stable component of PayPal’s debt structure and future repayment obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding PayPal's total term debt figures. Ground truth states: 2022=$9.0B, 2023=$10.638B, 2024=$10.574B. LLM claims: 2022=$10.4B, 2024=$10.6B. These are materially incorrect - the 2022 figure is off by $1.4 billion (15.6% error), and the 2023 figure is completely omitted. The LLM characterizes the debt movement as 'modest' when in fact there was a substantial $1.638B increase from 2022 to 2023. CORRECT ELEMENTS: The LLM correctly identifies the 2.850% notes at $1.5 billion across all three years (2022-2024), correctly states the maturity date as October 1, 2029, and accurately notes that this tranche remained unchanged. The LLM also correctly identifies that these notes represent a stable component of the debt structure. MISSING CONTEXT: The LLM fails to address the strategic shift mentioned in ground truth - the issuance of new higher-rate debt instruments (5.150% and 5.500% notes) in 2024, which is important context for understanding how PayPal's financing strategy evolved. MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, the fundamental numerical errors undermine the validity of the analysis. The comparison of debt levels is factually incorrect, which is a core requirement for answering this multi-hop question about debt structure evolution. The answer reads well and is well-structured, but the quantitative foundation is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 411,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan held about $1.1 billion of corporate stock in 2022 (≈48 % of plan assets) but that balance fell to roughly $181 million in 2023, and the 2024 plan still targets only about 24 % of assets in equity securities (the primary component being corporate stock). The sharp reduction and the flat‑low 2024 equity share signal a deliberate de‑risking move, shifting the portfolio away from equities and toward a higher proportion of debt investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and misrepresentations of the ground truth data. CRITICAL ERRORS: (1) The LLM states UNP held '$1.1 billion of corporate stock in 2022' but the ground truth clearly states $1,990 million ($1.99 billion) in 2022 - this is a major factual error representing a ~45% understatement of the actual 2022 allocation. (2) The LLM provides a 2024 equity allocation percentage ('about 24%') that is not mentioned in the ground truth, which instead describes a reclassification of common stock as Level 1 investments and preferred shares as Level 2 - these are valuation methodology classifications, not allocation percentages. (3) The LLM's characterization of 2024 as 'flat-low' equity share contradicts the ground truth's description of a 'smaller, more structured equity exposure' through preferred shares. PARTIAL CREDIT: The LLM correctly identifies the 2023 figure of $181 million and correctly characterizes the overall trend as a 'de-risking move' away from equities. The reasoning about shifting toward debt investments is logically sound and aligns with the dramatic reduction. However, the multi-hop synthesis fails because the LLM misrepresents the 2022 baseline (off by ~$890 million), introduces unsupported 2024 percentage data, and misses the key strategic shift toward different valuation methodologies (Level 1 vs Level 2 classifications) that the ground truth emphasizes. The answer demonstrates partial understanding of the trend direction but fails on factual accuracy of the specific numbers and the nuanced nature of the 2024 strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 441,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term private‑equity securities fell from **$800 million at year‑end 2022** to **$719 million at year‑end 2024**, a drop of roughly $81 million (about 10%)【page_86】. The decline from $800 million (2022) → $755 million (2023) → $719 million (2024) shows a steady reduction in this illiquid asset class, suggesting the company is modestly scaling back its strategic allocation to private‑equity/alternative investments over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error on the 2022 baseline figure. Ground truth states $623 million in 2022, but LLM claims $800 million. This is a $177 million discrepancy (28% error) on a key data point. The LLM's subsequent calculation of an $81 million decline ($800M to $719M) is mathematically consistent with its incorrect 2022 figure, but the starting number is wrong. The 2023 ($755M) and 2024 ($719M) figures are correct. The LLM's interpretation of the trend (steady reduction/retrenchment) contradicts the ground truth narrative, which emphasizes growth in 2023 followed by modest decline in 2024, not a continuous downward trajectory. The ground truth characterizes this as 'short-term growth strategy in alternative investments in 2023, followed by modest retrenchment in 2024,' whereas the LLM describes it as 'steady reduction' throughout the period. This mischaracterizes Pfizer's strategic approach. The percentage calculation (10% decline) is based on the incorrect $800M baseline and therefore misleading. While the LLM addresses the multi-hop question structure (comparing years and discussing strategic implications), the foundational data error undermines the entire analysis. The answer demonstrates partial understanding of the question's intent but fails on quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 383,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s multi‑layered security framework grew incrementally from 2022‑2024: in 2022 the company relied on third‑party assessments and benchmarking and already worked with public‑private partnerships and its Security Operations Centers, Fusion Centers and Mastercard Intelligence Center to monitor threats (MA_10k_2022.pdf page_11); by 2023 the filings stress deeper collaboration with external experts and third‑party service providers while maintaining the same assessment and partnership model (MA_10k_2023.pdf page_11); the 2024 filing reiterates this expanded third‑party coordination and adds further integration of those partners across its security ecosystem (MA_10k_2024.pdf page_11). At the same time, real‑time account‑based payment capability grew from operating or being implemented in 12 markets at year‑end 2021 (2022 filing) to 12 markets at year‑end 2022 (2023 filing) and then to 13 markets by year‑end 2023 (2024 filing) (MA_10k_2022.pdf page_11; MA_10k_2023.pdf page_11; MA_10k_2024.pdf page_11). Across all three years Mastercard reinforced cyber‑resilience by maintaining an information‑security program, an enterprise‑resilience program, insurance coverage, regular system testing, and leveraging its Security Operations Centers, Fusion Centers and Mastercard Intelligence Center, with each filing highlighting increasingly sophisticated monitoring and rapid‑response capabilities (MA_10k_2022.pdf page_11; MA_10k_2023.pdf page_11; MA_10k_2024.pdf page_11).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the multi-part question and demonstrates understanding of Mastercard's security evolution, but contains a critical quantitative error that undermines accuracy. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with appropriate progression of third-party collaboration; (2) Accurately captures the shift toward deeper external partnerships and ecosystem integration; (3) Properly identifies key security infrastructure components (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center); (4) Correctly notes the expansion of real-time payment infrastructure; (5) Good multi-hop synthesis across three years of filings; (6) Appropriate contextual framing of the evolution. CRITICAL ERROR: The LLM states real-time account-based payment capability was operating/implemented in '12 markets at year-end 2021' and '12 markets at year-end 2022,' then '13 markets by year-end 2023.' However, the ground truth states it was '13 markets as of year-end' in the 2023 context. The LLM's claim of 12 markets in both 2021 and 2022 suggests stagnation, which contradicts the narrative of expansion. The ground truth indicates 13 markets by 2023, but the LLM's intermediate data points (12 in 2021, 12 in 2022) cannot be verified against the provided ground truth and appear inconsistent with the expansion narrative. MINOR ISSUES: (1) The answer provides specific page citations (page_11) which, while helpful, cannot be verified and may be hallucinated; (2) The phrase 'account-based payment capability' differs slightly from the ground truth's 'real-time payment infrastructure' though these are likely semantically equivalent. REASONING QUALITY: The multi-hop synthesis is sound in structure, correctly tracing evolution across years and connecting third-party collaboration, real-time payments, and cyber resilience. However, the quantitative inaccuracy regarding market numbers significantly impacts overall correctness despite good qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1705,
        "completion_tokens": 542,
        "total_tokens": 2247
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil disclosed that the collateral held under master‑netting arrangements (the line that appears in the footnote for “Other assets, including intangibles – net”) fell from **$1.494 billion in 2022** to **$800 million in 2023** and then to **$491 million in 2024**【page_102】【page_99】.  The steady drop signals that the firm is needing less margin for its derivative positions—either because its net derivative exposure has been trimmed or because its netting and margin‑management processes have become more efficient over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states collateral was '$1.494 billion in 2022' but the ground truth shows $800 million at end of 2022. This is a massive discrepancy ($1.494B vs $800M - off by ~$694M or 87%). The LLM correctly states $800M in 2023 and $491M in 2024, but the 2022 baseline is completely wrong. (2) CALCULATION ERROR: The LLM does not calculate or mention the 38% decrease from 2022-2024 that the ground truth identifies. The LLM's own numbers ($1.494B to $491M) would represent a 67% decline, but this calculation is not performed or verified. (3) TIMELINE CONFUSION: The ground truth clearly distinguishes between 'end of 2021 (reported in 2022 filing)' vs 'end of 2022 (reported in 2023 filing)' vs 'end of 2023 (reported in 2024 filing)'. The LLM conflates these by stating '$1.494 billion in 2022' without clarifying whether this is end-of-year 2022 or some other period. The ground truth's $641M (2021), $800M (2022), $491M (2023) sequence is the correct one. (4) REASONING: While the LLM's qualitative interpretation about reduced margin requirements and derivative exposure management is reasonable and aligns with the ground truth's conclusion, it is built on incorrect numerical foundations. (5) MISSING CONTEXT: The LLM fails to mention the 2021 baseline ($641M) which is important for understanding the full trend. The answer presents an incomplete picture of the multi-year trend. The core issue is that the LLM has fundamentally misidentified the 2022 collateral figure, which undermines the entire quantitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 457,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model used an expected volatility of 26.9 % for the 2022 awards【page_214】, which rose to 28.6 % for the 2023 awards【page_206】, then fell sharply to 18.7 % for the 2024 awards【page_215】. This pattern—an increase in 2023 followed by a steep decline in 2024—suggests that market participants viewed Duke Energy’s stock as more volatile in 2023 but perceived a markedly lower risk and greater price stability by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% for 2022, 28.6% for 2023, and 18.7% for 2024. The numerical progression and magnitude of changes (increase of 1.7 percentage points from 2022 to 2023, then decrease of 9.9 percentage points from 2023 to 2024) are accurately represented. (2) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR model is properly named as 'relative-TSR model,' and all years (2022, 2023, 2024) are correctly associated with their respective volatility figures. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year volatility trend and correctly interprets the pattern - identifying 2023 as a peak risk period followed by significant stabilization in 2024. The reasoning that this suggests 'lower risk and greater price stability by 2024' is logically sound and semantically equivalent to the ground truth's characterization of 'stabilization or reduced uncertainty.' (4) SEMANTIC EQUIVALENCE: The LLM's interpretation that 'market participants viewed Duke Energy's stock as more volatile in 2023 but perceived a markedly lower risk and greater price stability by 2024' conveys the same substantive meaning as the ground truth's statement about 'peak in perceived market risk in 2023, followed by a significant decline in 2024.' The inclusion of page citations adds credibility without affecting accuracy. Minor difference: The LLM uses 'steep decline' while ground truth uses 'significant decline' - both are semantically appropriate descriptions of a 9.9 percentage point drop. No calculation errors detected. The answer fully addresses the multi-part question regarding both the numerical changes and their implications for market risk perception.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 493,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "Across all three filings GM’s exposure to Stellantis has stayed essentially unchanged. In the 2022 10‑K the company said the Seller agreed to indemnify Stellantis for any emissions‑related, product‑liability and recall losses arising from the 2017 Opel/Vauxhall sale and noted that the Takata‑related indemnity was “immaterial” with no material accrual recorded (page 89‑90). The 2023 filing repeats the same language – GM still cannot estimate a material loss, the Takata indemnity remains immaterial and no specific accrual is disclosed (page 90). The 2024 filing likewise states that GM continues to indemnify Stellantis for emissions and product‑liability claims (subject to time limits, thresholds and caps) and that the Takata indemnity is immaterial and any further liability is remote, with only insignificant amounts recorded for these guarantees (page 91).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of GM's Stellantis indemnification obligations across 2022-2024, with mostly accurate characterization of the evolution. STRENGTHS: (1) Correctly identifies the core narrative that exposure remained minimal and stable across all three years; (2) Accurately characterizes indemnification as 'immaterial' in 2022-2023 and 'remote' for future liability in 2024; (3) Properly synthesizes multi-hop information across three years of filings; (4) Correctly identifies the key categories (emissions, product liability, recalls, Takata); (5) Appropriately notes the shift from 'immaterial' to 'remote' between 2023 and 2024; (6) Page references appear reasonable for 10-K filings. WEAKNESSES: (1) The LLM answer states GM 'agreed to indemnify Stellantis' when the ground truth indicates GM indemnified Stellantis (past tense/completed action), suggesting potential confusion about the direction of indemnification; (2) Missing explicit mention of the European Commission and UK CMA investigations into Opel conduct that the ground truth specifically highlights as a 2024 development with an accrual; (3) The phrase 'only insignificant amounts recorded' in 2024 is somewhat vague compared to ground truth's more precise characterization of accruals for EC/CMA investigations; (4) Does not clearly distinguish between the Takata-specific indemnity treatment versus the broader emissions/product liability indemnity framework. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the evolution pattern, though it misses one important 2024 development (EC/CMA accruals). SEMANTIC EQUIVALENCE: The core message aligns with ground truth - minimal, stable exposure - but the omission of EC/CMA investigation accruals represents a meaningful gap in completeness for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 504,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "In AMD’s 2022 Form 10‑K the “2011 Executive Incentive Plan” appears as Exhibit 10.1 and is incorporated by reference (see page 93). The 2023 filing repeats the identical reference to the same plan as Exhibit 10.1 (page 101), and the 2024 filing does the same (page 98). The unchanged citation across three consecutive years shows that AMD continues to rely on the same foundational incentive framework, indicating a deliberate, long‑term and stable approach to executive compensation rather than frequent plan overhauls.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that AMD consistently referenced the 2011 Executive Incentive Plan across 2022, 2023, and 2024 filings without amendments, and appropriately interprets this as indicating a stable executive compensation strategy. The qualitative reasoning about long-term stability is sound and well-articulated. However, there are significant quantitative accuracy issues: (1) The LLM provides specific page numbers (93, 101, 98) that cannot be verified against the ground truth, which does not mention these page references. (2) The ground truth explicitly states the plan was 'filed on April 2, 2011' and listed as 'Exhibit 10.1,' but the LLM omits the specific filing date. (3) The LLM adds the phrase 'incorporated by reference' which is not mentioned in the ground truth. While these additions may be accurate details from actual filings, they represent unverified claims that go beyond what the ground truth confirms. The core multi-hop synthesis is correct—the answer successfully connects information across three years and draws the appropriate conclusion about consistency and stability. The semantic meaning aligns well with the ground truth's interpretation. The main weakness is the introduction of specific page numbers and additional details that cannot be cross-referenced with the provided ground truth, which reduces confidence in the quantitative precision of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 396,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "In its 2022 filing PayPal warned that “bad‑transaction” risk was tied to defaults on its consumer‑ and merchant‑credit products, the higher‑margin but trade‑sensitive cross‑border business, and heavy reliance on unaffiliated lenders, banks and payment‑processor partners (PYPL_10k_2022.pdf: page_24‑25). In 2023 the company acted to curb that exposure by selling a large portion of its U.K. and European BNPL loan portfolio and establishing a forward‑flow receivable‑sale arrangement, while also diversifying its payment‑processor relationships and exploring alternative third‑party funding structures (PYPL_10k_2023.pdf: page_25). The 2024 filing still lists the same credit‑product, cross‑border and third‑party risks, showing the exposure persists but that the 2023 strategic actions are intended to mitigate it (PYPL_10k_2024.pdf: page_21‑23).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core risk evolution: 2022 warnings about bad transactions tied to credit defaults, cross-border trade sensitivity, and third-party dependencies; (2) Accurately captures the 2023 strategic action - selling U.K. and European BNPL loan receivables with a forward-flow arrangement (matches ground truth's €40 billion reference, though LLM doesn't specify the exact amount); (3) Properly synthesizes that 2024 filings continue to highlight these risks while acknowledging mitigation efforts; (4) Correctly identifies all three risk dimensions: credit products, cross-border trade, and third-party reliance; (5) Provides appropriate document citations with page numbers. MINOR GAPS: (1) The LLM mentions 'diversifying payment-processor relationships and exploring alternative third-party funding structures' which adds detail not explicitly in the ground truth - this is reasonable inference but slightly beyond what was confirmed; (2) Does not specify the €40 billion figure mentioned in ground truth, though this is a minor omission; (3) The phrase 'forward-flow receivable-sale arrangement' is accurate terminology but ground truth uses 'multi-year agreement' - semantically equivalent. QUANTITATIVE VERIFICATION: All numbers and dates are correct (2022, 2023, 2024 timeline; U.K. and European BNPL focus). MULTI-HOP REASONING: Excellent synthesis showing how risks evolved across three years and how 2023 actions addressed 2022 concerns while 2024 shows ongoing management. The answer correctly connects the dots between risk identification, strategic response, and continued monitoring. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth with appropriate professional terminology and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 512,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (6,204 owned, 1,038 leased) with an average age of 22.5 years in 2022 to 7,008 units (5,971 owned, 1,037 leased) at 24.3 years in 2023 and further to 6,893 units (5,973 owned, 920 leased) at 25.2 years in 2024 [page_24][page_19][page_19]. This shrinking total and leased count, coupled with a rising average age, shows the railroad is retiring older equipment, reducing lease reliance and pursuing a gradual modernization through selective new purchases and capital investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key trend of declining total fleet units and increasing average age from 2022 to 2024. The owned unit count for 2024 (5,973) matches ground truth exactly. The average ages for 2022 (22.5 years) and 2024 (25.2 years) are correct. The reasoning about fleet management strategy is sound and addresses the modernization question appropriately. The answer provides intermediate 2023 data showing the progression, which adds useful context.\n\nCRITICAL ERRORS: (1) Leased units in 2024: LLM states 1,037 leased units, but ground truth shows 920 leased units - this is a significant discrepancy of 117 units (12.7% error). (2) Owned units in 2023: LLM states 5,971 owned units, but this appears to be a typo or error since the ground truth shows 6,204 in 2022 declining to 5,973 in 2024, making 5,971 suspiciously close to the 2024 figure. (3) Average age in 2023: LLM states 24.3 years, but this intermediate value is not verified against ground truth and appears potentially inaccurate.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022-2024) and correctly interprets the implications: declining leased equipment, increasing average age, and the strategic implication of cost control over aggressive modernization. However, the interpretation differs slightly - the LLM suggests 'gradual modernization through selective new purchases' while ground truth emphasizes 'cost control over aggressive modernization' with no substantial increase in new purchases. This is a meaningful distinction.\n\nCALCULATION VERIFICATION: Total fleet calculations appear correct for 2022 (6,204 + 1,038 = 7,242) and 2024 (5,973 + 920 = 6,893), but the 2023 intermediate figures cannot be fully verified. The decline from 7,242 to 6,893 units (349 unit reduction) is correctly characterized.\n\nOVERALL ASSESSMENT: The answer contains one clear factual error (leased units in 2024) and potentially another (2023 owned units), which significantly impacts quantitative accuracy. The qualitative reasoning and strategic interpretation are mostly sound but slightly diverge from the ground truth's emphasis on cost control without substantial new purchases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 593,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell dramatically – it was $1.494 billion at 12/31/2022, dropped to $800 million in 2023, and declined further to $491 million by 12/31/2024【page_102】【page_99】. This steep reduction in un‑netted margin exposure suggests the company is tightening its derivative risk profile—likely by optimizing netting, scaling back the size of its derivative positions or using more efficient hedging structures—to manage risk while freeing up capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the 2022 figure. Ground truth states $641 million for 2022, but the LLM claims $1.494 billion—this is a 133% overstatement and fundamentally incorrect. The 2023 ($800 million) and 2024 ($491 million) figures are correct. The LLM's characterization of the trend as a 'dramatic fall' is misleading because it's based on the incorrect 2022 baseline. The actual trend per ground truth is: $641M (2022) → $800M (2023) → $491M (2024), which shows an initial INCREASE followed by a decrease, not a continuous decline as the LLM suggests. The LLM's interpretation of the trend (tightening derivative risk profile, optimizing netting, scaling back positions) is reasonable qualitative analysis, but it's built on incorrect quantitative foundations. The LLM also fails to address the ground truth's specific mention of level 3 fair value inputs for equity company receivables and long-term obligations, which is an important detail about valuation methodology. The answer does address the multi-hop nature of the question (comparing across years and inferring risk management strategy), but the fundamental numerical error severely undermines the credibility and accuracy of the response. The 2022 figure discrepancy is not a minor formatting issue—it represents a completely different data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 380,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” segment is defined the same way in each filing – it “primarily consists of packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware and ready‑to‑drink beverages, among other items”【page_86】, 【page_88】.  In FY 2022 it contributed $6.9 billion, or 21 % of total net revenue【page_86】; in FY 2023 it grew to $7.7 billion (22 % of total)【page_88】; and in FY 2024 it was $7.5 billion, again about 21 % of total revenue【page_88】.  Thus the mix of items stayed consistent while the dollar amount rose modestly and the percentage share peaked at 22 % in 2023 before returning to roughly 21 % in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and percentages. The specific numbers provided ($6.9B in 2022, $7.7B in 2023, $7.5B in 2024) and their corresponding revenue percentages (21%, 22%, 21%) are accurate and properly sourced. The answer correctly identifies that the composition of the 'Other' category remained consistent across all three years, listing the same key components: packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. The multi-hop synthesis is sound - the LLM successfully extracted and compared the category definitions across three different 10-K filings and tracked the financial evolution. The answer goes beyond the ground truth by providing specific dollar amounts and percentage shares, which adds valuable quantitative context while maintaining accuracy. Minor deduction: The ground truth notes that ready-to-drink beverages were mentioned in 2022 and 2023 but doesn't explicitly confirm their presence in 2024, though the LLM's statement that the structure was 'consistent with prior years' is reasonable. The LLM's conclusion that 'the mix of items stayed consistent while the dollar amount rose modestly' accurately captures the key insight that composition remained stable despite revenue fluctuations. The answer is well-structured, directly addresses the question about evolution from 2022-2024, and provides both qualitative (composition stability) and quantitative (revenue trends) analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 429,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "In the 2022 filing the company explained that on Google Network sites (AdMob, AdSense and Google Ad Manager) it tracks **impressions** and recognizes brand‑advertising revenue when the ad is displayed (and performance‑advertising revenue when a user engages) 【page_31】.  The 2023 and 2024 filings repeat that it evaluates whether it is the principal for those ads and, **as a matter of practice, reports the advertising revenue on a gross basis**—recording the full amount billed to advertisers as revenue and the payments to network partners as cost of revenue 【page_57】【page_58】.  Thus, from 2022 through 2024 the monetization model remained the same: impression‑based revenue is still recognized at display, and Google Network inventory continues to be reported on a gross‑revenue basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three Google Network properties (AdMob, AdSense, Google Ad Manager) mentioned in filings; (2) Accurately captures the impression-based revenue recognition model from 2022, specifically noting that brand-advertising revenue is recognized at display and performance-advertising revenue upon user engagement; (3) Properly synthesizes the multi-hop information showing consistency across 2022-2024 regarding gross revenue reporting; (4) Correctly explains the principal/agent distinction and gross revenue recognition approach emphasized in 2023-2024 filings; (5) Appropriately cites page references (31, 57, 58) indicating source verification; (6) Uses accurate financial/accounting terminology (cost of revenue, principal designation, gross basis). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and specific than the ground truth (e.g., explicitly naming AdMob, AdSense, Google Ad Manager; distinguishing brand vs. performance advertising), but this represents added clarity rather than inaccuracy; (2) The ground truth mentions 'cost-per-impression as a key metric' in 2022, which the LLM answer doesn't explicitly state, though this is a minor omission that doesn't affect the core narrative; (3) The ground truth emphasizes 'increasing transparency and accounting clarity over time' as an evolution theme, while the LLM answer states the model 'remained the same'—this is a subtle semantic difference but both characterizations are defensible given the data. QUANTITATIVE VERIFICATION: No specific dollar amounts, percentages, or calculations are present in either answer, so quantitative accuracy is not directly testable but the factual claims about revenue recognition methods are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and multiple filing sections, correctly identifying the evolution and consistency of the monetization strategy. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 570,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across all three filings Mondelēz consistently flags exposure to sales‑ and media‑marketing restrictions – notably front‑of‑pack labeling rules based on nutrient‑profile or environmental claims – and to extended‑producer‑responsibility (EPR) regimes. The 2022 Form 10‑K (page 15) notes that “front‑of‑pack labeling” requirements and “sales or media and marketing restrictions” apply to its products and that “over 25 countries in the European Union have implemented EPR policies…EPR policies are being implemented or contemplated…including India, Vietnam and certain states in the United States.” The same language appears unchanged in the 2023 filing (page 11) and again in the 2024 filing (page 11), indicating that the nature of the risk has remained stable while the jurisdictional footprint of EPR policies continues to expand.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims the 2022 filing states 'over 25 countries in the European Union have implemented EPR policies' and that 'EPR policies are being implemented or contemplated...including India, Vietnam and certain states in the United States.' However, the ground truth clearly indicates that in 2022, EPR policies were only noted in 'over 25 EU countries' with restrictions on advertising in place, while India, Vietnam, Indonesia, and the Philippines were only 'being considered' - NOT yet implemented. The LLM incorrectly attributes 2024 language (U.S. states implementation) to the 2022 filing. (2) TEMPORAL EVOLUTION MISSED: The LLM states the language 'appears unchanged' across all three years, which directly contradicts the ground truth showing clear evolution: 2022 (contemplation phase), 2023 (increased focus on front-of-pack labeling), 2024 (formal EU Directive adoption and shift to enforcement in India, Vietnam, and U.S. states). This is a critical failure in multi-hop reasoning. (3) JURISDICTIONAL ACCURACY: The LLM omits Indonesia and the Philippines entirely from the 2022-2023 discussion, and fails to capture the distinction between 'being considered' (2022) vs. 'being implemented or contemplated' (2024). (4) MISSING CONTEXT: The ground truth emphasizes a 'shift from contemplation to enforcement' and 'growing regulatory burden' - the LLM's claim of 'stable' risk directly contradicts this key insight. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the year-over-year progression that is central to the question's focus on 'evolution.' The answer reads as a static snapshot rather than a dynamic analysis of how exposure has changed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 494,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across all three filings, Mastercard’s Class A shares were unchanged – each share carried **one vote per share and full dividend rights** in 2022 (see 2022 10‑K page 96), 2023 (see 2023 10‑K page 99) and 2024 (see 2024 10‑K page 92). The steady‑state of voting and dividend entitlements signals a deliberate capital‑structure strategy that preserves a stable governance model (public shareholders retain voting power) while maintaining a predictable dividend policy, reinforcing long‑term shareholder confidence.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) Correctly identifies that Class A shares maintained one vote per share and dividend rights consistently across 2022, 2023, and 2024 - matching the ground truth exactly. (2) Properly synthesizes multi-hop information across three years of filings to demonstrate consistency. (3) Accurately names the company (Mastercard) and correctly identifies the share class (Class A). (4) Provides specific page references (96, 99, 92) which adds credibility and verifiability. (5) The interpretation of what this consistency indicates about capital structure strategy is sound and goes slightly beyond the ground truth by adding nuance about 'deliberate capital-structure strategy' and 'long-term shareholder confidence' - this is reasonable inference rather than overreach. (6) The reasoning about governance model preservation and predictable dividend policy is logically sound and contextually appropriate. MINOR CONSIDERATIONS: The LLM answer is slightly more elaborate than the ground truth (which is more concise), but this elaboration is substantive and accurate rather than speculative. The phrase 'public shareholders retain voting power' is a reasonable interpretation of the one-vote-per-share structure. No factual errors detected. All numeric claims (one vote per share, dividend rights) are correct. The multi-hop synthesis across three years is properly executed. The answer fully addresses both parts of the question: (1) how status evolved (answer: it didn't - remained consistent), and (2) what this indicates about strategy (answer: consistent/stable approach).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 448,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements linked to its “investments, advances and long‑term receivables” fell sharply – $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024 (2023 10‑K p. 102; 2024 10‑K p. 99). This downward trend implies a shrinking net derivative exposure or reduced initial‑margin requirements, suggesting the company’s derivative positions or the associated risk‑mitigation needs have been decreasing over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual discrepancy in the 2022 figure. Ground truth states $641 million for 2022, but the LLM reports $1.494 billion - a difference of $853 million or 133% overstatement. This is a fundamental quantitative error that undermines the entire analysis. The 2023 ($800M) and 2024 ($491M) figures are correct and match the ground truth. REASONING ISSUES: The LLM characterizes the trend as 'sharply fell' and 'downward trend,' which is technically correct for 2023-2024 but misleading when the 2022 baseline is wrong. The ground truth shows an increase from 2022 to 2023 ($641M to $800M), then a decrease to 2024 ($491M). The LLM's narrative of 'shrinking net derivative exposure' is qualitatively reasonable but is based on an incorrect starting point. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across three years and connect it to derivative exposure and margin requirements, which is appropriate. However, the incorrect 2022 figure breaks the analytical chain. COMPLETENESS: The answer addresses the question's core components (collateral amounts, trend analysis, implications) but the factual error in the primary data point is disqualifying. The page citations (2023 10-K p. 102; 2024 10-K p. 99) suggest specific sourcing but cannot verify accuracy. SEMANTIC EQUIVALENCE: While the qualitative interpretation about derivative exposure trends is reasonable, it cannot be considered semantically equivalent when based on fundamentally incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 423,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ 10‑K disclosures show that each year it pushed the horizon of its forward‑purchase and hedging program one year farther: the FY 2022 filing said its total purchase commitments and inventory would secure green‑coffee supply “through fiscal 2023” (2022 10‑K p. 12); the FY 2023 filing updated that language to “through fiscal 2024” (2023 10‑K p. 12); and the FY 2024 filing now projects adequate supply “through fiscal 2025” (2024 10‑K p. 12). This incremental extension of fixed‑price, price‑to‑be‑fixed and forward/futures contracts (supported by farmer‑support centers) signals a deliberate strategy to lock in coffee supply and hedge price volatility, thereby reducing supply‑chain risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE PROGRESSION: The LLM answer contains a fundamental factual error in the year-by-year progression. According to the ground truth, the timeline should be: FY2022→through fiscal 2023, FY2023→through fiscal 2025, FY2024→through fiscal 2025. However, the LLM claims: FY2022→through fiscal 2023, FY2023→through fiscal 2024, FY2024→through fiscal 2025. This is incorrect. The LLM shows a one-year increment each year (2023→2024→2025), when the actual pattern shows a two-year jump from FY2022 to FY2023 (2023→2025), then maintenance at the same level in FY2024 (still 2025). This is a significant multi-hop reasoning error that misrepresents the company's strategic evolution. The ground truth explicitly states 'By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025' and 'in fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025,' indicating a strategic shift followed by stabilization. The LLM's interpretation suggests continuous year-by-year extension, which contradicts the actual pattern of a major extension followed by maintenance. POSITIVE ASPECTS: The LLM correctly identifies the general strategy (locking in supply, hedging price volatility, reducing supply-chain risk), mentions forward/futures contracts, and references page numbers. However, the core quantitative facts about which fiscal years correspond to which supply horizons are materially incorrect, which is a critical failure for a financial analysis question. The reasoning about strategy is sound but built on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 444,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "In FY 2023 the company’s target mix for non‑U.S. defined‑benefit plans was 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % “other” (U.S. plans remained 100 % debt). By FY 2025 the target had shifted to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other (U.S. plans still 100 % debt). The move away from a debt‑heavy allocation toward more insurance‑linked assets, cash and a modest equity increase reflects a long‑term strategy to better match liabilities, lower market‑risk exposure and pursue risk‑adjusted returns that exceed inflation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data about ACN's target asset allocation shifts from FY2023 to FY2025, which is more concrete than the ground truth answer. Strengths: (1) The LLM correctly identifies specific percentage allocations for both fiscal years across multiple asset classes (equity, debt, cash, insurance contracts, other), (2) The numerical data appears internally consistent (FY2023: 27+48+4+11+10=100% for non-U.S. plans; FY2025: 28+36+7+21+8=100%), (3) The directional shifts are clearly articulated (debt declining from 48% to 36%, insurance contracts increasing from 11% to 21%, cash rising from 4% to 7%), (4) The interpretation of these shifts as reflecting liability matching, risk reduction, and inflation-beating returns aligns with the ground truth's characterization of the strategy. Minor considerations: (1) The ground truth is more general/qualitative, discussing 'continuity in strategy' and 'adaptive approach,' while the LLM provides specific allocation percentages that cannot be directly verified against the provided ground truth (though they appear plausible for a pension plan), (2) The LLM correctly notes U.S. plans remained 100% debt in both years, adding specificity, (3) The reasoning about why the allocation shifted (liability matching, lower market risk, risk-adjusted returns) is sound and well-supported by the data presented. The answer directly addresses the multi-hop question by synthesizing the allocation data across years and connecting it to strategic objectives. No calculation errors detected. The answer is more specific and data-driven than the ground truth, which is appropriate for this type of quantitative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 461,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "In the 2022 and 2023 10‑K filings, Olpasiran was listed as a Phase 3 cardiovascular‑disease candidate (page_25). By the 2024 filing Amgen highlighted Olpasiran as an siRNA that lowers Lp(a) for atherosclerotic cardiovascular disease, with Phase 2 and Phase 3 studies underway (pages_26, 28) and disclosed composition‑of‑matter patents in the U.S. and Europe that run to 2036 (page_27), underscoring a strategic shift toward a novel CV‑risk‑reduction therapy supported by long‑term IP protection.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) PHASE CLASSIFICATION ERROR - The LLM states Olpasiran was 'Phase 3' in 2022-2023, but the ground truth explicitly states it was in 'phase 2 trials' in 2022. This is a fundamental factual error about the clinical development stage. The LLM then claims 'Phase 2 and Phase 3 studies underway' in 2024, which contradicts the ground truth's statement that by 2024 it had transitioned from phase 2 investigation toward 'more advanced development or potential regulatory preparation' - the ground truth does not confirm Phase 3 status. (2) THERAPEUTIC INDICATION ACCURACY - The LLM correctly identifies the cardiovascular/atherosclerotic CV disease focus and mentions Lp(a) lowering, which aligns with ground truth's 'atherosclerotic cardiovascular (CV) disease' indication. (3) PATENT PROTECTION - Both answers correctly identify U.S. and European patent protection expiring in 2036, with the LLM specifying 'composition-of-matter patents' which is consistent with ground truth's 'Compounds' patent reference. (4) MULTI-HOP SYNTHESIS - The LLM attempts to synthesize information across 2022-2024 filings but makes critical errors in phase classification that undermine the narrative of progression. The ground truth shows evolution from phase 2 (2022) to more advanced development (2024), but the LLM mischaracterizes the 2022-2023 status as Phase 3. (5) MISSING CONTEXT - The LLM provides page references (which adds specificity) but the core clinical development stage information is incorrect, which is central to answering how development 'evolved.' The strategic positioning regarding IP is correctly captured, but the clinical development trajectory is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 465,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022 10‑K:** American Express said it was “increasingly relying on merchant acquirers, aggregators and processors” to manage merchant relationships, and warned that dependence on these third‑parties could lead to operational disruptions, data‑security breaches, misaligned partner interests and related regulatory or reputational harm (2022 p. 29‑31).  \n\n- **2023 10‑K:** The filing reiterated the same reliance on aggregators and stressed that their business strategies could be inconsistent with Amex’s, creating risk that card acceptance and usage could be impaired and that third‑party failures could affect service quality (2023 p. 29‑31).  \n\n- **2024 10‑K:** The company noted that the number of third‑party providers—including aggregators—had grown further as outsourcing and digital services expanded, and emphasized heightened operational complexity, governance challenges, regulatory scrutiny and the danger that aggregators could cease providing data or misuse it, leading to service interruptions, reputational damage and compliance penalties (2024 p. 35‑36).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the evolution of American Express's reliance on aggregators from 2022-2024. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and tracks the evolution of risks; (2) Accurately captures key risk themes: operational disruptions, data security, misaligned interests, regulatory concerns, and service interruptions; (3) Properly synthesizes multi-hop information showing progression from general operational concerns to broader systemic/legal risks; (4) Page references provided (though not verified against actual filings); (5) Semantic equivalence maintained with ground truth regarding merchant steering, surcharging, and third-party failures. WEAKNESSES: (1) The LLM answer does not explicitly mention 'merchant steering' and 'surcharging' as specific risk categories emphasized in the original answer, which were highlighted as particularly important in 2023; (2) The 2022 description is somewhat generic and doesn't capture the specific concern about 'how aggregators might act against AXP's interests' as distinctly as the ground truth; (3) Missing explicit connection between aggregator behavior and impact on 'card usage and merchant acceptance' as a specific causal chain in 2023; (4) The progression narrative could be clearer - while the answer shows evolution, it doesn't emphasize the 'shift from merchant behavior focus to systemic/legal concerns' as explicitly as ground truth. QUANTITATIVE ACCURACY: No specific numbers or calculations present in either answer, so this dimension is not heavily tested. Page numbers provided by LLM (29-31 for 2022-2023, 35-36 for 2024) cannot be verified but appear plausible. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and identifies the evolution pattern, though the specific risk categories could be more precisely aligned with ground truth. The logical flow is sound but somewhat less nuanced than the original answer's emphasis on shifting risk focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 555,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks consistently warned that green‑coffee prices are volatile and increasingly affected by hedge funds and commodity‑index funds, and it continued to hedge that exposure with forward contracts, futures and collars throughout fiscal 2022‑2024 【page_12】.  Over the same period the company lengthened its forward purchase commitments – covering supply through fiscal 2023 in the 2022 filing, through fiscal 2024 in the 2023 filing, and through fiscal 2025 in the 2024 filing 【page_12】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the three fiscal years (2022, 2023, 2024) and the progression of forward supply commitments; (2) Accurately states the timeline extension: fiscal 2023 (2022 filing) → fiscal 2024 (2023 filing) → fiscal 2025 (2024 filing); (3) Properly identifies commodity index funds as a key volatility factor; (4) Correctly notes hedging strategies (forward contracts, futures, collars); (5) Successfully synthesizes multi-hop information across three fiscal years. MINOR WEAKNESSES: (1) The answer mentions 'hedge funds' alongside commodity index funds, which is slightly broader than the ground truth focus on commodity index funds specifically; (2) The answer is more concise than the ground truth and omits some contextual nuance about 'strategic shift toward longer-term risk mitigation' and the characterization of this as a 'stabilized hedging and procurement strategy'; (3) Does not explicitly state that the 2024 supply outlook remained 'unchanged' from 2023 (both covering through fiscal 2025), though this is implied. QUANTITATIVE VERIFICATION: All fiscal years and forward commitment periods are correct. The progression (2023→2024→2025) is accurately stated. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the pattern of lengthening commitments. The connection between commodity index fund volatility and hedging strategy evolution is properly established. The answer is factually sound and directly responsive to the question, with only minor omissions of interpretive context rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 460,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture repurchased roughly $4.1 billion of its Class A shares in fiscal 2022 and, as of August 31 2022, still had about $3.13 billion of unused repurchase authority (page 94; page 93). By fiscal 2024 the annual buy‑back had grown to about $4.5 billion, the remaining authorization had slipped to $2.69 billion (as of August 31 2024) and the board raised the total authorized ceiling to $6.7 billion (page 39). This trajectory—larger buy‑backs each year combined with periodic boosts to the repurchase ceiling—signals a deliberate, accelerating capital‑return strategy that relies heavily on share repurchases to return cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that undermine its credibility. (1) FISCAL 2022 REPURCHASE AMOUNT: The LLM claims Accenture repurchased 'roughly $4.1 billion' in fiscal 2022, but the ground truth provides no such figure for fiscal 2022. The ground truth only mentions fiscal 2023 repurchases of 2,000,308 shares for $605 million. The LLM appears to have fabricated or misattributed this $4.1B figure. (2) FISCAL 2024 REPURCHASE AMOUNT: The LLM states the annual buy-back 'had grown to about $4.5 billion' by fiscal 2024, but again the ground truth provides no fiscal 2024 repurchase amount—only the authorization increase. This is another unsupported claim. (3) AUTHORIZATION FIGURES: The LLM correctly identifies $3.13 billion (fiscal 2022), $2.69 billion (August 31, 2024), and $6.7 billion (September 25, 2024) authorization amounts, which match the ground truth. (4) FISCAL 2023 DATA: The ground truth explicitly states fiscal 2023 repurchases were $605 million for 2,000,308 shares, but the LLM completely omits fiscal 2023 data, jumping from fiscal 2022 to fiscal 2024. This is a significant omission in a multi-year trajectory question. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the three-year evolution. It should have presented: FY2022 authorization ($3.129B), FY2023 repurchases ($605M) with remaining authorization ($2.694B as of Aug 31, 2024), and FY2024 new authorization ($4B additional, totaling $6.694B). Instead, it invents repurchase figures for FY2022 and FY2024 that don't exist in the source material. (6) REASONING QUALITY: While the LLM's conclusion about an 'accelerating capital-return strategy' is reasonable in tone, it's built on false premises—the invented $4.1B and $4.5B figures. The actual data shows more modest repurchase activity ($605M in FY2023) with periodic authorization increases, which is a different narrative than 'larger buy-backs each year.' The answer demonstrates poor fact-checking and appears to have hallucinated specific dollar amounts not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 561,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google reported that the long‑term portion of its marketable equity securities (subject to lock‑up restrictions) was **$803 million at year‑end 2022**, rose to **about $1.4 billion at year‑end 2023**, and then fell to **roughly $266 million at year‑end 2024**【page_65】【page_66】【page_67】. The sharp increase in 2023 followed by a steep decline in 2024 indicates that the company temporarily expanded its exposure to illiquid, locked‑up equity investments and then actively reduced or unlocked those positions, suggesting a flexible, opportunistic approach to managing illiquid assets rather than a steady‑state commitment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-to-year progression of values. According to the ground truth: 2022=$1.4B, 2023=$803M, 2024=$1.4B. The LLM reports: 2022=$803M, 2023=$1.4B, 2024=$266M. This represents a complete reversal and misalignment of the data across all three years. Specifically: (1) The 2022 value is wrong ($803M reported vs $1.4B actual), (2) The 2023 value is wrong ($1.4B reported vs $803M actual), (3) The 2024 value is completely incorrect ($266M reported vs $1.4B actual). The LLM essentially inverted the 2022-2023 values and introduced an entirely fabricated 2024 figure. (2) CALCULATION/SYNTHESIS ERROR: The LLM's narrative of 'sharp increase in 2023 followed by steep decline in 2024' contradicts the actual pattern of decrease then recovery. (3) REASONING FLAW: While the LLM's interpretation about 'flexible, opportunistic approach' could be reasonable IF the numbers were correct, it's based entirely on incorrect data, making the conclusion invalid. (4) MULTI-HOP SYNTHESIS: The model failed to correctly synthesize the three-year progression from the source documents. The ground truth shows a V-shaped pattern (down then up), while the LLM describes an inverted pattern (up then down). This is a fundamental failure in multi-hop data extraction and synthesis. The only partially correct element is the identification of Google and the general concept of lock-up restrictions, but the core numerical facts are severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 419,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "In the fourth quarter of 2022 GE re‑positioned its captive insurer, Electric Insurance Company (EIC), as a non‑core “business held for sale,” moving the unit off the operating balance sheet with roughly $541 million of assets against $378 million of liabilities 【page_48】. During 2023 the disposal group remained on the books with a $124 million valuation allowance and GE recorded a $109 million loss in other income related to the expected divestiture 【page_46】, while the assets‑and‑liabilities schedule showed the $541 million/$378 million figures 【page_46】. In the second quarter of 2024 GE completed the sale to Riverstone International Holdings for $120 million cash, eliminating the EIC assets, liabilities and valuation allowance from its balance sheet and turning the prior impairment loss into a modest net cash gain that improved liquidity 【page_48】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key entities (GE, Electric Insurance Company/EIC, Riverstone International Holdings), the three-year progression (2022-2024), and the major milestones (held for sale classification, 2023 loss, 2024 sale completion). The asset/liability figures ($541M assets, $378M liabilities) are accurate. The sale price ($120M cash) and the 2023 loss ($109M) are correct. The narrative flow and strategic context (non-core business exit, portfolio focus) are appropriate.\n\nCRITICAL ERRORS: (1) TIMELINE DISCREPANCY - The LLM states EIC was repositioned as 'held for sale' in Q4 2022, but the ground truth indicates this classification occurred by 2023. The ground truth explicitly states 'By 2023, GE had classified EIC as held for sale,' suggesting the classification happened in 2023, not Q4 2022. This is a significant factual error regarding when the held-for-sale status was established. (2) VALUATION ALLOWANCE - The LLM mentions a '$124 million valuation allowance' in 2023, which does not appear in the ground truth answer. This figure cannot be verified against the provided ground truth and may be incorrect or from a different source. (3) 2022 BASELINE - The ground truth explicitly states that in 2022, EIC had 'net claim reserves of $0.2 billion,' which the LLM completely omits. This is a material omission of the 2022 baseline position.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly traces the progression from operating unit to held-for-sale to completed sale. However, the timeline error undermines the accuracy of this synthesis.\n\nCALCULATION/VERIFICATION: The $541M - $378M = $163M net asset position is implicit but not explicitly calculated in either answer. The LLM's statement about the sale 'turning the prior impairment loss into a modest net cash gain' is somewhat vague and not clearly supported by the numbers provided.\n\nOVERALL ASSESSMENT: While the LLM captures the essential narrative and most key figures correctly, the Q4 2022 timing error for the held-for-sale classification, the unexplained $124M valuation allowance, and the omission of the 2022 baseline ($0.2B net claim reserves) represent material factual errors that prevent a higher score. The answer is substantially correct in structure and most details but contains enough inaccuracies to warrant a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 644,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen reported 13 Phase 3 programs in its 2022 filing (as of Feb 8 2022) 【page_25】; that number rose to 18 by Jan 31 2023 【page_26】, to 24 by Jan 31 2024 【page_26】, and was disclosed as 25 programs on Feb 4 2025 【page_25】. The near‑doubling of Phase 3 assets over two years reflects a deliberate pipeline expansion—driven by new Phase 3 initiations, strategic acquisitions (e.g., Horizon), and a broader mix of biosimilars, small‑molecule and biologic candidates—underscoring Amgen’s focus on diversifying therapeutic areas, leveraging genetics‑driven targets and collaborations to strengthen its R&D pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All numeric values are correct—13 programs (2022), 18 programs (2023), 24 programs (2024), and 25 programs (2025). The progression accurately reflects the ground truth data. The LLM correctly identifies the near-doubling trajectory over two years. ENTITY ACCURACY: Amgen is correctly identified, fiscal years are accurate (Feb 8 2022, Jan 31 2023, Jan 31 2024, Feb 4 2025), and Phase 3 programs are the correct metric. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing periods, connecting the numerical progression to underlying drivers (new Phase 3 initiations, Horizon acquisition, therapeutic diversification). The mention of Horizon acquisition aligns with the ground truth's reference to acquiring five programs in 2023. COMPLETENESS: The answer addresses all aspects of the question—the evolution from 2022-2024 (and beyond to 2025), what the progression reveals about R&D expansion, and strategic focus. The discussion of diversification across biosimilars, small-molecule and biologic candidates, genetics-driven targets, and collaborations provides appropriate context. MINOR CONSIDERATIONS: The ground truth states 24 programs in 2024, while the LLM correctly reports this. The ground truth mentions 25 programs by 2024 in one sentence but the LLM clarifies this was disclosed in 2025 (Feb 4 2025), which is more precise. The LLM provides slightly more granular detail about therapeutic diversification than the ground truth, which is appropriate elaboration rather than error. SEMANTIC EQUIVALENCE: The core message—significant pipeline expansion driven by strategic acquisitions and new initiations—is conveyed accurately in both versions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 494,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In 2022 American Express described itself as the fourth‑largest global card network, competing directly with Visa, Mastercard, UnionPay and others while facing “intense competition” from both traditional networks and emerging digital‑payment platforms【page_12】. By 2024, heightened regulatory scrutiny has reshaped that relationship: the company has exited its network‑licensing businesses in the EU and Australia because of local regulations, and it is preparing for possible interchange‑fee caps and new surcharging rules arising from pending Visa/Mastercard settlement actions that could pressure its merchant‑discount rates【page_34】【page_35】. This regulatory pressure, combined with the competitive push from alternative payment providers, has driven American Express to adjust its global network strategy and focus more on integrated‑payments offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of American Express's relationship with global card networks from 2022 to 2024, correctly identifying key regulatory pressures and strategic shifts. STRENGTHS: (1) Accurately identifies AXP's positioning as a major global card network competing with Visa, Mastercard, and UnionPay in 2022; (2) Correctly identifies the 2024 regulatory exits from EU and Australia network-licensing businesses; (3) Properly synthesizes the shift from competitive positioning to regulatory constraint; (4) Appropriately mentions emerging digital payment platforms as competitive pressures; (5) References pending Visa/Mastercard settlement impacts on interchange fees and merchant discount rates. WEAKNESSES: (1) The answer omits specific mention of cobrand arrangement uncertainties in the EU that the ground truth highlights as a distinct regulatory challenge; (2) Does not explicitly mention China UnionPay as a specific competitor (though 'UnionPay' is mentioned); (3) Less emphasis on the evolution of alternative payment platforms like Alipay and PayPal as specific competitive dynamics mentioned in ground truth; (4) The characterization of the shift is somewhat simplified - ground truth emphasizes a progression from 'primarily competitive posture' to 'complex dynamic' to 'constrained environment shaped by regulatory dependencies,' while LLM presents it more linearly. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024 timeframes and connects regulatory pressures to strategic adjustments. The logic linking regulatory constraints to business model changes is sound. ENTITY ACCURACY: All company names and years are correct. QUANTITATIVE ACCURACY: No specific financial metrics or percentages are provided in either answer, so this dimension is less applicable, but the answer avoids numerical errors. The answer is substantially correct but misses some nuanced details about cobrand arrangements and specific alternative payment platform dynamics that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 552,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE stake in the first quarter of 2022, selling the remaining 91 million CVE common shares and applying the cash to repurchase ≈ 87.7 million of its own shares that year.  The buy‑back program then grew to a cumulative 383 million shares at a total cost of about $29 billion through 2023, and to 433 million shares at a total cost of $34.3 billion through 2024 (an additional ≈ 49.1 million shares and ≈ $5.3 billion of repurchases in 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with mostly correct numbers and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the Q1 2022 completion of CVE monetization with 91 million shares sold; (2) Accurately states cumulative repurchase totals: 383 million shares at $29 billion through 2023, and 433 million shares at $34.3 billion through 2024; (3) Correctly calculates 2024 incremental repurchases (≈49.1 million shares, ≈$5.3 billion); (4) Properly synthesizes the multi-hop relationship between CVE monetization proceeds and share repurchase program; (5) Provides specific dollar amounts and share volumes across the three-year period as requested. MINOR ISSUES: (1) The LLM states 87.7 million shares repurchased in 2022 specifically from CVE proceeds, but the ground truth doesn't explicitly confirm this specific allocation - it only states 383 million total repurchases in 2022 at $29 billion cost. The ground truth says 'repurchased a total of 383 million shares' in 2022, not that this was the cumulative through 2023. Upon closer reading, the LLM appears to have misinterpreted the timeline: it states '383 million shares...through 2023' but the ground truth indicates 383 million was repurchased in 2022 alone. (2) The October 2024 authorization increase to $65 billion mentioned in ground truth is omitted from LLM answer, though this is a minor contextual detail. CALCULATION VERIFICATION: 433M - 383M = 50M (LLM states ≈49.1M, which is approximately correct); $34.3B - $29B = $5.3B (correct). The slight variance in share count (49.1M vs 50M) is negligible and within rounding tolerance. Overall, the answer effectively addresses the question's core requirements with accurate synthesis of multi-hop information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 482,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "The Home Depot disclosed that it had about **117 million shares** available for future grants under its 2005 Omnibus Stock Incentive Plan at the end of fiscal 2022 (January 30 2022)【page_67】; the pool fell to roughly **77 million shares** under the newly‑amended Omnibus Plan by the end of fiscal 2023 (January 28 2024)【page_66】, and further declined to approximately **70 million shares** by the end of fiscal 2024 (February 2 2025)【page_67】. This steady contraction shows the company is actively issuing stock‑based awards—consuming its authorized share pool—while still retaining a substantial reserve, indicating strong ongoing capacity for compensation but increasing utilization over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key numbers are correct—117 million shares (2022), 77 million shares (2023), and 70 million shares (2024). The numerical progression and decline pattern match the ground truth exactly. DATES/ENTITIES: The fiscal year dates provided (January 30, 2022; January 28, 2024; February 2, 2025) are reasonable and consistent with Home Depot's fiscal calendar. The plan names (2005 Omnibus Stock Incentive Plan, amended Omnibus Plan) are correctly identified. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years, tracking the evolution of available shares and correctly identifying the transition from the 2005 Plan to the amended Omnibus Plan. REASONING QUALITY: The interpretation is sound—the answer correctly identifies the 'steady contraction' trend (117→77→70 million shares) and appropriately concludes this reflects 'active issuing of stock-based awards' and 'increasing utilization over time.' The observation about 'replenishment mechanism' is implicit in the answer's acknowledgment of 'substantial reserve' retention. SEMANTIC EQUIVALENCE: The LLM's phrasing ('steady contraction,' 'actively issuing stock-based awards,' 'increasing utilization') conveys the same meaning as the ground truth's 'consistent drawdown' and 'steady utilization.' The answer directly addresses both parts of the question: (1) how availability evolved (the numbers and trend), and (2) what it indicates about capacity and utilization (strong capacity with increasing utilization). Minor note: The LLM includes specific page references and fiscal end dates, which adds helpful context beyond the ground truth but does not contradict it. No calculation errors detected. All factual claims are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 496,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "The 2022 Form 10‑K states that the Amended 2010 Share Incentive Plan authorizes a maximum of **127 million** Accenture Class A ordinary shares for awards【page_91】. The 2024 Form 10‑K shows that this ceiling was later increased to **141 million** shares【page_98】—an uplift of 14 million shares over the period. This rise signals that Accenture is deliberately expanding the pool of equity awards to give it greater flexibility in using share‑based compensation to attract, retain and motivate talent while aligning employee interests with shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct—127 million shares in 2022, 141 million shares in 2024, and the calculated difference of 14 million shares. The numeric values match the ground truth exactly. COMPLETENESS: The answer addresses the core question about the evolution from 2022 through 2024, though it could have been slightly more explicit about the 2023 data point (which remained at 141 million per the ground truth). The LLM mentions '2024 Form 10-K shows that this ceiling was later increased to 141 million shares' but doesn't explicitly state when this increase occurred (between 2022 and 2023). ENTITY ACCURACY: All entities are correctly identified—Accenture plc, Class A ordinary shares, Amended 2010 SIP (Share Incentive Plan), and the relevant fiscal years. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the progression (127M → 141M), calculates the uplift (14M), and provides appropriate strategic interpretation about flexibility in equity awards, talent attraction/retention, and alignment with shareholder interests. This reasoning aligns well with the ground truth's characterization of 'strategic expansion' and 'growing emphasis on equity-based incentives.' MINOR GAPS: The answer doesn't explicitly mention that the 141 million figure applied to both 2023 and 2024 (the ground truth states 'By 2023 and 2024, this number had increased to 141,000,000'), but this is a minor omission that doesn't significantly detract from the overall accuracy. The strategic interpretation provided is appropriate and well-reasoned. The page citations (page_91, page_98) add credibility, though they cannot be independently verified in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 481,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "American Express’s weighted‑average yield on its foreign government bonds and obligations rose sharply – from about **3.5 % in 2022** to **6.1 % in 2024** (up roughly 2.6 percentage points)【page_176】.  This upward move signals that the firm’s foreign‑bond portfolio is now earning higher returns, reflecting greater sensitivity to—and exposure from—rising international interest‑rate environments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the 2022 yield was 'about 3.5%' when the ground truth clearly shows 5.86%. The LLM states the 2024 yield was '6.1%' when ground truth shows 5.86%. The calculated difference of 'roughly 2.6 percentage points' is mathematically incorrect given the stated numbers (6.1% - 3.5% = 2.6%, which is correct arithmetic, but both underlying numbers are wrong). The ground truth shows 2023 as the peak year at 6.45%, with 2024 returning to 5.86% (the same as 2022), not a continuous rise to 6.1%. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM failed to capture the three-year trend properly. Ground truth shows: 2022 (5.86%) → 2023 (6.45%, peak) → 2024 (5.86%, reversal). The LLM presents only 2022 and 2024, missing the critical 2023 peak and the reversal pattern that is central to understanding the trend. (3) MISINTERPRETATION OF TREND: The LLM characterizes this as a 'sharp rise' and 'upward move' suggesting sustained exposure to rising rates, when the ground truth shows volatility with a peak in 2023 followed by a return to baseline in 2024, suggesting stabilization or strategic adjustment rather than sustained upward pressure. (4) MISSING CONTEXT: The LLM omits the dollar amount ($630 million) and the specific instrument classification ('due within one year'), which are relevant details from the ground truth. The LLM's conclusion about 'greater sensitivity to rising international interest-rate environments' is contradicted by the actual 2024 return to 2022 levels, which suggests the opposite.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 454,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "In 2022 the foreign‑government bond portfolio was almost entirely short‑term – $628 m of the $630 m total was due within one year – and carried yields of roughly 1.7 %‑2.4 % (see Note 4, page 121). By 2023 the weighted‑average yield had jumped to about 6.45 % and then eased to roughly 5.85 % in 2024, indicating that American Express moved into longer‑dated, higher‑coupon sovereign debt as global rates rose and then modestly re‑balanced as rates softened, while still maintaining a higher‑yield stance than in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key portfolio metrics and yield progression (6.45% in 2023, 5.85% in 2024) and provides reasonable strategic interpretation. However, there is a significant quantitative discrepancy regarding 2022 yields. The LLM states yields were 'roughly 1.7%-2.4%' in 2022, but the ground truth does not provide specific yield percentages for 2022 - it only describes the portfolio composition ($630M total, $628M due within one year). The LLM appears to have introduced yield figures for 2022 that are not supported by the ground truth, which is a material error in quantitative accuracy. The LLM correctly captures: (1) the $630M and $628M portfolio values for 2022, (2) the short-duration focus in 2022, (3) the 6.45% yield in 2023, (4) the 5.85% yield in 2024, and (5) the strategic interpretation about moving into longer-dated higher-coupon debt as rates rose. The reasoning about market conditions and portfolio rebalancing is sound and aligns with the ground truth's interpretation. The multi-hop synthesis across years is generally correct. The main weakness is the introduction of unsupported 2022 yield figures (1.7%-2.4%), which represents a factual error. The answer is otherwise well-reasoned and addresses the question's core components, but the quantitative inaccuracy regarding 2022 yields prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 378,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In the 2022 10‑K the 7 % Debentures due 2029 were lumped together with common stock in a single table row, showing “COP CUSIP‑718507BK1” under the trading‑symbol column (page 1). The 2023 filing split the debt into its own line, separately listing the 7 % Debentures, its CUSIP and exchange (page 1). The 2024 filing again groups the securities under one heading but places the CUSIP on a distinct line, making the debenture identification clearer (page 1). This evolution shows ConocoPhillips progressively refining its disclosure to provide more granular and transparent reporting of the debenture while remaining consistent with Section 12(b) registration requirements.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. Key issues: (1) QUANTITATIVE/FACTUAL ERRORS: The LLM claims the 2022 filing showed 'COP CUSIP-718507BK1' under the trading-symbol column, but the ground truth states the debentures were listed 'alongside its Common Stock' without separate CUSIP identification in 2022. The CUSIP-718507BK1 was only introduced in 2023 according to ground truth. (2) STRUCTURAL MISCHARACTERIZATION: The LLM describes 2024 as 'groups the securities under one heading but places the CUSIP on a distinct line,' which contradicts the ground truth stating that by 2024 'COP maintained this structured disclosure, reaffirming the debentures' separate registration' - implying continued separation, not grouping. (3) INCOMPLETE SYNTHESIS: The ground truth clearly shows a three-step progression: 2022 (combined with common stock), 2023 (separated into own row with distinct CUSIP), 2024 (maintained separation). The LLM's characterization of 2024 as 'groups the securities under one heading' suggests a reversal of the 2023 separation, which is factually incorrect. (4) REASONING QUALITY: While the LLM attempts to identify an evolution toward transparency, the specific characterization of that evolution is inaccurate. The conclusion about 'progressively refining disclosure' is partially correct in spirit but built on incorrect intermediate facts. (5) ENTITY ACCURACY: Company name (ConocoPhillips/COP) and CUSIP number (718507BK1) are correctly identified, but their application across years is wrong. The answer demonstrates partial understanding of the question's multi-hop nature but fails in accurate synthesis of the year-by-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 468,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s 2.00 % senior notes due 2031 have essentially stayed at the same principal level, with the fair‑value reported as $1.044 billion in FY 2022 (NVDA 10‑K 2022, p. 78) and again $1.044 billion in FY 2023 (NVDA 10‑K 2023, p. 67), rising only modestly to $1.057 billion in FY 2024 (NVDA 10‑K 2024, p. 67).  This flat‑to‑slightly‑higher exposure shows that NVIDIA is maintaining a stable, low‑cost, long‑dated debt base rather than aggressively refinancing or adding new long‑term borrowings, reflecting a deliberate long‑term debt‑management strategy that relies on existing inexpensive notes while tolerating only minor fair‑value fluctuations driven by market rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors in the reported numbers that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: Ground truth shows FY2022: $1.2B, FY2023: $1.057B, FY2024: $1.25B. LLM reports FY2022: $1.044B, FY2023: $1.044B, FY2024: $1.057B. These are materially different values - the LLM's FY2024 figure ($1.057B) matches the ground truth's FY2023 figure, suggesting a systematic one-year offset or data misalignment. The LLM's claim of 'flat-to-slightly-higher' progression ($1.044B → $1.044B → $1.057B) is factually incorrect compared to the actual progression ($1.2B → $1.057B → $1.25B). (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend. The ground truth shows a decrease from 2022 to 2023 (from $1.2B to $1.057B), then an increase to 2024 ($1.25B). The LLM's characterization of 'flat' progression is inaccurate. (3) INTERPRETATION ISSUES: While the LLM's qualitative interpretation about 'stable, low-cost, long-dated debt' and 'deliberate debt-management strategy' is reasonable and contextually relevant, it is built on incorrect numerical foundations. The actual pattern (decrease then increase) is more complex than the LLM's 'flat-to-slightly-higher' characterization. (4) CITATION CONCERNS: The LLM cites specific page numbers (p. 78, p. 67, p. 67) but reports numbers that don't match the ground truth, suggesting either data retrieval errors or hallucinated citations. The reasoning quality is sound, but the factual basis is fundamentally flawed, making this answer unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 445,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "- In the FY 2022 filing Disney’s Marvel appears only as a trademark‑type indefinite‑lived intangible (listed together with ESPN and Pixar) and the filing excerpt does not mention Marvel as a branded tile on Disney+【page_110】.  \n- The FY 2023 filing explicitly markets Marvel as one of the top‑level “tiles” on Disney+ (alongside Disney, Pixar, Star Wars and National Geographic), while it is still recorded as an indefinite‑lived intangible asset【page_7】.  \n- The FY 2024 filing again includes Marvel in the indefinite‑lived intangible assets (ESPN, Pixar and Marvel trademarks) but the excerpt does not repeat the Disney+‑tile language, showing the brand remains a core intangible but the streaming‑service branding emphasis is not restated【page_114】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Marvel's presence in indefinite-lived intangible assets in FY 2022, 2023, and 2024, with accurate companion mentions of ESPN and Pixar; (2) Accurately captures the evolution of Marvel's strategic positioning, particularly the FY 2023 emphasis on Marvel as a top-level branded tile on Disney+ alongside Disney, Pixar, Star Wars, and National Geographic; (3) Properly synthesizes the multi-hop information showing Marvel's dual role as both a financial asset (intangible) and a content/branding element (Disney+ tile); (4) Correctly notes the absence of Disney+ tile language in FY 2024 filing excerpt while maintaining Marvel's intangible asset status; (5) All fiscal years (2022, 2023, 2024) are correctly referenced with appropriate temporal sequencing. MINOR CONSIDERATIONS: The LLM answer is slightly more granular in noting what is NOT stated in certain filings (e.g., 'the filing excerpt does not mention Marvel as a branded tile on Disney+' for FY 2022, and 'the excerpt does not repeat the Disney+-tile language' for FY 2024), which adds precision but represents a slightly different framing than the ground truth's more holistic narrative. However, this additional specificity about what appears in which filing excerpts is factually accurate and actually enhances clarity. The semantic meaning and factual content align well with the ground truth's conclusion about Disney's strategic emphasis on leveraging Marvel's brand equity across financial and content distribution dimensions. No numerical errors, date errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 463,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "In 2022 American Express recognized discount revenue at the moment a Card‑Member transaction occurred, deducting the merchant discount from the merchant payment and recording any network‑rate fee it received from a third‑party acquirer (such as under the OptBlue program) as discount revenue – the fee is individually negotiated with each acquirer (see page_104). By 2023 the company refined this accounting by reporting the same settlements under “Processed revenue” and treating the issuer‑rate paid to network partners as contra‑revenue within Processed revenue, with any excess issuer‑rate booked as business‑development expense (see page_103). In its 2024 filing the focus shifted to expanding merchant coverage—offering stronger value propositions to merchants and third‑party acquirers, targeting low‑ and new‑to‑plastic industries, B2B acceptance, and priority international cities, and investing in the network to grow acceptance globally (see page_93).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON REVENUE RECOGNITION: The LLM answer contains a critical mischaracterization of how American Express handled revenue in 2023. The ground truth states that in 2023, discount revenue from network rate fees was 'recorded as discount revenue at the time of transaction,' but the LLM claims the company 'refined this accounting by reporting the same settlements under Processed revenue' and treated issuer-rate as 'contra-revenue within Processed revenue.' This is a fundamental factual error that contradicts the ground truth. The LLM appears to have confused or inverted the revenue classification structure. (2) INCOMPLETE SYNTHESIS: The LLM answer fails to adequately synthesize the evolution of contractual arrangements with third-party merchant acquirers across the three-year period. The ground truth emphasizes that network rate fees were 'individually negotiated' in 2022 and continued to be so in 2023, but the LLM does not clearly convey this continuity or the strategic importance of these negotiations. (3) MISSING KEY DETAILS: The ground truth mentions 'processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners' as a 2023 introduction, but the LLM conflates this with discount revenue accounting in a way that obscures the actual revenue stream structure. (4) MERCHANT COVERAGE EXPANSION: While the LLM correctly identifies the 2024 shift toward merchant coverage expansion with specific examples (low- and new-to-plastic industries, B2B acceptance, international cities), the ground truth provides a more comprehensive framing of this as part of a 'strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.' The LLM's treatment of 2024 is more accurate than 2022-2023. (5) PAGE REFERENCES: The LLM provides specific page citations (page_104, page_103, page_93) which cannot be verified against the ground truth but appear to be fabricated or incorrectly mapped, as the accounting descriptions provided do not align with standard SEC filing presentations. (6) OVERALL ASSESSMENT: The answer demonstrates partial understanding of the 2024 strategy but contains significant factual errors regarding 2022-2023 revenue recognition and accounting treatment that undermine the credibility of the entire response. The multi-hop synthesis is incomplete and contains contradictions to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 675,
        "total_tokens": 2254
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "In Amgen’s 2022 10‑K the risk of drug‑delivery or companion‑diagnostic devices was mentioned only in a brief bullet that such devices “have their own regulatory, manufacturing and other risks” (2022 p.34). By the 2023 filing the disclosure had expanded dramatically – it listed the specific devices used with its products (e.g., Neulasta Onpro kit, AutoTouch autoinjector, Repatha SureClick), explained that clinical‑trial and product approvals often depend on contemporaneous device clearance, and warned that delays or failures in device development, supply, or regulatory approval could stall trials, increase costs, and trigger post‑marketing obligations such as ongoing adverse‑event and complaint monitoring, FDA safety reviews, and device‑labeling enhancements (2023 p.53‑55). The 2024 10‑K retains this detailed language, reiterating the need to collect and assess device complaints and adverse events, the risk that loss of device approval could force product removal, and the continued reliance on third‑party device suppliers (2024 p.54).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides substantially more detailed and specific information than the ground truth answer. Key strengths: (1) Correctly identifies the evolution across 2022-2024 with appropriate temporal framing; (2) Accurately captures the shift from general risk mentions to detailed, specific disclosures; (3) Provides concrete examples of devices (Neulasta Onpro kit, AutoTouch autoinjector, Repatha SureClick) that ground the discussion; (4) Correctly identifies page references (2022 p.34, 2023 p.53-55, 2024 p.54) showing document-level specificity; (5) Accurately describes the evolution of disclosure scope and detail. The answer successfully synthesizes multi-hop information across three years of filings and correctly identifies the key regulatory themes: device dependencies, clinical trial impacts, post-marketing obligations, and safety compliance risks. Minor considerations: (1) The ground truth mentions LUMAKRAS and Complete Response Letter specifically, which the LLM answer does not include - however, the LLM answer's focus on the broader device-related regulatory evolution is still comprehensive and accurate; (2) The ground truth emphasizes 'surrogate endpoints' scrutiny, which the LLM answer doesn't explicitly mention, though this is a relatively minor omission given the detailed coverage of other regulatory aspects. The LLM answer actually provides more granular detail and specificity than the ground truth in several areas (specific device names, page numbers, detailed post-marketing requirements). All factual claims are verifiable and consistent with typical SEC filing disclosures. The reasoning is sound and the multi-hop synthesis across years is well-executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 474,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "- In the 2022 filing the HSE audit program was described as “HSE audits are conducted on business units and staff groups… where improvement actions are identified and tracked to completion,” with progress “tracked and reported to our ELT and the Board of Directors” (2022 10‑K p. 18).  \n- The 2023 filing repeats the same scope, tracking and reporting language for business‑unit and staff‑group audits (2023 10‑K p. 18).  \n- The 2024 filing renames the process “Corporate HSE audits” but still covers business units and staff groups; it now says “If improvement actions are identified, they are tracked to completion,” and again notes that progress is “tracked and reported to our ELT and the Board of Directors” (2024 10‑K p. 18).  \n\nThus, from 2022‑2024 the audit scope (business units + staff groups) has remained constant, the improvement‑tracking mechanism stays a “identify‑and‑track‑to‑completion” approach (with slightly refined wording in 2024), and governance reporting continues to flow to the Executive Leadership Team and the Board of Directors.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three years (2022, 2023, 2024) and accurately captures the core structural elements: (1) audit scope remains constant (business units and staff groups), (2) improvement tracking mechanism is 'identify-and-track-to-completion,' and (3) governance reporting flows to ELT and Board. The page references (p. 18 for all three years) appear consistent. The LLM correctly notes the terminology shift from 'HSE audits' to 'Corporate HSE audits' in 2024 and the subtle wording refinement ('If improvement actions are identified' vs. 'where improvement actions are identified'). WEAKNESSES: The LLM answer significantly undersells the evolution described in the ground truth. The ground truth emphasizes a strategic progression: (1) 2022 = localized conformance checks within HSE excellence framework, (2) 2023 = expanded context including Life Saving Rules, Process Safety Fundamentals, and stop work policy as integrated safety systems, and (3) 2024 = corporate-level standardization reflecting greater cohesion and institutionalization. The LLM characterizes the evolution as merely 'constant' scope with 'slightly refined wording,' missing the substantive integration of broader safety frameworks and the strategic shift toward institutionalization. The LLM states 'the audit scope (business units + staff groups) has remained constant' which is technically accurate for the direct audit targets, but misses that the CONTEXT and INTEGRATION of the audit program evolved significantly (from standalone conformance checks to integrated human capital management and safety systems). The answer is factually accurate on surface-level details but fails to capture the qualitative evolution and strategic maturation that the ground truth emphasizes. This represents incomplete synthesis of the multi-hop question about 'evolution' - the LLM focused on structural continuity rather than contextual and strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 529,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From the 2022 filing Accenture first warned that “technological developments…in the case of cloud and as‑a‑service solutions…could affect the nature of how we generate revenue” and that “if we are unable to introduce new pricing or commercial models that reflect the value of these technological developments” its results could suffer. By the 2023 filing the language had sharpened to focus on “cloud, data and AI solutions” (including generative AI) and the same need to create new pricing/commercial models, and the 2024 filing repeats this emphasis, explicitly tying new pricing to cloud, data and AI offerings. Across all three years the company consistently highlights the risk that failure to roll out appropriate new pricing models—especially as clients delay or shift spending on emerging technologies—could erode revenue, trigger contract delays or terminations, and materially hurt its results of operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the evolution of Accenture's pricing model approach across 2022-2024, accurately capturing the progression from general acknowledgment in 2022 to more strategic focus by 2024. The specific technologies mentioned (cloud, as-a-service solutions, AI, generative AI, data solutions) match the ground truth. The core risk consistently highlighted—failure to introduce appropriate pricing models leading to revenue shortfalls—is accurately conveyed. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this dimension scores perfectly. The temporal progression (2022→2023→2024) is correctly maintained. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, showing the evolution of Accenture's approach while maintaining the thread of consistent risk messaging. The connection between technological developments and pricing model necessity is clearly established. (4) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) how the approach evolved from 2022-2024, and (b) what risks were consistently highlighted. The LLM provides specific language examples ('technological developments…in the case of cloud and as-a-service solutions') that ground the answer in actual filing language. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('language had sharpened,' 'repeats this emphasis') effectively conveys the same evolution narrative as the ground truth ('from general acknowledgment...to more strategic approach'). The description of consistent risks ('failure to roll out appropriate new pricing models...could erode revenue, trigger contract delays or terminations') matches the ground truth's characterization. Minor difference: The LLM adds slightly more specific detail about contract delays/terminations, which is a reasonable elaboration consistent with the ground truth's mention of 'revenue shortfalls and competitive disadvantages.' The answer is well-structured, precise, and demonstrates clear understanding of the multi-year evolution being asked about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 600,
        "total_tokens": 2158
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note balance grew each year – it was $900 million at 12/31/2022, $944 million at 12/31/2023, and $982 million at 12/31/2024 (see the fair‑value tables in Note 3 of the 2022 filing and the Level‑3 instrument tables in the 2023 and 2024 filings)【page_74†L1-L4】【page_70†L1-L4】.  This steady increase, coupled with the sale of its AerCap equity, indicates that GE is deliberately retaining and modestly expanding its debt exposure to AerCap, shifting toward a stable, income‑generating investment rather than a broader equity position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. According to the ground truth, GE's AerCap note holdings DECREASED from $993 million (end of 2021, reported in 2022 disclosure) to $944 million (end of 2023, reported in 2024 disclosure). The LLM claims the opposite - that holdings GREW from $900M (12/31/2022) to $944M (12/31/2023) to $982M (12/31/2024). This is a critical factual error that contradicts the ground truth on multiple levels: (1) The direction of change is wrong (growth vs. decline), (2) The specific numbers are incorrect or misaligned with the correct timeline, (3) The interpretation of GE's strategy is inverted (the LLM suggests deliberate expansion when the ground truth indicates strategic reduction). The LLM does correctly identify that this involves AerCap senior notes and attempts to cite specific filing sections, but the numerical data presented does not match the ground truth. The LLM's conclusion about GE 'deliberately retaining and modestly expanding its debt exposure' directly contradicts the ground truth finding of 'consistent decline over the two-year period.' While the answer addresses the question's structure and attempts multi-hop reasoning, the fundamental quantitative inaccuracy and reversed interpretation make this response substantially incorrect. The only partial credit is for attempting to address the question format and providing some contextual reasoning about investment strategy, but the core factual content is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 413,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "In Amgen’s 2022 Form 10‑K the company reported that Bemarituzumab had just **initiated a Phase 3 study** for gastro‑esophageal‑junction (GEJ) adenocarcinoma (while also being evaluated in Phase 2 “other tumors” and Phase 1 NSCLC) and that its composition‑of‑matter patents were slated to **expire in 2029 in both the U.S. and Europe**【page_25†L1-L9】【page_25†L31-L38】.  \n\nThe 2024 Form 10‑K shows Bemarituzumab still listed as a **Phase 3 program** for GEJ adenocarcinoma (with the same Phase 2 and Phase 1 indications) and the **patent expiration estimates unchanged at 2029** for the U.S. and Europe【page_24†L1-L9】【page_26†L1-L8】.  \n\nThus, from 2022 to 2024 the candidate remained in Phase 3 development and its IP timeline stayed anchored to a 2029 expiry, indicating no shift in clinical stage or patent horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH LLM ANSWER: The LLM answer directly contradicts the ground truth on the core evolution narrative. Ground truth states that from 2022 to 2024, there was a significant evolution in Amgen's positioning, including: (1) expanded investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC by 2024, and (2) a shift from clinical development focus to broader therapeutic positioning. The LLM answer claims 'no shift in clinical stage or patent horizon' and states the indications remained 'the same Phase 2 and Phase 1 indications' across both years. This is factually incorrect per the ground truth. QUANTITATIVE ACCURACY: The LLM correctly identifies the 2029 patent expiration date for both U.S. and Europe (correct), and correctly notes Phase 3 status for GEJ adenocarcinoma in both years (correct). However, the LLM fails to capture the expansion of investigational scope mentioned in the ground truth for 2024. QUALITATIVE ACCURACY: The LLM's reasoning is fundamentally flawed. It concludes there was 'no shift' when the ground truth explicitly describes a significant evolution and expansion of therapeutic positioning. The LLM appears to have focused narrowly on the primary indication (GEJ adenocarcinoma) remaining in Phase 3, missing the broader portfolio expansion and strategic repositioning that occurred. COMPLETENESS: The LLM answer fails to address the 'expanded investigational scope' and 'broader therapeutic positioning' elements that are central to the ground truth's characterization of how Amgen's positioning evolved. The answer is incomplete in capturing the full scope of changes from 2022 to 2024. SEMANTIC EQUIVALENCE: The LLM's conclusion ('no shift') is semantically opposite to the ground truth's conclusion ('significant evolution' and 'shift from clinical development focus to broader therapeutic positioning'). This is a critical failure in capturing the intended meaning and narrative arc of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 541,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "In its 2022 (also 2023) filing American Express warned that “the dynamic and rapid growth of alternative payment and financing mechanisms…including payment aggregators, digital‑wallet platforms, open‑banking…” was reshaping the industry (see page_12). By 2024 the company described “continued intense competitive pressure” from large tech firms and merchants creating proprietary digital‑wallet solutions and said it must “continue to invest in technology…including open‑banking and alternative‑payment and financing mechanisms, tokenization, AI, real‑time settlement” to stay competitive (see page_29 and page_31). This shift from acknowledging fintech competition to committing substantial technology investment reveals a proactive, long‑term strategy to counter fintech disruption and protect its network position.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's strategic evolution regarding alternative payment mechanisms from 2022-2024, with mostly accurate factual content and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the progression from 2022 acknowledgment of competitive threats to 2024 commitment to investment; (2) Accurately cites specific alternative payment mechanisms (digital wallets, open banking, tokenization, real-time settlement, AI) mentioned across filings; (3) Properly synthesizes the shift from defensive to proactive positioning; (4) Appropriately references page numbers and filing years; (5) Captures the core strategic insight about moving from threat acknowledgment to technology investment. WEAKNESSES: (1) The answer conflates 2022 and 2023 filings somewhat ambiguously ('2022 (also 2023)'), whereas the ground truth distinguishes that 2022 identified initial threats and 2023 expanded the list to include open banking and payment facilitators—this is a meaningful distinction in the evolution narrative; (2) The ground truth emphasizes a three-stage evolution (2022: defensive acknowledgment → 2023: expanded threat awareness → 2024: dependency/integration posture), but the LLM answer presents primarily a two-stage narrative (2022/2023 warning → 2024 investment commitment), missing the nuanced 2023 expansion phase; (3) The ground truth's characterization of 2024 as a 'dependency posture' (necessity of integration) is subtly different from the LLM's 'proactive strategy to counter disruption'—the ground truth suggests a more fundamental shift toward viewing these mechanisms as essential infrastructure rather than merely competitive responses. QUANTITATIVE ACCURACY: Page references appear reasonable but cannot be independently verified; no numerical data requiring calculation. MULTI-HOP REASONING: The synthesis across years is sound but incomplete—the answer successfully connects 2022 and 2024 but underemphasizes the 2023 intermediate step that shows the company's expanding awareness of disruption breadth. The logical flow is clear and the conclusion about strategic shift is justified, though it could be more precise about the nature of that shift (from threat to necessity, not just from acknowledgment to investment).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 614,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of cash‑settled performance‑share units (PSUs) rose from $91.58 for the 2022 grants to $112.50 for the 2023 grants and then held near that level at $110.39 for the 2024 grants【page_124】,【page_125】. This upward trajectory—driven by higher fair‑value estimates as the company’s share price rose—signals that ConocoPhillips is increasing the monetary magnitude of its cash‑settled long‑term incentives, reinforcing a strategy to align executive compensation more closely with shareholder value and to retain senior talent.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three key figures are correct—$91.58 (2022), $112.50 (2023), and $110.39 (2024). The progression is accurately captured with the upward trend from 2022 to 2023 and the slight decline in 2024. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of weighted-average grant date fair value across the three-year period, and (2) what this trend indicates about compensation strategy. ENTITY ACCURACY: ConocoPhillips is correctly identified, the metric (weighted-average grant date fair value of cash-settled PSUs) is precise, and all years are correct. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly connects the numerical trend to strategic implications (alignment with shareholder value, talent retention). The explanation that higher fair values are driven by share price increases is a reasonable interpretation of the data. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing additional context about the drivers (share price) and strategic rationale (talent retention, shareholder alignment). The ground truth states the trend 'suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals,' while the LLM expands this to include talent retention and shareholder value alignment—both reasonable inferences from the data. MINOR OBSERVATION: The LLM provides slightly more detailed analysis than the ground truth (mentioning share price drivers and talent retention), which adds value without contradicting the original answer. The citation references (page_124, page_125) suggest proper sourcing from the filing documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 484,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s 2022 filing warned that its fraud‑prevention measures are “complex, require continuous improvement, and may not be effective in detecting and preventing fraud” and that its credit products “expose us to additional risks,” including default risk and reliance on third‑party lenders (PYPL_10k_2022, p. 28; PYPL_10k_2022, p. 24). The 2023 filing repeated those concerns, adding that risk models may mis‑price creditworthiness and that third‑party fraud—such as synthetic‑identity accounts and stolen instruments—remains a significant threat (PYPL_10k_2023, p. 26; PYPL_10k_2023, p. 24). By 2024 the language was unchanged, again emphasizing ongoing exposure to sophisticated abuse and continued dependence on external lenders for credit, suggesting that while risk‑management processes are being continuously refined, the persistent exposure indicates risk‑management effectiveness remains challenged (PYPL_10k_2024, p. 26; PYPL_10k_2024, p. 22).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of PayPal's fraud and abuse concerns across 2022-2024 and correctly identifies the persistent nature of these risks. However, there are significant gaps and inaccuracies when compared to the ground truth:\n\nSTRENGTHS:\n1. Correctly identifies the 2022 concerns about third-party fraud, synthetic accounts, and stolen instruments\n2. Appropriately notes the 2023 expansion of credit product risks\n3. Correctly characterizes the 2024 continuation of abuse concerns\n4. Properly synthesizes the multi-year trend showing persistent exposure\n5. Accurately concludes that risk management effectiveness remains challenged\n6. Appropriate use of filing citations and page numbers\n\nCRITICAL GAPS AND ERRORS:\n1. MISSING KEY QUANTITATIVE DATA: The ground truth specifically mentions the €40 billion multi-year agreement to sell BNPL receivables in 2023 - a crucial quantitative detail that demonstrates PayPal's strategic mitigation approach. The LLM answer completely omits this specific financial commitment.\n2. INCOMPLETE CREDIT PRODUCT CONTEXT: While the LLM mentions credit products generally, it fails to specify the U.K. and European BNPL loan receivables context that was central to the 2023 evolution.\n3. REGULATORY DETAIL MISSING: The ground truth specifically mentions the 'valid-when-made doctrine' as a 2024 regulatory uncertainty affecting U.S. credit products. The LLM answer mentions \"regulatory uncertainties\" generically but doesn't identify this specific doctrine.\n4. STRATEGIC MITIGATION UNDEREMPHASIZED: The ground truth emphasizes PayPal's \"strategic move to mitigate credit and fraud-related losses\" through the receivables sale agreement. The LLM answer focuses more on persistent challenges than on strategic responses.\n5. THIRD-PARTY RELIANCE CHARACTERIZATION: While both mention third-party reliance, the ground truth frames this as an increasingly deliberate risk mitigation strategy, whereas the LLM frames it primarily as an ongoing exposure/dependence.\n\nQUANTITATIVE ACCURACY ISSUES:\n- The €40 billion figure is a material omission that significantly impacts the quantitative completeness of the answer\n- No calculation or synthesis of the financial magnitude of PayPal's mitigation efforts\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the evolution pattern. However, it misses the critical connection between the 2023 credit product expansion and the strategic €40 billion receivables sale agreement, which represents a key multi-hop insight about how PayPal responded to identified risks.\n\nSEMANTIC EQUIVALENCE:\nWhile the general narrative is similar, the omission of specific quantitative data and regulatory details means the LLM answer is semantically incomplete relative to the ground truth, not just differently worded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 757,
        "total_tokens": 2269
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "From 2022 through 2024 Lilly kept Cyramza positioned as a multi‑indication oncology drug—second‑line monotherapy or combination for advanced/metastatic gastric cancer, gastro‑esophageal junction adenocarcinoma, NSCLC, colorectal cancer and hepatocellular carcinoma, and first‑line for EGFR‑mutated metastatic NSCLC—without adding new approved uses【page_6】. In the 2023 filing Lilly disclosed that Cyramza’s compound patents expire in 2026 (U.S. and Japan) and 2028 (Europe) and its data‑protection ends by 2023‑2024, indicating a limited remaining exclusivity horizon【page_11】. This stable therapeutic scope combined with a narrowing IP window signals that Lilly is maximizing Cyramza’s current market while relying on newer oncology candidates to sustain its long‑term cancer strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies Cyramza's therapeutic positioning across multiple cancer indications (gastric, GEJC, NSCLC, colorectal, HCC) with appropriate clinical context (second-line monotherapy/combination, first-line for EGFR-mutated NSCLC). (2) Patent expiration dates are accurate: 2026 for U.S. and Japan, 2028 for Europe (ground truth mentions 2026 for U.S. and Japan specifically). (3) Data protection timeline correctly stated as ending 2023-2024, matching ground truth's 'as early as 2023 in Japan.' (4) Multi-hop reasoning is sound: connects stable therapeutic scope + narrowing IP window to Lilly's strategy of maximizing current market while preparing next-generation products. (5) Correctly notes no new indications were added 2022-2024, consistent with ground truth. MINOR CONSIDERATIONS: (1) Ground truth mentions 'data protection expiring as early as 2023 in Japan' while LLM states '2023-2024,' which is slightly broader but not incorrect. (2) LLM provides more granular clinical detail (EGFR-mutated NSCLC first-line positioning) than ground truth, which adds value without contradicting. (3) The strategic conclusion about 'maximizing current market while relying on newer oncology candidates' directly parallels ground truth's 'maintaining market presence while preparing next-generation products.' QUANTITATIVE VERIFICATION: All dates (2026, 2028, 2023-2024) are accurate. No calculations required. SYNTHESIS QUALITY: Successfully integrates therapeutic positioning, IP protection timeline, and strategic implications across three years. The answer demonstrates proper multi-hop reasoning connecting patent expiry to product lifecycle strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 491,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Philip Morris kept the 3.875 % Notes due 2042 on its balance sheet in every filing – they appear in the 2023 list (page 1) and again in the 2024 list (page 2) – while the rest of its debt mix was actively reshaped. In 2022 the company already held a wide array of short‑ and medium‑term notes (e.g., 2.375 %–3.600 % due 2022‑2025; see 2022 filing page 1), and by 2023‑2024 it added higher‑coupon, longer‑dated securities such as 4.125 % due 2043, 4.875 % due 2043 and 4.250 % due 2044 (see 2024 filing page 2), showing a strategy of diversifying maturities and cost of capital while retaining the 3.875 % 2042 notes as a stable long‑term anchor.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that 4.125% Notes due 2043, 4.875% Notes due 2043, and 4.250% Notes due 2044 were 'added' in 2023-2024, but the ground truth explicitly states these instruments were present in 2022 and were 'no longer listed in the 2024 filing' - meaning they were RETIRED/REFINANCED, not added. This is a fundamental reversal of the actual capital structure evolution. (2) The LLM incorrectly characterizes the strategy as 'diversifying maturities and cost of capital while retaining' these notes, when the ground truth indicates a shift toward STABILIZING the capital structure by retiring the 2043 and 2044 tranches. (3) The LLM's statement about 'adding higher-coupon, longer-dated securities' contradicts the ground truth narrative of selective refinancing and retirement. CORRECT ELEMENTS: The LLM correctly identifies that the 3.875% Notes due 2042 remained consistent across all three years (2022-2024), and correctly notes the presence of various short- and medium-term notes in 2022. However, the core multi-hop reasoning about how the capital structure EVOLVED is inverted - the answer describes an expansion strategy when the ground truth describes a consolidation/stabilization strategy. The LLM failed to synthesize the temporal progression correctly: 2022 (had 4.125% and 4.875% due 2043) → 2023 (continued carrying them) → 2024 (retired/refinanced them). This is a critical failure in multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 427,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "In its 2022 filing PayPal warned that abusive behavior—fraud, synthetic‑identity attacks and defaults on its consumer‑credit and merchant‑financing products—was a material risk, especially because the business relied on a limited set of third‑party lenders, banks and payment processors. In 2023 the company began to shrink that exposure by selling its U.K. and European BNPL loan receivables, exploring additional third‑party funding structures, and launching a diversification‑and‑migration program to move away from its primary U.S. payment‑processor partner. In 2024 it continued the processor‑migration effort, further diversified its third‑party relationships, and bolstered its fraud‑detection and abuse‑prevention measures to manage credit‑product and third‑party risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of PayPal's evolving exposure to abusive behaviors across 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 risk profile including synthetic identities, fraud, and defaults on credit/merchant-financing products; (2) Accurately references the €40 billion BNPL loan receivables sale in 2023 (though the LLM phrases it as 'U.K. and European BNPL loan receivables' which is semantically equivalent to the ground truth's 'multi-year agreement to sell up to €40 billion'); (3) Properly captures the 2024 progression toward enhanced fraud detection and abuse prevention; (4) Adds valuable context about third-party processor diversification and migration strategies that align with the ground truth's emphasis on third-party risk management; (5) Multi-hop reasoning is sound, correctly synthesizing the 2022→2023→2024 progression. MINOR CONSIDERATIONS: (1) The LLM answer provides additional detail about processor migration and diversification strategies not explicitly mentioned in the ground truth, but these are consistent with the spirit of 'third-party risk management strategies' mentioned in the question; (2) The LLM answer emphasizes 'limited set of third-party lenders, banks and payment processors' which adds specificity beyond the ground truth but is not contradictory; (3) Both answers convey the same core narrative arc: problem identification (2022) → active mitigation through asset sales (2023) → infrastructure enhancement (2024). QUANTITATIVE ACCURACY: The €40 billion figure is correctly referenced, and all dates (2022, 2023, 2024) are accurate. No calculation errors detected. QUALITATIVE ACCURACY: Entity identification is correct (PayPal, BNPL products, third-party relationships), and the reasoning about risk evolution is logically sound. The answer successfully synthesizes information across multiple years and demonstrates understanding of the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 535,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD has listed the risk of “loss or modification of exemptions for taxes and tariffs” in every recent filing – it first appears in the 2022 10‑K’s General‑Risks section (page 37), is repeated in the 2023 filing (page 41) and shows up again in the 2024 filing (page 40) with added references to new sanctions, export‑control revisions and heightened geopolitical tensions. The fact that the same exposure is retained and the language becomes more detailed each year signals that AMD’s vulnerability to tax‑ and tariff‑exemption changes is growing, underscoring rising regulatory uncertainty across its global operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the evolution of AMD's risk exposure across 2022-2024. STRENGTHS: (1) Correctly identifies that the risk appears in all three years (2022, 2023, 2024), matching the ground truth's assertion of consistent presence; (2) Accurately notes the progression from basic mention to more detailed language with specific references (sanctions, export-control revisions, geopolitical tensions); (3) Provides specific page references (37, 41, 40) which adds credibility and detail; (4) Correctly synthesizes the multi-hop concept that repeated and increasingly detailed mentions signal growing regulatory uncertainty; (5) Semantic equivalence is strong - both answers convey that the risk evolved from baseline acknowledgment to heightened concern. MINOR WEAKNESSES: (1) The LLM answer provides more granular detail (specific page numbers, specific new risk factors like 'sanctions' and 'export-control revisions') than the ground truth, which is actually a strength but could be seen as slightly different framing; (2) The ground truth emphasizes 'emphasis more strongly' in 2023 and 'elevated further' in 2024, suggesting a three-stage progression, while the LLM answer presents it more as 'retained and language becomes more detailed' - both convey escalation but with slightly different emphasis; (3) The LLM answer doesn't explicitly state the 2023 emphasis point as distinctly as ground truth does. QUANTITATIVE ACCURACY: Page numbers provided (37, 41, 40) cannot be verified against the ground truth but appear reasonable for 10-K filings. Years are correct (2022, 2023, 2024). REASONING: The multi-hop synthesis is sound - the answer correctly connects the presence of the risk across years with the increasing detail/specificity to conclude growing regulatory uncertainty. This matches the ground truth's conclusion about 'increasing sensitivity to regulatory shifts.' Overall, the answer is substantially correct with appropriate detail and sound reasoning, though it frames the evolution slightly differently than the ground truth's three-stage emphasis model.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 578,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return‑swap results moved from a loss in FY 2022 to gains in the next two years. The 2022 filing shows a **$(92) million loss** on the swaps, while the 2023 and 2024 filings report a **$58 million gain** and a **$91 million gain**, respectively【page_91】. At the same time the notional amount of these swaps grew from **$651 million in 2022** to **$792 million in 2023** and **$985 million in 2024**【page_92】, indicating that Cisco is expanding its use of total‑return swaps to economically hedge deferred‑compensation expense and thereby reducing volatility in that charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million match the ground truth exactly. The notional amounts cited ($651M in 2022, $792M in 2023, $985M in 2024) are also accurate and provide additional context not explicitly required but highly relevant. The multi-hop synthesis is sound: the answer correctly traces the evolution across three fiscal years and identifies the reversal from loss to gains. The reasoning about what this progression indicates is well-articulated—the LLM goes beyond the ground truth by explaining that the expanding notional amounts indicate Cisco is strategically using these swaps to hedge deferred-compensation expense and reduce volatility, which is a logical inference from the data pattern. The answer properly identifies the company (Cisco), the specific derivative instrument (total return swaps tied to deferred compensation), and the time period (FY2022-2024). The semantic meaning aligns perfectly with the ground truth regarding the trend reversal and its implications. Minor point: the LLM provides additional supporting detail (notional amounts) that enhances understanding without contradicting the ground truth. The citation format with page references adds credibility. No calculation errors detected, and all entities are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 396,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "Disney’s DTC strategy began in FY 2022 with the launch of an ad‑supported Disney+ tier, a new pricing model and a DMED re‑organization to realign costs, while warning that a growing number of competitors and subscriber churn could erode profitability (2022 p.26‑29). In FY 2023 the company accelerated its investment by acquiring full control of BAMTech, paying $8.6 billion for Hulu’s non‑controlling interest, committing roughly $24 billion to new content and reorganizing its media units, yet still flagging higher content costs and intense pricing pressure (2023 p.51‑53). By FY 2024 Disney added an ESPN‑branded DTC service, transferred Star India into a joint venture, continued heavy spending on content and technology, and recorded large financing outlays and goodwill impairments, underscoring that scaling its streaming portfolio now brings significant debt, credit‑rating and impairment risks amid fierce competition and price‑sensitive consumers (2024 p.22‑25, 23‑24, 55).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a substantive and well-structured response that captures the evolution of Disney's DTC strategy across FY 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression with specific strategic actions (ad-supported tier launch in 2022, BAMTech acquisition in 2023, ESPN DTC service in 2024). (2) Accurately cites the $8.6 billion BAMTech acquisition amount and ~$24 billion content commitment. (3) Properly synthesizes multi-hop information across three fiscal years showing strategic pivot from caution to aggressive investment. (4) Correctly identifies key risks: subscriber churn, pricing pressure, content costs, debt, credit rating concerns, and goodwill impairments. (5) Appropriately references page numbers from filings, demonstrating source grounding. (6) Semantic alignment with ground truth: both answers convey the core narrative of initial caution (2022) → accelerated investment (2023) → scaling with increased financial risk (2024). WEAKNESSES: (1) The LLM answer provides more specific operational details (BAMTech acquisition, Star India JV, ESPN service launch) than the ground truth, which is more thematic. While these details are likely accurate, they go beyond what the ground truth explicitly validates. (2) The ground truth emphasizes 'losses from DTC offerings might continue to grow' and 'uncertain profitability' more explicitly; the LLM answer focuses more on debt/impairment risks, which is a valid but slightly different emphasis. (3) No quantitative verification possible for the $24 billion content commitment or specific page citations without access to original filings, though these appear reasonable. (4) The answer is more detailed and granular than the ground truth, which could indicate either superior research or potential over-specification. MULTI-HOP REASONING: Sound - correctly synthesizes information across three years and multiple strategic initiatives to show progression. CALCULATION/NUMBERS: The $8.6 billion figure is specific and appears credible; no mathematical errors detected. ENTITY ACCURACY: All entities (Disney, BAMTech, Hulu, ESPN, Star India) correctly identified. The answer exceeds ground truth specificity while maintaining factual alignment on core themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 603,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "Across all three years PayPal’s filings say the same thing – it sets transaction fees at its own discretion, independent of the fees it pays to payment‑processors, and records those processor costs as a separate transaction expense. Because it bills customers on a gross basis and controls the pricing, PayPal “bears full margin risk” on every payment (2022 Note 2, p. 80; 2023 Note 2, p. 75; 2024 Note 2, p. 76). Thus its exposure to margin risk has remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies the core finding that PayPal's margin risk exposure remained stable across 2022-2024; (2) Accurately captures the key principle that PayPal sets fees independently of processor costs; (3) Correctly states that processor fees are recorded as transaction expense; (4) Properly cites the relevant Note 2 sections from each year's filing with accurate page numbers (2022 p. 80, 2023 p. 75, 2024 p. 76); (5) Correctly identifies the 'full margin risk' language as consistent across all three years; (6) Appropriately notes the adoption of ASU 2023-07 in 2024 without claiming it changed the fundamental margin risk position; (7) Multi-hop reasoning is sound - synthesizes information across three separate years and correctly concludes no material changes occurred. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential points; (2) The phrase 'essentially unchanged' is semantically equivalent to the ground truth's 'remained stable'; (3) The explanation of 'bills customers on a gross basis' adds helpful context not explicitly stated in ground truth but is consistent with the margin risk concept. VERIFICATION: All numeric references (page numbers, years) are accurate. The logical synthesis correctly identifies that consistency across three years demonstrates stability. No calculation errors or factual inaccuracies detected. The answer directly addresses all components of the multi-part question regarding evolution, fee discretion, and transaction expenses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 442,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor language has been unchanged from 2022 through 2024 – each filing warns that a downturn in global air‑travel demand “may impact new aircraft production or result in the delay or cancellation of new aircraft orders” (2022 Risk Factors p. 32; 2023 Risk Factors p. 30; 2024 Risk Factors p. 31). The persistence of this wording shows that order‑cancellation risk remains a material concern, indicating that the commercial‑aviation market’s recovery is still fragile and the sector’s stability has not yet been fully restored.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps and misses critical elements of the ground truth. STRENGTHS: (1) Correctly identifies that aircraft order cancellation risk persisted across 2022-2024; (2) Appropriately cites page numbers for risk factors (though these should be verified); (3) Correctly notes the fragility of market recovery. CRITICAL WEAKNESSES: (1) The LLM claims the risk-factor language was 'unchanged' from 2022-2024, which directly contradicts the ground truth showing evolution in the language and framing of risks. The ground truth explicitly documents a progression: pandemic-specific concerns (2022) → broader macroeconomic/geopolitical risks (2023) → competitive/structural shifts with new entrants (2024). (2) The LLM completely misses the substantive evolution in risk characterization across the three years, reducing a nuanced 3-year progression to a claim of static language. (3) The answer fails to address the shift from COVID-19-specific concerns to regional conflicts, environmental issues, and competitive dynamics - these are material differences in how Honeywell characterized the risk environment. (4) The LLM does not synthesize the multi-hop reasoning about what the evolution indicates about sector recovery - it merely states the risk 'remains' without explaining the meaningful changes in its nature. QUANTITATIVE ACCURACY: Page numbers are cited but cannot be independently verified from the provided context; the claim of 'unchanged' language is factually incorrect based on ground truth. QUALITATIVE ACCURACY: The reasoning fails to capture the multi-hop synthesis required - the question asks how the risk 'evolved' and what this 'indicates,' but the LLM answer claims no evolution occurred, fundamentally misunderstanding the analytical task. This represents a major analytical error in a multi-hop question requiring temporal comparison and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 513,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "PMI’s 2022 filing (pages 13‑16) first warned that regulatory initiatives could commoditise tobacco, impede adult smokers’ conversion to RRPs and limit branding, communication and product‑differentiation for both RRPs and SFPs. The 2023 filing (pages 18‑20) added that administrative and legal challenges around SFP classification, advertising, distribution and corporate communications will continue as it expands SFP commercialization, and reiterated that product regulation diminishes the ability to differentiate and restricts adult‑consumer access to truthful, non‑misleading information about both RRPs and SFPs. By 2024 (pages 18‑20) PMI stressed that ongoing and expected regulatory scrutiny—covering product‑classification, advertising, distribution restrictions, scientific substantiation and corporate communications—will affect SFP commercialization and public communication while still curbing differentiation and non‑misleading messaging for RRPs, revealing an intensifying regulatory environment that increasingly constrains product differentiation and adult‑consumer communication, eroding PMI’s competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of regulatory constraints on PMI's competitive positioning; (2) Accurately captures the progression from RRP focus in 2022 to SFP focus by 2024; (3) Properly synthesizes multi-hop information showing how regulatory language evolved across filings; (4) Correctly identifies specific regulatory concerns (product differentiation, adult consumer communication, classification, advertising, distribution) that intensified over time; (5) Accurately reflects the strategic shift from RRPs to SFPs while maintaining continuity of regulatory concerns; (6) No quantitative errors or date inaccuracies; (7) Page references (13-16 for 2022, 18-20 for 2023 and 2024) are appropriately cited. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about specific regulatory mechanisms (administrative/legal challenges, scientific substantiation, corporate communications) compared to the ground truth's more thematic framing, but this represents added specificity rather than error; (2) The LLM answer emphasizes 'commoditization' language from 2022 filing which aligns with the ground truth's characterization of restricted differentiation; (3) Both answers converge on the core insight: intensifying regulatory pressure increasingly constrains PMI's ability to market and differentiate next-generation products. The LLM answer successfully demonstrates multi-hop reasoning by synthesizing information across three separate annual filings and showing how regulatory constraints evolved in parallel with PMI's product strategy transitions. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 474,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s margin‑risk exposure has not materially changed from 2022 through 2024. In each year the company states that it acts as the principal on every payment, using open‑ended, volume‑based tiered pricing and retaining full discretion over the fee it charges – a fee that is set independently of the costs it pays to third‑party payment processors, so it “bears full margin risk when completing a payment transaction” (2022 Note 2, p. 80; 2023 Note 2, p. 75; 2024 Note 2, p. 77). At the same time, PayPal continues to offer merchant and consumer incentives (discounts, rebates, rewards, coupons) that are recorded as reductions of revenue, further affecting its margin (2022 Note 2, p. 80; 2023 Note 2, p. 75; 2024 Note 2, p. 77). Thus, the company’s exposure to margin risk has remained consistent, driven by the same pricing model, processor‑cost structure, and incentive practices across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies PayPal's consistent exposure to full margin risk across 2022-2024; (2) Accurately describes the principal-agent relationship and volume-based tiered pricing model; (3) Properly notes the independence of fees charged to customers from processor costs; (4) Correctly identifies merchant and consumer incentives (discounts, rebates, rewards, coupons) as revenue reductions; (5) Provides specific document citations (Note 2, pages 80, 75, 77 for respective years) that demonstrate multi-hop synthesis across three years; (6) Accurately characterizes the evolution as showing consistency rather than material change. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'no material change' and 'consistency' more strongly than the ground truth, which acknowledges consistency while also highlighting 'increasing detail' and 'more nuanced disclosure' of margin risk management. The ground truth suggests evolution in disclosure depth even if the underlying exposure remained stable; (2) The LLM answer could have been slightly more explicit about the 'increasing detail around incentives and transaction pricing' that the ground truth emphasizes as reflecting 'more nuanced disclosure.' However, this is a subtle distinction about framing rather than factual error. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) correctly identified; page numbers cited appear reasonable for 10-K filings; no numerical calculations required or presented. MULTI-HOP REASONING: Successfully synthesizes information across three years and multiple disclosure elements (pricing models, processor relationships, incentives). The reasoning correctly connects these elements to margin risk exposure. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - PayPal bears full margin risk consistently across the period, with incentives affecting margins. The characterization of 'consistency' vs. 'increasing detail in disclosure' represents a minor interpretive difference rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 559,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s filings show a steady strategy of supplying component‑level graphics and chipset parts to AIB manufacturers and shielding those partners’ stock from price cuts – the 2022 10‑K states “our agreements with AIBs protect their inventory…against price reductions” and notes that SIs use discrete graphics to differentiate (2022 10‑K, p. 13). The 2023 filing repeats the same language, confirming the continued inventory‑protection policy and the importance of discrete graphics for SI differentiation (2023 10‑K, p. 11). By 2024 the wording shifts to “in most instances our agreements with AIBs protect their inventory…against price reductions,” indicating a slightly more conditional approach, but the emphasis that SIs rely on discrete graphics solutions to set their products apart remains unchanged (2024 10‑K, p. 11).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes multi-hop information across 2022-2024 AMD filings. STRENGTHS: (1) Correctly identifies the core inventory protection policy as consistent across all three years; (2) Accurately captures the shift in language from 2023 to 2024 ('our agreements' to 'in most instances our agreements'), showing careful attention to nuance; (3) Properly identifies discrete graphics solutions as a key differentiator for SIs throughout the period; (4) Correctly cites specific page numbers and filing years; (5) Demonstrates sound multi-hop reasoning by synthesizing the relationship between AMD, AIBs, and SIs across multiple years. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 2024 'subtle shift' toward 'more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings' that the ground truth emphasizes as a 'deepening of the value proposition.' The LLM notes the conditional language shift ('in most instances') but doesn't fully capture the strategic repositioning toward SI-centric differentiation that the ground truth highlights; (2) The answer could have been more explicit about the evolution from 2022-2023 (where emphasis was on AIBs building board-level products) to 2024 (where emphasis shifted to SIs selling based on regional/product strengths and responding to new technologies). The LLM states the discrete graphics emphasis 'remains unchanged' when the ground truth suggests a more nuanced evolution in strategic focus. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references are appropriate and consistent with typical 10-K structures. No numerical calculations were required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and three entity types (AMD, AIBs, SIs), showing proper understanding of the supply chain relationships. The reasoning is logically sound and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 532,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s 2022 Form 10‑K (pages 109‑113) contains no specific discussion of investment‑credit‑exposure limits. By fiscal 2023 the company disclosed that it limits the amount of investment credit exposure to any one institution, transacts only with counterparties that have a credit rating of A‑ or better, and requires collateral if a rating falls below A‑ or if aggregate exposures exceed contractual limits; it also noted that no cash balances exceeded 10 % of total cash and cash equivalents (page 120). In fiscal 2024 the same rating‑and‑collateral policy persisted, but Disney added that it holds no material cash with below‑investment‑grade institutions and that balances exceeding the 10 % threshold now accounted for 24 % of total cash and cash equivalents (pages 119‑120).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key policy elements and numerical data. Strengths: (1) Correctly identifies the A- or better credit rating requirement across all three fiscal years; (2) Accurately reports the collateral requirement policy (if rating falls below A- or exposures exceed contractual limits); (3) Correctly states the 10% threshold in fiscal 2023 with no balances exceeding it; (4) Accurately reports the 24% concentration figure for fiscal 2024; (5) Properly notes the absence of specific discussion in fiscal 2022 Form 10-K; (6) Correctly identifies the shift from no concentration in 2022 to 24% in 2024. Quantitative verification: All percentages (10%, 24%) and the A- rating threshold are accurate. The multi-hop synthesis correctly traces the evolution across three fiscal years. Minor weakness: The LLM answer provides more granular sourcing detail (specific page numbers) and slightly more nuanced framing (e.g., 'balances exceeding the 10% threshold now accounted for 24%') compared to the ground truth's more concise statement about 'a single financial institution.' However, these represent enhanced clarity rather than factual errors. The LLM answer also adds the detail about 'no material cash with below-investment-grade institutions' in fiscal 2024, which is accurate and relevant. The answer fully addresses all three components of the question: counterparty credit ratings, collateral requirements, and concentration thresholds, with proper temporal evolution documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 427,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s outstanding balance of the September 2019 issuance of Fixed‑rate 2.850 % notes that mature on Oct 1 2029 was $1.5 billion in each of the three most recent years – $1.5 billion as of Dec 31 2022 (2023 10‑K table), $1.5 billion as of Dec 31 2023 (2023 10‑K table), and $1.5 billion as of Dec 31 2024 (2024 10‑K table)【page_107†L13-L16】【page_104†L13-L16】.  \n\nHolding the same $1.5 billion of long‑dated, low‑rate debt across these years shows PayPal is deliberately preserving a stable, inexpensive long‑term financing base, locking in favorable rates and managing interest‑rate risk as part of its long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All numbers are correct - the $1.5 billion (or $1,500 million) outstanding balance for the Fixed-rate 2.850% notes maturing October 1, 2029 is accurately stated for all three years (Dec 31, 2022, 2023, and 2024). The date references and issuance information (September 2019) are correct. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of exposure across the three-year period, (2) the consistency of the balance, and (3) what this pattern suggests about debt management strategy. ENTITY ACCURACY: Company (PayPal/PYPL), debt instrument (Fixed-rate 2.850% notes), maturity date (Oct 1, 2029), and fiscal years are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that despite new debt issuances in 2023-2024 (including higher-rate notes), this specific instrument remained unchanged, and correctly interprets this as a deliberate strategic choice to preserve favorable terms and manage interest-rate risk. MINOR CONSIDERATIONS: The original answer mentions 'possibly to preserve favorable interest terms or manage cash flow predictability' while the LLM answer states this more definitively as 'deliberately preserving' and 'locking in favorable rates.' Both interpretations are semantically equivalent and reasonable given the facts. The LLM provides slightly more specific context about the September 2019 issuance date and the October 1 maturity date, which adds helpful detail. The citation references to specific 10-K pages add credibility. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 460,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s Performance Materials & Technologies segment disclosed that about 63 % of its raw‑material supply base was under contract at the end of 2022, rising only modestly to roughly 64 % at the end of 2023【page_33】. After the 2024 realignment (the segment is now called Energy & Sustainability Solutions), the filing says a “majority” of the raw‑material supply base is under contract, indicating coverage above 50 %【page_31】. Although contract coverage has crept upward, the company continues to flag raw‑material price, demand and supply volatility as a key operational risk, suggesting that Honeywell’s exposure to commodity‑market swings remains material despite the slight mitigation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific quantitative data (63% in 2022, 64% in 2023, majority/50%+ in 2024) that is not present in the ground truth answer, which suggests the LLM may be drawing from actual filing data. However, this creates a critical evaluation problem: the ground truth answer does not mention these specific percentages at all, instead focusing on qualitative risk disclosures and thematic evolution. The LLM's approach is more concrete and data-driven, but it fundamentally addresses a different aspect of the question than the ground truth. The ground truth emphasizes the EVOLUTION OF RISK FRAMING across years (2022: commoditization and illegal imports; 2023: oil/gas price volatility; 2024: production capacity and downtime), while the LLM focuses on CONTRACT COVERAGE PERCENTAGES as the key metric of vulnerability. These are complementary but distinct analytical approaches. Strengths of LLM answer: (1) Provides specific, verifiable metrics (63%, 64%, majority); (2) Correctly identifies segment rebranding to Energy & Sustainability Solutions in 2024; (3) Logically concludes that despite modest improvements in contract coverage, commodity volatility remains a material risk. Weaknesses: (1) Does not address the qualitative evolution of risk disclosure framing across the three years; (2) Does not mention specific 2022 risks like illegal HFC imports or 2023 emphasis on oil/gas price impacts; (3) The ground truth's emphasis on CONSISTENT PRESENCE of risk across years is not fully captured; (4) The LLM's metric (contract coverage %) is a different lens than the ground truth's risk disclosure analysis. The quantitative data appears reasonable (contract coverage increasing from 63% to 64% to majority), but without access to the actual filings, cannot verify these specific percentages. The answer is partially correct but addresses the question through a different analytical framework than the ground truth, missing key qualitative evolution details while adding quantitative specificity not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 549,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, Imperial Brands PLC is listed each time as a member of PMI’s peer group (see the peer‑group listings in 2022 page 21, 2023 page 26 and 2024 page 26). The unchanged inclusion of Imperial Brands over the three‑year span shows that PMI maintains a stable benchmark set of large global tobacco and consumer‑products companies, using Imperial Brands as a consistent reference point for size, market reach and product mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies Imperial Brands PLC as consistently included in PM's peer group across all three years (2022, 2023, 2024) - matching the ground truth exactly. (2) Provides specific page references (2022 page 21, 2023 page 26, 2024 page 26) that add credibility and verifiability. (3) Accurately characterizes the benchmarking strategy as 'stable' with 'unchanged inclusion,' which aligns with the ground truth's emphasis on consistency. (4) Correctly identifies the rationale for inclusion: global presence, revenue scale, market capitalization, and product mix - all semantically equivalent to the ground truth's 'similar global presence, revenue scale, and market capitalization.' (5) Uses appropriate terminology ('PMI' for Philip Morris International, 'peer group,' 'benchmark set') consistent with SEC filing conventions. (6) The multi-hop reasoning is sound - synthesizing information across three years of filings to demonstrate consistency. MINOR CONSIDERATIONS: (1) The LLM answer uses 'PMI' while the question uses 'PM' - both are acceptable abbreviations for Philip Morris International, so this is not an error. (2) The LLM answer is slightly more specific and detailed than the ground truth (providing page numbers), which enhances rather than detracts from accuracy. (3) Both answers convey the same core insight: Imperial Brands remained a consistent peer throughout the period, reflecting stable benchmarking strategy. No factual errors, calculation errors, or entity misidentifications detected. The answer fully addresses the question's inquiry into trajectory and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 459,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding balance of the September 2019 fixed‑rate 2.850 % notes was $1.5 billion at the end of 2022, remained $1.5 billion at the end of 2023, and was still $1.5 billion at the end of 2024【page_107】【page_104】. The unchanged exposure over three years shows that PayPal is deliberately keeping this low‑coupon, long‑dated debt on its balance sheet, locking in cheap fixed‑rate financing and preserving a stable maturity profile rather than aggressively refinancing or retiring the notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS OF FACTS: All numerical values are correct - the $1.5 billion balance is accurately stated for 2022, 2023, and 2024. The interest rate of 2.850% is correctly identified. The characterization of these as 'September 2019 fixed-rate notes' provides additional specificity beyond the ground truth. (2) QUANTITATIVE ACCURACY: All dollar amounts and percentages are precise and match the ground truth exactly. No calculation errors present. The three-year period (2022-2024) is correctly tracked. (3) QUALITATIVE REASONING: The LLM successfully synthesizes the multi-hop information by tracking the debt balance across three fiscal years and drawing appropriate conclusions about PayPal's debt management strategy. The interpretation that PayPal is 'deliberately keeping this low-coupon, long-dated debt on its balance sheet' and 'locking in cheap fixed-rate financing' is semantically equivalent to and consistent with the ground truth's assessment that the company is 'maintaining a consistent long-term liability position' and 'leveraging the low fixed rate as part of a broader capital structure strategy.' (4) ENTITY ACCURACY: PayPal (PYPL) is correctly identified, the specific debt instrument is properly characterized, and all years are accurate. (5) COMPLETENESS: The answer addresses both parts of the question - how the exposure evolved (remained stable at $1.5B) and what this indicates about debt management strategy (deliberate retention of low-cost financing). Minor enhancement: The LLM provides slightly more specific context by naming the September 2019 issuance date, which adds value. The citation references (page_107, page_104) suggest proper sourcing from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 477,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "In 2022 ConocoPhillips said HSE audits were performed on business‑unit and staff‑group levels simply to verify conformance with its HSE policies and standards (page 18 – 2022). By 2024 the audits are described as “Corporate HSE audits,” expanding the scope to a company‑wide program, explicitly tracking any identified improvement actions to completion and reporting audit results and HSE performance to the Executive Leadership Team and the Board of Directors, thereby embedding the audits in corporate governance (page 18 – 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of ConocoPhillips' HSE audit approach from 2022 to 2024, with accurate dates and entities. The answer accurately captures: (1) 2022 baseline - audits at business-unit and staff-group levels for conformance verification; (2) 2024 evolution - shift to 'Corporate HSE audits' with explicit tracking of improvement actions and reporting to ELT and Board. The page references (page 18 for both 2022 and 2024) are appropriately cited. However, the LLM answer has a notable omission: it does not explicitly mention the 2023 intermediate step where audit outcomes were linked to annual objectives, targets, and deadlines - this represents a missing piece of the multi-hop synthesis across the three-year period. The ground truth emphasizes this 2023 reinforcement as part of the evolutionary narrative, showing progressive integration with corporate governance. The LLM answer does capture the overall arc (localized checks → integrated governance-driven model) but compresses the timeline by jumping from 2022 to 2024 without acknowledging the 2023 intermediate development. The characterization of the shift as moving toward 'a more centralized oversight approach' is implicit in the LLM answer but not explicitly stated. Quantitatively, all dates and entities are correct. Qualitatively, the reasoning is sound but incomplete in capturing the full three-year evolution narrative that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 404,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "AMD’s 10‑K filings for all three years continue to incorporate the 2011 Executive Incentive Plan as an exhibit—2022 (see page 93), 2023 (see page 101) and 2024 (see page 98)—showing that the company still treats it as a core governance document. While the 2023 and 2024 reports also list newer plans and amendments (e.g., the 2004 Equity Incentive Plan, 2017 ESP and 2018/2019 Executive Incentive Plan amendments), the 2011 plan remains consistently referenced amid the broader executive‑compensation disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative that AMD's 2011 Executive Incentive Plan remained consistently referenced across 2022, 2023, and 2024 as a foundational governance document. The qualitative reasoning about continuity and the presence of newer plans alongside the 2011 plan is sound and aligns with the ground truth. However, there are significant quantitative accuracy issues: (1) The LLM provides specific page numbers (page 93 for 2022, page 101 for 2023, page 98 for 2024) that cannot be verified against the ground truth, which does not provide page citations. These page numbers may be incorrect or hallucinated. (2) The LLM mentions specific newer plans (2004 Equity Incentive Plan, 2017 ESP, 2018/2019 Executive Incentive Plan amendments) that are not mentioned in the ground truth answer. While these may exist in the actual filings, introducing unverified plan names without ground truth support weakens confidence in the response. (3) The ground truth explicitly states the plan was listed as exhibit *10.1* in all three years—a key quantitative detail the LLM omits entirely, instead only saying it was 'incorporated as an exhibit' without the specific exhibit number. The LLM's multi-hop synthesis across the three years is logically sound and the semantic meaning aligns with the ground truth regarding continuity and foundational status. The answer appropriately addresses the evolution question by showing consistency rather than change. However, the introduction of unverified page numbers and plan names, combined with the omission of the specific exhibit designation (*10.1*), represents a meaningful departure from factual precision expected in financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 467,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "Across the three years GM’s filings consistently describe its indemnification of Stellantis for legacy Opel/Vauxhall emissions claims and certain recalls (including Takata‑inflator recalls) as “immaterial,” not probable or estimable, and no material accruals are recorded (2022 Note p. 89; 2023 Note p. 92; 2024 Note p. 93‑94). Although the maximum undiscounted future payments for all related guarantees rose modestly from $3.5 billion in 2023 to $3.7 billion in 2024, the portion tied to the Opel/Vauxhall sale remains insignificant, indicating that GM’s exposure to post‑sale liabilities from that transaction has stayed limited and uncertain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially diverge from the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($3.5 billion in 2023 rising to $3.7 billion in 2024) for 'maximum undiscounted future payments for all related guarantees' tied to Opel/Vauxhall. The ground truth makes no mention of these specific figures and does not quantify the exposure in this manner. These numbers appear to be fabricated or misattributed. (2) MISSING GEOGRAPHIC EXPANSION: The ground truth explicitly documents the geographic and legal scope expanding from 2022 through 2024, with Germany, UK, and Netherlands mentioned in 2023, and Austria added in 2024. The LLM answer completely omits this critical evolution of exposure. (3) MISSING REGULATORY DEVELOPMENTS: The ground truth specifically mentions the European Commission and UK CMA regulatory investigation related to end-of-life vehicle practices at Opel in 2024, with an immaterial accrual recorded. The LLM answer fails to capture this important regulatory escalation. (4) INCOMPLETE TAKATA CONTEXT: While the LLM mentions Takata-inflator recalls, it doesn't contextualize that Stellantis initiated these recalls for legacy Opel vehicles in 2023, which is a key detail showing how the exposure evolved. (5) MISSING ACCRUAL INFORMATION: The ground truth notes that in 2024 an immaterial accrual was recorded due to regulatory investigations, whereas the LLM states 'no material accruals are recorded' across all three years, which is factually incorrect for 2024. (6) INCOMPLETE ANSWER TO QUESTION: The question asks how obligations 'evolved' and what this 'indicates about GM's exposure.' The ground truth provides a clear narrative of evolution (expanding jurisdictions, new regulatory actions, increasing complexity) and concludes that this indicates 'growing complexity and persistence of post-sale liabilities.' The LLM answer suggests exposure 'has stayed limited and uncertain,' which contradicts the ground truth's conclusion about growing complexity. WHAT WAS CORRECT: The LLM correctly identifies that the obligations are characterized as 'immaterial' and that no material accruals were recorded in 2022-2023. The general characterization of these as contingent liabilities is appropriate. However, these correct elements are overshadowed by the fabricated numbers, missing geographic/regulatory details, and incorrect conclusion about the trajectory of exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 663,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 Eli Lilly earned roughly $2 billion from bamlanivimab (U.S. $2,008.9 million plus $14.7 million outside the U.S.) and, under its worldwide license with AbCellera, was required to pay tiered royalties in the mid‑teens to mid‑twenties percent of those sales (recorded as cost of sales)【page_72】【page_67】. By 2023 and 2024 the “COVID‑19 antibodies” line shows “‑”, indicating no bamlanivimab sales and thus no royalty outflows【page_68】, revealing that the product’s financial exposure dropped sharply after the pandemic‑era EUA and that its importance was largely short‑term rather than a lasting strategic driver for Lilly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: (1) 2022 U.S. revenue of $2,008.9 million is correctly cited and matches ground truth exactly; (2) The mention of $14.7 million outside U.S. adds precision beyond the ground truth summary but is consistent with typical filing disclosures; (3) Royalty percentages (mid-teens to mid-twenties) are correctly stated; (4) The 2023-2024 transition to zero revenue (indicated by dashes) is accurately captured. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly traces the evolution from significant revenue contribution to complete phase-out. The connection between revenue decline and royalty obligation elimination is logically sound. ENTITY ACCURACY: Eli Lilly (LLY), AbCellera, bamlanivimab, and COVID-19 antibodies category are all correctly identified. REASONING QUALITY: The conclusion that bamlanivimab was 'short-term rather than a lasting strategic driver' directly aligns with the ground truth assessment about loss of strategic importance post-pandemic. The answer appropriately contextualizes the product's trajectory within the broader shift to cardiometabolic health (though this specific mention is implicit rather than explicit). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The citation of page numbers adds transparency. The phrase 'recorded as cost of sales' provides helpful accounting context. No material factual errors detected. The answer fully addresses all components of the multi-part question regarding financial exposure evolution, royalty obligations, revenue contribution, and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 488,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "- 2022 10‑K (page 7) lists Jackpot as one of the “important local cigarette brands… in the Philippines.”  \n- 2023 10‑K (page 6) repeats the same phrasing, again naming Jackpot among its key local brands in the Philippines.  \n- 2024 10‑K (page 5) still highlights Jackpot alongside other local brands, showing it remains a pillar of the Philippines portfolio.  \n\nAcross the three years PMI’s filings keep Jackpot in the spotlight, indicating a steady strategic commitment to retain strong local‑brand presence in a key market even as its overall cigarette footprint shrinks and the company pivots toward smoke‑free products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Jackpot as a key local cigarette brand in the Philippines across all three years (2022, 2023, 2024); (2) Accurately captures the consistent messaging across the three 10-K filings with appropriate page references; (3) Properly synthesizes the multi-hop information showing year-over-year consistency; (4) Correctly interprets the strategic implication that PMI maintained commitment to local brands while pivoting toward smoke-free products; (5) No quantitative errors - all years and references are accurate. MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly mention Fortune as another local brand in the Philippines (mentioned in ground truth for 2022), though this is a minor omission that doesn't affect the core narrative about Jackpot's trajectory; (2) The phrasing differs slightly from ground truth (e.g., 'keeps Jackpot in the spotlight' vs. 'consistently listed Jackpot'), but the semantic meaning is equivalent and conveys the same strategic positioning; (3) The LLM answer is slightly more concise than the ground truth but captures all essential elements of the 3-year evolution. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the pattern of consistent strategic positioning. The conclusion about PMI's dual strategy (maintaining local brands while transitioning to smoke-free products) is logically sound and well-supported. FACTUAL VERIFICATION: All references to years, company name (PMI/Philip Morris International), brand name (Jackpot), and geography (Philippines) are correct. The characterization of Jackpot as a 'local cigarette brand' is accurate throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 495,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal warned that its credit‑product portfolio and its BNPL loans were a major source of “bad‑transaction” risk – defaults, fraudulent or erroneous payments, merchant insolvencies and heavy reliance on third‑party processors could drive up loss rates (2022 p.24‑28). In 2023 the company began off‑loading most of that exposure by signing a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL receivables, which shifted the bulk of BNPL credit risk off its balance sheet, but the filing still stressed ongoing fraud, charge‑back and credit‑default risks and the possibility of third‑party processing disruptions (2023 p.23‑26). By 2024, after the BNPL sale was largely completed, PayPal’s risk narrative focused on the remaining consumer‑ and merchant‑credit products, with continued emphasis on fraud and third‑party‑processor vulnerabilities as the primary sources of bad‑transaction exposure (2024 p.21‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of PayPal's bad transaction exposure evolution from 2022-2024. QUANTITATIVE ACCURACY: All key numbers are correct - the €40 billion BNPL receivables sale figure is accurate and properly contextualized. The timeline (2022 initial risk warnings, June 2023 sale agreement, 2024 post-completion focus) is accurate. Page references (2022 p.24-28, 2023 p.23-26, 2024 p.21-25) appear reasonable and specific. QUALITATIVE ACCURACY: The answer correctly identifies the three-phase evolution: (1) 2022 - growing exposure with fraud/synthetic identity/third-party risks, (2) 2023 - major de-risking through €40B sale while maintaining fraud concerns, (3) 2024 - shifted focus to remaining credit products with persistent fraud/processor vulnerabilities. The multi-hop reasoning is sound - the answer synthesizes information across three years and correctly shows how the 2023 sale represented a strategic shift in risk management. COMPLETENESS: The answer addresses all major elements of the question: the evolution trajectory, the specific €40B sale detail, fraud risks, third-party processing disruptions, and the ongoing nature of risks despite the sale. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core narrative as the ground truth - PayPal transitioned from managing growing bad transaction exposure to offloading BNPL risk through the 2023 sale, while continuing to face fraud and operational risks. The characterization of the sale as 'off-loading most of that exposure' and 'shifting the bulk of BNPL credit risk off its balance sheet' aligns with the ground truth's description of 'partially offloading that risk' and 'reducing its direct exposure.' Minor differences in wording (e.g., 'largely completed' vs. ground truth's more cautious framing) are reasonable interpretations of the same underlying facts. The answer is slightly more specific and detailed than the ground truth in some respects (e.g., explicitly listing 'defaults, fraudulent or erroneous payments, merchant insolvencies') which adds value without contradicting the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 574,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In its 2022 filing Honeywell warned that the Safety and Productivity Solutions business could suffer lower market share, reduced selling prices and margin pressure if retail‑market demand swung, flagging “fluctuations in retail markets” as a material risk for the segment【page_32】. By 2024, after the segment was reorganized as Industrial Automation, the same retail‑fluctuation risk was disclosed, yet the unit still posted a 3 % increase in net sales and a $35 million rise in segment profit, indicating it was able to absorb some of the volatility【page_28】【page_30】. The 2023 10‑K’s risk discussion reiterated retail‑market volatility as a key risk for both Safety and Productivity Solutions and Industrial Automation, reflecting an elevated overall risk posture that the company continues to monitor【page_31】. Together, these disclosures show that Honeywell’s industrial portfolio remains sensitive to retail demand volatility, but strategic realignment and operational actions have begun to mitigate the impact while the exposure remains a prominent risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative about Honeywell's exposure to retail market fluctuations across the three-year period (2022-2024), properly names the segments (Safety and Productivity Solutions, Industrial Automation), and accurately captures the risk progression across years. The answer correctly notes that the risk was reiterated in 2023 and tied to the restructured Industrial Automation segment in 2024. The semantic understanding of the multi-hop synthesis is sound.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM cites specific financial metrics (3% increase in net sales, $35 million rise in segment profit) that are NOT present in the original answer and cannot be verified against the ground truth. These appear to be fabricated or hallucinated numbers with specific page citations (page_28, page_30) that suggest false confidence. (2) UNVERIFIABLE CLAIMS - The page citations provided (page_32, page_28, page_30, page_31) cannot be cross-referenced with the ground truth, raising concerns about data accuracy. (3) INCOMPLETE ALIGNMENT - While the LLM adds detail about 'lower market share, reduced selling prices and margin pressure,' the original answer emphasizes 'reduced investments in safety monitoring and process automation' as the mechanism of impact, which the LLM omits.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the evolution of the risk disclosure, but the addition of unverified financial performance metrics (3% sales increase, $35M profit increase) introduces factual errors that undermine the analysis. The conclusion about 'strategic realignment and operational actions' mitigating impact is speculative and not supported by the ground truth.\n\nVERIFICATION ISSUES: The ground truth makes no mention of specific financial performance improvements (3% sales growth, $35M profit increase) in 2024. The LLM's claim that the segment 'was able to absorb some of the volatility' based on these metrics cannot be verified and appears to be an inference not grounded in the source material.\n\nSCORING RATIONALE: Correctness score of 6 reflects that while the core narrative and multi-hop synthesis are directionally correct, the introduction of unverified quantitative claims significantly undermines credibility. Quantitative accuracy is 4 due to the fabricated financial metrics. Qualitative accuracy is 7 because the reasoning framework is sound despite the data issues. Contextual relevance is 8 as the answer addresses all parts of the multi-part question, though with problematic additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 694,
        "total_tokens": 2265
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 through 2024 the Incyte‑Lilly deal kept the same royalty framework—tiered double‑digit royalties up to about 20 % of worldwide net sales and an extra low‑teens royalty on COVID‑19 sales that exceed a set threshold—while the milestone component shifted from the $210 M (2020) and $260 M (2021) payments that were capitalized and amortized to a continued eligibility for up to $100 M of additional sales‑based milestones (noted in the 2023 filing, with no new milestone terms disclosed in 2024).  Strategically, Olumiant’s role grew, with net product revenue rising from $830.5 M in 2022 to $922.6 M in 2023 and $957.4 M in 2024, reflecting an expanding focus on the product and its COVID‑19 indication.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) MILESTONE PAYMENT DISCREPANCY: The LLM states 'up to $100 M of additional sales-based milestones' but the ground truth clearly indicates Incyte was eligible for 'up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones)' in 2022. This is a critical factual error - the LLM understates the milestone obligations by 50%. (2) HISTORICAL MILESTONE REFERENCE ERROR: The LLM references '$210 M (2020) and $260 M (2021)' as prior capitalized payments, but the ground truth only mentions '$260.0 million in milestone payments' capitalized in 2022 itself. The LLM appears to have confused or misattributed historical milestone data. (3) INCOMPLETE MILESTONE EVOLUTION: The ground truth emphasizes the shift from capitalized milestone payments in 2022 to 'ongoing revenue recognition' in 2023-2024, showing a strategic evolution. The LLM mentions this shift but incompletely and with incorrect dollar amounts. (4) REVENUE FIGURES: The LLM provides Olumiant revenue data ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024) which cannot be verified against the ground truth provided, but these appear to be specific product revenue figures not mentioned in the original answer. (5) ROYALTY STRUCTURE: The LLM correctly identifies the tiered royalty structure (up to 20% on general sales, low teens on COVID-19 sales above threshold), which matches the ground truth. (6) STRATEGIC POSITIONING: The LLM mentions Olumiant's expanded use and COVID-19 indication, but misses the ground truth's emphasis on EUA usage and follow-on compounds as indicators of deepening strategic alignment. STRENGTHS: Correct identification of royalty framework consistency, appropriate focus on Olumiant's revenue growth trajectory, and recognition of the partnership's maturity. WEAKNESSES: Significant understatement of contingent milestone payments ($100M vs $200M), confused historical milestone references, incomplete discussion of the strategic evolution from capitalized to expensed treatment, and missing context about EUA and follow-on compounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 565,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria continued to own UST LLC (through its wholly‑owned USSTC) on a 100 % basis in each filing – the 2023 “Background and Basis of Presentation” note and the 2024 business description both list UST as a wholly‑owned subsidiary【page_60】【page_4】.  The MST and snus trademarks acquired with UST are carried as indefinite‑life intangible assets valued at roughly $8.8 billion, which together with $5.1 billion of goodwill make up the $9.1 billion of other intangible assets and $5.1 billion of goodwill reported for the oral‑tobacco segment in the 2022 goodwill note【page_66】, and no impairment to those assets has been recorded since 2020 (no impairment charges noted in the asset‑impairment disclosures)【page_67】.  UST’s oral‑tobacco business remains embedded in Altria’s oral‑tobacco segment and is explicitly referenced as part of the company’s “smoke‑free future” vision and transition strategy in the 2024 business overview【page_4】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Quantitative accuracy is strong - the LLM correctly identifies the $8.8 billion in MST and snus trademarks as indefinite-lived intangible assets, the $5.1 billion goodwill figure, and the $9.1 billion total other intangible assets. These numbers match the ground truth. (2) Entity accuracy is correct - UST LLC, USSTC, MST, snus, and Helix/NJOY are all properly identified. (3) Ownership structure is accurately stated as 100% wholly-owned subsidiary across all three years (2022-2024). (4) The LLM correctly notes no impairment charges since 2020. (5) The connection to smoke-free transition strategy is mentioned.\n\nWEAKNESSES: (1) INCOMPLETE TEMPORAL EVOLUTION: The LLM answer focuses heavily on 2022-2024 consistency but fails to adequately capture the strategic evolution described in the ground truth. The ground truth emphasizes how the relationship 'evolved' with Altria's portfolio shifting toward oral nicotine pouches (Helix) and e-vapor (NJOY), suggesting UST's traditional MST business was 'increasingly complemented by newer alternatives.' The LLM mentions the smoke-free strategy but doesn't clearly articulate this strategic diversification or evolution. (2) MISSING COMPARATIVE ANALYSIS: The ground truth explicitly states this shows a '3-year trajectory' of 'maintaining UST's financial value while strategically diversifying around it.' The LLM doesn't synthesize this comparative evolution across the three years - it reads more as a static description of 2022-2024 consistency rather than showing how the relationship evolved. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies individual facts, it doesn't fully synthesize how the intangible asset valuation, ownership structure, AND integration into broader strategy all evolved together as a coherent narrative. (4) MISSING STRATEGIC CONTEXT: The ground truth emphasizes the shift toward 'potentially less harmful tobacco alternatives' and how UST's role changed from being the primary focus to being 'complemented by' newer products. The LLM mentions the smoke-free vision but doesn't capture this strategic repositioning.\n\nNUMBER VERIFICATION: All financial figures are correct ($8.8B trademarks, $5.1B goodwill, $9.1B total intangible assets). The 100% ownership and 2009 acquisition context are accurate. No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM successfully connects ownership structure across years and links intangible assets to the smoke-free strategy, but fails to fully synthesize the evolution of UST's strategic role within Altria's broader portfolio transition. The answer is more descriptive than analytical regarding the 'evolution' requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 716,
        "total_tokens": 2193
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50 % senior note always carried a $500 million principal, but its effective cost rose sharply – from roughly 3.2 % in FY 2022 (July 30 2022) to about 6.4 % in FY 2023 (July 29 2023) and 6.7 % in FY 2024 (July 27 2024)【page_89】. The jump in effective rate, despite the fixed 3.5 % coupon, signals that market yields and Cisco’s borrowing costs climbed markedly, reflecting tighter capital‑market conditions and higher cost of debt over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: All effective interest rates are correct - 3.20% (FY2022), 6.38% (FY2023 rounded to ~6.4%), and 6.66% (FY2024 rounded to ~6.7%). The fiscal year dates provided (July 30 2022, July 29 2023, July 27 2024) are accurate Cisco fiscal year-end dates. The principal amount of $500 million is correctly identified. The multi-hop reasoning is sound: the answer correctly synthesizes the evolution of effective rates across three fiscal years and properly interprets this trend as reflecting tightening capital market conditions and higher borrowing costs. The distinction between the fixed 3.5% coupon and the rising effective rate is well-explained, demonstrating understanding of how market yields affect the economic cost of debt. Minor deviations from ground truth: (1) The answer uses rounded percentages (6.4% and 6.7%) rather than the precise 6.38% and 6.66%, though this is acceptable given the context and clarity of communication. (2) The answer adds the principal amount detail ($500 million) which, while not in the original answer, is factually correct and adds useful context. The answer fully addresses all parts of the question - the evolution of interest rate exposure, the trend analysis, and the implications for borrowing costs and capital market conditions. The semantic meaning aligns perfectly with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 394,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 senior‑note balance fell from $16 billion at 12/31/2022 to $15 billion at 12/31/2023 (Note 6 table) and then to $13 billion at 12/31/2024 (Note 6 table)【page_58】【page_57】. The steady decline—$1 billion in 2023 and $2 billion in 2024—shows the company is actively repaying or retiring this tranche of debt, reflecting a deliberate deleveraging strategy that strengthens its balance sheet while preserving financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $16 billion (2022), $15 billion (2023), $13 billion (2024). The year-over-year reductions are accurately stated ($1 billion in 2023, $2 billion in 2024). The dates are correct (12/31/2022, 12/31/2023, 12/31/2024). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of the 2017 Notes balance across the three-year period, (2) the reduction trajectory, and (3) what this indicates about debt management strategy. ENTITY ACCURACY: Correctly identifies Amazon, the 2017 Notes, and the relevant fiscal years. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the specific 2017 Notes balance reductions to the broader debt management strategy. The characterization of the pattern as 'steady decline' and 'deliberate deleveraging strategy' is appropriate and well-supported by the data. MINOR OBSERVATION: The original answer provides additional context about total long-term debt reduction ($67.2B to $52.6B), which the LLM answer does not include. However, the question specifically asks about the 2017 Notes evolution and what it indicates about debt management strategy, which the LLM answer fully addresses. The LLM's interpretation that this reflects 'deliberate deleveraging strategy' and 'strengthens balance sheet while preserving financial flexibility' is semantically equivalent to the ground truth's characterization of 'deliberate debt management strategy to gradually retire this issuance.' The inclusion of source citations (Note 6 table, page references) adds credibility. Overall, this is a high-quality answer with accurate numbers, sound reasoning, and appropriate interpretation of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 488,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "- Fiscal 2022: the 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million** and an **effective interest rate of 5.18 %** (AVGO 2022 10‑K, p. 101).  \n- Fiscal 2023: the same notes still showed **$606 million** outstanding at an **effective rate of 5.18 %** (AVGO 2023 10‑K, p. 81).  \n- Fiscal 2024: the balance and rate remained unchanged at **$606 million** and **5.18 %** (AVGO 2024 10‑K, p. 81).  \n\nThe unchanged principal and unchanged effective cost over three years indicate that Broadcom has deliberately kept this instrument on its balance sheet, using it as a stable, long‑term source of financing and opting not to accelerate repayment or refinance it before its 2030 maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: the principal balance of $606 million is consistent across fiscal 2022, 2023, and 2024, and the effective interest rate of 5.18% is accurately reported for all three years. The multi-hop synthesis across three fiscal years is sound, correctly identifying the static nature of this debt instrument. The reasoning about AVGO's (Broadcom's) debt management strategy is logical and well-supported: the unchanged principal and interest rate over three years does indicate a deliberate decision to maintain this as stable, long-term financing without acceleration or refinancing. The LLM correctly identifies the company as Broadcom (AVGO ticker) and accurately cites the relevant 10-K filings with page numbers. The answer addresses all parts of the question: the evolution (or lack thereof) of the principal balance and interest rate, and the implications for debt management strategy. Minor note: The answer uses 'Broadcom' in the interpretation section while the question uses 'AVGO,' but this is not an error as they are the same entity. The semantic equivalence is strong - the LLM conveys the same information as the ground truth with slightly different wording that is equally valid. The interpretation that this represents a 'static approach' and 'stable, long-term source of financing' aligns perfectly with the ground truth's characterization of maintaining a 'static approach' with 'no reduction or increase.' All financial metrics, dates, and entities are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 436,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- In the 2022 Form 10‑K Netflix listed a stand‑alone “Performance Bonus Plan” as Exhibit 10.6 (originally filed April 28 2014) 【page_66】.  \n- In the 2023 filing the company replaced that with an “Amended and Restated Performance Bonus Plan” (Exhibit 10.5, filed December 9 2022) 【page_68】, and the exhibit table shows it is incorporated by reference into the executive officers’ indemnification/compensation agreement (Exhibit 10.1) 【page_69】.  \n- The 2024 Form 10‑K continues to reference the same Amended and Restated Performance Bonus Plan (Exhibit 10.5, Dec 9 2022) 【page_67】, confirming that the restated plan has become a formal, integrated part of Netflix’s executive compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All dates are correct - December 9, 2022 for the 8-K filing matches ground truth; April 28, 2014 original filing date is accurate; (2) Exhibit numbers and filing references are precise (Exhibit 10.6 for 2022, Exhibit 10.5 for 2023-2024); (3) The multi-hop reasoning correctly traces the evolution: stand-alone plan (2022) → Amended and Restated Plan (2023) → integrated framework (2024); (4) The answer properly identifies the key strategic shift from a standalone document to an integrated component of executive compensation architecture; (5) The incorporation by reference into Exhibit 10.1 is correctly noted, showing understanding of how the plans interconnect. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth, providing exhibit numbers and filing dates that add precision; (2) The ground truth mentions 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement' as additional context for 2024, which the LLM answer does not explicitly reference - however, this is a minor omission as the core evolution narrative is complete; (3) The LLM answer's inclusion of page references and exhibit citations demonstrates strong source documentation. VERIFICATION: The dates (December 9, 2022; April 28, 2014) are factually correct; the exhibit progression (10.6 → 10.5) is accurate; the characterization of formalization and integration aligns with ground truth. The answer successfully synthesizes information across three fiscal years and multiple filing types (10-K, 8-K) to show the plan's evolution. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 482,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In the 2022 filing AIG quantified its international terrorism risk – it disclosed a modeled loss of about $1.3 billion for a five‑ton bomb attack (net of the Terrorism Risk Insurance Program Re‑authorization Act (TRIPRA) and reinsurance recoveries) and noted that TRIPRA covered roughly 80 % of U.S. losses above an estimated $1.7 billion deductible, with limited private reinsurance and reliance on government‑sponsored terrorism pools for non‑U.S. exposure. By the 2023 and 2024 filings the company stopped publishing a specific dollar‑loss figure, instead emphasizing ongoing scenario‑based modeling, routine monitoring of concentration, targeted reinsurance purchases and continued participation in country terrorism pools, while still using TRIPRA for U.S. coverage and government‑arranged terrorism reinsurance programs internationally. The evolution reflects a shift from a single quantified scenario to a broader, continuously‑updated risk‑monitoring and mitigation framework, while the core reinsurance and government‑backed protections remain in place.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's terrorism exposure management from 2022 to 2024 and correctly identifies the shift from specific quantified scenarios to broader monitoring frameworks. However, there are significant gaps and some inaccuracies when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- The $1.3 billion modeled loss figure for a five-ton bomb attack in 2022 is accurate\n- Correct identification of TRIPRA coverage and its role\n- Accurate characterization of the shift from specific dollar-loss figures to scenario-based monitoring\n- Correct mention of reinsurance purchases and government-backed programs\n- Appropriate synthesis of multi-year evolution\n\nSIGNIFICANT OMISSIONS:\n- Missing the specific 2024 retention points: $200 million for Japan and $125 million for rest of world - these are concrete quantitative details from the ground truth\n- Missing the $20.1 billion collateral figure for reinsurance recoverable assets mentioned in 2024\n- Missing the specific mention of global property per risk covers for non-critical and critical catastrophe events outside North America\n- Missing the 2023 emphasis on \"routine monitoring of international terrorism exposure concentration\" as a distinct strategic element\n\nQUANTITATIVE ACCURACY ISSUES:\n- While the $1.3 billion figure is correct, the LLM mentions an \"estimated $1.7 billion deductible\" for TRIPRA which is not in the ground truth and appears to be inferred or incorrect\n- The 80% TRIPRA coverage figure is mentioned but not verified in the ground truth\n- Missing quantitative details from 2024 ($200M, $125M, $20.1B) significantly weakens quantitative accuracy\n\nREASONING QUALITY:\n- The multi-hop synthesis across 2022-2024 is sound in concept\n- The characterization of evolution is reasonable but incomplete\n- The answer correctly identifies the strategic shift but misses specific tactical implementations\n\nThe answer provides a reasonable high-level narrative but fails to capture important specific metrics and risk mitigation details that are central to the ground truth answer, particularly the 2024 retention points and collateral figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 581,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth Group’s venture portfolio grew sharply: total equity‑security holdings rose from $3.7 billion at the end of 2022 to $4.9 billion in 2023 and stayed at $4.9 billion in 2024 【page_50】,【page_52】.  At the same time, equity‑method stakes in health‑care operating businesses increased from roughly $1.5 billion in 2023 to about $3.8 billion by year‑end 2024 【page_51】,【page_52】.  This reflects a clear shift toward larger direct investments in health‑care businesses while maintaining a larger overall venture‑style equity portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers that are essential to answering this question. (1) EQUITY SECURITIES HOLDINGS - 2022: LLM states $3.7 billion, but ground truth shows $3.5 billion. This is a $200 million discrepancy (5.7% error). The 2023 and 2024 figures of $4.9 billion are correct. (2) EQUITY METHOD INVESTMENTS - The LLM completely omits the 2022 baseline of $1.3 billion, which is critical for showing the evolution. The LLM states equity-method stakes were 'roughly $1.5 billion in 2023' but ground truth shows $1.4 billion (a minor discrepancy of ~7%). The 2024 figure of $3.8 billion is correct. (3) MISSING CRITICAL DATA POINT: The ground truth explicitly states that equity method investments in healthcare businesses declined slightly from $1.3 billion (2022) to $1.4 billion (2023) before surging to $3.8 billion (2024). The LLM omits the 2022 figure entirely and misses the intermediate decline, which is essential to understanding the 'evolution' requested in the question. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the strategic pivot toward deeper involvement in operating businesses, it fails to capture the complete trajectory because it's missing the 2022 baseline for equity method investments. The reasoning about 'shift toward larger direct investments' is sound, but it's based on incomplete data. (5) SEMANTIC ACCURACY: The LLM's interpretation of the strategic shift is reasonable and aligns with ground truth conclusions, but the factual foundation is compromised. The answer addresses the question's main themes but with insufficient historical context due to missing 2022 equity method data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 468,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 1.700 % Notes due 2025 (ticker MO25) appear unchanged in the securities‑registration tables of each filing – they are listed in the 2022 Form 10‑K (MO_10k_2022 p.1), again in the 2023 Form 10‑K (MO_10k_2023 p.1), and remain present in the 2024 Form 10‑K (MO_10k_2024 p.1). The fact that this low‑coupon, medium‑term bond has been retained year‑over‑year indicates Altria is deliberately maintaining a stable, inexpensive debt instrument and extending its maturity profile rather than frequently issuing or retiring notes, reflecting a disciplined, long‑term debt‑management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Altria's 1.700% 2025 Notes were present across all three years (2022, 2023, 2024) and accurately characterizes the debt management strategy as disciplined and focused on maintaining stable, long-term instruments. The core factual claims are sound: the notes appear in all three filings and were retained year-over-year. The LLM appropriately notes the low-coupon nature and medium-term maturity profile. However, there are some notable gaps compared to the ground truth: (1) The LLM does not mention the maturation of the 1.000% 2023 Notes in 2023, which is a key element of the multi-year progression showing active debt management; (2) The LLM does not reference other debt instruments (2.200% 2027 Notes, 3.125% 2031 Notes) that provide context for Altria's broader capital structure evolution; (3) The LLM's characterization of 'extending its maturity profile' is somewhat vague and doesn't clearly explain the strategic implication of retiring short-term debt while maintaining mid-term obligations. The quantitative accuracy is strong (the 1.700% rate and 2025 maturity date are correct), and the reasoning about disciplined debt management is sound, but the answer is incomplete in its multi-hop synthesis. The LLM successfully identifies the persistence of the 2025 Notes but misses the important context of what changed in the debt portfolio (retirement of 2023 Notes), which is central to understanding the 'evolution' requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 413,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose each year – it was $51.354 billion at 12/31/2022, grew to $60.429 billion at 12/31/2023, and reached $71.431 billion at 12/31/2024【page_69†L31-L38】【page_68†L31-L38】.  This steady, accelerating increase reflects a deliberate capital‑allocation focus on share repurchases, signalling that the company is using excess cash to return value to shareholders and is confident in its financial strength.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 treasury stock figure. Ground truth shows $(36,658) million in 2022, but the LLM states $51.354 billion ($51,354 million). This is a discrepancy of approximately $14.7 billion - a massive error of ~40% for the baseline year. The 2023 and 2024 figures ($60.429B and $71.431B) are correct and match the ground truth. SIGN CONVENTION ISSUE: The ground truth uses negative notation $(36,658) million, $(60,429) million, and $(71,431) million to represent treasury stock (a contra-equity account), which is the standard accounting convention. The LLM converted these to positive billions ($51.354B, $60.429B, $71.431B), which changes the accounting representation, though the magnitude of 2023-2024 is preserved. MULTI-HOP REASONING: The LLM correctly synthesized the trend analysis - identifying the consistent year-over-year increase and correctly interpreting this as reflecting capital allocation strategy focused on share repurchases and shareholder value return. The reasoning about confidence in financial strength is sound. COMPLETENESS: The answer addresses both parts of the question (evolution of treasury stock AND what it suggests about capital allocation strategy). However, the incorrect 2022 baseline severely undermines the accuracy of the 'evolution' analysis. CALCULATION VERIFICATION: The year-over-year increases from 2023-2024 are correct ($60.429B to $71.431B = $11.002B increase), but the 2022-2023 comparison cannot be verified as correct due to the wrong 2022 figure. The qualitative interpretation of the trend is appropriate despite the quantitative error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 461,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s “total‑return swaps‑deferred compensation” line swung from a $92 million loss in fiscal 2022 to a $58 million gain in fiscal 2023, and then to a $91 million gain in fiscal 2024, turning a negative exposure into a growing positive one—a net improvement of $183 million from 2022 to 2024【page_91】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: the $92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024 are all accurately stated. The calculation of the net improvement ($183M from 2022 to 2024) is mathematically correct: -$92M + $58M + $91M = $57M cumulative change, or alternatively $91M - (-$92M) = $183M swing from lowest to highest point, which the LLM correctly interprets as the net improvement trajectory. The multi-hop reasoning is sound—the answer successfully synthesizes the three-year progression and correctly identifies the reversal from loss to gains and the strengthening trend. Entity identification is accurate (Cisco, Total Return Swaps-Deferred Compensation, fiscal years 2022-2024). The semantic meaning matches the ground truth perfectly: both convey that the financial exposure shifted from negative to positive with strengthening performance. The LLM answer adds slightly more analytical depth by explicitly characterizing this as 'turning a negative exposure into a growing positive one' and quantifying the overall improvement, which enhances clarity without introducing any inaccuracies. The citation reference【page_91】adds credibility. Minor note: The phrasing 'net improvement of $183 million' could be interpreted as the cumulative swing rather than the simple sum, but in context this is clearly the intended meaning and is mathematically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 397,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From 2022 through 2024 Netflix’s 10‑K risk disclosures repeatedly stressed that its streaming service is fundamentally dependent on studios and other rights‑holders granting distribution licences, and that as those owners launch their own streaming platforms they may refuse or withdraw licences, driving up costs and intensifying competition for exclusive rights (2022 p. 11; 2023 p. 6; 2024 p. 4). At the same time the filings increasingly highlighted regulatory headwinds—new content‑quota rules, levies, ownership‑right limits and the risk of bans on controversial titles—that can force rights‑holders to limit or pull content, further amplifying Netflix’s reliance on favourable licensing terms (2022 p. 9; 2023 p. 4; 2024 p. 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core evolution of Netflix's dependency on rights holders across all three years; (2) Accurately captures the three main risk dimensions: content licensing risks (studios launching competing platforms, license withdrawal, cost increases), competition for exclusive rights, and regulatory pressures (content quotas, levies, ownership limits); (3) Properly synthesizes multi-hop information showing how these pressures intensified over time; (4) Uses appropriate page citations (though not verifiable here, they appear plausible for 10-K filings); (5) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'licensing agreements' vs 'distribution licences'). MINOR WEAKNESSES: (1) The LLM answer includes specific page references that cannot be independently verified against the ground truth, though this adds specificity rather than detracting from accuracy; (2) Slightly more technical/legalistic tone compared to ground truth, but this is appropriate for SEC filing analysis; (3) The phrase 'risk of bans on controversial titles' is mentioned in LLM answer but not explicitly in ground truth, though it could reasonably be inferred from regulatory pressures discussion. QUANTITATIVE ASSESSMENT: No specific financial metrics, percentages, or dollar amounts are required for this question, so quantitative accuracy is high by default. The years (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and three distinct risk categories, showing proper understanding of how these factors interact and evolve. The logical progression from 2022 concerns about competing platforms → 2023 licensing disputes → 2024 regulatory constraints is sound and matches the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 520,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group reported that the amounts it accrued, paid or charged to income for service‑level guarantees were **immaterial in each of the years 2022, 2023 and 2024** — the 2024 Form 10‑K notes that “none of the amounts accrued, paid or charged to income for service level guarantees were material as of December 31 2024, 2023 or 2022.” This consistent immateriality indicates that the company’s financial exposure from such guarantees has not grown, reflecting a stable level of service‑delivery commitments across its subsidiaries over the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies that service level guarantees were immaterial across 2022-2024, which matches the ground truth. However, the answer is significantly incomplete and misses critical quantitative information that directly addresses the question about how financial obligations 'evolved' over the 3-year period. Specific issues: (1) MISSING KEY DATA: The ground truth explicitly provides notes payable to subsidiaries figures ($8.1B in 2022, $9.9B in 2023, $2.0B in 2024), which are essential to answering the 'evolution' and 'trend' aspects of the question. The LLM completely omits these numbers. (2) INCOMPLETE ANALYSIS: The question asks about the 3-year trend and what it suggests about stability. The ground truth notes that while service level guarantees were immaterial, the internal financing structure 'experienced notable variation,' suggesting shifting liquidity strategies. The LLM only addresses the immateriality of service level guarantees and concludes with 'stable level of service-delivery commitments,' which is partially correct but misses the more nuanced finding about fluctuating internal financing. (3) MULTI-HOP SYNTHESIS: The question requires synthesizing two related but distinct pieces of information: (a) service level guarantee accruals/charges, and (b) the parent company's notes payable to subsidiaries. The LLM only addresses the first element. (4) SEMANTIC ISSUE: The LLM's conclusion that 'financial exposure from such guarantees has not grown' is accurate but narrow—it doesn't capture the fuller picture that the ground truth provides about the relationship between immaterial guarantee charges and significant fluctuations in internal financing structures. The answer is partially correct on the service level guarantee component but fails to provide the complete financial picture needed to properly assess the 3-year trend and its implications for stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 518,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s pension portfolio cut its exposure to below‑investment‑grade bonds from about $756 million – roughly 15 % of its fixed‑income holdings (≈12 % of total assets) in 2022 – to about 11 % of fixed‑income (≈9 % of total) in 2023 and further to 8 % of fixed‑income (≈7 % of total) in 2024【page_87】【page_86】【page_90】. Its post‑retirement portfolio fell from $7 million of below‑investment‑grade debt (≈7 % of total assets) in 2022 to roughly 9 % of fixed‑income (≈4 % of total) in 2023 and to 8 % of fixed‑income (≈3 % of total) in 2024【page_88】【page_86】【page_90】. The steady decline in lower‑rated credit exposure signals a more conservative risk appetite, as Altria leans toward higher‑quality, lower‑risk fixed‑income assets to better match its long‑duration liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. PENSION PLAN ALLOCATION ERRORS:\n   - 2022: LLM states 15% of fixed income (≈12% of total), but ground truth is 16% of fixed income (≈11% of total). The LLM also incorrectly includes a dollar amount ($756 million) not mentioned in ground truth.\n   - 2023: LLM states 11% of fixed income (≈9% of total) - this matches ground truth correctly.\n   - 2024: LLM claims 8% of fixed income (≈7% of total), but ground truth explicitly states that 2024 specific percentages were NOT disclosed. This is a major factual error.\n\n2. POSTRETIREMENT PLAN ALLOCATION ERRORS:\n   - 2022: LLM states 7% of total assets, but ground truth is 8% of fixed income holdings (≈3% of total assets). The LLM appears to have confused or misrepresented the metric.\n   - 2023: LLM states 9% of fixed income (≈4% of total) - this matches ground truth.\n   - 2024: LLM claims 8% of fixed income (≈3% of total), but ground truth states 2024 specific percentages were NOT disclosed.\n\n3. TREND ANALYSIS ERRORS:\n   - The LLM describes a \"steady decline\" in below-investment-grade exposure, but the ground truth shows the pension allocation decreased from 2022-2023 while the postretirement allocation increased slightly from 2022-2023. The LLM's characterization of a consistent downward trend is inaccurate.\n   - The LLM fabricates 2024 data that was explicitly not disclosed in the ground truth, fundamentally misrepresenting the available information.\n\n4. MULTI-HOP REASONING:\n   - The LLM failed to properly synthesize the distinction between pension and postretirement plans' divergent trends in 2022-2023.\n   - The LLM incorrectly concluded a \"steady decline\" when the actual pattern was more nuanced (pension down, postretirement up).\n   - The LLM invented 2024 data rather than acknowledging non-disclosure.\n\n5. SEMANTIC ISSUES:\n   - While the final conclusion about conservative risk appetite is reasonable, it's based on fabricated 2024 data, making the reasoning unsound.\n   - The inclusion of dollar amounts ($756 million, $7 million) without ground truth support suggests hallucination.\n\nThe answer demonstrates critical failures in factual accuracy, particularly the invention of 2024 data that contradicts the ground truth's explicit statement that such data was not disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 638,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s estimate of settlement exposure has not changed from 2022 through 2024 – each filing states that gross exposure is calculated by multiplying the average daily payment volume for the three months prior to year‑end by the estimated number of days of exposure, with risk‑mitigation arrangements applied and the methodology reviewed periodically (2022 Note 22, p. 108; 2023 Note 22, p. 110; 2024 Note 22, p. 102). The consistency of this approach shows that Mastercard relies on a stable, data‑driven risk‑management framework to monitor settlement risk even as regulatory scrutiny and litigation pressures have grown.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that Mastercard's settlement exposure methodology remained consistent across 2022-2024, using the same calculation approach (average daily payment volume × estimated days of exposure). The answer accurately cites the relevant note references (Note 22) and page numbers for each year's filing, demonstrating proper multi-hop synthesis across three years of documents. The quantitative accuracy is strong - the methodology description is factually correct and the page citations appear accurate. However, the answer has notable omissions compared to the ground truth: (1) It does not specifically mention the regulatory investigations (FTC, DOJ in 2023; European Commission in 2024) that provide important context for the 'increasing regulatory scrutiny' mentioned in the question; (2) It does not detail specific litigation risks like the U.S. Liability Shift Litigation or TCPA class action; (3) It does not explain the risk mitigation mechanism (cash collateral or credit enhancements based on individual risk assessments) that was unchanged across the three years; (4) The interpretation of what consistency 'indicates' about risk management is less developed - the LLM states it shows reliance on a 'stable, data-driven framework' but doesn't fully articulate that the company viewed existing practices as 'robust and sufficient' despite external pressures. The LLM answer is accurate in what it states but incomplete in addressing the full scope of the question regarding regulatory scrutiny and litigation risks. The reasoning is sound but lacks the comprehensive context that would fully answer the multi-part question about how methodology evolution reflects risk management approach amid increasing external pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 483,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco kept the $2 billion 5.90 % senior note fully outstanding in each year – $2,000 million in FY 2022, FY 2023 and FY 2024 – and the note’s effective interest rate stayed at roughly 6.11 % throughout that period【CSCO_10k_2022.pdf page_89】,【CSCO_10k_2023.pdf page_89】,【CSCO_10k_2024.pdf page_89】.  This unchanged utilization and rate show that Cisco is deliberately maintaining a long‑dated, fixed‑rate debt tranche (supported by interest‑rate swaps that hedge exposure) to lock in financing costs and provide stability to its long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - $2,000 million ($2 billion) principal balance maintained consistently across FY 2022, FY 2023, and FY 2024; effective interest rate of 6.11% stable throughout the period. The format variation ($2 billion vs $2,000 million) is appropriately handled. COMPLETENESS: The answer addresses all components of the multi-part question: (1) utilization evolution (consistent $2B), (2) effective interest rate evolution (stable 6.11%), and (3) strategic implications for debt management. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three fiscal years and multiple 10-K filings, properly identifying the consistent nature of both the principal and rate metrics. ENTITY ACCURACY: Cisco correctly identified, fiscal years properly specified (2022-2024), financial metrics accurately labeled (5.90% coupon, 6.11% effective rate, senior note). REASONING QUALITY: The interpretation that this represents deliberate strategic maintenance of fixed-rate debt for capital structure stability is sound and well-supported. The mention of interest-rate swaps as hedging instruments adds appropriate context. MINOR CONSIDERATIONS: The LLM answer includes slightly more interpretive detail about interest-rate swaps than the ground truth, but this is supplementary and not contradictory - it enhances rather than detracts from the answer. The semantic meaning is fully aligned with the ground truth conclusion about strategic intent to maintain predictable obligations. The citation references to specific PDF pages and page numbers add credibility and traceability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 464,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an outstanding principal of **$495 million** at the end of FY 2022, FY 2023 and FY 2024 – the balance is shown as $495 million in the senior‑notes schedule for each year【page_81】. The figure did not change over the three‑year period, indicating that the company has chosen to keep this low‑cost, fixed‑rate debt on its books rather than repaying it early, reflecting a strategy of preserving cheap financing until the notes mature.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All numbers are correct - $495 million principal balance is accurately stated for FY 2022, FY 2023, and FY 2024. The 3.125% interest rate is correctly identified. No calculation errors present. ENTITY ACCURACY: AVGO (Broadcom) correctly identified, the specific debt instrument (3.125% senior notes due January 2025) properly characterized, and all three fiscal years correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to identify the trend (unchanged balance), which is the core requirement of the question. SEMANTIC EQUIVALENCE: The LLM's interpretation that the stable balance indicates a strategy of preserving cheap financing until maturity is semantically equivalent to the ground truth's statement about a 'consistent approach to managing this portion of its fixed-rate debt portfolio.' Both convey that the company made no early repayments or refinancing adjustments. COMPLETENESS: The answer addresses all parts of the question - the evolution (or lack thereof) of the balance across the three-year period and what this indicates about debt management strategy. The citation reference (page_81) adds credibility. MINOR CONSIDERATIONS: The LLM's characterization of the debt as 'low-cost, fixed-rate debt' is a reasonable inference from the 3.125% rate and the decision to hold it, though the ground truth uses slightly different language. This is a minor wording variation that does not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 430,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "In 2022 CMCSA’s wireless handsets, tablets and smart‑watch services were sold only as part of a qualifying broadband bundle, with customers able to select an unlimited, a shared‑data, or a per‑gigabyte plan【page_7】. The 2023 filing shows the same bundling approach continued—wireless remained tied to broadband, still offering shared‑data options while adding device‑financing and multiple‑line activation for added flexibility【page_5】. By 2024 the bundling model persisted, but CMCSA introduced prepaid unlimited data plans under the NOW brand, giving customers a contract‑free unlimited choice alongside the existing shared‑data plans【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. FACTUAL ACCURACY: All core facts are correct - the 2022 bundling requirement with broadband, the three pricing options (unlimited, shared-data, per-gigabyte), the 2023 continuation of the bundling approach with added flexibility features (device-financing, multiple-line activation), and the 2024 introduction of prepaid unlimited data plans under the NOW brand. QUANTITATIVE ACCURACY: No numeric values are provided in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three years and multiple service dimensions, showing the evolution from basic bundling to enhanced flexibility to brand expansion. The progression is logically presented and matches the ground truth narrative. ENTITY ACCURACY: CMCSA is correctly identified throughout, and all service offerings (wireless, broadband, shared data plans, NOW brand) are accurately named. SEMANTIC EQUIVALENCE: The LLM answer conveys the same strategic evolution as the ground truth - moving from structured bundling toward greater customer choice and service integration. The phrase 'contract-free unlimited choice' effectively captures the flexibility enhancement. MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information. The citation markers (【page_7】, 【page_5】) add credibility and traceability. The answer could have slightly emphasized the 'deepening service integration' aspect mentioned in the ground truth, but this is a minor omission that doesn't affect the core accuracy. Overall, the LLM demonstrates excellent understanding of the multi-year evolution and correctly identifies the strategic shift toward customer flexibility while maintaining bundling integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 514,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s 10‑K disclosures show that in 2022, 2023 and 2024 the company repeatedly warned that CMS can change Medicare Advantage risk‑adjustment payments – altering capitation rates, revising the risk‑adjustment formula and conducting RADV audits that may lead to retroactive payment cuts, fines or corrective actions (2022 p. 25‑26; 2023 p. 20‑21; 2024 p. 20‑21). In response, UnitedHealth has consistently “adjusted members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both medical and operating cost‑management” to blunt the recurring funding pressures (2022 p. 25; 2023 p. 20; 2024 p. 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the core issue: CMS changing Medicare Advantage risk-adjustment payments across all three years; (2) Accurately captures the specific strategic responses: selective benefit/premium adjustments, ceased offerings in certain counties, and intensified cost management; (3) Properly synthesizes the recurring nature of these pressures and the company's reactive posture; (4) Includes specific page references (2022 p. 25-26, 2023 p. 20-21, 2024 p. 20-21) that add credibility; (5) Mentions additional mechanisms like RADV audits and retroactive payment cuts that provide more granular detail than the ground truth. MINOR WEAKNESSES: (1) The LLM answer adds details about RADV audits and retroactive payment cuts that, while likely accurate, are not explicitly mentioned in the ground truth answer - this represents a slight expansion beyond the provided ground truth rather than an error; (2) The answer could have been slightly more explicit about the 'reactive posture' and lack of full resolution mentioned in the ground truth, though this is implied in the language 'blunt the recurring funding pressures'; (3) No quantitative metrics (dollar amounts, percentage changes) are provided, though the question doesn't specifically require them and the ground truth also lacks specific numbers. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate years and identifies the pattern of recurring pressures and consistent strategic responses, demonstrating sound multi-hop reasoning. The connection between CMS actions and UnitedHealth's responses is clearly established across the timeline. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while using slightly different phrasing and adding some contextual detail about audit mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 536,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "- In 2022 Mastercard’s multi‑layered security model already combined third‑party assessments, public‑private partnerships and real‑time fraud‑scoring/tokenization controls, and it operated or was implementing real‑time clearing and settlement infrastructure in 12 of the top‑50‑GDP markets (page 11).  \n- By 2023 the firm began embedding those real‑time capabilities into new payment flows such as virtual‑card and bill‑pay solutions and expanded its footprint to 13 markets (Key 2023 Developments, page 13).  \n- In 2024 the approach was further hardened – it now explicitly monitors services from third‑party providers, integrates real‑time account‑based payments into VCN and other third‑party platforms, and continues to operate or roll out real‑time payments in 13 markets worldwide (page 11; Key 2024 Developments, page 13).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key numeric milestones (12 markets in 2022, 13 markets in 2023-2024) and accurately captures the evolution timeline across the three-year period. The answer appropriately mentions third-party collaboration, real-time service integration, and geographic expansion as required by the question. The multi-hop synthesis across years is logically structured.\n\nWEAKNESSES: (1) The LLM answer introduces specific details (virtual-card solutions, bill-pay, VCN platforms, account-based payments, explicit monitoring of third-party providers) that are NOT present in the ground truth answer. While these may be factually accurate from the source documents, they represent significant elaboration beyond what the knowledge graph confirms. (2) The ground truth specifically mentions 'EMV' technical standards and 'fraud scoring and tokenization' as integrated services in 2023, but the LLM answer presents these as already present in 2022, potentially misrepresenting the evolution timeline. (3) The ground truth mentions 'domestic transaction processing in China through a joint venture' as a 2024 development, which the LLM answer completely omits - this is a material omission of a specific geographic expansion example. (4) The LLM answer's claim about 'explicit monitoring of services from third-party providers' in 2024 is not substantiated in the ground truth.\n\nMULTI-HOP REASONING: The answer demonstrates reasonable synthesis across the three-year period and correctly identifies the progression of market expansion (12→13 markets). However, the omission of the China joint venture represents a failure to fully synthesize all key developments mentioned in the ground truth.\n\nNUMERIC VERIFICATION: Market counts (12 and 13) are correct. Years (2022, 2023, 2024) are correct. No calculation errors detected.\n\nOVERALL ASSESSMENT: The answer is partially correct with accurate core numbers and timeline, but contains material omissions (China JV) and introduces unverified elaborations that diverge from the ground truth narrative. The answer would benefit from stricter adherence to documented facts rather than inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 582,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s low‑cost 1.500 % Note due 2030, introduced in the June 3 2020 Officers’ Certificate that was part of its 2022 10‑K filing, appears unchanged in the 2023 report (see page 75) and again in the 2024 report (see page 76), indicating the company has kept this long‑dated debt on its balance sheet throughout the period. By retaining the cheap, 13‑year‑maturity note while adding newer, higher‑rate issuances in 2024, Amazon shows a strategy of locking in inexpensive long‑term financing and only refinancing or issuing new debt when market conditions warrant, reflecting disciplined long‑term debt management and selective refinancing priorities.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant issues that prevent it from matching the ground truth:\n\n1. QUANTITATIVE ACCURACY: The LLM correctly identifies the 1.500% interest rate and the 2030 maturity date. However, it incorrectly states the note was 'introduced in the June 3 2020 Officers' Certificate' - the ground truth indicates it was 'issued in 2020' without specifying June 3. More critically, the LLM claims the note has a '13-year-maturity' as of 2022, which would be incorrect (2030 minus 2022 = 8 years remaining, not 13). This is a factual error in the calculation/characterization.\n\n2. COMPLETENESS: The LLM answer fails to address the key evolution described in the ground truth. It does not mention:\n   - The Term Loan Agreement dated January 3, 2023 (Exhibit 10.8) introduced in 2023\n   - The 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9)\n   - The shift toward securing short- and medium-term liquidity alongside long-term obligations\n   - The layered financing approach combining fixed-rate long-term debt with flexible short-term facilities\n\n3. ENTITY ACCURACY: The LLM correctly identifies Amazon and the 1.500% Note due 2030. However, it fails to identify the new credit agreements that are central to understanding the financing strategy evolution.\n\n4. REASONING & MULTI-HOP SYNTHESIS: The ground truth demonstrates a clear evolution across three years with specific new instruments introduced in 2023 and 2024. The LLM answer treats the period as essentially static ('unchanged,' 'appears unchanged,' 'again in the 2024 report'), missing the critical strategic shift toward a layered financing approach. The LLM's conclusion about 'selective refinancing priorities' is partially correct but incomplete - it misses the strategic addition of short-term credit facilities that represent a meaningful evolution in financing strategy.\n\n5. SEMANTIC EQUIVALENCE: While the LLM correctly characterizes the strategy as 'locking in inexpensive long-term financing,' it fundamentally misses the evolution component of the question. The ground truth reveals a strategic balance between long-term fixed debt AND flexible short-term credit lines, whereas the LLM only addresses the long-term debt component.\n\n6. SPECIFIC ERRORS:\n   - Missing discussion of 2023 Term Loan Agreement (Exhibit 10.8)\n   - Missing discussion of 2024 364-Day Revolving Credit Agreement (Exhibit 10.9)\n   - Incorrect characterization of maturity length ('13-year' is wrong)\n   - Incomplete answer to the 'evolution' aspect of the question\n   - Vague page references ('page 75,' 'page 76') without exhibit numbers\n\nThe LLM answer captures the basic fact that the 1.500% Note remained on the balance sheet but fails to capture the strategic evolution through new credit agreements, which is the core of what the question asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 753,
        "total_tokens": 2193
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "The filings show that the wireless‑telecom threat to Comcast’s broadband has moved from a broad acknowledgment in 2022 that “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” were a competitor (2022 p. 28) to a more detailed, technology‑specific challenge in 2023 and 2024, where the company notes “various wireless companies are offering internet services using 5G fixed‑wireless networks and 4G and 5G wireless broadband services” and that these rivals are bundling lower‑priced packages (2023 p. 8; 2024 p. 21).  Both the 2023 and 2024 reports warn that these wireless offerings and subsidized broadband initiatives “could negatively impact the demand for our domestic broadband services” (2023 p. 8) and that “our competitive position may be negatively affected if we do not provide our customers with a satisfactory customer experience” (2024 p. 21), evidence that the pressure is shaping Comcast’s market positioning and prompting stronger customer‑retention efforts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about competitive threat evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the progression of wireless threats from 4G/5G in 2022 to 5G fixed wireless networks in 2023-2024; (2) Accurately captures the escalation to bundled offerings and subsidized packages; (3) Properly synthesizes evidence of impact on CMCSA's market positioning and customer retention strategies; (4) Correctly cites specific page references and quotes from filings showing competitive pressure language; (5) Demonstrates sound multi-hop reasoning by connecting technological evolution to strategic business implications. MINOR GAPS: (1) The LLM answer mentions 'lower-priced packages' and 'subsidized broadband initiatives' but the ground truth specifically emphasizes 'bundling DTC streaming services and offering unlimited data-usage plans' - while the LLM captures the bundling concept, it doesn't explicitly mention the DTC streaming component or unlimited data plans that were highlighted in the ground truth; (2) The LLM answer focuses more on direct quotes from filings regarding negative impact on demand and competitive position, while the ground truth more explicitly connects this to 'customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings' - though the LLM does reference customer experience requirements. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no calculations required; page references appear reasonable though cannot be independently verified. REASONING: The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and connects technological changes to business strategy implications. The semantic equivalence is strong despite some wording differences from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 513,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance‑recoverable balance fell sharply – from roughly $74 billion in the 2022 filing (the $74.3 billion total reported at Dec 31 2021 in the 2022 10‑K 【page_172】) to $67.5 billion at Dec 31 2023 (2023 10‑K 【page_122】) and then to $38.0 billion at Dec 31 2024 (2024 10‑K 【page_88】). The steep decline in assets that AIG expects to collect from reinsurers signals a markedly lower net exposure to insurance‑loss risk over this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 baseline figure. The LLM states '$74.3 billion total reported at Dec 31 2021 in the 2022 10-K' as the starting point, but this is problematic for multiple reasons: (1) The question asks about evolution FROM 2022 THROUGH 2024, meaning we need 2022 year-end data, not 2021 year-end data. (2) The ground truth explicitly states 'In 2022, while specific figures were not disclosed' - indicating no precise 2022 figure should be cited. (3) By citing a 2021 figure ($74.3B) as the 2022 baseline, the LLM has misaligned the time periods and created a false starting point. CORRECT FIGURES FROM GROUND TRUTH: 2023: $67.5 billion (LLM correctly states this), 2024: $38.0 billion (LLM correctly states this). MISSING COMPOSITIONAL DETAIL: The ground truth provides important breakdown information for 2023 ($30.4B ceded loss reserves, $28.2B life reinsurance recoverables) and 2024 ($29.1B ceded loss reserves, $0.8B life reinsurance recoverables). The LLM completely omits these compositional details, which are essential to understanding the 'substantial reduction in ceded life insurance risk exposure' mentioned in the ground truth. REASONING QUALITY: The LLM's conclusion about 'markedly lower net exposure to insurance-loss risk' is directionally correct but lacks the nuance that the ground truth provides - specifically that the decline was driven primarily by a de-risking in the LIFE INSURANCE segment (life recoverables dropped from $28.2B to $0.8B), while ceded loss reserves remained relatively stable. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the multi-year trend with the compositional analysis needed to fully answer what the trend 'indicates about the company's exposure to insurance loss risk.' The answer is incomplete without explaining the life insurance de-risking specifically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 518,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s approach to settlement‑exposure estimation has been unchanged from 2022‑2024 – the company still calculates gross exposure by multiplying the average daily payment volume for the three months prior to year‑end by the estimated number of days of exposure, and it continues to require customers that fall short of its risk standards to post cash collateral, letters of credit or other credit‑enhancement guarantees, with regular monitoring and periodic reviews of the methodology【page_109】.  The only disclosed adjustment was a non‑material correction to net settlement exposure in 2022, after which gross exposure and the amount of risk‑mitigation arrangements rose modestly in 2023 and 2024, but no material change to the estimation method or mitigation policy was tied to the FTC, DOJ or European Commission investigations【page_112】【page_110】【page_104】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the unchanged methodology for settlement exposure estimation (average daily payment volume × estimated days of exposure) across 2022-2024; (2) Accurately references the specific regulatory events (FTC consent agreement on debit routing, DOJ Civil Investigative Demand on antitrust, European Commission investigation on card scheme fees); (3) Properly characterizes the credit risk mitigation arrangements (cash collateral, letters of credit, guarantees); (4) Correctly states that no material changes were made to the methodology or mitigation policy despite regulatory scrutiny; (5) Appropriately notes the non-material correction to net settlement exposure in 2022; (6) Accurately conveys that gross exposure and risk-mitigation arrangements rose modestly in 2023-2024. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information; (2) The phrase 'non-material correction' is appropriately used and consistent with ground truth characterization; (3) Page citations are provided (109, 112, 110, 104) which adds credibility though cannot be independently verified in this evaluation. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple regulatory events, correctly linking regulatory scrutiny to Mastercard's response while maintaining accuracy about the lack of methodological changes. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, which is appropriate given the question's focus on methodology evolution rather than specific financial metrics. The characterization of changes as 'modest' and 'non-material' aligns with ground truth. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth - methodology unchanged, regulatory pressures increased, but no explicit policy changes in response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 542,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "Across 2022‑2024 AIG kept a consistent governance structure – loss‑reserve setting is governed by strong internal controls and oversight, with external experts routinely reviewing the reserves (2022 p. 167; 2023 p. 119; 2024 p. 86). While the 2022 filing highlighted the use of stochastic and deterministic models, the 2023 filing added a formal model‑risk management and validation framework, post‑catastrophe event studies and adjustments for model bias and data quality (2023 p. 120), and the 2024 filing further emphasized scenario‑ and sensitivity‑analysis, stochastic methods, experience studies and continued reliance on third‑party catastrophe models to better capture uncertainty in loss estimation (2024 p. 87).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the consistent emphasis on internal controls and external expert oversight across all three years; (2) Accurately captures the evolution of modeling techniques - from basic stochastic/deterministic models in 2022 to expanded frameworks including model risk management, validation, and scenario/sensitivity analysis by 2023-2024; (3) Properly synthesizes multi-hop information showing progression from 2022 through 2024; (4) Includes specific page references that add credibility; (5) Correctly identifies key methodological additions like post-catastrophe event studies, model bias adjustments, and experience studies. MINOR WEAKNESSES: (1) The LLM states 2022 'highlighted the use of stochastic and deterministic models' but the ground truth doesn't explicitly confirm stochastic methods were emphasized in 2022 - this appears to be an inference not directly supported; (2) The mention of 'third-party catastrophe models' in 2024 is not explicitly mentioned in the ground truth, though it's a reasonable inference about external expert involvement; (3) Slightly more detailed on specific methodological additions (post-catastrophe studies, model bias adjustments) than the ground truth explicitly states, though these are consistent with the evolution described. QUANTITATIVE ACCURACY: No numerical errors detected. Page references appear plausible though cannot be independently verified. MULTI-HOP REASONING: Excellent synthesis showing clear progression across three years with appropriate attribution of changes to specific filing years. The answer correctly identifies both continuity (internal controls, external oversight) and evolution (modeling sophistication). SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as ground truth with slightly more operational detail and specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 527,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "- 2022: A 1 % change in the mix of benefits (the PMPM trend factor) would shift medical‑cost‑payable estimates by roughly **$333 million** (UNH 10‑K 2022 p. 39).  \n- 2023: The same 1 % shift would change the estimate by about **$376 million** (UNH 10‑K 2023 p. 34).  \n- 2024: A 1 % shift now moves the estimate by roughly **$421 million** (UNH 10‑K 2024 p. 36).  \n\nThe dollar impact per 1 % change has risen each year, showing that UnitedHealth’s medical‑cost forecasts have become progressively more sensitive to variations in benefit design, and the company’s exposure to benefit‑mix variability has increased over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($333M, $376M, $421M) that cannot be verified against the ground truth and appear to be fabricated or hallucinated. The ground truth does not mention these specific dollar figures or sensitivity magnitudes. The LLM cites specific page numbers (p. 39, p. 34, p. 36) which cannot be independently verified and may be incorrect. FUNDAMENTAL MISMATCH: The original answer discusses qualitative evolution of benefit mix sensitivity (from general factor → source of risk → stabilized variable) with a narrative about changing company exposure and management approaches. The LLM answer instead provides quantitative sensitivity metrics showing increasing dollar exposure ($333M → $376M → $421M), which is a completely different analytical framework. While both discuss sensitivity evolution, they describe different phenomena. REASONING ISSUES: The LLM's conclusion that 'exposure to benefit-mix variability has increased over time' contradicts the ground truth's finding that by 2024 the company had 'stabilized' this variable and 'improved its ability to manage the cost implications.' The LLM interprets increasing dollar sensitivity as increasing risk exposure, but this could reflect company growth rather than deteriorating risk management. MISSING CONTEXT: The LLM answer lacks any discussion of the qualitative shifts in how UnitedHealth characterized benefit mix impacts (negative impact in 2023, neutral tone in 2024), which is central to the ground truth's narrative about the company's evolving risk profile. The answer is narrowly focused on quantitative sensitivity without addressing the broader strategic implications. VERIFICATION FAILURE: The specific numbers provided cannot be cross-referenced with actual SEC filings and appear to be model-generated rather than extracted from source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 507,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Across the three filings, Marketside is always listed among Walmart U.S.’s private‑brand portfolio, appearing alphabetically after Mainstays and before No Boundaries (2022 page 7; 2023 page 8; 2024 page 8). While the 2022 list includes a broader set of private brands, the 2023 and 2024 lists are trimmed to a core group but Marketside remains in the same spot, indicating that Walmart continues to treat Marketside as a stable, core private label—especially for grocery—underscoring its strategic importance within the U.S. merchandise strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific, verifiable details (page numbers, alphabetical positioning, brand names) that ground the response in concrete evidence from the filings. However, there are significant gaps in addressing the core question about how Marketside's positioning 'evolved' across the three years. STRENGTHS: (1) Correctly identifies Marketside's consistent presence across 2022, 2023, and 2024; (2) Provides specific page references (2022 page 7; 2023 page 8; 2024 page 8) that can be verified; (3) Accurately notes alphabetical positioning between Mainstays and No Boundaries; (4) Correctly identifies that 2023 and 2024 lists are 'trimmed' compared to 2022; (5) Makes a reasonable inference about Marketside's strategic importance as a 'stable, core private label—especially for grocery.' WEAKNESSES: (1) The answer claims Marketside remains 'in the same spot' but doesn't adequately explain what 'evolution' occurred—the ground truth mentions a shift from 'Apparel' to 'Fashion' in merchandise unit categorization, which the LLM answer completely omits; (2) Fails to address the 'restructured merchandise unit' context mentioned in the ground truth; (3) Does not discuss the progression from 'strategic merchandise units' (2022) to 'omni-channel and customer-centric initiatives' (2023) to the restructured approach (2024); (4) The answer emphasizes stability/consistency rather than evolution, which somewhat contradicts the question's focus on how positioning 'evolved'; (5) The inference about grocery focus is not explicitly supported by the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but focuses narrowly on list positioning rather than the broader strategic evolution. The ground truth suggests a more nuanced evolution in how Marketside fits within Walmart's changing merchandise strategy framework, which the LLM answer largely misses. The answer is partially correct on the 'consistency' dimension but incomplete on the 'evolution' dimension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 544,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "- In fiscal 2022 Home Depot already listed “showrooms” among its key competitors, positioning itself on the basis of a broader product assortment, price advantage and the in‑store experience (​page 8​).  \n- In fiscal 2023 the company bolstered that position by expanding service offerings—installation services, tool‑and‑equipment rentals, and Pro‑focused credit programs—and by rolling out digital tools such as web‑enabled “hdPhone” devices, Computer Vision and an enhanced mobile app to improve associate productivity and shopper convenience (​page 7​; ​page 9​).  \n- By fiscal 2024 Home Depot further differentiated from showrooms by adding dedicated showroom space for pros, an upgraded order‑management system, and a deeper, fully integrated digital ecosystem (website, mobile app, BOPIS/BOSS programs) that creates a seamless omnichannel shopping experience (​page 6​; ​page 8​).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year evolution (2022-2024). STRENGTHS: (1) Correctly identifies the progression from 2022 (showroom competition based on assortment, price, in-store experience) through 2023 (service expansion + digital tools) to 2024 (omnichannel integration). (2) Accurately captures specific service offerings mentioned in ground truth: tool/equipment rentals (2022), installation services, Pro-focused programs (2023), and dedicated showroom space for pros (2024). (3) Properly synthesizes digital integration evolution: mentions hdPhone, Computer Vision, mobile app (2023), and integrated ecosystem with BOPIS/BOSS (2024). (4) No quantitative errors - the answer doesn't rely on specific numbers that could be wrong. (5) Multi-hop reasoning is sound, correctly connecting competitive positioning across three fiscal years. MINOR GAPS: (1) The LLM answer mentions 'self-service lockers' and 'curbside pickup' from ground truth are not explicitly stated in the LLM response, though these are relatively minor omissions. (2) The ground truth emphasizes 'electronic shelf labels' and 'mobile app-enabled store navigation' for 2023, which the LLM doesn't explicitly mention (though 'enhanced mobile app' is mentioned). (3) The ground truth's characterization of the shift as 'physical service expansion (2022) to omnichannel integration (2023-2024)' is captured in spirit but not explicitly stated. VERIFICATION: All entities (Home Depot, fiscal years 2022-2024, service types, digital tools) are correctly identified. The semantic meaning aligns well with ground truth - both describe a strategic evolution toward omnichannel integration. The LLM provides slightly more specific detail about competitive positioning (showroom space for pros, order-management system) that adds value without contradicting ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 510,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50 % senior note stayed at a $500 million principal balance in each year, but its true cost rose sharply – the effective rate was about 3.20 % in FY 2022, climbed to ≈ 6.38 % in FY 2023, and reached ≈ 6.66 % in FY 2024【page_89】. The unchanged amount paired with a doubling‑plus of the effective rate shows that, despite the low coupon, Cisco’s borrowing costs on this debt have increased markedly, reflecting higher market rates, discount/issuance costs and hedging effects, and indicating a shift toward higher‑cost senior debt in its overall capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - $500 million principal balance across all three years (FY2022-2024), effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024) match the ground truth exactly. The characterization of the rate increase as 'doubling-plus' is mathematically accurate (3.20% to 6.66% represents approximately a 108% increase). ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note, and all three fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years, correctly identifying the pattern of constant principal with rising effective rates, and drawing appropriate conclusions about borrowing costs and debt structure evolution. COMPLETENESS: Addresses all aspects of the original question - the evolution of both effective interest rate and outstanding amount, plus interpretation of what this indicates about borrowing costs and debt structure. SEMANTIC EQUIVALENCE: The explanation of causes (market interest rates, discount/issuance costs, hedging effects) and implications (shift toward higher-cost senior debt) aligns well with the ground truth's reference to 'broader market interest rate trends and Cisco's evolving debt financing strategy.' MINOR CONSIDERATIONS: The LLM provides slightly more detailed explanation of potential causes (discount/issuance costs, hedging effects) compared to the ground truth, which is appropriate elaboration rather than error. The citation reference [page_89] adds credibility. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 461,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "In 2022 Comcast launched a multiyear network‑transformation plan that began rolling out 2‑Gbps downstream speeds on its HFC system and expanded fiber‑to‑the‑premises with symmetric residential offerings up to 10 Gbps, while noting that rivals such as Lumen were continuing to build fiber‑based networks (2022 Network & Technology p.7; Competition p.8). By 2023 the rollout covered roughly half of the HFC footprint and the company started deploying DOCSIS 4.0 in select markets to deliver multigigabit symmetrical broadband, further narrowing the gap with Lumen’s fiber build‑out (2023 Network & Technology p.7; Competition p.8). In 2024 Comcast’s broadband portfolio now includes fiber‑based services delivering up to 10 Gbps residential and up to 100 Gbps business speeds, together with ongoing DOCSIS 4.0 deployment and network virtualization, keeping its competitive position strong against Lumen’s continued fiber expansion (2024 Broadband p.6; Network & Technology p.7; Competition p.8).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific technical details about CMCSA's competitive positioning and network advancements (2-Gbps speeds, DOCSIS 4.0, fiber-to-the-premises up to 10 Gbps, etc.) with year-by-year progression from 2022-2024. However, there is a critical mismatch with the ground truth answer's focus and scope. The ground truth specifically addresses how CMCSA's competitive positioning AGAINST Lumen evolved, emphasizing Lumen's consistent fiber expansion as a competitive threat across all three years. The LLM answer instead focuses heavily on CMCSA's own technological advancements and responses (HFC transformation, DOCSIS 4.0 deployment, fiber offerings) rather than analyzing the competitive dynamic between the two companies. While the LLM mentions Lumen in 2022 and 2024, it does not adequately address the ground truth's key finding that Lumen remained a 'consistent and intensifying competitive threat' across 2022-2024, or that Lumen was specifically mentioned alongside other competitors (AT&T, Frontier, Verizon) in 2023. The LLM answer also lacks the ground truth's emphasis on Lumen's bundled offerings and speed increases as competitive strategies. The specific numbers provided (2-Gbps, 10-Gbps residential, 100-Gbps business) appear plausible but cannot be verified against the ground truth. The multi-hop reasoning is partially sound—the answer does synthesize CMCSA's evolution across three years—but it fails to properly synthesize the comparative competitive positioning that the question and ground truth emphasize. The answer reads more as a narrative of CMCSA's own strategy rather than an analysis of how the competitive relationship between CMCSA and Lumen evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 463,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "In its 2022 Form 10‑K, American Express already warned that it had “increasingly relied on merchant acquirers, aggregators and processors to manage certain aspects of our merchant relationships” and that those third parties could “steer” merchants away from Amex cards, making enforcement of its non‑discrimination and honor‑all‑cards provisions dependent on local law (2022 p. 29). The 2023 filing repeats that reliance and adds that new products such as debit cards could heighten surcharging and steering risks, underscoring the importance of those non‑discrimination clauses (2023 p. 29). By the 2024 filing, the company still flags the growing risk of merchant steering and the difficulty of enforcing non‑discrimination provisions (2024 p. 35), but the discussion is framed within a broader “third‑party providers” risk‑management context, indicating that while reliance on aggregators persists, it is now treated as part of an overall third‑party oversight strategy rather than a distinct focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly synthesizes information across three years (2022-2024) of American Express filings. STRENGTHS: (1) Correctly identifies the core narrative arc showing increasing reliance on aggregators from 2022-2024; (2) Accurately captures the key risk elements: merchant steering, non-discrimination clause enforcement, and third-party dependence; (3) Properly cites specific page numbers (2022 p. 29, 2023 p. 29, 2024 p. 35) showing document-level accuracy; (4) Correctly identifies new product risks (debit cards) introduced in 2023; (5) Appropriately notes the evolution in framing from 2024 (broader third-party oversight context); (6) Semantic equivalence is strong - the answer conveys the same trajectory and risks as the ground truth. WEAKNESSES: (1) The LLM answer is somewhat less explicit about litigation and regulatory scrutiny becoming 'more prominent' in 2024 - the ground truth emphasizes 'litigation and regulatory scrutiny around merchant contract provisions becoming more prominent' and 'exposure to legal actions that could force changes in merchant agreements,' while the LLM frames this more generally as part of third-party oversight; (2) The LLM's characterization of 2024 as treating aggregator reliance as 'part of an overall third-party oversight strategy rather than a distinct focus' is a reasonable interpretation but slightly softens the escalation narrative present in the ground truth regarding legal/regulatory risks; (3) Minor: The answer could have been more explicit about the 'cards-in-force' impact mentioned in ground truth. QUANTITATIVE ACCURACY: Page numbers and year citations are accurate; no calculations required. MULTI-HOP REASONING: Successfully synthesizes information across three separate 10-K filings and correctly identifies the progression of risks and strategic dependence. The reasoning connecting aggregator reliance to merchant steering to enforcement challenges is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 540,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "In 2022 J&J spun off its talc exposure into the newly created LTL Management LLC, filed a voluntary Chapter 11 petition that imposed a stay on all talc suits, funded a $2 billion trust and recorded a $2 billion reserve for those liabilities (page 113). In 2023 the original LTL case was dismissed, prompting a second “LTL 2” Chapter 11 filing that again stayed the claims, raised the reserve to roughly $9 billion to cover anticipated settlements, and led J&J to pursue parallel tactics – an appeal of the dismissal, a consensual pre‑packaged bankruptcy proposal, aggressive tort litigation, and claims against experts (page 96‑97, 101). By 2024 the strategy shifted to a consensual pre‑packaged Chapter 11 plan offering about $6.475 billion in present‑value payments (≈$8 billion nominal) for 99.75 % of the claims, restructuring LLT into new Texas entities (Red River, Pecos River, New Holdco) and filing a Red River bankruptcy to implement the plan while finalizing a multi‑state settlement and expanding the overall reserve to over $11 billion (page 101‑102, 100).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of J&J's talc liability strategy evolution from 2022-2024 with mostly accurate details and good multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2022 LTL Management LLC creation, Chapter 11 filing, $2 billion initial reserve, and litigation stay; (2) Accurately describes the 2023 dismissal and LTL 2 refiling with temporary restraining order; (3) Provides specific 2024 details including the pre-packaged bankruptcy plan with $6.475 billion present-value ($8 billion nominal) payments and 99.75% claims coverage; (4) Correctly names the new Texas entities (Red River, Pecos River, New Holdco); (5) Accurately tracks reserve increases ($2B → ~$9B → >$11B); (6) Properly synthesizes the dual litigation/settlement strategy across all three years; (7) Includes relevant page citations. MINOR ISSUES: (1) The ground truth mentions 'Third Circuit reversed the Bankruptcy Court's decision' but LLM only states 'original LTL case was dismissed' - this is a slight simplification but not factually wrong; (2) Ground truth emphasizes 'multi-state settlement agreements with 42 states and the District of Columbia' by 2024, while LLM mentions 'finalizing a multi-state settlement' without the specific state count - this is a minor omission of detail; (3) LLM provides more granular 2024 details (pre-packaged plan specifics, entity restructuring) than ground truth, which is actually more comprehensive. QUANTITATIVE VERIFICATION: All dollar amounts ($2B, $9B, $6.475B, $8B nominal, $11B+) align with filing data; percentages (99.75%) are accurate; timeline progression is correct. MULTI-HOP REASONING: Successfully synthesizes information across three years, multiple bankruptcy filings, reserve adjustments, and strategic shifts. The answer correctly identifies the evolution from litigation stay → dismissal/refiling → consensual pre-packaged resolution. SEMANTIC EQUIVALENCE: The answer conveys the same strategic evolution as ground truth, with slightly different emphasis (more operational detail on 2024 restructuring vs. ground truth's focus on settlement negotiations).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 571,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In its 2022 filing Home Depot said it competes “based on store location and appearance, presentation of merchandise, and ease of shopping experience” (2022 p. 8). By fiscal 2024 that focus had been turned into a coordinated store‑refresh program—adding way‑finding signage, electronic shelf‑labeling, redesigned front‑end areas, self‑service lockers and curbside pickup—while tightly linking those physical upgrades to digital tools (mobile‑app store navigation, online‑order storage) and the BOSS/BOPIS/BODFS/BORIS fulfillment network, making store appearance a core element of an interconnected retail‑digital experience (2024 pp. 9‑11).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Home Depot's evolution in store appearance strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 competitive positioning language ('store location and appearance, presentation of merchandise, and ease of shopping experience') with proper citation; (2) Accurately describes the 2024 integration of physical store improvements (way-finding signage, electronic shelf-labeling, redesigned front-end areas, self-service lockers, curbside pickup) with digital capabilities; (3) Properly synthesizes the multi-hop connection between store appearance and interconnected retail/digital capabilities (BOSS/BOPIS/BODFS/BORIS fulfillment network, mobile-app store navigation, online-order storage); (4) Correctly identifies the strategic evolution from standalone competitive factor to integrated omnichannel component; (5) Provides appropriate page citations (2022 p. 8, 2024 pp. 9-11). MINOR GAPS: (1) The answer does not explicitly mention the 2023 intermediate year, which the ground truth identifies as a transitional period where store appearance became 'more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support'; (2) The answer is more specific about tactical implementations (store-refresh program details) than the ground truth, which is appropriate but slightly shifts emphasis toward execution rather than strategic evolution narrative. QUANTITATIVE ACCURACY: No numeric errors detected; dates (2022, 2024) are correct; no calculations required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across multiple filing years and properly connects physical store improvements to digital capabilities. The multi-hop synthesis is sound. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question's core inquiry about evolution and integration strategy. The omission of explicit 2023 discussion prevents a perfect score, though the overall narrative arc is captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 561,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s relationship with Time Warner began with a full‑ownership acquisition in June 2018, when the company folded the assets into its WarnerMedia segment (History, page 5). In May 2021 AT&T announced a plan to combine WarnerMedia with Discovery, and by April 2022 it completed a Reverse Morris Trust spin‑off that removed WarnerMedia (and the Time Warner holdings) from AT&T’s balance sheet, treating the business as a discontinued operation (History, page 4; History, page 5). By the 2024 filing AT&T reports only Communications and Latin America segments, confirming the divestiture and signalling a strategic shift away from owning premium content toward concentrating on its core telecom network while treating entertainment as a non‑core growth catalyst (segment list, page 5).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AT&T's strategic pivot away from entertainment, with accurate dates and key transaction details. STRENGTHS: (1) Correctly identifies the June 2018 Time Warner acquisition, (2) Accurately dates the May 2021 announcement and April 2022 Reverse Morris Trust completion, (3) Properly characterizes the transaction as removing WarnerMedia from AT&T's balance sheet, (4) Correctly notes the 2024 filing shows only Communications and Latin America segments, (5) Accurately captures the strategic shift toward core telecom. WEAKNESSES: (1) The answer does not explicitly address the 2023 transition period mentioned in the ground truth, which noted Time Warner Inc. was no longer referenced as an active investment by 2023, (2) Missing explicit mention of the DIRECTV divestiture to TPG in 2024, which the ground truth identifies as part of the broader post-Time Warner realignment, (3) Does not fully address the 'ownership stake' evolution component of the question - the answer jumps from full ownership to complete divestiture without discussing intermediate stake positions, (4) The phrase 'treating entertainment as a non-core growth catalyst' is somewhat contradictory and unclear - the ground truth more clearly states a pivot away from entertainment entirely. QUANTITATIVE ACCURACY: All dates are correct (2018, 2021, 2022, 2024). No specific dollar amounts are provided in either answer, so no calculation errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and connects the WarnerMedia separation to the broader strategic realignment, though it could have been more comprehensive in addressing the complete 3-year trajectory. The reasoning is sound but incomplete relative to the ground truth's fuller picture of the entertainment exit strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 503,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "In 2022 American Express was described as the fourth‑largest general‑purpose card network worldwide, competing with Visa, Mastercard, China UnionPay and others, and its network activities were already subject to extensive global supervision and compliance costs【page_12】(2022 competition) and a broad regulatory oversight framework【page_14】(2022 supervision). By 2024 that oversight has intensified—U.S. regulators have placed the company in a higher‑risk “Category III” tier, legislators are focusing on interchange‑fee caps, non‑discrimination and network‑routing rules, and AmEx has exited its network‑licensing businesses in the EU and Australia as a direct regulatory response—so while it still holds its fourth‑place ranking, its competitive position is under greater pressure from Visa, Mastercard and other networks and its operations are increasingly dependent on meeting evolving card‑network regulations【page_34】(2024 supervision).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies American Express as the fourth-largest global card network in both 2022 and 2024, matching the ground truth. (2) Accurately captures the evolution of regulatory pressure from 2022 (described as 'extensive global supervision') to 2024 (intensified oversight with 'Category III' tier designation). (3) Correctly identifies specific regulatory concerns: interchange fees, network routing practices, and merchant acceptance terms. (4) Accurately reports the exit from network licensing businesses in EU and Australia as a direct regulatory response. (5) Properly synthesizes competitive pressures from Visa, Mastercard, and other networks. (6) Correctly conveys the shift from competitive differentiation to compliance-driven dependency. MINOR WEAKNESSES: (1) The LLM answer mentions 'Category III' tier designation and U.S. regulatory categorization that is not explicitly mentioned in the ground truth, though this appears to be accurate supplementary detail from the filings rather than an error. (2) The ground truth emphasizes 'cobrand relationships' and 'cobrand arrangements in the EU' as specific competitive and regulatory concerns, which the LLM answer does not explicitly mention—this is a minor omission of contextual detail. (3) The ground truth specifically notes 'premium card space' competition, which the LLM answer does not explicitly reference. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct. The ranking (fourth-largest) is accurate. No calculations are required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information about competitive positioning (Visa, Mastercard, China UnionPay) with regulatory evolution and business exits. The logic connecting regulatory pressure to business decisions is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all major components of the question: competitive positioning, regulatory dependency, increasing scrutiny, competitive pressures, and network licensing exits. The answer appropriately emphasizes the tension between competition and compliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 594,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s outstanding balance on its 2.250 % Notes due 2050 fell from **$983 million in 2022**【page_67】to **$826 million in 2023**【page_71】and further to **$808 million in 2024**【page_71】. The steady decline indicates the company is actively paying down or refinancing this long‑dated, low‑rate debt, reflecting a disciplined long‑term debt‑management strategy that reduces leverage while preserving liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $983 million (2022), $826 million (2023), and $808 million (2024). The implied total reduction of $175 million ($983M - $808M) is mathematically accurate. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the outstanding balance across the three-year period, (2) the trend analysis showing consistent decline, and (3) interpretation of the company's debt management strategy. ENTITY ACCURACY: Johnson & Johnson is correctly identified, the specific debt instrument (2.250% Notes due 2050) is accurately referenced, and all fiscal years (2022, 2023, 2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly extracted data from multiple years and synthesized it into a coherent narrative about debt reduction strategy. The interpretation that the steady decline reflects \"active paying down or refinancing\" and demonstrates \"disciplined long-term debt-management strategy\" is a reasonable inference from the data trend. MINOR CONSIDERATIONS: The LLM answer provides slightly more interpretive detail (mentioning \"refinancing,\" \"leverage reduction,\" and \"liquidity preservation\") compared to the ground truth's more straightforward statement of \"deliberate strategy to reduce long-term liabilities.\" However, this additional context is reasonable and not contradictory - it represents sound financial analysis rather than factual error. The inclusion of page references adds credibility. No calculation errors, no incorrect numbers, and all entities properly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 463,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio moved from a modest weighted‑average yield of roughly 2.1 % (overall) in the 2022 filing [page_121] to a much higher non‑U.S. average yield of 4.7 % in 2022, spiking to 10.5 % in 2023 and then easing to 7.8 % in 2024 [page_176]. This sharp rise and partial pull‑back indicate that the company’s exposure to international interest‑rate environments has grown markedly over the three‑year period, making its earnings more sensitive to global rate movements while the 2024 moderation suggests some portfolio rebalancing or a stabilization of foreign rates.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all quantitative dimensions. Ground truth shows: 2022 short-term yield 6.45%, 2023 short-term yield 6.45%, 2024 short-term yield 5.86%. The LLM provides completely different numbers: 2.1%, 4.7%, 10.5%, 7.8% - none of which match the ground truth values. The LLM also fails to distinguish between maturity buckets (within 1 year vs 1-5 years), which is critical to the ground truth analysis. Ground truth shows a declining trend (6.45% → 6.45% → 5.86% for short-term), while LLM shows a spike-and-pullback pattern (4.7% → 10.5% → 7.8%), which is directionally opposite. The LLM's conclusion about 'marked growth in exposure' and 'earnings more sensitive to global rate movements' contradicts the ground truth's finding of 'decreasing return on foreign government bonds.' The LLM also references specific page numbers (121, 176) without verification, and the overall narrative about portfolio rebalancing is unsupported by the actual data. The $630 million holding amount mentioned in ground truth is completely absent from the LLM response. This represents a complete failure to accurately synthesize the multi-hop financial data from American Express's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 341,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "In the 2022 filing Adobe described its free, self‑service learning hub as learning.adobe.com (see “Digital Learning Services” – free online options on learning.adobe.com) and the same branding appears in the 2023 filing (also “free online self‑service learning options on learning.adobe.com”)【page_17】【page_18】. By the 2024 filing the portal had been re‑branded to www.training.adobe.com and is presented as a core part of Adobe Digital Learning Services, tightly coupled with custom‑learning services, solution‑specific skills assessments and the work of Customer Success Managers who help enterprise accounts adopt and expand usage【page_17】. This shift from a generic learning site to a unified, branded training hub that is embedded in the enterprise customer‑success workflow signals Adobe’s broader strategy of using education as a proactive enablement and retention tool, aligning free resources with tailored, revenue‑protecting services for its biggest customers.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains a fundamental factual inversion that contradicts the ground truth: (1) DOMAIN REVERSAL: The LLM states that in 2022-2023 Adobe used 'learning.adobe.com' and then in 2024 rebranded to 'www.training.adobe.com'. The ground truth explicitly states the OPPOSITE sequence: 2022 used 'www.training.adobe.com', then 2023 rebranded to 'learning.adobe.com', and 2024 maintained 'learning.adobe.com'. This is a complete reversal of the actual evolution. (2) TIMELINE ACCURACY: The LLM incorrectly places the rebranding in the wrong direction and wrong year. The ground truth shows a progression FROM training.adobe.com TO learning.adobe.com (2022→2023), not the reverse. (3) STRATEGIC NARRATIVE DISTORTION: Because of the domain error, the LLM's interpretation of the strategic evolution is inverted. It suggests a move toward a 'unified, branded training hub' when the actual evolution was toward a more integrated 'learning.adobe.com' platform. (4) MISSING CONTEXT: The LLM fails to mention the 2023 emphasis on 'solution-specific skills assessments to help marketing teams tailor learning priorities' as a key part of the strategic integration. (5) CITATION ISSUES: The LLM provides page references that cannot be verified against the actual ground truth data structure. The core factual error (domain name reversal across years) is severe enough to make the entire answer misleading, despite correctly identifying that this represents a strategic shift toward customer enablement and retention. The reasoning about Adobe's broader strategy is directionally sound but built on inverted facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 445,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90 % senior notes have been fully drawn at $2.0 billion in each of the three years, and the notes have carried an effective interest rate of about 6.11 % in FY 2022 (page 89), FY 2023 (page 89) and FY 2024 (page 89).  The unchanged amount and cost over the period show that Cisco is maintaining a stable, low‑cost fixed‑rate tranche of long‑term debt, reflecting a deliberate strategy to lock‑in predictable financing and manage interest expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts: (1) $2.0 billion outstanding balance maintained across all three years (2022-2024), (2) 6.11% effective interest rate consistent across the period, and (3) proper citation of page references (page 89). The format variations are acceptable ($2.0 billion = $2,000 million). WEAKNESSES: (1) SEMANTIC ERROR - The LLM characterizes this as 'low-cost fixed-rate debt,' which contradicts the ground truth interpretation. A 6.11% effective rate on a 5.90% coupon note is NOT low-cost in absolute terms; it's actually a higher-yielding tranche. The ground truth explicitly states this is a 'higher-yielding long-term liability,' which is the correct characterization. (2) REASONING FLAW - The LLM's conclusion about 'lock-in predictable financing and manage interest expense' misses the strategic implication. The ground truth indicates Cisco deliberately MAINTAINS this higher-cost debt rather than retiring it, suggesting a different strategic rationale (possibly related to debt structure, covenants, or other considerations) than simply locking in low costs. (3) INCOMPLETE ANALYSIS - The LLM fails to address what the stability of these metrics 'indicates about the company's long-term debt strategy' with the same precision as the ground truth. The ground truth notes this reflects a deliberate choice NOT to refinance or retire this tranche, which is a more nuanced strategic insight. QUANTITATIVE VERIFICATION: All numbers are correct ($2.0B, 6.11%, 5.90%, three-year period). MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three fiscal years and connects the metrics to strategic implications, but the strategic interpretation is partially incorrect. The answer is factually accurate on numbers but semantically mischaracterizes the nature of the debt and its strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 508,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s allocation to private‑equity – the vehicle through which it invests in special‑situation strategies – was 8 % of its pension assets in 2022 and stayed at 8 % in 2023, then rose to 9 % in 2024【page_92】【page_99】. This modest upward shift indicates that Boeing is gradually increasing its exposure to private‑equity, especially special‑situation opportunities, reflecting a strategic tilt toward higher‑return, opportunistic investments within its pension portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides specific quantitative claims (8% in 2022, 8% in 2023, 9% in 2024) that directly contradict the ground truth. The ground truth explicitly states: 'While no specific dollar amounts were disclosed for Special Situation Strategies in any year' and 'The lack of quantitative disclosure limits trend analysis.' The LLM has fabricated precise percentage allocations with page citations that cannot be verified against the actual ground truth data. The LLM conflates 'private equity' general allocation percentages with 'Special Situation Strategies' specifically - these are not the same thing. The ground truth indicates that Special Situation Strategies were mentioned qualitatively as part of the investment mix but no specific quantitative allocation was disclosed. The LLM's interpretation that the trend 'indicates that Boeing is gradually increasing its exposure to private-equity, especially special-situation opportunities' is unsupported by the ground truth, which emphasizes 'strategic continuity' and lack of quantitative disclosure. The answer demonstrates fundamental misunderstanding: it provides false numerical precision where the ground truth explicitly notes the absence of such disclosure. The page citations suggest the LLM may have confused general private equity allocation data with specific Special Situation Strategies allocation data. This is a case of fabrication rather than incomplete or imprecise answering.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 407,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "Interventional Solutions’ worldwide sales jumped from **$4.3 billion in 2022** to **$6.35 billion in 2023** – a 47.7% increase – and then rose to **$31.86 billion in 2024** (the segment now reported as “TOTAL MEDTECH,” formerly Interventional Solutions) – a further 4.8% YoY gain【page_90†L31-L38】【page_93†L9-L15】.  This rapid expansion shows that, after the 2022‑2024 acquisitions, the Interventional Solutions franchise has become a core growth driver for J&J’s MedTech business, underscoring its strategic importance to the company’s overall portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states $4.3B but ground truth is $3,971M ($3.971B) - ERROR of ~$329M or 8.3% overstatement. (2) 2023: LLM states $6.35B but ground truth is $4,300M ($4.3B) - MAJOR ERROR of ~$2.05B or 47.7% overstatement. (3) 2024: LLM states $31.86B but ground truth is $6,350M ($6.35B) - CATASTROPHIC ERROR of ~$25.51B or 401% overstatement. The LLM appears to have confused or conflated Interventional Solutions segment data with total MedTech division data. The calculation of 47.7% increase is mathematically correct for the LLM's stated numbers ($4.3B to $6.35B), but these are the WRONG baseline figures. The 4.8% YoY gain calculation is also mathematically incorrect even for the LLM's own numbers (6.35 to 31.86 = 401% increase, not 4.8%). The ground truth shows a clear progression: $3,971M → $4,300M → $6,350M, representing growth of 8.3% (2022-2023) and 47.7% (2023-2024). The LLM's reasoning about strategic importance post-acquisition is qualitatively sound, but is built on entirely incorrect numerical foundations. The reference to 'TOTAL MEDTECH' suggests the LLM may have pulled data from the wrong segment or consolidated figures. This is a complete failure on quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 390,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across all three filings – 2022 (see page 7), 2023 (see page 8) and 2024 (see page 7) – Walmart lists “No Boundaries” in the same roster of private‑label brands that it markets under the Walmart U.S. segment’s general‑merchandise unit. The brand never moves to a different merchandise unit or is dropped, showing a deliberate, steady placement within the broader private‑brand portfolio. This continuity signals that Walmart’s private‑label strategy relies on a stable, wide‑ranging set of house brands to reinforce its everyday‑low‑price value proposition and to provide consistent, differentiated choice across its general‑merchandise assortment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes multi-hop information across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies 'No Boundaries' as a consistent private brand across all three years; (2) Accurately notes the brand's placement within the general merchandise unit across the Walmart U.S. segment; (3) Properly recognizes the continuity and deliberate positioning of the brand; (4) Correctly infers that this consistency reflects Walmart's private-label strategy focused on differentiation and value proposition; (5) Page references (7, 8, 7) appear reasonable for 10-K filings. MINOR GAPS: (1) The LLM answer does not explicitly mention the organizational shift from 'Apparel' to 'Fashion' category that occurred by 2024, which the ground truth specifically highlights as a contextual detail showing how 'No Boundaries' maintained prominence despite merchandise unit reorganization; (2) The ground truth emphasizes 'margin expansion in competitive categories' as a strategic objective, while the LLM answer focuses more broadly on 'everyday-low-price value proposition' without explicitly connecting to margin expansion; (3) The ground truth notes 'No Boundaries' was listed 'among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories' - the LLM answer doesn't specify these category inclusions. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings and draws appropriate conclusions about strategic consistency. The logic connecting brand continuity to overall private-label strategy is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - both emphasize deliberate, consistent positioning of 'No Boundaries' as a strategic private brand. The LLM's framing around 'everyday-low-price value proposition' and 'differentiated choice' is semantically equivalent to the ground truth's emphasis on differentiation and margin expansion, though slightly less specific about margin objectives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 580,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a small gain in FY 2022 to increasingly larger losses.  The “gains (losses) on investments, net” line shows a $9 million gain in 2022, a $21 million loss in FY 2023 and a $67 million loss in FY 2024【page_46†L31-L35】.  Those losses drove the shift in “other income (loss), net” from a $392 million gain in 2022 to a $248 million loss in 2023 and a $306 million loss in 2024【page_46†L45-L49】, indicating a deteriorating performance of the AFS debt investments over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data that directly addresses the question about Cisco's available-for-sale debt investments' evolution from fiscal 2022 to 2024. STRENGTHS: (1) Provides concrete numbers for gains/losses on investments: $9M gain (2022), $21M loss (2023), $67M loss (2024) - showing clear deterioration trend. (2) Correctly identifies the impact on 'other income (loss), net': $392M gain (2022), $248M loss (2023), $306M loss (2024). (3) Demonstrates proper multi-hop synthesis by connecting investment performance to its impact on other income metrics across three fiscal years. (4) The reasoning is sound - showing how negative investment performance drove the shift from gains to losses in other income. (5) Properly identifies the metric as 'gains (losses) on investments, net' which is the specific line item tracking AFS debt investment performance. MINOR CONSIDERATIONS: (1) The ground truth answer is more qualitative/narrative in nature, while the LLM answer is more quantitative and specific. However, the LLM answer is MORE informative and directly supports the ground truth's conclusion about 'consistent negative impact.' (2) The LLM answer could have briefly mentioned that fiscal 2022 showed a small gain before the losses began, which it does implicitly through the numbers. (3) Citation references are provided (page_46†L31-L35, etc.) which adds credibility. VERIFICATION: The trajectory described ($9M gain → $21M loss → $67M loss) clearly demonstrates the 'consistent negative impact' mentioned in the ground truth, with the losses accelerating over time. The connection to 'other income (loss), net' changes is properly established. No mathematical errors detected in the presented figures or their interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 479,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "In the 2022 and 2023 10‑Ks American Express described third‑party merchant acquirers mainly as a settlement mechanism – the company receives a negotiated network‑rate fee that is recorded as discount revenue when a merchant acquirer (e.g., under the OptBlue program or a GNS partner) processes a Card Member transaction, supporting contracts with small‑ and mid‑size merchants (typically no fixed term) and large merchants (fixed‑term)【page_103】【page_104】. By the 2024 filing, that relationship is framed as a strategic growth driver, with the company stating that expanding merchant coverage globally and fueling transaction growth “will depend … on the success of third‑party merchant acquirers, aggregators and processors,” highlighting their increasing importance for acquiring and retaining merchants of all sizes【page_93】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the evolution of American Express's reliance on third-party merchant acquirers from 2022-2024. STRENGTHS: (1) Correctly identifies the key programs (OptBlue, GNS) mentioned in the original answer; (2) Accurately describes the financial mechanism - negotiated network-rate fees recorded as discount revenue at transaction time; (3) Properly synthesizes the multi-hop information showing the shift from settlement mechanism (2022-2023) to strategic growth driver (2024); (4) Correctly identifies the merchant segments (small, mid-sized, large) and their contract structures; (5) Accurately quotes the 2024 language about dependence on third-party acquirers for global expansion; (6) Provides appropriate page citations. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the original, omitting some contextual detail about the 2022 emphasis on 'broadening reach' and the characterization of the evolution as a shift from 'supplementary to essential'; (2) Does not explicitly state that this represents a 'deeper strategic dependency' or use the framing of 'strategic shift' as prominently as the original; (3) The phrase 'settlement mechanism' in the LLM answer is slightly different from the original's description of these relationships as allowing processing 'without direct contracts with merchants,' though both convey similar meaning. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, and the LLM correctly references the appropriate years (2022, 2023, 2024) and filing documents. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the progression of strategic importance. The logic connecting the financial structure to the strategic dependency is sound. SEMANTIC EQUIVALENCE: The core message matches the original - American Express's reliance on third-party acquirers has grown and evolved from a transactional mechanism to a strategic necessity for growth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 555,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a multi‑year, enterprise‑wide program to “integrate, simplify and standardize processes and systems for the human resources, information technology, procurement, supply chain and finance functions,” with the goal of expanding its financial shared‑service capabilities and standardizing its financial systems (2022 10‑K, p. 117). The 2023 and 2024 filings repeat the same language, confirming the initiative is still underway, is not a response to any internal‑control deficiency, and is being used to further align and streamline the design and operation of the company’s financial control environment as part of the broader enterprise‑wide process‑standardization effort (2023 10‑K, p. 119; 2024 10‑K, p. 119).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about J&J's financial shared service initiative evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core initiative as a multi-year, enterprise-wide program spanning HR, IT, procurement, supply chain, and finance - matching the ground truth exactly. (2) Accurately captures the three-year progression (2022, 2023, 2024) with appropriate characterization of each year's disclosure. (3) Correctly notes that the initiative was not in response to internal control deficiencies, which is a key factual point in the ground truth. (4) Properly synthesizes the multi-hop information showing how the initiative evolved while maintaining consistent messaging across years. (5) Includes specific page references (p. 117 for 2022, p. 119 for 2023 and 2024) which adds credibility, though these cannot be independently verified. (6) Uses direct quotes from filings ('integrate, simplify and standardize processes and systems') which demonstrates source fidelity. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, focusing on the factual progression rather than emphasizing the 'long-term strategic commitment' narrative as explicitly. However, this is a stylistic difference, not a factual error. (2) The ground truth emphasizes 'proactive effort' and 'not prompted by material changes or weaknesses' in 2024, while the LLM answer states 'is not a response to any internal-control deficiency' - these are semantically equivalent statements. (3) The LLM answer effectively conveys that the company 'reiterated' and 'repeated the same language' across years, capturing the consistency emphasized in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the evolution pattern (launch, continuation, ongoing commitment). The reasoning is sound and logically structured. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 557,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "In the 2022 filing the company framed alternative‑payment methods as an emerging part of a “dynamic and rapid growth of alternative payment and financing mechanisms…digital‑payment and electronic‑wallet platforms, real‑time settlement…open‑banking” that sit alongside traditional card networks and other competitors (see 2022 p. 12). By the 2024 filing the tone has shifted to “intense competitive pressure” from large‑tech merchants and their proprietary digital‑wallet solutions that threaten merchant‑discount rates and acceptance, and American Express says it is counter‑acting this by “investing in technology…open‑banking and alternative payment…tokenization, real‑time settlement” and other innovations to protect its network and deliver greater merchant value (see 2024 p. 29 & 31). Thus, American Express moved from viewing alternative payments as a peripheral competitive factor in 2022 to treating them as a core strategic threat in 2024 and is actively adapting its technology and merchant‑value strategy accordingly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of American Express's evolving positioning toward alternative payment mechanisms from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 framing of alternative payments as 'dynamic and rapid growth' threat, accurately quoting the language; (2) Accurately captures the 2024 shift to 'intense competitive pressure' and strategic adaptation; (3) Properly synthesizes the multi-hop evolution showing progression from peripheral threat (2022) to core strategic concern (2024); (4) Correctly identifies specific technologies mentioned: open banking, digital wallets, real-time settlement, tokenization; (5) Appropriately cites specific page references (2022 p. 12, 2024 p. 29 & 31) showing document-level verification; (6) Accurately characterizes the strategic shift from viewing alternatives as external threats to adopting them as essential components. MINOR GAPS: (1) The LLM answer emphasizes 'large-tech merchants and proprietary digital-wallet solutions' as the specific competitive pressure vector in 2024, which is more specific than the ground truth's broader framing but not contradictory; (2) The ground truth explicitly mentions 2023 as an intermediate year where 'scope of alternative mechanisms expanded to include open banking platforms,' while the LLM answer jumps from 2022 to 2024 without discussing 2023 evolution - this is a minor omission of temporal granularity; (3) The ground truth's characterization of the transformation as moving from 'external threats' to 'essential components of technological roadmap' is semantically equivalent to the LLM's 'peripheral competitive factor to core strategic threat' framing, though slightly different emphasis. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high (9/10) - the page references provided by LLM add credibility. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct, though the omission of 2023 as an intermediate evolution point slightly reduces completeness (8/10). CONTEXTUAL RELEVANCE: The answer directly addresses all components of the multi-part question regarding competitive pressure, strategic adaptation, and technological innovations (9/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 621,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "Adobe’s 2022 Form 10‑K (pages 95‑99) contains no discussion of Frame.io, indicating that the platform was not yet a highlighted part of Adobe’s product narrative at that time. By the 2023 filing (page 12) Adobe describes Frame.io as “our cloud‑native creative collaboration platform” that is “directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront” and is offered through Adobe GenStudio for large‑scale content production; the 2024 filing (page 12) repeats this positioning, emphasizing the same deep integration across the Creative Cloud suite. This shift from no mention in 2022 to a prominently integrated, cross‑app collaboration hub in 2023‑2024 signals Adobe’s strategy to embed Frame.io as a core, cloud‑based collaboration layer that unifies video‑centric and broader creative workflows throughout its ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant discrepancies from the ground truth. STRENGTHS: (1) Correctly identifies the 2023-2024 positioning of Frame.io as a 'cloud-native creative collaboration platform'; (2) Accurately notes integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront; (3) Properly captures the strategic shift from 2022 to 2023-2024; (4) Correctly synthesizes the multi-hop information across years. WEAKNESSES: (1) The claim that 2022 Form 10-K contains 'no discussion of Frame.io' contradicts the ground truth, which states Frame.io was 'listed among Adobe's trademarks' in 2022, indicating strategic importance; (2) The LLM states Frame.io was integrated with 'Photoshop, Lightroom and Workfront' in 2023, but the ground truth indicates these integrations were expanded in 2024, not 2023; (3) Missing key 2023 capabilities mentioned in ground truth: 'real-time upload, review, and approval with frame-accurate commenting'; (4) Missing the 2024 expansion into broader video workflows such as 'casting, location scouting, and marketing campaign management'; (5) The characterization of 2022 as having 'no mention' is inaccurate - it was listed as a trademark, which is a form of mention indicating strategic importance. The LLM's conclusion about Adobe's strategy is directionally correct but incomplete, missing the specific evolution of capabilities and the scope of 2024 expansion beyond post-production workflows. The answer conflates 2023 and 2024 positioning rather than showing the distinct progression the ground truth describes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 441,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s outstanding balance on the 2017 unsecured senior notes fell from $16 billion at 12/31/2022 to $15 billion at 12/31/2023 and then to $13 billion at 12/31/2024【page_58】【page_57】.  The year‑over‑year reductions show Amazon is actively redeeming or repaying this tranche of debt, indicating a deliberate strategy to shrink its leverage and lower interest‑cost exposure on the 2017 issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) QUANTITATIVE ACCURACY: All financial figures are correct - $16.0 billion (12/31/2022), $15.0 billion (12/31/2023), and $13.0 billion (12/31/2024). The year-over-year progression matches the ground truth exactly. (2) ENTITY ACCURACY: Correctly identifies Amazon's 2017 unsecured senior notes and the relevant fiscal year-end dates. (3) MULTI-HOP REASONING: Successfully synthesizes the three-year debt balance evolution and correctly interprets the pattern as indicating deliberate debt management strategy. The LLM goes slightly beyond the ground truth by specifically mentioning 'actively redeeming or repaying' and 'lower interest-cost exposure,' which are reasonable inferences from the declining balance pattern and represent sound financial reasoning. (4) COMPLETENESS: Addresses all parts of the question - the evolution of the balance across the three years and what it indicates about debt management strategy. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberate' and focused on 'shrinking leverage' is semantically equivalent to the ground truth's 'deliberate debt management strategy to gradually pay down this liability.' The minor enhancement regarding interest-cost exposure is a logical extension that doesn't contradict the ground truth. The only minor distinction is that the LLM uses 'unsecured senior notes' terminology while the ground truth simply says '2017 Notes,' but this is more precise rather than incorrect. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 428,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s Global Services description has listed “upgrades and conversions” as a core service in each of its recent 10‑K filings – first in the 2022 filing (Item 1, page 3) 【page_3】, then again in the 2023 filing (Item 1, page 5) 【page_5】, and once more in the 2024 filing (Item 1, page 5) 【page_5】. The unchanged prominence of this capability over three years shows a steady strategic emphasis on using upgrades and conversions to extend, modernize and sustain Boeing’s aerospace platforms throughout their life cycles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies 'Upgrades and Conversions' as a consistent core service across all three years (2022, 2023, 2024) in Boeing's Global Services segment; (2) Accurately captures the strategic implication of this consistency - a sustained, deliberate focus on lifecycle management and platform modernization; (3) Properly synthesizes the multi-hop information showing the trajectory across three separate 10-K filings; (4) Uses appropriate terminology ('extend, modernize and sustain') that aligns with the ground truth's characterization of lifecycle management and service-based revenue streams; (5) Correctly identifies the unchanged nature of this emphasis as significant strategic signal. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page references (page 3 for 2022, page 5 for 2023 and 2024) which add helpful specificity but cannot be verified against the ground truth provided; however, these do not contradict the ground truth; (2) The LLM answer is slightly more concise than the ground truth but captures all essential information - it doesn't explicitly mention 'supply chain management and maintenance' as comparative services, though this omission is minor since the question focuses on the evolution of Upgrades and Conversions specifically; (3) Both answers correctly convey that the consistency of this offering across three years indicates strategic commitment to aging fleet support and legacy system adaptation. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate annual filings to establish a pattern and draw a strategic conclusion - this is sound multi-hop reasoning. No numerical calculations are required for this question, so quantitative accuracy is perfect by default. The semantic equivalence is strong - the LLM conveys the same strategic narrative as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 530,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy shifted from a split‑formula system (Final Average Pay for hires before 1 Jan 2015 and Retirement Value for hires after 2014) to a unified Retirement Value approach for **all eligible U.S. non‑union employees**, regardless of hire date, with the change slated to take effect on **1 Jan 2026**. The company first disclosed this expansion in a January 2021 announcement and then reiterated the same eligibility expansion and 2026 implementation date in its 2022 filing [page 73], again in the 2023 filing [page 75], and once more in the 2024 filing [page 77], showing a consistent communication strategy throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2026 implementation date is accurate; (2) The January 2021 announcement date is correct; (3) The identification of the shift from Final Average Pay to Retirement Value formula is accurate; (4) The consistent communication across 2022-2024 filings is correctly identified; (5) The reference to U.S. non-union employees is correct. PROBLEMATIC ELEMENTS: (1) The LLM characterizes this as a 'shift' or 'expansion' to a 'unified' approach, but the ground truth indicates NO CHANGE occurred from 2022-2024 - the company merely 'consistently communicated' and 'reiterated' the same plan without modifications. The LLM's framing suggests evolution/change when the ground truth emphasizes consistency and lack of change; (2) The LLM states employees hired after 2014 would move to Retirement Value, but the ground truth clarifies that employees hired after 2014 were ALREADY under the Retirement Value formula - this is a critical distinction about the timing of when the formula applied; (3) The LLM's characterization of 'eligibility expansion' is misleading - the ground truth shows eligibility criteria 'remained unchanged' across all three years; (4) The LLM provides specific page numbers (73, 75, 77) which cannot be verified against the ground truth and may be fabricated. MULTI-HOP REASONING: The LLM failed to properly synthesize the key insight from the ground truth: that there was NO EVOLUTION or CHANGE in the pension strategy from 2022-2024, only consistent reiteration of a plan announced in 2021. The question asks 'how did...evolve' and the correct answer is essentially 'it didn't evolve - it remained consistent.' The LLM instead presents this as an active shift/expansion, which misrepresents the ground truth. QUANTITATIVE ACCURACY: Dates are correct (January 2021, 2026 implementation), but the characterization of what happened is inaccurate. The answer conflates the original 2021 announcement with ongoing 2022-2024 communication, presenting it as if changes were occurring when they were not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 564,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO reported an outstanding principal balance of **$606 million** on its 5.000 % senior notes due April 2030 in fiscal 2022 (AVGO 10‑K 2022 p. 101), and the same $606 million balance appears in both fiscal 2023 and fiscal 2024 (AVGO 10‑K 2023 p. 81 and AVGO 10‑K 2024 p. 81). The balance has remained flat over the three‑year period, indicating that the company has chosen to retain the note to maturity rather than accelerate repayment, using it as a stable, low‑cost source of financing while directing cash to other priorities such as dividends and share repurchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. According to the original answer (from the knowledge graph), AVGO's 5.000% notes due April 2030 had an outstanding principal balance of $1,086 million in fiscal 2022, which decreased to $606 million in fiscal 2023, and remained at $606 million in fiscal 2024. However, the LLM claims the balance was $606 million in fiscal 2022, which is INCORRECT. This is a major quantitative error that undermines the entire answer. The LLM states 'the balance has remained flat over the three-year period,' which is factually wrong - there was a significant $480 million reduction from FY2022 to FY2023. The LLM's interpretation that 'the company has chosen to retain the note to maturity rather than accelerate repayment' directly contradicts the ground truth's assessment that this 'indicates a deliberate reduction in this specific debt instrument' and 'a targeted debt repayment or refinancing strategy.' The LLM mischaracterized a period of active debt reduction as a period of flat retention. While the LLM correctly identifies the FY2023 and FY2024 balances as $606 million, the missing/incorrect FY2022 figure ($606M stated instead of $1,086M) is a critical error. The reasoning about debt management strategy is also inverted - the ground truth emphasizes deliberate reduction, while the LLM emphasizes retention. The LLM's multi-hop synthesis failed to correctly identify the key evolution pattern across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 421,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T’s tie‑up with Time Warner started when the 2018 acquisition was absorbed into its WarnerMedia segment, and the company later pursued a merger of WarnerMedia with Discovery (agreement announced in 2021).  In April 2022 AT&T completed a Reverse Morris Trust transaction that separated WarnerMedia—together with the Time Warner assets—from AT&T and treated it as discontinued operations (see 2022 history and WarnerMedia sections).  The 2023 and 2024 10‑K filings now list only the Communications and Latin America segments, confirming that the former WarnerMedia business (including Time Warner) has been divested to the new Warner Bros. Discovery entity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates and events. Strengths: (1) Correctly identifies the 2018 Time Warner acquisition and its integration into WarnerMedia segment; (2) Accurately states the April 2022 Reverse Morris Trust transaction completion date; (3) Correctly notes the merger with Discovery and creation of Warner Bros. Discovery entity; (4) Properly identifies the transition to Communications and Latin America segments in 2023-2024 filings; (5) Accurately characterizes the divestiture as discontinued operations. Quantitative accuracy is high with all dates (2018, 2021 announcement, April 2022 completion) and entity names correct. Multi-hop reasoning is sound, synthesizing the acquisition, integration, separation, and final divestiture across the 2022-2024 period. Minor weaknesses: (1) The answer could have been slightly more explicit about the 2024 DIRECTV divestiture mentioned in the ground truth as 'the last major asset tied to the entertainment strategy'; (2) The phrase 'treated it as discontinued operations' is accurate but could have emphasized more clearly the strategic pivot away from media/entertainment back to core telecom services, which is a key theme in the ground truth. The answer is semantically equivalent to the ground truth and captures the essential evolution of AT&T's relationship with Time Warner through divestiture, though it could have emphasized the strategic repositioning aspect more strongly. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 428,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "AIG’s international terrorism risk management moved from a highly detailed 2022 approach—using a third‑party vendor model that quantified a five‑ton bomb scenario at a $1.3 bn loss net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA, which covers 80 % of losses above a $1.7 bn deductible) and supplementing it with limited private reinsurance, targeted purchases and government‑sponsored pools (2022 10‑K, p. 168‑169)—to a more generic vendor‑based scenario model that no longer discloses specific loss figures but still relies on TRIPRA, limited private reinsurance, targeted reinsurance purchases and pool arrangements (2023 10‑K, p. 121; 2024 10‑K, p. 88). Geographically, AIG introduced explicit attachment points in 2023, lowering the Japan attachment to $150 m (rest‑of‑world $125 m) (2023 10‑K, p. 120), and in 2024 retained core attachment points of $200 m for Japan and $125 m for the rest of the world (2024 10‑K, p. 88).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of AIG's terrorism risk management from 2022-2024, properly cites the $1.3 billion five-ton bomb scenario for 2022, accurately notes the shift to less specific modeling in 2023-2024, and correctly identifies the 2024 attachment points of $200M for Japan and $125M for rest of world. The answer demonstrates good multi-hop synthesis across three years of filings and appropriately contextualizes TRIPRA's role (80% coverage above $1.7B deductible). The narrative arc from reactive to proactive risk management is sound.\n\nCRITICAL ERRORS: The LLM states that in 2023, Japan's attachment point was $150M (rest-of-world $125M), but the ground truth indicates these were the 2024 figures. The ground truth shows Japan at $200M and rest-of-world at $125M in 2024, not the $150M/$125M split the LLM attributes to 2023. This is a significant factual error in the temporal sequencing of attachment point changes. The LLM appears to have conflated or misplaced the 2023 attachment point data.\n\nMINOR ISSUES: The LLM provides extensive citation details (page numbers, TRIPRA mechanics) that add credibility but aren't verified against the ground truth. The characterization of 2022 reinsurance as \"limited\" versus 2023-2024 as maintaining similar structures could be more precisely differentiated. The answer doesn't explicitly state whether the attachment point changes represent an increase or decrease in retained risk exposure.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing sections, correctly tracking the evolution of modeling sophistication and reinsurance structures. However, the temporal misplacement of the $150M Japan figure undermines the accuracy of the geographic attachment point evolution narrative.\n\nQUANTITATIVE VERIFICATION: $1.3B (2022) ✓, $1.7B TRIPRA deductible ✓, 80% TRIPRA coverage ✓, $125M rest-of-world (2024) ✓, $200M Japan (2024) ✓, but $150M Japan (2023) ✗ - this appears to be incorrect or misattributed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 555,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "In the 2022 filing Emerson’s Safety & Productivity segment described its pipe‑working line as “pipe wrenches, pipe cutters, pipe threading and roll‑grooving equipment, mechanical crimping tube‑joining systems, tubing tools, drain cleaners and diagnostic systems”【page_9】. By the 2024 filing the same segment still offers pipe wrenches, cutters, threading/roll‑grooving and drain‑cleaning tools, but now adds “battery‑hydraulic tools for press connections” and highlights “sewer inspection cameras and locating equipment” as part of its diagnostic offerings【page_73】. This evolution shows Emerson is augmenting its core hand‑tool portfolio with powered, battery‑operated and advanced diagnostic solutions, signaling a strategic push to become a broader, higher‑value provider in the professional tools market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Emerson's product portfolio evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the company (Emerson/EMR) and relevant segment (Safety & Productivity). (2) Accurately captures the 2022 product lineup including pipe wrenches, cutters, threading equipment, drain cleaners, and diagnostic systems. (3) Correctly identifies the 2024 additions: battery-hydraulic tools for press connections and enhanced diagnostic offerings (sewer inspection cameras and locating equipment). (4) Provides proper citations to source documents (page 9 and page 73). (5) The multi-hop synthesis is sound - comparing 2022 vs 2024 portfolios and drawing strategic conclusions about modernization and market positioning. (6) The reasoning about strategic shift toward higher-value, technology-integrated solutions aligns with the ground truth. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 intermediate year that appears in the ground truth, which showed the introduction of battery hydraulic tools and enhanced diagnostics. The ground truth specifically notes 'By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems' as a distinct progression point. The LLM answer jumps from 2022 to 2024 without acknowledging this 2023 milestone. (2) The ground truth emphasizes 'digital integration' as a 2024 focus, which the LLM answer doesn't explicitly mention, though it does reference 'advanced diagnostic solutions' which partially captures this concept. QUANTITATIVE ACCURACY: All product categories and years are correctly identified. No numerical errors detected. QUALITATIVE ACCURACY: The strategic interpretation is sound and well-reasoned, though the omission of the 2023 progression point represents a minor gap in the multi-year narrative completeness. The answer correctly synthesizes information across multiple filing years to support the strategic positioning conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 547,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s 10‑K disclosures for 2022, 2023 and 2024 all state that free‑rent periods (and step‑rent provisions) are recognized on a straight‑line basis over the lease’s original term and any extension options the company is reasonably certain to exercise. Those periods are treated as lease incentives that reduce the minimum lease payments, which are then discounted to determine the lease liability and the right‑of‑use (ROU) asset—so the free‑rent periods lower the present‑value of lease payments and consequently the ROU asset. The accounting treatment and disclosure language remained essentially unchanged over the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Costco used straight-line recognition for free-rent periods across 2022-2024 and accurately describes the mechanics of how these periods reduce ROU assets through discounted lease payments. However, the answer fundamentally misses the key evolution that the ground truth emphasizes: the SHIFT IN DISCLOSURE DEPTH over time. The ground truth explicitly states that 2022 included detailed disclosure of the discounting process, incremental borrowing rate derivation, and ARO treatment, while 2023-2024 filings moved to 'more standardized ASC 842 compliance language without elaborating on the valuation mechanics.' The LLM answer claims 'accounting treatment and disclosure language remained essentially unchanged over the three years,' which directly contradicts the ground truth's central finding about decreased disclosure specificity and depth. This is a critical error in addressing the 'evolution' aspect of the question. The LLM correctly describes the accounting mechanics and the impact on ROU asset valuation, but fails to capture the material change in disclosure practices and the 'maturation of lease accounting practices post-adoption period' that the ground truth identifies. The answer is partially correct on the technical accounting but incomplete and inaccurate on the disclosure evolution component, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 387,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "- In the 2022 filing the only 2.000 % series shown was in the **Tenth Supplemental Indenture (Exhibit 4.13)**, which listed “2.000 % Notes due 2020” 【page_105】.  \n- The 2023 filing added a new 2.000 % series in the **Eleventh Supplemental Indenture (Exhibit 4.14)**, this time “2.000 % Notes due 2023” 【page_105】.  \n- By the 2024 filing the 2.000 % series had been replaced; the **Twelfth Supplemental Indenture (Exhibit 4.15)** lists “2.400 % Notes due 2022” and “2.875 % Notes due 2024” (no 2.000 % notes), showing Microsoft moved to higher‑coupon notes for the 2024 period 【page_106】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth across multiple critical dimensions: (1) INDENTURE IDENTIFICATION ERROR: The LLM claims 2022 shows 'Tenth Supplemental Indenture' with '2.000% Notes due 2020', but ground truth states the 2.000% Notes were under the 'Eleventh Supplemental Indenture dated August 8, 2016' with maturity of 2023 in 2022. This is a major factual error. (2) EVOLUTION NARRATIVE MISMATCH: The LLM describes a progression from 2020 notes to 2023 notes to replacement with 2.400%/2.875% notes, suggesting significant structural changes. The ground truth explicitly states 'no structural changes' and 'consistent debt instrument' across all three years. (3) MATURITY DATE ERRORS: The LLM lists '2.000% Notes due 2020' in 2022 (which would be past maturity), contradicting ground truth's 2023 maturity date. (4) MISSING CONSISTENCY: Ground truth emphasizes that the same 2.000% Notes under the same Eleventh Supplemental Indenture appeared consistently across 2022, 2023, and 2024, with the 2024 reference being historical documentation. The LLM's narrative of replacement and evolution directly contradicts this. (5) EXHIBIT NUMBER DISCREPANCIES: The LLM cites different exhibit numbers (4.13, 4.14, 4.15) and different supplemental indentures than ground truth, suggesting either misreading of source documents or fabrication. The core answer fails to capture the key finding: stability and consistency of the same debt instrument across three years, not evolution and replacement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 419,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "In the 2022 Form 10‑K Amazon described its seller programs as earning “fixed fees, a percentage of sales, per‑unit activity fees, interest, or some combination thereof” but did not specify when that revenue is recorded【page_3】. By the 2023 filing the company clarified that “the commissions and any related fulfillment and shipping fees we earn … are recognized when the services are rendered, which generally occurs upon delivery of the related products to a third‑party carrier or, in the case of an Amazon delivery, to the customer”【page_43】. The 2024 filing (pages 1‑5) contains no revised language, indicating the same timing and composition of revenue recognition for third‑party seller services continues unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amazon's revenue recognition evolution. STRENGTHS: (1) All factual information is correct - accurately cites 2022 disclosure of 'fixed fees, a percentage of sales, per-unit activity fees, interest, or some combination thereof'; (2) Correctly identifies the 2023 clarification with precise quote about recognition timing 'upon delivery of the related products to a third-party carrier or...to the customer'; (3) Properly synthesizes the multi-hop information across three years (2022-2024) showing evolution from vague to specific disclosures; (4) Accurately notes that 2024 contains no revised language, indicating continuity; (5) Includes helpful page references that ground the answer in source material; (6) The reasoning is sound - correctly identifies that the evolution shows increasing clarity in disclosures while maintaining consistent recognition principles. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which mentions 'increasing clarity in disclosures over time' as an explicit conclusion - the LLM implies this through its narrative structure but doesn't state it as explicitly; (2) The ground truth uses slightly different phrasing ('consistent approach to revenue recognition tied to service delivery') which the LLM captures semantically but not verbatim. QUANTITATIVE VERIFICATION: No numerical calculations required; all dates (2022, 2023, 2024) are correct; all quoted language matches expected disclosure patterns. MULTI-HOP SYNTHESIS: Successfully combines information across three fiscal years and multiple disclosure documents to show the evolution pattern. The answer correctly identifies that 2023 was the key year for clarification and that 2024 maintained the same approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 501,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings still list a “Guaranty of certain obligations of … Southwestern Bell Telephone Co.” (see the guaranty exhibits referenced on pages 98 and 103), indicating that the company continues to back‑stop the debt of this legacy subsidiary. By maintaining that guarantee into 2022‑2024, AT&T is using its strong balance‑sheet and credit profile to assume long‑term liability for historic telecom entities, thereby managing legacy debt risk while preserving overall financial flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that AT&T maintained a guarantee of Southwestern Bell Telephone Co.'s obligations across 2022-2024, which aligns with the ground truth. The answer accurately references the guaranty exhibits and correctly identifies this as a legacy telecom entity management strategy. However, there are some differences in emphasis and interpretation: (1) The LLM answer adds interpretive language about 'strong balance-sheet and credit profile' and 'preserving overall financial flexibility' that goes beyond what the ground truth explicitly states. The ground truth emphasizes the 'unchanging commitment' and 'no indication of reduction or restructuring,' while the LLM frames it more as a strategic choice to 'assume long-term liability' for risk management. (2) The LLM references specific page numbers (98 and 103) which cannot be verified against the ground truth provided. (3) The LLM's characterization of the strategy as using AT&T's 'strong balance-sheet' to manage legacy debt is reasonable inference but represents added interpretation beyond the factual observation that the guarantee persisted unchanged. (4) Both answers correctly identify the three-year period (2022-2024) and the consistent nature of the guarantee. The core factual accuracy is sound - the guarantee did persist across all three years with no changes indicated. The reasoning about what this suggests about liability management strategy is somewhat different in tone but not fundamentally contradictory. The LLM answer is slightly more interpretive and less strictly factual than the ground truth, but the core message about AT&T's stable, unchanged commitment to these legacy obligations is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 469,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "- In 2022 Johnson & Johnson held **$808 million** of its 2.250 % notes due 2050; the balance rose to **$826 million** in 2023 and then returned to **$808 million** in 2024, while the effective interest rate stayed at roughly **2.29 %** each year【page_71】【page_72】.  \n\n- This modest swing – a slight increase followed by a re‑alignment to the prior level – shows the company is maintaining a stable, ultra‑long‑dated, low‑cost debt position, using the 2050 notes to lock in cheap financing for the far future as part of its long‑term debt strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 figure. According to the ground truth, J&J held $983 million in 2.250% Notes due 2050 in 2022, but the LLM states $808 million for 2022. This is a $175 million discrepancy (18% error). The LLM correctly identifies $826 million for 2023 and $808 million for 2024, and correctly states the effective interest rate of 2.29%. However, the inverted sequence presented ($808M → $826M → $808M) misrepresents the actual progression ($983M → $826M → $808M), which shows a significant decline from 2022-2023 followed by a minor decline in 2024, not a 'modest swing' as characterized. The ground truth indicates a 16% reduction from 2022 to 2023 and a 2% reduction from 2023 to 2024, suggesting a more deliberate debt reduction strategy than the LLM's characterization of 'stable' positioning. The LLM's qualitative interpretation about maintaining 'stable, ultra-long-dated, low-cost debt position' is partially reasonable but is undermined by the incorrect starting point and mischaracterization of the trend. The reasoning about locking in cheap financing is sound, but the factual foundation is compromised. The answer does address the evolution question and attempts multi-hop synthesis, but the quantitative errors are severe enough to substantially undermine the credibility of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 386,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 were carried at the same $1.25 billion amount in each of the three years – $1,250 million in 2022, 2023 and 2024 (2022 table shows $1,250 million [page 52]; the 2024 table lists $1,250 million for both 2023 and 2024 [page 52]). At the same time, total long‑term debt fell from $6.59 billion at the end of 2022 to $5.92 billion at the end of 2024, indicating that Costco is preserving a low‑cost, long‑dated debt tranche while actively retiring higher‑rate notes and reducing overall leverage to maintain financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - the 1.375% Senior Notes are correctly stated at $1,250 million for all three years (2022, 2023, 2024), and the total long-term debt figures are accurate ($6.59 billion in 2022 declining to $5.92 billion in 2024). The LLM correctly uses the format variation '$1.25 billion' and '$1,250 million' interchangeably, which is appropriate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the specific debt instrument's evolution (constant at $1,250M), (2) the broader debt structure changes (total debt declining from $6.59B to $5.92B), and (3) capital management strategy implications. MULTI-HOP REASONING: The synthesis is sound - the model correctly connects the constant 1.375% notes with the declining overall debt to infer selective debt management. The interpretation that Costco is 'preserving a low-cost, long-dated debt tranche while actively retiring higher-rate notes' is logically consistent with the data pattern. ENTITY ACCURACY: Company (Costco), debt instrument (1.375% Senior Notes due June 2027), years (2022-2024), and metrics (principal amounts, total debt) are all correctly identified. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer uses slightly different phrasing ('preserving a low-cost, long-dated debt tranche while actively retiring higher-rate notes') versus the ground truth's 'selective capital management strategy that prioritized repayment of other debt tranches.' Both convey the same strategic insight, though the LLM's phrasing is more specific about the mechanism (low-cost preservation + higher-rate retirement). The LLM also includes page references (page 52) which adds credibility. No calculation errors detected. The answer is semantically equivalent to and slightly more insightful than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 512,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s filings show that its multi‑layered security program—originally a “robust…program to protect…cyber and information‑security threats” with fraud‑scoring, tokenization and EMV standards in 2022—was deepened in 2023 and 2024 with added enterprise‑resilience, insurance coverage, regular testing and public‑private partnership monitoring, all woven into a distributed, real‑time routing architecture. At the same time, its real‑time account‑based payments network grew from operating in 12 top‑GDP markets in 2022 to 13 markets by the end of 2023 and then expanded globally in 2024 (including domestic processing in China). This synchronized evolution indicates a strategy of scaling new payment flows and geographies only as layered security safeguards are reinforced, using advanced risk‑management controls to protect the ecosystem as the network grows worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core timeline (2022-2024), accurately cites the 12 markets in 2022 and 13 markets by 2023, and properly synthesizes the parallel evolution of security and real-time payments infrastructure. The answer appropriately captures the qualitative shift toward broader global deployment in 2024. The reasoning about intentional scaling of security alongside infrastructure expansion is sound and matches the ground truth's interpretation. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces unsupported specifics about security features ('fraud-scoring, tokenization and EMV standards') that are not mentioned in the ground truth, potentially overstating what the filings explicitly state. (2) FACTUAL INACCURACY - The LLM claims Mastercard expanded to include 'domestic processing in China' in 2024, which is NOT mentioned in the ground truth and appears to be an unsupported addition. (3) INCOMPLETE GROUNDING - While the ground truth notes the filings 'do not explicitly state that security measures directly enabled infrastructure expansion,' the LLM states this more definitively ('scaling new payment flows and geographies only as layered security safeguards are reinforced'), which overstates the causal relationship. (4) VAGUE LANGUAGE - The LLM's description of 'distributed, real-time routing architecture' is not grounded in the provided ground truth. The answer demonstrates good multi-hop reasoning and appropriate synthesis of the 2022-2024 evolution, but introduces unsupported details and makes stronger causal claims than the evidence supports. The core narrative is correct, but the execution includes factual embellishments that reduce reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 467,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Microsoft’s 10‑K filings all list the 4.000 % Notes due 2021 only as part of the “Third Supplemental Indenture” (Exhibit 4.6) – there is no new issuance of that series after its original 2011 issuance, and the notes have simply matured and are being retired【page_104】. The unchanged, non‑renewed presence of this note shows Microsoft’s long‑term debt strategy of issuing bonds with staggered maturities and then letting them run to maturity rather than repeatedly refinancing the same tranche, thereby diversifying its debt profile and limiting refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 4.000% Notes due 2021 are correctly identified as appearing in all three fiscal years (2022, 2023, 2024); (2) The Third Supplemental Indenture (Exhibit 4.6) reference is accurate; (3) The note's maturity date of 2021 is correct; (4) The general concept of staggered maturities in debt management is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM states the notes 'have simply matured and are being retired' - this is presented as definitive fact, but the ground truth indicates uncertainty ('suggesting either a delayed settlement, rollover, or ongoing disclosure requirement'). The LLM's assertion goes beyond what can be confirmed from the filings; (2) The LLM claims 'there is no new issuance of that series after its original 2011 issuance' - the ground truth does not mention a 2011 issuance date, and this specific date claim cannot be verified; (3) The LLM's interpretation that Microsoft is 'letting them run to maturity rather than repeatedly refinancing the same tranche' is speculative and not explicitly supported by the ground truth, which emphasizes 'consistent and transparent approach to debt disclosure' rather than a deliberate non-refinancing strategy; (4) The ground truth emphasizes the significance of continued disclosure POST-MATURITY (by 2024), which the LLM downplays by simply stating they are 'being retired.' MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but makes interpretive leaps not supported by the source material. The ground truth is more cautious about what the pattern indicates, while the LLM presents assumptions as facts. SEMANTIC ISSUES: The LLM's conclusion about 'limiting refinancing risk' through non-refinancing is somewhat contradictory and not clearly explained in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 503,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s 10‑K filings for 2022, 2023 and 2024 all list the same Officers’ Certificate dated June 3 2020 that contains a **Form of 1.500 % Note due 2030** (see exhibit 4.5/4.6 on pages 72, 75 and 76) — a low‑coupon, ten‑year‑plus bond that the company repeatedly keeps on its balance sheet. By contrast, the other debt instruments disclosed in the same exhibits carry higher rates and staggered maturities (e.g., 2.730 % due 2024, 3.300 % due 2027, 4.700 % due 2024‑2032, etc., see exhibit 4.2 on page 75), indicating that Amazon deliberately anchors its capital structure with a cheap, long‑dated note while using higher‑cost, shorter‑term notes to diversify funding sources and manage overall interest expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 1.500% Note due 2030 as a consistent element across 2022, 2023, and 2024 filings; (2) Accurately characterizes it as a low-coupon, long-dated instrument; (3) Correctly notes the presence of higher-yielding instruments with staggered maturities; (4) Properly synthesizes the strategic intent of balancing low-cost long-term debt with higher-cost shorter-term instruments; (5) Appropriately references exhibit locations (4.5/4.6, 4.2) and page numbers. WEAKNESSES: (1) QUANTITATIVE ERROR - Lists '2.730% due 2024' as a comparison instrument, but the ground truth mentions '4.700% Note due 2024' and '4.700% Note due 2032' - the 2.730% figure appears incorrect or unsupported; (2) INCOMPLETE SYNTHESIS - Fails to mention the 2060 maturity instruments referenced in the ground truth as part of the broader 2022 issuance strategy; (3) MISSING CONTEXT - Does not explicitly discuss the 2023 transition period where newer instruments like the 4.700% Note due 2024 were introduced alongside the 1.500% Note; (4) VAGUE DATING - References 'June 3 2020' for the Officers' Certificate but doesn't clearly establish the timeline of when the 1.500% Note was actually issued relative to other instruments; (5) INCOMPLETE COMPARISON - While it mentions 'staggered maturities,' it doesn't fully articulate the layered maturity profile concept that mitigates refinancing risk as emphasized in the ground truth. The answer captures the core strategic insight (low-cost anchor with higher-cost diversification) but lacks the comprehensive temporal and comparative analysis present in the ground truth. The quantitative error regarding the 2.730% rate is concerning for financial accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 490,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "- 2022: AT&T disclosed that it “continue[d] to hold a 41.3 % interest in SKY Mexico, a leading pay‑TV provider in Mexico” and that the investment was accounted for under the equity‑method as a non‑controlling interest in an international joint venture【page_93】.  \n- 2023: The same 41.3 % stake still appeared on AT&T’s balance sheet, listed among its equity‑method affiliates together with DIRECTV and Gigapower【page_68】.  \n- 2024: In June 2024 AT&T sold its entire 41.3 % interest in SKY Mexico, removed the investment from the equity‑method table and reflected the disposition in the equity‑affiliates reconciliation (beginning‑year balance $1,251 m, ending‑year $295 m)【page_66】.  \n\nThis three‑year arc—holding a sizable minority stake, continuing equity‑method accounting (with related impairments), then exiting the investment—illustrates AT&T’s systematic divestiture of non‑core, international pay‑TV assets, converting legacy holdings into cash as part of a broader strategy to exit declining foreign pay‑TV markets and focus on its core U.S. operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about AT&T's SKY Mexico strategic evolution. STRENGTHS: (1) All quantitative data is correct - the 41.3% ownership stake is accurately cited for all three years (2022-2024), the June 2024 sale date is precise, and the equity reconciliation figures ($1,251M beginning balance, $295M ending balance) are accurate. (2) Multi-hop synthesis is sound - the answer correctly traces the progression across three years and multiple accounting treatments (equity method in 2022-2023, exit in 2024). (3) Entity identification is accurate - SKY Mexico, DIRECTV, Gigapower, and the Mexican pay-TV market context are all correctly identified. (4) The reasoning about AT&T's divestiture strategy is logically sound and well-supported by the specific facts presented. (5) Page citations (93, 68, 66) add credibility and specificity. (6) The answer directly addresses all components of the question: ownership stake evolution, equity method accounting treatment, eventual exit, and broader strategic implications. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (including reconciliation figures and page references), but this represents added value rather than error. The semantic meaning and factual content align perfectly with the ground truth. The characterization of the strategy as 'systematic divestiture of non-core, international pay-TV assets' matches the ground truth's description of 'deliberate divestiture strategy targeting non-core international assets.' No calculation errors, date errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 458,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy ties the “return‑seeking” portion of the U.S. qualified plan to its funded ratio, cutting growth assets and adding liability‑hedging assets as the plan becomes more funded 【page_310】. Accordingly, the target mix fell from 15 % equity, 75 % fixed‑maturity and 10 % other in 2022 【page_310】to a 2024 target of 9 % equity, 80 % fixed‑maturity and 11 % other 【page_252】—with the 2023 actual allocation already at 8 % equity, 77 % fixed‑maturity and 15 % other 【page_252】. The steady reduction in equity and increase in fixed‑income exposure shows AIG progressively de‑risking the plan as its funded status improves.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable numbers and a clear understanding of AIG's de-risking strategy. STRENGTHS: (1) All numeric allocations are precise and correctly cited: 2022 target (15% equity, 75% fixed-maturity, 10% other), 2023 actual (8% equity, 77% fixed-maturity, 15% other), and 2024 target (9% equity, 80% fixed-maturity, 11% other). (2) The quantitative progression is accurately presented showing the directional shift toward liability-hedging assets. (3) The core de-risking narrative is sound and well-supported by the data. (4) Multi-hop synthesis is effective, connecting the glide path policy to funded ratio improvements to specific allocation changes. (5) Page citations (310, 252) provide traceability. MINOR WEAKNESSES: (1) The answer focuses primarily on the 2022-2024 progression but doesn't explicitly address the temporal relationship between funded status measurements and target allocations (e.g., that 2024 targets are based on Dec 31, 2023 funded status), which the ground truth emphasizes. (2) The answer doesn't explicitly mention that each year's target allocation is based on the prior year-end funded status, a nuance in the ground truth. (3) The phrase 'return-seeking' portion is introduced but not fully explained in context of the glide path mechanism. CALCULATION VERIFICATION: The equity percentages decline (15% → 8% → 9%), fixed-maturity increases (75% → 77% → 80%), and other allocations shift (10% → 15% → 11%), all consistent with de-risking. The sums are reasonable (100% allocations). SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information about AIG's methodical de-risking strategy through glide path adjustments tied to funded status, matching the ground truth's core message despite different wording and slightly less emphasis on the temporal/funded-status-based mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 509,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s credit‑risk buffers were steadily expanded as its settlement exposure grew – the company’s risk‑mitigation arrangements rose from $9.2 billion in 2022 to $13.5 billion in 2024 (gross exposure $64.9 billion → $78.4 billion) and the firm added more cash collateral, letters of credit and guarantees for customers that did not meet its risk standards【page_112†L31-L38】【page_105†L1-L8】.  At the same time, Mastercard tightened its risk‑management framework, entered a 2022 FTC consent agreement to provide PANs for tokenized debit routing【page_110†L1-L5】, settled large litigation claims (e.g., a £200 million U.K. settlement in 2024)【page_103†L1-L5】, and regularly reviewed and adjusted its risk‑standard policies and monitoring processes【page_102†L31-L38】【page_106†L1-L5】.  This evolution shows the company’s risk‑management is highly adaptable, scaling mitigation tools and governance in direct response to rising regulatory scrutiny and litigation risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Mastercard's credit risk mitigation strategies from 2022-2024, including the types of mitigation tools (cash collateral, letters of credit, guarantees). It appropriately references regulatory events (FTC consent agreement 2022, DOJ investigation) and litigation (U.K. settlement £200 million in 2024). The qualitative assessment of adaptability is sound and well-reasoned. The answer demonstrates good multi-hop synthesis across regulatory, litigation, and risk management dimensions.\n\nCRITICAL WEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific dollar figures ($9.2B in 2022 to $13.5B in 2024 for risk mitigation arrangements; gross exposure $64.9B → $78.4B) that CANNOT be verified against the ground truth answer. The ground truth does not provide these specific numerical values, making it impossible to confirm accuracy. This is a significant problem because the question asks about evolution over time, and precise numbers are critical for demonstrating this evolution. The LLM appears to have cited specific page references, but without access to verify these numbers against actual 10-K filings, the quantitative claims are unsubstantiated.\n\nMISSING CONTEXT: The ground truth emphasizes that despite escalating external pressures (FTC agreement, DOJ investigation, U.S. Liability Shift Litigation, European Commission investigation), Mastercard \"consistently reported a low level of losses from customer settlement failures across all three years.\" This key insight about the EFFECTIVENESS of the strategies despite mounting external risks is absent from the LLM answer. The LLM focuses on expansion of buffers but doesn't address the outcome metric (low settlement losses) that validates the strategies' effectiveness.\n\nPARTIAL ALIGNMENT: The LLM correctly identifies the 2022 FTC consent agreement and mentions regulatory/litigation pressures, but doesn't specifically reference the DOJ antitrust investigation into the U.S. debit program (mentioned in ground truth as initiated in 2023) or the U.S. Liability Shift Litigation and European Commission investigation (2024 pressures noted in ground truth).\n\nCALCULATION VERIFICATION: The LLM states risk mitigation rose from $9.2B to $13.5B (a 46.7% increase) and gross exposure from $64.9B to $78.4B (a 20.8% increase). While the ratio of mitigation to gross exposure improved from 14.2% to 17.2%, these specific numbers cannot be confirmed from the ground truth provided.\n\nOVERALL ASSESSMENT: The answer demonstrates reasonable understanding of the question and provides a coherent narrative about Mastercard's risk management evolution. However, the unverifiable quantitative claims and missing emphasis on the effectiveness outcome (low settlement losses despite rising risks) represent significant gaps. The answer would score higher if the numbers were verifiable or if the answer focused more on the qualitative evolution without unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 793,
        "total_tokens": 2365
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The Omnibus Stock Incentive Plan, adopted in May 2022, authorizes up to 80 million shares (plus a further ≤10 million for underlying awards) for future grants [HD_10k_2024.pdf, p. 69]. The pool of shares actually available fell to about 77 million at the end of fiscal 2023 [HD_10k_2023.pdf, p. 66] and to roughly 70 million at the end of fiscal 2024 [HD_10k_2024.pdf, p. 69]. This steady decline shows Home Depot has been actively issuing awards from the plan, depleting the share pool while still maintaining a substantial reserve, underscoring a continued reliance on stock‑based compensation to attract and retain talent.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the declining trend in available shares (77M in 2023, 70M in 2024) and properly synthesizes the multi-hop information about Home Depot's stock-based compensation strategy. The reasoning about active issuance of awards and reliance on equity incentives is sound and matches the ground truth conclusion. The answer appropriately cites source documents and fiscal years.\n\nCRITICAL ERRORS: The LLM answer contains a significant factual discrepancy regarding the 2022 baseline. The ground truth states 117 million shares were available in 2022 under the 2005 Plan, but the LLM answer states the plan was 'adopted in May 2022' with authorization for 'up to 80 million shares.' This represents a fundamental misunderstanding of the plan's history and creates confusion about the starting point for the three-year trend analysis. The LLM fails to mention the 2022 figure of 117 million shares entirely, which is a critical omission for answering a question specifically asking about evolution 'from 2022 to 2024.'\n\nADDITIONAL ISSUES: The LLM introduces information about '≤10 million for underlying awards' which, while potentially accurate, is not mentioned in the ground truth and adds complexity without clarifying the core trend. The answer also conflates the 2005 Plan with the Omnibus Plan without clearly explaining the transition between them.\n\nMULTI-HOP REASONING: The synthesis of the declining share availability across three fiscal years is correct (77M → 70M), and the interpretation about active issuance and equity reliance is sound. However, the missing 2022 baseline severely undermines the completeness of the multi-hop analysis.\n\nQUANTITATIVE ACCURACY: While the 2023 and 2024 figures are correct, the omission of the 2022 figure (117M) and the incorrect characterization of the plan's adoption date represent material quantitative errors that prevent a full assessment of the three-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 527,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom’s 3.625 % senior notes due October 2024 carried a $1.25 billion principal balance in FY 2022 (AVGO_10k_2022.pdf p. 101), fell to $622 million by FY 2023 (AVGO_10k_2024.pdf p. 81), and were fully retired by FY 2024, where the schedule shows a dash (zero) for the instrument (AVGO_10k_2024.pdf p. 81). This step‑down reflects a deliberate debt‑reduction strategy, using cash and proceeds from newer senior‑note issuances and the VMware merger to pay down and extinguish the older 3.625 % notes before maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual discrepancy in the FY 2022 figure. The ground truth clearly states that Broadcom reported a $622 million obligation for the 3.625% notes due October 2024 in fiscal year 2022. However, the LLM claims the principal balance was $1.25 billion in FY 2022, which directly contradicts the ground truth. This is a significant quantitative error that undermines the entire progression analysis. The LLM correctly identifies: (1) FY 2023 amount as $622 million, (2) FY 2024 as fully retired (zero), and (3) the general debt management strategy. However, the incorrect FY 2022 starting point ($1.25B vs. $622M) creates a false narrative about the debt reduction trajectory. The LLM appears to have confused or misread the source documents, potentially conflating different debt instruments or misinterpreting the data. The reasoning about debt management strategy is sound in principle, but it's built on an incorrect factual foundation. The multi-hop synthesis across three fiscal years fails because the first data point is wrong. The answer does address all parts of the question and provides contextual information about the debt reduction strategy, but the fundamental numerical error is disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 370,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T’s tie‑up with Time Warner moved from integration to a clean break: after acquiring Time Warner in 2018 and folding it into its WarnerMedia segment, the company announced in May 2021 that WarnerMedia would be combined with Discovery and completed that Reverse‑Morris‑Trust spin‑off in April 2022, re‑classifying the former Time Warner assets as discontinued operations (see History 2022 10‑K p.4; acquisition & agreement p.5). By the 2023 filing the WarnerMedia business was fully separated, and in September 2024 AT&T agreed to sell its remaining DIRECTV interest—its last major entertainment holding—signalling a final exit from content and a sharpened focus on core telecom platforms such as 5G, fiber and connectivity (see 2024 10‑K p.6).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant chronological error that undermines its accuracy. The ground truth states the Reverse Morris Trust transaction with Discovery was completed in 2023, but the LLM claims it was completed in April 2022. This is a material factual error regarding a key milestone in the strategic evolution. The LLM correctly identifies: (1) the 2018 Time Warner acquisition, (2) the WarnerMedia/Discovery combination as a Reverse Morris Trust, (3) the September 2024 DIRECTV sale to TPG, and (4) the overall strategic shift from entertainment back to telecom focus. However, the timing error is critical because the question specifically asks about evolution 'from 2022 through 2024,' and misplacing the WarnerMedia separation to 2022 instead of 2023 distorts the narrative of AT&T's strategic progression during this period. The LLM correctly synthesizes the multi-hop reasoning (acquisition → integration → separation → divestiture) and accurately conveys the strategic pivot away from entertainment. The answer appropriately addresses all parts of the question including integration, divestiture planning, and final exit strategy. The inclusion of specific document references (10-K pages) adds credibility but doesn't compensate for the date error. The semantic understanding of the strategic reversal is sound, but the quantitative accuracy is compromised by the year misplacement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 390,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "Emerson has consistently placed its pipe‑cutters within the Safety & Productivity segment, grouping them with other pipe‑working tools such as wrenches, threading and roll‑grooving equipment 【page_73】. By 2024 the segment narrative adds a clear focus on “battery hydraulic tools… and diagnostic systems” (e.g., sewer‑inspection cameras), showing that the company is positioning pipe‑cutters as part of an integrated, battery‑powered and digitally‑enabled tool portfolio to improve field safety and productivity 【page_73】.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some correct elements but has significant gaps in addressing the evolution from 2022 to 2024.\n\nCORRECT ELEMENTS:\n- Correctly identifies Emerson (EMR) and the Safety & Productivity segment\n- Accurately notes the 2024 positioning with battery hydraulic tools and diagnostic systems (sewer inspection cameras)\n- Correctly identifies the integration of battery-powered technologies and diagnostic systems\n- Properly contextualizes pipe cutters within a broader tool ecosystem\n\nSIGNIFICANT OMISSIONS:\n- FAILS to address the 2022 baseline: The ground truth explicitly states that in 2022, Pipe Cutters were described as \"standalone tools used by plumbing professionals.\" The LLM answer completely omits this starting point, which is critical for demonstrating evolution.\n- FAILS to address the 2023 transition: The ground truth identifies 2023 as a key inflection point where Pipe Cutters were \"explicitly linked with battery hydraulic tools for press connections.\" The LLM answer skips this intermediate year entirely.\n- INCOMPLETE TEMPORAL ANALYSIS: The question specifically asks about evolution \"from 2022 to 2024,\" requiring a three-year progression. The LLM answer only discusses 2024 positioning without establishing the baseline or transition points.\n\nMULTI-HOP REASONING ASSESSMENT:\nThe question requires synthesizing information across three fiscal years (2022, 2023, 2024) to show product line evolution. The LLM answer fails this multi-hop requirement by:\n1. Not establishing the 2022 starting point (standalone tools)\n2. Not identifying the 2023 transition (battery hydraulic integration)\n3. Only addressing the 2024 endpoint\n\nThis represents incomplete synthesis across the required temporal dimension.\n\nQUANTITATIVE ACCURACY: No specific numbers or calculations are involved in this question, so quantitative accuracy is not directly applicable. The answer correctly references page 73 as a source.\n\nSEMANTIC EQUIVALENCE: While the LLM's description of 2024 positioning is semantically equivalent to the ground truth, the answer is fundamentally incomplete because it omits the critical evolution narrative that the question specifically requests.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (5/10): Partially correct on 2024 positioning but fails to address the core requirement of showing evolution from 2022-2024. Missing 2022 baseline and 2023 transition is a major gap.\n- Quantitative Accuracy (7/10): No calculations needed; source citations appear appropriate.\n- Qualitative Accuracy (4/10): Weak multi-hop reasoning; fails to synthesize across all three required years; incomplete entity/temporal analysis.\n- Contextual Relevance (6/10): Addresses the segment and product line but misses the temporal evolution aspect that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 747,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson has repeatedly described the same multi‑year, enterprise‑wide effort in each filing – in 2022 it noted that it was “implementing a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for the human resources, information technology, procurement, supply chain and finance functions…to support the growth of the Company’s financial shared‑service capabilities and standardize financial systems”【page_118】; the 2023 report restates this initiative with identical language【page_118】; and the 2024 filing again emphasizes the ongoing program and its alignment with the financial control environment【page_119】. The unchanged focus across three consecutive years shows that J&J is steadily advancing a strategic priority to centralize and standardize its financial processes, reinforcing a long‑term commitment to shared‑service growth and operational consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year, enterprise-wide initiative spanning 2022-2024; (2) Accurately captures the core functions mentioned (HR, IT, procurement, supply chain, finance); (3) Properly synthesizes the consistent messaging across three consecutive years; (4) Correctly interprets the strategic significance - long-term commitment to process standardization and shared-service growth; (5) Appropriately cites page references (118, 119) showing source verification; (6) Uses semantically equivalent language ('steadily advancing,' 'centralize and standardize') that conveys the same meaning as the ground truth's 'consistently emphasized' and 'long-term strategic commitment.' MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more concise language than the ground truth, which provides marginally more contextual detail about the 2022 framing ('not in response to any internal control deficiencies') - however, this omission is minor and doesn't affect the core answer's accuracy; (2) The LLM answer emphasizes 'unchanged focus' and 'identical language' which is a reasonable inference from the ground truth's 'consistent messaging' but represents a slight interpretive choice rather than explicit ground truth statement. QUANTITATIVE ACCURACY: No numerical errors; dates (2022, 2023, 2024) are correct; no calculations required. MULTI-HOP REASONING: Successfully synthesizes information across three years and multiple functions to demonstrate strategic continuity. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental insight - J&J's sustained commitment to financial process standardization as a strategic priority.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 476,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Across fiscal 2022, 2023 and 2024 Costco’s Form 10‑K exhibit tables all list the Executive Health Plan as Exhibit 10.1* “Costco Wholesale Executive Health Plan,” incorporated by reference, filed with the 10‑K and showing the same period ended 9 Sept 2012 and filing date 19 Oct 2012 in each year (see Exhibit tables on page 66 of each filing). The unchanged presentation signals that the plan has remained a permanent, unaltered executive benefit, underscoring Costco’s consistent, long‑term commitment to providing health coverage for its senior executives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key details: (1) Correctly identifies the Executive Health Plan as Exhibit 10.1* across fiscal years 2022, 2023, and 2024; (2) Accurately states the 'Period Ended' date as September 2, 2012 (LLM states '9 Sept 2012' - semantically equivalent, minor format variation); (3) Correctly identifies the 'Filing Date' as October 19, 2012 (LLM states '19 Oct 2012' - semantically equivalent); (4) Properly synthesizes the multi-hop information showing consistency across three fiscal years. The LLM answer adds a specific page reference ('page 66 of each filing') which is a helpful detail not in the ground truth but doesn't contradict it. The reasoning is sound: the unchanged presentation across years indicates no material updates or amendments, supporting the conclusion about stable long-term executive benefit strategy. Minor differences: (1) The LLM uses slightly different date formatting (9 Sept vs September 2) but both refer to the same date; (2) The LLM adds interpretive language about 'permanent, unaltered executive benefit' which is a reasonable inference from the consistency but goes slightly beyond the ground truth's more measured statement about 'no material updates or amendments.' The core multi-hop synthesis is correct - comparing the same exhibit across three years and drawing conclusions about strategic consistency. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 408,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "Mastercard’s Class A shares have kept the same governance features over the period – the certificate of incorporation continues to describe Class A as “One vote per share” in both the 2023 and 2024 10‑K filings【page_99†L13-L16】【page_92†L13-L16】.  At the same time, the cash dividend per Class A share has risen each year, from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024【page_92†L30-L34】【page_99†L30-L34】.  This steady increase in payouts combined with unchanged voting rights signals a shareholder‑friendly governance strategy that preserves equal voting power for public investors while progressively enhancing cash returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with one significant enhancement over the ground truth. STRENGTHS: (1) Correctly identifies voting rights as 'one vote per share' consistently across 2022-2024, matching ground truth. (2) Provides specific dividend per share data ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that the ground truth omitted, adding valuable quantitative detail. (3) Correctly synthesizes the multi-hop information showing voting rights remained constant while dividends increased. (4) Provides proper citations to 10-K filings. (5) Interprets governance strategy appropriately as 'shareholder-friendly' while preserving voting equality. MINOR DISCREPANCY: The ground truth states 'standard dividend rights' for all three years without specifying actual dividend amounts, while the LLM provides specific per-share dividend figures showing year-over-year increases. This is not an error but rather an enhancement—the LLM went beyond the ground truth by including concrete dividend data. The dividend increases ($2.04→$2.37→$2.74) are mathematically consistent with the narrative of 'steady increase in payouts.' REASONING QUALITY: The LLM correctly identifies the dual governance strategy: unchanged voting structure combined with increasing cash returns. This is sound multi-hop synthesis across voting rights and dividend data. The conclusion about 'shareholder-friendly governance' is well-supported by the evidence presented. The answer fully addresses all parts of the question regarding how dividend and voting rights evolved and what this reveals about governance strategy. No calculation errors detected. The only minor limitation is that the ground truth's emphasis on 'consistency' in dividend rights is somewhat de-emphasized in favor of highlighting dividend amount increases, though both interpretations are factually valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 506,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform was first described in the FY 2022 filing as a solution that makes mainframe‑security‑posture data available for use with customers’ own security‑information‑and‑event‑management (SIEM) tools【AVGO_10k_2022.pdf page 11】. In the FY 2023 filing the description was expanded to say the platform “quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps on an ongoing and ad‑hoc basis,” while still providing data for in‑house tools【AVGO_10k_2023.pdf page 11】. The FY 2024 filing retains this enhanced wording, emphasizing continuous risk identification and integration with internal security tools, indicating the platform’s evolution toward more proactive, integrated risk management【AVGO_10k_2024.pdf page 11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a structured evolution narrative across the three fiscal years with specific document citations. However, there are significant discrepancies with the ground truth that warrant careful evaluation:\n\nSTRENGTHS:\n1. Correctly identifies all three fiscal years (2022, 2023, 2024)\n2. Accurately cites the core functionality: SIEM integration and mainframe security posture assessment\n3. Properly notes the FY 2023 expansion to include 'ongoing and ad hoc remediation planning'\n4. Correctly identifies that FY 2024 retained the enhanced description\n5. Document citations appear consistent with filing structure\n\nCRITICAL ISSUES:\n1. FACTUAL CONTRADICTION ON FY 2022: The LLM states FY 2022 described the platform as making data 'available for use with customers' own SIEM tools' but does NOT mention risk identification or assessment capabilities in that year. The ground truth explicitly states FY 2022 included 'assessing mainframe security posture and identifying risks.' This is a material factual error about what was described in the earliest year.\n\n2. CHARACTERIZATION OF EVOLUTION: The LLM describes FY 2023 as an 'expansion' and FY 2024 as 'enhanced wording,' suggesting progressive improvement. However, the ground truth indicates FY 2023 was 'more explicitly tied' to remediation (not necessarily new functionality) and FY 2024 'retained the same description,' suggesting stability rather than continued evolution. The LLM overstates the degree of change.\n\n3. SEMANTIC MISALIGNMENT: The ground truth emphasizes 'stable functionality and consistent integration' and describes it as a 'mature and well-defined offering,' whereas the LLM frames it as 'evolution toward more proactive, integrated risk management.' These characterizations diverge on whether the platform was evolving or stable.\n\n4. MISSING NUANCE: The ground truth notes that in FY 2022, risk identification was already present (not added later), which the LLM fails to capture accurately.\n\nQUANTITATIVE ACCURACY: No numeric values are involved, so this scores high on the limited quantitative content (dates are correct).\n\nQUALITATIVE ACCURACY: The multi-hop reasoning is partially sound but contains a fundamental error in characterizing what was described in FY 2022, which undermines the accuracy of the evolution narrative.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution across the three years and provides appropriate context about integration and risk identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 669,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "- 2022 (10‑K p. 167): AIG said loss‑reserve risk is managed through “internal controls and oversight of the loss‑reserve setting process…as well as reviews by external experts,” with a model‑risk‑management framework and a review‑and‑challenge process.  \n\n- 2023 (10‑K p. 119): The company added that reserve adequacy is quantified using “stochastic methods, deterministic single‑point estimates, sensitivity and scenario analyses, actuarial profitability and reserve reviews, and experience‑monitoring,” still under the same internal controls and external‑expert validation.  \n\n- 2024 (10‑K p. 86): AIG again emphasizes a “multi‑layered” approach—internal controls and oversight, quantitative modeling (stochastic/deterministic, scenario testing) and “reviews by external experts”—showing continuity in the external‑expert role while the quantitative methodologies have become more explicitly described.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate page references to 10-K filings; (2) Accurately captures the core methodologies: internal controls, external expert reviews in 2022; addition of stochastic/deterministic methods, sensitivity/scenario analyses, actuarial reviews in 2023; and multi-layered approach with explicit quantitative modeling in 2024; (3) Properly synthesizes the multi-hop information showing progression from basic oversight to more structured, formalized approaches; (4) Correctly identifies the consistent role of external experts across all three years; (5) Accurately characterizes the evolution as moving toward more explicit description and formalization of methodologies. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'multi-layered' vs 'multi-tiered') but these are semantically equivalent; (2) The LLM answer emphasizes 'continuity' in external expert role while ground truth emphasizes 'maturing and increasingly proactive approach'—both perspectives are valid and not contradictory; (3) The LLM answer could have slightly more explicitly stated the 'expansion' and 'reinforcement' language used in ground truth, but the factual content is present. QUANTITATIVE VERIFICATION: All page numbers and year references are accurate. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and identifies the progression of methodologies and oversight mechanisms. The reasoning chain is sound and logically presented. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth—that AIG's loss reserve risk management evolved from basic internal controls and external reviews to more sophisticated, formalized quantitative methodologies with continued external validation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 535,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In the 2022 filing Emerson grouped electrical‑distribution equipment inside its broader “Industrial Solutions” product line – a set of fluid‑control, pneumatic and electrical‑distribution offerings for a variety of manufacturing operations【page_76】. By the 2023 and 2024 filings the company’s narrative places that same equipment explicitly in the “Discrete Automation” segment, listing it with solenoid valves, pneumatic valves, actuators and other discrete‑industry hardware【page_73】. The move from a generic industrial‑solutions umbrella to a dedicated discrete‑automation segment signals Emerson’s strategic emphasis on positioning electrical‑distribution gear as a core growth driver in the discrete‑automation market.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Electrical Distribution Equipment positioning across the three years (2022, 2023, 2024) and accurately captures the strategic shift from Industrial Solutions to Discrete Automation segments. The factual claims are sound: (1) 2022 positioning within Industrial Solutions with fluid control and pneumatic/electrical distribution offerings is correct; (2) 2023-2024 repositioning within Discrete Automation segment is accurate; (3) the associated products mentioned (solenoid valves, pneumatic valves, actuators) align with ground truth. The multi-hop reasoning is sound—the model successfully synthesized information across three fiscal years to demonstrate the strategic evolution. However, there are minor gaps in completeness: (1) The LLM answer omits specific mention of 'materials joining products' that were explicitly noted in the 2022 positioning in the ground truth; (2) The 2024 description in the ground truth specifically mentions 'electric linear motion solutions and programmable control systems' as closer groupings, which the LLM answer generalizes to 'discrete-industry hardware' without this specificity; (3) The ground truth emphasizes 'deepening strategic focus on integrated automation solutions' more explicitly than the LLM answer conveys. The LLM's conclusion about strategic emphasis on discrete automation is correct and well-reasoned, but lacks the nuanced detail about the 'deepening' and 'integration' aspects highlighted in the ground truth. No quantitative errors detected (dates and years are all correct). The answer demonstrates solid understanding of the multi-hop synthesis required but misses some contextual details that would elevate it to a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 476,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "From 2022 through 2024 Johnson & Johnson kept a dual‑formula pension system—employees hired before 1 Jan 2015 earned benefits under the Final Average Pay formula, while those hired after 2014 used the Retirement Value formula—but each filing reiterated the 2021 announcement that, effective 1 Jan 2026, **all** eligible U.S. non‑union employees will earn benefits under the Retirement Value formula【page_73】【page_76】【page_77】.  The “Amendments” line in the benefit‑obligation tables shows a small positive adjustment in 2022 (Amendments = 7), a negative adjustment in 2023 (Amendments = (6)), and no amendment in 2024, reflecting a phased accounting of the upcoming change【page_78】.  This multi‑year transition signals J&J’s long‑term workforce strategy to unify and simplify its retirement plan, improve cost predictability and align employee incentives across the entire non‑union workforce.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the dual-formula system (Final Average Pay for pre-2015 hires, Retirement Value for post-2014 hires) and the 2026 transition date to unified Retirement Value formula. (2) Accurately cites the consistent messaging across 2022-2024 filings. (3) Provides specific quantitative details about Amendments line items (7 in 2022, (6) in 2023, 0 in 2024) that add credibility and demonstrate document-level verification. (4) Correctly synthesizes the strategic implications: cost predictability, workforce unification, and simplified retirement planning. (5) Properly attributes the 2021 announcement as the origin of this policy. (6) Page citations (73, 76, 77, 78) suggest proper source verification. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail (specific Amendments figures) than the ground truth, which is not incorrect but represents a different level of specificity. (2) The ground truth emphasizes 'preservation of Final Average Pay benefits accrued before 2026' more explicitly, while the LLM focuses on the dual-formula structure and transition mechanics. Both convey the same essential information but with different emphasis. (3) The LLM's characterization of 'phased accounting' of the upcoming change is a reasonable interpretation of the Amendments data, though the ground truth doesn't explicitly frame it this way. QUANTITATIVE VERIFICATION: All dates are correct (2022-2024 period, January 1, 2026 effective date, 2015/2014 hire date cutoff). The Amendments figures (7, (6), 0) appear specific and verifiable. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and connects specific accounting line items to broader strategic implications. The logic linking accounting adjustments to workforce strategy is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth regarding consistent messaging, strategic shift, and long-term workforce implications, with slightly enhanced technical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 571,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The filings do not break out Downy’s share of the Fabric & Home Care segment – they only give the segment’s overall share of total net sales (35 % in 2022 and 36 % in 2024). Nevertheless, Downy is consistently listed among the segment’s “major brands,” and the segment’s share of net sales has held steady‑to‑slightly risen, indicating that Downy remains a core, strategically important brand in P&G’s portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer contains a significant factual error. It states the segment's share was '35% in 2022 and 36% in 2024' but omits 2023 data entirely. The ground truth clearly shows 36% in 2023, which is essential for evaluating the 3-year trend requested in the question. The LLM should have reported: 35% (2022), 36% (2023), 36% (2024). This is a material omission for a question specifically asking about evolution 'from 2022 to 2024.' (2) INCOMPLETE SYNTHESIS - The question asks about Downy's percentage contribution specifically, and the LLM correctly identifies that individual brand breakdowns aren't provided in filings. However, the ground truth answer provides the segment-level percentages (35%-36%-36%) as the relevant metric for assessing Downy's strategic importance within that segment. The LLM only partially reports these numbers. (3) REASONING QUALITY - The LLM's logic that 'steady-to-slightly risen' positioning indicates strategic importance is sound, but this conclusion is based on incomplete data presentation. The full 3-year trend (35%→36%→36%) actually shows growth from 2022-2023 followed by stability, which is a more nuanced picture than presented. (4) MISSING CONTEXT - The ground truth emphasizes that the segment 'grew' and Downy's 'sustained strategic importance' is evidenced by consistent positioning within that growing segment. The LLM mentions the segment 'held steady-to-slightly risen' but doesn't fully capture the growth narrative. (5) SEMANTIC EQUIVALENCE - While the LLM correctly notes that individual brand breakdowns aren't available, it fails to provide the complete segment-level data that serves as the proxy metric for answering the question. The answer is partially correct but materially incomplete for a 3-year trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 494,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s senior‑and‑subordinated notes rose from a carrying value of **$27.2 billion at 12/31/2022** (Table 8.2, 2022 filing) to **$31.3 billion at 12/31/2023** (Table 8.2, 2023 filing) and then slipped slightly to **$30.7 billion at 12/31/2024** (Table 9.1, 2024 filing)【page_189】【page_179】【page_188】. The jump in 2023 indicates the company leaned more heavily on senior/subordinated note issuance to fund growth or refinance, while the modest decline in 2024 suggests a shift toward stabilizing or modestly reducing that debt component, reflecting a more measured debt‑financing approach after the earlier expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2024 figure. Ground truth states the 2024 carrying value was $31,248 million ($31.248 billion), but the LLM claims it was $30.7 billion at 12/31/2024. This is a material discrepancy of approximately $548 million (1.75% difference), which is substantial for financial analysis. The 2022 figure of $27.2 billion ($27,219 million) is correct. The 2023 figure of $31.3 billion is approximately correct (ground truth shows $31,248 million, LLM shows $31.3 billion - acceptable rounding). REASONING ERROR: The LLM's interpretation of the trend is fundamentally flawed. The ground truth indicates the carrying value peaked in 2023 at $31,248 million and remained at that same level in 2024 ($31,248 million), representing a flat trend from 2023-2024, NOT a 'modest decline' as the LLM claims. This mischaracterization leads to an incorrect strategic interpretation - the LLM suggests a 'shift toward stabilizing or modestly reducing that debt component,' when the actual data shows stabilization at the higher 2023 level. MULTI-HOP SYNTHESIS: The LLM correctly identified the upward trend from 2022 to 2023 and attempted to synthesize a three-year narrative, but the incorrect 2024 figure undermines the entire analysis. The ground truth's conclusion about 'general upward trend' and 'strategic shift toward issuing more senior and subordinated notes' is more accurate than the LLM's narrative of decline and moderation. COMPLETENESS: The answer addresses the evolution question and attempts to discuss strategic implications, but the factual errors prevent proper assessment of the actual strategy. The LLM's citation format and table references appear fabricated or inaccurate, adding to credibility concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 491,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022 AT&T still owned a 41.3 % stake in SKY Mexico and accounted for it under the equity‑method as an equity affiliate investment 【page_93】. The same 41.3 % holding persisted through 2023, appearing in the equity‑method investment portfolio together with DIRECTV and Gigapower 【page_68】. In June 2024 AT&T sold its entire 41.3 % interest, removing SKY Mexico from its equity‑method balance sheet 【page_66】—a clear sign that the company is systematically exiting the Latin‑American pay‑TV market by divesting non‑core video assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE ACCURACY: All numeric values are correct—41.3% ownership stake is accurate for all three years (2022, 2023, 2024), and the June 2024 exit date is precise. No calculation errors present. ENTITY ACCURACY: All entities correctly identified—T/AT&T, SKY Mexico, DIRECTV, Gigapower, and the Latin American pay-TV market context. COMPLETENESS: The answer addresses all three components of the question: (1) ownership stake evolution (41.3% maintained 2022-2023, then divested 2024), (2) equity method accounting treatment (explicitly mentioned for 2022-2023, removed in 2024), and (3) eventual exit (June 2024 sale). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple documents (pages 93, 68, 66 cited), correctly tracing the progression from holding to divestiture. The logical connection between the three-year trajectory and T's broader divestiture strategy is sound—the answer correctly identifies this as a deliberate strategic shift to exit non-core international assets. SEMANTIC EQUIVALENCE: The LLM's characterization of the trajectory as \"systematically exiting the Latin-American pay-TV market by divesting non-core video assets\" aligns well with the ground truth's description of \"deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.\" Minor note: The LLM uses \"AT&T\" while ground truth uses \"T,\" but these are semantically equivalent (AT&T is the full name, T is the ticker). The answer is well-structured, cites specific pages, and demonstrates clear understanding of the multi-year strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 475,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "- In the 2022 Form 10‑K (Risk Factors, p. 5) BNY Mellon warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock,” and that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status or capital‑adequacy and liquidity rules … could result in limitations on our activities.” 【page_5】\n\n- The 2023 filing (Risk Factors, p. 5) repeated the same language verbatim, reaffirming that capital returns remain constrained by U.S. banking law, capital‑planning requirements, Delaware law and the need to pay preferred‑stock dividends, and that non‑compliance with “well‑capitalized”/“well‑managed” or other capital‑adequacy rules could limit the firm’s actions. 【page_5】\n\n- The 2024 Form 10‑K (Risk Factors, p. 5) kept the core disclosure unchanged but added references to “any material reduction in our credit ratings” and the “application of our Title I preferred resolution strategy,” while still emphasizing that capital returns are at Board discretion and may be limited by U.S. banking laws, capital‑planning rules, Delaware law and the obligation to pay full and timely preferred‑stock dividends, and that failure to meet “well‑capitalized”/“well‑managed” or other capital‑adequacy and liquidity standards could restrict activities. 【page_5】\n\nOverall, the company’s stance on regulatory constraints, dividend obligations and capital‑adequacy requirements has remained consistent from 2022 through 2024, with the 2024 filing adding only ancillary language about credit‑rating impacts and resolution strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about BNY Mellon's capital return disclosures across 2022-2024. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately cites page 5 for each filing's Risk Factors section; (2) Accurately captures the core regulatory constraints mentioned: U.S. banking laws, capital adequacy rules, Delaware law, preferred dividend obligations, 'well-capitalized'/'well-managed' status requirements; (3) Correctly synthesizes the evolution: 2022 baseline disclosure → 2023 verbatim repetition → 2024 additions of credit rating impacts and Title I preferred resolution strategy; (4) Properly identifies the consistency theme across years while noting incremental additions in 2024; (5) Provides specific quotations that appear authentic and contextually appropriate. MINOR WEAKNESSES: (1) The ground truth mentions 'ESG-related regulatory pressures' and 'new strategic initiatives' in 2023, which the LLM answer does not explicitly reference—though the LLM does mention 'Title I preferred resolution strategy' in 2024, which may partially address strategic transformation; (2) The ground truth emphasizes 'Parent company's reliance on subsidiary dividends' as a 2024 development, which is not mentioned in the LLM answer; (3) The ground truth notes 'increasing contextual complexity' as a trend, while the LLM characterizes 2024 changes as 'ancillary language,' which may understate the significance of the additions. QUANTITATIVE ACCURACY: No calculations or specific dollar amounts are required; dates and page citations are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the evolution pattern. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information about regulatory constraints and their evolution, though it omits some contextual details present in the ground truth regarding ESG pressures and subsidiary dividend reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1711,
        "completion_tokens": 563,
        "total_tokens": 2274
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 filing 3M grouped structural adhesives as a distinct line within its Safety & Industrial segment (listed alongside “tapes”). In 2023 the segment still described the offering simply as “Structural adhesives and tapes” 【page_107】. By 2024 the company had created an Industrial Specialties division inside Safety & Industrial that combined the former Industrial Adhesive and Tapes business (including structural adhesives) with closure, masking, packaging and personal‑safety products 【page_110】. This evolution from a stand‑alone adhesive line to a bundled specialty‑product division shows 3M treats adhesives as a platform technology that can be cross‑sold with adjacent industrial solutions, underscoring its strategic importance in broader industrial applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and provides a coherent narrative of structural adhesives' evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression with specific positioning changes; (2) Accurately captures the 2024 shift to 'Industrial Specialties division' bundling adhesives with closure, masking, packaging, and personal-safety products; (3) Provides page references (107, 110) showing source verification; (4) Correctly synthesizes the strategic insight that adhesives function as a 'platform technology' for cross-selling; (5) Properly identifies the segment as 'Safety & Industrial' throughout. WEAKNESSES: (1) The 2022 description mentions 'tapes' but the ground truth emphasizes 'industrial abrasives, autobody repair solutions, and electrical materials' - the LLM's characterization is narrower and potentially incomplete; (2) The 2023 description in LLM ('Structural adhesives and tapes') is more specific than ground truth's broader mention of 'packaging and closure systems' emphasis; (3) The ground truth mentions 'construction and maintenance' applications by 2024, which the LLM doesn't explicitly address; (4) The LLM's framing of 'Industrial Specialties division' as a new creation in 2024 is accurate but the ground truth's language about 'shift toward more specialized industrial applications' suggests a more nuanced evolution. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the bundling strategy as the key strategic evolution. The conclusion about platform technology and cross-selling aligns well with the ground truth's assertion about 'foundational component in complex industrial systems.' QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The page references provided (107, 110) appear reasonable for 10-K filings. OVERALL: The answer is substantially correct in its core narrative and strategic insight, with minor gaps in completeness regarding the full product suite mentioned in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 574,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "In the 2022 filing, Cyramza was positioned as a multi‑indication oncology asset—approved for second‑line monotherapy or combination therapy in advanced or metastatic gastric/gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and also as a first‑line option for adult patients with EGFR‑mutated metastatic NSCLC (see pages 5‑6). By the 2023 filing, Lilly disclosed a layered IP shield for Cyramza: compound patents covering the molecule in the U.S. through 2026, in major European countries through 2028 and in Japan through 2026, plus biologics data protection in the U.S. through 2026 and additional data‑protection extensions to 2024 in Europe and 2023 in Japan (see page 11). The 2024 filing retains the same therapeutic scope described in 2022 while the patent and data‑protection expiries remain as outlined in 2023, showing Lilly’s strategy of sustaining market exclusivity in its key U.S., European and Japanese markets through a broad indication portfolio and layered IP protection into the mid‑2020s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Cyramza's therapeutic indications and IP protections, but contains critical date discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) Therapeutic indications are accurately described across 2022-2024 (gastric, lung, colorectal, liver cancers, EGFR-mutated NSCLC); (2) The multi-indication portfolio strategy is correctly identified; (3) The concept of layered IP protection across U.S., Europe, and Japan is sound; (4) The overall strategic narrative about managing lifecycle and preparing for competition is appropriate. CRITICAL ERRORS: (1) Patent expiry dates are problematic - LLM states 'compound patents...in the U.S. through 2026, in major European countries through 2028 and in Japan through 2026' but ground truth indicates data protection (not compound patents) expires in Japan 2023, Europe 2024, and U.S. 2026. The 2028 European date appears incorrect; (2) LLM conflates 'compound patents' with 'data protection' - these are distinct IP mechanisms with different timelines; (3) The statement about 'data-protection extensions to 2024 in Europe and 2023 in Japan' is confusing and potentially inverted from ground truth which states Japan expires 2023 and Europe 2024. MULTI-HOP REASONING: The LLM successfully synthesizes information across three filing years and identifies the strategic evolution, but the IP protection timeline synthesis is flawed. The answer correctly identifies that therapeutic indications remained consistent while IP protections were a key strategic consideration, matching the ground truth narrative. However, the specific patent/data protection dates and their geographic application are presented with insufficient precision. The answer demonstrates good qualitative reasoning about strategy but fails on quantitative accuracy of the IP timeline, which is a core component of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 510,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes rose from **$24.1 billion at a weighted‑average interest rate of roughly 4.45 %** at year‑end 2022 to **$27.2 billion at the same 4.45 % rate** at year‑end 2023, then slipped slightly to **$26.9 billion while the weighted‑average rate climbed to about 4.84 %** by year‑end 2024 【page_178】【page_188】. The increase in the balance shows the company added or rolled over a sizable amount of fixed‑rate debt, but the jump in the average rate in 2024 reflects higher market rates, indicating that while Capital One has built a large fixed‑rate funding base, the cost of servicing that debt is now rising.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022 Value: LLM states $24.1 billion, but ground truth is $19,975 million ($19.975 billion). This is a $4.125 billion overstatement (20.6% error).\n   - 2022 Rate: LLM states 4.45%, but ground truth is 2.91%. This is a 1.54 percentage point error (53% higher than actual).\n   - 2023 Value: LLM states $27.2 billion, but ground truth shows progression to $26,930 million by 2024. The 2023 intermediate value is not provided in ground truth, making this unverifiable but suspicious given the 2024 endpoint.\n   - 2023 Rate: LLM states 4.45% (unchanged from 2022), but ground truth shows 2.91% in 2022 rising to 4.84% in 2024, suggesting a gradual increase, not a flat rate.\n   - 2024 Value: LLM states $26.9 billion, which matches ground truth of $26,930 million. This is the only correct number.\n   - 2024 Rate: LLM states 4.84%, which matches ground truth. This is correct.\n\n2. MULTI-HOP REASONING FAILURE:\n   The LLM failed to correctly synthesize the 3-year trend. The ground truth shows a clear progression: carrying value increased from $19.975B to $26.930B (a $6.955B increase of 34.8%), while rates rose from 2.91% to 4.84% (a 1.93 percentage point increase). The LLM's narrative about 2022-2023 being flat at 4.45% is completely inconsistent with the ground truth starting point of 2.91% in 2022.\n\n3. ENTITY AND METRIC ACCURACY:\n   - Company correctly identified as Capital One (COF)\n   - Metric correctly identified as fixed unsecured senior debt\n   - Years correctly identified (2022-2024)\n   - However, the actual values for these entities are wrong\n\n4. SEMANTIC INTERPRETATION:\n   While the LLM correctly interprets that higher rates reflect market conditions and that the company built a fixed-rate funding base, this interpretation is based on incorrect underlying numbers. The actual story from ground truth is more dramatic: Capital One issued significantly more debt (34.8% increase) while rates more than doubled from 2.91% to 4.84%, representing a substantial increase in both debt volume and financing costs.\n\n5. MISSING CONTEXT:\n   The LLM answer fails to capture the magnitude of the strategic shift. The ground truth indicates Capital One increased fixed unsecured senior debt by nearly $7 billion while interest rates rose by nearly 2 percentage points - a much more significant strategic repositioning than the LLM's narrative suggests.\n\nCONCLUSION: The LLM answer contains fundamental numerical errors that undermine its credibility. Only 2 of 6 key data points (2024 value and rate) are correct. The 2022 baseline is significantly misstated, making the entire trend analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 738,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s exposure to the total‑return swaps used to hedge deferred‑compensation obligations grew each year – the contracts had a notional amount of **$651 million in FY 2022**, rose to **$792 million in FY 2023**, and reached **$985 million in FY 2024**【page_92】.  The accounting impact swung from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and a **$91 million gain in FY 2024**【page_91】, showing that the swap position is highly volatile, producing large opposite‑direction results as market conditions change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: the loss of $92 million in FY 2022, gain of $58 million in FY 2023, and gain of $91 million in FY 2024 match the ground truth exactly. The answer also provides additional valuable context by including the notional amounts of the swaps ($651M, $792M, $985M across the three years), which shows the growing exposure over time and enhances understanding of the instrument's scale. The multi-hop reasoning is sound: the answer correctly synthesizes information about both the notional exposure amounts and the accounting impacts (gains/losses), then draws a logical conclusion about volatility. The characterization of the pattern as 'volatile' with 'large opposite-direction results' accurately reflects the swing from loss to gains. The answer directly addresses all parts of the question: (1) how exposure evolved (notional amounts increasing), (2) the gains/losses pattern across three years, and (3) what this reveals about volatility. Minor note: The answer goes slightly beyond the original ground truth by including notional amounts, but this is additive information that strengthens rather than contradicts the answer. The semantic meaning is fully preserved - the core finding about volatility and the specific financial impacts are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 379,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "In the 2022 filing Home Depot identified store location and appearance as a core competitive factor and highlighted past “store‑refresh” and way‑finding sign projects that were already “driving higher customer‑satisfaction scores” (2022 p.8‑10). By 2023 the narrative shifted to an “aging store base” that required ongoing maintenance, space‑reallocation and appearance upgrades to protect market share, again stressing appearance as a differentiator (2023 p.14‑16). In 2024 the emphasis moved to actively executing new refresh packages, redesigning front‑end areas, adding signage and opening 12 new stores—efforts the company says are “driving higher customer‑satisfaction scores” and now enable roughly 50 % of U.S. online orders to be fulfilled through stores, bolstering its competitive position versus multichannel and purely online rivals (2024 p.10).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-year evolution of Home Depot's store appearance strategy from 2022-2024. STRENGTHS: (1) Correctly identifies the progression from standalone store appearance focus (2022) to integrated omnichannel strategy (2024); (2) Accurately captures key strategic shifts: 2022 emphasis on store-refresh projects and customer satisfaction, 2023 focus on aging store base maintenance, 2024 execution of refresh packages and new store openings; (3) The 50% figure for U.S. online orders fulfilled through stores is a concrete, measurable metric that demonstrates competitive impact; (4) Properly synthesizes multi-hop information showing how store appearance evolved to support omnichannel capabilities; (5) Correctly identifies competitive positioning against multichannel and online retailers. MINOR WEAKNESSES: (1) The answer provides specific page citations (2022 p.8-10, 2023 p.14-16, 2024 p.10) that cannot be verified against the ground truth, though this adds specificity rather than detracting from accuracy; (2) The ground truth emphasizes the strategic pivot from 'standalone in-store experience to hybrid model' more explicitly, while the LLM answer focuses more on tactical execution details (refresh packages, signage, new stores) rather than the conceptual strategic evolution; (3) The LLM answer could have more explicitly stated the connection between store appearance and digital capabilities (mobile platforms, in-store digital tools) mentioned in the ground truth. QUANTITATIVE VERIFICATION: The 50% figure for online order fulfillment through stores is presented as a measurable impact metric and appears reasonable for 2024 competitive positioning. The 12 new stores figure is specific and verifiable. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects store appearance evolution to competitive positioning against both multichannel and online retailers, meeting the core requirement of the multi-hop question. The reasoning chain is logical and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 566,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s net carrying amount for the 3.50 % Notes Due 2050 was $1.637 billion at the end of fiscal 2022 (NVDA 10‑K 2022, p. 78) and remained $1.637 billion at the end of fiscal 2023 (NVDA 10‑K 2023, p. 67), then fell to $1.604 billion by the end of fiscal 2024 (NVDA 10‑K 2023, p. 67). This modest $33 million decline reflects the gradual amortization of the note’s discount and a slight reduction in NVIDIA’s long‑term debt, indicating a marginal improvement in its long‑term debt positioning.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that make it almost entirely incorrect: (1) QUANTITATIVE ERRORS - The LLM provides completely wrong numbers: FY2022: $1.637B (should be $2,147M), FY2023: $1.637B (should be $1,637M), FY2024: $1.604B (should be $2,000M). The LLM's FY2022 figure matches the correct FY2023 figure, indicating a systematic misalignment of data across years. The claimed $33M decline between FY2023-2024 is fabricated; the actual progression shows an increase from $1,637M to $2,000M. (2) TEMPORAL MISALIGNMENT - The LLM incorrectly states FY2022 was $1.637B when this was actually the FY2023 value. This represents a one-year shift in all reported figures. (3) CALCULATION ERRORS - The LLM's interpretation of a 'modest $33 million decline' is mathematically incorrect given the stated figures, and contradicts the actual data showing stabilization at $2,000M in FY2024. (4) MULTI-HOP SYNTHESIS FAILURE - The answer fails to correctly synthesize the three-year progression required by the question. The ground truth shows: $2,147M → $1,637M → $2,000M (decrease then recovery/stabilization), while the LLM shows: $1,637B → $1,637B → $1,604B (flat then slight decline). (5) INTERPRETATION ERROR - The LLM's conclusion about 'marginal improvement in long-term debt positioning' is unsupported by the actual data, which shows a temporary reduction followed by strategic repositioning back to higher levels. The answer demonstrates fundamental data retrieval and synthesis failures rather than minor wording differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 428,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 to 2024 3M’s Scotchgard exposure went from a few early settlements – a $65 million New York settlement, an immaterial Wolverine‑World Wide settlement and a proposed $10‑$12 billion public‑water‑system (PWS) settlement filed in June 2022 – to a fully approved $10.5‑$12.5 billion PWS settlement (court‑approved March 2024, effective May 2024) that will resolve claims from roughly 678 public water systems and thousands of individual PFAS suits. In that span the litigation base broadened dramatically, adding state‑ and territorial‑level actions in Alabama, Georgia, Maine, Massachusetts, Illinois, Missouri, Connecticut, Virginia, Guam, the Northern Mariana Islands and other jurisdictions, each naming 3M together with multiple co‑defendants such as DuPont, Chemours, carpet manufacturers and local water utilities, pushing the total PFAS‑related docket to about 6,775 lawsuits (including 48 putative class actions) by the end of 2023 and continuing to expand in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially more detail than the ground truth, including information about a major $10.5-$12.5 billion PWS (public water system) settlement approved in March 2024 and effective May 2024, covering approximately 678 public water systems. It also cites a total PFAS-related docket of about 6,775 lawsuits (including 48 putative class actions) by end of 2023. However, there are critical issues: (1) The ground truth does not mention the $10-$12 billion PWS settlement at all, making it unclear whether this information is accurate or represents information beyond the knowledge graph. (2) The LLM claims a 'proposed' settlement was 'filed in June 2022' but provides no corroboration in the ground truth. (3) The specific numbers (678 water systems, 6,775 total lawsuits, 48 putative class actions) cannot be verified against the ground truth. (4) The LLM correctly identifies the $65 million New York (Baker) settlement and the Wolverine World Wide Michigan settlement as immaterial, matching ground truth. (5) Geographic expansion is correctly identified (Alabama, Georgia, Maine, Massachusetts, Illinois, Missouri, Connecticut, Virginia, Guam, Northern Mariana Islands), though the ground truth only explicitly mentions Alabama and Georgia. (6) Co-defendants are correctly identified (DuPont, Chemours, carpet manufacturers, water utilities), matching ground truth. The answer demonstrates strong multi-hop reasoning and addresses all question components (settlements, geographic expansion, defendants), but introduces substantial new quantitative claims not present in the ground truth, creating uncertainty about factual accuracy. The semantic structure and reasoning quality are sound, but the quantitative claims require verification beyond the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 488,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "In 2022 the AbCellera agreement still provided a tiered royalty of roughly mid‑teens to mid‑twenties percent on worldwide net sales of bamlanivimab and bebtelovimab, and no material milestone payments were disclosed; the collaboration generated $2.02 billion of net product revenue [page_73]. By 2023 the royalty structure remained unchanged, but the EUA‑authorized antibodies were no longer sold, so net product revenue fell to $0 and no milestone payments were reported [page_74]; the same zero‑revenue, unchanged‑royalty situation persisted through 2024 [page_74].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. STRENGTHS: (1) All quantitative data is correct: $2.02 billion in 2022 revenue, zero revenue in 2023-2024, tiered royalty structure of mid-teens to mid-twenties percent. (2) All entities correctly identified: LLY, AbCellera, bamlanivimab, bebtelovimab, EUA authorization. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years (2022-2024), connecting financial terms (royalty structure), milestone payments (none disclosed), and commercial performance (revenue trajectory). (4) The answer properly explains the causal relationship between EUA authorization status and sales decline. (5) Temporal accuracy is precise: correctly identifies 2022 as peak revenue year, 2023-2024 as zero-revenue years. (6) The answer appropriately notes that royalty structure remained unchanged despite sales cessation, which is a key insight about the agreement's terms. MINOR CONSIDERATIONS: The LLM answer adds helpful context by naming the specific antibodies (bamlanivimab and bebtelovimab) and mentioning EUA authorization, which enhances understanding beyond the ground truth but doesn't contradict it. The phrase 'no material milestone payments were disclosed' is slightly more precise than the ground truth's 'no new milestone payments were made,' but this is semantically equivalent and actually more accurate to typical disclosure practices. Page references [page_73, page_74] are included, demonstrating source attribution. The answer fully addresses all three components of the question: financial terms (royalty structure), milestone payments (none), and net product revenue (evolution from $2.02B to $0).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 486,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Across the three filings, Dawn has been consistently positioned as a core home‑care brand inside the Fabric & Home Care segment. In the 2022 filing Dawn is listed among the segment’s major brands and is singled out as one of the key brands that drive P&G’s roughly 25 % global home‑care market share (2022 p. 18); the same language and brand list appear unchanged in the 2023 and 2024 filings (2023 p. 18; 2024 p. 18). This continuity shows that Dawn remains a cornerstone product in the segment, underscoring its strategic importance to P&G’s overall sales, earnings and market‑share objectives.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - MISSING KEY QUANTITATIVE DATA: The LLM answer completely omits the segment performance metrics that are central to the ground truth answer. The original answer provides specific financial data: 2022 (35% net sales, 31% earnings), 2023 (36% net sales, 34% earnings), 2024 (36% net sales, 34% earnings). The LLM answer mentions only a '25% global home-care market share' figure from 2022, which is a different metric entirely (market share vs. segment contribution) and is not verified in the ground truth. This represents a significant gap in quantitative completeness. STRENGTHS: The LLM correctly identifies that Dawn remained consistently positioned as a core brand across 2022-2024, correctly notes the unchanged brand listing across all three years, and appropriately concludes that this indicates sustained strategic importance. The reasoning about consistency and strategic positioning is sound. WEAKNESSES: (1) Missing segment contribution percentages (net sales and earnings) for all three years - these are fundamental to demonstrating 'evolution' and strategic importance; (2) The 25% market share figure appears to be either incorrect or from a different context than the segment metrics; (3) The answer focuses on brand listing consistency rather than providing the full picture of segment performance evolution; (4) Does not address whether the segment's role changed relative to other P&G segments. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the consistency pattern, but fails to incorporate the quantitative dimension that would complete the multi-hop analysis. The answer is qualitatively sound but quantitatively incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 470,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then edged up to $562 million in 2024 (Table 8.1, 2023 10‑K)【page_178】; its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024 (Table 9.1, 2024 10‑K)【page_188】, leaving total debt of $48.7 billion, $49.9 billion and $45.6 billion respectively. Over the three‑year span the company eliminated its floating‑rate unsecured senior debt, which was $1.6 billion in 2022, $349 million in 2023 and $0 in 2024 (Table 8.1)【page_178】【page_188】, shifting the debt mix toward fixed‑rate instruments and raising the weighted‑average rate on senior notes to about 4.8% in 2024 (up from ~4.5% in prior years). This trend shows a move to a more stable, fixed‑rate capital structure while reducing exposure to variable‑rate interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the overall trend (debt increase in 2023, decline in 2024), accurately captures the elimination of floating unsecured senior debt ($1.6B→$349M→$0), and correctly notes the shift toward fixed-rate debt with rising weighted-average rates. The reasoning about interest rate exposure and strategic debt structure changes is sound and well-articulated. The answer appropriately addresses all parts of the multi-hop question.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) Total debt figures are slightly off: LLM states $48.7B, $49.9B, $45.6B vs. ground truth of $43.086B, $48.715B, $45.551B for 2022-2024. The 2022 figure is significantly understated ($48.7B vs $43.086B - a $5.6B discrepancy). (2) Long-term debt breakdown: LLM claims $47.8B→$49.3B→$45.0B, but ground truth shows total debt of $43.086B in 2022, suggesting the long-term component is overstated. (3) Floating unsecured senior debt 2022: LLM states $1.6B vs. ground truth of $1.709B (minor but notable discrepancy). (4) Weighted-average interest rate on fixed unsecured senior debt: LLM states \"about 4.8% in 2024 (up from ~4.5% in prior years)\" but ground truth shows 4.84% in 2024, 4.45% in 2023, and 2.91% in 2022 - the prior year comparison is incomplete/imprecise.\n\nMULTI-HOP REASONING: The synthesis across years and debt components is logically sound. The model correctly connects the elimination of floating-rate debt to the shift toward fixed-rate instruments and rising rates. However, the foundational numbers are incorrect, which undermines the reliability of the trend analysis.\n\nSEMANTIC EQUIVALENCE: The qualitative conclusions about debt structure evolution and interest rate strategy are semantically equivalent to the ground truth, but the quantitative foundation is flawed.\n\nJUSTIFICATION: The answer demonstrates good understanding of the question's multi-hop nature and provides relevant context about debt structure and interest rate exposure. However, significant numerical errors (particularly the 2022 total debt figure being $5.6B too high) and incomplete rate comparisons prevent a higher score. The answer is partially correct but contains material factual errors that would mislead users relying on specific numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 604,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s $2 billion 5.90 % senior note stayed at the same principal amount and carried a 6.11 % effective rate in FY 2022, FY 2023 and FY 2024【page_89†L31-L38】【page_89†L31-L38】【page_89†L31-L38】. While it represented roughly 22‑24 % of total debt ($8.9 billion total, $8,416 m long‑term in FY 2022 and $8.4 billion total, $6,658 m long‑term in FY 2023)【page_89†L45-L53】【page_89†L45-L53】, its share fell to about 10 % after Cisco’s $13.5 billion senior‑note issuance in FY 2024, when total debt rose to $20.1 billion and the note remained classified as long‑term debt ($19,621 m)【page_89†L45-L53】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the core facts: (1) the $2 billion principal amount remained constant across 2022-2024, (2) the 6.11% effective interest rate was unchanged, and (3) the note's proportion of total debt declined as Cisco expanded its debt portfolio. STRENGTHS: The answer correctly synthesizes information across three fiscal years, accurately captures the shift in debt composition (from ~22-24% to ~10% of total debt), correctly identifies the $13.5 billion senior note issuance in FY 2024 as the driver of this shift, and properly classifies the note as long-term debt throughout. The semantic meaning aligns well with the ground truth. WEAKNESSES: Minor quantitative discrepancies exist: (1) FY 2023 long-term debt is stated as $6,658M in the LLM answer, but the ground truth implies a different figure (the original answer shows progression from $8,416M in 2022 to $19,621M in 2024, suggesting FY 2023 was intermediate); (2) Total debt figures in FY 2023 ($8.4 billion) appear inconsistent with the long-term debt figure of $6,658M (long-term debt should not exceed total debt); (3) The percentage calculations (22-24% and 10%) are approximately correct but would benefit from verification against stated figures. The answer successfully addresses all parts of the multi-part question: principal amount evolution, effective interest rate, debt composition changes, and long-term classification. The multi-hop reasoning is sound—correctly connecting the stable note characteristics to the changing debt portfolio context. The minor numerical inconsistencies prevent a higher score, but the core answer is fundamentally correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 471,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "The 1.55 % notes due 2028 have been carried at roughly the same low‑cost level over the period – about $1.1 billion at FY 2023 year‑end and $1.25 billion at FY 2024 year‑end【page_67】【page_72】 – and the effective interest rate has stayed essentially unchanged at roughly 1.6 % (FY 2024 = 1.64%, matching the 1.55 % coupon). This modest rise in carrying amount as the discount amortizes, together with a consistently low effective rate, shows NVIDIA’s strategy of locking in inexpensive, long‑dated debt to support growth while keeping financing costs minimal.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer omits the FY 2022 carrying value ($1,200 million) entirely, which is a significant omission for a question explicitly asking about evolution 'from fiscal years 2022 through 2024.' The LLM only provides FY 2023 (~$1.1B) and FY 2024 ($1.25B) values. CALCULATION/INTERPRETATION ERROR: The LLM states the effective interest rate 'has stayed essentially unchanged at roughly 1.6%' and notes FY 2024 = 1.64%, but this misses the ground truth's key point that the effective interest rate INCREASED from an implied rate in 2022 to 1.64% in 2024. The LLM's characterization of 'consistently low effective rate' contradicts the ground truth's statement of an increase. MISSING CRITICAL TREND: The ground truth explicitly notes a decrease from $1,200M (2022) to $1,099M (2023) followed by a rise to $1,250M (2024), suggesting strategic reacquisition. The LLM misses this important three-year pattern and the temporary decrease in 2023. PARTIAL CREDIT: The LLM correctly identifies the FY 2024 carrying value ($1.25B) and effective interest rate (1.64%), and provides reasonable strategic interpretation about locking in low-cost debt. The reference citations suggest source verification was attempted. However, the incomplete data set (missing FY 2022), the mischaracterization of the interest rate trend as 'unchanged' rather than 'increased,' and the omission of the 2023 dip represent substantial gaps in answering a multi-hop question that explicitly requires three-year evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 423,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In 2022 Alphabet still framed Pixel phones as a core part of a “growing family of hardware devices,” pointing to new models such as the Pixel 5a 5G and Pixel 6 and saying the company was “investing … for the long run” in hardware innovation【page_7】. By the 2023 filing the Pixel line had been folded into the “devices” line of the “Google subscriptions, platforms, and devices” segment – a non‑advertising revenue category that the company now notes can weigh on margins, while still emphasizing broad R&D spending in its strategic focus areas【page_33】【page_31】. The 2024 report keeps the same categorization (“devices, which primarily include sales of the Pixel family of devices”) but the narrative shifts to inventory and cost‑of‑revenue considerations for devices, with no explicit emphasis on new Pixel innovation, signalling a more mature, cost‑focused view of the hardware business【page_59】【page_60】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 3-year progression (2022-2024) with accurate characterization of each period: 2022 as investment/long-term focus, 2023 as explicit categorization under 'devices' segment, 2024 as mature/cost-focused. (2) Accurately references specific Pixel models (Pixel 5a 5G, Pixel 6) mentioned in 2022 filings. (3) Correctly identifies the revenue categorization evolution - from general hardware emphasis to explicit 'devices' segment within 'Google subscriptions, platforms, and devices.' (4) Properly synthesizes the multi-hop information: tracking how Pixel positioning changed across three years and filing documents. (5) Accurately captures the narrative shift from innovation emphasis to cost/inventory considerations. (6) Provides specific page references (7, 33, 31, 59, 60) that ground the answer in source material. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and nuanced than the ground truth (e.g., mentioning margin impacts, specific cost-of-revenue focus), but these additions are consistent with and supportive of the core narrative rather than contradictory. The characterization of the evolution as 'investment focus → mature, strategically embedded product line' (ground truth) aligns well with 'growing family → explicit segment categorization → mature, cost-focused view' (LLM answer). No quantitative errors detected. The reasoning correctly synthesizes information across multiple years and filing documents as required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 441,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon’s Item 14 reads the same: “The information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185.” (2022 p. 14; 2023 p. 13; 2024 p. 13). The unchanged wording and consistent reference to KPMG each year signal that the bank has retained the same principal accountant without alteration, underscoring a stable audit relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All numeric values are correct - PCAOB firm identification number 185 is accurately cited, page numbers (2022 p. 14; 2023 p. 13; 2024 p. 13) are precise and verifiable; (2) The core factual claim is correct - BNY Mellon's Item 14 disclosure remained unchanged across all three years with identical language; (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three separate 10-K filings and draws the appropriate conclusion about audit relationship stability; (4) The quoted language matches the ground truth exactly, demonstrating direct verification from source documents; (5) The reasoning is logical and well-articulated - unchanged disclosure language correctly implies stable audit relationship with no disruptions. MINOR CONSIDERATIONS: (1) The answer provides slightly more granular detail (specific page numbers) than the ground truth, which is actually a strength for verification purposes; (2) The answer uses direct quotation rather than paraphrase, which enhances credibility; (3) Both answers reach identical conclusions about stability and consistency. The LLM answer fully addresses the multi-part question: it shows HOW the disclosure evolved (it didn't - remained identical), WHAT the consistency reveals (stable relationship, no disruptions), and provides specific textual evidence. No calculation errors, no entity misidentification, and complete semantic equivalence with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 418,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "In 2022 the defined‑benefit pension plan held about **$8.9 billion** in private‑alternative assets (hedge funds, equity‑like funds, real estate and other), which was roughly **67 %** of the plan’s $13.2 billion total 【page 99】.  In 2023 the private‑alternative balance fell to **$8.6 billion** (≈ 63 % of $13.7 billion) 【page 100】, and in 2024 it declined further to **$8.2 billion** (≈ 60 % of $13.7 billion) 【page 99】.  This gradual reduction in both absolute dollars and share of assets shows that LLY is maintaining a substantial, but slowly decreasing, exposure to illiquid private‑alternative investments, suggesting a long‑term strategy that values such assets while progressively rebalancing toward a more diversified, potentially more liquid, portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth shows LLY's private alternative investments at $10,542.5M (2022), $10,335.2M (2023), and $10,051.0M (2024). The LLM reports $8.9B (2022), $8.6B (2023), and $8.2B (2024) - these are approximately 15-20% lower than actual values. The LLM also mischaracterizes the trend: ground truth shows a DECREASE from 2022-2024 ($10,542.5M → $10,051.0M), which the LLM correctly identifies directionally but with wrong absolute numbers. More critically, the LLM appears to be reporting pension plan data rather than company-wide investment allocation data, as evidenced by references to 'defined-benefit pension plan' and percentages of total plan assets ($13.2-13.7B). The question asks about 'LLY's allocation' broadly, not specifically pension plan allocations. The LLM's interpretation of the trend (decreasing exposure) aligns with ground truth directionally, but the numerical foundation is entirely wrong. The percentages cited (67%, 63%, 60%) are internally consistent with the LLM's own numbers but don't match the ground truth allocation percentages. The reasoning about 'rebalancing toward more liquid portfolio' is speculative and not supported by the ground truth answer. This represents a fundamental failure in quantitative accuracy - the core numbers are wrong by billions of dollars.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 393,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "Across all three filings, P&G placed Tampax in the Baby, Feminine & Family Care segment under the Feminine‑Care sub‑category described as “Adult Incontinence, Menstrual Care,” and listed it alongside Always and Always Discreet (shown as “Tampax Bounty”) in the major‑brands column – the same classification and brand emphasis appear in the 2022 table (page 18), the 2023 table (page 18) and the 2024 table (page 18) (PG_10k_2022 page_18; PG_10k_2023 page_18; PG_10k_2024 page_18). This indicates that Tampax’s positioning remained consistent, with no change in its category label or product‑line focus over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) CATEGORY EVOLUTION - Ground truth clearly states that 'Menstrual Care' explicitly replaced 'Feminine Care' as a sub-category by 2023, and that Tampax moved from 'Feminine Care' to 'Menstrual Care' by 2024. The LLM claims the classification remained 'Feminine-Care' across all three years with 'Adult Incontinence, Menstrual Care' as a consistent descriptor, which misrepresents the evolution. (2) SEGMENT COMPOSITION CHANGES - Ground truth indicates the segment was rebranded and 'Baby Care' was removed entirely by 2024, signaling a strategic shift. The LLM completely misses this structural change and claims 'no change in its category label or product-line focus.' (3) SALES CONTRIBUTION - Ground truth provides specific percentages: 25% in 2022, 24% in 2023, and 24% in 2024. The LLM provides no sales figures whatsoever, missing quantitative context entirely. (4) STRATEGIC EMPHASIS - Ground truth emphasizes a 'growing strategic emphasis on adult feminine hygiene and away from infant-related product lines' with the removal of Baby Care. The LLM completely fails to capture this strategic evolution and instead claims consistency. (5) MULTI-HOP SYNTHESIS - The question requires synthesizing changes across three years. The LLM's conclusion that positioning 'remained consistent' directly contradicts the ground truth's documentation of meaningful evolution in category naming and segment composition. The LLM appears to have misread or misinterpreted the filing data, possibly conflating consistent brand presence with unchanged categorization. This is a major failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 471,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One measured its net derivative liabilities (Level 3) with discounted‑cash‑flow models in each year. In 2022 the fair‑value balance was only $5 million and the model relied on a very narrow swap‑rate input (≈1 % weighted‑average) 【page_206】; by 2023 the balance had risen to $58 million and the valuation added both swap‑rate (3‑5 % range, 4 % weighted‑average) and default‑rate (53‑163 % range, 4 % weighted‑average) assumptions 【page_208】; in 2024 the balance grew to $69 million and the approach remained a discounted‑cash‑flow model with swap‑rates as the key unobservable input, still at a 4 % weighted‑average (range not disclosed) 【page_215】【page_217】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) 2022 Fair Value: LLM states $5 million, but ground truth shows $19 million - a $14 million discrepancy. (2) 2024 Fair Value: LLM states $69 million, but ground truth shows $58 million - a $11 million error. (3) 2023 Fair Value: Both agree on $58 million (correct). (4) Valuation Methodology: LLM claims 2022 used discounted cash flow models with 1% swap rate, but ground truth explicitly states 'the specific valuation technique was not disclosed' for 2022. This is a fundamental misrepresentation. (5) Default Rates: LLM correctly identifies 53-163% range for 2023, but ground truth does not mention default rates being used in 2024, while LLM implies they were. (6) Swap Rates: LLM provides weighted-average percentages (1%, 4%, 4%) that are not mentioned in the ground truth, which only provides ranges (3-5%). The introduction of weighted-average data not in ground truth is problematic. (7) Multi-hop Synthesis: While the LLM attempts to track evolution across years, the foundational numbers are wrong, undermining the entire analysis. The progression narrative is compromised by incorrect 2022 and 2024 values. The answer demonstrates some understanding of the structure (DCF models, ranges, evolution over time) but fails on core quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 395,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a modest positive contribution in FY 2022 to increasingly negative impacts on the company’s bottom line: it generated a **$9 million gain** in FY 2022, a **$21 million loss** in FY 2023, and a **$67 million loss** in FY 2024 (see “Gains (losses) on investments, net – Available‑for‑sale debt investments” in the Other Income (Loss), Net table)【page_46】.  This shift from a small gain to larger losses shows that the fair‑value of the AFS debt holdings declined and unrealized/realized losses grew, indicating deteriorating performance and a higher market‑risk exposure for these investments over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) that directly contradict the ground truth. The ground truth explicitly states that 'In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results.' The LLM's claim of a $9M gain in FY2022 is factually incorrect according to the knowledge graph. Additionally, the ground truth does not provide the specific loss figures of $21M and $67M for 2023 and 2024 - it only states that 'higher losses in AFS debt investments were a primary driver' and 'AFS debt investment losses again significantly contributed' without quantifying these amounts. The LLM appears to have fabricated specific numbers with a citation reference ('page_46') that cannot be verified against the ground truth. While the LLM correctly identifies the general trend (from positive to negative impact) and the correct fiscal years, the introduction of unverified specific dollar amounts is a fundamental factual error. The reasoning about deteriorating performance and market-risk exposure is sound, but it is built on potentially false quantitative foundations. The answer fails on quantitative accuracy (the core issue) and therefore significantly undermines the overall correctness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 403,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks said its purchase‑commitments + inventory would be enough to meet demand through fiscal 2023 in the 2022 filing 【page_12】. The 2023 filing lifted that horizon, projecting an adequate green‑coffee supply through fiscal 2024 【page_12】. The 2024 filing again extended the outlook, expecting adequacy through fiscal 2025 【page_12】. Together, the year‑over‑year extensions show a forward‑looking sourcing strategy that relies on long‑term fixed‑price and price‑to‑be‑fixed contracts, diversified sourcing, inventory buffers and hedging to mitigate supply‑chain risk and secure a reliable supply of high‑quality green coffee.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL 2023 PROJECTION: The LLM states that the 2023 filing projected adequacy through fiscal 2024, but the ground truth clearly indicates it extended to fiscal 2025. This is a significant factual error in the multi-hop synthesis. CORRECT ELEMENTS: (1) Fiscal 2022 filing correctly identified as projecting adequacy through fiscal 2023; (2) Fiscal 2024 filing correctly identified as projecting adequacy through fiscal 2025; (3) Overall narrative of year-over-year extensions is correct; (4) The qualitative assessment of sourcing strategy (long-term contracts, diversification, inventory buffers, hedging) is accurate and well-articulated. QUANTITATIVE ACCURACY ISSUES: The progression should be FY2022→FY2023, FY2023→FY2025, FY2024→FY2025 (a 2-year extension in 2023, then maintained in 2024). The LLM shows FY2022→FY2023, FY2023→FY2024, FY2024→FY2025, which misrepresents the actual progression. This is a material error in the multi-hop reasoning across three fiscal years. STRENGTHS: The answer demonstrates good understanding of Starbucks' risk mitigation approach and provides relevant context about sourcing mechanisms. The citation format and structure are clear. WEAKNESSES: The core factual error regarding the fiscal 2023 projection undermines the credibility of the multi-year progression analysis, which is the central focus of the question. The error suggests incomplete or inaccurate synthesis of information across the three filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 407,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA did not list any 2.00 % Notes Due 2031 in its FY 2022 filing (the instrument is absent from the 2022 tables). In FY 2023 the company reported $1.25 billion of these notes on its balance sheet (net carrying amount) and a fair‑value of $1.044 billion [page 67]; by FY 2024 the net carrying amount remained at $1.25 billion and the fair‑value rose slightly to $1.057 billion [page 72]. The unchanged principal balance across FY 2023‑24 shows that NVIDIA added a modest, low‑coupon, long‑dated tranche of debt and has kept it stable, reflecting a deliberate strategy of using a small, low‑cost, long‑term financing source to support its growth rather than repeatedly expanding its long‑term debt load.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The ground truth clearly states FY2022: $1,200M, FY2023: $1,044M, FY2024: $1,250M. The LLM claims the instrument was 'absent from the 2022 tables' and reports FY2023 as $1.25B (which matches FY2024, not FY2023). The LLM also cites fair values of $1.044B and $1.057B, which appear to confuse the carrying amounts with fair values or misread the data entirely. The ground truth shows $1,044M in 2023 (which the LLM incorrectly attributes as a fair value rather than the actual balance). (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly track the three-year trend. The ground truth shows: 2022→2023 (decrease from $1,200M to $1,044M), then 2023→2024 (increase from $1,044M to $1,250M). The LLM's narrative of 'unchanged principal balance across FY2023-24' is factually wrong—there was a $206M increase from 2023 to 2024. (3) ENTITY/METRIC CONFUSION: The LLM conflates carrying amounts with fair values and misidentifies which year corresponds to which figure. (4) REASONING QUALITY: While the LLM attempts to provide strategic interpretation, this interpretation is built on incorrect data, making the conclusions unreliable. The claim that the company 'added a modest, low-coupon, long-dated tranche of debt' in 2023 contradicts the ground truth showing the instrument existed in 2022. The statement about 'unchanged principal balance' is demonstrably false given the $206M increase from 2023 to 2024. The answer shows some effort at financial analysis but is fundamentally undermined by data accuracy failures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 454,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 filing (reflected in the 2023 filing’s segment description on page 107), fall‑protection was shown only as one component of the broader “Respiratory, hearing, eye and fall protection solutions” line‑item within the Safety and Industrial segment, grouped together with other personal‑protective equipment. By the 2024 filing (page 110), after the creation of an Industrial Specialties division, fall‑protection is now described as part of the “Industrial specialty products” set – placed inside the new division and highlighted alongside other industrial‑safety and specialty offerings, shifting its positioning from a generic personal‑safety item to an industrial‑specialty product within Safety and Industrial.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that fall protection was grouped with respiratory, hearing, and eye protection in 2022-2023, and that there was a shift in positioning by 2024. The mention of an 'Industrial Specialties division' creation and the shift from generic personal-safety to industrial-specialty positioning aligns with the ground truth's description of 'revised grouping' and 'alignment with broader industrial safety systems.' (2) PROBLEMATIC ELEMENTS: The LLM introduces specific page numbers (107, 110) that cannot be verified against the ground truth and may be fabricated. The ground truth does not mention the creation of an 'Industrial Specialties division' explicitly - it only notes a 'slightly revised grouping' and alignment with 'broader industrial safety systems.' The LLM's characterization of the shift as moving from 'generic personal-safety item to industrial-specialty product' is more definitive than the ground truth's more cautious 'subtle shift' language. (3) MULTI-HOP REASONING: The LLM does attempt to synthesize information across years (2022→2023→2024) and connect product categorization changes to organizational structure changes, which is appropriate for the question. However, the specificity about divisional reorganization goes beyond what the ground truth supports. (4) SEMANTIC ALIGNMENT: While the core narrative of evolution is present, the LLM adds interpretive details (divisional creation, specific page citations) that either cannot be verified or exceed the ground truth's more measured assessment. The ground truth emphasizes 'subtle shift' while the LLM presents it as a more structural reorganization. This represents overconfidence in specific details not clearly supported by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 502,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s COVID‑19 antibody line (which includes bamlanivimab) generated about $2.0 billion of U.S. sales (plus $14.7 million abroad ≈ $2.02 billion total) in 2022【page_71】. The same line shows $0 revenue in 2023【page_65】 and again $0 in 2024【page_67】. The drop from multi‑billion‑dollar sales to nil indicates that Lilly has essentially exited reliance on bamlanivimab and its broader COVID‑19 antibody portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: (1) 2022 revenue of ~$2.0 billion U.S. + $14.7 million international = $2.01-2.02 billion total matches the ground truth figure of $2.01 billion (minor rounding difference is acceptable); (2) 2023 revenue of $0 is correct; (3) 2024 revenue of $0 is correct. The LLM properly synthesized the multi-hop information by combining U.S. and international sales figures to arrive at the total, demonstrating accurate cross-source synthesis. The trend analysis is sound: the answer correctly identifies the dramatic decline from $2.01 billion to $0 and appropriately characterizes this as indicating Eli Lilly's exit from reliance on the COVID-19 antibody portfolio. The reasoning is logically sound and the conclusion about the company's reduced dependence on this product line is well-supported by the data. The answer directly addresses all parts of the question: the revenue evolution across the three-year period and what the trend indicates about reliance. The inclusion of specific page references adds credibility. Minor note: The LLM uses slightly different phrasing ('essentially exited reliance') compared to ground truth ('rapid decline in reliance'), but this is semantically equivalent and arguably more precise given the complete elimination of revenue. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 381,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks has consistently flagged that coffee‑price swings are amplified by trading activity from hedge funds and **commodity‑index funds** – language that appears in the “Product Supply” sections of its 2022, 2023 and 2024 Form 10‑K filings (all on page 12). In the 2022 filing the company said its existing purchase commitments and inventory would meet green‑coffee needs through **fiscal 2023**; the 2023 filing repeats the same commodity‑index‑fund exposure but extends the coverage to **fiscal 2024**; and the 2024 filing again cites the exposure while stating that its total purchase commitments and inventory now secure supply through **fiscal 2025**. This upward shift in the supply‑coverage horizon demonstrates that Starbucks is actively managing the commodity‑index‑fund risk by expanding fixed‑price, forward, futures and collar contracts, thereby locking in green‑coffee supply for an additional year and reducing vulnerability to price volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years. STRENGTHS: (1) All numeric/date references are correct - fiscal 2023 coverage in 2022 filing, fiscal 2024 in 2023 filing, fiscal 2025 in 2024 filing. (2) Correctly identifies the consistent acknowledgment of commodity index fund exposure across all three years. (3) Accurately describes the progression of supply visibility extension (2023→2024→2025). (4) Properly identifies the risk management tools (forward contracts, futures contracts, collars) used to hedge exposure. (5) Correctly notes the multi-year trend showing improved supply chain resilience. (6) Appropriately cites the specific location of information (Product Supply sections, page 12). MINOR CONSIDERATIONS: (1) The LLM answer uses 'hedge funds' alongside 'commodity-index funds' in the opening, while the ground truth focuses specifically on commodity index funds - this is a minor semantic variation that doesn't materially affect accuracy. (2) The LLM answer emphasizes 'fixed-price' contracts in addition to forward/futures/collar contracts, which aligns with typical hedging strategies but isn't explicitly contradicted by the ground truth. (3) Both answers convey the same core insight about strengthening risk management practices through extended supply commitments. The multi-hop reasoning is sound: the LLM correctly synthesizes information across three separate fiscal years to demonstrate the temporal progression of Starbucks' risk management strategy. The answer directly addresses how exposure evolved and what it reveals about risk management strategy, fully answering the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 466,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022 Alphabet described its Google Network revenue – which includes AdMob, AdSense and **Google Ad Manager** – as being driven by impressions and cost‑per‑impression, underscoring that impression‑based monetization through Google Ad Manager was a core revenue pillar (2022 p.31). The 2023 filing repeats that advertisers purchase inventory through **Google Ad Manager** and that impression‑based revenue remains central to the Google Network segment, and it also notes a January‑2023 accounting change that extended the useful lives of servers (from 4 to 6 years) and certain network equipment (from 5 to 6 years), which reduced depreciation expense by $3.9 billion and boosted net income by $3.0 billion (2023 p.57‑58). By 2024 the same ad‑manager‑driven impression model is still embedded in Alphabet’s advertising mix (depreciation expense rose to $15.3 billion in 2024, p.56), but the 2023 depreciation‑schedule adjustment has already enhanced long‑term profitability, giving the company a stronger earnings base to sustain and expand impression‑based monetization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct - server depreciation schedule change from 4 to 6 years, network equipment from 5 to 6 years, depreciation expense reduction of $3.9 billion, net income increase of $3.0 billion, and 2024 depreciation expense of $15.3 billion. All dates are accurate (2022, January 2023, 2024). COMPLETENESS: The answer addresses all three time periods requested (2022, 2023, 2024) and explicitly connects the depreciation adjustment to its implications for long-term profitability. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and filing documents, showing how: (1) 2022 established Ad Manager as impression-based revenue driver, (2) 2023 depreciation adjustment reduced costs by $3.9B, and (3) 2024 continued the same monetization model with enhanced profitability base. ENTITY ACCURACY: Correctly identifies Google Ad Manager, Google Network properties, AdMob, AdSense, and Alphabet. SEMANTIC EQUIVALENCE: The answer conveys the same core message as the ground truth - that the depreciation adjustment directly benefited infrastructure-heavy operations like Ad Manager and enhanced long-term profitability. MINOR OBSERVATIONS: The LLM provides slightly more granular detail (mentioning AdMob and AdSense as part of Google Network, citing specific page numbers) which adds credibility without contradicting the ground truth. The phrase 'depreciation expense rose to $15.3 billion in 2024' is contextually appropriate as it shows the depreciation adjustment's ongoing impact. No calculation errors detected. The reasoning chain is logical and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 471,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK filed a 2022 Form of Performance Share Unit Agreement (Exhibit 10.18) under its 2019 Long‑Term Incentive Plan, followed by a revised 2023 Form (Exhibit 10.23) and then a 2024 Form (Exhibit 10.25) in successive years【page_18】【page_19】. The annual updates show that BNY Mellon is continuously relying on performance‑share units and refining their terms, signaling a strategic emphasis on performance‑based equity awards to align executive pay with long‑term shareholder value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims BK filed a 2022 Form (Exhibit 10.18), a 2023 Form (Exhibit 10.23), and a 2024 Form (Exhibit 10.25), but the ground truth shows: 2022 referenced 2021 agreement (Exhibit 10.45), 2023 re-filed the 2019 plan (Exhibit 10.14), and 2024 included 2022 agreement (Exhibit 10.18). The exhibit numbers are completely wrong. (2) The LLM invents a 2023 Form (Exhibit 10.23) and 2024 Form (Exhibit 10.25) that don't appear in the ground truth. (3) The LLM misidentifies the progression - it suggests a linear annual update cycle (2022→2023→2024 forms), when the actual pattern is more complex: 2021 agreement referenced in 2022, 2019 plan re-filed in 2023, and 2022 agreement incorporated in 2024. (4) The LLM correctly identifies BK/BNY Mellon and the 2019 Long-Term Incentive Plan, but fails on the specific evolution pattern. (5) While the LLM's general conclusion about performance-based equity alignment is reasonable, it's based on incorrect exhibit citations and mischaracterized filing progression. The multi-hop reasoning is fundamentally flawed because it synthesizes incorrect information about which forms were filed in which years. The answer demonstrates a failure to accurately track the temporal evolution of PSU agreements across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 383,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "- 2022 – The Safety & Industrial segment listed “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a single, generic line item 【page_129】.  \n- 2023 – The description was refined to read “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” and was grouped with other industrial‑specialty offerings 【page_107】.  \n- 2024 – The wording stayed essentially the same, but the surrounding bullets were reorganized (e.g., “Industrial specialty products such as personal hygiene products, masking, and packaging materials”) while still highlighting the same electrical‑OEM product line 【page_110】.  \n\nThe steady, slightly more explicit phrasing across the three years shows 3M has kept electrical products a distinct, strategically‑important sub‑portfolio within Safety & Industrial, underscoring a continued focus on serving electrical original‑equipment‑manufacturer markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year progression (2022, 2023, 2024) and accurately captures the general evolution of language around electrical products and OEM markets. The page references provided (129, 107, 110) suggest proper sourcing. The answer correctly notes that 2023 introduced 'original equipment manufacturers (OEMs)' with the full acronym spelled out, and that 2024 maintained similar language. The conclusion about strategic emphasis on electrical OEM markets is reasonable and supported.\n\nWEAKNESSES: (1) The LLM answer contains a factual discrepancy regarding 2022 description. The ground truth states 2022 described products as serving 'construction and maintenance, power distribution and electrical OEMs' - notably WITHOUT 'and materials' in the original phrasing. The LLM adds 'and materials' to the 2022 description ('electrical products and materials for construction and maintenance...'), which may not match the exact 2022 filing language. (2) The LLM's characterization of 2023 as adding 'construction and maintenance' appears inconsistent with the ground truth, which suggests the 2023 refinement was specifically about spelling out 'original equipment manufacturers (OEMs)' rather than adding new categories. (3) The LLM states 2024 'wording stayed essentially the same' but the ground truth indicates 2024 evolved to 'power distribution and electrical original equipment manufacturers (OEMs)' - notably REMOVING 'construction and maintenance' from the description. This is a meaningful change that the LLM misses. (4) The LLM's interpretation that the evolution shows 'steady, slightly more explicit phrasing' understates the actual shift in 2024 where construction/maintenance was dropped, suggesting a more focused strategic pivot than the LLM conveys.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression toward greater specificity in OEM targeting. However, it misses the 2024 shift away from construction/maintenance, which is a key insight about strategic focus evolution.\n\nNUMERIC/FACTUAL VERIFICATION: No calculations or specific numbers are involved in this question, so quantitative accuracy relates to the precision of quoted language. The LLM's quoted language appears to have minor variations from ground truth that affect the interpretation of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 637,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "- 2022: Fixed unsecured senior debt carried **$24.1 bn** with a **weighted‑average interest rate of ~4.45 %**【page_178】.  \n- 2023: The balance grew to **$27.2 bn** while the average rate stayed at **~4.45 %**【page_178】.  \n- 2024: The carrying amount slipped slightly to **$26.9 bn** and the weighted‑average rate rose to **~4.84 %**【page_188】.  \n\nThe progression shows Capital One expanding its senior unsecured funding in 2023 (new issuances) and then modestly reducing the amount in 2024 while the cost of that debt increased as newer issues were priced at higher market rates. This reflects a long‑term strategy of maintaining a sizable, diversified senior unsecured portfolio and managing interest‑rate risk through active issuance and refinancing as rates move higher.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 and 2023 figures. (1) 2022 CARRYING VALUE: LLM states $24.1 bn, but ground truth is $19,975 million ($19.975 bn). This is a $4.125 billion overstatement (~20% error). (2) 2022 WEIGHTED-AVERAGE INTEREST RATE: LLM states ~4.45%, but ground truth is 2.91%. This is a massive error of 1.54 percentage points, representing a 53% misstatement of the actual rate. (3) 2023 CARRYING VALUE: LLM states $27.2 bn, which matches ground truth of $27,168 million ($27.168 bn) - CORRECT. (4) 2023 WEIGHTED-AVERAGE INTEREST RATE: LLM states ~4.45%, but ground truth is 4.45% - this appears correct by coincidence, but the LLM incorrectly claims it 'stayed' at 4.45% when it actually ROSE from 2.91% in 2022. (5) 2024 CARRYING VALUE: LLM states $26.9 bn, which matches ground truth of $26,930 million - CORRECT. (6) 2024 WEIGHTED-AVERAGE INTEREST RATE: LLM states ~4.84%, which matches ground truth - CORRECT. MULTI-HOP REASONING: The LLM's narrative interpretation about 'expanding in 2023 and reducing in 2024' is reasonable, but it is built on fundamentally incorrect 2022 baseline data. The ground truth shows a clear progression of rising rates (2.91% → 4.45% → 4.84%), which the LLM partially captures but misrepresents by claiming 2022 started at 4.45%. COMPLETENESS: The answer addresses all three years and both metrics (carrying value and weighted-average rate), but with critical accuracy failures. The strategic interpretation about 'locking in capital at increasingly higher costs' is semantically similar to ground truth but undermined by the incorrect 2022 rate. SUMMARY: 3 out of 6 data points are correct (2023 and 2024 carrying values, 2024 rate). The 2022 figures are severely wrong, which corrupts the multi-year progression analysis that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 506,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA has consistently recorded its 3.50 % Notes Due 2040 at original‑issuance value, net of unamortized discount and issuance costs (Note 9 footnote (1), p. 67) and classifies them as Level 2 fair‑value liabilities (p. 67). The fair‑value disclosed fell modestly from $870 million in FY 2023 to $851 million in FY 2024 (p. 67), while the FY 2022 filing applied the same accounting treatment with a comparable fair‑value near par (implied by the unchanged policy). This steady, slight decline in market value together with unchanged amortized‑cost accounting shows that NVIDIA’s long‑term debt strategy relies on low‑coupon senior unsecured notes held to maturity, using transparent fair‑value disclosures to monitor interest‑rate effects.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) WRONG NUMBERS: The LLM states FY 2023 fair value was $870 million and FY 2024 was $851 million. The ground truth clearly shows FY 2023 was $851 million (not $870M), and FY 2024 had a carrying amount of $1,000 million (not $851M). The LLM appears to have confused or inverted the FY 2023 and FY 2024 values. (2) MISSING FY 2022 DATA: The ground truth explicitly states FY 2022 fair value was $1,066 million. The LLM dismisses this with vague language ('implied by the unchanged policy' and 'comparable fair-value near par') rather than providing the actual $1,066M figure. This is a major omission for a multi-year progression question. (3) ACCOUNTING TREATMENT SHIFT NOT ADDRESSED: The ground truth reveals a critical shift from fair value reporting (FY 2022-2023) to carrying amount reporting (FY 2024). The LLM fails to identify or explain this methodological change, instead claiming 'unchanged amortized-cost accounting' throughout. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution and what it reveals about strategy. The ground truth identifies a shift in accounting approach. The LLM provides generic commentary about 'low-coupon senior unsecured notes held to maturity' without capturing the actual evolution in reporting methodology. (5) SEMANTIC ISSUES: The LLM's conclusion about 'steady, slight decline' is factually wrong given the $1,066M→$851M→$1,000M progression, which shows volatility and a significant rebound, not a steady decline. The answer demonstrates fundamental misreading of the source data and fails to synthesize the three-year progression correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 473,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s outstanding balance on its 2017 senior notes fell from $16 billion at 12/31/2022 to $15 billion at 12/31/2023 and further to $13 billion at 12/31/2024【page_58】【page_57】. The steady decline shows Amazon is actively repaying or redeeming this tranche, reflecting a disciplined debt‑management strategy that reduces leverage and interest costs while preserving balance‑sheet flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All financial figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024) match the ground truth exactly. The dates are properly specified (12/31/2022, 12/31/2023, 12/31/2024), and the year-over-year reductions are accurately presented. ENTITY ACCURACY: Amazon and the 2017 Notes are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trajectory and correctly interprets the pattern as evidence of deliberate debt management. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'disciplined debt-management' that 'reduces leverage and interest costs while preserving balance-sheet flexibility' is semantically equivalent to and slightly more detailed than the ground truth's 'deliberate debt management strategy to gradually retire this issuance.' The additional context about reducing leverage and interest costs is reasonable inference from the data pattern and adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM includes citation markers (【page_58】【page_57】) which are appropriate for SEC filing references. The phrasing 'actively repaying or redeeming' is accurate terminology for debt reduction. The only minor distinction is that the LLM provides slightly more analytical depth than the ground truth, but this represents enhancement rather than error. All core facts, numbers, and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 419,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 all reference the 2014 Officer’s Certificate (Exhibit 4.4) that lists “Floating Rate Notes due 2019” 【page_58】【page_56】. By continuing to disclose these notes, Apple signals that it still has short‑term floating‑rate debt on its books, exposing it to interest‑rate risk; as short‑term rates rise, the reset‑rate feature of the notes will increase Apple’s interest expense, making its overall borrowing cost more sensitive to a higher‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three years (2022, 2023, 2024) and the 2014 Officer's Certificate reference. (2) Correctly notes the Floating Rate Notes due 2019 and their presence across multiple filings. (3) Accurately explains the mechanics of floating rate notes and interest rate sensitivity in a rising rate environment. (4) Properly identifies the reset-rate feature and its impact on interest expense. (5) Correctly cites Exhibit 4.4 as the source document.\n\nWEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It fails to address the key insight that these notes had a 2019 maturity date, yet were still being disclosed in 2022, 2023, and 2024 filings—which is temporally anomalous and suggests ongoing obligations or disclosure requirements despite the maturity having passed. (2) Missing the important contextual point about 'rollover obligations' or 'continuing commitments' that the ground truth emphasizes. (3) Does not address the liquidity planning and capital structure flexibility implications mentioned in the ground truth. (4) The phrase 'still has short-term floating-rate debt on its books' is somewhat ambiguous given that the notes were due in 2019—the LLM doesn't clarify whether these are refinanced/rolled-over obligations or disclosure artifacts. (5) Less nuanced explanation of why these notes persist in disclosures despite their maturity date.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the basic multi-hop connection (filings → Officer's Certificate → Floating Rate Notes → interest rate sensitivity), but misses the deeper multi-hop insight about the temporal discrepancy (2019 maturity date appearing in 2022-2024 filings) and what that implies about Apple's debt structure and obligations.\n\nFACTUAL ACCURACY: All dates, document references, and technical explanations are correct. No calculation errors or factual inaccuracies detected. The core mechanics of floating rate notes and interest rate sensitivity are accurately described.\n\nCOMPLETENESS: The answer addresses the interest expense sensitivity question adequately but provides only a partial response to the broader question about 'ongoing exposure' and implications for liquidity/capital structure planning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 608,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "In 2022 Google described its hardware effort as a long‑run, portfolio‑building exercise, highlighting the “tremendous potential” of early Pixel models (Pixel 5a 5G, Pixel 6) and calling the creation of everyday‑use devices “a journey that we are investing in for the long run”【page_7】. By 2024 the Pixel line is singled out as the primary source of the “devices” revenue segment (“devices, which primarily include sales of the Pixel family of devices”) and earlier 2023 commentary already noted that device sales, while still pressure‑sensitive on margins, were a growing, distinct revenue stream【page_31】【page_59】. This evolution shows Google moving the Pixel from an exploratory, AI‑software‑hardware experiment to a mature, revenue‑generating pillar of its ecosystem, indicating a strategic commitment to a lasting hardware presence in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as a long-term investment with specific device mentions (Pixel 5a 5G, Pixel 6), matching the ground truth's characterization. (2) Accurately captures the 2023-2024 transition where Pixel moved from investment focus to revenue-generating category under 'devices' segment. (3) The quote about 'devices, which primarily include sales of the Pixel family of devices' directly reflects the structured revenue breakdown mentioned in ground truth. (4) Multi-hop reasoning is sound: synthesizes information across three time periods (2022, 2023, 2024) and correctly traces the evolution from exploratory phase to mature revenue pillar. (5) No quantitative errors - no specific dollar amounts or percentages are claimed, avoiding calculation risks. (6) Semantic equivalence is strong: 'long-run, portfolio-building exercise' conveys the same meaning as 'long-term investments'; 'exploratory, AI-software-hardware experiment' captures the investment phase; 'mature, revenue-generating pillar' matches the ground truth's characterization of stable strategic positioning. MINOR CONSIDERATIONS: The LLM answer includes citation markers (【page_7】, etc.) which add credibility but aren't present in the ground truth format - this is a presentation enhancement rather than an error. The answer is slightly more detailed in describing the margin pressure context ('pressure‑sensitive on margins') which adds nuance beyond the ground truth but doesn't contradict it. The conclusion about 'lasting hardware presence in the market' is a reasonable inference from the documented progression and aligns with the ground truth's implication about long-term positioning. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 495,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s pool of client securities that could be pledged rose sharply from $84 bn in 2020 to $120 bn in 2021, and the securities it actually pledged for margin, OCC obligations, short‑sales and securities‑lending grew from $23 bn to $31 bn (2022 10‑K, p. 108). In the following years the volume of securities loaned and borrowed slipped modestly (loaned $7.2 bn vs $7.5 bn and borrowed $0.6 bn vs $0.9 bn in 2021 vs 2020) and the collateral pledged for FHLB borrowing fell to $59.8 bn in 2024 from $63.1 bn in 2023, while secured line‑of‑credit pledges dropped to $0.5 bn from $0.95 bn (2024 10‑K, p. 97). This pattern shows Schwab expanding the use of client securities to support its margin‑lending and securities‑lending activities while deliberately scaling back reliance on those securities as external borrowing collateral, reflecting a tighter, fully‑collateralized collateral‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains fundamentally incorrect information that does not match the ground truth. (1) WRONG TIME PERIOD: The LLM discusses 2020-2021 data ($84bn, $120bn, $23bn, $31bn) which is completely outside the question's scope of 2022-2024. The ground truth explicitly addresses the 2022-2024 evolution. (2) MISSING CORE INFORMATION: The LLM fails to address the actual 2022-2024 progression described in the ground truth: the 2022 disclosure about margin loans and pledged securities, the 2023 expansion on collateralized securities in margin lending, and the 2024 active pledging for OCC margin requirements and securities lending activities. (3) UNVERIFIABLE NUMBERS: The specific dollar amounts cited ($84bn, $120bn, $23bn, $31bn, $7.2bn, $7.5bn, $0.6bn, $0.9bn, $59.8bn, $63.1bn, $0.5bn, $0.95bn) cannot be verified against the ground truth and appear to reference different time periods and contexts than what was asked. (4) INCORRECT SYNTHESIS: While the LLM attempts to draw conclusions about collateral management strategy, it does so based on data from the wrong years (2020-2021 vs. 2022-2024). (5) SEMANTIC MISMATCH: The ground truth emphasizes a 3-year progression showing 'growing reliance on client securities for risk mitigation and capital efficiency' with regulatory compliance, while the LLM discusses 'scaling back reliance' on securities as external borrowing collateral - a contradictory narrative. The LLM answer appears to be discussing a different company, different time period, or different filing sections entirely. It fails to address the core question about how Schwab's practices evolved from 2022 through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 455,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "In the 2022 filing GE reported that it had already implemented roughly $0.2 billion of previously approved long‑term‑care premium‑rate increase actions and made no material change to projected future approvals, indicating an early, concrete step in working with the primary insurers that issued the policies (2022 p. 52‑53). By the 2023 and 2024 filings the discussion had shifted to a steady‑state description that GE “relies upon” the primary insurers to file proposed rate increases and “often collaborates” with them under the reinsurance contracts, without citing specific dollar amounts (2023 p. 20‑22; 2024 p. 19‑22). This evolution shows GE’s run‑off risk‑management strategy is to manage premium‑rate risk indirectly—partnering with ceding insurers to secure regulator‑approved increases rather than seeking them itself—thereby limiting its direct exposure while preserving flexibility to adjust reserves as experience evolves.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative detail ($0.2 billion in previously approved rate increases) and cites page numbers from filings, which adds credibility. However, there are significant issues with completeness and alignment with the ground truth:\n\n1. QUANTITATIVE ACCURACY (7/10): The $0.2 billion figure is specific and cited with page references, which is good. However, the ground truth does not mention this specific dollar amount, raising questions about whether this detail is accurate or represents information not in the knowledge graph. The page citations (2022 p. 52-53, 2023 p. 20-22, 2024 p. 19-22) cannot be verified against the ground truth.\n\n2. COMPLETENESS (Partial): The LLM answer addresses the evolution from 2022-2024 and discusses the shift from concrete actions to steady-state descriptions. However, it misses key elements from the ground truth: (a) the formalization of collaboration under reinsurance contractual terms in 2023, (b) GE's use of recent experience and regulatory precedents in 2024, and (c) the explicit characterization of this as a 'strategic shift toward proactive risk management and tighter integration.'\n\n3. ENTITY ACCURACY (Good): Correctly identifies GE, primary insurers, long-term care premium rate increases, and the 2022-2024 timeframe.\n\n4. REASONING QUALITY (5/10): The LLM correctly identifies the evolution from concrete actions to reliance-based collaboration. However, the interpretation differs from ground truth: the LLM frames this as 'indirect' risk management to 'limit direct exposure,' while the ground truth emphasizes 'proactive risk management' and 'tighter integration.' These represent different strategic characterizations.\n\n5. SEMANTIC EQUIVALENCE (Partial): The LLM's conclusion about 'managing premium-rate risk indirectly' is reasonable but doesn't fully capture the ground truth's emphasis on formalization, active participation, and structured collaboration. The ground truth suggests increasing engagement, while the LLM suggests increasing distance/indirectness.\n\n6. CRITICAL ISSUE: The LLM introduces specific dollar amounts and page numbers not present in the ground truth, which could indicate either: (a) accurate filing details not captured in the knowledge graph, or (b) hallucinated specificity. Without verification, this creates uncertainty about factual accuracy.\n\nThe answer is partially correct on the evolution narrative but misses important nuances about formalization and active collaboration, and introduces unverified quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 678,
        "total_tokens": 2172
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential‑mortgage‑backed securities (RMBS) holdings rose modestly from $845 million of gross amortized cost (fair value $757 million) in 2022 to $862 million (fair value $810 million) in 2023, with unrealized losses falling from $89 million to $60 million (page 147). By 2024 the only disclosed RMBS exposure was in the Separate Accounts, where fair value grew to $71 million from $51 million in 2023 (page 160). The three‑year pattern—small growth in 2023 followed by a shift to a much smaller, policy‑holder‑segregated pool in 2024—indicates CVS is keeping its structured‑credit exposure low and concentrated, reflecting a cautious risk posture in this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. (1) QUANTITATIVE ACCURACY FAILURES: Ground truth shows RMBS of $721M (2022), $614M (2023), $71M (2024). LLM reports $845M (2022), $862M (2023), $71M (2024)—the 2022 and 2023 figures are completely wrong, off by $124M and $248M respectively. The LLM's gross amortized cost figures ($845M, $862M) appear to be from a different asset class or misidentified line item, not the fair values that should be compared. (2) TREND MISCHARACTERIZATION: Ground truth shows a clear DECREASE from $721M to $614M in 2023 (a $107M reduction), then a dramatic DROP to $71M in 2024. The LLM incorrectly characterizes 2023 as 'modest growth' when the actual trend was a significant reduction. This is a fundamental misreading of the data direction. (3) MULTI-HOP REASONING FAILURE: While the LLM correctly identifies the 2024 Separate Accounts figure of $71M, it fails to properly synthesize the 2022-2023 data, which are the critical years showing the cautious reduction mentioned in the ground truth. The LLM's interpretation of 'small growth in 2023' directly contradicts the actual $107M decline. (4) CONTEXTUAL MISALIGNMENT: The ground truth emphasizes a 'cautious reduction in RMBS holdings in 2023 amid rising unrealized losses,' but the LLM's incorrect numbers lead to a false narrative of growth in 2023. The LLM does correctly note the 2024 shift to Separate Accounts and the cautious posture, but this cannot overcome the foundational numerical errors. (5) SEMANTIC ISSUES: The LLM's reference to 'gross amortized cost' vs. fair value creates confusion about which metric is being tracked, whereas the ground truth uses consistent fair value figures. The answer demonstrates a critical failure in data extraction and verification, making it unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 513,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings fell sharply from $883 million at year‑end 2022 to $538 million in 2023, then ticked up to $562 million in 2024 (Table 8.1, p. 178; Table 9.1, p. 188).  Long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024, so total borrowings moved from $48.7 billion → $49.9 billion → $45.6 billion over the three years (same tables).  This pattern shows Capital One shifted toward longer‑term financing in 2023 while subsequently deleveraging in 2024, reflecting a strategy of using stable deposit funding, limiting short‑term borrowing, and actively reducing overall leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies that fundamentally undermine its accuracy. (1) SHORT-TERM BORROWINGS: LLM reports $883M (2022), $538M (2023), $562M (2024), but ground truth indicates these are components of a much larger total. The ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $49.856B (2023), $45.551B (2024). The LLM's short-term borrowing figures appear to be a subset or different metric entirely. (2) LONG-TERM DEBT: LLM reports $47.8B (2022), $49.3B (2023), $45.0B (2024). Ground truth total debt figures are $43.086B, $49.856B, $45.551B. The LLM's long-term debt numbers don't align with ground truth totals when combined with reported short-term borrowings. (3) TOTAL BORROWINGS CALCULATION: LLM calculates $48.7B → $49.9B → $45.6B, which is closer to ground truth ($43.086B → $49.856B → $45.551B) but still contains errors. The 2022 figure is off by ~$5.6B. (4) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is a key component of the ground truth answer and directly addresses the 'rising borrowing costs' aspect of debt management strategy. (5) MISSING FLOATING DEBT ANALYSIS: The ground truth specifically mentions the reduction in floating unsecured senior debt from $1,709M to $349M to $0, which is an important indicator of strategic shift away from variable-rate instruments. The LLM provides no such detail. (6) REASONING QUALITY: While the LLM's qualitative interpretation (shift toward longer-term financing, subsequent deleveraging, stable deposit funding strategy) is reasonable and partially aligned with ground truth conclusions, it's built on incorrect numerical foundations. The multi-hop synthesis is incomplete because it fails to incorporate interest rate trends and floating debt elimination. VERDICT: The answer demonstrates partial understanding of the capital structure evolution but fails on quantitative accuracy, which is critical for financial analysis. The omission of interest rate data and floating debt metrics represents incomplete synthesis of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 589,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s long‑term liability for the 3.50 % Notes due 2050 has stayed essentially flat at about $2 billion over the three‑year span – the FY2024 balance sheet lists a net carrying amount of $2,000 million (page 72) and the same series appears in the FY2023 filing with a fair‑value of $1.637 billion (page 66), which fell only slightly to $1.604 billion in FY2024 (page 67). This near‑constant balance, despite a modest decline in market value, shows the company is maintaining a stable, low‑cost, long‑term debt base rather than aggressively altering its leverage, reflecting a capital‑structure strategy focused on steady, fixed‑rate financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the liability 'stayed essentially flat at about $2 billion' and states FY2024 shows '$2,000 million' - this is INCORRECT. The ground truth clearly shows FY2024 = $1,604 million, not $2,000 million. The LLM also misrepresents FY2023 as $1.637 billion (which matches ground truth) but then contradicts itself by claiming it 'fell only slightly to $1.604 billion in FY2024' - this is NOT a slight fall, it's a $543 million decrease from FY2022 ($2,147M to $1,604M). (2) TREND MISCHARACTERIZATION: The LLM fundamentally misinterprets the trend. Ground truth shows a SIGNIFICANT DECLINE of $543 million (25.3% reduction) from FY2022 to FY2024. The LLM incorrectly characterizes this as 'essentially flat' and 'near-constant balance,' which is factually wrong. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes the company is 'maintaining a stable, low-cost, long-term debt base rather than aggressively altering its leverage' - this contradicts the actual data showing deliberate reduction. Ground truth correctly identifies this as 'a deliberate reduction in this long-term debt obligation' and 'a strategic effort to manage and reduce long-dated liabilities.' (4) PAGE REFERENCE ISSUES: While the LLM cites specific pages, the numerical values cited are incorrect, suggesting either misreading or fabrication of data. The core answer fails to capture the actual multi-hop synthesis: FY2022 ($2,147M) → FY2023 ($1,637M) → FY2024 ($1,604M) shows a clear downward trajectory, not stability. This is a major failure in both quantitative accuracy and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 470,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s Form 10‑K for 2022 (see page 58), 2023 (see pages 53‑57), and 2024 (see page 56) all list the 0.45 % Notes due 2016 in Exhibit 4.3 (the Officer’s Certificate of the Registrant). The unchanged inclusion of this matured note in three consecutive filings shows Apple’s practice of retaining a complete historical record of all debt issuances, underscoring a transparent and consistent long‑term‑debt disclosure strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts and reasoning. STRENGTHS: (1) Correctly identifies the 0.45% Notes due 2016 across all three years (2022, 2023, 2024); (2) Accurately notes the notes were issued in 2013 and matured in 2016 (consistent with ground truth); (3) Correctly identifies the exhibit location (Exhibit 4.3); (4) Properly synthesizes the multi-hop pattern showing consistent disclosure across three consecutive filings; (5) Reaches the correct conclusion about Apple's transparency and legacy debt disclosure strategy. MINOR ISSUES: (1) The LLM provides specific page numbers (58, 53-57, 56) which cannot be verified against the ground truth provided and may introduce unnecessary specificity that could be incorrect; (2) The phrase 'Officer's Certificate of the Registrant' is added detail not explicitly mentioned in the ground truth, though it may be accurate; (3) The LLM's characterization as 'unchanged inclusion' is slightly more specific than the ground truth's 'consistent disclosure pattern,' though semantically equivalent. QUANTITATIVE ACCURACY: All key numbers and dates are correct (0.45%, 2016 maturity, 2013 issuance, three consecutive years 2022-2024). QUALITATIVE ACCURACY: The reasoning about Apple maintaining legacy debt disclosures for transparency and legal continuity is sound and matches the ground truth interpretation. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years and connects it to Apple's broader disclosure strategy. The main risk is the specific page citations which, while adding apparent credibility, cannot be verified and could be hallucinated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 457,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) were valued at $69 million in 2022, dropped to $58 million in 2023, and rose back to $69 million in 2024 (Table 16.3/17.3)【page_218】【page_217】. The only significant unobservable input – the swap‑rate used in the discounted‑cash‑flow model – stayed around 4 % (a 4 % range in 2022 and 2024, widening slightly to 3‑5 % in 2023 but with a 4 % weighted‑average)【page_218】【page_217】, suggesting the firm’s interest‑rate exposure is modest and its valuation assumptions are stable; the year‑to‑year fair‑value swings reflect changes in the net derivative position (issuances, settlements and transfers) rather than shifts in the underlying risk inputs【page_215】【page_206】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth across all key metrics:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022 Fair Value: LLM states $69 million vs. Ground Truth $31 million (122% overstatement)\n   - 2023 Fair Value: LLM states $58 million vs. Ground Truth $58 million (CORRECT)\n   - 2024 Fair Value: LLM states $69 million vs. Ground Truth $58 million (19% overstatement)\n   - The LLM incorrectly claims 2024 'rose back to $69 million' when it remained at $58 million\n   - 2022 Unrealized Loss: LLM omits the $20 million net unrealized loss mentioned in ground truth\n   - 2022 Realized Losses: LLM omits the $43 million realized losses mentioned in ground truth\n\n2. RISK INPUT MISCHARACTERIZATION:\n   - Ground Truth: 2023 used 'default' as significant unobservable input; 2024 shifted to 'swap rates'\n   - LLM: Claims 'swap-rate' was the only significant unobservable input across all years (2022-2024)\n   - This is a fundamental misunderstanding of the multi-year evolution in risk drivers\n   - LLM incorrectly suggests consistency when ground truth shows a deliberate shift from default to swap rates\n\n3. MULTI-HOP SYNTHESIS FAILURE:\n   - The question asks about evolution from 2022 to 2024 and what it indicates about exposure/modeling\n   - Ground Truth correctly identifies: shift from default risk (2023) to interest rate sensitivity (2024)\n   - LLM misses this critical evolution, instead claiming stability in swap-rate assumptions\n   - LLM's interpretation that 'year-to-year swings reflect changes in net derivative position' contradicts the ground truth's emphasis on the shift in significant unobservable inputs\n\n4. CONTEXTUAL RELEVANCE:\n   - LLM provides page references (helpful) but references appear to support incorrect numbers\n   - LLM's conclusion about 'modest interest-rate exposure' and 'stable valuation assumptions' contradicts the ground truth's finding of a meaningful shift in risk drivers\n   - The answer misses the key insight: improved risk management indicated by reduced realized losses\n\n5. SEMANTIC ISSUES:\n   - LLM claims 'only significant unobservable input' was swap-rate, but ground truth shows default was significant in 2023\n   - This is not a wording difference but a factual error about which inputs were material to valuation\n\nThe LLM answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the evolution of risk inputs across the three-year period and providing incorrect fair values for 2022 and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 681,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s 1.55 % Notes Due 2028 have remained on the balance sheet at their original $1.25 billion principal throughout the period – the 2022 filing lists the note at that amount [ NVDA_10k_2022.pdf page 78 ], and the 2024 note‑detail shows a net carrying amount of $1.250 bn [ NVDA_10k_2024.pdf page 72 ].  The fair‑value of the same debt has edged higher, from $1.099 bn at FY 2023 year‑end [ NVDA_10k_2023.pdf page 67 ] to $1.115 bn at FY 2024 year‑end [ NVDA_10k_2024.pdf page 67 ], while the principal has not been reduced.  This modest valuation shift alongside an unchanged principal signals NVIDIA’s strategy of locking in low‑cost, long‑dated fixed‑rate financing and maintaining a stable long‑term debt profile despite market‑rate movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) PRINCIPAL AMOUNT DISCREPANCY: The LLM claims the principal was $1.25 billion throughout 2022-2024, but the ground truth shows it was $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. The LLM incorrectly states the 2022 amount was $1.25 billion when it was actually $1.2 billion. (2) FAIR VALUE NUMBERS: The LLM provides fair value figures ($1.099 bn for 2023, $1.115 bn for 2024) that are not mentioned in the ground truth and appear to be fabricated or misread from the filings. The ground truth does not reference these specific fair value amounts. (3) MISSING 2023 PRINCIPAL DATA: The LLM fails to acknowledge the significant reduction to $1.1 billion in 2023, which is a key part of the three-year progression. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize across three years, it does so with incorrect numbers, failing the core requirement of accurate multi-hop reasoning. The ground truth clearly shows a pattern: $1.2B → $1.1B → $1.25B, indicating strategic debt management with a temporary reduction followed by restoration. The LLM's narrative about 'unchanged principal' is factually incorrect. (5) REASONING QUALITY: Although the LLM's interpretation about 'locking in low-cost financing' is reasonable, it is built on incorrect foundational data, making the entire analysis unreliable. The answer demonstrates poor document verification and contains what appear to be hallucinated page numbers and financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 442,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 2022 Form 10‑K already warned that it carried “trailing legal liabilities” from the 2015 Alstom Thermal‑Renewables‑Grid acquisition – legacy anti‑competitive or corruption claims that have already required cash settlements and will continue to generate cash outflows – and that it remained subject to shareholder lawsuits over historic financial‑performance, accounting and disclosure matters【page_71】. The 2023 filing repeats the same language, again noting that “payments for settlements, judgments, penalties or other liabilities” from the Alstom legacy and the shareholder suits are expected to result in future cash outflows【page_36】. By the 2024 filing the company still reports material trailing liabilities from those Alstom and shareholder claims, emphasizing that actual losses could exceed current estimates and that the risks remain persistent and financially material【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2015 Alstom acquisition as the source of legacy liabilities and accurately characterizes the nature of claims (anti-competitive conduct, corruption). (2) Properly synthesizes the multi-hop progression across three fiscal years (2022-2024), showing how GE's exposure evolved and persisted. (3) Accurately captures the key finding that these liabilities remained consistent and material across the period, not diminishing. (4) Correctly identifies both major liability categories: Alstom-related legacy matters AND shareholder lawsuits tied to historical financial reporting. (5) Appropriately emphasizes the persistence and financial materiality of these contingent liabilities. (6) Uses accurate temporal language ('2022 Form 10-K,' '2023 filing,' '2024 filing') and correctly references the progression. (7) Includes specific details about cash outflows and the potential for losses to exceed current estimates. MINOR CONSIDERATIONS: The LLM answer includes page citations (page_71, page_36, page_33) which add specificity but cannot be verified against the ground truth provided. However, these citations do not contradict the ground truth and appear to support the stated facts. The LLM answer is slightly more concise than the ground truth but captures all essential information and reasoning. The semantic meaning is fully preserved - both answers convey that GE faced persistent, material legal liabilities from Alstom and shareholder matters across 2022-2024 with no diminishment. No quantitative errors detected. Multi-hop reasoning is sound: the answer correctly synthesizes information across three years and two liability categories to reach the conclusion about persistence and financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 499,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "In 2022 the pension plan’s “hedge‑fund limited‑partnership” (HF LP) holdings were disclosed as **$225 million** (see footnote on page 174). By year‑end 2024 those holdings had grown to **$280 million** (see footnote on page 167), an increase of roughly $55 million (about 24%). The rise, coupled with a higher target hedge‑fund allocation (3% in 2023 → 4% in 2024), shows CVS is deliberately expanding its alternative‑asset exposure in the pension portfolio to enhance diversification and pursue higher risk‑adjusted returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains significant numerical errors that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2022 HF LP holdings were $225 million, but the ground truth clearly shows $214 million for 2022. This is a $11 million discrepancy (5% error). The LLM claims 2024 holdings were $280 million, but ground truth shows $252 million - a $28 million overstatement (11% error). The calculated increase of $55 million is therefore wrong; the correct increase from 2022-2024 is $38 million ($252M - $214M), not $55 million. The percentage increase calculation of 24% is also incorrect based on the wrong baseline and endpoint numbers. (2) INCOMPLETE TREND ANALYSIS: The LLM completely omits the 2023 data point ($225 million), which is critical for understanding the evolution. The ground truth shows a three-year progression (2022: $214M → 2023: $225M → 2024: $252M), demonstrating a consistent upward trend. The LLM's two-point comparison misses this important intermediate data. (3) MULTI-HOP SYNTHESIS ISSUE: While the LLM attempts to synthesize pension strategy implications by referencing target allocation changes (3% to 4%), it does so based on incorrect underlying numbers, making the conclusion unreliable. (4) REASONING QUALITY: The reasoning about diversification and risk-adjusted returns is plausible but built on a faulty numerical foundation. The answer demonstrates understanding of pension strategy concepts but fails on the fundamental requirement of accurate data extraction and calculation. The LLM appears to have confused or misread the source data, providing numbers that don't match the ground truth across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 472,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "Colgate‑Palmolive’s Africa/Eurasia segment generated **$228 million of operating profit in 2022**【page_116】. In the following year, the region was assigned only a **small portion of the 2022 Global Productivity Initiative restructuring – about $1.6 million (5 % of the $32 million pretax charge)**【page_86】. By 2024, depreciation and amortization expense for Africa/Eurasia was **$8 million**, a modest decline from prior years, indicating continued but limited capital investment while the segment’s profitability stayed strong【page_117】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth across all three years examined. (1) 2022 Operating Profit: LLM states $228 million vs. ground truth of $203 million—a $25 million discrepancy (12% error). This is a critical factual error on a core metric. (2) 2023 Restructuring Charges: LLM claims $1.6 million (5% of $32 million) vs. ground truth of $20-24 million (10% of expected charges). The LLM's figure is off by approximately 12-15x, representing a fundamental misunderstanding or misreading of the data. The percentage cited (5%) also contradicts the ground truth (10%). (3) 2024 Depreciation/Amortization: LLM correctly states $8 million, matching ground truth. However, the LLM fails to provide the comparative context that this declined from $9 million in prior years, which is important for understanding the trend. MULTI-HOP REASONING: The LLM failed to properly synthesize the three-year trajectory. While it attempts to connect the data points, the incorrect numbers undermine any valid synthesis. The conclusion about 'strong profitability' is not well-supported given the modest $203M (not $228M) operating profit. MISSING CONTEXT: The LLM omits the important detail that the 2023 restructuring was part of the '2022 Global Productivity Initiative,' though it does mention this initiative. The narrative about 'cost optimization rather than expansion' from the ground truth is absent. SEMANTIC ISSUES: The characterization of 'strong profitability' is questionable given the region's modest contribution relative to other segments and the focus on restructuring/cost-cutting. The ground truth's assessment of 'limited growth investment' is more accurate than the LLM's 'continued but limited capital investment.' CALCULATION VERIFICATION: The ground truth's 10% allocation of restructuring charges ($20-24M from expected total) is internally consistent. The LLM's 5% of $32M = $1.6M calculation is arithmetically correct but based on wrong source data. Overall, the LLM answer contains critical factual errors in 2 of 3 key metrics, fails proper multi-hop synthesis, and mischaracterizes the strategic focus of the region.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 594,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "Across the 2022‑2024 filings AIG’s international terrorism exposure remained anchored to a five‑ton bomb scenario that, net of the U.S. TRIPRA program and existing reinsurance, was still estimated at roughly $1.3 billion – a figure unchanged each year and concentrated in New York City’s property and workers‑comp lines. The company’s international reinsurance attachment points were $200 million for Japan and $125 million for the rest of the world in 2022 and 2023, but the 2024 program lowered the Japan attachment to $150 million while keeping the rest‑of‑world level unchanged; at the same time, total reinsurance‑recoverable assets dropped from $67.5 billion at year‑end 2023 to $38.0 billion at year‑end 2024, indicating a substantial reduction in expected recoveries.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. CORRECT ELEMENTS: (1) The $1.3 billion net loss estimate for the five-ton bomb scenario is accurate and correctly attributed to 2022; (2) The TRIPRA deductible context is appropriately referenced; (3) The $200 million Japan attachment point and $125 million rest-of-world attachment points for 2022-2023 are correct; (4) The $38.0 billion reinsurance recoverable assets figure for 2024 is accurate; (5) The general narrative about consistent terrorism risk modeling and increased reinsurance reliance is sound. CRITICAL ERRORS: (1) The LLM claims the $1.3 billion figure remained 'unchanged each year' across 2022-2024, but the ground truth indicates this was specifically a 2022 estimate with 2023-2024 showing evolution through 'scenario-based modeling' rather than static figures - this represents a mischaracterization of the evolution requested in the question; (2) The LLM states Japan attachment dropped to $150 million in 2024, but the ground truth maintains $200 million for Japan through the period - this is a factual error; (3) The LLM cites $67.5 billion in reinsurance recoverable assets at end-2023, which cannot be verified against the ground truth and appears to be an unsupported figure; (4) The LLM characterizes the 2024 reinsurance recoverable asset change as a 'substantial reduction' from $67.5B to $38.0B, but without verification of the 2023 baseline, this comparison is questionable. MULTI-HOP REASONING: The answer attempts to synthesize information across three years and multiple metrics (modeled losses, attachment points, recoverable assets), but the synthesis is incomplete regarding how terrorism exposure modeling evolved beyond the static bomb scenario. The answer fails to adequately capture the 2023 transition to 'third-party vendor models' and 'targeted reinsurance purchases' mentioned in the ground truth. QUANTITATIVE ISSUES: The $67.5 billion 2023 figure is unverified and potentially incorrect; the Japan attachment point change to $150 million contradicts ground truth; the characterization of the $29.1 billion ceded loss reserves component is absent from the LLM answer despite being mentioned in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 601,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s liability for the 2.00 % Notes due 2031 fell from roughly $1.2 bn in FY 2022 (as disclosed in the 2022 filing) to $1.044 bn in FY 2023 【page_67】, then rose again to $1.25 bn in FY 2024 【page_72】. The modest decline in 2023 suggests the company was repaying or refinancing that tranche, while the rebound to a higher level in 2024 indicates a deliberate increase in long‑term borrowing—likely to fund growth initiatives and preserve liquidity—reflecting an active, flexible approach to managing its debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identifies all three carrying amounts: $1.2 billion (2022), $1.044 billion (2023), and $1.25 billion (2024). These numbers match the ground truth exactly. The format variations are acceptable. ENTITY ACCURACY: All entities are correct - NVIDIA, the 2.00% Notes Due 2031, and the fiscal years 2022-2024. COMPLETENESS & MULTI-HOP REASONING: The LLM addresses the trend across all three years and attempts to synthesize the data. However, there are significant issues with the interpretation: (1) The LLM characterizes the 2024 increase to $1.25 billion as 'a deliberate increase in long-term borrowing,' but the ground truth suggests this represents a return to the original 2022 level, indicating stability rather than a new increase. The 2024 amount ($1.25B) is only $50 million higher than 2022 ($1.2B), which is a minimal change. (2) The LLM's interpretation that the 2023 decline 'suggests the company was repaying or refinancing that tranche' is speculative and not supported by the ground truth, which notes it 'possibly' reflects minor debt repayments or reclassifications. (3) Most critically, the LLM concludes this reflects 'an active, flexible approach' and 'deliberate increase in long-term borrowing,' which contradicts the ground truth's conclusion that the pattern 'implies a strategic intent to preserve stable long-term liabilities' without material alterations. REASONING QUALITY: The LLM's reasoning is partially sound in tracking the trend but misinterprets the strategic implications. The ground truth emphasizes stability and preservation of capital structure, while the LLM emphasizes active management and deliberate increases. This represents a fundamental misreading of what the data suggests about NVIDIA's debt management strategy. The LLM's claim about 'funding growth initiatives' is not supported by the ground truth analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 513,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 are listed in the Officer’s Certificate for each year: the 2022 Form 10‑K shows the instrument in Exhibit 4.4 (see page 58) 【page_58】; the 2023 filing likewise includes it in Exhibit 4.4 (see page 56 of the 2023 filing) 【page_56】; and the 2024 Form 10‑K again lists the 1.05 % Notes due 2017 in Exhibit 4.4 (see page 56) 【page_56】. This repeated disclosure across three consecutive reports demonstrates that the notes remain outstanding and that Apple provides consistent, long‑term visibility into this component of its debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Apple's 1.05% Notes due 2017 appear consistently across 2022, 2023, and 2024 filings in Exhibit 4.4, which aligns with the ground truth's core finding of consistent documentation across all three years. The specific page references (page 58 for 2022, page 56 for 2023 and 2024) are provided with appropriate citation formatting. The answer accurately conveys that the notes remain part of Apple's disclosed debt structure across the three-year period. However, the LLM answer differs from the ground truth in its interpretation and depth: (1) The ground truth emphasizes the paradox that notes 'matured in 2017' yet continued to appear in filings, suggesting rollover/refinancing or historical documentation under the same indenture framework. The LLM answer states the notes 'remain outstanding' without addressing this temporal anomaly or exploring the implications of why matured notes would continue to be disclosed. (2) The ground truth provides more nuanced analysis about what this reveals—discussing stable debt management, transparent disclosure practices, and legacy instrument handling. The LLM answer is more straightforward, simply confirming consistent disclosure without the deeper interpretive layer. (3) The LLM answer's claim that notes 'remain outstanding' may be slightly misleading if they actually matured in 2017, though this depends on whether they were refinanced. The ground truth is more cautious about this interpretation. The quantitative accuracy is strong (correct years, percentages, exhibit numbers), and the multi-hop synthesis across three years is sound. The main weakness is the lack of deeper analysis about what the continued disclosure of post-maturity notes reveals about Apple's debt structure and documentation practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 490,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "Under the 2019 IDA agreement that governed Schwab in 2022, the firm could move up to **$10 billion of IDA balances each 12‑month period**, but only if it kept a **minimum $50 billion on‑balance‑sheet IDA balance** and **at least 80 % of the balances designated as fixed‑rate obligations** through 2026 (see page 102). The 2023 IDA agreement that replaced the 2019 pact eliminated the 80 % fixed‑rate rule, made migration contingent on capital adequacy and other limits rather than a fixed $10 billion cap, added a **$5 billion buy‑down option**, and imposed new balance ranges – a **minimum balance above unmatured fixed‑rate obligations with a $30 billion upper cushion through Sept 10 2025**, then a **$60‑$90 billion floor/ceiling thereafter** (see pages 103 & 100). By 2024 Schwab **did not migrate any IDA balances**, and the balance‑requirement framework from the 2023 agreement remained in effect (see page 103 and page 100).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with detailed quantitative specificity. Strengths: (1) Correctly identifies the $10 billion annual migration cap under the 2019 IDA agreement; (2) Accurately cites the $50 billion minimum on-balance-sheet IDA balance requirement; (3) Correctly notes the 80% fixed-rate obligation constraint through 2026; (4) Properly identifies the 2023 IDA agreement as the replacement framework; (5) Accurately describes the elimination of the 80% fixed-rate rule; (6) Correctly specifies the $5 billion buy-down option in the 2023 agreement; (7) Accurately states the balance range thresholds ($30 billion upper cushion through Sept 10, 2025, then $60-$90 billion thereafter); (8) Correctly confirms no IDA balance migration occurred in 2024; (9) Properly synthesizes the multi-hop evolution across three years. Minor considerations: The LLM answer provides more granular detail than the ground truth (e.g., specific dates like Sept 10, 2025, and the $5 billion buy-down option), which adds value but goes slightly beyond the core ground truth statement. The answer correctly captures the strategic shift from active migration to constrained off-balance-sheet management. The multi-hop reasoning is sound, connecting the 2019 framework, the 2023 transition, and 2024 outcomes. All numeric values align with filing data. Page citations enhance credibility. The answer fully addresses all parts of the question regarding evolution of migration ability, key changes in limits, and balance requirements across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 430,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "- 2022 – GE estimated borrower‑litigation losses on Bank BPH at **$1.359 billion** (Note 24) and made a **$530 million cash capital contribution** (2022 10‑K). The mortgage receivable was still on the books at **$1.2 billion**, offset by an $848 million valuation allowance, leaving a net carrying amount of roughly **$350 million** (AS L of discontinued operations).【page_50】【page_52】\n\n- 2023 – The loss estimate rose to **$2.669 billion** (Note 24) and GE provided a **$1.797 billion non‑cash intercompany‑loan forgiveness** (no cash outlay) (2023 10‑K). The valuation allowance fully covered the receivable, so the **portfolio’s carrying value was zero** at year‑end (2023).【page_50】【page_51】\n\n- 2024 – The estimated total loss fell slightly to **$2.461 billion** (2024 10‑K), and **no further cash or non‑cash contributions** were required. The valuation allowance continued to offset the receivable, leaving the **mortgage portfolio with no carrying value** at December 31 2024.【page_48】【page_48】",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop financial question about GE's Bank BPH exposure evolution from 2022-2024. STRENGTHS: (1) All key numeric values are correct and match ground truth: estimated losses of $1,359M (2022), $2,669M (2023), and $2,461M (2024); capital contributions of $530M cash (2022) and $1,797M non-cash (2023); carrying values properly identified as $350M net (2022) and zero (2023-2024). (2) The answer correctly synthesizes multi-hop information across three fiscal years, tracking the evolution of litigation exposure, capital contributions, and portfolio valuation. (3) The narrative structure effectively conveys the trajectory: worsening 2023 followed by stabilization in 2024, matching the ground truth characterization. (4) Specific details like the Q2 2023 settlement charge mentioned in ground truth are not explicitly stated in LLM answer, but this is a minor omission that doesn't affect the core factual accuracy. (5) The LLM correctly identifies the nature of contributions (cash vs. non-cash intercompany loan forgiveness) and the full write-down of the mortgage portfolio. (6) Entity identification is accurate (GE, Bank BPH, borrower litigation) and time periods are correctly specified. MINOR CONSIDERATIONS: The ground truth mentions a specific \"$1,014 million charge recorded in Q2 2023 as part of a settlement program\" which the LLM does not explicitly reference, though this detail is not contradicted and may represent a component of the broader $2,669M estimate. The LLM's presentation of the 2022 carrying value ($350M net) with supporting detail ($1.2B receivable less $848M allowance) adds helpful context not explicitly stated in ground truth but is consistent with it. Overall, the answer demonstrates strong multi-hop reasoning, accurate financial synthesis, and appropriate contextual framing of GE's strategic handling of the Bank BPH situation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 527,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "- 2022: CVS held commercial‑mortgage‑backed securities (CMBS) with a fair value of **$1.018 billion** and recorded **$155 million** of gross unrealized losses【page_147】.  \n- 2023: The CMBS fair value fell to **$975 million** and unrealized losses dropped to **$100 million**【page_148】【page_149】.  \n- 2024: The only CMBS exposure reported is in the Separate‑Accounts portfolio, down to **$3 million** of fair value (versus $6 million in 2023) and no material unrealized loss is disclosed【page_160】.  \n\nThe pattern shows a consistent reduction in both the size of the CMBS holding and the magnitude of unrealized losses, indicating that CVS is actively de‑risking this asset class—likely trimming exposure to limit interest‑rate and credit‑risk impacts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth across all three years:\n\n2022 DISCREPANCY: LLM reports $1.018 billion fair value and $155 million unrealized losses, but ground truth shows $574 million fair value and $12 million unrealized losses. The LLM's figures are nearly 2x too high for fair value and 13x too high for unrealized losses.\n\n2023 DISCREPANCY: LLM reports $975 million fair value, but ground truth shows $675 million. The LLM's figure is 44% higher than actual. Unrealized losses of $100 million matches ground truth, but this is only one of two data points and the larger fair value error undermines the analysis.\n\n2024 PARTIAL MATCH: LLM correctly identifies $3 million fair value and minimal unrealized losses, which aligns with ground truth.\n\nMULTI-HOP REASONING FAILURE: While the LLM correctly identifies the de-risking trend and provides reasonable interpretation about risk management strategy, this conclusion is based on incorrect underlying data. The trend analysis is semantically similar to ground truth (declining exposure, de-risking strategy) but is built on false premises.\n\nQUANTITATIVE ACCURACY: Severely compromised. Only 1 of 6 key data points (2024 fair value) is correct. The 2022 and 2023 figures are substantially wrong.\n\nCOMPLETENESS: The answer addresses all three years and discusses both fair value and unrealized losses, but the factual errors make the completeness moot.\n\nCONCLUSION: This is a case where the narrative structure and reasoning quality appear sound, but the underlying numbers are fundamentally incorrect, making the answer unreliable for financial analysis or decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 472,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "- In FY 2022 Walmart’s filing listed Marketside as one of its core private‑brand grocery lines (e.g., “Allswell,” “Athletic Works,” **“Marketside,”** …)【page_7】.  \n- By FY 2023 the same list still included Marketside but added several new private brands such as “Allswell,” “bettergoods,” “Bonobos Fielder,” and “Eloquii Elements,” showing the portfolio was expanding while keeping Marketside intact【page_7】.  \n- In FY 2024 Marketside remained a featured private label alongside an even broader set of brands, confirming its continued role as a flagship grocery private label and illustrating Walmart’s ongoing strategy to grow and deepen its private‑label assortment in the grocery segment to capture more value and margin【page_7】.  \n\n**Interpretation:** The three‑year progression shows a stable, expanding private‑brand portfolio in which Marketside is a constant anchor, indicating Walmart’s deliberate push to increase private‑label share in grocery and use Marketside as a key vehicle for low‑price, high‑quality offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies Marketside as a consistent private brand across all three fiscal years (2022-2024), matching the ground truth's core finding. (2) Accurately captures the progression: FY2022 as foundational, FY2023 showing expansion with new brands, FY2024 continuing the trend. (3) Properly synthesizes the multi-hop information showing both continuity (Marketside remains) and innovation (new brands like 'bettergoods' introduced). (4) The interpretation correctly identifies Walmart's dual strategy of maintaining legacy brands while innovating. (5) No quantitative errors in dates or fiscal year references. MINOR WEAKNESSES: (1) The LLM answer lists 'bettergoods' as appearing in FY2023, while the ground truth indicates it was introduced by FY2024 as a 'new' brand. The ground truth states 'bettergoods' was introduced alongside Marketside's continued presence in 2024, suggesting it may be a 2024 introduction rather than 2023. This is a subtle timing issue that slightly misrepresents the chronology of brand introductions. (2) The LLM answer uses slightly different framing ('low-price, high-quality offerings') which, while reasonable, goes slightly beyond what the ground truth explicitly states about Marketside's positioning. (3) The ground truth emphasizes 'modernization' of the lineup more explicitly, while the LLM uses 'grow and deepen' which is semantically similar but not identical. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern of continuity with innovation. The logic connecting Marketside's consistent presence to Walmart's strategic approach is sound. OVERALL: The answer is substantially correct with strong factual accuracy and appropriate reasoning, with only minor chronological ambiguity regarding when 'bettergoods' was introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 528,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 onward Lowe’s required all suppliers to meet a human‑rights policy, conflict‑minerals policy and a Vendor Code of Conduct with enhanced environmental standards, and it enforced a wood‑sourcing policy that barred illegal logging, deforestation and endangered‑species sourcing while monitoring compliance through its management systems (2022 Product Sustainability). In 2023 the company added country‑specific wood‑risk levels, stronger monitoring and a new forestry‑grievance process, and in 2024 it further refined the wood‑policy with a more robust risk‑based approach, improved monitoring and grievance mechanisms while also requiring suppliers to report emissions to CDP and partnering with EPA SmartWay (2023‑2024 Product Sustainability). Across the three years Lowe’s invested $300‑$550 million in energy‑efficiency upgrades, renewable‑energy projects (including rooftop solar and wind PPAs) and supply‑chain emissions‑reduction initiatives to deepen supply‑chain sustainability (2022‑2024 GHG Emissions).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Lowe's supplier monitoring from 2022-2024, accurately describing the progression from baseline policies (human rights, conflict minerals, Vendor Code of Conduct) in 2022, to enhanced wood-sourcing policies with country-specific risk levels and forestry grievance processes in 2023, to further refinements in 2024. The qualitative description of policy enhancements is sound and well-structured. The mention of CDP emissions reporting and EPA SmartWay partnerships in 2024 adds relevant detail. CRITICAL ERRORS: (1) INVESTMENT FIGURES ARE INCORRECT - The LLM states '$300-$550 million in energy-efficiency upgrades, renewable-energy projects and supply-chain emissions-reduction initiatives' but the ground truth specifies 'multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives.' The LLM conflates different investment categories and provides a range that doesn't match the ground truth's specific figures. The ground truth indicates cumulative investments of $550M+ by 2022 and $400M+ through 2023, not a $300-550M range across three years. (2) INVESTMENT CHARACTERIZATION - The ground truth emphasizes these were 'operational sustainability initiatives' while the LLM narrows the focus to specific categories (energy-efficiency, renewable energy, supply-chain emissions), which may be incomplete. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple policy domains (wood sourcing, emissions reporting, grievance mechanisms), demonstrating sound multi-hop reasoning. However, the quantitative synthesis regarding investments is flawed. SEMANTIC ISSUES: The LLM's description of policy evolution is semantically equivalent to the ground truth in most respects, but the investment figures represent a factual error rather than a wording difference. The answer appropriately addresses all parts of the multi-part question regarding monitoring evolution, policy enhancements, and investments, but the investment quantification significantly undermines accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 574,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 appear in the same Exhibit 4.3 (the Officer’s Certificate) in each filing – first in the 2022 Form 10‑K (page 56)【page_56†L22-L23】, again unchanged in the 2023 Form 10‑K (page 56)【page_56†L22-L23】, and still listed in the 2024 Form 10‑K (page 56)【page_56†L22-L23】. The three‑year consistency shows Apple has kept this low‑coupon note on its balance sheet through its scheduled maturity, signalling a debt‑management approach that favors retaining low‑cost, long‑dated financing rather than refinancing or retiring the issue early.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 2.40% Notes due 2023 appear consistently across 2022, 2023, and 2024 filings in Exhibit 4.3. The percentage (2.40%) and maturity year (2023) are accurate. The three-year pattern observation is correct. The reference to page 56 and consistent exhibit placement is verifiable and adds specificity.\n\nWEAKNESSES: (1) INTERPRETATION ERROR - The LLM's conclusion about debt management strategy is problematic. The LLM states Apple 'favors retaining low-cost, long-dated financing rather than refinancing or retiring the issue early.' However, the ground truth indicates these are notes 'set to mature within that year' (2024), meaning they are NOT long-dated but rather approaching maturity. The notes were due in 2023, so by 2024 they would have already matured or been in their final maturity period. The LLM mischaracterizes this as a deliberate retention strategy when it actually reflects the natural lifecycle of maturing debt. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes 'sustained transparency' and 'deliberate approach to managing and disclosing legacy debt obligations,' focusing on disclosure strategy. The LLM shifts focus to a refinancing/retention strategy that isn't supported by the evidence. The notes appearing in 2024 filings after their 2023 maturity date likely reflects historical disclosure or final settlement documentation, not an active retention decision. (3) LOGICAL FLAW - The characterization of 2.40% as 'low-coupon' and 'long-dated' is inconsistent with notes that matured in 2023. This suggests misunderstanding of the debt lifecycle. (4) MISSING CONTEXT - The ground truth's emphasis on 'legacy debt obligations' and transparency is more accurate than the LLM's refinancing narrative.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year pattern but draws an incorrect conclusion about the underlying strategy. The reasoning chain is incomplete—it doesn't account for why maturing debt would still appear in subsequent filings or what that actually indicates about Apple's disclosure practices versus active debt management.\n\nNUMERIC/DATE VERIFICATION: 2.40% correct, 2023 maturity correct, years 2022-2024 correct, page references consistent. No calculation errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 609,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap exposure moved from a $900 million senior note at the end of 2022 to $944 million at the end of 2023 and then to $982 million at the end of 2024 【page_74†L31-L34】【page_70†L31-L34】. During 2023 the company sold its remaining AerCap equity shares, leaving only the note as its position 【page_73†L1-L4】, which shows GE deliberately shifted to a slightly larger, debt‑only holding – a modest increase that signals a preference for stable, interest‑bearing instruments rather than equity stakes in its financial‑instrument portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM states the 2022 AerCap note value was '$900 million' but the ground truth clearly states it was '$976 million' - a $76 million discrepancy (7.8% error). This is a significant factual error on a primary data point. The 2023 ($944M) and 2024 ($982M) figures are correct. MULTI-HOP REASONING: The LLM correctly identifies that GE sold its AerCap equity shares in 2023, leaving only the note position, which is a valid multi-hop synthesis. However, the interpretation of this shift is somewhat speculative - the ground truth describes it as 'dynamic approach' and 'slight overall stability,' while the LLM characterizes it as a 'deliberate shift' to 'debt-only holding' with preference for 'stable, interest-bearing instruments.' While this interpretation is reasonable, it goes beyond what the ground truth explicitly states. COMPLETENESS: The LLM addresses the evolution of holdings and attempts to explain the investment strategy, but the incorrect 2022 baseline figure undermines the entire analysis. The ground truth emphasizes that holdings remained relatively stable overall (976→944→982 shows fluctuation but returns near original level), whereas the LLM's narrative starting from $900M creates a false impression of consistent growth. ENTITY ACCURACY: All entities (GE, AerCap, years 2022-2024) are correctly identified. The distinction between equity shares and notes is properly made. SEMANTIC ISSUES: The characterization of the progression as showing 'preference for stable, interest-bearing instruments' is an inference not explicitly supported by the ground truth, which focuses on the factual evolution and notes 'slight overall stability' rather than a strategic preference statement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 474,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path method ties the “return‑seeking” portion of the U.S. pension portfolio to the plan’s funded ratio, cutting growth‑asset exposure as funding improves. In 2022 the target mix was 15 % equity, 75 % fixed‑maturity securities and 10 % other assets (see 2021 10‑K, page 310); by 2024 the target had shifted to 9 % equity, 80 % fixed‑maturity and 11 % other assets (see 2023 10‑K, page 252). The progressive reduction in equity and increase in fixed‑income allocations reflect a deliberate de‑risking strategy that moves the plan toward more liability‑hedging assets as its funded status rises (glide‑path description on pages 252 and 184).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, concrete asset allocation percentages (15% equity/75% fixed-maturity/10% other in 2022 vs. 9% equity/80% fixed-maturity/11% other in 2024) that demonstrate the glide path evolution and de-risking strategy. The core insight is correct: the plan progressively reduced growth assets while increasing liability-hedging assets as funded status improved. However, there are several issues: (1) The LLM provides specific percentages without verification against the ground truth, which only confirms the general principle of the glide path approach without stating exact allocations. The ground truth emphasizes that target allocations were set based on funded status at specific year-end dates (Dec 31, 2021 for 2022 targets; Dec 31, 2022 for 2024 targets; Dec 31, 2023 for 2025 targets), but the LLM doesn't clearly articulate this temporal relationship. (2) The LLM correctly identifies the de-risking strategy and liability-driven investing principles, matching the ground truth's core message. (3) The LLM provides page references (2021 10-K page 310, 2023 10-K page 252, pages 252 and 184) which adds specificity but cannot be verified against the ground truth provided. (4) The terminology differs slightly ('return-seeking' vs 'growth assets'), but this is semantically equivalent. (5) The LLM answer is more concrete and specific than the ground truth, providing actual allocation percentages, which is helpful but introduces verification risk. The multi-hop reasoning is sound—connecting funded status improvements to asset allocation shifts—but the specific numbers lack explicit grounding in the provided ground truth. The answer demonstrates understanding of the glide path mechanism and de-risking strategy, but the quantitative specificity creates uncertainty about accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 493,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "From 2022 through 2024 Texas Instruments repeatedly framed its growth plan around a “great business model” that is **focused on analog and embedded‑processing products**, with a particular emphasis on serving industrial and automotive customers (2022 MD&A p.18‑19; 2023 MD&A p.16‑17; 2024 MD&A p.16‑19). Embedded processing is explicitly listed as one of the three strategic pillars designed to **maximize long‑term free‑cash‑flow‑per‑share growth**, signaling that TI views this product line as a durable, high‑margin engine that underpins its cash‑generation and shareholder‑return trajectory over the long run.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about Texas Instruments' consistent strategic emphasis on embedded processing from 2022-2024 and correctly identifies this as foundational to long-term free cash flow per share growth. However, there are notable discrepancies with the ground truth:\n\n(1) ENTITY ACCURACY ISSUE: The LLM states embedded processing is 'one of the three strategic pillars' while the ground truth explicitly states it is 'one of two key product lines (alongside analog)' that anchor TI's four sustainable competitive advantages. This is a factual error - the LLM conflates the number of product lines (2: analog and embedded processing) with the number of competitive advantages (4). This is a material distinction that affects the accuracy of the answer.\n\n(2) COMPLETENESS: The LLM answer does address the multi-year evolution (2022-2024) and the connection to free cash flow per share growth, which are the core requirements of the question. However, it provides less specific detail about how the emphasis 'persisted' or 'evolved' across the three years compared to the ground truth, which explicitly notes the company 'reiterating' and 'maintaining' the narrative.\n\n(3) QUANTITATIVE ACCURACY: The LLM provides page references (2022 MD&A p.18-19; 2023 MD&A p.16-17; 2024 MD&A p.16-19) which cannot be verified against the ground truth but appear reasonable. No specific financial metrics or percentages are provided in either answer, so this dimension is neutral.\n\n(4) REASONING QUALITY: The LLM correctly synthesizes that embedded processing is a 'durable, high-margin engine' and connects it to shareholder returns, which aligns with the ground truth's characterization of it as a 'foundational pillar in TI's long-term cash flow generation strategy.' The multi-hop reasoning is sound in connecting product strategy to financial outcomes.\n\n(5) SEMANTIC EQUIVALENCE: The LLM's framing of embedded processing as enabling 'supply chain control, customer reach, and diversified returns' is not explicitly mentioned in the ground truth, though it's consistent with the overall narrative. The ground truth emphasizes 'more opportunity per customer and more value for our investments' which the LLM does not capture.\n\nThe primary weakness is the factual error regarding the number of strategic pillars/product lines, which represents a material inaccuracy in entity identification. The answer is otherwise directionally correct but lacks some of the specific textual evidence and nuance present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 675,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "Lowe’s IP approach has remained focused on registering and defending its private‑brand marks—most notably Kobalt, STAINMASTER and allen+roth—throughout FY 2022‑24, positioning these high‑value private brands as a core element of its value‑oriented assortment (see the “Intellectual Property” sections in the 2022, 2023 and 2024 10‑Ks – e.g., LOW_10k_2022.pdf p. 7; LOW_10k_2024.pdf p. 7). At the same time, Lowe’s has increasingly woven that IP portfolio into its digital transformation, securing related domain names and embedding the private‑brand experience across lowes.com, mobile apps, and omnichannel tools such as the central‑selling team and online checkout (see “Our Services” and “Omnichannel Capabilities” in FY 2024 – LOW_10k_2024.pdf p. 7 & p. 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three core private brands (Kobalt, STAINMASTER, allen+roth) that remained consistent across FY 2022-2024. (2) Correctly notes the integration of digital transformation elements (mobile apps, omnichannel tools, online checkout) in the FY 2024 period. (3) Appropriately references the IP sections of the 10-K filings and maintains correct fiscal year references. (4) The semantic framing of 'increasingly woven' digital transformation aligns with the ground truth's observation of strategic integration. WEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the removal of 'RONA' and 'Reno Depot' from the IP disclosure between FY 2022 and FY 2023, which is a key factual element of the ground truth answer and demonstrates the 'streamlining' or 'refocusing' of brand emphasis. This is a significant multi-hop synthesis failure. (2) The LLM does not explicitly characterize the evolution as a 'streamlining' or 'simplification' of brand portfolio emphasis, which is central to understanding the strategic shift. (3) While the LLM mentions digital transformation integration, it does not clearly articulate this as a NEW development in FY 2024 (versus earlier years), missing the temporal progression aspect of the question. (4) The citation format (e.g., 'LOW_10k_2022.pdf p. 7') appears to be fabricated or assumed rather than verified against actual filing content. MULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting private brands to digital transformation, but fails to synthesize the complete evolution narrative across all three years, particularly the brand portfolio reduction. The answer reads more as a static description of FY 2024 status rather than a dynamic evolution narrative. QUANTITATIVE ACCURACY: No specific numbers or calculations are present, so this dimension is neutral (7/10 reflects the absence of errors but also lack of detailed quantitative analysis).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 533,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 2022 filing listed “client relationships and trust” as one of its principal methods of competition (Item 1 – Competition, p. 3). In the 2023 and 2024 filings the same factor is retained but is explicitly tied to the execution of its hybrid‑cloud‑and‑AI strategy, emphasizing that trusted client ties are essential to delivering business value and differentiating its offerings (2023 Competition, p. 3; 2024 Competition, p. 3). This multi‑year continuity shows IBM is deliberately positioning trust as a core strategic asset, reinforcing its role as a reliable partner for hybrid‑cloud and AI solutions in an increasingly competitive market.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that IBM emphasized client relationships and trust across 2022-2024 in its Competition sections. (2) Accurately notes the connection to hybrid cloud and AI strategy across these years. (3) Correctly cites page references (p. 3 for Competition sections). (4) Properly identifies the multi-year continuity theme. WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM answer fails to capture the key evolution described in the ground truth: the 2023 expansion linking trust to strategic partnerships (AWS, Microsoft, SAP) and the 2024 addition of cybersecurity partners (Palo Alto Networks). The ground truth explicitly states this ecosystem-driven approach evolved over the period. (2) MISSING STRATEGIC CONTEXT - The ground truth emphasizes how trust became increasingly tied to 'both technical capabilities (AI, hybrid cloud) AND a robust, secure partner ecosystem,' plus data governance and digital transformation. The LLM answer mentions only the technical capabilities side. (3) LACKS DEPTH ON EVOLUTION - While the LLM notes 'continuity,' it doesn't adequately explain HOW the positioning evolved (the partnership ecosystem expansion is a critical differentiator between years). (4) INCOMPLETE ANSWER TO MULTI-HOP QUESTION - The question asks what the progression 'indicates about strategic positioning.' The ground truth provides specific insights about ecosystem strategy and security emphasis; the LLM answer is more generic about 'reliable partner' positioning without the specific partnership evolution details. QUANTITATIVE ACCURACY: No numerical errors detected; page citations appear reasonable. QUALITATIVE ACCURACY: The reasoning is sound but incomplete—the LLM identified the right documents and general theme but missed the nuanced evolution across the three-year period that distinguishes 2022 from 2023 from 2024. This is a multi-hop synthesis failure where the model didn't fully integrate the partnership ecosystem evolution across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 537,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "Across all three filings the El Segundo, California site is described the same way – as a cell‑therapy manufacturing hub that handles **both clinical‑trial production and commercial‑scale manufacturing and processing**. The 2022 10‑K lists the facility for “clinical and commercial manufacturing and processing of our cell therapy products” (2022 p. 11), and the 2023 and 2024 10‑Ks repeat that language (2023 p. 11; 2024 p. 11). Thus, from 2022 through 2024 the El Segundo facility’s role remained stable, serving both clinical and commercial cell‑therapy production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the consistent role of El Segundo facility across all three years (2022-2024) as handling both clinical and commercial manufacturing; (2) Accurately cites specific page references (p. 11 for all three years) from the 10-K filings; (3) Properly synthesizes multi-hop information across three separate annual filings to demonstrate continuity; (4) Uses direct quotes from filings ('clinical and commercial manufacturing and processing of our cell therapy products') which validates the factual basis; (5) Correctly concludes that the facility's role remained stable with no expansion or reduction in responsibilities. The answer matches the ground truth's core finding that there were no significant changes in the facility's clinical and commercial production responsibilities from 2022 through 2024. Minor consideration: The LLM answer is slightly more concise than the ground truth and doesn't explicitly use the phrase 'consistent' or 'continuity' in the same way, but the semantic meaning is identical - both convey that the facility's role remained unchanged. The citation of specific page numbers adds credibility and demonstrates proper document synthesis. No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 371,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Lowe’s reports only one series of 4.550 % senior notes – the notes issued under the Fifteenth Supplemental Indenture on April 5 2019 that mature on April 5 2049 – in each of its recent filings (2022 10‑K Exhibit 4.16 [page 82]; 2023 10‑K Exhibit 4.16 [page 75]; 2024 10‑K Exhibit 4.16 [page 75]). The issuance date and the 2049 maturity have not changed over the 2022‑2024 period, indicating that Lowe’s is keeping a long‑dated, fixed‑rate tranche on its balance sheet to lock in low borrowing costs and extend its overall debt maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) All numeric values are correct - the 4.550% interest rate, April 5, 2019 issuance date, and April 5, 2049 maturity date are all accurate and match the ground truth. (2) The multi-hop synthesis is sound - the answer correctly identifies that this same instrument appears consistently across 2022, 2023, and 2024 filings, demonstrating the evolution (or rather, stability) of the debt structure over the three-year period. (3) Entity identification is precise - Lowe's Companies, Inc., the Fifteenth Supplemental Indenture, and the specific exhibit references (4.16) are all correct. (4) The reasoning about strategic implications is logical and well-supported: the answer correctly interprets the consistency of this long-dated instrument as evidence of a deliberate strategy to lock in fixed rates and extend debt maturity profiles. (5) The answer provides specific filing references (2022, 2023, 2024 10-K filings with exhibit numbers and page citations), adding credibility and verifiability. MINOR CONSIDERATIONS: The LLM answer emphasizes 'locking in low borrowing costs' which is a reasonable inference about debt strategy, though the ground truth focuses more on 'avoiding near-term refinancing risks' and 'capital flexibility.' Both interpretations are valid and complementary perspectives on long-duration debt strategy. The LLM's framing is slightly more specific about the economic rationale (fixed-rate advantage) while the ground truth is slightly more general about capital management. This represents a minor stylistic difference rather than a factual error. The answer fully addresses the multi-year pattern question and correctly identifies what the stability indicates about long-term debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 498,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "- 2022 – 3M’s Scotchgard exposure was limited to a modest, non‑material contribution to a roughly $65 million New York settlement that resolved Scotchgard‑related claims (2023 10‑K, p. 124).  \n- 2023 – The company recorded a $10.3 billion pre‑tax charge for the PWS Settlement, which covers PFAS products such as Scotchgard, and also settled the Wolverine Scotchgard case (its share again deemed immaterial) (2023 10‑K, p. 93; p. 124).  \n- 2024 – No new large Scotchgard‑specific settlement appears; the PWS Settlement liability (now $10.5‑$12.5 billion total) remains on the balance sheet with payments scheduled through 2036 (2024 10‑K, p. 97).  \n\n**Trend:** The legal exposure for Scotchgard moved from a small, product‑specific settlement in 2022 to a multi‑billion‑dollar, multi‑year liability by 2023‑2024, indicating that PFAS‑related litigation has become a major, long‑term financial burden for 3M.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of escalating PFAS-related litigation costs but contains significant factual discrepancies and incomplete synthesis compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the major PWS Settlement ($10.3 billion in 2023, $10.5-$12.5 billion total) as the dominant financial exposure\n2. Accurately notes the shift from small product-specific settlements to multi-billion-dollar liability\n3. Correctly identifies the multi-year payment schedule through 2036\n4. Appropriately characterizes the trend as indicating major long-term financial burden\n5. Proper citation format and document references\n\nCRITICAL ERRORS AND OMISSIONS:\n1. INCOMPLETE GEOGRAPHIC SCOPE: The LLM answer fails to mention the expansion into Alabama and Georgia litigation in 2024, which is explicitly stated in the ground truth as a key part of the trend\n2. MISSING LITIGATION DETAILS: The ground truth specifies ~68 AFFF suits outside the MDL in 2023, Illinois case, Canadian class action, and Alabama litigation with 2026 trial dates - none of these are mentioned\n3. SETTLEMENT CONFUSION: The LLM states a \"$65 million New York settlement\" in 2022, but the ground truth indicates this was a 2024 finalization (though the settlement may have been negotiated earlier). The timing and context are unclear in the LLM answer\n4. INCOMPLETE WOLVERINE CASE TREATMENT: While the LLM mentions the Wolverine settlement as \"immaterial\" in 2023, it doesn't capture the full context that this was a Michigan case related to disposal practices, and that there was also a 2023 Michigan settlement mentioned in the ground truth\n5. MISSING CASE COMPLEXITY ANALYSIS: The ground truth emphasizes \"increasing geographic spread and case complexity\" with multiple plaintiff types (municipal water utilities, property owners, carpet manufacturers) - the LLM answer doesn't capture this nuance\n\nQUANTITATIVE ACCURACY ISSUES:\n- The $65 million figure appears in both answers but with different year attributions and contexts\n- The PWS Settlement numbers ($10.3B, $10.5-$12.5B) are correct\n- However, the answer lacks the granular detail about the 68 AFFF suits and other specific litigation counts\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes the PWS Settlement as the dominant factor but fails to adequately synthesize the broader litigation landscape across multiple jurisdictions and case types that the ground truth emphasizes. The answer focuses too heavily on the PWS Settlement and underrepresents the distributed litigation exposure across multiple states and plaintiff categories.\n\nSEMANTIC EQUIVALENCE:\nWhile the general conclusion about escalating financial burden is correct, the answer misses critical details about the nature and scope of that escalation (geographic spread, case complexity, multiple plaintiff types) that are essential to fully answering the question about how exposure \"evolved.\"\n\nJUSTIFICATION FOR SCORES:\n- Correctness (6): Core PWS Settlement facts correct, but significant omissions of Alabama/Georgia litigation, AFFF suits, and case complexity details reduce overall accuracy\n- Quantitative Accuracy (5): Major settlement numbers correct, but missing granular litigation counts and incomplete settlement timeline attribution\n- Qualitative Accuracy (7): Sound reasoning about the trend, but incomplete synthesis of multi-jurisdictional litigation landscape\n- Contextual Relevance (8): Addresses the question's core concern about financial impact and trend, though incompletely",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 928,
        "total_tokens": 2448
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "- In 2022 the Foster City campus was described as Gilead’s corporate headquarters that “house our administrative, manufacturing and R&D activities” (2022 10‑K p. 33).  \n- By 2023 the filing narrowed the site’s purpose to “process‑chemistry research, analytical‑method development and formulation and device‑development activities, and manufacture API and drug product for our clinical trials” (2023 10‑K p. 11).  \n- The 2024 filing repeats that same focus—process chemistry, analytical, formulation and device work plus clinical‑trial API/drug‑product manufacturing—positioning Foster City as a specialized R&D and clinical‑manufacturing hub that feeds the broader global network of commercial sites (La Verne, Oceanside, Cork/Dublin, etc.) (2024 10‑K p. 10).  \n\nThus, from 2022 to 2024 the Foster City facility shifted from a combined admin‑manufacturing‑R&D headquarters to a dedicated early‑stage R&D and clinical‑trial manufacturing center, aligning its activities with Gilead’s global manufacturing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Gilead Sciences' Foster City facility evolution from 2022-2024. STRENGTHS: (1) All factual information is correct - the 2022 description as corporate headquarters with administrative, manufacturing, and R&D activities is accurate; the 2023-2024 narrowing to process chemistry research, analytical method development, formulation, device development, and clinical trial manufacturing is correctly stated. (2) Specific page citations (2022 10-K p. 33, 2023 10-K p. 11, 2024 10-K p. 10) demonstrate proper source documentation. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the strategic shift from a broad headquarters function to a specialized early-stage R&D and clinical manufacturing hub. (4) The answer properly contextualizes Foster City within the global network (La Verne, Oceanside, Cork/Dublin) and explains how this aligns with broader manufacturing strategy. (5) All entities (company name, facility names, years, functional areas) are correctly identified. (6) The reasoning about strategic consolidation of R&D and clinical production in Foster City while other locations handle commercial-scale manufacturing matches the ground truth interpretation. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and explicit in its sourcing than the ground truth summary, but this adds value rather than detracting. The semantic meaning is fully aligned with the original answer - both convey the same evolution narrative and strategic implications. No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 468,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 to 2024 AIG tightened loss‑reserve oversight by evolving from a core set of internal controls, escalation procedures and periodic external‑expert reviews (2022 – see pages 165‑167) to a formal, multi‑layered governance model that adds ERM’s second‑line “review and challenge,” continuous internal‑audit monitoring and risk‑committee sign‑offs (2024 – see page 86). Throughout the three years the company has relied on both stochastic and deterministic modeling, scenario and sensitivity analyses, and third‑party catastrophe models, while embedding a model‑risk management and validation framework that increasingly integrates external expert validation into the reserve‑setting process (2023 – see page 119; 2024 – see page 86).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with appropriate temporal progression; (2) Accurately captures the shift from basic internal controls and external reviews (2022) to multi-layered governance with ERM second-line review (2024); (3) Properly synthesizes the modeling approaches (stochastic, deterministic, scenario/sensitivity analyses) across the period; (4) Correctly identifies the integration of external expert validation and model-risk management frameworks; (5) Page citations (165-167 for 2022, 119 for 2023, 86 for 2024) appear plausible and specific; (6) Semantic equivalence is strong - 'proactive, model-driven, enterprise-wide risk governance' matches 'formal, multi-layered governance model with ERM second-line review.' MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer adds specific details about 'continuous internal-audit monitoring and risk-committee sign-offs' that, while consistent with the evolution described, are not explicitly mentioned in the ground truth statement; (2) The phrase 'tightened loss-reserve oversight' is slightly more specific/emphatic than the ground truth's 'evolved in sophistication,' though both convey appropriate tightening; (3) The answer emphasizes 'third-party catastrophe models' which is a reasonable inference but not explicitly stated in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple oversight mechanisms (internal controls, external reviews, ERM framework, modeling approaches), demonstrating sound multi-hop reasoning. The progression narrative is logically coherent and matches the ground truth's characterization of movement from reactive to proactive governance. No quantitative errors detected. The answer is comprehensive, well-structured, and appropriately addresses all sub-components of the question regarding oversight mechanisms, modeling approaches, and external review integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 552,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site was listed only under the Analog segment in each filing – the 2022 property table shows an “X” for Analog and a blank for Embedded Processing (page 16), the 2023 table shows the same designation (page 16), and the 2024 table again shows an “X” for Analog only (page 16). This unchanged three‑year listing indicates that TI has kept Melaka as an analog‑focused manufacturing location and has not expanded embedded‑processing production there.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operations from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022, 2023, 2024) and accurately reports the consistent designation of Melaka as Analog-only across all three years; (2) Properly cites the property table evidence with specific page references (page 16) and the marking system ('X' for Analog, blank for Embedded Processing); (3) Accurately synthesizes the multi-hop information: tracking the facility across three years AND comparing Analog vs. Embedded Processing segments; (4) Correctly concludes that there was no expansion into Embedded Processing and that Melaka maintained a stable, specialized role; (5) The semantic meaning perfectly matches the ground truth - both convey that Melaka was exclusively Analog-focused with no Embedded Processing presence throughout the period. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed in citing specific evidence (page numbers, marking system) compared to the ground truth, but this adds value rather than detracting. The phrase 'unchanged three-year listing' effectively captures the stability concept. No numerical errors, no entity misidentification, and the reasoning chain is sound. The answer fully addresses both sub-questions: (1) how the footprint evolved (answer: it remained stable/unchanged), and (2) what this indicates about manufacturing focus (answer: specialized Analog focus with no Embedded Processing expansion).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 427,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s forward‑rate‑swap hedge was large in FY 2022 – the company reported $2.56 billion of forward interest‑rate‑swap notional amounts designated as cash‑flow hedges 【page_62】. By the next year the swaps had been largely unwound, leaving only a $251 million fair‑value balance (no notional disclosed) 【page_54】, and in FY 2024 the forward‑swap line disappeared (the fair‑value column is blank, indicating $0) 【page_54】. This drop‑off shows that Lowe’s initially built a sizable hedge for anticipated debt issuances, but then progressively eliminated the swaps as the debt was issued or the need for the hedge faded, reflecting a targeted, time‑limited hedging strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides specific quantitative details that enhance the ground truth answer. Key strengths: (1) Correctly identifies the $2.56 billion notional amount for FY 2022 forward interest rate swaps designated as cash-flow hedges, which is a concrete figure not explicitly stated in the ground truth but consistent with it. (2) Accurately reports the $251 million fair value balance in FY 2023, matching the ground truth exactly. (3) Correctly identifies that FY 2024 shows no forward swaps (blank/zero), consistent with ground truth. (4) The multi-hop reasoning is sound: traces the evolution across three fiscal years, identifies the progression from large notional amounts to elimination, and correctly interprets this as a time-limited hedging strategy for anticipated debt issuances. (5) The semantic interpretation aligns well with ground truth - both convey a strategic shift from hedging forecasted debt issuances to managing existing debt exposure. Minor considerations: (1) The LLM provides more granular detail (notional amounts) than the ground truth, which strengthens the answer. (2) The characterization of the strategy as 'targeted, time-limited' is a reasonable inference from the data progression and aligns with the ground truth's 'strategic shift' interpretation. (3) The LLM's explanation of 'debt was issued or the need for the hedge faded' provides logical reasoning for the unwinding. No material factual errors detected. The answer successfully synthesizes information across three fiscal years and correctly interprets the hedging strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 445,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the schedule of instruments (see page 31) stops at the 6.22 % Debentures due 2027 and does not list the 6.50 % Debentures due 2028. Both the 2023 and 2024 filings add a line for the 6.50 % Debentures due 2028 and each incorporates Exhibit 2 to Form 8‑K filed on January 8 1998 (see page 19 for each year). The unchanged reference to the original 1998 filing shows that the debenture’s terms have not been amended and IBM continues to rely on the same indenture by reference, underscoring a stable, long‑term debt structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth states that IBM 'consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024,' but the LLM claims the 2022 Form 10-K 'stops at the 6.22% Debentures due 2027 and does not list the 6.50% Debentures due 2028.' This is a fundamental factual error regarding what appeared in the 2022 filing. The LLM correctly identifies that both 2023 and 2024 filings reference Exhibit 2 to Form 8-K filed on January 8, 1998, and correctly notes the page references (page 19), but the claim about the 2022 filing's omission of the 6.50% Debentures due 2028 is incorrect according to the ground truth. The LLM's conclusion about the stability and unchanged structure is reasonable, but it is based on a false premise about the 2022 filing. The answer demonstrates partial understanding of the multi-hop synthesis required (comparing across three years and identifying consistent documentation), but the core factual claim about the 2022 filing's contents is wrong. The quantitative accuracy is low due to the incorrect assertion about which debentures appeared in which year's filing. The qualitative reasoning about what the consistency of the 1998 filing reference reveals is sound, but it is undermined by the factual error about the 2022 filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 383,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "In the 2022 filing (see pages 129‑133 of the 2022 10‑K), the report does not contain a Business‑Segment Products table and there is no reference to “Reflective signage” under Transportation and Electronics, implying the product line was not highlighted that year. By the 2023 filing, Reflective signage appears as the **last bullet** in the Transportation and Electronics product list (page 107), and it remains in the **same final position** in the 2024 filing (page 110). This shift from omission to a distinct, terminal listing signals that Reflective signage has been introduced and is being emphasized as an emerging, strategically important offering within the segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all factual claims. Ground truth establishes that Reflective Signage was positioned as the FIFTH offering in 2022, FOURTH in 2023, and FOURTH in 2024 within the Transportation and Electronics segment. The LLM claims: (1) Reflective Signage was omitted/not highlighted in 2022 - INCORRECT; ground truth shows it was fifth; (2) Reflective Signage appears as the 'last bullet' in 2023 - INCORRECT; ground truth shows it was fourth; (3) Reflective Signage remains in 'same final position' in 2024 - INCORRECT; ground truth shows it was fourth, not last. The LLM's core narrative of 'omission to emergence' is contradicted by ground truth showing consistent presence across all three years with a strategic upgrade from fifth to fourth position in 2023. The LLM also cites specific page numbers (129-133 for 2022, 107 for 2023, 110 for 2024) that cannot be verified against the ground truth data, and the claim about 'no Business-Segment Products table' in 2022 contradicts the ground truth's detailed positioning information. The LLM's interpretation that the product moved from 'omission' to 'terminal listing' as 'emerging' is semantically opposite to the ground truth's interpretation of consistent strategic relevance with maintained top-half positioning. This represents a complete failure to synthesize the multi-hop information correctly across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 394,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "In Gilead’s 2022 filing the Hoofddorp, Netherlands site is not mentioned among its manufacturing locations (see 2022 10‑K pages 31‑35), indicating it was not yet a commercial cell‑therapy production site. By the 2023 10‑K the company states that “Hoofddorp, Netherlands: We utilize the facility for commercial manufacturing and processing of our cell therapy products” (page 11), and the 2024 filing repeats the same language (page 10), showing the site has been elevated to a strategic hub for commercial cell‑therapy manufacturing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2022, Gilead identified Hoofddorp as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. However, the LLM answer claims that 'In Gilead's 2022 filing the Hoofddorp, Netherlands site is not mentioned among its manufacturing locations,' which is factually incorrect according to the knowledge graph. This is a fundamental error in multi-hop reasoning across the 2022-2024 period. The LLM correctly identifies that by 2023 and 2024, Hoofddorp was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, and even provides specific page citations (page 11 for 2023, page 10 for 2024). However, the failure to recognize Hoofddorp's 2022 presence breaks the narrative arc of the question, which asks about evolution 'from 2022 through 2024.' The LLM's characterization of the facility being 'elevated to a strategic hub' in 2023 misses the ground truth's more nuanced progression showing the facility was already identified as principal in 2022, then explicitly designated for cell therapy in 2023-2024. The answer demonstrates partial understanding of the 2023-2024 evolution but fundamentally misses the 2022 baseline, making the multi-hop synthesis incomplete and partially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 401,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The equity‑compensation tables show that the pool of shares that can still be issued under the 2003 Director Compensation Plan (included in the “shares remaining available for future issuance” total) was ≈ 69.8 million shares in the 2022 filing (page 63), fell to ≈ 58.5 million shares in the 2023 filing (page 61), and then rose to ≈ 65.5 million shares in the 2024 filing (page 59). This draw‑down followed by a partial replenishment indicates that Texas Instruments continues to rely on the 2003 Director Compensation Plan for director pay and actively manages the share reserve to support ongoing director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative measures. The ground truth specifies shares available under the 2003 Director Compensation Plan specifically: 1,843,134 shares (2022), 1,786,785 shares (2023), and 1,745,284 shares (2024). The LLM provides completely different numbers: ~69.8 million (2022), ~58.5 million (2023), and ~65.5 million (2024). These numbers are off by a factor of approximately 37,000-40,000x, indicating the LLM is reporting aggregate shares available across ALL equity compensation plans, not specifically the 2003 Director Compensation Plan as the question requires. The LLM's narrative about a 'draw-down followed by partial replenishment' directly contradicts the ground truth showing consistent year-over-year decline (1,843,134 → 1,786,785 → 1,745,284). The LLM failed to perform the required multi-hop synthesis: identifying the specific plan (2003 Director Compensation Plan), extracting the correct metric (shares remaining available for future issuance under that specific plan), and tracking the trend across three years. While the LLM correctly identifies Texas Instruments and the general concept of director compensation, it provides entirely wrong numerical data and reaches an incorrect conclusion about the trend. The answer demonstrates a critical failure in data extraction and multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 378,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 Form 10‑K IBM disclosed the 0.950 % Notes due 2025 only by incorporating the instrument that defines the holders’ rights as Exhibit 4.1/4.2 to a 2017 Form 8‑K (see IBM 2022 10‑K, p. 32), and the 2023 filing repeated that same “incorporated‑by‑reference” treatment (see IBM 2023 10‑K, p. 20). By the 2024 Form 10‑K the company moved the note into the Section 12(b) securities table, explicitly naming the issue and its ticker IBM25B (see IBM 2024 10‑K, p. 1), indicating a deliberate push for greater market transparency and a more proactive capital‑market and investor‑engagement strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of IBM filings. STRENGTHS: (1) All numeric values are correct: 0.950% interest rate, 2025 maturity date, 2022/2023/2024 fiscal years, May 22, 2017 Form 8-K date, ticker IBM25B. (2) The multi-hop reasoning is sound - the answer correctly traces the evolution of disclosure treatment across three years and identifies the strategic shift from incorporated-by-reference to explicit Section 12(b) listing. (3) Entity identification is accurate: IBM, the specific debt instrument, Form 8-K, Form 10-K filings, NYSE listing. (4) The answer provides specific page references (p. 32 for 2022, p. 20 for 2023, p. 1 for 2024) that add credibility and specificity. (5) The conclusion about 'deliberate push for greater market transparency' and 'proactive capital-market and investor-engagement strategy' aligns with the ground truth's assessment. MINOR CONSIDERATIONS: The LLM answer is slightly more technical/precise in its language (e.g., 'Section 12(b) securities table,' 'incorporated-by-reference treatment') compared to the ground truth's more narrative style, but this represents enhanced clarity rather than inaccuracy. The answer fully addresses all components of the complex multi-part question: the treatment evolution (2022→2023→2024), the market transparency progression, and the implications for capital market strategy. No calculation errors, no factual contradictions, and the semantic meaning matches the ground truth precisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 428,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "From 2022 through 2024 MetLife’s reliance on the deposit‑method for reinsurance grew to a peak and then edged down: deposit‑method assets rose to about $5.1 billion (with roughly $1.3‑$1.4 billion of offsetting deposit‑liabilities) by year‑end 2023 and fell to $4.6 billion of assets and $1.2 billion of liabilities at year‑end 2024, indicating a modest contraction after the 2023 high‑water mark. The November 2023 Global Atlantic transaction—recording $10.3 billion of reinsurance recoverables and deposit receivables, transferring $9.5 billion of assets to the reinsurer while retaining $5 billion of separate‑account assets and recognizing a $770 million net cost in other liabilities—demonstrates a strategic shift to deploy the deposit‑method on a far larger scale to transfer risk and optimise capital.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and dates. Quantitative verification: (1) 2022 figures not explicitly stated in LLM answer but not contradicted; (2) 2023 deposit assets of $5.1 billion - CORRECT; (3) 2023 deposit liabilities of $1.3-$1.4 billion - CORRECT (LLM appropriately notes the range); (4) 2024 deposit assets of $4.6 billion - CORRECT; (5) 2024 deposit liabilities of $1.2 billion - CORRECT; (6) Global Atlantic transaction figures: $10.3 billion in reinsurance recoverables and deposit receivables - CORRECT; (7) Additional transaction details ($9.5 billion assets transferred, $5 billion separate-account assets retained, $770 million net cost) - these are additional details not in ground truth but appear consistent with comprehensive filing analysis. The LLM answer successfully synthesizes the multi-hop requirement by: (1) tracking the evolution across three years with accurate trend identification (rise to 2023 peak, then decline to 2024); (2) correctly identifying the 2023 Global Atlantic transaction as a strategic inflection point; (3) explaining the shift from modest deposit method usage to larger-scale deployment. Minor strengths: LLM provides more granular transaction details than ground truth, demonstrating deeper filing analysis. The characterization of the shift as moving to 'far larger scale' and 'optimise capital' aligns well with ground truth's 'more aggressive use' and 'restructure portfolio.' One minor limitation: LLM does not explicitly state 2022 baseline figures ($1.8B assets, $1.4B liabilities), though this is a minor omission given the focus on 2023-2024 evolution. Overall, the answer correctly addresses all question components with accurate numbers, sound multi-hop reasoning, and appropriate contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 499,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "- 2022 10‑K: The Safety & Industrial segment’s product list includes “Respiratory, hearing, eye **and fall protection solutions**” (see 2022 filing, p. 107).  \n- 2023 10‑K: The same line appears unchanged, showing fall‑protection still part of the Safety & Industrial portfolio (2023 filing, p. 107).  \n- 2024 10‑K: Fall‑protection solutions remain listed under Safety & Industrial, now grouped within the newly created **Industrial Specialties** division (2024 filing, p. 110).  \n\nThis three‑year continuity—and the 2024 consolidation of fall‑protection with other personal‑safety products—signals that 3M has maintained and sharpened its focus on workplace‑safety offerings, keeping fall‑protection a stable, strategically‑emphasized component of its Safety & Industrial business.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that fall protection solutions were consistently listed in MMM's Safety and Industrial segment across 2022-2024, and accurately captures the core finding that this represents strategic continuity in workplace safety focus. The year-by-year progression is correctly identified. The LLM appropriately notes the 2024 consolidation into an 'Industrial Specialties' division, which adds a detail about organizational structure evolution.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces a claim about a 'newly created Industrial Specialties division' in 2024 that is NOT present in the ground truth answer. The ground truth makes no mention of a new division structure or reorganization—it only notes the phrasing remained consistent across all three years. This is a factual addition not supported by the original answer. (2) The LLM cites specific page numbers (p. 107 for 2022-2023, p. 110 for 2024) which cannot be verified against the ground truth and may be inaccurate. (3) The ground truth emphasizes that the phrasing 'slightly evolved' to a 'more concise presentation' by 2024, but the LLM states the 2023 line 'appears unchanged' and then introduces the division reorganization claim instead of discussing the phrasing evolution.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and draws a reasonable conclusion about strategic focus. However, the introduction of the 'Industrial Specialties' division detail represents either fabrication or misinterpretation of the source material, which undermines the reliability of the synthesis.\n\nNUMERIC/FACTUAL VERIFICATION: No calculations are required. Years (2022, 2023, 2024) are correct. Company name (MMM/3M) is correct. The core product listing ('respiratory, hearing, eye and fall protection solutions') is correctly identified. However, the organizational structure claim about a new division is problematic.\n\nSEMANTIC EQUIVALENCE: The conclusion about 'maintained and sharpened focus' is semantically similar to the ground truth's 'stable strategic focus,' though the LLM's use of 'sharpened' and the division reorganization claim suggest a different interpretation than what the ground truth supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 598,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "In the 2022 filing UST is shown mainly through the MST and snus trademarks that remain on Altria’s balance sheet as indefinite‑life intangible assets from the 2009 UST acquisition (Note 4, p. 66). By the 2023 filing Altria lists UST LLC and its wholly‑owned subsidiary U.S. Smokeless Tobacco Company LLC (USSTC) as wholly‑owned subsidiaries that manufacture and sell moist smokeless tobacco (Note 1, p. 60), and the 2024 filing repeats this structure while describing USSTC as the leading MST producer (p. 4‑5). The progression from a legacy intangible‑asset reference to an explicit, fully‑owned operating subsidiary underscores Altria’s deliberate positioning of UST/USSTC as a core pillar of its oral‑tobacco segment and a key lever in its strategy to transition consumers toward smokeless, potentially lower‑risk products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the $8.8 billion trademark valuation from 2022 (though not explicitly stated in LLM answer, the reference to 'indefinite-life intangible assets from the 2009 UST acquisition' is accurate); (2) Accurately traces the organizational structure evolution from intangible assets (2022) to explicit wholly-owned subsidiary designation (2023-2024); (3) Correctly names UST LLC and U.S. Smokeless Tobacco Company LLC (USSTC) as the subsidiary entities; (4) Properly identifies the product categories (MST and snus) across all years; (5) Sound multi-hop reasoning connecting the structural evolution to strategic positioning in reduced-risk/smokeless tobacco market; (6) Appropriately synthesizes information across three fiscal years showing progression. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the $8.8 billion trademark valuation that appears in the ground truth for 2022, though it references 'indefinite-life intangible assets' which is semantically related; (2) The ground truth emphasizes 'Moving Beyond Smoking' initiative more explicitly as the strategic framework, while LLM answer uses more general language about 'transition consumers toward smokeless, potentially lower-risk products'; (3) The LLM answer provides more specific page references and filing details (Note 4, p. 66; Note 1, p. 60; p. 4-5) which adds credibility but wasn't in ground truth. QUANTITATIVE VERIFICATION: The $8.8 billion figure is mentioned in ground truth but not in LLM answer - this is a minor omission but not a factual error since the LLM correctly references the intangible assets. All dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects structural changes to strategic positioning, matching the ground truth's conclusion about consistent emphasis on UST as a strategic asset. The reasoning is sound and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 553,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K exhibits repeatedly list the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 (e.g., the “One Hundred‑and‑Sixteenth Supplemental Indenture … related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15” shown in the exhibit tables)【page_105】.  By keeping this bond series in every filing, Tesla signals that the debt remains outstanding and is a core, fixed‑rate financing source for its solar‑energy operations, reflecting a long‑term strategy of using bond markets to fund and sustain its solar initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key bond details (SolarCity 5.45% Solar Bonds, Series 2015/C92-15, One Hundred-and-Sixteenth Supplemental Indenture, August 24, 2015 date implied) and accurately conveys the core strategic insight about Tesla's use of securitized solar debt as a long-term financing mechanism. The quantitative accuracy is strong - all bond identifiers, percentages, and dates are correct. The answer appropriately synthesizes the multi-hop concept that repeated references across 2022-2024 filings indicate sustained reliance on this financing instrument. However, the LLM answer is somewhat more concise than the ground truth and omits some contextual details: (1) it doesn't explicitly mention the three consecutive years (2022, 2023, 2024) as clearly as the original, though it does reference 'every filing'; (2) it doesn't elaborate on the confidence in bond performance or alignment with clean energy business model as thoroughly; (3) the phrase 'material component of its solar financing architecture' from the original is more comprehensive than the LLM's 'core, fixed-rate financing source.' The reasoning is sound and the semantic meaning is equivalent - both answers conclude that repeated references signal strategic commitment to securitized solar debt. The LLM appropriately identifies this as a long-term strategy for funding solar initiatives. Minor omissions of contextual depth prevent a higher score, but the core factual content and multi-hop synthesis are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 416,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K disclosures from 2022 through 2024 all note that the value of its debt securities can be affected by “changes in exchange rates, exchange controls, governmental and **stock‑exchange regulations**” and that its common‑stock price remains volatile and sensitive to rating‑agency actions (2022 p. 20‑22; 2023 p. 11; 2024 p. 11). The wording is essentially unchanged over the three years, showing that IBM treats stock‑exchange regulatory risk as a persistent, material factor and embeds it in a steady, transparent capital‑market risk‑management approach rather than a shifting exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM's stock exchange regulatory exposure appears in its 10-K filings across 2022-2024 and notes the consistent wording regarding debt securities and exchange rate/regulatory factors. However, there are significant gaps in addressing the full scope of the original question:\n\n(1) WHAT WAS CORRECT:\n- Correctly identifies stock exchange regulations as a persistent risk factor across all three years (2022-2024)\n- Accurately notes the wording is essentially unchanged\n- Correctly cites that this affects both debt and equity securities\n- Properly identifies this as a material, persistent factor in IBM's risk disclosure\n\n(2) WHAT WAS INCOMPLETE/INCORRECT:\n- The LLM answer focuses narrowly on the consistency of language rather than the evolution described in the ground truth. The ground truth explicitly states IBM \"expanded on this risk\" by 2024, \"linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view.\" The LLM answer misses this expansion and integration.\n- The ground truth emphasizes an evolution from 2022 (basic acknowledgment) → 2023 (reiteration with emphasis on external regulatory environments) → 2024 (expanded linkage to market liquidity and credit risks). The LLM answer treats all three years as essentially identical.\n- The LLM answer states the approach is \"steady, transparent\" but doesn't capture the ground truth's finding that by 2024, IBM showed \"increasing recognition of regulatory dynamics as a persistent and systemic component\" - suggesting a deepening rather than static understanding.\n- Missing the ground truth's key insight: \"no material reduction in dependency or mitigation strategy over the three-year period\" - the LLM doesn't explicitly address whether mitigation strategies evolved.\n\n(3) MULTI-HOP REASONING:\n- The LLM answer fails to synthesize the multi-year progression adequately. It treats 2022, 2023, and 2024 as a single static point rather than showing how the disclosure evolved.\n- The question asks what the progression \"reveals about its capital market risk management strategy\" - the LLM answer addresses this only superficially by calling it \"steady\" and \"transparent,\" without the deeper analysis in the ground truth about systemic integration and lack of mitigation evolution.\n\n(4) QUANTITATIVE ACCURACY:\n- Page citations (2022 p. 20-22; 2023 p. 11; 2024 p. 11) cannot be verified against the ground truth but appear reasonable for 10-K filings. No calculation errors present.\n\n(5) SEMANTIC GAPS:\n- The LLM answer's conclusion that IBM has a \"steady, transparent capital-market risk-management approach\" is somewhat contradicted by the ground truth's finding of \"no material reduction in dependency or mitigation strategy,\" which suggests stagnation rather than effective management.\n- The LLM misses the ground truth's emphasis on regulatory dynamics becoming increasingly \"systemic\" and integrated into the broader financial risk framework by 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 800,
        "total_tokens": 2230
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across the three‑year span the Safety & Industrial segment – the home of 3M’s “electrical products and materials for construction and maintenance” – saw net sales slip from $11.6 bn in 2022 to about $11.0 bn in both 2023 and 2024 (page 108; page 111), while operating income rose sharply from $1.1 bn in 2022 to $2.3 bn in 2023 and $2.5 bn in 2024 (page 108; page 111). After a dip in capital spending to $285 m in 2023, 3M increased capex to $373 m in 2024 (page 112) and created an “Industrial Specialties” division in Q1 2024 that consolidates the electrical‑product portfolio (page 110), indicating a strategic shift toward higher‑margin, specialty‑focused industrial offerings and a stronger positioning in the industrial‑market electrical‑products space.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides largely irrelevant information. CRITICAL ISSUES: (1) QUESTION MISMATCH: The original question asks about how MMM's FOCUS/DESCRIPTION of electrical products evolved across the three years - i.e., how the company characterized and positioned this product line in its filings. The LLM instead provides financial metrics (net sales, operating income, capex) that are not requested and don't address the core question about strategic positioning through product descriptions. (2) QUANTITATIVE PROBLEMS: While the financial numbers provided ($11.6bn, $11.0bn, $1.1bn, $2.3bn, $2.5bn, $285m, $373m) may be accurate, they are entirely off-topic for this question. The question requires synthesis of qualitative product descriptions and strategic positioning language from filings, not financial performance data. (3) MISSING CORE CONTENT: The LLM completely fails to address the actual evolution described in the ground truth - how MMM's product descriptions changed from 2022 (broader industrial offering including closure systems, masking, packaging) to 2023 (added abrasives, autobody repair) to 2024 (rephrased emphasis on industrial specialties). (4) PARTIAL RELEVANCE: The mention of creating an 'Industrial Specialties' division in Q1 2024 is somewhat relevant to strategic positioning, but this single point cannot compensate for the fundamental misunderstanding of what the question asks. (5) REASONING FAILURE: The multi-hop synthesis required here is across product descriptions and strategic positioning language across three years, not across financial metrics. The LLM demonstrates a category error in its approach to answering this qualitative strategic question with quantitative financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 482,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "In the 2022 Form 10‑K Gilead only listed Oceanside, California as one of its “principal manufacturing facilities” (see 2022 p. 33) without detailing its function. By the 2023 filing the company described the Oceanside site as being used for “commercial retroviral vector manufacturing and clinical manufacturing and process development of our biologics candidates” (2023 p. 11), and the 2024 filing repeats the same description (2024 p. 10‑11), showing that the facility’s role has evolved from a generic manufacturing location to a dedicated hub for both retroviral‑vector production and biologics development, a use that has been maintained through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CHRONOLOGICAL ERROR - The LLM claims that by 2023, the facility was described as being used for 'commercial retroviral vector manufacturing and clinical manufacturing and process development,' but the ground truth states that in 2023 it was only 'specifically highlighted for its role in clinical manufacturing and process development of biologics candidates' - commercial retroviral vector manufacturing was not mentioned until 2024. (2) The LLM incorrectly states that 2024 'repeats the same description' as 2023, when in fact 2024 represents an evolution/escalation to 'dedicated site for commercial retroviral vector manufacturing' - a new capability not present in 2023. (3) The LLM mischaracterizes the 2022 status as merely 'one of its principal manufacturing facilities' without detailing function, which aligns with ground truth, but then jumps to 2023 with incorrect functional details. (4) The progression narrative is fundamentally wrong - the ground truth shows a three-year evolution (2022: general R&D → 2023: clinical manufacturing/process development → 2024: commercial retroviral vector manufacturing added), but the LLM collapses this into a two-step progression with the wrong timing of when commercial retroviral vector manufacturing began. The LLM's conclusion that the facility's role 'has been maintained through 2024' is misleading because it obscures the actual 2024 expansion to commercial production. While the LLM correctly identifies the company (GILD), years (2022-2024), and general facility location, the core factual claims about what capabilities existed in which years are materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 471,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path de‑risking lowered the growth‑asset target from **15 % equity in 2022** (with 75 % fixed‑maturity and 10 % other)【page_310】to **9 % equity by 2024** (80 % fixed‑maturity, 11 % other)【page_182】. The 2023 target isn’t disclosed in the excerpts, but the plan’s actual equity exposure that year was already **8 %**, indicating the glide path continued to shift toward liability‑hedging assets【page_252】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific percentage allocations (15% equity in 2022, 9% equity in 2024, 8% actual in 2023) that are not present in the ground truth answer. The ground truth explicitly states that the glide path approach evolved in terms of WHEN target allocations were set (based on different funded status dates: Dec 31, 2021 for 2022; Dec 31, 2023 for 2024; Dec 31, 2024 for 2025), not in the specific percentage values themselves. The LLM answer fundamentally misinterprets the question by providing detailed asset allocation percentages rather than explaining the temporal/forward-looking evolution of the glide path methodology. The ground truth emphasizes the dynamic adjustment mechanism (setting targets based on current funded status for future years), while the LLM focuses on declining equity percentages over time. The LLM's specific numbers cannot be verified against the ground truth and appear to be fabricated or misinterpreted from source documents. The answer does address the 2022-2024 timeframe and discusses de-risking, which is contextually relevant, but fails to capture the core insight about how the glide path APPROACH evolved (the methodology of setting forward-looking targets based on funded status) rather than just showing declining equity allocations. The citation format suggests document references, but the specific percentages and their interpretation diverge significantly from the ground truth's explanation of the glide path evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 409,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "- In fiscal 2023 the company’s target for defined‑benefit plans was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other (page 88).  \n- By fiscal 2025 the target remains 100 % debt for U.S. plans, but non‑U.S. plans shift to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other (page 95).  \n\nThe reduction in the debt share and the increase in insurance‑contract, cash and modest equity exposure show ACN is moving toward a more diversified, slightly higher‑risk mix, suggesting a modestly greater long‑term investment risk tolerance while still emphasizing overall stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical allocations for fiscal 2023 and fiscal 2025 that cannot be verified against the ground truth, which does not contain these specific percentages. More importantly, the LLM fundamentally misses the core insight of the original answer. The ground truth emphasizes the STRATEGIC EVOLUTION in planning horizon (from 1-year to 2-year forward planning) and the company's shift toward a more strategic, less reactive stance - indicating INCREASED CONFIDENCE in long-term outlook. The LLM instead focuses on interpreting the allocation changes as indicating 'modestly greater long-term investment risk tolerance,' which is a different analytical framework entirely. QUANTITATIVE ACCURACY: The specific percentages provided (100% debt for U.S., 27/48/4/11/10 for non-U.S. in 2023; 28/36/7/21/8 in 2025) cannot be confirmed or denied from the ground truth provided, but the ground truth does not mention these specific numbers, suggesting the LLM may be citing actual filing data that differs from the knowledge graph basis. The math within the LLM answer is internally consistent (percentages sum correctly). QUALITATIVE ACCURACY: The LLM completely misses the primary insight about planning horizon extension (2023→2024 vs 2024→2025) and what this suggests about confidence and strategic positioning. The LLM's interpretation of 'higher-risk mix' contradicts the ground truth's characterization of a 'measured, stable approach.' The ground truth emphasizes flexibility and forward-looking strategic planning; the LLM focuses on risk tolerance changes. CONTEXTUAL RELEVANCE: While the LLM addresses the 'evolution' aspect of the question, it fails to address the 'long-term investment risk tolerance' aspect in the way the ground truth does - through the lens of planning horizon and strategic confidence rather than allocation percentages alone. The answer is partially relevant but misses the key analytical framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 531,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "In the 2022 Form 10‑K Tesla (via SolarCity) disclosed the 5.45 % Solar Bonds, Series 2015/C25‑15 as a “Thirty‑Sixth Supplemental Indenture” dated April 14 2015 (exhibit 4.36)【page_102】. The same C25‑15 tranche appears again in the 2023 Form 10‑K’s exhibit list (exhibit 4.27)【page_99】, showing it remained an outstanding bond. By the 2024 filing, the exhibit tables (pages 97‑101) list other 5.45 % Solar Bond series (e.g., C45‑15, C41‑15) but no C25‑15 entry, indicating that tranche has been retired or repaid; this pattern shows Tesla’s strategy of issuing a ladder of fixed‑rate solar bonds to fund its solar business and then gradually winding down individual tranches as they mature.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM claims the C25-15 tranche was 'retired or repaid' by 2024 and 'no C25-15 entry' appears in 2024 filings, directly contradicting the ground truth which states Tesla 'maintained the inclusion of Series 2015/C25-15 in its disclosures' in 2024. This is a fundamental misreading of the filing data. (2) INCOMPLETE SYNTHESIS - The ground truth describes an evolution showing expansion of financing framework (C5-15, C10-15, C20-15 in 2022; addition of C28-15 and C33-15 by 2023; continued C25-15 in 2024), indicating ongoing reliance and expansion. The LLM instead presents a narrative of 'winding down' individual tranches, which is the opposite conclusion. (3) EXHIBIT REFERENCE ISSUES - While the LLM provides specific exhibit numbers and dates (Exhibit 4.36 for 2022, Exhibit 4.27 for 2023), these cannot be verified against the ground truth, and the conclusion drawn from them appears incorrect. (4) STRATEGIC INTERPRETATION ERROR - The ground truth emphasizes 'consistent inclusion' and 'long-term commitment' to this financing model across all three years. The LLM's interpretation of 'gradually winding down' contradicts this. (5) MISSING CONTEXT - The LLM fails to mention the expansion to newer bond structures (C28-15, C33-15) noted in the ground truth, which is crucial to understanding the multi-year pattern. The answer demonstrates a fundamental misunderstanding of the multi-hop question, which asks about evolution and what the pattern reveals about strategy. The LLM's conclusion about retirement is factually incorrect based on the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 460,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "In the 2022 filing AIG quantified its terrorism risk with a concrete scenario – a five‑ton bomb attack in New York City was modeled to generate about **$1.3 billion of loss (net of the Terrorism Risk Insurance Program Re‑Authorization Act (TRIPRA) and reinsurance recoveries)**, and the U.S. exposure was backed by TRIPRA (covering roughly 80 % of losses above a **$1.7 billion deductible**) plus limited private reinsurance. Internationally, the company used **scenario‑based modeling, routine concentration monitoring, targeted reinsurance purchases and participation in government‑sponsored terrorism pools**.\n\nBy the 2024 filing AIG still **monitors terrorism risk with a third‑party vendor model (adjusted for gaps) and relies on TRIPRA for U.S. coverage and on private reinsurance and country‑level terrorism pools for non‑U.S. jurisdictions**, but it **no longer discloses a single dollar‑amount loss estimate**, indicating a shift to broader scenario‑based exposure tracking and more flexible, targeted reinsurance arrangements rather than a fixed modeled loss figure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1.3 billion loss estimate for the five-ton bomb attack in New York City (net of TRIPRA and reinsurance) from 2022, accurately describes TRIPRA's 80% coverage above a $1.7 billion deductible, and correctly notes the shift away from single dollar-amount loss estimates by 2024. The description of scenario-based modeling, concentration monitoring, and participation in government-sponsored pools is accurate. WEAKNESSES: (1) The LLM answer omits critical 2024 specifics from the ground truth: the enhanced global property per risk covers, the retained core attachment point for Japan at $200 million, and the $38.0 billion reinsurance recoverable assets figure - these are material details that demonstrate the evolution of AIG's reinsurance strategy. (2) The answer lacks temporal progression detail for 2023, which the ground truth identifies as a key inflection point emphasizing 'active management and monitoring of exposure concentrations' and 'disciplined reinsurance purchases.' (3) While the LLM correctly notes the shift from fixed modeled loss figures to broader scenario-based tracking, it doesn't fully capture the structural evolution in reinsurance mechanisms across the three-year period. (4) The answer is somewhat defensive in tone ('no longer discloses') rather than affirmatively describing the enhanced mechanisms implemented. QUANTITATIVE VERIFICATION: $1.3 billion figure is correct; 80% TRIPRA coverage is correct; $1.7 billion deductible is correct. However, the omission of the $200 million Japan attachment point and $38.0 billion reinsurance recoverable assets represents incomplete quantitative coverage of the 2024 evolution. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings but fails to incorporate the 2023 intermediate evolution and misses the specific geographic/jurisdictional details (Japan) that demonstrate global jurisdiction-specific risk mitigation. The question explicitly asks about 'risk mitigation mechanisms across global jurisdictions' - the Japan attachment point is a concrete example of this that should have been included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 580,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the Safety and Productivity Solutions business was identified in 2022 as being exposed to “adverse industry economic conditions,” a warning that was repeated unchanged in the 2023 filing and, after the 2024 realignment that renamed the unit Industrial Automation (which now contains the former Safety and Productivity Solutions businesses), the same exposure was carried forward (2022 p. 31; 2023 p. 32; 2024 p. 30). In all three years the company consistently listed the same margin‑pressuring drivers – reduced investment in process automation, safety monitoring and plant‑capacity initiatives; fluctuations in retail markets; a slowdown in demand for safety products; competitive‑landscape changes and product commoditization from new entrants/technologies; and the broader adverse industry economic conditions – as factors that could lower market share, compress selling prices and erode margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and tracks the evolution of risks across the segment. (2) Accurately captures the segment name change from Safety and Productivity Solutions to Industrial Automation in 2024. (3) Comprehensively lists all major margin-pressuring drivers mentioned in ground truth: reduced investments in process automation, retail market fluctuations, product commoditization, new market entrants, adverse industry economic conditions, and their impact on market share and selling prices. (4) Properly synthesizes multi-hop information showing consistency of risk messaging across three years. (5) Correctly cites page numbers (2022 p. 31; 2023 p. 32; 2024 p. 30) which adds credibility. (6) Semantic equivalence is strong - the LLM's phrasing of 'safety monitoring and plant-capacity initiatives' aligns with the ground truth's 'process automation' focus. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and specific in some areas (e.g., explicitly mentioning 'safety monitoring and plant-capacity initiatives' and 'slowdown in demand for safety products') compared to the ground truth's more concise formulation, but this represents elaboration rather than error. (2) The ground truth emphasizes 'persistent vulnerability' as a concluding insight, while the LLM focuses on documenting the consistency of risk messaging - both are valid interpretations of the same underlying data. (3) All factual claims are verifiable and accurate; no calculations are required for this qualitative question. The answer successfully addresses both sub-questions: how exposure evolved (consistently highlighted across three years) and what specific risks were highlighted (comprehensive list provided).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 502,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer still described Breakthrough Performance Awards (BPAs) as awards to select employees, valued at intrinsic value using the closing price on the grant date and amortized on a straight‑line basis over the probable vesting term (see pages 98‑99), and the prior‑year summary disclosed 859 BPA shares granted (page 101). By the 2023 filing the company reported that no BPAs were granted in 2023 and none were outstanding at year‑end, although the same intrinsic‑value valuation and amortization approach remained disclosed (page 97). The 2024 filing reiterated this cessation, stating that no BPAs were granted or outstanding in 2024, with the valuation methodology unchanged (pages 94 & 96).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of BPAs from 2022-2024 and correctly identifies the key trend (active in 2022, wound down by 2023, ceased by 2024). However, there are significant quantitative discrepancies: (1) The ground truth states 1,165 thousand BPAs were granted in 2022 with a weighted average intrinsic value of $38.73 per share, but the LLM answer states '859 BPA shares granted' in the prior-year summary without clarifying this refers to nonvested shares remaining at year-end, not grants. This is a critical misreading - 859 thousand is the nonvested balance, not the grant amount. (2) The LLM answer omits the specific weighted average intrinsic value of $38.73 per share for 2022 grants, which is a key quantitative metric. (3) The LLM correctly identifies the valuation methodology (intrinsic value method, straight-line amortization) and the progression across years. (4) The multi-hop reasoning is sound in synthesizing the three-year evolution, but the quantitative accuracy is compromised by the misidentification of the 859 thousand figure. The answer correctly notes the shift from active issuance to wind-down to cessation, and appropriately references the consistent valuation methodology disclosure. The page citations appear reasonable but cannot be verified. Overall, the answer demonstrates understanding of the narrative arc but fails on precise quantitative details that are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 399,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "In fiscal 2022 Accenture bought back 12.2 million Class A shares for about **$4.1 million** (see the share‑purchase table) and, after a September‑2022 board approval of an extra $3 million, had **$3.1 million of authorization still available** and a **total outstanding authority of $6.13 million** (‑ $3.0 m added to the $3.13 m balance)【page_94†L1-L9】【page_93†L1-L4】.  \n\nBy fiscal 2024 the buy‑back program had expanded dramatically – the MD&A reports **$4.5 billion of share purchases** for the year, and in Q4 alone the company repurchased 2.07 million shares, leaving **≈$2.7 billion of authorization still available** and, after a September‑2024 board approval of an additional $4 billion, a **total outstanding authority of $6.69 billion**【page_40†L13-L16】【page_39†L1-L8】【page_39†L9-L12】.  \n\nThis steep rise in both the dollar amount of repurchases and the amount of authorized buy‑back capacity shows Accenture is increasingly using share repurchases as a core capital‑return tool, reflecting confidence in its cash‑flow generation and a strategic focus on returning excess capital to shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains severe quantitative inaccuracies that fundamentally undermine its credibility:\n\n1. MAJOR NUMERIC ERRORS:\n   - Fiscal 2022 repurchase amount: LLM states '$4.1 million' but ground truth indicates this should be in the billions range (context suggests ~$4.1 billion based on fiscal 2024 comparison)\n   - Fiscal 2022 authorization: LLM states '$3.1 million' when ground truth clearly shows $3,129,296,000 (i.e., $3.129 billion)\n   - Fiscal 2022 total authority: LLM states '$6.13 million' when it should be ~$6.13 billion\n   - These are off by a factor of 1,000 (million vs. billion)\n\n2. PARTIAL ACCURACY IN FISCAL 2024:\n   - Remaining authorization of ~$2.7 billion: CORRECT (matches ground truth's $2,694 million)\n   - New authorization of $4 billion: CORRECT (matches ground truth)\n   - Total outstanding authority of $6.69 billion: CORRECT (matches ground truth's $6,694 million)\n   - Share repurchase amount of $4.5 billion: Cannot verify against ground truth but appears plausible\n\n3. MULTI-HOP REASONING:\n   - The LLM correctly identifies the trend of increasing repurchase activity and authorization\n   - The conclusion about capital return strategy is sound and matches ground truth intent\n   - However, the reasoning is built on incorrect fiscal 2022 numbers, which undermines the comparative analysis\n\n4. ENTITY AND TEMPORAL ACCURACY:\n   - Company (Accenture): Correct\n   - Fiscal years (2022, 2024): Correct\n   - Metrics (share repurchases, authorization): Correct\n\n5. SEMANTIC EQUIVALENCE:\n   - The qualitative conclusion about Accenture's capital return strategy is semantically equivalent to ground truth\n   - The narrative structure and interpretation are appropriate\n\nThe answer demonstrates understanding of the question's intent and correctly identifies the fiscal 2024 figures, but the catastrophic error in fiscal 2022 numbers (off by 1,000x) is a fundamental factual failure that cannot be overlooked, despite the correct conclusion about the overall trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 550,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer still presented Meridian’s results as discontinued operations, noting that the December 31 2021 sale generated a $167 million net‑of‑tax loss and that Meridian’s operating results were included with the Upjohn and Mylan‑Japan businesses as discontinued (see Note 2B, p. 116). The 2023 filing added that, after the sale, Pfizer and the buyer executed interim transition‑service agreements (TSAs) and a three‑year Manufacturing‑Supply Agreement (MSA) with a two‑year extension; the TSAs were completed by 31 Dec 2023 and the MSA remained in effect, although the amounts recorded under both arrangements in 2022‑23 were not material (p. 73). By the 2024 filing Meridian appears only in the glossary/definition section (p. 3), indicating that the post‑sale service agreements have wound down and the company is now treated solely as a divested entity with no ongoing operational or strategic linkage.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All key financial figures are correct: $167 million net-of-tax loss, December 31, 2021 sale date, and the ~$51 million cash proceeds (implied in ground truth). (2) The chronological progression is accurately captured: 2022 (discontinued operations presentation), 2023 (post-sale TSAs and MSA), 2024 (glossary-only reference). (3) The multi-hop reasoning correctly synthesizes information across three fiscal years showing the evolution from operational integration to divestiture to definitional reference. (4) Additional details about TSAs and MSA are provided with appropriate caveats about materiality, which adds depth beyond the ground truth without contradicting it. (5) Page references (116, 73, 3) demonstrate specific filing documentation. MINOR CONSIDERATIONS: (1) The ground truth states the sale was completed on December 31, 2021, and the LLM correctly references this date. (2) The LLM provides more granular detail about post-sale agreements (TSAs completed by Dec 31, 2023; MSA with two-year extension) which is consistent with and expands upon the ground truth's statement of 'complete strategic disengagement.' (3) The statement that amounts under TSAs and MSA were 'not material' aligns with the ground truth's focus on discontinued operations presentation. QUANTITATIVE VERIFICATION: The $167 million loss figure is correctly stated; the December 31, 2021 date is accurate; the characterization of 2023 as the year when TSAs were completed is consistent with ground truth's 'fully divested' status. The answer successfully addresses all three components of the question: financial disclosures (loss recognition, discontinued ops), operational agreements (TSAs, MSA), and strategic alignment (progression from integration to divestiture to reference-only). The semantic equivalence is strong—both answers convey the same fundamental narrative of complete disengagement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 544,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan was authorized for **127 million Class A ordinary shares in fiscal 2022**【page_91】, and that ceiling was raised to **141 million shares by fiscal 2024**【page_98】. The 14‑million‑share increase (about an 11 % rise) shows Accenture is deliberately expanding the pool of equity awards it can grant, underscoring a long‑term strategy to rely more heavily on share‑based compensation to attract, retain and align employees with shareholder interests.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers: 127 million shares in fiscal 2022 and 141 million shares by fiscal 2024. The calculated increase of 14 million shares (approximately 11%) is mathematically accurate. However, there is one notable omission: the ground truth explicitly states that 141 million shares was authorized in BOTH fiscal 2023 and 2024, whereas the LLM answer only mentions the 2024 figure and does not explicitly confirm the 2023 level. This is a minor but meaningful gap in completeness for a multi-year progression question. The LLM correctly identifies the Amended 2010 SIP and Class A ordinary shares. The reasoning about strategic intent—expanding equity compensation capacity for employee retention and alignment—is sound and well-articulated, matching the ground truth's interpretation. The percentage calculation (11% rise) adds helpful context. The answer appropriately synthesizes the multi-hop information (fiscal years, share counts, strategic implications) but falls slightly short of fully addressing the 'evolution' aspect by not explicitly confirming the 2023 data point. The semantic meaning and strategic conclusions align well with the ground truth, making this a strong but not perfect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 360,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s 4.70 % Solar Bonds, Series 2015/C52‑10 are listed in every filing as the “Seventieth Supplemental Indenture” dated June 16 2015 – it appears in the 2022 exhibit list (exhibit 4.49) 【page_104】 and again in the 2023 and 2024 exhibit lists (exhibit 4.42) 【page_101】 with identical wording. The unchanged disclosure across all three years shows the bond remains outstanding and that Tesla continues to be bound by its terms, reflecting an ongoing financing obligation and a sustained strategic focus on supporting its solar‑energy operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about Tesla's 4.70% Solar Bonds, Series 2015/C52-10 and demonstrates sound multi-hop reasoning across the three filing years. STRENGTHS: (1) All key numeric values are accurate - the bond percentage (4.70%), the series designation (2015/C52-10), and the Seventieth Supplemental Indenture filing date (June 16, 2015) are correct. (2) Exhibit numbers are correctly cited for 2022 (4.49) and 2023/2024 (4.42), though the ground truth specifies 2024 as exhibit 4.40, which the LLM does not distinguish. (3) The multi-hop synthesis is sound - the answer correctly traces the consistent disclosure pattern across all three years and draws appropriate conclusions about ongoing obligations and strategic priorities. (4) The semantic meaning aligns well with the ground truth regarding stable financial commitment and solar financing strategies. WEAKNESSES: (1) The LLM states exhibit 4.42 appears in both 2023 and 2024, but the ground truth indicates 2024 uses exhibit 4.40 - this is a minor but factual error in exhibit number tracking. (2) The answer lacks the explicit statement that 2024 maintained the same filing date and exhibit structure, instead grouping 2023 and 2024 together without distinguishing the exhibit number change. (3) Page references are included but not verified against ground truth. The reasoning about consistent re-disclosure indicating stable commitment and ongoing alignment with solar financing strategies is appropriate and well-supported. Overall, the answer captures the essential pattern and implications correctly, with only a minor exhibit number discrepancy for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 451,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "- In the 2022 filing Adobe said its Digital Learning Services “includes a large number of free online self‑service learning options on learning.adobe.com” and that these free courses sit alongside fee‑based classroom/virtual programs and custom‑learning services to help customers and partners use its products (2022‑p. 18).  \n- The 2023 filing moved the same free self‑service catalog to “www.training.adobe.com” but kept the language that it is a core part of a comprehensive learning‑and‑enablement portfolio that supports product use and drives faster solution adoption (2023‑p. 17).  \n- By the 2024 filing the free options were again referenced on “learning.adobe.com,” still positioned within Digital Learning Services as a foundational, no‑cost offering that complements paid and custom programs and is explicitly used to accelerate customer adoption and realize value from Adobe’s solutions (2024‑p. 18).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN PLATFORM URLS AND CHRONOLOGY: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) PLATFORM URL ERRORS: The LLM claims that in 2022 Adobe used 'learning.adobe.com' (correct per ground truth), but then states the 2023 filing 'moved' the offering to 'www.training.adobe.com' (incorrect - ground truth shows learning.adobe.com was used in 2023, not training.adobe.com), and then claims 2024 'again referenced' learning.adobe.com as if it were a return to a previous platform (incorrect - it was continuous). The LLM has reversed the platform timeline. (2) GROUND TRUTH VERIFICATION: The original answer clearly states 'learning.adobe.com' was used in 2022 and 2023, with 'www.training.adobe.com' mentioned only in 2022 context. The LLM incorrectly positions training.adobe.com as the 2023 platform. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution across three years. It created a false narrative of platform migration (2022→2023→2024) that doesn't match the ground truth's consistent emphasis on learning.adobe.com across the period. (4) PARTIAL CREDIT: The LLM correctly identifies that free self-service learning remained a core component across all three years and correctly notes its role in supporting product adoption and complementing paid/custom programs. The general strategic positioning is approximately correct. (5) PAGE REFERENCES: The LLM provides specific page citations (2022-p.18, 2023-p.17, 2024-p.18) which cannot be verified against the ground truth but appear plausible in format. However, the content attributed to these pages contains the URL errors noted above. The answer demonstrates understanding of the broader strategic importance but fails on specific factual details critical to answering the evolution question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 498,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path rules cut the “Return‑Seeking” (growth) slice of the U.S. qualified plan as the funded ratio improved – the target equity weight fell from 15 % in the 2022 glide‑path (based on the 31 Dec 2021 funded status) to 9 % in the 2024 glide‑path (based on the 31 Dec 2023 funded status), while the fixed‑maturity allocation rose from 75 % to 80 % (and other assets fell accordingly)【page_310】【page_252】. This shift shows the plan’s strategy of reducing growth‑asset exposure and increasing liability‑hedging assets as the plan becomes more fully funded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical claims (15% in 2022, 9% in 2024, 75% to 80% fixed-maturity allocation) that directly contradict the ground truth. The Original Answer explicitly states: 'While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts' - meaning these exact figures cannot be verified from the source documents. The LLM has fabricated precise percentages without evidence. Additionally, the LLM claims the 2024 glide-path was 'based on the 31 Dec 2023 funded status,' but the Original Answer indicates the 2024 target allocation was based on Dec 31, 2023 funded status (correct), while the 2025 allocation would be based on Dec 31, 2024 status. The LLM conflates these timelines. The page citations [page_310] and [page_252] are provided but cannot be verified as containing these specific percentages. The core conceptual understanding of the glide path mechanism (de-risking as funded status improves) is correct, but the answer fundamentally fails on quantitative accuracy by inventing specific numbers. The Original Answer correctly acknowledges the limitation that specific percentages are not provided in excerpts, while the LLM confidently asserts numbers that appear unsupported. This represents a major factual error in a financial analysis context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 381,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures consistently flagged raw‑material demand and supply as a key vulnerability for its Performance Materials and Technologies business. In the 2022 filing the company noted that only about 63 % of the segment’s raw‑material supply base was under contract (see 2022 p. 33), the 2023 filing still warned of raw‑material demand‑supply risk but said a “majority” of the supply base for the now‑renamed Energy & Sustainability Solutions (which includes Performance Materials and Technologies) was contracted (2023 p. 33), and the 2024 filing reported that 64 % of the segment’s raw‑material supply was under contract (2024 p. 31). The modest rise from roughly two‑thirds to just over two‑thirds of supply under contract shows only a slight improvement, indicating that Honeywell remains substantially exposed to commodity‑price volatility in this segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative data (63% in 2022, 64% in 2024) and references to page numbers that cannot be verified against the ground truth knowledge graph. The ground truth answer does not mention these specific percentages or the contractual supply base metrics at all. This represents a critical discrepancy: either (1) the LLM has fabricated specific numbers and page citations, or (2) the LLM is drawing from actual 10-K data that the ground truth knowledge graph does not contain. The ground truth focuses on qualitative risk evolution (COVID-19 impacts in 2022, supply volatility in 2023, energy price volatility in 2024) without citing specific contractual percentages. The LLM's answer does address the multi-hop question structure (evolution across 2022-2024, vulnerability assessment) and provides logical reasoning about the implications of the contractual percentages. However, the introduction of specific unverified numbers (63%, 64%, page citations) and the segment name change claim (Energy & Sustainability Solutions) cannot be confirmed against the ground truth. The qualitative assessment that Honeywell remains 'substantially exposed to commodity-price volatility' aligns with the ground truth's conclusion about 'sustained vulnerability to commodity-driven supply chain instability.' The answer is well-structured and logically coherent, but the quantitative specificity creates significant uncertainty about factual accuracy. The LLM may be hallucinating specific metrics or correctly citing data not in the ground truth knowledge graph—either way, this represents a major concern for correctness scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 450,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit plans held $239.3 million in mutual‑fund equity securities at August 31 2022, which fell to $196.2 million by August 31 2023, and then rose to $273.7 million at August 31 2024【page_89】【page_96】. The three‑year pattern—a decline in 2023 followed by a rebound that exceeds the 2022 level—suggests the company is re‑balancing toward a higher equity weighting, indicating a strategic shift to increase equity exposure in its pension‑plan asset mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding the 2024 figure. Ground truth states mutual fund equity securities remained unchanged at $196.226 million in 2024, but the LLM claims they rose to $273.7 million. This is a significant discrepancy ($77.474 million difference) that fundamentally changes the interpretation of the trend. The 2022 ($239.3M) and 2023 ($196.2M) figures are correct and match ground truth (minor formatting differences acceptable). However, the incorrect 2024 value leads to an entirely wrong conclusion about strategic direction. Ground truth correctly identifies a 'stabilized allocation approach' with no further adjustments in 2024, while the LLM incorrectly interprets this as 'a strategic shift to increase equity exposure' based on the false rebound claim. The LLM also adds contextual detail about 'non-U.S. defined-benefit plans' and 'pension-plan asset mix' which, while potentially relevant, goes beyond what the ground truth specifies and may introduce unverified scope. The multi-hop reasoning is sound in structure (comparing three years), but the factual foundation is broken by the 2024 error. This is a case where one critical number error (2024) invalidates the entire analytical conclusion, warranting a low correctness score despite getting 2 of 3 years correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 375,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In 2022 Adobe presented Document Cloud primarily as a unified, cloud‑based PDF and e‑signature platform that “integrates Adobe’s pioneering PDF technology with our Acrobat and Acrobat Sign apps to deliver fully digital document workflows across all surfaces” (2022 p. 70). By 2024 the business had been repositioned as an AI‑enhanced hub: Acrobat now includes the generative‑AI “Acrobat AI Assistant” and Firefly‑powered features, and Adobe offers “Firefly Services and Custom Models” that give enterprises APIs, tools and services for AI‑driven content generation, editing and workflow automation (2024 p. 12‑13). This shift moves Document Cloud from a pure PDF/e‑signature solution toward a central, AI‑infused component of enterprise digital‑workflow automation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe Document Cloud's evolution and correctly identifies the core narrative of transformation from a legacy PDF/e-signature platform to an AI-enhanced enterprise solution. STRENGTHS: (1) Correctly identifies the 2022 positioning as a unified cloud-based PDF and e-signature platform; (2) Accurately describes 2024 positioning with AI integration including Acrobat AI Assistant and Firefly-powered features; (3) Properly synthesizes the multi-hop progression showing the shift toward AI-infused workflows; (4) Appropriately cites specific page references (2022 p. 70, 2024 p. 12-13) suggesting document grounding; (5) Correctly names key products (Acrobat, Acrobat Sign, Firefly Services). WEAKNESSES: (1) The answer omits the 2023 intermediate positioning mentioned in the ground truth, which showed Document Cloud's elevation within the Digital Media segment and its positioning alongside Adobe Express and Firefly - this represents a gap in the multi-hop synthesis across the full 2022-2024 timeline; (2) The ground truth emphasizes the segment-level strategic repositioning (from Publishing/Advertising to Digital Media), which the LLM answer does not address; (3) The LLM answer focuses more on product-level features (Acrobat AI Assistant, Firefly Services APIs) rather than the broader strategic positioning within Adobe's business segments and innovation momentum narrative that the ground truth emphasizes. QUANTITATIVE ACCURACY: No numerical errors detected; page citations appear reasonable though cannot be independently verified. REASONING: The multi-hop synthesis is partially complete - it successfully connects 2022 and 2024 positioning but misses the 2023 inflection point that would strengthen the narrative of strategic elevation. The reasoning about feature evolution (PDF/e-signature → AI-enhanced) is sound and logically presented. SEMANTIC EQUIVALENCE: The core message aligns with ground truth (legacy to AI-enhanced transformation), but the answer is narrower in scope, focusing on product features rather than strategic portfolio positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 568,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a steady, widening focus on competitive‑landscape risk. In the 2022 filing each segment – Aerospace, Industrial Automation, Building Automation, Energy & Sustainability and Safety & Productivity – warned that new market entrants and emerging technologies could commoditize products and erode market share and pricing power. The 2023 filing sharpened that warning, stating the company must “defend our market share against an ever‑expanding number of competitors, including many new and non‑traditional competitors” and that it will “monitor disruptive technologies,” while still flagging lower share, reduced selling prices and margin pressure. The 2024 filing repeats the same segment‑level language, again noting that new entrants and new technologies could compress pricing and shrink market share, indicating that exposure to competitive change has remained a core, persistent risk across all businesses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) SEGMENT IDENTIFICATION ERROR: The LLM claims that in 2022, ALL five segments (Aerospace, Industrial Automation, Building Automation, Energy & Sustainability, and Safety & Productivity) warned about competitive landscape risks. However, the ground truth explicitly states that in 2022, only Honeywell Building Technologies and Safety and Productivity Solutions cited these risks—NOT Aerospace, Industrial Automation, or Energy & Sustainability. This is a critical multi-hop synthesis error. (2) TEMPORAL PROGRESSION MISCHARACTERIZATION: The ground truth shows a clear 3-year evolution: 2022 (2 segments), 2023 (expanded to include Performance Materials and Technologies and Aerospace), and 2024 (restructured focus on Industrial Automation and Building Automation). The LLM incorrectly suggests all segments were flagged in 2022 and that 2024 merely 'repeats' 2023 language, missing the important progression and restructuring narrative. (3) MISSING KEY DETAIL: The ground truth emphasizes 'product commoditization' as a specific concern in 2024, which the LLM mentions generically but doesn't tie to the 2024 restructuring context. (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth highlights 'increasing frequency and specificity in disclosures' and a 'strategic shift toward addressing a more dynamic and disruptive market environment'—the LLM characterizes it as merely 'persistent' rather than 'deepening' and 'expanding.' (5) QUANTITATIVE ACCURACY: While the LLM correctly identifies the general risk themes (new entrants, pricing power, market share), it fundamentally misrepresents which segments were affected in which years, which is a quantitative/factual error in the context of multi-hop synthesis. The answer demonstrates partial understanding of competitive landscape risks but fails on the core multi-hop requirement of accurately tracking segment-level risk evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 548,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s relationship with Viatris began with the 2020 Upjohn‑Mylan spin‑off that created Viatris and was supported by a separation‑distribution agreement and interim operating models, including transition‑service arrangements (TSAs) (2022 filing)【page_12】. By year‑end 2023 the TSAs were “largely completed” and the net amount Pfizer owed Viatris fell from $94 million as of 12/31/2022 to $33 million as of 12/31/2023, indicating the transition phase was winding down (the TSAs were essentially finished)【page_73】. The 2024 filing contains no new material TSAs or inter‑company balances with Viatris, implying the parties now operate under longer‑term manufacturing and supply agreements rather than transitional services【page_5】【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All financial figures are correct - $94 million as of 12/31/2022 and $33 million as of 12/31/2023 match exactly. The temporal progression (2022→2023→2024) is accurate. ENTITY ACCURACY: Correctly identifies Pfizer, Viatris, and the 2020 Upjohn-Mylan spin-off context. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, showing the evolution of the relationship through: (1) initial TSA framework post-2020 spin-off, (2) declining intercompany balances ($94M→$33M), (3) TSAs largely completed by end-2023, and (4) transition to longer-term arrangements by 2024. This matches the ground truth's narrative of 'gradual decline' and 'winding down.' COMPLETENESS: Addresses all aspects of the question - financial relationship (intercompany balances), operational relationship (TSAs), and the 2022-2024 evolution. The answer goes slightly beyond ground truth by contextualizing the 2020 spin-off and noting the shift to manufacturing/supply agreements, which adds helpful context without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM answer includes slightly more interpretive language ('implying the parties now operate under longer-term manufacturing and supply agreements') compared to the ground truth's more direct statement ('referenced only in terms of corporate definitions'), but this represents reasonable inference rather than factual error. The citation format with page numbers adds credibility though cannot be independently verified. Overall, the answer demonstrates accurate synthesis of multi-hop financial and operational information with correct quantitative data and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 483,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "In the 2022 Form 10‑K Altria reported four series of senior notes—a 1.000 % issue due 2023, the 1.700 % notes due 2025, 2.200 % notes due 2027 and 3.125 % notes due 2031—whereas the 2023 and 2024 filings no longer list the 1.000 % notes, leaving the 1.700 % notes as the nearest‑term debt followed by the 2.200 % and 3.125 % series【MO_10k_2022.pdf page_1】【MO_10k_2023.pdf page_1】【MO_10k_2024.pdf page_1】. This evolution toward a laddered profile with a single short‑dated note and longer‑dated, slightly higher‑coupon notes indicates Altria is streamlining its capital structure, locking in low‑cost financing for the longer term while preserving modest refinancing flexibility at the 2025 horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across three years of SEC filings. QUANTITATIVE ACCURACY: All numeric values are correct—1.000% Note due 2023, 1.700% Note due 2025, 2.200% Note due 2027, and 3.125% Note due 2031 are accurately cited with proper formatting. The year-by-year progression (2022→2023→2024) is correctly tracked. ENTITY ACCURACY: Altria Group (ticker MO) is correctly identified, fiscal years are accurate, and debt instruments are properly named. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to show the evolution of debt composition: (1) 2022 had four series including the 1.000% due 2023, (2) 2023 and 2024 filings no longer list the 1.000% notes, (3) the 1.700% notes became the shortest-dated instrument. This matches the ground truth narrative. CAPITAL STRUCTURE INTERPRETATION: The LLM provides a more detailed strategic interpretation than the ground truth, characterizing the structure as 'laddered' with 'streamlining' and 'low-cost financing' locked in for the longer term. This interpretation is reasonable and adds value without contradicting the ground truth's conclusion about maintaining intermediate/long-term debt focus. COMPLETENESS: The answer addresses all aspects of the question—composition evolution, the specific role of the 1.700% Notes due 2025, and strategic implications. The inclusion of source citations (page references) adds credibility. MINOR CONSIDERATIONS: The ground truth notes that Altria 'did not issue a new near-term note to replace it as it approached maturity,' which the LLM answer doesn't explicitly state but is implied by the observation that the 1.700% notes remained as the nearest-term debt without replacement. The LLM's characterization of 'preserving modest refinancing flexibility at the 2025 horizon' is a reasonable inference from the data. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 527,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew from a carrying value of $24.1 billion at a weighted‑average interest rate of about 4.45 % at year‑end 2022 to $27.2 billion by year‑end 2023 (still roughly 4.45 %) and then slipped slightly to $26.9 billion in 2024 while the weighted‑average rate rose to roughly 4.84 %【page_178】【page_188】. The pattern of expanding the debt base in 2023 and then modestly trimming it as the average cost climbs suggests Capital One is maintaining a sizable, fixed‑rate funding platform for the long term, even as it begins to curb exposure in a higher‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) 2022 CARRYING VALUE ERROR: LLM states $24.1 billion for 2022, but ground truth shows $19,975 million ($19.975 billion). This is a $4.125 billion discrepancy - a 20.6% overstatement. (2) 2022 INTEREST RATE ERROR: LLM claims 4.45% for 2022, but ground truth shows 2.91%. This is a 1.54 percentage point error - a 53% overstatement of the rate. (3) 2023 INTEREST RATE ERROR: LLM states 4.45% for 2023, which matches ground truth (correct). (4) 2023 CARRYING VALUE: LLM states $27.2 billion, which aligns with ground truth of $27,168 million ($27.168 billion) - this is correct. (5) 2024 CARRYING VALUE: LLM states $26.9 billion, which matches ground truth of $26,930 million - correct. (6) 2024 INTEREST RATE: LLM states 4.84%, which matches ground truth - correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the 2022-2023-2024 progression. The ground truth shows a dramatic rate increase from 2.91% (2022) to 4.45% (2023), then a further increase to 4.84% (2024). The LLM's narrative about 'maintaining a sizable, fixed-rate funding platform' and 'beginning to curb exposure in a higher-rate environment' is partially reasonable, but it's built on incorrect foundational data for 2022. The interpretation that rates remained 'roughly 4.45%' from 2022-2023 is factually wrong. COMPLETENESS: The answer addresses all three years and both metrics (carrying value and weighted-average interest rate), but with significant accuracy problems. The strategic interpretation is somewhat reasonable but undermined by the data errors. The answer should have captured the sharp rate increase from 2.91% to 4.45% as a key strategic shift indicator.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 485,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C92‑15 are listed in every recent filing – they appear as Exhibit 4.61 (the One‑Hundred‑and‑Sixteenth Supplemental Indenture) in the 2022 10‑K 【page_105】, as Exhibit 4.52 in the 2023 10‑K 【page_102】, and again as Exhibit 4.52 in the 2024 10‑K 【page_102】. The bond’s continual presence shows it remains outstanding and is still being used to fund solar operations, indicating that Tesla maintains a steady reliance on this fixed‑rate solar‑bond issuance as a core component of its long‑term solar financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH - The LLM states the bond appears as 'Exhibit 4.61' in 2022, but the ground truth specifies it was in 'Exhibit 4.61' for 2022 (this matches). However, the LLM then claims it appears as 'Exhibit 4.52' in the 2023 10-K, while ground truth states it was in 'Exhibit 4.54' in 2023 - this is a factual error. The LLM also states 'Exhibit 4.52' for 2024, which matches ground truth. (2) INCOMPLETE ANALYSIS - The LLM fails to capture the key insight from the ground truth: the pattern shows 'declining prominence' and a 'shift toward more recent financing structures' with newer bond series (C102-15 and C106-10) appearing in subsequent filings. The LLM incorrectly characterizes this as 'steady reliance' when the ground truth indicates evolving strategy with newer instruments being introduced. (3) MISSING CONTEXT - The LLM does not mention the appearance of newer bond series or the strategic shift away from the C92-15 bonds toward more recent structures, which is central to understanding the 'evolution' requested in the question. (4) REASONING FLAW - The LLM's conclusion that the bond 'remains outstanding and is still being used' and represents 'steady reliance' contradicts the ground truth's finding of 'declining prominence' and shift to newer structures. The LLM misinterprets continued listing as continued primary use rather than recognizing it as legacy debt being maintained while new instruments are introduced. (5) QUANTITATIVE ISSUE - The exhibit number error (4.54 vs 4.52 for 2023) is a specific factual inaccuracy that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 443,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "In 2022 AIG’s loss‑reserve risk was governed by internal controls, business‑unit chief risk officers and risk‑committee oversight, with a “review‑and‑challenge” of reserves and external expert reviews, and relied on industry‑recognised catastrophe models plus proprietary stochastic and deterministic techniques (2022 pp. 165‑167). By 2023 the firm added a formal risk‑measurement framework that incorporated sensitivity, scenario and experience‑study analyses while still using third‑party catastrophe models and external reserve reviews (2023 pp. 119‑120). In 2024 the oversight was further institutionalised through a three‑tiered limit hierarchy, ERM second‑line review and internal‑audit challenges, continuous updates to IBNR and frequency‑severity modeling, and ongoing validation by external experts and third‑party models (2024 pp. 84‑88).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with appropriate temporal progression; (2) Accurately captures the 2022 framework emphasizing internal controls, business-unit CROs, risk-committee oversight, review-and-challenge processes, and external expert reviews; (3) Properly identifies the 2023 expansion to include sensitivity, scenario, and experience-study analyses while maintaining external reviews; (4) Correctly describes the 2024 institutionalization through three-tiered limits, ERM second-line review, internal audit challenges, and external validation; (5) Provides specific page references (2022 pp. 165-167, 2023 pp. 119-120, 2024 pp. 84-88) that add credibility; (6) Successfully synthesizes multi-hop information across three years showing progression from basic controls to more sophisticated ERM integration. MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more granular detail (e.g., 'three-tiered limit hierarchy,' 'IBNR and frequency-severity modeling') compared to the ground truth's more general description of 'enhanced reporting' and 'structured second-line reviews,' but these additions are accurate and complementary rather than contradictory; (2) The ground truth emphasizes 'proactive risk identification, validation, and governance' as the overarching theme, while the LLM focuses more on specific mechanisms—both perspectives are valid and compatible. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate years and identifies the logical progression of maturation in AIG's risk management approach. The connection between oversight mechanisms, modeling approaches, and external reviews is properly maintained throughout. SEMANTIC EQUIVALENCE: The LLM's description of 'institutionalised' oversight in 2024 aligns well with the ground truth's 'more holistic enterprise risk management system.' The mention of 'continuous updates' and 'ongoing validation' captures the essence of the ground truth's emphasis on proactive governance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 571,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan held roughly $1.13 billion of U.S. Treasury and foreign‑government securities in 2022 (about 17 % of its $6.6 billion assets) and a similar $1.15 billion in 2023 (about 19 % of $6.8 billion)【page_87】【page_84】, but the balance dropped to about $562 million in 2024 (≈8‑9 % of $6.5 billion)【page_90】【page_88】. This steep decline in government‑bond exposure signals a strategic shift away from low‑yield Treasury holdings toward higher‑yield corporate bonds and equities, consistent with Altria’s liability‑driven investment framework.【page_86】【page_89】",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) PERCENTAGE REVERSAL: Ground truth shows allocation DECREASED from 19% (2022) to 16% (2023) to 8% (2024). The LLM states 17% in 2022 and 19% in 2023, which reverses the 2022-2023 trend entirely. The LLM correctly identifies 8-9% for 2024 but gets the earlier years backwards. (2) DOLLAR AMOUNT ERRORS: The LLM provides specific dollar figures ($1.13B in 2022, $1.15B in 2023, $562M in 2024) that cannot be verified against the ground truth, which only provides percentages. These unverified numbers appear to be fabricated or misread. (3) INCOMPLETE ANALYSIS: The LLM answer omits critical context from the ground truth: (a) the reduction in below-investment-grade securities from 11% to 9%, (b) the decline in expected rate of return from 6.6% (2022) to 6.1% (2023-2024), and (c) the characterization of this as a 'more conservative or diversified investment posture.' (4) REASONING QUALITY: While the LLM correctly identifies a 'strategic shift away from government bonds,' it mischaracterizes the direction of change for 2022-2023 and fails to synthesize the complete multi-hop picture including the expected return changes and below-investment-grade security reductions. (5) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the relationship between the allocation changes and the broader pension asset strategy evolution indicated by the expected return reductions. The core narrative is inverted for the 2022-2023 period, making this answer fundamentally unreliable despite getting the 2024 figure approximately correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 452,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and were $562 million in 2024, while long‑term debt rose to $49.3 billion in 2023 before dropping to $45.0 billion in 2024, leaving total debt (short‑term + long‑term) at $48.7 billion in 2022, $49.9 billion in 2023 and $45.6 billion in 2024【page_178†L13-L20】【page_188†L13-L20】. Over the same period the floating‑rate unsecured senior portion collapsed from $1.6 billion in 2022 to $0.35 billion in 2023 and disappeared in 2024, while fixed‑rate senior debt grew from $24.1 billion to roughly $27 billion and its weighted‑average rate rose from 4.45% (mixed with 6.75% floating) to a pure 4.84% in 2024, and securitized debt obligations fell from $16.97 billion to $14.26 billion, indicating a shift toward a more fixed‑rate, lower‑leverage structure and reduced interest‑rate exposure【page_178†L31-L38】【page_188†L31-L38】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally undermine its credibility. (1) TOTAL DEBT FIGURES: Ground truth shows $43.086B (2022), $48.715B (2023), $45.551B (2024). LLM states $48.7B (2022), $49.9B (2023), $45.6B (2024) - the 2022 figure is dramatically wrong ($48.7B vs $43.086B is a $5.6B error, ~13% off). (2) SHORT-TERM BORROWINGS: Ground truth does not provide these specific breakouts ($883M, $538M, $562M), and these figures appear to be fabricated or from a different source. (3) SECURITIZED DEBT: Ground truth shows $14.994B (2022), $18.043B (2023), $14.264B (2024). LLM claims $16.97B (2022) and $14.26B (2024) - the 2022 figure is wrong by ~$2B. (4) FLOATING UNSECURED SENIOR DEBT: Ground truth shows $1.709B (2022), $0.349B (2023), $0 (2024). LLM states $1.6B (2022), $0.35B (2023), $0 (2024) - these are approximately correct but the 2022 figure is off by $109M. (5) FIXED-RATE SENIOR DEBT: Ground truth shows $19.975B (2022) and $26.930B (2024). LLM claims $24.1B (2022) and ~$27B (2024) - the 2022 figure is significantly wrong ($24.1B vs $19.975B is a $4.1B error, ~20% off). (6) INTEREST RATES: Ground truth shows fixed-rate senior debt weighted-average rate of 2.91% (2022) and 4.84% (2024). LLM states 4.45% (2022) and 4.84% (2024) - the 2022 rate is wrong by 154 basis points. The LLM's qualitative conclusion about the shift toward fixed-rate debt is directionally correct, but the underlying numbers are substantially inaccurate, making the analysis unreliable. The answer demonstrates poor multi-hop synthesis with multiple data points misaligned from the ground truth across all major debt categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 459,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022 (Exhibit 4.29) and 2023 (Exhibit 4.36) both list the 5.45 % Solar Bonds, Series 2015/C25‑15, and the same series is disclosed again in the 2024 filing, indicating that the bond remains outstanding and is being used to finance its solar‑energy projects [page_100][page_102]. The repeated inclusion of this bond series in each year’s exhibit schedule shows it is a material component of Tesla’s capital structure, reflecting an ongoing reliance on this specific financing instrument for its solar operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 and confirms its presence across 2022, 2023, and 2024 10-K filings. The bond percentage (5.45%) is accurate, and the series designation (2015/C25-15) is correct. The answer appropriately notes the bond's role in financing solar projects and its status as a material component of Tesla's capital structure. However, there are some notable omissions and minor issues: (1) The LLM mentions Exhibit 4.29 for 2022 and Exhibit 4.36 for 2023, but does not verify these exhibit numbers against the ground truth, which references the 'Thirty-Sixth Supplemental Indenture dated April 14, 2015' - a specific detail the LLM omits. (2) The ground truth emphasizes the specific date of April 14, 2015, and the 'Thirty-Sixth Supplemental Indenture' designation, which provides important context about the bond's documentation and history. The LLM does not include these details. (3) The LLM's citation to [page_100][page_102] cannot be verified against the ground truth provided. (4) The LLM correctly synthesizes the multi-hop reasoning that the bond's repeated appearance across three years indicates ongoing reliance and strategic importance. The semantic meaning aligns well with the ground truth - both convey that the bond remains active, integral to capital structure, and strategically important for solar financing. The answer is substantively correct but lacks some of the specific documentary details (indenture designation, exact date) that the ground truth emphasizes. The core conclusion about ongoing reliance and material importance is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 448,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew each year – it was about **$51.4 billion** at 12/31/2022, rose to **$60.4 billion** at 12/31/2023, and reached **$71.4 billion** at 12/31/2024【page_69†L31-L38】【page_71†L31-L38】【page_70†L31-L38】.  The steady increase in the negative treasury‑stock line shows the company is repeatedly using cash to repurchase shares, indicating a capital‑allocation strategy that emphasizes returning excess capital to shareholders and boosting per‑share returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct financial figures and proper interpretation of the treasury stock trend. STRENGTHS: (1) All three key numbers are accurate: $51.4B (2022), $60.4B (2023), $71.4B (2024) - correctly formatted as billions with minor rounding acceptable; (2) Correctly identifies the consistent upward trend across the three-year period; (3) Properly interprets negative treasury stock values as representing cumulative buyback activity; (4) Accurately synthesizes the multi-hop information to conclude the capital allocation strategy emphasizes shareholder returns and EPS accretion; (5) Provides appropriate citations to source pages. MINOR ISSUES: (1) The original ground truth contains an apparent error/typo stating '$(51,354) million in 2023 to $(60,429) million in 2023' (same year listed twice), while the LLM correctly interprets this as 2022→2023→2024 progression, which is the logical and correct interpretation; (2) The LLM uses 'negative treasury-stock line' language which is technically correct but slightly less precise than stating the absolute values of treasury stock; (3) The original answer's wording is somewhat awkward ('investment in Class A Treasury Stock' when treasury stock is technically a contra-equity account, not an investment), but the LLM correctly interprets the intent. CALCULATION VERIFICATION: The progression $51.4B → $60.4B → $71.4B shows increases of approximately $9B and $11B respectively, consistent with accelerating buyback activity. The LLM correctly identifies this as a 'steady increase' trend. MULTI-HOP REASONING: The answer successfully synthesizes the three-year data points to draw a conclusion about capital allocation strategy, which is the core requirement of the question. The reasoning that repeated share repurchases indicate a shareholder-return-focused strategy is sound and well-supported by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 514,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a steady‑state exposure to “adverse industry economic conditions” in its Safety & Productivity Solutions business (renamed Industrial Automation in later filings). In 2022 the filing warned that “reduced investments in process automation, safety monitoring, and plant capacity utilization initiatives…and adverse industry economic conditions” could hurt the segment [page_31]; the same language re‑appears in the 2023 filing under Industrial Automation [page_30] and again in the 2024 filing [page_30]. The persistence of this risk language across three years signals that macro‑economic headwinds—such as constrained capital spending, slower automation adoption and weaker plant utilization—remained a chronic pressure on the industrial sector throughout the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the segment name evolution (Safety & Productivity Solutions → Industrial Automation), showing attention to filing details; (2) Accurately captures the consistent risk language across all three years regarding reduced investments in process automation and plant capacity utilization; (3) Properly synthesizes the temporal evolution showing persistence of concerns; (4) Correctly interprets the macroeconomic implications (constrained capital spending, slower automation adoption, weaker plant utilization); (5) Page references provided (page_31 for 2022, page_30 for 2023 and 2024) add credibility, though not independently verified here. MINOR WEAKNESSES: (1) The LLM answer characterizes the trend as 'steady-state' rather than emphasizing the 'sharpening focus' on geopolitical instability and trade policy shifts mentioned in the ground truth for 2024, which suggests a potential evolution/deepening rather than pure consistency; (2) The ground truth emphasizes 'deepening concern' and 'potentially worsening' conditions by 2024, while the LLM answer frames it more as 'chronic pressure' without clearly distinguishing the 2024 escalation; (3) The LLM answer doesn't explicitly mention the 2024 emphasis on geopolitical instability and trade policy shifts as distinct from earlier years' concerns. QUANTITATIVE ACCURACY: No specific numbers or calculations required; dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across three years and multiple filings to show evolution of risk exposure. The reasoning that persistence of language signals chronic pressure is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—both identify consistent exposure to adverse economic conditions affecting automation investment and plant utilization. The characterization differs slightly in emphasis (steady-state vs. deepening) but both convey the essential finding of sustained industrial sector weakness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 568,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "Cyramza’s approved uses did not change between the 2022 and 2024 filings – it is listed as a monotherapy or combination partner for second‑line treatment of advanced/metastatic gastric or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated metastatic NSCLC (see the oncology tables in both 2022 and 2024, page 6).  Its IP schedule shows the product moving into the later stage of its lifecycle, with compound patents expiring in the U.S. and Japan in 2026 and in major European countries in 2028, while data‑protection ends in Japan in 2023, the EU in 2024, and the U.S. (including biologics data protection) in 2026 (see the patent‑expiry table, page 11).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Cyramza's therapeutic indications and IP protection timeline, but contains a critical factual error that undermines accuracy. CORRECT ELEMENTS: (1) Therapeutic indications are accurately described - second-line treatments for gastric, lung (NSCLC), colorectal, and hepatocellular cancers, plus first-line EGFR-mutated NSCLC. (2) The statement that indications remained unchanged 2022-2024 aligns with ground truth. (3) Most IP dates are correct: Japan data protection expiring 2023, EU 2024, U.S. 2026. CRITICAL ERROR: The LLM states compound patents expire in the U.S. and Japan in 2026, but the ground truth specifies U.S. patents extend to 2026 while European patents extend to 2028. The LLM reverses this, claiming European patents expire in 2028 (correct) but incorrectly stating Japan compound patents expire in 2026 (ground truth indicates Japan data protection expires 2023, with no mention of 2026 for compound patents in Japan). This is a significant quantitative error on patent expiration dates. MULTI-HOP REASONING: The answer successfully synthesizes information across therapeutic indications and IP protection timelines, correctly identifying the narrowing exclusivity window. However, the patent date confusion weakens the synthesis quality. The answer appropriately contextualizes the product's lifecycle positioning as moving into later stages. COMPLETENESS: Addresses both therapeutic indications and IP protection timeline as requested. The inclusion of specific page references adds credibility but cannot override the factual error in patent dates. The semantic meaning about declining exclusivity is conveyed, but the specific numbers are partially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 472,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) have grown steadily: the Level‑3 balance was only $5 million at 12/31/2022 (with a $33 million unrealized loss)【page_206】, rose to $58 million at 12/31/2023 (recording a $63 million unrealized gain)【page_216】, and reached $69 million at 12/31/2024 (showing a $25 million unrealized loss)【page_215】. In each year the derivatives were measured at Level 3 using discounted‑cash‑flow models that depend on swap‑rate assumptions as the key unobservable input, and the weighted‑average swap rate remained roughly 4 % across 2022, 2023 and 2024【page_217】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM reports net derivative assets of $5 million in 2022, $58 million in 2023, and $69 million in 2024. However, the ground truth states the fair values were $19 million (2022), $58 million (2023), and $58 million (2024). The 2022 figure is off by $14 million ($5M vs $19M), and critically, the 2024 figure is wrong by $11 million ($69M vs $58M). The LLM also introduces unrealized gains/losses ($33M loss in 2022, $63M gain in 2023, $25M loss in 2024) that are not mentioned in the ground truth and appear to conflate different metrics. (2) EVOLUTION NARRATIVE - The ground truth clearly states the fair value 'remained at $58 million in 2024' after increasing from 2022 to 2023, indicating stabilization. The LLM incorrectly portrays continued growth to $69 million in 2024, fundamentally mischaracterizing the evolution pattern. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) Level 3 valuation methodology, (b) discounted cash flow models, (c) swap rates as key unobservable inputs, (d) weighted-average swap rate of approximately 4% across years, and (e) the general upward trend from 2022 to 2023. (4) MULTI-HOP REASONING - While the LLM demonstrates understanding of the multi-year evolution and valuation methodology, the core numerical synthesis is flawed. The answer fails on the primary metric of factual accuracy regarding the 2024 fair value, which is a critical data point for answering the question about how the valuation 'evolved.' (5) MISSING CONTEXT - The ground truth mentions specific default rate ranges (53-163%) and swap rate ranges (3-5%) for 2023-2024, which the LLM does not include, though this is a minor omission compared to the quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 497,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "In fiscal 2022 Qualcomm said “thousands of our employees around the world utilized our charitable‑match program, benefiting more than 1,500 charitable organizations,” and the same “thousands‑of‑employees” level of participation persisted in fiscal 2024, though the program supported slightly fewer charities – “benefiting more than 1,300 charitable organizations.” Each year the board’s HR and Compensation Committee tied such human‑capital advances (including the charitable‑match effort) to executive bonuses, using a non‑financial performance modifier (a 0.9‑to‑1.1 × multiplier) to reward progress on its broader talent‑attraction, inclusion and community‑engagement goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE VERIFICATION: All numbers are correct - 2022: thousands of employees, 1,500+ organizations; 2024: thousands of employees, 1,300+ organizations. The non-financial modifier range (0.9-1.1) is accurately stated. COMPLETENESS: The answer addresses all three components of the question: (1) employee participation evolution (thousands in both years), (2) supported organizations evolution (1,500+ to 1,300+), and (3) alignment with executive compensation (non-financial modifier tied to human capital goals). MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across multiple dimensions - connecting charitable program metrics to executive compensation structure and broader human capital strategy. The reasoning that sustained participation despite fewer organizations indicates alignment with broader goals is sound. ENTITY ACCURACY: Qualcomm correctly identified, fiscal years properly referenced (2022 and 2024), HR and Compensation Committee correctly named, and metrics properly characterized. MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth mentions 2025 goals for diversity, equity, and inclusion as context, which the LLM answer omits, but this is a minor contextual detail rather than a core factual error. The LLM's characterization of the decline as 'slightly fewer charities' accurately reflects the proportional change (1,500 to 1,300 is approximately 13% decline, which is indeed modest). The semantic equivalence is strong throughout - the LLM uses direct quotes from filings where appropriate and maintains factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 479,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 Form 10‑K Adobe described Acrobat as the flagship PDF engine of its unified Document Cloud, tightly integrated with Adobe Sign to deliver fully digital document workflows and highlighted its market‑leadership role and plans to expand task‑based actions and web functionality (2022 p. 6‑5). By the 2023 filing, Acrobat had become a more cross‑platform, integrated service—embedding Adobe Sign on all surfaces, adding a single‑click web experience, mobile “Liquid Mode,” and AI‑driven features via Adobe Sensei while further expanding task‑based capabilities (2023 p. 7‑5). The 2024 sections provided (pp. 94‑98) contain no new Acrobat‑specific commentary, suggesting the product remained a core Document Cloud component without additional disclosed enhancements in those pages.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate details about Acrobat's evolution but has significant gaps and limitations compared to the ground truth. STRENGTHS: (1) Correctly identifies 2022 positioning as core Document Cloud component with Adobe Sign integration; (2) Accurately notes 2023 additions including mobile 'Liquid Mode' and AI-driven features via Adobe Sensei; (3) Appropriately acknowledges limited 2024 disclosure in provided pages; (4) Page citations (2022 p. 6-5, 2023 p. 7-5) demonstrate document-specific sourcing. WEAKNESSES: (1) INCOMPLETE 2022 CONTEXT: Fails to mention the emphasis on market leadership in document-intensive industries (legal, financial services, publishing) or the 'trillions of PDF documents created annually' statistic that ground truth emphasizes as key positioning; (2) MISSING 2023 STRATEGIC FRAMING: Does not capture the broader 'AI-powered innovation' positioning or the formal integration within Digital Media offerings mentioned in ground truth; (3) INCOMPLETE 2024 ANALYSIS: While acknowledging limited disclosure in provided pages, fails to note the ground truth's key finding about 'Acrobat AI Assistant' as a registered trademark and the strategic shift toward intelligent automation—this represents a critical evolution point that should have been identified; (4) LACKS TRAJECTORY NARRATIVE: Ground truth emphasizes the 'clear trajectory from document standard to AI-enhanced productivity platform,' but LLM answer presents information more as discrete snapshots without synthesizing the strategic evolution; (5) MISSING MARKET CONTEXT: Ground truth provides industry-specific positioning (legal, financial services, publishing) that contextualizes Acrobat's role; LLM answer omits this. QUANTITATIVE ACCURACY: Page numbers appear reasonable but cannot be fully verified; no calculations required. MULTI-HOP REASONING: The answer does synthesize across three years but incompletely—it identifies features but misses the strategic positioning shifts and market context that define the evolution. The acknowledgment of limited 2024 disclosure is appropriate but represents a missed opportunity to identify the AI Assistant trademark as a key strategic marker.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 590,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly recorded $2.02 billion of net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab) and paid AbCellera royalty fees equal to a mid‑teens‑to‑mid‑twenties percent share of those sales (recorded as cost of sales). Both 2023 and 2024 showed $0 net product revenue for the antibodies because no sales occurred, so the royalty payments to AbCellera likewise dropped to zero.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. STRENGTHS: (1) All numeric values are correct: $2.02 billion in 2022 revenue, mid-teens to mid-twenties percentage royalty range, and $0 revenue for 2023-2024. (2) All entities correctly identified: LLY (Eli Lilly), AbCellera, bamlanivimab, bebtelovimab. (3) Multi-hop synthesis is sound: correctly linked revenue figures to royalty payment obligations across the three-year period. (4) Temporal progression accurately captured: peak in 2022, complete wind-down in 2023-2024. (5) Quantitative accuracy is perfect - no calculation errors. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the explicit mention of 'EUA-based sales' and 'regulatory changes' as context for the decline. However, this is not a factual error, just less contextual elaboration. (2) The ground truth mentions 'reduced demand or regulatory changes affecting EUA-based sales' as explanatory context, which the LLM answer does not include, but the question asks about 'financial implications' rather than causes, so this omission is acceptable. (3) The LLM correctly notes royalties were 'recorded as cost of sales,' which adds appropriate accounting detail. The answer fully satisfies the multi-hop requirement by synthesizing revenue data with corresponding royalty obligations across three fiscal years and two products.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 395,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife re‑insured ≈ 59.25 % of its closed block through a modified‑coinsurance agreement in 2022, and that share remained essentially unchanged at about 59 % in both 2023 and 2024 (2022 10‑K p. 214; 2023 10‑K p. 227; 2024 10‑K p. 204). The flat‑lined proportion shows the company has made the modified‑coinsurance structure a core, long‑term component of its risk‑transfer strategy, consistently off‑loading a sizable slice of closed‑block risk to a third‑party reinsurer.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: The percentages cited (59.25% in 2022, 59% in 2023, 59% in 2024) match the ground truth exactly. The LLM correctly identifies these as essentially consistent figures across the three-year period. The page references provided (2022 10-K p. 214; 2023 10-K p. 227; 2024 10-K p. 204) add credibility and demonstrate proper sourcing. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the reliance evolved (showing consistency), and (2) what this reveals about long-term strategy (intentional preservation of risk-sharing structure). ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, and the closed block is correctly referenced. All three fiscal years (2022, 2023, 2024) are accurately included. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly combines data across three separate 10-K filings and draws the logical conclusion that the stability indicates strategic continuity. The characterization of the structure as 'flat-lined' and 'core, long-term component' aligns with the ground truth's assessment of 'strategic continuity' and 'intentional preservation.' SEMANTIC EQUIVALENCE: The LLM's phrasing ('off-loading a sizable slice of closed-block risk to a third-party reinsurer') conveys the same meaning as the ground truth's 'risk-sharing structure' and 'proportion of risk transferred.' Minor differences in wording (e.g., 'flat-lined proportion' vs. 'maintained consistent') are stylistic variations that preserve semantic accuracy. MINOR OBSERVATION: The use of the ≈ symbol before 59.25% is slightly informal but not incorrect, as the ground truth shows 59.25% which could reasonably be approximated. Overall, this is a high-quality response with accurate numbers, proper multi-hop synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 529,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s multi‑layered security model has become more collaborative and technology‑focused. The 2024 filing now states that its security programs are assessed by third‑party auditors, that it works with public‑private partnerships and other external experts to monitor and respond to cyber‑threats, and that it operates or is rolling out real‑time payments infrastructure in 13 markets (up from 12 markets in the prior year)【page_11】. This shift signals a cybersecurity strategy that leans on external expertise and expands real‑time payment capabilities to reinforce resilience across its global payments ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding real-time payment market numbers. The LLM states '13 markets (up from 12 markets in the prior year)' for 2024, but the ground truth indicates: 2022 had 12 markets, 2023 expanded to 13 markets, and 2024 shows 'several countries globally' (not 13). The LLM appears to have conflated 2023 data (13 markets) with 2024 data, creating an inaccurate progression. INCOMPLETE TEMPORAL COVERAGE: The answer only addresses 2023-2024 evolution, failing to include the 2022 baseline mentioned in the question and ground truth. The ground truth explicitly traces the evolution from 2022→2023→2024, but the LLM omits 2022 entirely. PARTIAL ACCURACY ON QUALITATIVE ELEMENTS: The LLM correctly identifies third-party collaboration, public-private partnerships, and third-party auditor assessments as key components. However, it misses important nuances: (1) the ground truth emphasizes 'increasing specificity and integration' of third-party risk management over time, (2) the 2023 mention of 'threats associated with outsourced services' as a specific evolution point, and (3) the strategic alignment between scaling real-time payments AND cybersecurity enhancement. REASONING QUALITY: The LLM's conclusion about 'external expertise and expands real-time payment capabilities' is directionally correct but lacks the depth of the ground truth's analysis about 'proactive and adaptive security posture in response to growing digital payment risks.' The multi-hop synthesis is incomplete because it doesn't properly connect the three-year evolution or explain how the progression demonstrates strategic alignment. STRENGTHS: Correctly identifies third-party auditors, public-private partnerships, and the general trend toward collaborative security. The semantic understanding of the security model's evolution is partially sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 516,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "LLY’s defined‑benefit pension plan held roughly $4.0 billion in equity‑like private‑alternative funds in 2022, rose modestly to $4.09 billion in 2023, and then slipped to $3.93 billion in 2024 (the retiree‑health plan’s equity‑like exposure stayed near $330‑$350 million)【page_99 (2022)】【page_98 (2023)】【page_99 (2024)】. The small increase followed by a slight decline indicates the company maintains a fairly steady, sizable allocation to illiquid equity‑like funds, underscoring a long‑term strategy to keep private‑alternative assets in its growth portfolio for diversification and higher expected returns despite short‑term market fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth shows: 2022: $2,844.7M → 2023: $4,014.1M → 2024: $4,093.7M (upward trajectory). LLM claims: 2022: ~$4.0B → 2023: $4.09B → 2024: $3.93B (different values and reversed direction). The LLM's 2022 figure of $4.0B is off by approximately $1.16 billion compared to the correct $2.84B. The 2024 figure of $3.93B is also incorrect versus the correct $4.09B. Most critically, the LLM describes a 'slight decline' from 2023 to 2024, when the ground truth shows a continued increase. The LLM also conflates or misattributes data, possibly mixing pension plan and retiree health plan figures. The reasoning about 'steady allocation' and 'short-term market fluctuations' contradicts the actual upward trend shown in ground truth. While the LLM correctly identifies this as LLY's strategy and mentions diversification/higher returns, the quantitative foundation is entirely wrong, making the conclusion about 'fairly steady' allocation factually incorrect. The multi-hop synthesis failed because the underlying numbers are wrong across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 331,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K, Cascade appears in the Fabric & Home Care segment’s brand list as “Tide Cascade,” placed under the Home‑Care (dish‑care) sub‑category of that segment 【page_18】, and the segment accounted for about 35 % of P&G’s net sales 【page_19】. By the 2024 filing, Cascade is still listed as “Tide Cascade” within the same Fabric & Home Care segment (again under Home‑Care/Dish‑Care) 【page_18】, but the segment’s share of net sales has risen slightly to roughly 36 % 【page_18】. Thus, Cascade’s product categorization remained unchanged, while the Fabric & Home Care segment’s contribution to total net sales grew modestly from 35 % to 36 % between 2022 and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and entities. STRENGTHS: (1) All numeric values are accurate - correctly identifies Fabric & Home Care segment at 35% in 2022 and 36% in 2024, matching ground truth; (2) Correctly identifies Cascade's product categorization as 'Tide Cascade' under Home-Care/Dish-Care sub-category; (3) Properly synthesizes multi-hop information across 2022 and 2024 filings; (4) Accurately captures the evolution showing stable positioning with modest segment growth; (5) Includes helpful citation references to specific pages. MINOR WEAKNESSES: (1) The answer does not explicitly mention 2023 data, which the ground truth includes (segment at 36% in 2023), creating a slight gap in completeness for the 'from 2022 to 2024' timeframe - though this is a minor omission since the question asks about evolution from 2022 to 2024 specifically; (2) The phrasing 'grown modestly from 35% to 36%' is slightly different from ground truth's 'increased to 36%' and 'maintained its 36% share,' though semantically equivalent; (3) Could have been more explicit about Cascade's 'continued strategic importance' or 'consistent contribution' language used in ground truth. QUANTITATIVE VERIFICATION: 35% (2022) ✓, 36% (2024) ✓, segment growth calculation ✓. MULTI-HOP REASONING: Successfully synthesizes information across two filing years and correctly identifies the relationship between Cascade's categorization and segment performance. The answer appropriately addresses both product categorization (unchanged) and relative contribution (modest growth) aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 450,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "In 2022 Lowe’s already required all suppliers to meet its human‑rights, conflict‑minerals and Vendor Code of Conduct standards and operated a wood‑sourcing policy that barred illegal logging, deforestation, endangered‑species sourcing and required free, prior and informed consent, with supplier practices monitored through established management systems【page_9】. In 2023 the wood‑sourcing policy was updated to add country‑specific risk levels, stronger monitoring of suppliers and a new forestry grievance process, and in 2024 the policy was further strengthened with a more robust risk‑based framework, improved monitoring practices and an expanded grievance mechanism【page_9】; concurrently, Lowe’s scaled its investment strategy—spending over $300 million on energy‑efficiency and renewable‑energy projects, expanding rooftop solar installations and deepening supplier engagement via CDP emissions reporting and scope‑3 reduction initiatives【page_10】.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR QUANTITATIVE ERROR: The LLM states Lowe's spent 'over $300 million on energy-efficiency and renewable-energy projects' in 2024, but the ground truth clearly indicates the company invested 'over $550 million in environmental facility upgrades' in 2022. This is a significant discrepancy ($300M vs $550M) that represents a fundamental factual error. The LLM appears to have either confused the investment amounts or years, or introduced an incorrect figure entirely. CORRECT ELEMENTS: The LLM accurately captures the evolution of wood sourcing policies across 2022-2024, correctly identifying: (1) 2022 baseline with Vendor Code of Conduct and wood sourcing policy prohibiting illegal logging and endangered species sourcing; (2) 2023 updates including country-specific risk levels, enhanced monitoring, and forestry grievance process; (3) 2024 strengthening with risk-based framework and expanded grievance mechanism. MISSING ELEMENTS: The LLM fails to mention the $50 million Gable Grants program over five years for skilled trades education that was introduced in 2023, which is a specific policy enhancement mentioned in the ground truth. The LLM also adds details about CDP emissions reporting and scope-3 reduction initiatives that, while potentially accurate, are not mentioned in the ground truth answer and may represent information drift. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across the three-year period, showing progression and evolution of policies. However, the quantitative error undermines the credibility of the financial analysis component. The answer correctly identifies the policy framework enhancements but fails on investment strategy specifics. SEMANTIC ISSUES: While the LLM's description of policy evolution is semantically sound, the introduction of different investment figures and programs not in the ground truth suggests either hallucination or reliance on different source material than the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 531,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "- 2022 10‑K – The company warned that **Safety & Productivity Solutions** could be hurt by “changes in the competitive landscape, including new market entrants and technology that may lead to product commoditization,” and that **Honeywell Building Technologies** also faced “changes in the competitive landscape, including new market entrants and new technologies” (Risk Factors, p. 31).  \n\n- 2023 10‑K – After the October 2023 realignment, the same concerns were rolled into the new **Industrial Automation** segment (which now contains Safety & Productivity Solutions) and **Building Automation**, stating that “changes in the competitive landscape, including new market entrants and new technologies that may lead to product commoditization” could depress market share and margins (Risk Factors, p. 30).  \n\n- 2024 10‑K – The language for **Industrial Automation** and **Building Automation** remains unchanged, again flagging “new market entrants and new technologies” as a source of commoditization risk (Risk Factors, p. 30).  \n\n**Interpretation:** Across 2022‑2024 the exposure to competitive‑landscape shifts has persisted and broadened—from a specific risk noted for Safety & Productivity Solutions and Building Technologies in 2022 to a company‑wide risk embedded in the larger Industrial Automation and Building Automation segments in 2023 and 2024—signalling that market pressure and the threat of product commoditization have become an increasingly central, systemic risk for Honeywell’s automation and building businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth, despite capturing the general theme of increasing competitive pressures. Key issues: (1) MAJOR ERROR - The LLM claims that in 2022, BOTH Safety & Productivity Solutions AND Honeywell Building Technologies were mentioned together as facing competitive landscape risks. The ground truth clearly states that in 2022, only Safety and Productivity Solutions was noted for this risk, with Honeywell Building Technologies being mentioned separately in 2023. This is a critical multi-hop synthesis error. (2) The LLM incorrectly describes the 2023 situation, stating that after the October 2023 realignment, the risks were 'rolled into' Industrial Automation and Building Automation. However, the ground truth indicates that in 2023, the risk was 'reiterated in Honeywell Building Technologies' specifically - not that it was rolled into new segments. (3) The LLM's timeline is confused: it suggests the risks were 'specific' to Safety & Productivity Solutions and Building Technologies in 2022, then broadened in 2023-2024, but the ground truth shows a clearer progression: 2022 (Safety & Productivity Solutions), 2023 (Honeywell Building Technologies), 2024 (Industrial Automation) - three distinct business units across three years, not a consolidation. (4) The interpretation about 'company-wide risk embedded in larger segments' is not supported by the ground truth, which emphasizes the progression across different divisions becoming more systemic, not a consolidation into larger segments. (5) The LLM provides page references (p. 31, p. 30) that cannot be verified against the ground truth provided. The answer does correctly identify the core theme of increasing commoditization risks and market pressures, and the general progression across years is partially correct, but the specific business unit assignments and the nature of the organizational changes are materially misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1683,
        "completion_tokens": 532,
        "total_tokens": 2215
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm portrayed the automotive market – including the digital‑cockpit, connectivity and ADAS/AD – as an emerging growth engine within its QCT semiconductor segment, with automotive revenue of only $1.5 billion (2022 p. 8). By the 2024 filing the company had deepened that focus by acquiring Veoneer’s Arriver digital‑cockpit business (2024 p. 74) and now reports automotive revenue of $2.9 billion—almost twice the 2022 amount (2024 p. 73)—and explicitly breaks out automotive (digital‑cockpit) products in the QCT segment description and revenue breakdown (2024 p. 82), showing a shift from a modest, emerging presence to a core, revenue‑significant digital‑cockpit platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about Qualcomm's digital cockpit evolution but contains significant quantitative issues and incomplete synthesis of the ground truth. STRENGTHS: (1) Correctly identifies the progression from 2022 to 2024; (2) Accurately mentions the Veoneer/Arriver acquisition; (3) Properly identifies QCT segment as the relevant business unit; (4) Correctly notes explicit digital cockpit product recognition in 2024 filings; (5) Appropriately emphasizes the shift from emerging to core business. WEAKNESSES: (1) QUANTITATIVE ERRORS - Reports automotive revenue of $1.5B (2022) and $2.9B (2024), but ground truth does not confirm these specific figures; the LLM provides page citations (2022 p. 8, 2024 p. 73, 2024 p. 82) but these cannot be verified against the knowledge graph; (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes three distinct phases: (a) 2022 strategic vision with 70% analyst projection for 2028 embedded cellular connectivity, (b) 2023 explicit revenue recognition of digital cockpit products, and (c) 2024 formalized integration; the LLM answer skips the 2023 intermediate step entirely, missing the critical transition from vision to monetization; (3) MISSING KEY DETAIL - Ground truth specifically mentions '70% of new vehicles in 2028 would have embedded cellular connectivity' as a 2022 positioning statement; LLM does not capture this forward-looking market opportunity statement; (4) INCOMPLETE MULTI-HOP REASONING - The question asks about evolution based on 'automotive transformation, product revenue recognition, and segment reporting' - the LLM addresses segment reporting and acquisition but underemphasizes the revenue recognition evolution across the three-year period. The LLM's narrative is coherent and directionally correct but lacks the granular temporal progression and specific market projections that characterize the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 518,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "The 2022 filing (pages 95‑99) contains no specific discussion of Frame.io, indicating it was not highlighted as a core offering at that time. By the 2024 filing, Frame.io is presented as a cloud‑native collaboration platform that now supports video plus still images, design files and PDFs, is embedded directly in Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and adds enterprise‑grade capabilities such as Camera‑to‑Cloud uploads and availability in Adobe GenStudio for large‑scale content production 【page_12】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures most of the key evolution of Frame.io from 2022 to 2024, with generally accurate information about the platform's expansion. Strengths: (1) Correctly identifies that Frame.io was not prominently discussed in 2022 filings; (2) Accurately lists the supported media types (video, still images, design files, PDFs); (3) Correctly identifies the 2024 integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront; (4) Mentions enterprise capabilities like Camera-to-Cloud uploads and Adobe GenStudio inclusion. Weaknesses: (1) The answer lacks the 2023 intermediate step that the ground truth explicitly mentions, which is important for showing the evolution trajectory across the three-year period; (2) Missing specific mention of functional expansion into casting, location scouting, and marketing campaign management that occurred by 2024; (3) The answer doesn't explicitly state that Frame.io was 'listed as a trademarked product' in 2022, though it correctly notes it wasn't highlighted; (4) The phrasing 'cloud-native creative collaboration platform' appears in both answers but the LLM version doesn't emphasize the progression from post-production-focused to broader use cases. The multi-hop reasoning is sound in connecting the 2022 absence to 2024 presence, but the answer incompletely addresses the full evolution requested in the question by omitting the 2023 intermediate state and the specific functional expansions beyond post-production. The answer is factually accurate in what it states but incomplete in scope relative to the ground truth's more comprehensive coverage of the three-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 453,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 to 2024 Mastercard’s Class A shareholders received a rising cash dividend – $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 【page 92】 – while each Class A share continued to carry one vote per share, unchanged throughout the period 【page 96】【page 92】. The pattern of increasing payouts alongside steady voting rights shows that the company is boosting shareholder returns without altering the voting structure, indicating a stable governance framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misinterprets the question and provides incorrect information. (1) FACTUAL INCORRECTNESS: The ground truth explicitly states that MA's A Class shares maintained consistent dividend rights and voting rights with NO CHANGES across 2022-2024. The LLM instead reports specific cash dividend per-share amounts ($2.04, $2.37, $2.74) that appear to be actual dividend payments, not the structural rights associated with the share class itself. The question asks about the RIGHTS associated with A Class shares (what rights do holders have), not the actual dividend amounts paid in those years. (2) MISUNDERSTANDING OF QUESTION: The question specifically asks about 'dividend and voting rights associated with MA's A Class shares' - this refers to the contractual/structural rights granted to that class of shares, not the dollar amounts of dividends distributed. The ground truth confirms these rights remained stable (one vote per share, dividend rights maintained). The LLM conflates dividend payment amounts with dividend rights. (3) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the multi-hop requirement - it should have identified that across all three years (2022, 2023, 2024), the A Class share structure remained unchanged. Instead, it created a narrative about 'rising cash dividends' that contradicts the ground truth's finding of stability. (4) GOVERNANCE STRUCTURE ANALYSIS: While the LLM's conclusion about 'stable governance framework' aligns with the ground truth's conclusion, the supporting evidence is entirely wrong. The LLM attributes stability to 'steady voting rights' while 'boosting shareholder returns,' but the ground truth indicates stability because the rights themselves never changed - not because of dividend payment trends. (5) CITATION ISSUES: The LLM provides page references that cannot be verified against the ground truth data, and the specific dividend per-share numbers lack proper context about whether they represent rights or actual payments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 550,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell flags fluctuations in retail markets as a specific risk to its Safety and Productivity Solutions segment in each of its 2022‑2024 10‑K filings [page_32 (2022); page_30 (2023); page_32 (2024)]. The segment’s net sales rose from $5.996 bn in FY 2022 to $6.239 bn in FY 2023 and $6.425 bn in FY 2024, but segment profit slipped from $1.555 bn in 2022 to $1.487 bn in 2023 before recovering to $1.522 bn in 2024 [page_28], showing that retail‑market volatility compressed margins in 2023 and that the segment remains vulnerable to consumer‑demand swings over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Honeywell flagged retail market fluctuations as a risk across 2022-2024 and provides specific financial metrics showing segment performance. However, there are significant quantitative accuracy issues: (1) The financial numbers provided ($5.996bn, $6.239bn, $6.425bn for net sales; $1.555bn, $1.487bn, $1.522bn for segment profit) cannot be verified against the ground truth, which does not provide these specific figures. The ground truth focuses on qualitative risk disclosures rather than quantitative performance data. (2) The LLM cites specific page numbers (page_32, page_30, page_32, page_28) without verification that these correspond to actual filing locations. (3) The LLM's interpretation that 'retail-market volatility compressed margins in 2023' is a reasonable inference from the profit decline, but this specific causal claim is not explicitly stated in the ground truth. Strengths: The answer correctly identifies the segment name changes (Safety and Productivity Solutions to Industrial Automation), addresses all three fiscal years, and synthesizes the multi-hop requirement of tracking the segment across years. The qualitative reasoning about persistent vulnerability is sound and aligns with the ground truth's conclusion. However, the introduction of specific financial metrics without ground truth verification is problematic for a financial analysis question where accuracy is paramount. The answer would be stronger if it either verified these numbers or focused more on the qualitative risk disclosures that form the basis of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 443,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 to 2024 the Olumiant deal with Incyte kept the same royalty framework – Incyte receives tiered double‑digit royalties (up to roughly 20 % of worldwide net sales) plus an additional low‑teens royalty on COVID‑19 sales, which was added by a 2020 amendment. The $260 million (2021) and $210 million (2020) milestone payments remain capitalized and amortized, and Incyte continues to be eligible for up to $100 million of extra sales‑based milestones (the $100 million success‑based regulatory milestone noted in the 2022 filing is no longer highlighted in the 2023‑2024 filings).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant issues that prevent it from being considered substantially correct:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The LLM cites '$260 million (2021) and $210 million (2020) milestone payments' which appear to be historical figures unrelated to the 2022-2024 evolution being asked about. The ground truth specifies 'up to $100 million in additional regulatory milestones and $100 million in sales-based milestones' for the 2022 period.\n   - These historical milestone figures (2020-2021) are not relevant to the 2022-2024 evolution and create confusion about what milestones were actually in play during the requested timeframe.\n   - The LLM correctly identifies the royalty structure (up to 20% and low-teens for COVID-19) but misplaces the context of milestone payments.\n\n2. COMPLETENESS ISSUES:\n   - The LLM does address the royalty structure and COVID-19 addition, which is good.\n   - However, it fails to clearly articulate the key evolution described in the ground truth: the shift from milestone-driven obligations (2022) to a more stable royalty-based payment model (2023-2024).\n   - The ground truth emphasizes that 'most contingent payments had likely been triggered or expired' by 2024, which the LLM only partially captures by noting the regulatory milestone is 'no longer highlighted.'\n\n3. ENTITY AND TEMPORAL ACCURACY:\n   - The LLM correctly identifies LLY, Incyte, and Olumiant.\n   - The 2020 amendment reference is correct.\n   - However, the temporal framing is confused by introducing 2020-2021 milestone figures when the question specifically asks about 2022-2024 evolution.\n\n4. REASONING AND SYNTHESIS:\n   - The LLM attempts multi-hop synthesis but does so imprecisely.\n   - It correctly notes that the regulatory milestone is 'no longer highlighted in 2023-2024 filings,' which aligns with the ground truth's observation about milestone expiration.\n   - However, the inclusion of unrelated historical milestone amounts undermines the clarity of the 2022-2024 evolution narrative.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core insight about royalty stability is present.\n   - The observation about milestone de-emphasis is present but not clearly framed as an evolution.\n   - The answer lacks the clear narrative arc of the ground truth (milestone-driven → royalty-based).\n\nThe answer demonstrates partial understanding but contains factual confusion regarding which milestone amounts were relevant to the 2022-2024 period, and fails to clearly articulate the structural evolution of the relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 683,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In 2022 the Baby, Feminine & Family Care segment was broken out into three sub‑categories—Baby Care, Feminine Care (adult‑incontinence + menstrual) and Family Care—and the segment’s “Major Brands” list included Always (alongside Pampers, Luvs, Always Discreet, Tampax, Bounty, Charmin and Puffs) (see 2022 table on page 19). By the 2023 and 2024 filings the segment’s product categories were presented only as Feminine Care (adult‑incontinence + menstrual) and Family Care (see 2024 table on page 18), dropping the explicit Baby‑Care category from the table (though the narrative still notes baby‑care leadership under Pampers); Always remained a flagship brand for menstrual and adult‑incontinence products, highlighted alongside Tampax and Always Discreet and retaining a top‑ranked position relative to other segment brands such as Bounty, Charmin and Puffs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM claims that in 2022 the segment included 'Baby Care' as an explicit sub-category alongside Feminine Care and Family Care. The ground truth states that in 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' - there is no mention of Baby Care being a separate categorization in the 2022 structure. The LLM appears to have fabricated or misinterpreted the 2022 categorization structure. (2) INCORRECT BRAND LISTING - The LLM lists 'Pampers' as part of the Major Brands list in 2022 alongside Always. The ground truth lists 'Always Discreet, Tampax, Bounty, Charmin, and Puffs' but does NOT mention Pampers in this context. This is a significant error in entity identification. (3) PARTIAL ACCURACY ON EVOLUTION - The LLM correctly identifies that the categorization shifted from 2022 to 2023-2024, and that Always maintained prominence. However, the specific details about the 2022 structure are wrong. (4) CORRECT ELEMENTS - The LLM correctly notes that by 2023-2024, the categorization became 'Feminine Care (adult-incontinence + menstrual)' and that Always remained a flagship brand alongside Tampax and Always Discreet. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years, the foundational facts about 2022 are incorrect, undermining the entire analysis. The claim about dropping 'Baby Care' from the table is not supported by the ground truth. The answer demonstrates poor accuracy on the core factual claims needed to answer this multi-hop question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 436,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "In the 2022 filing ACN’s fiscal‑2023 target kept U.S. plan assets at 100 % debt and set non‑U.S. plan assets at 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other【page_88】. The 2023 filing (as of August 31 2023) showed the non‑U.S. mix move to 19 % equity, 43 % debt, 6 % cash, 22 % insurance and 10 % other, while U.S. plans remained 100 % debt【page_95】. The 2025 target (reported in both the 2023 and 2024 filings) shifts the non‑U.S. allocation to 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other, again with U.S. plans at 100 % debt【page_95】. This progression shows ACN gradually tilting its non‑U.S. pension assets toward higher‑return equity while retaining a substantial debt/insurance core to match liability duration, reflecting a balanced approach to risk‑adjusted returns and liability matching.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All specific percentages are correctly cited across three fiscal years (2023, 2024, 2025 targets), with proper attribution to filing sources. (2) The answer correctly identifies the consistent U.S. plan allocation at 100% debt across all periods. (3) The non-U.S. allocation percentages are accurately tracked across the progression: 2023 target (27% equity, 48% debt, 4% cash, 11% insurance, 10% other), August 31, 2023 actual (19% equity, 43% debt, 6% cash, 22% insurance, 10% other), and 2025 target (28% equity, 36% debt, 7% cash, 21% insurance, 8% other). (4) The multi-hop synthesis correctly traces the evolution across three separate filings (2022, 2023, 2024) and identifies the strategic pattern. (5) The qualitative analysis appropriately characterizes the progression as 'gradually tilting toward higher-return equity while retaining substantial debt/insurance core' which accurately reflects the data. (6) The answer correctly identifies the dual objectives of risk-adjusted returns and liability duration matching. MINOR CONSIDERATIONS: The LLM answer is more specific and data-driven than the ground truth, providing exact percentages rather than general descriptions. This represents a strength in precision rather than an error. The ground truth uses broader language ('diversified portfolio,' 'stable investment framework') while the LLM provides concrete numerical evidence supporting the same conclusions. The reasoning about liability duration matching through debt/insurance retention is sound and well-supported by the data presented. Page citations (page_88, page_95) add credibility though cannot be independently verified in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 481,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure fell dramatically – the company held $2.56 billion of forward swaps designated as cash‑flow hedges at the end of fiscal 2022 (see page 52), the fair‑value of those swaps was $251 million in 2023 (page 54) and they no longer appear on the balance sheet in 2024 (fair‑value column blank on page 54). At the same time the firm shifted from using forward swaps as cash‑flow hedges (page 46) to holding fixed‑to‑floating swaps as fair‑value hedges (page 46), indicating a move from hedging anticipated future debt issuances to hedging the interest‑rate risk on existing debt and a more immediate, direct risk‑management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error that fundamentally contradicts the ground truth. The LLM claims Lowe's held '$2.56 billion of forward swaps designated as cash-flow hedges at the end of fiscal 2022' - this specific number does not appear in the ground truth and appears to be fabricated. The ground truth explicitly states 'no current fair value was listed for 2022 itself,' indicating the company did NOT disclose a fair value for forward swaps in 2022. The LLM's citation to 'page 52' and 'page 54' cannot be verified against the ground truth provided. The LLM correctly identifies: (1) the $251 million fair value in 2023, (2) the shift from cash flow hedges to fair value hedges, (3) the transition from hedging anticipated debt issuances to hedging existing debt, and (4) the absence of forward swaps in 2024. However, the introduction of an unsubstantiated $2.56 billion figure for 2022 is a serious quantitative error that undermines credibility. The reasoning about the strategic shift is sound and aligns with ground truth, but the fabricated 2022 number and unsupported page citations represent hallucination. The answer demonstrates partial understanding of the multi-hop synthesis required (comparing 2022-2023-2024 evolution and hedge accounting changes) but fails on factual accuracy for the 2022 baseline, which is critical for evaluating 'evolution' over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 392,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO had **no 5.000 % senior notes due April 2030 outstanding in fiscal 2022** – the 2022 filing (pages 101‑105) contains no line item for that series, implying a $0 exposure. By fiscal 2023 the company reported **$606 million of these notes** (October 29, 2023) and the amount **remained at $606 million in fiscal 2024** (November 3, 2024)【page_81】. The introduction of a modest, fixed‑rate tranche in 2023 and its steady level thereafter shows AVGO is deliberately diversifying its capital structure with long‑dated, low‑cost debt while keeping overall leverage disciplined.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on the most fundamental factual claim. Ground truth states AVGO had $1,086 million in 5.000% notes due April 2030 in fiscal 2022, but the LLM claims there was $0 exposure in 2022 ('no 5.000% senior notes due April 2030 outstanding in fiscal 2022'). This is a major factual error that undermines the entire answer. The LLM correctly identifies $606 million for both 2023 and 2024, which matches ground truth. However, the missing $1,086 million figure for 2022 is a critical omission that prevents proper analysis of the three-year progression. The LLM's interpretation that the notes were 'introduced' in 2023 is incorrect—they existed in 2022 at a higher amount. The ground truth clearly shows a deliberate reduction strategy (from $1,086M to $606M), which the LLM completely misses by claiming 2022 had zero exposure. The LLM's reasoning about 'introducing a modest, fixed-rate tranche in 2023' is factually wrong and contradicts the actual debt management pattern of reduction/repayment. The answer fails to capture the key insight: AVGO reduced this specific debt obligation by $480 million over the period, indicating active debt repayment strategy. The LLM's interpretation of the data as showing 'introduction' rather than 'reduction' demonstrates a fundamental misunderstanding of the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 387,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s $276 million 7.620 % debentures were described the same way in each filing – they mature on April 1 2030, pay interest semi‑annually, have no sinking‑fund requirement and can be called at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining payments discounted at a Treasury yield + 5 bps.  \n\n* **2022 10‑K** – the note explained that the debentures were issued at 8.375 % and were reset to 7.620 % on April 1 2020, then gave the redemption formula and the 2030 maturity.  \n* **2023 10‑K** – the table still listed a 7.620 % rate and the same maturity; the narrative repeated the redemption terms but omitted the historical 8.375 %‑to‑7.620 % change.  \n* **2024 10‑K** – the disclosure again shows a $276 million issue, 7.620 % rate, April 1 2030 maturity and identical redemption language, with no reference to the earlier rate‑reset.  \n\nThus, the interest rate and maturity remained unchanged after the 2020 reset, while the filings moved from a detailed historical explanation (2022) to a streamlined description of the current terms (2023‑2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $276 million principal amount, 7.620% interest rate, April 1, 2030 maturity date, 8.375% original rate, April 1, 2020 reset date, and 5 basis points redemption spread. All dates and percentages match the ground truth exactly. COMPLETENESS: The answer addresses all three components of the question: (1) interest rates - correctly notes the 8.375% to 7.620% reset in 2020 and consistency thereafter, (2) redemption terms - accurately describes the callable feature with the greater-of formula (principal + accrued interest vs. present value of remaining payments at Treasury + 5 bps), and (3) maturity structure - confirms the April 1, 2030 maturity and notes the absence of sinking fund requirements. MULTI-HOP SYNTHESIS: The answer effectively synthesizes information across three years of filings, correctly identifying the evolution in disclosure approach: detailed historical context in 2022, omission of historical rate change in 2023, and streamlined current-terms-only approach in 2024. This matches the ground truth's characterization of 'evolution in clarity and emphasis.' ENTITY ACCURACY: All entities are correct (UPS, debentures, fiscal years 2022-2024). REASONING QUALITY: The conclusion that the structure remained stable while disclosure emphasis shifted from historical to current terms is logically sound and well-supported. MINOR DIFFERENCES: The LLM uses slightly different phrasing than the ground truth (e.g., 'called at any time at the greater of' vs. 'callable at any time at UPS's option, with the redemption price based on either...or'), but these are semantically equivalent and actually more concise. The LLM also explicitly notes the semi-annual interest payment schedule and no sinking fund requirement, which aligns with the ground truth's mention of 2024 placing 'more emphasis' on these terms. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 530,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "In Amgen’s 2022 10‑K, Olpasiran was described as an siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease and was being studied in Phase 2. The 2023 filing still listed it as a Phase 2 cardiovascular candidate but disclosed that composition‑of‑matter patents covering Olpasiran had been issued in the United States and Europe (expiring in 2036), establishing a firm IP foothold. The 2024 10‑K continued to show Olpasiran in Phase 2 with the same US and European patents in force, reflecting Amgen’s sustained focus on Lp(a)‑lowering therapy while securing long‑term patent protection as the program moves toward later‑stage trials.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains mostly accurate numeric and date information but has a significant factual error regarding clinical phase progression. CORRECT ELEMENTS: (1) 2022 description as siRNA lowering lipoprotein(a) for atherosclerotic cardiovascular disease in Phase 2 - accurate; (2) Patent information (US and Europe, expiring 2036) - accurate; (3) Numeric dates and years - all correct. CRITICAL ERROR: The LLM states Olpasiran remained in Phase 2 through 2024, but the ground truth indicates it had progressed beyond Phase 2 by 2024 (implied by 'movement toward later-stage trials' and the broader therapeutic indication change). The ground truth shows therapeutic indication expanded from 'atherosclerotic cardiovascular disease' to simply 'cardiovascular disease' by 2024, suggesting clinical/regulatory evolution. The LLM missed this important therapeutic indication shift and incorrectly characterized the 2024 status as 'same' Phase 2. MULTI-HOP REASONING: The LLM failed to synthesize the evolution across three years - it treated 2023 and 2024 as largely static rather than showing progression. The ground truth emphasizes 'movement from mid-stage development toward more defined commercial and IP strategy' and 'moves toward later-stage trials,' which the LLM's statement of sustained Phase 2 status contradicts. COMPLETENESS: The answer addresses IP protection timeline adequately but incompletely addresses clinical phase progression and therapeutic focus evolution. The semantic shift in indication (from specific ASCVD to broader cardiovascular disease) is a key marker of strategic evolution that the LLM overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 447,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Across all three filings, Tampax stayed in the same place – the Feminine Care sub‑category of the “Baby, Feminine & Family Care” segment – and was consistently listed among the segment’s major brands (Always, Always Discreet, Tampax, Bounty, Charmin, Puffs) 【page_18】. Both the 2022 and 2024 tables and narrative describe Tampax as one of the two leading menstrual‑care brands behind Always, with over 25 % global market share, indicating no re‑categorization or change in its prominence over the period 【page_19】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims 'no re-categorization or change' occurred, but the ground truth explicitly states that in 2023, P&G reclassified feminine care offerings from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Feminine Care (Adult Incontinence, Menstrual Care)' - this is a clear sub-category change that the LLM completely missed. (2) INCOMPLETE ANALYSIS - The LLM fails to capture the evolution described in the ground truth: the 2022 categorization was different from 2023, which then remained consistent through 2024. The LLM incorrectly states Tampax 'stayed in the same place' across all three years. (3) QUANTITATIVE CLAIM - The LLM mentions 'over 25% global market share' but this specific metric is not verified in the ground truth provided, making this an unsupported claim. (4) MISSING NUANCE - The ground truth emphasizes 'minor refinements in sub-category labeling over time' and describes the evolution as showing 'consistent strategic emphasis' despite categorization changes. The LLM's claim of no change directly contradicts this. (5) MULTI-HOP REASONING FAILURE - The question asks about evolution from 2022 to 2024, requiring synthesis across three years. The LLM failed to identify and explain the 2023 reclassification that is central to understanding this evolution. The answer demonstrates a fundamental misreading of the source material regarding categorization changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 417,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 2022 filing still notes that “when we acquire non‑agency RMBS and CMBS that have not been previously evaluated by the NAIC, an internally‑developed designation is used” (2022 10‑K p. 101), implying that some of its RMBS/CMBS holdings required internal ratings at that time. By the 2023 filing the RMBS and CMBS tables list every holding under NAIC designations 1‑6 (no separate “internal” line on page 95), and the 2024 tables show the same pattern (pages 84‑86), indicating that the need for internal designations has essentially disappeared. The trend shows that NAIC designations for non‑agency RMBS and CMBS have become increasingly available, and MetLife’s acquisition strategy has moved toward securities already carrying NAIC ratings, reducing its reliance on internally‑developed designations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core factual claim. Ground truth states that internally developed designations remained a 'consistent practice' across 2022-2024, with the practice continuing in 2023 and 2024. The LLM claims the opposite: that by 2023, 'the need for internal designations has essentially disappeared' and that MetLife's reliance on internally-developed designations decreased over time. This is a fundamental factual error that inverts the actual trend. The LLM cites specific page numbers (2022 p. 101, 2023 p. 95, 2024 pp. 84-86) and claims to have reviewed the tables, but the interpretation is backwards. The LLM states 'every holding under NAIC designations 1-6 (no separate \"internal\" line)' in 2023 and 2024, which would support the claim of disappearing internal designations, but this contradicts the ground truth that explicitly states the practice 'continued in 2023 and 2024.' The LLM's conclusion that 'NAIC designations for non-agency RMBS and CMBS have become increasingly available' and that MetLife moved toward 'securities already carrying NAIC ratings' is the opposite of what the ground truth indicates. The ground truth emphasizes that the persistence of internal designations across three years indicates a 'sustained strategy' of acquiring complex securities where 'NAIC evaluations lag behind acquisition timelines.' The LLM answer fails on the primary multi-hop reasoning task: synthesizing the evolution of this practice across three years to understand what it indicates about NAIC availability and MetLife's strategy. Instead of recognizing the sustained reliance on internal designations as indicating limited NAIC availability, the LLM incorrectly concludes that NAIC availability improved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 480,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "In fiscal 2022 Accenture repurchased roughly $4.1 billion of Class A shares (12.2 million shares) while it had $3.13 billion of unused open‑market authority (page 93‑94), and the Board added $3 million that year, raising total outstanding authority to $6.13 billion (page 94). By fiscal 2024 the buy‑back program had grown to about $4.5 billion of purchases (page 40) and the remaining authorization fell to $2.69 billion, even as the Board approved an additional $4 billion, lifting total authority to $6.69 billion (page 39), indicating a continued and modestly expanding capital‑return strategy through share repurchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Accenture's share repurchase program but contains several significant quantitative errors and inconsistencies that undermine its accuracy. CORRECT ELEMENTS: (1) The $3.13 billion available authorization in fiscal 2022 is correct. (2) The $2.69 billion available authorization as of August 31, 2024 is correct. (3) The $4 billion additional authorization approved on September 25, 2024 is correct. (4) The final total of $6.69 billion is correct. (5) The general narrative about growing capital return commitment is appropriate. PROBLEMATIC ELEMENTS: (1) The claim of '$4.1 billion of Class A shares (12.2 million shares)' repurchased in fiscal 2022 appears to be unsupported by the ground truth, which does not provide this specific figure. (2) The statement about 'Board added $3 million that year' raising total authority to '$6.13 billion' is confusing and appears incorrect - the ground truth does not mention a $3 million addition or a $6.13 billion intermediate figure. (3) The claim of '$4.5 billion of purchases' in fiscal 2024 is not verified in the ground truth, which only mentions 2,000,308 shares purchased for $605 million in Q4 fiscal 2024. (4) The LLM conflates Q4 fiscal 2024 activity with full fiscal 2024 activity without clarification. MULTI-HOP REASONING: The answer attempts to synthesize information across fiscal years and connect repurchase activity to authorization levels, which is appropriate. However, the specific numbers cited for repurchase amounts in fiscal 2022 and 2024 cannot be verified against the ground truth and appear to be fabricated or misinterpreted. The conclusion about 'modestly expanding capital-return strategy' is reasonable but based on potentially incorrect premises. The answer demonstrates understanding of the question's intent but fails on quantitative precision, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 517,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "In the 2022 filing Broadcom only mentioned industrial fiber optics in a broad description of its industrial portfolio (“Industrial End Markets…including industrial fiber optics”)【page_10】 and as a line‑item in a generic end‑market table【page_5】. By the 2023 filing the product was placed in the formal “Industrial” row of the end‑market matrix【page_5】 and highlighted again in the narrative on factory‑automation, renewable‑energy and automotive solutions【page_7】. The 2024 filing keeps the same table placement【page_5】 and narrative reference【page_7】, showing that Broadcom has moved industrial fiber optics from a peripheral mention to a clearly identified offering, signalling a sustained strategic emphasis on growing its industrial‑end‑market presence—particularly in automation, renewable‑energy and automotive applications.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer contains a critical error in its 2023 description. The ground truth states that in 2023, industrial fiber optics were 'listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components.' However, the LLM claims the product was 'placed in the formal Industrial row of the end-market matrix' AND 'highlighted again in the narrative on factory-automation, renewable-energy and automotive solutions.' The ground truth explicitly states these application-specific references (factory automation, renewable energy, automotive electronics) first appeared in 2024, NOT 2023. This is a significant chronological error that misrepresents the evolution timeline. (2) INCOMPLETE CHARACTERIZATION - The LLM fails to mention that in 2022, industrial fiber optics were described as part of a 'broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs,' which is important context for understanding the evolution from broad to more focused positioning. (3) MISSING DETAIL - The ground truth notes that in 2024, fiber optics were 'explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers.' The LLM omits the specific component groupings (Ethernet PHYs, camera microcontrollers) that demonstrate the maturing product strategy. (4) REASONING FLAW - While the LLM correctly identifies a progression from 'peripheral mention to clearly identified offering,' it incorrectly attributes the application-specific emphasis to 2023 when it actually emerged in 2024. This undermines the multi-hop synthesis across the three-year period. (5) CITATION ISSUES - The LLM provides page references that cannot be verified against the ground truth, which raises questions about source accuracy. The core narrative structure is reasonable, but the factual errors regarding timing of application-specific positioning are material to answering the question about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 577,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In the 2022 filing UPS described SurePost as a residential‑ground offering for non‑urgent, lightweight shipments that used UPS’s ground network for transport but “final delivery … often provided by the U.S. Postal Service”【page_6】. The 2024 filing still noted that USPS handled the last‑mile through 2024, but announced a strategic shift – beginning Jan. 1 2025 UPS will “insource” SurePost so it can control the entire delivery instead of relying on the Postal Service【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS SurePost's evolution from 2022-2024. QUANTITATIVE ACCURACY: All dates are correct (2022, 2023, 2024, and the January 1, 2025 implementation date). No numerical calculations are required for this question, and all temporal references are accurate. ENTITY ACCURACY: All entities correctly identified - UPS, UPS SurePost, U.S. Postal Service (USPS), and the service characteristics (residential ground, non-urgent, lightweight shipments). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the continuity from 2022-2023 (unchanged reliance on USPS) versus the strategic shift announced in 2024 (insourcing effective 2025). The reasoning chain is sound: service description → USPS reliance → strategic change → implementation date. COMPLETENESS: The answer addresses all key aspects of the question: (1) the role and delivery model of SurePost, (2) reliance on USPS, and (3) strategic changes. The characterization of the shift from third-party reliance to integrated/controlled delivery is implicit in the answer's description of insourcing. SEMANTIC EQUIVALENCE: The LLM's phrasing \"insource\" and \"control the entire delivery\" conveys the same meaning as the ground truth's \"transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.\" Minor note: The LLM answer could have been slightly more explicit about the 2023 status remaining unchanged (it mentions 2022 and 2024 but doesn't explicitly state 2023 continuity), though this is a very minor omission that doesn't affect the core accuracy of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 476,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s late‑stage pipeline expanded from **13 Phase 3 programs in 2022** (the company kept the total at 13 while receiving three FDA approvals, launching four new Phase 3 studies and terminating one COVID‑19 program) [page_25] to **18 programs in 2023** (adding five Horizon‑acquired assets, starting three new Phase 3 trials, gaining one FDA approval and seeing one study fail to meet its primary endpoint) [page_26] and then to **24 programs in 2024** (five additional Phase 3 initiations and four regulatory approvals – three by the FDA and one in Japan) [page_25]. This steady rise in the number of Phase 3 candidates, together with strategic acquisitions and multiple approvals, reflects Amgen’s deliberate R&D expansion strategy aimed at deepening its late‑stage pipeline, diversifying therapeutic modalities (including biosimilars and novel biologics) and accelerating the entry of new assets into development.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key Phase 3 program numbers: 13 (2022), 18 (2023), and 24 (2024). The answer correctly synthesizes multi-hop information across multiple years and filing documents, properly attributing the increase to both internal development (new Phase 3 initiations) and external growth (Horizon Therapeutics acquisition in 2023 adding five programs). The quantitative progression is accurate and well-documented with specific page references. The answer correctly identifies regulatory approvals (FDA and Japan) and program terminations/failures as contributing factors to the pipeline evolution. The reasoning about R&D expansion strategy is sound and supported by the data presented. Minor areas for improvement: (1) The ground truth mentions 25 Phase 3 programs by February 4, 2025, which the LLM answer does not include, though this may be outside the 2022-2024 timeframe specified in the question. (2) The LLM answer provides slightly more operational detail (e.g., specific numbers of FDA approvals, program terminations) which adds value but wasn't explicitly required. (3) The characterization of therapeutic modalities (biosimilars and novel biologics) adds helpful context not present in the ground truth but is reasonable inference from the data. Overall, the answer successfully addresses the core question about Phase 3 program evolution and strategic implications with accurate numbers and sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 422,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- FY 2022: the Amended 2010 Share Incentive Plan capped awards at **127 million** Accenture Class A ordinary shares.  \n- FY 2023: the cap was increased to **141 million** shares.  \n- FY 2024: the filing again shows a **141 million‑share** maximum, unchanged from the prior year.  \n\nThe rise from 127 M to 141 M shares shows Accenture deliberately expanded its equity‑award pool, using a larger share‑based compensation capacity to attract, retain and align the interests of employees and leadership with shareholders; the steady 141 M ceiling in FY 2024 indicates the company is now operating within that expanded framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - FY 2022: 127 million shares, FY 2023: 141 million shares, FY 2024: 141 million shares. The increase of 14 million shares (127M to 141M) is accurately captured. Number formatting is consistent and acceptable (127 M vs 127 million). COMPLETENESS: The answer addresses all three fiscal years requested and provides the progression clearly. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, and the Amended 2010 SIP (Share Incentive Plan). MULTI-HOP REASONING: The answer successfully synthesizes the three-year progression and draws appropriate conclusions about strategic intent. The interpretation that the increase from 127M to 141M represents deliberate expansion for talent retention and shareholder alignment is sound and matches the ground truth's characterization. The observation that FY 2024 remained steady at 141M is accurate and adds useful context about the company operating within the expanded framework. SEMANTIC EQUIVALENCE: The LLM's explanation of strategic intent ('attract, retain and align the interests of employees and leadership with shareholders') is semantically equivalent to the ground truth's description of 'talent retention and performance alignment strategy.' MINOR OBSERVATIONS: The LLM provides slightly more detailed context about the steady-state in FY 2024, which adds value without contradicting the ground truth. The answer is well-structured and clearly presents the data progression. No calculation errors detected. All facts align with the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 453,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks said its total purchase commitments plus existing inventory would cover green‑coffee demand **through fiscal 2023** in its 2022 filing, **through fiscal 2024** in its 2023 filing, and **through fiscal 2025** in its 2024 filing【SBUX_10k_2022.pdf page_12】【SBUX_10k_2023.pdf page_12】【SBUX_10k_2024.pdf page_12】.  By extending the coverage horizon by one year each time, the company maintains a rolling one‑year buffer of coffee supplies, reflecting a proactive inventory and risk‑management strategy to guard against price volatility and supply‑chain disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All fiscal year projections are correct - fiscal 2022 filing stated coverage through fiscal 2023, fiscal 2023 filing extended to fiscal 2025, and fiscal 2024 filing maintained fiscal 2025 coverage. The LLM correctly identified the progression across all three years with proper document citations. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly traces the evolution of supply coverage projections. REASONING QUALITY: The LLM provides sound interpretation of the data, noting the 'rolling one-year buffer' concept and connecting it to risk management strategy. This interpretation aligns with the ground truth's characterization of 'more forward-looking inventory and risk management strategy.' MINOR DISCREPANCY: The ground truth states fiscal 2023 projection extended to 'fiscal 2025' while the LLM states it extended to 'fiscal 2024' in the 2023 filing. However, reviewing the progression: 2022→2023, 2023→2025, 2024→2025 suggests the LLM may have a slight error here. The ground truth clearly indicates 2023 filing covered through 2025, not 2024. This is a factual error in the LLM's middle data point. CONTEXTUAL APPROPRIATENESS: The answer directly addresses both parts of the question - the evolution of coverage duration AND what it indicates about strategy. The explanation of supply chain risk management and price volatility protection is relevant and well-reasoned. ENTITY ACCURACY: Company (Starbucks), metric (green coffee supply coverage), and years are all correctly identified. The score reflects one factual error in the middle year's projection (stating 2024 instead of 2025 for the 2023 filing coverage), which prevents a perfect 10 despite otherwise excellent work.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 505,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 through 2024 UPS left the UPS/IBT Full‑Time Employee Pension Plan structurally unchanged – the last actuarial remeasurement (triggered by the American Rescue Plan Act) was disclosed for 2021 and no new plan amendment or remeasurement was reported in the 2022 filing (see NOTE 6, page 92) or the 2024 filing (see NOTE 5, page 86). In 2023, however, a new five‑year Teamsters national master agreement raised wage‑and‑benefit rates for participants in the UPS/IBT plan, and the resulting higher service‑cost and interest‑cost components turned the plan’s net periodic benefit result from a $88 million gain in 2022 (page 83) to a $1.212 billion expense in 2023 (page 83) and again in 2024 (page 88). The 2024 filing also shows updated actuarial assumptions – the discount rate remained at 5.42 % and the expected return on plan assets rose from 7.07 % in 2023 (page 84) to 7.17 % in 2024 (page 88) – reflecting the ongoing financial impact of the 2023 collective‑bargaining changes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on critical points: (1) MAJOR ERROR - The LLM claims the 2022 remeasurement was 'disclosed for 2021' and 'no new plan amendment or remeasurement was reported in the 2022 filing,' directly contradicting the ground truth that states the plan WAS remeasured in 2022 following the American Rescue Plan Act with a $3.3 billion pre-tax gain ($2.5 billion after-tax). This is a fundamental misunderstanding of the 2022 events. (2) QUANTITATIVE ERRORS - The LLM provides specific numbers ($88 million gain in 2022, $1.212 billion expense in 2023/2024, discount rate 5.42%, expected return 7.07% to 7.17%) that cannot be verified against the ground truth and appear to be fabricated or misread from filings. The ground truth does not provide these specific expense figures. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 2023 Teamsters agreement impact and its effect on service costs and interest costs, it fails to acknowledge the 2022 remeasurement gain, which is a critical component of the three-year evolution. (4) STRUCTURAL CLAIM ERROR - The assertion that the plan was 'left structurally unchanged' contradicts the ground truth's description of plan amendments and the significant financial impact of the 2023 collective bargaining agreement. (5) CITATION ISSUES - The LLM provides specific page references (NOTE 6 page 92, NOTE 5 page 86, etc.) that cannot be verified and may be hallucinated. The answer demonstrates partial understanding of the 2023-2024 period but fundamentally misrepresents the 2022 remeasurement event, which is central to understanding the three-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 461,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "In fiscal 2022, “Holiday Time” is simply listed among Walmart U.S.’s many private‑label brands without a distinct unit assignment (see page_7 and page_8). By fiscal 2023 the filing adds language about periodic revisions to strategic merchandise units and places Holiday Time within the seasonal‑merchandise portion of the Entertainment sub‑category of General merchandise, indicating a more deliberate positioning (see page_7 and page_8). In fiscal 2024 the brand remains in the private‑brand roster and the company continues to emphasize its categorization framework, showing a consistent strategy to treat Holiday Time as a focused seasonal private‑label offering that supports holiday‑season demand within its broader private‑label portfolio (see page_7 and page_8).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant factual discrepancies with the ground truth, particularly regarding the fiscal 2023 characterization and the overall evolution narrative.\n\nKEY ISSUES:\n\n1. FISCAL 2023 MISCHARACTERIZATION (Critical Error): The LLM claims that by fiscal 2023, 'Holiday Time' was placed \"within the seasonal-merchandise portion of the Entertainment sub-category of General merchandise.\" However, the ground truth states that in fiscal 2023, 'Holiday Time' \"remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role.\" This is a fundamental factual error - the LLM incorrectly attributes the seasonal merchandise categorization to fiscal 2023 when it actually occurred in fiscal 2024.\n\n2. FISCAL 2024 ACCURACY: The LLM correctly identifies that by fiscal 2024, 'Holiday Time' was placed within a dedicated seasonal framework under General Merchandise, which aligns with the ground truth statement about \"explicit restructuring\" and \"seasonal merchandise as a defined category.\"\n\n3. FISCAL 2022 ACCURACY: The LLM correctly characterizes fiscal 2022 as having 'Holiday Time' listed among private brands without distinct strategic emphasis, matching the ground truth.\n\n4. EVOLUTION NARRATIVE PROBLEM: The LLM's narrative suggests a more gradual, consistent evolution (2022→2023→2024) with strategic positioning beginning in 2023. However, the ground truth reveals a more significant shift occurred between 2023 and 2024, with 2023 being relatively unchanged from 2022 in terms of strategic positioning.\n\n5. MULTI-HOP REASONING: While the LLM attempts to synthesize information across three fiscal years, it fails to correctly identify the timing of the strategic shift, which is a critical element of the multi-hop analysis.\n\n6. CITATION REFERENCES: The LLM provides generic page references (page_7 and page_8) without specific evidence, making verification difficult. The ground truth provides more nuanced distinctions between years.\n\nSTRENGTHS:\n- Correctly identifies the three fiscal years in question\n- Recognizes the general trend toward more strategic seasonal positioning\n- Acknowledges the private label portfolio context\n- Correctly identifies fiscal 2024 as the year of explicit restructuring\n\nWEAKNESSES:\n- Misplaces the fiscal 2023 strategic shift (should be fiscal 2024)\n- Oversimplifies the fiscal 2023 status (claims more strategic positioning than actually occurred)\n- Fails to capture the distinction between \"listed among\" (2022-2023) versus \"explicitly restructured\" (2024)\n- Does not adequately convey that the major evolution occurred between 2023 and 2024, not gradually across all three years",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 727,
        "total_tokens": 2198
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit plans held $239 million in mutual‑fund equity securities at August 31 2022 (page 89), which fell to $196 million in 2023 (page 96 of the 2023 filing), and then rose to $274 million in 2024 (page 96 of the 2024 filing). The dip in 2023 followed by a sizable increase in 2024 suggests the company is shifting back toward, and expanding, its strategic allocation to equity‑focused mutual‑fund assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the 2024 figure. Ground truth shows mutual fund equity securities remained unchanged at $196.226 million in 2024, but the LLM claims they rose to $274 million. This is a significant discrepancy ($274M vs $196.226M) that fundamentally changes the narrative and conclusion. The LLM correctly identifies the 2022 figure ($239M, matching $239.293M) and 2023 figure ($196M, matching $196.226M), but the 2024 number is completely incorrect. REASONING ERROR: Based on the incorrect 2024 figure, the LLM draws the opposite conclusion from ground truth. Ground truth indicates a consistent decline with no change from 2023-2024, suggesting strategic rebalancing away from this asset class. The LLM incorrectly concludes the company is 'shifting back toward, and expanding' its allocation based on the false 2024 increase. MULTI-HOP SYNTHESIS: While the LLM appropriately identifies this as non-U.S. defined-benefit plans data and cites page references, the synthesis fails at the critical final data point. The answer demonstrates partial understanding of the question structure but fails on the most important quantitative accuracy requirement. The contextual framing about strategic allocation is reasonable in structure but reaches an incorrect conclusion due to the wrong 2024 number.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 378,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks repeatedly notes that green‑coffee prices are “subject to significant volatility” and “impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity‑index funds” (2022 10‑K p.12; 2024 10‑K p.12). In each filing the company says it “uses fixed‑price and price‑to‑be‑fixed purchase commitments… forward contracts, futures contracts and collars to hedge ‘C’ price exposure,” but the horizon of its purchase‑commitment buffer has been lengthened—from covering supply through fiscal 2023 in the 2022 filing to covering supply through fiscal 2025 in the 2024 filing (2022 10‑K p.12; 2024 10‑K p.12). This progression shows Starbucks is maintaining the same hedging toolkit while expanding its commitment window, reflecting a proactive risk‑management stance that seeks to blunt the impact of commodity‑index‑fund‑driven futures price swings on its coffee supply costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core narrative about green coffee price volatility and commodity index fund impacts across the 2022-2024 period. (2) Accurately captures the evolution of hedging strategy horizons: fiscal 2023 coverage in 2022 filing extended to fiscal 2025 in 2024 filing. (3) Properly identifies the consistent hedging toolkit (fixed-price, price-to-be-fixed, forward contracts, futures contracts, collars). (4) Correctly synthesizes the multi-hop reasoning: same tools + extended timeline = proactive risk management. (5) Appropriately cites specific page references (p.12 for both 2022 and 2024 10-Ks), demonstrating document-level accuracy. (6) Uses semantically equivalent language ('blunt the impact' vs 'mitigating the influence') while maintaining factual precision. MINOR CONSIDERATIONS: The LLM answer mentions 'hedge funds' in addition to commodity-index funds in the quote attribution, which is a slight expansion beyond the ground truth's focus on commodity index funds specifically, though this reflects actual filing language and doesn't contradict the ground truth. The answer is slightly more detailed in citing specific page numbers and providing direct quotes, which enhances credibility without introducing errors. The reasoning about 'proactive risk-management stance' is well-supported by the evidence presented. No calculation errors, no date errors, no entity misidentifications detected. The answer successfully addresses all components of the multi-part question regarding exposure evolution, hedging strategies, and risk management approach implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 462,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO carried $622 million of the 3.625 % senior notes that mature in October 2024 at the end of FY 2022 and again at the end of FY 2023 (the October‑2023 column shows $622 million)【page_81】, but the balance was fully retired by the end of FY 2024, leaving a $0 amount in the November‑2024 column【page_81】.  This move to eliminate the note demonstrates a deliberate near‑term debt‑reduction strategy, clearing a maturing obligation to lower short‑term leverage and improve liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. Quantitative verification: (1) $622 million principal amount for FY 2022 - CORRECT, matches ground truth; (2) $622 million for FY 2023 - CORRECT, matches ground truth; (3) Full retirement by FY 2024 with $0 balance - CORRECT, matches ground truth. The LLM correctly identifies the three-year progression and the complete elimination of the debt obligation. Multi-hop reasoning: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly interprets the progression as evidence of deliberate debt management strategy. Entity accuracy: AVGO correctly identified, 3.625% notes correctly specified, October 2024 maturity date correct. The LLM provides appropriate context by noting the strategic intent (debt-reduction strategy, lowering short-term leverage, improving liquidity), which aligns with the ground truth's characterization of 'deliberate near-term debt management strategy.' Minor note: The LLM references specific page numbers (page_81) which adds credibility but wasn't in the ground truth answer - this is a positive addition. The only minor difference is that the LLM uses slightly different phrasing ('debt-reduction strategy' vs 'debt management strategy') but both convey the same semantic meaning. The answer is complete, accurate, and demonstrates sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 401,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard’s settlement exposure rose sharply – gross exposure grew from $64.9 billion (2022) to $75.0 billion (2023) and $78.4 billion (2024), while net exposure increased from $55.7 billion to $62.9 billion and $64.9 billion respectively – and the amount of risk‑mitigation arrangements applied to that exposure climbed from $9.2 billion (2022) to $12.2 billion (2023) and $13.5 billion (2024), reflecting a broader use of cash collateral, letters of credit and guarantees for customers that did not meet the company’s risk standards【page_112†L1-L8】【page_105†L1-L8】.  This tightening of credit‑risk controls coincided with heightened regulatory scrutiny – an FTC consent agreement on the Durbin Amendment (finalized in 2023) and a DOJ civil investigative demand in 2023, plus a European Commission request for information in 2024【page_112†L31-L38】 – and rising litigation costs, including U.K. and Pan‑European merchant settlement charges ($223 m in 2022, $195 m in 2023, $251 m in 2024) and a $589 m qualified cash‑settlement fund at year‑end 2022 with an additional $344 m accrual in 2023 for the U.S. damages‑class claims【page_110†L31-L38】【page_105†L31-L38】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific quantitative data that appears well-sourced from SEC filings. STRENGTHS: (1) Specific settlement exposure figures are provided with clear progression (gross exposure $64.9B→$75.0B→$78.4B; net exposure $55.7B→$62.9B→$64.9B; risk mitigation $9.2B→$12.2B→$13.5B), showing multi-hop synthesis across years. (2) Regulatory events are correctly identified (FTC consent agreement 2023, DOJ civil investigative demand 2023, European Commission 2024). (3) Litigation costs are quantified ($223M, $195M, $251M for merchant settlements; $589M qualified cash settlement fund 2022; $344M accrual 2023). (4) The answer effectively connects credit risk mitigation strategies to regulatory/litigation pressures. (5) Risk mitigation mechanisms (cash collateral, letters of credit, guarantees) are correctly identified. MINOR WEAKNESSES: (1) The LLM answer is more quantitatively focused than the ground truth, which emphasizes the qualitative evolution of risk management framework and the transformation in external risk environment. (2) The ground truth mentions specific litigation details (EMV liability shift class action, European Commission investigation into anticompetitive behavior tied to network fees) that the LLM answer doesn't explicitly reference, though it does capture the broader litigation/regulatory context. (3) The ground truth emphasizes 'consistent framework' and 'stable internal controls' while the LLM emphasizes 'tightening' - these are complementary but slightly different framings. QUANTITATIVE VERIFICATION: The specific dollar amounts provided ($64.9B, $75.0B, $78.4B, etc.) cannot be independently verified from the ground truth provided, but they are presented with specific page citations suggesting they come from actual SEC filings. The progression is logical and internally consistent. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects settlement exposure trends to regulatory/litigation developments, demonstrating sound multi-hop reasoning. The answer directly addresses how credit risk mitigation strategies evolved in light of regulatory scrutiny and litigation risks, which was the core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 599,
        "total_tokens": 2249
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "In the 2022 Form 10‑K Amgen only flagged that “some of our products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks” (2022 p. 34). By the 2023 filing the discussion was expanded to detail concrete compliance duties – continuous collection of user‑complaints, adverse‑event and malfunction reports, routine FDA monitoring, labeling enhancements, and the risk that loss of device clearance could force product removal – and to tie those duties to post‑marketing obligations such as REMS reporting, inspections and possible recalls (2023 p. 54‑55). The 2024 filing further integrates device risk into its broader post‑marketing framework, emphasizing that drug‑delivery devices are subject to the same post‑marketing commitments, periodic assessment reports and enforcement actions (e.g., recalls, label changes, loss of clearance) as the drug products themselves, reflecting heightened safety oversight and regulatory scrutiny (2024 p. 54).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of how Amgen's disclosures evolved; (2) Accurately captures the 2022 baseline disclosure about drug delivery devices having 'distinct regulatory, manufacturing, and compliance risks'; (3) Correctly details the 2023 expansion to include specific post-marketing obligations (REMS reporting, inspections, recalls, adverse event reporting); (4) Accurately describes the 2024 integration of device risk into broader post-marketing framework with emphasis on enforcement actions; (5) Provides specific page references (2022 p. 34, 2023 p. 54-55, 2024 p. 54) that ground the answer in actual filings; (6) Successfully synthesizes multi-hop information across three years showing progression from general risk acknowledgment to detailed compliance requirements to integrated oversight framework. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and specific than the ground truth (includes page numbers, specific compliance duties like 'user-complaints, adverse-event and malfunction reports'), but this represents added value rather than error; (2) Both answers convey the same core narrative arc of increasing regulatory scrutiny and post-market compliance emphasis; (3) No quantitative errors detected - all years, entities, and regulatory concepts are correctly identified and sequenced. The answer fully addresses all parts of the multi-part question regarding compliance requirements, post-marketing obligations, and safety oversight evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 450,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Walmart’s 10‑K each lists “Parent’s Choice” among its private‑brand family (see the private‑brand lists in the Walmart U.S. segment on pages 7 of each filing). In every year the strategic merchandise units are described the same way – baby items and consumables sit inside the **Grocery** unit – and “Parent’s Choice” is implicitly tied to that unit as a private‑label option. This unchanged placement shows Walmart consistently positions Parent’s Choice as a core, low‑price private label for the baby‑care and consumables portfolio, reinforcing its value‑focused role in that segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies all three fiscal years (2022, 2023, 2024) with accurate temporal framing. (2) Accurately states that 'Parent's Choice' appears in private brand lists across all three years. (3) Correctly identifies the Grocery unit as the consistent merchandise categorization across all three years. (4) Accurately conveys that baby products and consumables are positioned within the Grocery unit. (5) Properly synthesizes the multi-hop information showing consistency in positioning across years. (6) Correctly interprets the strategic implication: reinforcement of Parent's Choice as a low-cost, value-focused private label. (7) Appropriately references EDLP (Everyday Low Price) philosophy alignment. (8) The reference to 'page 7 of each filing' provides specific sourcing, though this is not verifiable from the ground truth provided. MINOR CONSIDERATIONS: (1) The LLM uses 'implicitly tied' rather than explicitly stating the brand was 'listed among' the Grocery unit - this is a subtle semantic difference but semantically equivalent. (2) The ground truth mentions 'omni-channel convenience strategy' which the LLM answer does not explicitly include, though this is a minor contextual detail rather than a core factual omission. (3) The LLM answer is slightly more concise than the ground truth but captures all essential information. QUANTITATIVE ACCURACY: No numerical calculations or specific dollar amounts are required for this question, so quantitative accuracy is high (9/10) based on correct year identification and consistent reference to the same unit across years. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct - the model successfully connected information across three years to identify a pattern. The conclusion about strategic positioning is well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding evolution, categorization, and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 557,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 4.70 % Solar Bonds, Series 2015/C24‑10 were originally issued under a “Thirty‑Fifth Supplemental Indenture” dated April 14 2015 and appear unchanged in the exhibit tables of the 2022 10‑K (Exhibit 4.35) 【page_100】, the 2023 10‑K (Exhibit 4.35) 【page_99】 and the 2024 10‑K (Exhibit 4.35) 【page_100】. The bond’s repeated, un‑amended listing across three consecutive years shows it remains outstanding and is not being refinanced, indicating Tesla’s strategy of using a stable, long‑term fixed‑rate solar‑bond program to fund its solar operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond as 4.70% Solar Bonds, Series 2015/C24-10, (2) Accurately cites the Thirty-Fifth Supplemental Indenture dated April 14, 2015, (3) Correctly references the bond appearing in Exhibit 4.35 across 2022, 2023, and 2024 10-Ks, (4) Provides specific page numbers (100, 99, 100) for verification, (5) Numeric data and dates are accurate.\n\nWEAKNESSES: (1) The LLM's interpretation of the multi-year pattern is incomplete and somewhat misleading. The ground truth emphasizes that Tesla CONTINUED TO REFERENCE this bond alongside NEWER SERIES (2015/C27-10, 2015/C32-10) in 2023, indicating an EVOLVING and EXPANDING securitization strategy, not merely a 'stable, long-term' unchanged program. (2) The LLM concludes the bond is 'unchanged' and 'not being refinanced,' but the ground truth suggests the opposite—that Tesla was actively issuing NEW bond series while maintaining older ones, indicating a SCALABLE and RECURRING model with evolution over time. (3) The LLM misses the key insight about the 2024 context shift: the ground truth notes that 2024 references included EARLIER series (C4-10, C9-10), suggesting a matured historical framework, not just stability. (4) The LLM's reasoning about 'stable, long-term fixed-rate' is partially correct but fails to capture the multi-year EVOLUTION and EXPANSION of the solar financing strategy that the question specifically asks about.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years but interprets the pattern incorrectly. It identifies consistency but misses the evolution and expansion of the strategy. The ground truth indicates a progression from 2022 (initial reference) → 2023 (alongside newer series) → 2024 (within broader historical context), suggesting strategic maturation and scaling. The LLM's conclusion that the bond 'remains outstanding and is not being refinanced' contradicts the ground truth's emphasis on a 'consistent and SCALABLE securitization strategy' with newer series being added.\n\nCONTEXTUAL RELEVANCE: The question asks about how the bond 'evolved' and what the 'multi-year pattern suggests.' The LLM provides a static interpretation (unchanged, stable) rather than a dynamic one (evolving, expanding). This partially misses the intent of the question, which seeks to understand strategic evolution, not just consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 634,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "In the 2022 10‑K (see p.10‑11) Broadcom introduced the Security Insights Platform as a mainframe‑focused solution that “quickly interprets and assesses mainframe security posture… data is available for use with in‑house tools for security information and event management.” By the 2023 filing (p.10‑11) the platform was placed more prominently within the broader enterprise‑security suite, with language stressing that its risk‑assessment data can be fed into enterprise security tools. In the 2024 filing (p.10‑11) Broadcom again highlighted the platform’s purpose of delivering a trusted environment through continuous mainframe risk assessment, now emphasizing tighter integration with enterprise SIEM solutions while maintaining its core mainframe focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts and multi-hop synthesis across 2022-2024. STRENGTHS: (1) Correctly identifies the Security Insights Platform as a mainframe-focused solution across all three years; (2) Accurately captures the consistent emphasis on risk assessment and SIEM integration; (3) Properly synthesizes the evolution narrative showing stable core functionality with evolving emphasis on enterprise integration; (4) Correctly references the platform's ability to 'quickly interpret and assess mainframe security posture' and notes data availability for SIEM tools; (5) Appropriately identifies the 2024 shift toward 'tighter integration with enterprise SIEM solutions.' MINOR WEAKNESSES: (1) The LLM states the platform was 'placed more prominently within the broader enterprise-security suite' in 2023, which is not explicitly supported by the ground truth—the ground truth indicates the 2023 description 'remained largely consistent' rather than showing increased prominence; (2) The phrase 'delivering a trusted environment through continuous mainframe risk assessment' in 2024 is not directly quoted or clearly sourced from the ground truth, which focuses on 'identifying risks and proactively respond to potential threats'; (3) The LLM's characterization of 2024 as showing 'tighter integration' is slightly stronger than the ground truth's more measured 'subtle but meaningful reaffirmation.' QUANTITATIVE ACCURACY: No numerical data is required for this qualitative question, so this dimension scores high (9/10) for proper handling of dates and temporal sequencing. QUALITATIVE ACCURACY: The multi-hop reasoning across three years is sound, but the LLM introduces some interpretive language not fully grounded in the original answer (7/10). CONTEXTUAL RELEVANCE: The answer directly addresses the question's three components (2022, 2023, 2024 positioning) and the two key themes (enterprise integration and mainframe risk assessment) appropriately (8/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 543,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across 2022‑2024 Mastercard’s Class A shares consistently carried **one vote per share and full dividend rights** – the “Classes of Capital Stock” tables list A‑class as “One vote per share Dividend rights” in each filing (2022 § page 95, 2023 § page 97, 2024 § page 92).  The dividend entitlement remained but the amount grew, rising from **$2.04 per share in 2022** (page 95), to **$2.37 in 2023** (page 97), and **$2.74 in 2024** (page 92).  This continuity shows Mastercard’s capital‑structure strategy is to keep a stable, single‑voting public class while steadily increasing cash returns to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that A Class shares maintained one vote per share and dividend rights consistently across 2022-2024, matching the ground truth. The reasoning about capital structure stability is sound and well-articulated. However, there is a critical quantitative error: the LLM introduces dividend per-share amounts ($2.04, $2.37, $2.74) that are NOT present in the ground truth answer and appear to conflate dividend per share with the dividend rights themselves. The ground truth explicitly states 'dividend rights' remained consistent - it does not mention changing per-share dividend amounts. The LLM has added information about dividend growth that goes beyond what the original answer establishes, potentially introducing unsourced or incorrect data. While the page citations suggest the LLM attempted to verify these numbers from actual filings, the ground truth does not corroborate these specific dividend amounts as relevant to answering the question about voting rights and dividend entitlements evolution. The LLM's interpretation that 'dividend entitlement remained but the amount grew' represents a misunderstanding: the question asks about the STATUS of dividend entitlements (whether they exist), not the magnitude of dividends paid. The qualitative reasoning about capital structure strategy is appropriate and matches the ground truth's conclusion. The multi-hop synthesis is partially successful - the LLM correctly synthesized information across three years but added unsupported quantitative claims that detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 434,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen moved Bemarituzumab into a Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma in early 2022 and secured composition‑of‑matter patents in the United States and Europe that are projected to expire in 2029【page_25】. By the 2023 filing the antibody remained in Phase 3 for that indication while also being studied in Phase 2 for other solid‑tumor types and in Phase 1 for NSCLC, with the same 2029 patent expiration still shown【page_25】【page_26】. The 2024 filing continues to list Bemarituzumab in Phase 3 (GEJ adenocarcinoma), Phase 2 (other tumors) and Phase 1 (NSCLC) and retains the 2029 U.S. and European patent expiry, indicating a stable, multi‑indication development path paired with a consistent IP protection timeline【page_24】【page_26】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive detail than the ground truth. Key strengths: (1) All numeric values are correct - 2029 patent expiration dates for U.S. and Europe are accurately stated and consistent across years; (2) Clinical trial phases are correctly identified and tracked across the three-year period (Phase 3 for GEJ adenocarcinoma, Phase 2 for other solid tumors, Phase 1 for NSCLC); (3) Multi-hop synthesis is sound - the answer successfully traces the evolution from 2022 through 2024, showing both continuity (stable 2029 IP timeline) and expansion (additional indications in Phase 2 and Phase 1); (4) Entity identification is accurate (Amgen, Bemarituzumab, FGFR2b targeting, specific cancer types). Minor considerations: (1) The LLM answer provides more granular detail about multiple clinical trial phases than the ground truth, which focuses more on the Phase 3 initiation and IP strategy. This additional detail is accurate and relevant but goes slightly beyond the ground truth's scope; (2) The ground truth mentions 'potential regulatory exclusivity periods' as a 2024 development, while the LLM answer focuses on the consistent 2029 patent expiration without explicitly highlighting regulatory exclusivity - this is a minor omission but not a factual error; (3) The LLM answer's characterization of the strategy as 'stable, multi-indication development path' is a reasonable inference supported by the data. Overall, the answer correctly synthesizes multi-year information, maintains factual accuracy on all dates and clinical phases, and provides sound reasoning about the evolution of Amgen's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 457,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "No Boundaries was listed as one of Walmart U.S.’s private‑label lines inside the General Merchandise unit’s apparel segment in each filing – it appears under “Apparel” in the 2022 10‑K (page 7) and under the renamed “Fashion” sub‑category in both the 2023 (page 7) and 2024 (page 7) 10‑Ks. The shift from the term “Apparel” (2022) to “Fashion” (2023‑2024) shows Walmart is re‑positioning its clothing business toward a broader, style‑focused offering, while keeping No Boundaries as a core private‑brand player in that evolving segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) No Boundaries was listed under 'Apparel' in 2022, (2) it shifted to 'Fashion' in 2023-2024, and (3) this represents a strategic repositioning. The answer accurately captures the timeline and the categorical shift. However, there are notable gaps compared to the ground truth: (1) The LLM does not mention that 'Fashion' includes 'adult and children's apparel, shoes, jewelry, and accessories' - a key detail about the expanded scope of the category. (2) The LLM does not explicitly address the connection to 'omni-channel offerings and customer-centric experiences' that the ground truth identifies as the strategic rationale. (3) The LLM does not emphasize the 'continuity of No Boundaries in all three years' as a marker of consistent importance. The LLM's statement about 'style-focused offering' is a reasonable interpretation but less specific than the ground truth's explanation of the broader merchandising strategy. The page references (page 7) are cited but cannot be independently verified from the provided context. The multi-hop reasoning is sound - the answer correctly synthesizes the categorical evolution across years - but it lacks the deeper strategic context about what this shift reveals about Walmart's broader business direction. The answer is factually accurate in what it states but incomplete in addressing the full scope of the original question about what the shift 'reveals about the company's shifting focus.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 412,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "In the 2022 10‑K, IBM listed “client relationships and trust” as one item among a long set of competitive factors (2022 Item 1 Competition, page 4). The 2023 filing repeated the same language, keeping client relationships and trust in the competitive‑method list (2023 Item 1 Competition, page 3). By the 2024 filing, IBM moved trust from a generic differentiator to a highlighted risk factor, explicitly tying its brand reputation and client trust to its hybrid‑cloud and AI leadership (2024 Risk Factors, page 5), indicating that client trust has become a core pillar of its hybrid‑cloud/AI strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of 2022, 2023, and 2024 filings is accurate; (2) The general claim that client relationships and trust appeared in competitive factors is reasonable; (3) The recognition that trust became more strategically emphasized over time aligns with the ground truth. PROBLEMATIC ELEMENTS: (1) The LLM claims that in 2024, IBM 'moved trust from a generic differentiator to a highlighted risk factor' - this is a significant mischaracterization. The ground truth indicates IBM maintained positioning while EXPANDING context through partnerships, not moving it to risk factors. This represents a fundamental misreading of the strategic evolution; (2) The LLM states trust was moved to 'Risk Factors, page 5' in 2024, which appears to be an incorrect document location/characterization. The ground truth describes trust being linked to hybrid cloud/AI capabilities through ecosystem collaboration, not repositioned as a risk; (3) The LLM's framing suggests a shift in how trust is presented (from competitive method to risk factor), whereas the ground truth shows continuous reinforcement and expansion of trust as a competitive asset through partnerships; (4) The LLM misses the key insight about ecosystem collaboration with hyperscalers and global system integrators that the ground truth emphasizes as central to the evolution. MULTI-HOP REASONING: The LLM attempted to synthesize across three years but drew an incorrect conclusion about the nature of the evolution. The ground truth shows trust being consistently reinforced and extended through partnerships, while the LLM suggests a repositioning to risk factors, which contradicts the strategic narrative. SEMANTIC ACCURACY: While the LLM uses similar language about trust and hybrid cloud/AI, the core interpretation of how trust evolved is materially different and less accurate than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 527,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 are listed in each year’s filing as Exhibit 4.36 – the “Thirty‑Sixth Supplemental Indenture” dated April 14 2015 (see page_100 and page_102 for 2022, page_100 and page_102 for 2023, and page_100 for 2024). The unchanged, recurring disclosure shows the 2015 bond issue remains outstanding and is a core, long‑term financing vehicle, indicating Tesla’s strategy of relying on stable, fixed‑rate solar bonds rather than issuing new debt each year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the bond series (5.45% Solar Bonds, Series 2015/C25-15), the supplemental indenture date (April 14, 2015), and the exhibit designation (Exhibit 4.36). The multi-year pattern across 2022, 2023, and 2024 is correctly identified, and the core insight about Tesla's consistent reliance on this structured debt instrument is sound. The answer appropriately synthesizes the multi-hop information by showing the bond's persistence across three years and drawing a logical conclusion about Tesla's solar financing strategy (stable, fixed-rate bonds rather than new issuances). The specific page references (page_100, page_102) add credibility, though these cannot be independently verified from the ground truth. The LLM correctly interprets the 3-year pattern as indicating a consistent strategy. Minor weaknesses: (1) The answer is slightly more technical/exhibit-focused than the ground truth, which emphasizes the broader strategic implications more explicitly; (2) The ground truth mentions 'legal and financial linkage' and 'asset-backed financing' which the LLM answer touches on but doesn't emphasize as strongly; (3) The LLM answer could have been more explicit about the 'early 2015' issuance context mentioned in the ground truth. However, these are minor omissions that don't affect the core factual accuracy. The quantitative data (bond percentage, date, exhibit number) are all correct, and the reasoning about what the multi-year persistence indicates is logically sound and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 441,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "In Emerson’s 2022 filing the Safety & Productivity segment was described as offering conventional pipe‑working tools – pipe wrenches, cutters, threading and roll‑grooving equipment, mechanical crimping, drain cleaners, tubing tools and CCTV inspection devices【page_9】. By the 2023 filing (and unchanged in 2024) the segment’s description added “battery hydraulic tools for press connections” (and for cutting/crimping electrical cable), showing the introduction of cordless, battery‑powered technology into its pipe‑working portfolio【page_73】. This evolution signals a deliberate push toward product innovation and mobility, positioning Emerson as a more modern, competitive player in the professional‑tools market.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core evolution of Emerson's Safety & Productivity segment from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 baseline offerings (pipe wrenches, cutters, threading equipment, CCTV inspection) with appropriate detail; (2) Accurately captures the 2023 introduction of battery hydraulic tools for press connections; (3) Correctly notes the continuation and expansion of battery-powered tools into 2024 (cutting/crimping electrical cable); (4) Properly synthesizes the multi-hop progression across three years; (5) Appropriately concludes that this represents a strategic shift toward modernization and competitive positioning. WEAKNESSES: (1) The answer is somewhat condensed compared to the ground truth, omitting some specific product details mentioned in the original (e.g., roll-grooving equipment, mechanical crimping, drain cleaners, tubing tools, sewer inspection cameras, locating equipment); (2) The phrase 'unchanged in 2024' is potentially misleading - while the 2023 description may have carried forward, the ground truth indicates further integration and specific highlighting of battery hydraulic tools for cutting/crimping in 2024, suggesting evolution rather than stasis; (3) Missing the explicit mention of 'sewer inspection cameras and locating equipment' as part of the 2024 expansion; (4) The answer could have been more explicit about the 'consistent mention of pipe wrenches across all three years' as a foundational element. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the progression pattern. The logic connecting product innovation to strategic market positioning is sound. NUMERIC/DATE ACCURACY: All years (2022, 2023, 2024) are correct; no calculations required. The answer avoids numeric errors. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth - Emerson deliberately modernized its toolset through battery-powered innovation - though with less comprehensive detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 550,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "In 2022 Gilead’s filing only referenced a general plan to “continue to develop additional manufacturing capabilities” for future biologics candidates (2022 10‑K, Item 3, p. 33). By the 2023 report the company had specifically allocated capital to its El Segundo, California site for both clinical and commercial cell‑therapy manufacturing (2023 10‑K, Manufacturing Facilities, p. 11), and the 2024 filing still lists El Segundo as a core cell‑therapy production hub (2024 10‑K, Manufacturing Facilities, p. 10), showing a shift from a broad capability‑building approach to a targeted investment that supports Gilead’s wider biologics development priorities.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Gilead's El Segundo facility from 2022-2024, with accurate year-by-year progression and proper document citations. Strengths: (1) Correctly identifies the shift from general manufacturing capabilities in 2022 to dedicated cell therapy focus by 2023-2024; (2) Properly cites the relevant 10-K filings and page numbers; (3) Accurately synthesizes the multi-hop information across three years; (4) Correctly identifies El Segundo as a core cell-therapy production hub by 2024. Minor weaknesses: (1) The LLM answer omits a key detail from the ground truth about Gilead's reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies, which was explicitly mentioned in the 2024 filing and suggests increased investment in securing/scaling proprietary processes; (2) Does not explicitly mention the potential CAPEX or R&D spend implications tied to facility upgrades and process development, which the ground truth identifies as part of the strategic shift; (3) The phrase 'general plan to continue to develop additional manufacturing capabilities' in the LLM answer is a reasonable paraphrase of the 2022 filing's general manufacturing designation, but lacks the specificity that the ground truth provides about El Segundo being listed among 'principal manufacturing facilities' without specific cell therapy emphasis. The LLM answer demonstrates sound multi-hop reasoning across the three-year period and correctly identifies the strategic shift, but misses some nuanced details about proprietary technology protection and investment implications that would strengthen the answer. No numerical errors or date inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 475,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "In IBM’s 2022 Form 10‑K (pages 28‑32) there is no explicit mention of the 1.250 % Notes due 2027, so the securities table does not highlight that issue. In the 2023 Form 10‑K the notes are disclosed in the “Instruments defining the rights of the holders” list, incorporated by reference to a 2019 Form 8‑K filing (see page 20). By the 2024 Form 10‑K the 1.250 % Notes due 2027 are listed in the Section 12(b) securities table with ticker IBM27B, showing they are now an actively registered and reported debt instrument (see page 1).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The 2023 reference to the notes being disclosed in the 'Instruments defining the rights of the holders' list is accurate; (2) The 2024 listing in Section 12(b) securities table with ticker IBM27B is correct; (3) The general progression from disclosure to active registration is sound. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM states there is 'no explicit mention' of the 1.250% Notes due 2027 in the 2022 Form 10-K, but the ground truth indicates IBM DID disclose these notes in 2022 as part of its exhibit list, referencing the instrument defining the rights of holders filed on January 30, 2019. This is a significant factual error that contradicts the ground truth; (2) The LLM provides specific page references (pages 28-32, page 20, page 1) that cannot be verified against the ground truth and may be inaccurate; (3) The LLM's characterization of 2022 as having 'no explicit mention' fundamentally misrepresents the evolution described in the ground truth, which shows continuous disclosure from 2022 onward. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression from disclosure to active trading, but the error regarding 2022 disclosure undermines the completeness of the multi-hop analysis. The answer should have shown continuous disclosure across all three years, not a gap in 2022. QUANTITATIVE ACCURACY: The dates (2022, 2023, 2024), the interest rate (1.250%), maturity year (2027), and ticker symbol (IBM27B) are all correct. The filing dates mentioned (February 8, 2022; February 3, 2023; January 30, 2019) align with ground truth references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 465,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the original 5.45 % Solar Bonds, Series 2015/C45‑15 (e.g., the Sixty‑Second Supplemental Indenture) and then a succession of later supplemental indentures for additional series (C46‑15, C47‑15, C48‑15, etc.)【page_101】【page_103】. The repeated, multi‑year references indicate that Tesla has continued to fund its solar operations through a stable, long‑term bond program—extending and refinancing the 2015 bond series rather than moving to a fundamentally different financing structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 5.45% interest rate and the original Series 2015/C45-15 bond. (2) It accurately notes that Tesla's 10-K filings from 2022-2024 all reference these bonds. (3) The core insight about continued reliance on structured solar financing is correct. (4) The observation that Tesla is extending/refinancing rather than fundamentally changing the structure is sound. WEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM claims Tesla referenced 'C46-15, C47-15, C48-15, etc.' but the ground truth specifically identifies C53-15 (June 16, 2015), C62-15 (June 29, 2015), and C72-15 (July 21, 2015). The LLM's sequential numbering (C46, C47, C48) does not match the actual bond series referenced in filings. (2) INCOMPLETE SYNTHESIS: The ground truth provides specific bond series with exact dates (C53-15, C62-15, C72-15) showing an iterative expansion pattern across 2023-2024. The LLM vaguely references 'a succession of later supplemental indentures' without naming the specific series or dates, failing to demonstrate the detailed multi-hop synthesis required. (3) MISSING STRATEGIC INSIGHT: The ground truth emphasizes the deliberate progression showing Tesla 'refining a scalable, repeatable financing model' and 'reducing reliance on traditional corporate debt.' The LLM's conclusion about 'extending and refinancing' is more passive and misses the strategic evolution aspect. (4) CITATION ISSUES: The LLM provides page references (page_101, page_103) but these cannot be verified against the ground truth data. (5) The LLM answer is shorter and less detailed in explaining the evolution from 2022 through 2024, treating it more as a static continuation rather than a deliberate progression. The answer captures the general concept but fails on specific bond series identification and the nuanced strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 510,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In the 2022 10‑K Adobe framed Acrobat as the centerpiece of its Document Cloud, stressing AI‑driven enhancements through Adobe Sensei, its leadership in document‑intensive sectors such as government, financial services, legal, aerospace and technical publishing, and the growth of a unified, cloud‑based platform that integrates Acrobat, Adobe Sign and APIs (2022 10‑K, pp. 6‑7). The 2024 filing excerpts (pages 94‑98) are limited to governance disclosures and do not restate those product‑level details, indicating that Acrobat’s positioning has been folded into broader corporate narratives while still underpinning Adobe’s AI‑enabled, industry‑focused Document Cloud strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH LLM ANSWER: (1) FACTUAL ERRORS: The LLM claims the 2022 10-K discusses 'AI-driven enhancements through Adobe Sensei' for Acrobat, but the ground truth indicates 2022 emphasized market adoption and leadership WITHOUT AI integration as a primary positioning. The AI pivot came in 2023, not 2022. This is a significant chronological error. (2) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to address the critical 2023 transition period where Adobe introduced forward-looking AI statements. The ground truth explicitly identifies 2023 as the signaling year for AI innovation strategy. The LLM jumps from 2022 to 2024 without capturing this crucial middle step. (3) MISSING 2024 ACROBAT AI ASSISTANT: The LLM acknowledges 2024 filing excerpts are 'limited to governance disclosures' but fails to note that the ground truth specifically identifies the formal introduction of 'Acrobat AI Assistant' as a trademark in 2024. This is a concrete product development that should have been highlighted. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks for evolution across three dimensions: (a) AI integration, (b) market adoption in document-intensive industries, (c) expansion of digital document services platform. The LLM addresses some of these but incompletely: mentions market sectors (government, financial, legal, aerospace, publishing) but doesn't trace how positioning evolved across the three-year period. (5) CONTEXTUAL FRAMING: The LLM's statement that 'Acrobat's positioning has been folded into broader corporate narratives' contradicts the ground truth's clear trajectory showing increasing strategic emphasis on Acrobat as an AI-driven solution. (6) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. (7) ENTITY ACCURACY: Adobe and Acrobat are correctly identified, but the temporal sequencing of strategic positioning is incorrect. The ground truth shows a clear 2022→2023→2024 progression; the LLM conflates 2022 with AI positioning that didn't occur until 2023-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 551,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website was the core RIA portal, offering interactive tools, proprietary software and free integration via Schwab Advisor Portfolio Connect with third‑party CRM, portfolio‑management and planning systems (page 7). In 2023 the firm expanded that platform by adding TD Ameritrade technology—launching the thinkpipes real‑time charting and trading platform and the iRebal customizable rebalancing solution for RIAs, and introducing Schwab Trading Powered by Ameritrade (pages 6 & 8). By 2024 Schwab was further integrating thinkpipes and iRebal into its unified Schwab Trading Powered by Ameritrade experience, delivering a more modern, intuitive interface and broader integration capabilities for RIAs (page 10).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer contains significant factual inaccuracies that contradict the ground truth. Most critically, the LLM claims Schwab Advisor Portfolio Connect existed in 2022, but the ground truth indicates it was introduced in 2024 as a new offering. The LLM also introduces TD Ameritrade technology products (thinkpipes, iRebal, Schwab Trading Powered by Ameritrade) in 2023-2024 that are NOT mentioned in the ground truth at all. (2) UNSUPPORTED CLAIMS - The LLM provides specific product names and launch dates (thinkpipes, iRebal, Schwab Trading Powered by Ameritrade) with page references that cannot be verified against the ground truth knowledge graph. These appear to be hallucinated details. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH - The ground truth emphasizes: (a) 2022: proprietary software, dedicated website, third-party integrations (CRM, portfolio management); (b) 2023: continued emphasis on Advisor Services website with educational content; (c) 2024: Schwab Advisor Portfolio Connect as a free portfolio management solution with expanded integrations. The LLM's narrative diverges significantly from this progression. (4) MULTI-HOP REASONING FAILURE - While the LLM attempts to synthesize evolution across three years, it does so by introducing information not present in the ground truth, failing the core requirement of accurate multi-hop synthesis. (5) PAGE REFERENCES - The LLM cites specific pages (7, 6, 8, 10) which cannot be verified and appear to be fabricated citations. The ground truth does not reference specific page numbers for these claims. CORRECT ELEMENTS: The LLM correctly identifies Charles Schwab, the 2022-2024 timeframe, and the general concept of platform evolution and integrations. However, these correct elements are overshadowed by substantial factual errors regarding specific products and their introduction dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 516,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In the 2022 filing Emerson listed air‑preparation equipment as a core pneumatic product within its Discrete Automation portfolio – together with solenoid valves, pneumatic cylinders, actuators and other “Industrial Solutions” that “transform air or gas into energy and power” (see page 6). By the 2023 and 2024 filings the segment description was updated to group air‑preparation equipment with pneumatic valves, pressure‑ and temperature‑switches, electric‑linear‑motion solutions, programmable automation control systems and software, highlighting its role as an integrated part of the broader pneumatic‑control architecture (see page 73). Thus, while the product remained in the Discrete Automation segment each year, Emerson’s positioning evolved from a standalone pneumatic offering in 2022 to an explicitly integrated solution that works with other pneumatic components and control technologies by 2023‑2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the core evolution of Emerson's Air Preparation Equipment positioning across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) as required; (2) Accurately captures the shift from standalone pneumatic offering to integrated solution; (3) Correctly names associated technologies (solenoid valves, pneumatic cylinders, actuators, pressure/temperature switches, programmable automation control systems); (4) Properly identifies the Discrete Automation segment as the consistent home; (5) Captures the integration theme across all three years; (6) References specific filing pages (6, 73) showing document engagement. WEAKNESSES: (1) Missing explicit mention of Industry 4.0 and digital transformation trends highlighted in ground truth for 2024; (2) Does not mention smart actuation, predictive maintenance capabilities, or secure wireless communication as 2024 positioning elements; (3) Less emphasis on the mechanical-to-digital shift narrative that ground truth emphasizes; (4) The characterization of 2022 as 'standalone' is somewhat overstated - ground truth indicates 2022 already showed integration with solenoid valves, actuators, and pressure switches, though less explicitly than later years. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing documents, correctly tracing the evolution. However, it misses some of the more sophisticated digital/Industry 4.0 positioning elements that distinguish 2024 from earlier years. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - evolution from mechanical to integrated digital solution - but lacks the depth on digital transformation aspects. The answer is fundamentally correct but incomplete in capturing the full scope of the positioning evolution, particularly regarding Industry 4.0 alignment and advanced capabilities in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 538,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "Coca‑Cola’s 0.125 % Notes due 2029 first appear in the 2022 10‑K as a single 2020 issuance (exhibit 4.23) [page_134]. By the 2023 filing the company added a second 2021 issuance (exhibit 4.31) [page_134], and both the 2020 and 2021 notes remain listed in the 2024 filing [page_130]. This continuity of ultra‑low‑rate, near‑term notes alongside a broader mix of higher‑rate, longer‑dated debt shows the company’s strategy of repeatedly tapping cheap short‑term financing to cover upcoming obligations while diversifying its overall financing program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally undermine its credibility. (1) CRITICAL ERRORS: The LLM claims there were TWO separate issuances of the 0.125% Notes due 2029 (one in 2020 and one in 2021), with the 2023 filing allegedly adding a second issuance. This is factually incorrect - the 0.125% Notes due 2029 represent a single debt instrument, not multiple issuances. The ground truth indicates consistent reference to this single note across all three years, not an accumulation of multiple issuances. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific exhibit numbers (4.23, 4.31) and page numbers (134, 130) without verification. These citations cannot be verified against the ground truth and appear to be fabricated details. The claim of 'two issuances' is mathematically/factually wrong. (3) MULTI-HOP REASONING FAILURE: The LLM misinterprets the evolution of Coca-Cola's debt strategy. While the ground truth correctly identifies a strategic pivot toward higher-yielding, longer-term instruments as the 2029 note approached maturity, the LLM incorrectly frames this as 'repeatedly tapping cheap short-term financing' through multiple issuances of the same note - a fundamental misunderstanding. (4) SEMANTIC DIVERGENCE: The ground truth emphasizes a deliberate refinancing strategy in response to approaching maturity dates, while the LLM suggests ongoing issuance of the same ultra-low-rate note, which contradicts the actual debt management pattern. The LLM's conclusion about 'repeatedly tapping cheap short-term financing' is unsupported by the actual facts about this single instrument. (5) MISSING CONTEXT: The LLM fails to address the key insight from the ground truth - the introduction of significantly higher-yielding instruments (5.000% and 5.400% notes) in 2024, which is central to understanding the company's strategic pivot. The answer demonstrates poor synthesis of multi-hop information and contains fabricated details that reduce confidence in its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 551,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "- In the 2022 Form 10‑K BNY Mellon warned that, as a non‑operating holding company, it “is dependent on dividends from its subsidiaries and extensions of credit … to provide funds for share repurchases, payment of income taxes and payment of dividends to its stockholders,” and that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p. 5).  \n- The 2023 and 2024 filings repeat the same caveat – the Board’s discretion to pay dividends or buy back shares “may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (2023 p. 3; 2024 p. 3) – indicating that the regulatory exposure has persisted unchanged, with later reports simply restating the constraint rather than adding new limitations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains accurate citations and correctly identifies the regulatory language from the filings (2022 p. 5; 2023 p. 3; 2024 p. 3), with proper quotations that appear factually sound. However, the answer fundamentally contradicts the ground truth's core finding about how BNY Mellon's disclosures evolved. The ground truth explicitly states that the framing evolved from 'general caution in 2022' to 'more specific references' in 2023-2024, with 'increasing specificity and formalization' in how regulatory constraints were communicated. The LLM answer directly contradicts this by claiming the regulatory exposure 'persisted unchanged' and that 'later reports simply restate the constraint rather than adding new limitations.' This is a critical misinterpretation of the multi-hop synthesis required by the question. The ground truth identifies a meaningful evolution in disclosure specificity (from general caution to structured emphasis on 'well capitalized' status and capital adequacy rules), while the LLM characterizes the same disclosures as static repetition. The LLM's conclusion that there were no new limitations or changes in how constraints were communicated directly contradicts the ground truth's finding of increasing specificity and formalization. While the LLM correctly identifies the regulatory constraints themselves and provides accurate citations, it fails to synthesize the temporal evolution across the three-year period that is central to the question. The answer demonstrates poor multi-hop reasoning by not recognizing or articulating the shift in disclosure framing that the ground truth emphasizes as the key finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 454,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, McDonald’s describes McGriddles in the same way – as a regular breakfast sandwich listed alongside the Egg McMuffin, Sausage McMuffin with Egg, biscuit and bagel sandwiches, oatmeal, hash browns, burritos and hotcakes (2022 p. 6‑7; 2023 p. 6‑7; 2024 p. 6‑7). The product is presented as a core, permanent menu item rather than a new or limited‑time innovation, showing that McDonald’s breakfast strategy has remained steady, keeping McGriddles as a staple while other menu innovations are pursued elsewhere.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core insight that McDonald's portrayed McGriddles consistently across 2022-2024 as a stable breakfast staple rather than an innovated product, which aligns with the ground truth's main conclusion. However, there are significant issues with quantitative accuracy and completeness:\n\n(1) PAGE NUMBER DISCREPANCIES: The LLM cites pages 6-7 for all three years (2022 p. 6-7; 2023 p. 6-7; 2024 p. 6-7), while the ground truth specifies different pages: 2022 (page 7), 2023 (page 6), and 2024 (page 6). The 2022 citation is incorrect - the ground truth explicitly states page 7, not pages 6-7. This is a factual error in document citation.\n\n(2) MISSING CONTEXTUAL DETAILS: The ground truth provides specific chunk references (chunk_1 for each year) and emphasizes the company's stated positioning around 'continuous evolution' (2023) and 'testing new products on an ongoing basis' (2024) as contrasts to McGriddles' static presentation. The LLM answer omits these important contextual details about McDonald's broader innovation messaging, which weakens the analysis of what the consistency reveals about strategy.\n\n(3) PRODUCT LIST EXPANSION: The LLM adds products not mentioned in the ground truth (burritos, hotcakes, oatmeal, hash browns, biscuit and bagel sandwiches), which may be accurate but represents information not verified against the ground truth source material. This introduces unverified details.\n\n(4) REASONING QUALITY: The LLM's conclusion about 'steady' breakfast strategy and McGriddles as a 'staple' is sound and matches the ground truth's interpretation. The logic that consistency across years reveals strategic stability is valid.\n\n(5) SEMANTIC ALIGNMENT: The core message - McGriddles remained consistent and positioned as a core offering without innovation - is correctly conveyed, though with less nuance than the ground truth regarding the contrast between company-wide innovation messaging and McGriddles' static treatment.\n\nThe answer is directionally correct but contains citation errors and omits important contextual nuances that support the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 569,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "- In the FY 2022 filing Adobe described its free online self‑service learning as a core part of Adobe Digital Learning Services, delivered through the learning.adobe.com site (2022 10‑K p. 18).  \n- In the FY 2023 filing the same offering remained within Adobe Digital Learning Services but the URL was changed to www.training.adobe.com (2023 10‑K p. 17).  \n- In the FY 2024 filing Adobe again placed the free self‑service learning under Digital Learning Services and reverted to the learning.adobe.com platform (2024 10‑K p. 17).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains a fundamental factual inversion that directly contradicts the ground truth across all three years: (1) 2022: LLM states learning.adobe.com was used, but ground truth clearly indicates www.training.adobe.com was the platform in 2022. (2) 2023: LLM states www.training.adobe.com was used, but ground truth indicates learning.adobe.com was the platform in 2023. (3) 2024: LLM correctly identifies learning.adobe.com, which matches ground truth. The LLM has reversed the platform URLs for 2022 and 2023, creating a completely inverted narrative of the evolution. The ground truth shows a progression: training.adobe.com (2022) → learning.adobe.com (2023) → learning.adobe.com (2024), indicating a domain shift and then stabilization. The LLM presents the opposite sequence: learning.adobe.com (2022) → training.adobe.com (2023) → learning.adobe.com (2024), suggesting a reversion rather than a forward evolution. While the LLM correctly identifies that the offerings remained within Adobe Digital Learning Services across all three years and correctly cites page numbers from the 10-K filings, the core factual content about platform URLs is inverted. This is a critical multi-hop synthesis error that undermines the entire answer's credibility. The question specifically asks about 'platforms used to deliver these offerings,' making URL accuracy essential to answering correctly. The LLM's answer would lead to completely incorrect conclusions about Adobe's strategic evolution in digital learning infrastructure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 427,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "In the 2022 filing Emerson placed commercial vacuums in the **Tools & Home Products** segment, describing them as “other professional tools” alongside water‑jetters, wet‑dry vacuums and bolt‑cutters (see page 9). By the 2023 and 2024 filings the same product line appears in the **Safety & Productivity** segment, still listed as “other professional tools” with water‑jetters and wet‑dry vacuums, but now framed as part of a portfolio that “delivers tools for professionals… that support infrastructure, promote safety and enhance productivity” (see page 73). The shift moves commercial vacuums from a broader consumer‑oriented Tools & Home Products category to a tighter, safety‑focused professional‑tools positioning within Safety & Productivity.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Commercial Vacuums positioning from 2022-2024, with accurate segment transitions (Tools & Home Products in 2022 → Safety & Productivity in 2023-2024). The answer accurately captures the key product associations mentioned (water jetters, wet-dry vacuums, bolt-cutters in 2022; water jetters and wet-dry vacuums in 2023-2024). The characterization of the shift from 'broader consumer-oriented' to 'safety-focused professional-tools positioning' is semantically sound and aligns with the ground truth's description of repositioning from 'general tools category' to 'integrated part of industrial safety and productivity solutions.' However, there are notable omissions: (1) The LLM does not mention the 2023-2024 alignment with more technologically advanced tools like 'programmable automation control systems and electrical distribution equipment,' which the ground truth explicitly highlights as signaling a strategic shift toward industrial productivity tools. (2) The LLM's characterization focuses primarily on the professional tools framing but misses the deeper strategic emphasis on integration with broader productivity-enhancing industrial solutions. (3) The answer lacks discussion of the evolution in 'strategic emphasis' regarding technological advancement and industrial integration that the ground truth emphasizes. The multi-hop reasoning is sound in connecting the segment transitions and product categorizations across years, but the synthesis is incomplete regarding the full scope of strategic repositioning. The answer is factually accurate in what it states but falls short of capturing the complete evolution described in the ground truth, particularly the shift toward alignment with more advanced industrial productivity tools.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 490,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the Hoofddorp, Netherlands site is listed only as a “principal manufacturing facility” with no detail on its function (2022 p. 33).  \n- The 2023 filing adds that Gilead “utilizes the facility for commercial manufacturing and processing of our cell‑therapy products” (2023 p. 10).  \n- The 2024 filing repeats the same description, indicating the Hoofddorp plant continues to serve the commercial manufacturing and processing of cell‑therapy products (2024 p. 10).  \n\nThus, the facility’s role evolved from a generic manufacturing location in 2022 to a clearly defined commercial cell‑therapy manufacturing and processing site in 2023, a role that has been maintained through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. FACTUAL ACCURACY: All key facts are correct - the facility was identified as a 'principal manufacturing facility' in 2022 with no specific function detail, then explicitly described as serving 'commercial manufacturing and processing of cell-therapy products' in 2023, with this role maintained in 2024. The page citations (2022 p. 33, 2023 p. 10, 2024 p. 10) provide verifiable sourcing. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) and identifies the evolution pattern: generic manufacturing → specialized cell therapy focus → sustained cell therapy role. COMPLETENESS: The answer addresses all aspects of the question - the facility's utilization, the time period (2022-2024), and the specific focus on cell therapy manufacturing and commercial processing. REASONING QUALITY: The conclusion that the facility's role 'evolved from a generic manufacturing location in 2022 to a clearly defined commercial cell-therapy manufacturing and processing site in 2023, a role that has been maintained through 2024' is logically sound and matches the ground truth's characterization of 'a strategic shift toward advanced therapies' with 'sustained and potentially expanding role.' MINOR OBSERVATION: The LLM answer uses slightly more precise language ('generic manufacturing location' vs. ground truth's 'principal manufacturing site') but this represents appropriate specificity rather than inaccuracy. The semantic meaning is equivalent - both convey that 2022 lacked specific functional detail while 2023-2024 provided explicit cell therapy focus. No quantitative errors, calculation issues, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 484,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 10‑K reports from 2022‑2024 all list the 1.000 % Notes due 2028 (Exhibit 4.26) as a standing piece of its debt portfolio, underscoring a continued reliance on a low‑cost, long‑dated bond tranche【page_129】.  In the 2024 filing the company added higher‑coupon issuances—5.000 % Notes due 2034 (Exhibit 4.39) and 5.400 % Notes due 2064 (Exhibit 4.41)—signalling a shift to diversify maturities and accept higher financing costs, reflecting a more active approach to managing debt costs and capital structure【page_130】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Coca-Cola's debt financing strategy. QUANTITATIVE ACCURACY: All numeric values are correct - the 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 are all accurately cited with correct percentages and maturity dates. The time period (2022-2024) is correctly identified. ENTITY ACCURACY: Coca-Cola is correctly identified, the specific debt instruments are properly named, and the fiscal years are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings (2022, 2023, 2024) and correctly identifies the pattern: persistent reference to low-cost 1.000% Notes combined with introduction of higher-yield instruments in 2024. The logical connection between these facts and their implications for capital structure management is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Coca-Cola maintained a low-cost debt instrument while diversifying into higher-yield notes, reflecting a strategic shift in debt portfolio management. The phrase 'more active approach to managing debt costs and capital structure' is semantically equivalent to the ground truth's 'recalibration of the company's capital structure management.' MINOR OBSERVATIONS: The LLM answer includes specific exhibit references (4.26, 4.39, 4.41) and page numbers that add credibility and specificity beyond the ground truth. The phrasing 'accept higher financing costs' and 'diversify maturities' provides slightly more granular detail than the ground truth. The answer is comprehensive, well-structured, and directly addresses all aspects of the question without omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 483,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "In Emerson’s 2022 filing the pipe‑cutter was described only as a conventional “pipe‑working” tool alongside wrenches, threading and roll‑grooving equipment, with no reference to cordless or diagnostic features (see page 9). By the 2023 and 2024 filings the Safety & Productivity segment explicitly lists “battery hydraulic tools” and “diagnostic systems, including sewer‑inspection cameras” together with pipe wrenches and cutters (see page 73). This progression shows Emerson deliberately expanding its pipe‑cutter line toward battery‑powered, technology‑enabled solutions, positioning the company as a leader in high‑productivity, connected tools for professional plumbers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 3-year progression (2022→2023→2024) with accurate characterization of each phase: 2022 as traditional/conventional tools, 2023 as introduction of battery hydraulic technology, 2024 as diagnostic system integration. (2) Accurately captures the strategic shift toward battery-powered and diagnostic-integrated tools. (3) Properly synthesizes multi-hop information across three fiscal years and multiple product categories. (4) Correctly identifies the Safety & Productivity segment as the relevant business unit. (5) Appropriately contextualizes the positioning as targeting professional plumbers with high-productivity, connected solutions. (6) Uses specific product examples (sewer-inspection cameras, locating equipment, pipe wrenches, cutters) that align with ground truth. MINOR CONSIDERATIONS: (1) The LLM includes specific page references (page 9, page 73) which are not in the ground truth but add credibility and specificity without contradicting the source material. (2) The LLM uses slightly different phrasing ('cordless' vs 'battery-powered', 'connected tools' vs 'technology-enhanced tools') but these are semantically equivalent and demonstrate understanding rather than error. (3) The answer is slightly more detailed and structured than the ground truth but maintains factual accuracy throughout. NO QUANTITATIVE ERRORS: No numbers, dates, percentages, or calculations are present in either answer, so quantitative accuracy is based on correct temporal sequencing and entity identification, both of which are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple product categories to demonstrate strategic evolution, matching the ground truth's analytical framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 507,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K the Santa Monica site is mentioned only as an R&D location (“We also have R&D facilities … Santa Monica, California” – page 31). By the 2023 filing the same campus appears under “Our Manufacturing Facilities” with the note that it is “utilized … for clinical manufacturing and processing of our cell‑therapy products” (page 11), and the 2024 filing repeats that language (page 10). This evolution from a research‑only site to a dedicated clinical‑manufacturing hub for cell‑therapy indicates that Santa Monica has become a strategic node in Gilead’s manufacturing network, supporting the development and eventual commercial scale‑up of its cell‑therapy portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about GILD's Santa Monica facility evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with accurate characterization of each phase: 2022 as R&D-only, 2023 as transition to clinical manufacturing for cell therapy, 2024 as continuation of that role. (2) Provides specific textual evidence with page citations (page 31 for 2022, page 11 for 2023, page 10 for 2024), demonstrating document-level verification. (3) Accurately synthesizes the multi-hop reasoning: connects the facility's changing designation across years to draw a conclusion about its strategic role in the manufacturing network. (4) Correctly identifies related facilities (El Segundo and Frederick mentioned in ground truth are contextually appropriate comparisons). (5) Uses semantically equivalent language to ground truth: 'research-only site to dedicated clinical-manufacturing hub' matches 'transitioned from a general R&D site to a dedicated cell therapy manufacturing hub.' MINOR CONSIDERATIONS: The LLM answer adds interpretive language about 'eventual commercial scale-up' which goes slightly beyond the ground truth's explicit statements, though this is a reasonable inference from the progression described and doesn't contradict the source material. The answer is more detailed and evidence-based than the ground truth, providing specific page references that enhance credibility. All factual claims are accurate, the multi-hop synthesis across three years is sound, and the conclusion about strategic importance is well-supported by the documented progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 460,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s 2022 Form 10‑K makes no mention of Frame.io in the Creative Cloud discussion (see pages 95‑99). In the 2023 filing, Frame.io is introduced as a cloud‑native collaboration platform that supports video, still images, design files and PDFs and is directly integrated only with Premiere Pro and After Effects for frame‑accurate commenting, with “Camera‑to‑Cloud” upload (see page 12). By the 2024 filing, Frame.io’s role has broadened: it remains support‑rich for video, stills, design files and PDFs but is now integrated across Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and is offered in Adobe GenStudio for cross‑app content production at scale (see page 12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in tracking Frame.io's evolution across the 2022-2024 period. STRENGTHS: (1) Correctly identifies that Frame.io was not mentioned in 2022 Form 10-K, matching the ground truth's characterization of 2022 as only listing it in trademark portfolio without functional description. (2) Accurately captures 2023 positioning: cloud-native collaboration platform, support for still images, design files, PDFs, and integration with Premiere Pro and After Effects for frame-specific feedback. (3) Correctly identifies 2024 expansion: broadened video support beyond post-production (casting, location scouting, marketing implied through 'cross-app content production'), integration with Photoshop, Lightroom, and Workfront, and positioning within Adobe GenStudio. (4) All dates and years are correct. (5) Multi-hop synthesis is sound—properly connects the evolution across three years and identifies the progression from limited mention to detailed integration to enterprise-scale positioning. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'Camera-to-Cloud' upload as a specific 2023 feature, which is not explicitly mentioned in the ground truth but represents additional detail rather than contradiction. (2) The ground truth mentions 'casting, location scouting, and marketing campaign management' as specific 2024 use cases, while the LLM generalizes this as 'cross-app content production at scale'—this is a reasonable semantic compression rather than an error. (3) The LLM provides specific page references (pages 95-99, page 12) which adds credibility and specificity. The answer successfully addresses all parts of the multi-part question regarding supported media types and cross-application collaboration features across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 486,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "Emerson has kept electrical distribution equipment inside its Discrete Automation segment throughout the period, but the way the business talks about it has moved from a “hardware‑only” component to a key part of an integrated automation portfolio. In the 2022 filing the segment is described as a collection of solenoid and pneumatic valves, switches, linear‑motion devices, programmable automation control systems **and** electrical distribution equipment 【page_73】, while the 2024 filing stresses that the same equipment now sits alongside “programmable automation control systems and software” as part of a broader suite that also includes materials‑joining solutions 【page_73】—showing a deliberate push to fuse the distribution hardware with digital control and software capabilities and to broaden the product scope for discrete‑industry customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Emerson (EMR) and the Discrete Automation segment as the focus. (2) It accurately captures the core narrative that electrical distribution equipment evolved from a standalone component to an integrated part of a broader automation portfolio. (3) The mention of programmable automation control systems, software, and materials-joining solutions aligns with the ground truth's description of product scope expansion. (4) The characterization of the shift from 'hardware-only' to integrated solutions is semantically consistent with the ground truth's framing of 'deeper alignment with intelligent automation systems.' (5) The citation references (page_73) suggest proper sourcing from filings.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to clearly establish the 2022 baseline positioning. The ground truth explicitly states that in 2022, Electrical Distribution Equipment was positioned within the 'Industrial Solutions business' as a 'foundational product,' but the LLM's 2022 description conflates this with Discrete Automation segment language without clearly distinguishing the 2022 organizational structure. (2) INCOMPLETE TEMPORAL PROGRESSION: The ground truth provides a clear 3-year evolution (2022→2023→2024) with specific positioning changes at each stage. The LLM only compares 2022 and 2024, missing the 2023 intermediate step where the equipment was 'more specifically embedded within the Discrete Automation segment' alongside 'programmable automation control systems and software.' (3) MISSING PRODUCT SCOPE DETAILS: The ground truth mentions 'electric linear motion solutions' as a 2024 addition, but the LLM only references 'linear-motion devices' in 2022 context and doesn't clearly articulate the 2024 expansion to include these alongside materials-joining solutions. (4) VAGUE SOURCING: While page citations are provided, the LLM doesn't clearly distinguish which statements come from which year's filing, making the temporal evolution harder to verify. (5) INCOMPLETE ANSWER TO MULTI-HOP QUESTION: The question asks specifically about evolution 'from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion.' While the LLM addresses integration, it doesn't systematically track product scope expansion across all three years.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on correct identification of years (2022, 2023, 2024) and product categories. The LLM correctly identifies 2022 and 2024 but omits 2023 entirely, which is a significant gap in a 3-year evolution question.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting product positioning across years and linking hardware to software/digital capabilities. However, it fails to fully synthesize the complete 3-year progression that the ground truth establishes, instead providing a simplified 2-point comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 793,
        "total_tokens": 2256
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew from a carrying value of $19.975 billion with a weighted‑average rate of 2.91 % in 2022 [page 189] to $27.168 billion at 4.45 % in 2023 [page 178], then slipped slightly to $26.93 billion while the rate rose to 4.84 % in 2024 [page 188]. This jump in both size and cost shows the bank added higher‑coupon fixed‑rate debt as market rates climbed, locking in financing and shifting its debt profile toward a larger, higher‑cost fixed‑rate base to manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - carrying values of $19.975B (2022), $27.168B (2023), and $26.93B (2024) match ground truth exactly (minor formatting: billion vs million notation is semantically equivalent). Weighted-average interest rates of 2.91% (2022), 4.45% (2023), and 4.84% (2024) are all accurate. The progression and year-over-year changes are correctly identified. COMPLETENESS: The answer addresses all required elements - the evolution of both carrying value and weighted-average interest rate across the three-year period, and provides strategic interpretation. ENTITY ACCURACY: Capital One (COF) correctly identified, fiscal years 2022-2024 properly sequenced, and the debt instrument (fixed unsecured senior debt/notes) accurately characterized. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical progression to strategic implications, noting the company's proactive approach to locking in higher-rate debt as market conditions changed. The interpretation that this represents a strategy to manage interest-rate risk through a larger, higher-cost fixed-rate base is logically consistent with the data. MINOR OBSERVATIONS: The LLM uses 'billion' notation while ground truth uses 'million' - both are correct representations of the same values ($19,975M = $19.975B). The LLM's characterization as 'fixed-rate unsecured senior notes' is semantically equivalent to 'fixed unsecured senior debt.' The strategic interpretation in the LLM answer ('locking in financing and shifting its debt profile') is slightly more detailed than the ground truth but remains consistent and accurate. No calculation errors detected. All facts are verifiable and correctly synthesized across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 501,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for product‑performance and operating‑cost guarantees fell from **$1.109 billion at 12/31/2022** to **$1.091 billion at 12/31/2023** and then to **$0.993 billion at 12/31/2024** (Note 16, “Guarantees” table on page 102).  The drop reflects that settlements and other adjustments exceeded the amount of new guarantees issued each year, indicating a modest but steady reduction in the company’s long‑term product‑performance risk exposure in its commercial‑aerospace business.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative dimensions. The ground truth establishes that RTX's liabilities for performance and operating cost guarantees were: 2022: $120 million, 2023: $120 million, and 2024: $101 million. The LLM provides completely different numbers: 2022: $1.109 billion, 2023: $1.091 billion, and 2024: $0.993 billion. These are off by a factor of approximately 10x. The LLM's numbers are roughly 9-10 times larger than the actual figures. While the LLM correctly identifies the direction of change (a decrease over the period), the magnitude is entirely wrong. The LLM also cites 'Note 16' and 'page 102' as sources, but these references do not validate the incorrect numbers provided. The reasoning about settlements exceeding new guarantees is logically sound in structure, but it is applied to the wrong financial figures. The ground truth indicates the liability decreased from $120M to $101M (a $19M or 15.8% decrease), while the LLM shows a decrease from $1.109B to $0.993B (a $116M or 10.5% decrease). Both show a declining trend, but the LLM's interpretation of 'modest but steady reduction' is based on fundamentally incorrect data. The core insight about reduced risk exposure is directionally correct but is built on false numerical foundations. This is a critical failure for a financial analysis question where precision of numbers is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 388,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "The 2022 filing (page 40) first disclosed that for non‑publicly traded investments the Company “uses … discounted cash flows, **estimates of sales proceeds** and appraisals” and warned that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value.” The 2023 filing (page 78) and the 2024 filing (page 79) repeat the same reliance on “estimates of sales proceeds” but phrase it as part of “various valuation methodologies” and continue to stress the difficulty of cash‑flow forecasting in emerging markets. Together, the three years show a consistent use of the sales‑proceeds approach while increasingly emphasizing the uncertainty of applying it in emerging markets, indicating a more cautious and transparent fair‑value assessment over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy in capturing the core narrative of Coca-Cola's evolving use of 'estimates of sales proceeds' across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression and the consistent use of the methodology across all three years; (2) Accurately cites the specific warning language about emerging and developing markets appearing in 2022 and continuing through 2023-2024; (3) Properly synthesizes the multi-hop information showing how the company's disclosure evolved from initial disclosure to continued reliance; (4) Correctly identifies page references (40, 78, 79) which adds credibility; (5) Accurately characterizes the shift toward 'more cautious and transparent fair-value assessment.' WEAKNESSES: (1) The LLM characterizes the evolution as 'consistent use' with 'increasingly emphasizing uncertainty,' which slightly undersells the ground truth's more nuanced three-stage progression: disclosure → deepening dependence → risk-aware integration. The ground truth emphasizes a more dynamic evolution ('strategic evolution from disclosure to operational reliance, followed by risk-aware integration'), while the LLM presents it as more static ('consistent use'); (2) The LLM does not explicitly capture the 2023 shift to 'relies on' language as a distinct intensification of dependence, instead grouping 2023 and 2024 together as repetitive; (3) Minor semantic difference: the ground truth emphasizes 'deepening dependence' in 2023 as a distinct phase, whereas the LLM treats 2023-2024 as essentially the same. QUANTITATIVE ACCURACY: Page numbers and year citations are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is present, but the characterization of the evolution's nature is slightly flattened compared to ground truth. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution and what it reveals about changing approach, though with less emphasis on the strategic phases of that evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 549,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor disclosures in 2022, 2023 and 2024 all contain the same statement that the company’s ability to return capital to shareholders “is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” [page_5]. Because the language is unchanged over the three years, the firm’s strategic flexibility for dividends or share‑repurchases remains consistently bounded by the same regulatory constraints, showing no expansion of leeway in shareholder capital distributions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core regulatory language present in all three years (2022-2024) regarding capital return limitations under U.S. banking laws, Delaware law, and preferred stock dividend failures. (2) The numeric/date references are accurate - correctly cites 2022, 2023, and 2024. (3) The LLM accurately notes that the language remained unchanged across the three-year period. CRITICAL WEAKNESSES: (1) The LLM answer MISSES the key evolution highlighted in the ground truth: the 2024 disclosure added NEW emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends. This is a material addition that represents an evolution in disclosures, not mere repetition. (2) The LLM concludes 'showing no expansion of leeway in shareholder capital distributions' which is technically correct but INCOMPLETE - it fails to capture that the 2024 disclosure introduced a new structural/internal capital flow dimension that wasn't emphasized in prior years. (3) The question specifically asks about how disclosures 'evolved' and what the 'multi-year progression suggests' - the LLM's answer that language was 'unchanged' misses the nuanced evolution in emphasis and focus areas. (4) The LLM provides a citation '[page_5]' without verification that this is accurate or complete. REASONING ASSESSMENT: The LLM demonstrates partial multi-hop synthesis by comparing across three years, but fails to identify the qualitative evolution in disclosure focus that distinguishes 2024 from prior years. The conclusion about 'consistently bounded' constraints is accurate but represents an incomplete analysis of the progression. The answer reads as a surface-level comparison rather than a deep analysis of how strategic flexibility implications evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 499,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD has flagged the possibility of “loss or modification of exemptions for taxes and tariffs” as a political‑legal‑economic risk in every filing – it appears in the 2022 10‑K (p. 37) 【page_37】, again in the 2023 10‑K (p. 41) 【page_41】 and in the 2024 10‑K (p. 40) 【page_40】. Although the wording of the risk itself is unchanged, the 2023 and 2024 disclosures add new references to sanctions, export‑control revisions and heightened geopolitical tensions (e.g., Russia‑Ukraine, China‑Taiwan), suggesting that AMD’s exposure to losing tax and tariff exemptions is growing amid an increasingly complex and volatile global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent presence of the tax/tariff exemption risk across all three years (2022, 2023, 2024) with accurate page references (p. 37, p. 41, p. 40). (2) Accurately captures the evolution of AMD's disclosure: static risk language paired with expanding contextual references to geopolitical tensions and regulatory changes. (3) Correctly identifies specific geopolitical events (Russia-Ukraine, China-Taiwan) and regulatory developments (sanctions, export-control revisions) that drove increased complexity. (4) Properly synthesizes the multi-hop reasoning: connects the unchanged risk wording to the expanding contextual disclosures to conclude that exposure is growing. (5) Uses appropriate qualifiers ('growing,' 'increasingly complex and volatile') that match the ground truth's assessment of escalating risk. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth, focusing on the key evolution pattern rather than elaborating on 'internal expansion' as a driver. However, this is a stylistic difference rather than a factual omission, as the answer captures the essential trend. The page references add specificity and verifiability that enhance credibility. The answer correctly interprets that the risk itself remained nominally unchanged while its context became more acute—a nuanced understanding that demonstrates sound multi-hop reasoning. No quantitative errors, date errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 436,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then edged up to $562 million in 2024, while its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024【page_178†L13-L20】【page_188†L13-L20】.  During the same period the company virtually eliminated its floating‑rate unsecured senior debt – down from $1.6 billion in 2022 to $349 million in 2023 and to zero in 2024 – shifting the debt mix toward fixed‑rate senior notes and thereby reducing its exposure to interest‑rate volatility, even though the weighted‑average rate on the remaining senior debt edged higher (≈4.5% → 4.8%)【page_178†L27-L33】【page_188†L27-L33】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that contradict the ground truth across multiple key metrics:\n\n1. TOTAL DEBT FIGURES - MAJOR DISCREPANCY:\n   - Ground Truth: 2022=$43.086B, 2023=$49.856B, 2024=$45.551B\n   - LLM Answer: 2022=$48.683B (883M+47.8B), 2023=$49.838B (538M+49.3B), 2024=$45.562B (562M+45.0B)\n   - The LLM's short-term borrowings figures ($883M, $538M, $562M) appear to be incorrect or misidentified. The ground truth shows total short-term + long-term debt of $43.086B in 2022, not $48.683B.\n\n2. SHORT-TERM BORROWINGS - INCORRECT:\n   - LLM claims: $883M (2022), $538M (2023), $562M (2024)\n   - These numbers don't reconcile with the ground truth total debt figures\n   - The LLM appears to have confused or misidentified what constitutes 'short-term borrowings'\n\n3. FLOATING UNSECURED SENIOR DEBT - PARTIALLY CORRECT:\n   - Ground Truth: $1.709B (2022), $349M (2023), $0 (2024)\n   - LLM Answer: $1.6B (2022), $349M (2023), $0 (2024)\n   - The 2022 figure is off by $109M ($1.709B vs $1.6B) - approximately 6.4% error\n   - The 2023 and 2024 figures are correct\n\n4. INTEREST RATE ACCURACY:\n   - Ground Truth: 2022=1.01%, 2023=6.75% (for floating debt); fixed debt 2022=2.91%, 2024=4.84%\n   - LLM Answer: Approximates as \"≈4.5% → 4.8%\" for weighted-average rate\n   - This is misleading and conflates different debt categories. The LLM fails to distinguish between floating and fixed rates properly\n   - The 1.01% rate for 2022 floating debt is completely omitted\n   - The 6.75% rate for 2023 floating debt is completely omitted\n\n5. FIXED UNSECURED SENIOR DEBT - MISSING:\n   - Ground Truth explicitly states: $21.045B (2022), $27.168B (2023), $26.930B (2024)\n   - LLM Answer: Does not provide these figures at all\n   - This is a significant omission of key debt structure information\n\n6. MULTI-HOP SYNTHESIS - INCOMPLETE:\n   - The question asks about evolution from 2022-2024 and what it reveals about debt structure and interest rate exposure\n   - LLM provides partial information but with incorrect base numbers\n   - The strategic pivot narrative is partially correct (floating to fixed) but undermined by incorrect supporting numbers\n\n7. CALCULATION VERIFICATION:\n   - Ground Truth total 2022: $43.086B (verifiable)\n   - LLM implied total 2022: $48.683B (incorrect)\n   - This represents a ~13% overstatement of 2022 debt\n\nThe LLM answer demonstrates some understanding of the strategic shift from floating to fixed-rate debt and the elimination of floating-rate exposure, but the foundational numbers are significantly wrong, making the analysis unreliable. The omission of fixed unsecured senior debt figures and the conflation of interest rates across debt categories further undermine the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 737,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG was disclosed as 57 % (and 51 % in the related IAE LLC) in the 2022 filing and the same 57 % figure appears in both the 2023 and 2024 filings【page_112】【page_101】. The unchanged majority stake shows RTX (via Pratt & Whitney) remains the primary beneficiary and strategic leader of the V2500 engine collaboration, underscoring its continued commitment and dominant positioning in the program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states RTX's net program share interest was 57% in 2022, but the ground truth clearly indicates it was 61% in 2022, declining to 57% in 2023 and 2024. This is a 4 percentage point discrepancy for 2022 - a material error. The LLM also mentions '51% in the related IAE LLC' which is not addressed in the ground truth and appears to conflate different metrics. (2) MULTI-HOP REASONING FAILURE: The LLM completely misses the core finding that RTX's stake DECREASED from 61% to 57% over the period. Instead, it claims the stake was 'unchanged' at 57% across all three years, which is factually incorrect. This represents a failure to synthesize the temporal evolution that is central to the question. (3) INTERPRETATION ERROR: The LLM's conclusion that the 'unchanged majority stake shows RTX remains the primary beneficiary' is based on the false premise that the stake remained constant. The ground truth interpretation - that the reduction indicates 'strategic adjustment' and 'gradual dilution' of RTX's direct economic exposure - is the opposite of what the LLM concludes. (4) INCOMPLETE ANSWER: The LLM fails to address what the change indicates about RTX's strategic positioning. The ground truth explains this indicates a shift in financial burden/risk to sub-collaborators, but the LLM provides no such analysis. The LLM's answer is internally inconsistent and contradicts documented facts from the SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 432,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade has remained a core, flagship brand in P&G’s Fabric & Home Care segment throughout the three most recent filings. In the 2022 10‑K, Cascade is listed among the major home‑care brands and is called out as a primary driver of the segment’s roughly 25 % global home‑care market share (2022 p. 19). The 2023 filing continues to place Cascade in the same “major brands” list for Fabric & Home Care (2023 p. 18) and the 2024 filing again lists Cascade alongside Dawn, Febreze and Swiffer, noting the segment’s ~25 % home‑care share (2024 p. 18). Overall, Cascade’s positioning has not changed – it stays highlighted as a leading home‑care brand while the Fabric & Home Care segment’s share of net sales grew modestly from about 35 % in 2022 to 36 % in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Cascade's consistent positioning within P&G's Fabric & Home Care segment and accurately notes the segment's net sales percentages (35% in 2022 growing to 36% in 2024). However, there are significant quantitative discrepancies: (1) The LLM introduces a '~25% global home-care market share' metric that is not present in the ground truth answer, which focuses on segment contribution percentages rather than market share. This appears to be either fabricated or from a different context. (2) The LLM omits critical earnings contribution data entirely - the ground truth specifies that the Fabric & Home Care segment represented 31% of net earnings in 2022, 34% in 2023, and 34% in 2024. This is a significant omission as the ground truth explicitly notes the earnings contribution increase from 31% to 34%. (3) The LLM provides page references (p. 19, p. 18, p. 18) that cannot be verified against the ground truth. On the positive side, the LLM correctly identifies the three-year period, correctly names Cascade and companion brands (Dawn, Febreze, Swiffer), and accurately conveys that Cascade's positioning remained stable. The qualitative assessment of Cascade as a 'core, flagship brand' aligns with the ground truth's characterization. The multi-hop reasoning is sound in synthesizing information across three filing years, but the incomplete financial picture (missing earnings percentages) and the unexplained market share metric represent material gaps in accuracy. The answer is partially correct but incomplete on quantitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 435,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon only gave a partial, relative link for the Directors’ Code of Conduct (“bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf”) and the employee Code of Conduct was hosted on the older “www.bny.com” domain【page_13】. By the 2023 filing the company switched to a full HTTPS URL on the unified “www.bnymellon.com” domain (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf) and retained that same structure in the 2024 filing【page_13】, while the disclosure now explicitly ties the Directors’ Code of Conduct to the broader corporate‑governance framework (referencing the proxy, director‑compensation and board‑committee sections) and states that any amendments will be posted on the website【page_13】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. CRITICAL URL PATH ERRORS:\n   - 2022: LLM claims 'investor-relations' path, but ground truth shows 'in relations' (typo in original) or 'inv relations' (2023). The LLM incorrectly modernizes the 2022 path.\n   - 2023: LLM correctly identifies 'inv relations' path, matching ground truth.\n   - 2024: LLM fails to mention the transition to 'bny.com' domain and the corrected 'investor-relations' path that ground truth emphasizes as a key evolution.\n\n2. DOMAIN BRANDING EVOLUTION MISSED:\n   - Ground truth explicitly highlights the 2024 transition from 'bnymellon.com' to 'bny.com' as a significant strategic shift in brand consistency.\n   - LLM answer completely omits this critical domain change, stating the company 'retained that same structure in the 2024 filing' when the domain actually changed.\n   - This is a major oversight as domain branding evolution is explicitly part of the question.\n\n3. CONTRADICTORY CLAIMS ON 2022:\n   - LLM states 2022 had a 'partial, relative link' and mentions 'www.bny.com' for employee code.\n   - Ground truth indicates 2022 used 'bnymellon.com' domain with a specific path structure.\n   - These accounts are inconsistent regarding which domain was primary in 2022.\n\n4. PARTIAL CREDIT FOR GOVERNANCE INTEGRATION:\n   - LLM correctly identifies that 2024 filing explicitly ties the Directors' Code to broader corporate governance framework (proxy, director compensation, board committees).\n   - This is accurate and represents one of the few correct elements.\n   - LLM also correctly notes the amendment disclosure commitment.\n\n5. MULTI-HOP SYNTHESIS FAILURE:\n   - The question asks about evolution from 2022-2024 across three dimensions: URL structure, domain branding, and governance integration.\n   - LLM fails on domain branding (misses 2024 transition to bny.com).\n   - LLM partially fails on URL structure (gets 2023-2024 partially right but mischaracterizes 2022).\n   - LLM succeeds only on governance integration aspect.\n   - Overall synthesis is incomplete and contains directional errors.\n\n6. SEMANTIC ACCURACY:\n   - The core narrative of evolution from 'siloed document-focused' to 'stakeholder-oriented, brand-consistent' governance disclosure is not captured.\n   - LLM presents a flatter narrative without the strategic evolution emphasized in ground truth.\n\nThe answer demonstrates partial understanding but fails on the most critical factual elements (domain transition in 2024, URL path accuracy in 2022) that are central to answering the question about how disclosures evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 708,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "AMD’s 2022 filing said that “in most instances, our agreements with AIBs protect their inventory of our products against price reductions” and that “SIs often use discrete graphics solutions as a means to differentiate their products and add value to their customers” (AMD 10‑K 2022 p. 11). By the 2023 filing the language had shifted to a blanket statement – “Our agreements with AIBs protect their inventory of our products against price reductions” – while retaining the same emphasis on discrete graphics for differentiation (AMD 10‑K 2023 p. 13). The 2024 filing repeats the definitive inventory‑protection wording and continues to stress that system integrators rely on discrete graphics solutions to differentiate and add value (AMD 10‑K 2024 p. 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of inventory protection language from 'in most instances' (2022) to definitive statements (2023-2024), showing careful attention to nuanced policy shifts. (2) Accurately cites specific page numbers (p. 11 for 2022 and 2024, p. 13 for 2023) and filing years. (3) Properly synthesizes the consistent emphasis on discrete graphics as a differentiation strategy across all three years. (4) Correctly identifies the key entities (AMD, AIBs, SIs) and their relationships. (5) The reasoning about the 'shift' from conditional to definitive language is sound and adds analytical depth beyond the ground truth. MINOR CONSIDERATIONS: (1) The ground truth uses 'consistently maintained' while the LLM describes a 'shift' in language - this is actually a more precise observation that the ground truth doesn't explicitly capture, representing added analytical value rather than an error. (2) The LLM provides direct quotations with specific page citations, which enhances credibility and verifiability. (3) All three years are properly addressed with appropriate detail. The answer fully addresses the multi-part question regarding inventory protection policies and discrete graphics solutions' role in differentiation strategies. No numerical errors, calculation errors, or factual inaccuracies detected. The semantic meaning aligns perfectly with the ground truth while providing more granular detail about the policy language evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 437,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In the 2022 10‑K McDonald’s listed the Egg McMuffin as a staple breakfast item and said the menu is continuously evolved to meet customers’ expectations for taste, quality, value and nutrition, while its supply‑chain discussion emphasized high food‑safety standards, a Food‑Safety Advisory Council and supplier collaboration for innovation and sustainable sourcing. The 2023 filing repeats the Egg McMuffin reference but adds a digital‑transformation and data‑excellence focus to the supply‑chain strategy, highlighting risk‑management and consistent quality across the system. By 2024 the company again spotlights the Egg McMuffin as a core breakfast product and frames its supply‑chain approach around consistency—using virtual supplier visits, contingency planning and scale‑driven cost predictability—to ensure the item meets customer expectations for quality and consistency.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the Egg McMuffin as a staple breakfast item across all three years (2022-2024). (2) Accurately captures the evolution from general quality assurance to more technologically integrated approaches. (3) Correctly notes the presence of supply chain collaboration and digital transformation elements. (4) No quantitative errors in dates or numeric values. (5) Properly synthesizes multi-hop information across three fiscal years.\n\nWEAKNESSES: (1) The LLM introduces specific details not present in the ground truth (e.g., 'virtual supplier visits,' 'contingency planning,' 'scale-driven cost predictability' in 2024) that cannot be verified against the original answer and may represent hallucination or over-specification. (2) The 2023 description differs significantly - the ground truth emphasizes 'Global Chief Supply Chain Officer' and 'comprehensive global supply chain strategy,' while the LLM mentions 'digital-transformation and data-excellence focus' which appears to conflate 2023 and 2024 elements. (3) The ground truth explicitly states the 2024 shift involves 'digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance,' but the LLM frames 2024 around 'virtual supplier visits' and 'contingency planning' instead. (4) Missing the specific mention of 'Global Chief Supply Chain Officer' from 2023 disclosure. (5) The characterization of 2022 supply chain discussion (Food-Safety Advisory Council, supplier collaboration) is not explicitly confirmed in the ground truth, which only mentions 'ongoing menu evolution.'\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by tracking the Egg McMuffin across three years and connecting it to evolving supply chain narratives. However, the specific details introduced for 2024 appear to deviate from the ground truth's focus on 'digital transformation project' and 'data excellence' metrics.\n\nCRITICAL ISSUE: The LLM's 2024 description introduces concrete supply chain tactics (virtual visits, contingency planning) that are not mentioned in the ground truth, suggesting either hallucination or reliance on information not in the provided knowledge graph. This represents a factual accuracy concern despite the overall narrative coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 621,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle’s 10‑K exhibit tables for 2022, 2023 and 2024 all list a “4.30 % Note due 2034” (see the 2022 filing on page 113 and the 2023/2024 filings on page 110). The repeated inclusion shows that the company has kept this fixed‑rate, long‑dated bond as a core component of its debt portfolio, reflecting a deliberate strategy to lock in relatively low‑cost financing for the next decade and to maintain a balanced, long‑term maturity profile for funding growth and other strategic needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 4.30% Note due 2034 as a consistent element across 2022, 2023, and 2024 filings, and accurately notes its presence on specific pages (113 for 2022, 110 for 2023/2024). The numeric values (4.30%, 2034 maturity date) are correct. However, the answer has significant weaknesses: (1) It lacks the multi-hop synthesis that the ground truth provides by comparing the 4.30% Note alongside OTHER instruments in each year (3.625% Note due 2023, 4.50% Note due 2044 in 2022; 2.950% Notes due 2024 in 2023). The ground truth demonstrates how Oracle's debt portfolio evolved while maintaining the 4.30% Note, showing a diversified maturity profile strategy. (2) The LLM answer provides generic interpretation ('lock in relatively low-cost financing,' 'balanced, long-term maturity profile') without the specific contextual evidence from the filings about how the debt portfolio changed across years. (3) The ground truth explicitly notes the 'evolving debt portfolio' and how newer instruments were issued while the 4.30% Note persisted, suggesting strategic debt management. The LLM answer misses this nuance. (4) The LLM answer is more superficial in its analysis—it states the note is 'core' and reflects 'deliberate strategy' but doesn't substantiate this with the comparative analysis across years that the ground truth provides. The answer is partially correct on the basic facts but incomplete in addressing the full scope of what the consistent disclosure indicates about Oracle's financing priorities and debt structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 430,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "- 2022 – Capital One valued its net derivative assets/liabilities as Level 3 instruments using discounted‑cash‑flow models that rely on **swap‑rate assumptions** (the only significant unobservable input).  The fair‑value table shows a $19 million Level 3 amount (swap‑rate range 1‑2 %, weighted‑average 2 %) and the roll‑forward balance at year‑end was $5 million【page 222】.  \n\n- 2023 – The same methodology persisted, but the fair‑value amount grew to **$58 million** (swap‑rate range 3‑5 %, weighted‑average 4 %) and the year‑end balance was $58 million【page 208】【page 206】.  \n\n- 2024 – The approach remained unchanged (discounted cash flows with swap‑rate inputs), and the Level 3 fair‑value rose further to **$69 million** (swap‑rate range 4 %, weighted‑average 4 %) with a year‑end balance of $69 million【page 217】【page 215】.  \n\n**Interpretation:** The valuation technique for the derivative position has been stable, but the fair‑value of the net derivative assets/liabilities has risen sharply from 2022 to 2024, indicating a growing exposure to unobservable swap‑rate inputs and a larger Level 3 derivative exposure over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - 2022: LLM states $19M fair value with swap rates 1-2% (weighted avg 2%), but also mentions $5M year-end balance. Ground truth confirms $19M fair value but does NOT mention swap rates for 2022 - only mentions net unrealized loss of $20M.\n   - 2023: LLM correctly identifies $58M fair value and swap rates 3-5% (weighted avg 4%), matching ground truth.\n   - 2024: LLM states $69M fair value with 4% swap rates. CRITICAL ERROR: Ground truth explicitly states the fair value remained at $58M in 2024, NOT $69M. This is a $11M discrepancy.\n   - The LLM's claim of a \"sharp rise from 2022 to 2024\" is factually incorrect since 2024 maintained 2023 levels at $58M.\n\n2. METHODOLOGY ISSUES:\n   - LLM attributes swap-rate inputs to 2022, but ground truth does not mention swap rates for 2022 - only for 2023-2024.\n   - LLM claims consistent DCF methodology across all years, but ground truth indicates a transformation in methodology from 2022 (mixed realized/unrealized loss position) to 2023-2024 (stable fair value with structured inputs).\n   - Ground truth mentions default rates (53-163%) as unobservable inputs in 2023, which LLM completely omits.\n\n3. INTERPRETATION ERRORS:\n   - LLM's conclusion about \"sharp rise from 2022 to 2024\" is contradicted by the actual data showing $19M → $58M → $58M (plateau, not continued rise).\n   - LLM misses the key insight from ground truth: the transformation from a mixed loss position in 2022 to stable fair value methodology in 2023-2024.\n   - LLM fails to capture the full range of unobservable inputs (default rates missing).\n\n4. MULTI-HOP SYNTHESIS:\n   - The answer attempts to synthesize across three years but introduces a critical factual error in 2024 that undermines the entire analysis.\n   - The reasoning about \"growing exposure\" is logically flawed given the actual data trajectory.\n\nThe LLM answer demonstrates partial understanding of the structure and some correct data points (2023 figures), but the 2024 valuation error ($69M vs. $58M) is a fundamental factual mistake that invalidates the core conclusion about trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 605,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX disclosed that the Rolls‑Royce‑related obligation is a “flight‑hour” payment tied to each hour flown by V2500‑powered aircraft through June 2027. In the 2022 filing the company said these contingent payments would be **capitalized as collaboration intangible assets as they are made** (page 112). By the 2023 filing the same payments were **being capitalized as collaboration assets and amortized to cost of sales** (page 73), and the 2024 filing reiterated the **capital‑as‑paid approach** with amortization to cost of sales (page 103). The overall contractual‑obligation balance fell from **$818 million at year‑end 2022 to $735 million at year‑end 2023**, with **$81 million of consumption expected in 2024** (page 112).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core structure of RTX's Rolls-Royce obligations (flight-hour payments through June 2027, capitalization as collaboration assets, amortization to cost of sales) and demonstrates good understanding of the evolution from 2022-2024. However, there are significant quantitative accuracy issues that prevent a higher score: (1) The specific dollar amounts cited ($818M at end-2022, $735M at end-2023, $81M expected in 2024) cannot be verified against the ground truth, which does not provide these specific figures. The ground truth mentions $14.1B in total commercial aerospace commitments for 2024 but does not break out the Rolls-Royce obligation amounts for 2022-2023. (2) The page references (112, 73, 103) are provided but cannot be independently verified. (3) The LLM provides more granular financial detail than the ground truth, which raises questions about accuracy - either these numbers are correct but not in the ground truth, or they may be fabricated/hallucinated. The qualitative aspects are strong: the answer correctly identifies the payment structure evolution, the capitalization policy, the amortization approach, and the June 2027 endpoint. The multi-hop reasoning is sound in connecting the 2012 acquisition context to the ongoing obligations. However, the unverifiable specific numbers and the discrepancy between the detailed figures provided and the ground truth's more general statements create significant uncertainty about factual correctness. The answer would score higher if the specific dollar amounts could be verified or if the LLM had acknowledged uncertainty about precise figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 451,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "- 2022 10‑K (p. 51): Amgen said that after the FDA’s 2017 review of the Neulasta Onpro kit the company “implemented device and labeling enhancements to address product complaints” and that it “continuously monitor[s] complaints and adverse events and implement additional enhancements as needed.”  \n- 2023 10‑K (p. 54): The same language was repeated – the 2017 FDA‑driven device/label changes and ongoing complaint monitoring were disclosed, with no new device actions reported.  \n- 2024 10‑K (p. 53): Amgen again references the 2017 device and labeling upgrades and continuous monitoring, but now couples this with broader operational‑resilience disclosures (p. 52) that detail backup‑generator use, power‑outage mitigation, and supply‑chain safeguards to ensure uninterrupted manufacturing and supply of the kit.  \n\nThus, the company’s narrative evolved from focusing solely on the kit’s device‑related enhancements and complaint monitoring (2022‑2023) to a more comprehensive risk‑mitigation approach that also emphasizes manufacturing and supply‑chain resilience (2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Amgen's disclosures regarding Neulasta Onpro kit; (2) Accurately references the 2017 FDA evaluation as the foundational event; (3) Properly captures the consistent focus on device and labeling enhancements across all three years; (4) Correctly notes the shift in 2024 to include operational resilience measures; (5) Appropriately identifies backup generators and power outage mitigation as new elements in 2024; (6) Accurately synthesizes the multi-hop relationship between manufacturing resilience and user experience/complaints. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page numbers (p. 51, p. 54, p. 53, p. 52) which add precision but cannot be verified against the ground truth provided; however, these do not contradict the ground truth and enhance credibility; (2) The LLM answer provides slightly more structural detail by organizing information chronologically with specific filing references, which is a strength rather than a weakness; (3) The ground truth mentions 'an island-wide outage on December 31, 2024' as a specific example, while the LLM answer generalizes to 'power-outage mitigation' - this is a minor omission of a specific detail but does not affect the overall accuracy of the narrative evolution. QUANTITATIVE ACCURACY: All dates (2017, 2022, 2023, 2024) are correct. No calculations are required for this qualitative question. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and identifies the evolution pattern, demonstrating sound multi-hop reasoning. The connection between operational resilience (backup generators, power outages) and device production/user experience is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 545,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon’s Item 14 still reads that the ratification of KPMG LLP as its principal accountant is incorporated by reference to the proxy (Item 3) and that KPMG’s PCAOB firm identification number is 185【page_14】. The wording and the PCAOB number are unchanged from year to year, indicating that the company has retained the same auditor and that its audit‑governance framework has remained continuous and stable over this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies BK/BNY Mellon as the subject company across all three years (2022, 2023, 2024); (2) Accurately states KPMG LLP as the principal accountant in all three filings; (3) Correctly identifies PCAOB firm number 185 consistently across all years; (4) Properly synthesizes the multi-hop information showing no changes year-to-year; (5) Correctly interprets the consistency as indicating stable audit governance and auditor continuity; (6) Appropriately references Item 14 and Item 3 (proxy incorporation by reference) showing knowledge of 10-K structure. MINOR WEAKNESSES: (1) The answer uses 'BNY Mellon' (full legal name) while the question uses 'BK' (ticker), though this is a minor semantic variation and both are correct; (2) The answer is slightly more concise than the ground truth, omitting some contextual language about 'institutional trust' and 'strong' governance practices, though the core message about continuity and stability is preserved; (3) The phrase 'still reads' could be interpreted as slightly awkward phrasing, though it conveys the intended meaning. QUANTITATIVE VERIFICATION: The PCAOB number 185 is stated correctly and consistently. The three-year period (2022, 2023, 2024) is correctly identified. No calculations are required for this question. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate filings to demonstrate consistency and draw conclusions about governance continuity. The logic is sound: unchanged disclosure + unchanged PCAOB number = stable audit relationship. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with the core conclusion about audit governance continuity clearly stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 496,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s total commercial‑aerospace financing guarantees fell from $304 million at year‑end 2022 to $288 million at year‑end 2023 and $274 million at year‑end 2024【page_100†L1-L4】【page_102†L1-L4】.  During the same period the portion attributable to collaboration partners slipped from about $142 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100†L9-L11】【page_102†L9-L11】, signalling a deliberate move to shrink partner‑backed exposure and tighten risk‑management around these customer‑financing guarantees.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three key collaboration partners' share figures ($142M in 2022, $135M in 2023, $131M in 2024) and accurately characterized the downward trend. The numbers are formatted correctly and match the ground truth exactly. The LLM also correctly identified the overall total guarantees declining from $304M to $288M to $274M, providing additional context not explicitly requested but relevant to understanding the trend.\n\nWEAKNESSES: (1) The LLM answer is incomplete in addressing the full scope of the original question. The ground truth emphasizes that RTX 'maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.' This important contextual element about asset valuation confidence is entirely absent from the LLM answer. (2) The LLM's characterization of the trend as 'a deliberate move to shrink partner-backed exposure' is reasonable but less nuanced than the ground truth's explanation that it 'potentially reflects a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities.' The LLM provides one interpretation without acknowledging alternative explanations. (3) The LLM answer lacks the broader context about RTX's overall risk management strategy beyond just the partner share reduction - it doesn't discuss the company's confidence in underlying asset values or the relationship between guarantee reductions and reserve adequacy.\n\nMULTI-HOP REASONING: The LLM successfully synthesized the collaboration partners' share data across three years and correctly identified the declining trend. However, it failed to synthesize the complete picture that includes the relationship between guarantee values and underlying asset values, which is a critical component of understanding RTX's risk management strategy in this domain.\n\nNUMERIC VERIFICATION: All dollar amounts are correct. The trend analysis (declining from $142M to $135M to $131M) is accurate. The additional total guarantee figures ($304M, $288M, $274M) are presented correctly and add value, though they weren't explicitly requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 606,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "P&G’s 10‑K tables from 2022‑2024 all list the Baby, Feminine & Family Care segment as “Feminine Care (Adult Incontinence, Menstrual Care)” with the major brands “Always, Always Discreet, Tampax…” 【page_19】. In each filing Always (with Tampax) is still described as the leading menstrual‑care brand, while Always Discreet is the adult‑incontinence brand; however the narrative evolves – the 2022 filing notes Always Discreet holds about 10 % market share, whereas the 2024 filing says its share has risen to roughly 15 % 【page_19】 【page_18】. This shows the categorization stayed the same, but the emphasis on the broader feminine‑hygiene portfolio grew, with Always remaining the flagship menstrual brand and Always Discreet gaining a stronger market‑share focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) SEGMENT NAMING ERROR: The LLM claims the segment was called 'Baby, Feminine & Family Care' with subtitle 'Feminine Care (Adult Incontinence, Menstrual Care)' in all three years (2022-2024). However, the ground truth explicitly states that in 2022 it was listed as 'Feminine Care' (not 'Baby, Feminine & Family Care'), and only in 2023 was it renamed to 'Baby, Feminine & Family Care.' This is a critical factual error about the evolution being asked. (2) SEGMENT CONTRIBUTION PERCENTAGES: The ground truth provides specific percentages (25% in 2022, 24% in 2023 and 2024), but the LLM answer completely omits these key metrics that directly address the question about positioning and emphasis. (3) MARKET SHARE CLAIMS: The LLM introduces market share figures (10% for Always Discreet in 2022, rising to 15% in 2024) that are not mentioned in the ground truth answer. While these may be factually present in the filings, they represent a different analytical angle than what the ground truth emphasizes, and their accuracy cannot be verified against the provided ground truth. (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes the structural evolution (segment renaming, product grouping changes, formatting streamlining), while the LLM focuses on market share trends and brand positioning within categories. The LLM misses the key point that the segment name itself changed from 'Feminine Care' to 'Baby, Feminine & Family Care.' (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the year-by-year evolution that the question specifically asks for ('from 2022 through 2024'). The ground truth clearly delineates changes by year; the LLM treats all years as having the same categorization. The answer does correctly identify the brands (Always, Always Discreet, Tampax) and their roles, but fundamentally misrepresents the timeline and nature of the positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 543,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In the 2022 filing AMD listed “difficulties in protecting our intellectual property” as one of many generic foreign‑operation risks and called out specific Chinese‑entity issues (the THATIC JV and its placement on the U.S. Entity List) while noting that 72 % of its revenue already came from international sales and that it relied on third‑party foundries and assembly in China, Malaysia and Taiwan (2022 p. 36‑37, 39). By the 2024 filing, with international sales still around two‑thirds of revenue, AMD’s risk discussion ties IP‑protection challenges directly to its expanded Asian footprint—its greater dependence on third‑party wafer foundries and final‑assembly facilities in China, Malaysia and Taiwan and the heightened geopolitical tensions between China and Taiwan—showing a materially higher exposure to IP‑protection difficulties (2024 p. 40‑41).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's IP protection challenges and their evolution, with generally sound multi-hop reasoning across the 2022-2024 period. However, there are notable quantitative discrepancies that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the core evolution: IP protection challenges becoming more complex and regionally concentrated in Asia\n2. Accurately names the specific manufacturing locations (China, Malaysia, Taiwan) across both years\n3. Properly identifies the THAIC JV and U.S. Entity List issue as a 2022-specific concern\n4. Correctly notes the emergence of China-Taiwan geopolitical tensions as a 2024 risk factor\n5. Sound multi-hop synthesis connecting international sales percentages to IP exposure\n6. Appropriate page citations (2022 p. 36-37, 39; 2024 p. 40-41)\n\nWEAKNESSES:\n1. QUANTITATIVE DISCREPANCY: LLM states \"72% of its revenue already came from international sales\" in 2022, but the ground truth specifies \"65% of net revenue\" for 2023. The LLM conflates the 2022 figure (72%) with the 2023 figure (65%), creating ambiguity about which year's percentage is being cited. This is a material error in precision.\n2. The LLM states international sales were \"still around two‑thirds of revenue\" in 2024, which is approximately correct (66.7% = 2/3), but this is less precise than the ground truth's specific percentages.\n3. Missing explicit mention of the 2023 data point (65% international sales, heightened IP risks in those regions) - the answer jumps from 2022 to 2024, omitting the middle year's evolution.\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three years and connects multiple concepts (international sales %, manufacturing locations, geopolitical risks, IP protection challenges). The reasoning that expanded Asian footprint correlates with higher IP exposure is sound and well-articulated.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns with ground truth: IP challenges evolved from generic foreign-operation risks to more specific, regionally-concentrated Asian risks tied to geopolitical tensions. The wording differs but conveys equivalent meaning.\n\nJUSTIFICATION:\nThe 72% vs 65% discrepancy and omission of the 2023 midpoint data prevent a score above 7. While the qualitative analysis is strong (8/10) and contextual relevance is high (8/10), the quantitative accuracy suffers (6/10) due to the percentage confusion and lack of precision in year-to-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 668,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle’s 2.300 % notes due 2028 do not appear in the 2022 Form 10‑K – the exhibit list on pages 112‑116 only shows earlier series (e.g., 2.95 %‑2025, 2.65 %‑2026) and contains no 2.300 %‑2028 entry. By the 2023 filing, Oracle includes a “2.300 % Notes due 2028” as part of a 2021 issuance of a multi‑tranche series (1.650 %‑2026, 2.300 %‑2028, 2.875 %‑2031, 3.650 %‑2041, 3.950 %‑2051, 4.100 %‑2061) in Exhibit 4.14 (page 111). The 2024 filing again references the same series in Exhibit 4.16 (page 114), showing the notes remain outstanding. This pattern reveals Oracle’s strategy of building a laddered, low‑coupon debt program with staggered maturities that spreads refinancing risk and locks in inexpensive financing over a long horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 2.300% Notes due 2028 'do not appear in the 2022 Form 10-K,' but the ground truth explicitly states Oracle 'first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16.' This is a direct contradiction on a core factual claim. (2) EXHIBIT MISMATCH - The LLM states the 2024 filing references the notes in 'Exhibit 4.16 (page 114),' but the ground truth indicates it should be in 'Exhibit 4.14' for 2024 (consistent with 2023). The LLM appears to have confused exhibit numbers across years. (3) ISSUANCE DATE DISCREPANCY - The LLM claims the 2.300% Notes are 'part of a 2021 issuance,' which aligns with ground truth mentioning 'notes issued in March 2021,' but this contradicts the LLM's own claim that they don't appear in 2022 (they should if issued in 2021). (4) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the multi-tranche series structure and provides reasonable strategic interpretation about laddered maturities and refinancing risk, this analytical insight cannot compensate for the factual errors about when the notes first appeared in filings. (5) MULTI-HOP REASONING FAILURE - The question asks how the issuance 'evolved from 2022 to 2024,' requiring tracking across three years. The LLM failed to correctly establish the 2022 baseline, undermining the entire multi-hop analysis. The ground truth shows consistent inclusion across all three years (2022, 2023, 2024), while the LLM incorrectly excludes 2022. The strategic conclusion about 'stable and deliberate approach' in the ground truth is more accurate than the LLM's framing, which misses the continuity element.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 489,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "BA’s private‑equity approach did not change materially between 2022 and 2024. In each filing the company describes its private‑equity vehicles as “primarily limited partnerships (LPs) that mainly invest in **U.S. and non‑U.S.** leveraged‑buyout, **venture‑capital, growth and special‑situation** strategies – language that appears unchanged in the 2022 filing (page 110), the 2023 filing (page 92) and the 2024 filing (page 99). Thus, the geographic scope stayed global and the strategic focus remained on those four investment themes throughout the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims BA's private equity strategy 'did not change materially between 2022 and 2024,' directly contradicting the ground truth which documents clear evolution: 2022 focused on leveraged buyout/venture capital/growth/special situations; 2023 expanded to 'global private investments in real assets such as energy, farmland, and infrastructure'; 2024 added 'increased sophistication in investment vehicles, including derivatives.' (2) The LLM completely omits the 2023 expansion into real assets (energy, farmland, infrastructure), which is a material strategic shift documented in the ground truth. (3) The LLM fails to capture the 2024 evolution toward derivatives and performance transfer mechanisms. (4) The LLM's conclusion that 'geographic scope stayed global and strategic focus remained on those four investment themes throughout the period' is incomplete and misleading—while the core four themes persisted, the ground truth shows significant additions and sophistication enhancements. POSITIVE ASPECTS: The LLM correctly identifies the four core investment strategies (leveraged buyout, venture capital, growth, special situations) and correctly notes the U.S. and non-U.S. geographic scope. The page citations (110, 92, 99) appear plausible. However, the fundamental failure to recognize and articulate the documented evolution in strategy—particularly the 2023 expansion into real assets and 2024 sophistication in derivatives—represents a major comprehension failure on a multi-hop question specifically asking about evolution. The answer reads as static when the ground truth clearly shows dynamic strategic development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 475,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen first listed Bemarituzumab as a Phase 3 candidate (an “initiated Phase 3 study” for gastro‑esophageal‑junction adenocarcinoma) in its 2022 10‑K – and the same filing also showed it in Phase 2 for other tumors and Phase 1 for NSCLC, with composition‑of‑matter patents projected to expire in 2029 in both the United States and Europe【page_25†L1-L9】【page_25†L31-L38】. The 2023 filing continued to place Bemarituzumab in the Phase 3 program table (still an initiated Phase 3 study) and retained the 2029 U.S. and European expiration dates【page_25†L1-L9】【page_26†L1-L8】, and the 2024 filing showed no change – it remained a Phase 3 program for GEJ adenocarcinoma (ongoing Phase 3 study) with the same 2029 patent‑expiration estimates for both territories【page_25†L1-L9】【page_26†L1-L8】. In short, from 2022 through 2024 Bemarituzumab stayed in Phase 3 (ongoing) and its U.S. and European patent expirations were consistently projected for 2029.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key milestones and patent timelines. STRENGTHS: (1) All numeric values are correct - 2029 patent expiration dates for both U.S. and Europe are accurately stated across all three years (2022-2024); (2) Clinical phase progression is correctly tracked: Phase 3 initiated in 2022, continued through 2023-2024; (3) Multi-hop synthesis is sound - the answer successfully integrates information across three separate 10-K filings to show consistency in both clinical development and IP positioning; (4) Entity identification is accurate - Amgen, Bemarituzumab, GEJ adenocarcinoma, and FGFR2b targeting are all correctly identified; (5) The answer provides more granular detail than the ground truth (mentioning Phase 2 and Phase 1 programs in other indications), which adds value without contradicting the core answer. MINOR WEAKNESSES: (1) The LLM answer is more technical/detailed than the ground truth, which may be seen as slightly over-specifying (mentioning composition-of-matter patents specifically, Phase 2/Phase 1 programs) - though this is factually accurate and not incorrect; (2) The ground truth emphasizes the 'stable intellectual property position' narrative more explicitly, while the LLM answer focuses on factual consistency without as much interpretive framing; (3) The LLM answer could have more explicitly stated the monoclonal antibody description and FGFR2b targeting mechanism that appears in the 2024 filing, though this is a minor omission. CALCULATION/DATE VERIFICATION: All dates (2022, 2023, 2024, 2029) are correct. No calculations required. The patent expiration timeline of 2029 is consistently and correctly cited across all three years. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to demonstrate the evolution (or lack thereof) of Bemarituzumab's development and IP position. The reasoning that 'no change' occurred from 2022-2024 is logically sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 549,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "In 2022 Dawn was already listed as one of the core brands in the Fabric & Home Care segment, a segment that contributed 31 % of P&G’s net earnings (35 % of net sales) 【page_19†L31-L38】. By 2024 Dawn is still shown among the segment’s major brands, and the segment’s earnings share rose to 34 % of net earnings (36 % of net sales) 【page_18†L31-L38】. Thus Dawn’s positioning remained a key brand, while the Fabric & Home Care segment grew to a larger share of overall earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Dawn's positioning evolution. QUANTITATIVE VERIFICATION: All numbers are correct - 2022: 31% earnings/35% sales; 2024: 34% earnings/36% sales. The LLM correctly identifies the earnings increase from 31% to 34% and the sales stability (35% to 36%). COMPLETENESS: The answer addresses the core question by tracking Dawn's positioning across both years, noting its consistent presence as a core/major brand and the segment's growing earnings importance. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and correctly connects Dawn's brand listing to the segment's financial performance metrics. MINOR GAPS: The original answer provides slightly more comprehensive context by explicitly mentioning all three years (2022, 2023, 2024) and noting the 2023 sales figure (36%), whereas the LLM focuses primarily on 2022 and 2024 endpoints. The original also emphasizes the 'stable' nature of sales percentages more explicitly. However, the LLM's statement that sales 'remained stable' is semantically equivalent and accurate. ENTITY ACCURACY: All entities correctly identified (P&G, Fabric & Home Care segment, Dawn, net earnings, net sales). REASONING QUALITY: The conclusion that 'Dawn's positioning remained a key brand, while the Fabric & Home Care segment grew to a larger share of overall earnings' is logically sound and directly supported by the data. The answer effectively conveys the evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 429,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "Schwab’s reliance on client‑held securities expanded markedly after 2022. In 2022 the firm noted that client equities were chiefly used for securities‑loan activities (≈ $7.2 bn of securities loaned) and that margin loans were fully collateralized by client securities, but the amount pledged to third parties was not quantified (page_107). By 2023 Schwab explicitly disclosed that client securities were pledged to meet margin‑requirement obligations for options clearing, short‑sales and securities‑lending, with total third‑party pledged collateral of $31.4 bn (page_99; page_75‑76). In 2024 the pledged pool grew substantially, underpinning $59.8 bn of borrowing capacity at the Federal Home‑Loan Bank and $30.5 bn at the Federal Reserve, while secured lines of credit backed by client margin securities fell to $500 m from $950 m a year earlier, indicating a larger but more diversified exposure to client‑held assets (page_97).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and numerical errors that undermine its credibility:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n- The LLM cites specific dollar amounts ($7.2bn securities loaned in 2022, $31.4bn pledged in 2023, $59.8bn FHLB borrowing capacity, $30.5bn Federal Reserve capacity, $500m and $950m secured lines) with page references, but these numbers cannot be verified against the ground truth answer, which does not provide these specific figures.\n- The ground truth answer does NOT mention any of these specific dollar amounts, suggesting the LLM may have fabricated or misattributed these numbers.\n- The LLM provides precise page citations (page_107, page_99, page_75-76, page_97) that cannot be verified and appear to be hallucinated.\n\n2. COMPLETENESS AND SYNTHESIS:\n- The ground truth emphasizes the evolution of pledging practices and collateral management across three years, focusing on regulatory compliance (ASC 326), options clearing, and securities lending.\n- The LLM answer shifts focus heavily toward quantifying borrowing capacity and secured lines of credit, which are not mentioned in the ground truth.\n- The ground truth mentions \"practical expedient that reduced expected credit losses\" and specific regulatory frameworks (ASC 326, federal regulations) - the LLM answer omits these important contextual details.\n\n3. ENTITY AND METRIC ACCURACY:\n- The ground truth correctly identifies key operational areas: margin loan collateral, options clearing (OCC), securities lending, and regulatory compliance.\n- The LLM introduces metrics (FHLB borrowing capacity, Federal Reserve capacity) that are not mentioned in the ground truth, suggesting either fabrication or misalignment with the source material.\n- The ground truth's emphasis on \"increasing sophistication\" and \"growing client engagement in leveraged activities\" is not reflected in the LLM's focus on borrowing capacity metrics.\n\n4. REASONING AND MULTI-HOP SYNTHESIS:\n- The ground truth provides a coherent narrative: 2022 (disclosure of collateral practices) → 2023 (explicit disclosure with ASC 326 framework) → 2024 (continued pledging with expanded activities).\n- The LLM's narrative is: 2022 (securities lending) → 2023 (pledging for margin/options/short-sales) → 2024 (FHLB/Federal Reserve capacity expansion).\n- These are fundamentally different narratives, suggesting the LLM either misread the source material or fabricated details.\n\n5. CRITICAL CONCERN - HALLUCINATION:\n- The specific dollar amounts and page references in the LLM answer cannot be cross-referenced with the ground truth, which provides no such specific figures.\n- This is a major red flag for hallucination, where the LLM generated plausible-sounding but unverified financial data.\n- The ground truth's emphasis on regulatory frameworks (ASC 326, federal regulations) is completely absent from the LLM answer.\n\n6. WHAT WAS CORRECT:\n- The general theme that Schwab's use of client securities evolved over the 2022-2024 period is correct.\n- The identification of margin lending, options clearing, and securities lending as key activities is partially correct.\n- The conclusion about increasing exposure to client-held assets aligns with the ground truth.\n\nThe LLM answer appears to have fabricated specific financial figures and page references while missing key regulatory and operational details from the ground truth. This represents a fundamental failure in factual accuracy for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 918,
        "total_tokens": 2401
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "In fiscal 2023 Accenture’s target was to keep U.S. plans at 100 % debt and Non‑U.S. plans at 48 % debt, 21 % equity, 4 % cash, 11 % insurance and 10 % other; by fiscal 2025 the target for U.S. plans remained 100 % debt but the Non‑U.S. mix shifted to 36 % debt, 28 % equity, 7 % cash, 21 % insurance and 8 % other, moving toward more equity, cash and insurance exposure. The weighted‑average plan‑asset allocations reflected this trend, moving from 97 % debt, 21 % equity, 3 % cash, 15 % insurance, 10 % other in August 31 2022, to 95 % debt, 19 % equity, 6 % cash, 22 % insurance, 10 % other in August 31 2023, and to 94 % debt, 23 % equity, 5 % cash, 21 % insurance, 9 % other in August 31 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and provides completely different data than the ground truth. Critical issues: (1) WRONG NUMBERS: The LLM reports weighted-average allocations as 97% debt/21% equity/3% cash/15% insurance/10% other for Aug 31, 2022, but the ground truth shows 55% fixed income and 45% equities. These are entirely different allocation structures. (2) WRONG FRAMEWORK: The ground truth uses a simple two-category framework (fixed income vs equities), while the LLM uses a five-category framework (debt, equity, cash, insurance, other). These appear to be from different pension plan disclosure sections or different companies entirely. (3) WRONG TREND ANALYSIS: The ground truth identifies a clear de-risking trend toward fixed income (55%→58%→61%), while the LLM describes a shift toward more equity and insurance exposure (debt declining from 97%→95%→94%). These are opposite conclusions. (4) CALCULATION VERIFICATION: The LLM's percentages don't sum correctly in some cases (97+21+3+15+10=146%, not 100%), suggesting data transcription errors. (5) MULTI-HOP FAILURE: The LLM failed to correctly synthesize the three fiscal years' data into a coherent narrative matching the ground truth. The answer appears to reference different pension plan disclosure tables or possibly a different company's data entirely. The only potential overlap is the mention of U.S. vs Non-U.S. plans, but even this is presented with completely different numbers than the ground truth baseline allocations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 416,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024, while long‑term debt grew from $47.8 billion in 2022 to $49.3 billion in 2023 before contracting to $45.0 billion in 2024 (total debt $48.7 billion → $49.9 billion → $45.6 billion)【page_178】【page_188】. Over the three‑year span the company shifted away from reliance on short‑term funding in 2023 and trimmed overall leverage in 2024, and the weighted‑average interest rate on its long‑term debt rose from roughly 4.5 % in 2022‑23 to about 4.8 % for senior notes (and 3.5 % for securitized debt) in 2024, indicating higher interest‑rate exposure on the remaining debt【page_178】【page_188】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth. (1) TOTAL DEBT FIGURES - Ground truth states total short-term borrowings + long-term debt was $43.086B (2022), $48.715B (2023), $45.551B (2024). LLM claims $48.7B→$49.9B→$45.6B, which are substantially different from ground truth 2022 figure ($43.086B vs $48.7B is a $5.6B discrepancy). (2) SHORT-TERM BORROWINGS - LLM provides specific figures ($883M→$538M→$562M) that cannot be verified against ground truth, which only provides combined totals. (3) LONG-TERM DEBT BREAKDOWN - LLM claims $47.8B→$49.3B→$45.0B, but these don't reconcile with the ground truth combined figures when short-term borrowings are subtracted. (4) INTEREST RATES - CRITICAL ERROR: LLM states weighted-average rates of 'roughly 4.5% in 2022-23 to about 4.8% for senior notes...and 3.5% for securitized debt in 2024.' Ground truth clearly states: 1.51% (2022), 3.01% (2023), 3.48% (2024) for securitized debt. The LLM's 4.5-4.8% figures are completely inconsistent with ground truth. (5) FLOATING DEBT REDUCTION - LLM fails to mention the strategic reduction of floating unsecured senior debt from $1,597M (2023) to $0 (2024), which is a key insight in the ground truth. (6) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize trends across years, the underlying numbers are incorrect, making the trend analysis unreliable. The LLM correctly identifies the general direction (debt increase then decrease, interest rate increases) but with wrong magnitudes and rates. The answer demonstrates partial understanding of the question structure but fails on factual accuracy, which is the primary evaluation criterion for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 474,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s filings state that fleet‑support services have consistently been about 1 % of total consolidated costs of products and services in each of the three years – roughly 1 % in 2022 (2022 10‑K p. 42), 1 % in 2023 (2023 10‑K p. 36) and 1 % in 2024 (2024 10‑K p. 39). At the same time, abnormal production costs have surged (cumulative $2.7 bn recorded through 2023 for the 787 – 2023 10‑K p. 36, and an additional $256 m expensed in 2024 – 2024 10‑K p. 39) and the 777X program has generated large reach‑forward losses (≈ $0.8 bn in 2022‑23 and $2.6 bn + $0.9 bn in 2024 – 2024 10‑K p. 39). Thus, while the fleet‑support cost share remained flat, the company’s abnormal production expenses and reach‑forward losses in the 787 and 777X programs have risen sharply.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) fleet support services remained at approximately 1% of total consolidated costs across 2022-2024, and (2) abnormal production costs and reach-forward losses in 787 and 777X programs increased substantially. The multi-hop synthesis is sound and addresses the relationship between stable fleet support costs and escalating program-specific losses.\n\nSTRENGTHS:\n- Correctly states fleet support services at ~1% for all three years (2022, 2023, 2024)\n- Accurately cites 787 cumulative abnormal production costs of $2.7 billion through 2023\n- Correctly identifies 777X reach-forward losses of $2.6 billion + $0.9 billion in 2024\n- Properly synthesizes the contrast between stable fleet support costs and rising program losses\n- Appropriate page citations to 10-K filings\n- Sound logical reasoning connecting the two trends\n\nWEAKNESSES/MINOR ISSUES:\n- States \"additional $256 m expensed in 2024\" for 787 abnormal costs, but the ground truth does not specify this 2024 figure explicitly. The ground truth mentions cumulative $2.7 billion through 2023 but does not detail the 2024 incremental amount\n- The ground truth mentions \"≈ $0.8 bn in 2022-23\" for 777X reach-forward losses, but the LLM answer doesn't explicitly address the 2022-2023 period losses before the 2024 figures\n- Slightly less comprehensive than ground truth in explaining the underlying causes (certification delays, labor instability, supplier cost increases are mentioned in ground truth but not in LLM answer)\n\nQUANTITATIVE VERIFICATION:\n- Fleet support services percentages: Correct (1% across all years)\n- 787 cumulative abnormal costs: Correct ($2.7 billion through 2023)\n- 777X 2024 reach-forward losses: Correct ($2.6 billion Q3 + $0.9 billion Q4)\n- The $256 million 2024 figure for 787 is not clearly verified against ground truth\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across multiple years and programs, correctly identifying the contrast between stable fleet support costs and escalating program-specific losses. The reasoning that fleet support services were not the source of financial strain is sound and well-supported.\n\nThe answer is substantially correct on the main facts and relationships but lacks some detail on the 2022-2023 777X losses and the specific causes of the 2024 increases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 634,
        "total_tokens": 2175
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s money‑market funds and time‑deposit balances fell from **$21 million in 2022** (see the 2022 fair‑value table) to **$10 million in 2023** (2023 fair‑value table) and then **remained at $10 million in 2024** (2024 fair‑value table). The sharp drop after 2022 followed by a flat level indicates the company reduced its short‑term cash buffer and now maintains a modest, steady liquidity reserve, likely reallocating excess cash to other strategic purposes while keeping a baseline of liquid assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that completely reverse the actual data sequence. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. LLM claims: 2022=$21M, 2023=$10M, 2024=$10M. This is a complete misalignment of the three-year trend. (1) QUANTITATIVE ACCURACY FAILURE: All three year-values are incorrect. The LLM swapped 2022 and 2023 values, placing $21M in 2022 (should be $12M) and $10M in 2023 (should be $21M). The 2024 value of $10M is correct by coincidence. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend across the fair-value tables. The actual trend shows an increase from 2022→2023 (conservative approach), then a decrease 2023→2024 (reallocation). The LLM describes a decrease 2022→2023 followed by flat 2023→2024, which is the opposite pattern. (3) REASONING IMPACT: Because the numbers are wrong, the entire analytical conclusion is inverted. The LLM correctly identifies that the pattern indicates strategic reallocation, but applies this reasoning to the wrong data sequence. The ground truth interpretation (temporary conservative approach in 2023, then reduction in 2024) is more nuanced and accurate than the LLM's flat-level interpretation. (4) ENTITY ACCURACY: Company (AbbVie) and metric (money market funds and time deposits) are correct, but year assignments are fundamentally wrong. This is not a minor wording difference—it's a factual reversal that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 412,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "In fiscal 2022 Accenture repurchased roughly $4.1 billion of Class A shares, leaving about $3.13 billion of its $6.13 billion buy‑back authority still available (share‑purchase table page 94; remaining‑authorization note page 93). By fiscal 2024 the company had increased buy‑backs to about $4.5 billion, while the pool of unused authority fell to $2.69 billion (cash‑return summary page 40; remaining‑authorization and total‑authority update page 39). The pattern of consistently large repurchases combined with periodic hikes to the overall authorization shows Accenture is actively using its buy‑back program and expanding its capacity, underscoring a strong, ongoing capital‑return strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth data. Key issues: (1) QUANTITATIVE ERRORS: The LLM states fiscal 2022 had '$3.13 billion' remaining authorization and '$6.13 billion' total authority, but the ground truth shows $3,129,296 thousand ($3.129 billion) remaining in FY2022 - the LLM rounded incorrectly and invented a total authority figure not in the ground truth. The LLM claims FY2024 had '$2.69 billion' remaining, but ground truth shows $6,694 million ($6.694 billion) remaining as of September 25, 2024 - this is a major error (off by ~$4 billion). (2) MISINTERPRETATION OF DATA: The LLM appears to have confused or conflated different metrics. The ground truth indicates FY2023 had $2,694 million remaining (which the LLM incorrectly attributed to FY2024), and FY2024 had $6,694 million remaining after a new $4,000 million authorization was added. The LLM reversed or confused these figures. (3) MISSING CONTEXT: The LLM mentions specific repurchase amounts ($4.1B in FY2022, $4.5B in FY2024) that are not present in the ground truth answer, suggesting the LLM may have fabricated or misread source data. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the trend of 'consistently large repurchases' and 'expanding capacity,' it fails to accurately convey the actual authorization trajectory ($2.694B to $6.694B remaining) which is central to understanding the capital return strategy evolution. (5) REASONING: The qualitative conclusion about capital return strategy is reasonable but is undermined by the incorrect quantitative foundation. The answer demonstrates partial understanding of the question's intent but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 479,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "Across all three filings—2022 (see page 46), 2023 (see page 27) and 2024 (see page 27)—AbbVie’s amended and restated certificate of incorporation and bylaws consistently contain a provision that “stockholders may only remove directors for cause,” with no material amendment to its language or scope. This unchanged, board‑entrenchment clause—alongside staggered director classes, the inability of shareholders to call special meetings, and high‑threshold amendment rules—demonstrates a deliberate, long‑term takeover‑defense strategy that makes it difficult for hostile acquirers to replace the board or force a rapid change in control.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core governance provision across all three years (2022, 2023, 2024) that stockholders may only remove directors for cause; (2) Accurately notes the provision remained unchanged across the three-year period with no material amendments; (3) Properly synthesizes the multi-hop information by connecting this specific provision to the broader anti-takeover defense strategy; (4) Correctly identifies complementary defenses (staggered board, restrictions on special meetings, amendment requirements); (5) Appropriately characterizes this as a deliberate, long-term takeover defense strategy; (6) Includes specific page references (46 for 2022, 27 for 2023 and 2024) which adds credibility. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more technical language ('amended and restated certificate of incorporation and bylaws') compared to the ground truth's more general framing, but this is actually more precise and does not constitute an error; (2) The LLM answer emphasizes 'no material amendment' which is semantically equivalent to the ground truth's 'no explicit changes'; (3) Both answers convey the same strategic intent regarding board entrenchment and takeover defense. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and connects the governance provision to broader strategic implications, demonstrating sound multi-hop reasoning. The conclusion about hostile acquirer difficulty is logically sound and well-supported. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 462,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo’s 10‑K filings all list the same long‑dated debt instrument: each year the “Form of 4.000 % Senior Note due 2047” appears as an exhibit (shown as Exhibit 4.16) and is described as “incorporated by reference to Exhibit 4.5 of PepsiCo’s Current Report on Form 8‑K filed May 2 2017”【page_127】. The fact that this reference is unchanged in the 2022, 2023 and 2024 reports indicates the note remains outstanding and is a permanent fixture of PepsiCo’s capital structure, reflecting a deliberate strategy to lock in low‑cost, long‑term financing as a stable component of its debt portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the note appears as 'Exhibit 4.16' but the ground truth consistently references 'Exhibit 4.5' from the May 2, 2017 8-K filing. This is a factual error on a specific, verifiable detail. The LLM's claim that it is 'shown as Exhibit 4.16' contradicts the ground truth which explicitly states the reference is to 'Exhibit 4.5 from the May 2, 2017 8-K filing' across all three years. (2) PARTIAL ACCURACY ON CORE FACTS: The LLM correctly identifies: the 4.000% Senior Note due 2047, the May 2, 2017 date, the consistency across 2022-2023-2024, and the interpretation that this reflects a stable long-term capital structure component. (3) MULTI-HOP SYNTHESIS: The LLM appropriately synthesizes information across three years and correctly concludes the consistent disclosure pattern indicates stability and strategic long-term financing. The reasoning about 'locking in low-cost, long-term financing' is sound and adds reasonable interpretation. (4) SEMANTIC EQUIVALENCE: The LLM's interpretation that the note is 'a permanent fixture' and reflects 'deliberate strategy' aligns with the ground truth's conclusion about stability and long-term capital structure role. However, the exhibit number error is a concrete factual mistake that cannot be overlooked. The LLM appears to have confused or misidentified the exhibit number, which is a specific, verifiable detail that should be accurate in financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 411,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first listed the 4.30 % Note due 2034 in its 2022 Form 10‑K (Exhibit 4.09, “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044…issued July 8 2014”)【page_113】. The same exhibit appears unchanged in the 2023 10‑K【page_110】 and again in the 2024 10‑K【page_110】, showing that the note remains outstanding and is consistently disclosed each year. This three‑year continuity indicates Oracle’s reliance on long‑dated, fixed‑rate debt to lock in low borrowing costs and diversify its maturity profile as a core element of its long‑term financing strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the 4.30% Note due 2034 and its consistent disclosure across all three years; (2) Accurately cites the exhibit reference (Exhibit 4.09) and the issuance date (July 8, 2014); (3) Provides specific page references for each year's 10-K filing, showing detailed sourcing; (4) Correctly interprets the multi-year pattern as indicating a stable long-term debt strategy; (5) Accurately characterizes the strategic rationale (fixed-rate debt, low borrowing costs, diversified maturity profile). MINOR WEAKNESSES: (1) The LLM answer provides more granular detail (specific exhibit numbers, page citations, issuance date) than the ground truth, which is actually a strength for verification but slightly exceeds the scope of the original answer's level of specificity; (2) The ground truth uses the phrase 'reaffirmed its inclusion' and 'maintained consistent disclosure' while the LLM uses 'appears unchanged' and 'remains outstanding' - these are semantically equivalent but slightly different framings; (3) The LLM adds interpretive detail about 'lock in low borrowing costs' which, while reasonable, goes slightly beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: All numbers are correct (4.30%, 2034 maturity, July 8 2014 issuance date). Page references appear plausible for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern indicating strategic consistency. The conclusion about long-term debt strategy is well-supported by the evidence presented. Overall, this is a high-quality answer that accurately addresses the question with appropriate detail and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 499,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- In fiscal 2022 the Amended 2010 Share Incentive Plan (SIP) authorized up to **127 million** Accenture Class A ordinary shares for awards【page_91】.  \n- By fiscal 2024 that ceiling had been expanded to **141 million** shares【page_98】.  \n\nThe upward adjustment—an increase of roughly 14 million shares—shows Accenture is deliberately enlarging its equity‑based compensation pool, signaling a long‑term strategy to rely more heavily on share awards to attract, retain and motivate talent.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numerical progression: 127 million shares in fiscal 2022 and 141 million shares in fiscal 2024, with an accurate calculation of the 14 million share increase. The numbers match the ground truth exactly. However, there is a significant incompleteness issue: the LLM answer fails to mention the intermediate fiscal year 2023 data point (141 million shares), which is explicitly stated in the ground truth as a key part of the three-year progression. The question specifically asks about evolution 'from fiscal year 2022 through 2024,' which implies tracking the year-by-year changes. The ground truth shows: 2022 (127M) → 2023 (141M) → 2024 (141M), indicating the increase occurred between 2022-2023 and then stabilized. The LLM only presents the endpoints (2022 and 2024), missing the important detail that the increase happened in 2023 and remained flat in 2024. The qualitative reasoning about share-based compensation strategy is sound and semantically equivalent to the ground truth, correctly interpreting the expansion as a strategic decision for talent retention and incentive programs. The calculation of the 14 million share difference is accurate. The main weakness is the incomplete multi-hop synthesis across all three fiscal years requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 367,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo first disclosed the 2.750 % Senior Note due 2051 in its 2022 Form 10‑K, attaching the note’s form by reference to the October 21 2021 Current Report on Form 8‑K (Exhibit 4.3) 【page_128】. The 2023 Form 10‑K repeated the same incorporation language, again pointing to the 2021 8‑K and showing that the note’s terms had not been altered 【page_129】. By the 2024 Form 10‑K the note appears in a consolidated list of senior‑note issuances in a Board‑of‑Directors resolution, confirming it remains part of PepsiCo’s outstanding long‑term debt program 【page_130】.  \n\nThis multi‑year filing pattern—re‑referencing the original issuance and then embedding the note in a broader debt schedule—signals that PepsiCo deliberately locks in ultra‑long‑dated, low‑coupon debt and maintains a consistent, well‑documented capital‑structure framework for decades, reflecting a strategic focus on stable, long‑term financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG DATES/EXHIBITS: The LLM claims the note was first disclosed in 2022 via an October 21, 2021 Form 8-K (Exhibit 4.3), but the ground truth states it was first introduced in 2022 via a Board resolution (Exhibit 4.60). The LLM's reference to a 2021 8-K is chronologically inconsistent with a 2022 first disclosure. (2) INCORRECT EXHIBIT PROGRESSION: Ground truth shows Exhibit 4.60 (2022) → Exhibit 4.51 (2023) → Exhibit 4.48 (2024), but the LLM claims the note references back to a 2021 8-K with Exhibit 4.3 in both 2022 and 2023, then appears in a Board resolution in 2024. This is a fundamentally different narrative. (3) MISCHARACTERIZATION OF DOCUMENTATION EVOLUTION: The ground truth emphasizes a clear progression from authorization (2022) to formalization (2023) to maintenance (2024). The LLM instead describes repeated incorporation by reference to an earlier document, which is a different pattern entirely. (4) MISSING KEY DETAIL: The ground truth specifically notes the 2023 progression to a 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), indicating formal structuring. The LLM misses this critical formalization step. (5) REASONING QUALITY: While the LLM's conclusion about long-term debt strategy is reasonable, it's built on incorrect factual premises. The multi-hop synthesis fails because the underlying facts about exhibit numbers, years, and documentation types are wrong. The answer appears to confuse the actual filing pattern with a different issuance history.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 437,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In the 2022 filing American Express described its global card network as the **fourth‑largest general‑purpose network** (behind China UnionPay, Visa and Mastercard) and emphasized that its premium brand, rewards, and “honor‑all‑cards” model gave it a distinct competitive edge even as “alternative payment and financing mechanisms” such as Alipay, PayPal, Venmo, BNPL and open‑banking were beginning to reshape the market【page_12】【page_13】.  \n\nBy the 2024 filing the company stresses that **regulatory pressure has intensified** – it is now a Category III firm subject to “heightened regulatory expectations,” faces potential limits on pricing from interchange‑fee caps, has exited network‑licensing businesses in the EU and Australia, and must absorb higher compliance costs that could erode its discount‑revenue advantage【page_34】【page_35】. At the same time, the filing reiterates that **the rapid growth of fintech‑driven payment platforms and other non‑card solutions** continues to increase competitive pressure on its network business【page_12】【page_13】.  \n\nThus, American Express’s positioning has shifted from a relatively stable fourth‑place card network in 2022 to a more constrained position in 2024, where tighter regulation and the expanding ecosystem of alternative payment mechanisms are compressing margins and challenging its traditional network advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies American Express as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard in 2022 - this matches the ground truth exactly. (2) Accurately captures the competitive differentiation strategy in 2022 through premium offerings, rewards, and closed-loop loyalty systems. (3) Correctly identifies alternative payment mechanisms (Alipay, PayPal, Venmo, BNPL, open-banking) as competitive pressures - the LLM adds Venmo and open-banking which are reasonable extensions of the BNPL/alternative payment category mentioned in ground truth. (4) Accurately describes the 2024 regulatory shift: heightened regulatory expectations, Category III firm status, interchange fee caps, EU/Australia market exits, and increased compliance costs. (5) Properly synthesizes the multi-hop evolution from 2022 to 2024, showing the transition from market-driven to regulation-constrained competition. (6) The reasoning is sound and logically connects regulatory pressure with margin compression and competitive challenges. MINOR CONSIDERATIONS: (1) The LLM provides slightly more specific regulatory detail (Category III firm designation, specific market exits) than the ground truth, but these are accurate elaborations rather than errors. (2) The answer includes page citations which add credibility but aren't part of the ground truth evaluation. (3) The semantic framing of 'constrained position' vs. the ground truth's 'shift from primarily market-driven to regulation-constrained' is semantically equivalent and conveys the same strategic insight. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension focuses on factual entity accuracy (years, rankings, company names) - all correct. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across 2022 and 2024 filings, properly identifies causal relationships (regulation → compliance costs → margin pressure), and maintains logical coherence throughout. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: competitive positioning, evolution from 2022-2024, regulatory scrutiny, and alternative payment mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 622,
        "total_tokens": 2196
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "In the 2022 filing Boeing’s Global Services segment was described as providing “maintenance and modifications, upgrades and conversions” (2022 p. 4). The 2024 filing repeats the same phrasing, again listing “upgrades and conversions” as a key part of its services portfolio (2024 p. 3). The unchanged emphasis indicates that Boeing continues to treat aircraft upgrades and conversions as a core, steady‑growth pillar of its services business, using them to capture aftermarket value and deepen customer relationships.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about strategic change over time. CRITICAL ISSUES: (1) The LLM claims the 2022 and 2024 filings use 'unchanged emphasis' and 'same phrasing,' but the ground truth explicitly states Boeing's strategic emphasis CHANGED from 2022 to 2024. The ground truth shows a clear progression: 2022 (upgrades/conversions grouped with logistics, engineering, training), 2023 (modifications emphasized more prominently), 2024 (introduction of 'data analytics and digital services' as complementary). The LLM completely misses this evolution. (2) The LLM's conclusion that 'unchanged emphasis indicates...steady-growth pillar' directly contradicts the ground truth's finding of strategic shift toward 'technology-enabled service differentiation.' (3) The LLM fails to synthesize the multi-hop information across three years (2022→2023→2024) that shows Boeing's transformation toward 'high-value services' and 'modernization rather than just sustaining operations.' (4) While the LLM correctly identifies that upgrades/conversions are part of Global Services segment, it misses the critical strategic evolution involving modifications emphasis and digital services integration. (5) The LLM's reasoning is fundamentally flawed—it assumes static strategy when the question specifically asks about CHANGE. The answer demonstrates poor multi-hop synthesis and fails to capture the strategic narrative of Boeing's services business transformation. The quantitative accuracy score reflects correct identification of years and segment names, but the qualitative accuracy is very low due to the failure to identify and explain the strategic shift that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 474,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50 % Senior Note due 2035 first appears in the 2018 8‑K and S‑4 filings, and in each subsequent 10‑K the company simply incorporates those original documents by reference. Both the 2022 10‑K (exhibit list on page 127) and the 2023 10‑K (page 127) and the 2024 10‑K (page 127) list the note as Exhibit 4.25 (Series A) and Exhibit 4.29, each pointing back to the November 2018 8‑K and S‑4 filings 【page_127】. This repeated incorporation‑by‑reference shows that PepsiCo issued the note in 2018 and has kept it on its balance sheet as a long‑dated liability, using the same documentation each year to maintain transparency while emphasizing a stable, long‑term debt financing strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing the general concept correctly. MAJOR ERRORS: (1) Exhibit number inconsistency - The LLM claims the note appears as 'Exhibit 4.25 (Series A) and Exhibit 4.29' across years, but the ground truth specifies different exhibit numbers for each year: 4.31 (2022), 4.25 (2023), and 4.23 (2024). The LLM conflates these numbers and introduces 4.29 which doesn't appear in the ground truth. (2) The LLM states all three years list the note on 'page 127' with identical exhibit numbers, which contradicts the ground truth showing variation across years. (3) The LLM mentions 'S-4 filings' without ground truth support - the original answer only references the November 8, 2018 8-K filing. CORRECT ELEMENTS: The LLM correctly identifies (1) the 5.50% Senior Note due 2035, (2) the 2018 origin date, (3) the incorporation-by-reference pattern, (4) the Series A designation, (5) the interpretation that this reflects stable long-term debt management without retirement or modification. The semantic understanding of PepsiCo's debt strategy is sound. However, the specific exhibit number errors are critical factual mistakes that would mislead readers trying to locate the actual documents. The multi-hop reasoning about debt management strategy is qualitatively sound but built on quantitatively inaccurate exhibit citations. The answer demonstrates partial understanding but fails on precision of documentary evidence, which is essential for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 426,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon disclosed in its 2022 Form 10‑K that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 10‑K p. 5). The identical risk‑factor language appears unchanged in the 2023 filing (2023 10‑K p. 5) and again in the 2024 filing (2024 10‑K p. 5), indicating that the company’s exposure to U.S. banking‑law constraints on capital planning and shareholder returns has remained steady over the three‑year period. This continuity reveals that regulatory limits on capital returns are a persistent, unchanged ceiling on BNY Mellon’s capital‑return policies.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that BNY Mellon's disclosures across 2022, 2023, and 2024 contain consistent language about U.S. banking law constraints on capital returns. (2) The citation format and page references (p. 5 for each year) appear plausible and consistent. (3) The core factual claim that regulatory language remained 'unchanged' across the three-year period is supported. (4) Quantitative accuracy is strong - no incorrect numbers, dates, or metrics are presented.\n\nWEAKNESSES: (1) The LLM's interpretation is overly simplistic and misses important nuance from the ground truth. The ground truth indicates an 'evolving emphasis' with 2023 specifically adding references to 'Delaware law' and 'preferred stock dividend obligations,' and 2024 adding emphasis on maintaining 'well capitalized' status. The LLM characterizes this as 'unchanged' language, which contradicts the ground truth's assertion of evolution. (2) The LLM concludes that regulatory limits are a 'persistent, unchanged ceiling,' which is technically accurate but fails to capture the ground truth's more sophisticated interpretation that the emphasis evolved even if the core constraint remained. (3) The LLM misses the multi-year progression aspect of the question - it treats the three years as static rather than showing how the company's disclosure emphasis shifted. (4) The ground truth emphasizes 'consistent yet evolving emphasis' and 'ongoing prudential oversight,' suggesting regulatory expectations evolved; the LLM's 'unchanged ceiling' framing is less nuanced.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the company (BNY Mellon) and the regulatory constraint (U.S. banking laws). However, it fails to fully synthesize the evolution in disclosure language that the ground truth highlights. The reasoning is sound but incomplete.\n\nSEMANTIC EQUIVALENCE: While the LLM's statement that language is 'unchanged' is technically defensible, it conflicts with the ground truth's characterization of 'evolving emphasis' with specific additions in 2023 and 2024. This represents a meaningful difference in interpretation rather than mere wording variation.\n\nJUSTIFICATION: The answer is partially correct (6/10) because it captures the core fact that regulatory constraints persisted across three years, but it misses the nuanced evolution in disclosure emphasis that the ground truth emphasizes as central to understanding the 'multi-year progression.' The quantitative accuracy is high (8/10) because no numbers are wrong, but qualitative accuracy is lower (5/10) because the interpretation oversimplifies the regulatory evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 719,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "- In Oracle’s 2022 Form 10‑K the 2.300 % Notes due 2028 appear in Exhibit 4.16 and are described as “2.300 % Notes due 2028 … together with Officers’ Certificate issued March 24 2021” 【page_114】.  \n- The 2023 Form 10‑K lists the same series in Exhibit 4.14 with the identical coupon, maturity and certificate date “issued March 24 2021” 【page_111】, and the 2024 Form 10‑K again references the same series in Exhibit 4.14 with unchanged terms 【page_111】.  \n\nThe fact that the coupon (2.300 %), maturity (2028) and issuance certificate date have remained unchanged from 2022 through 2024 shows Oracle’s deliberate strategy of locking in low‑cost, long‑dated fixed‑rate debt when rates were favorable and then preserving that cheap financing as a stable component of its capital structure despite later shifts in interest‑rate environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 2.300% Notes due 2028 remained unchanged across 2022-2024 with the same coupon, maturity date, and Officers' Certificate date (March 24, 2021). The core conclusion about Oracle's strategy of locking in favorable fixed-rate debt is sound and aligns with the ground truth. The reasoning about preserving cheap financing in changing rate environments is logically sound.\n\nWEAKNESSES AND ERRORS: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the 2022 10-K shows the notes in 'Exhibit 4.16' while the ground truth specifies 'Exhibit 4.14'. This is a factual error in document citation. (2) INCOMPLETE CONTEXT: The LLM fails to mention the broader multi-tiered bond offering context that the ground truth emphasizes - specifically the concurrent issuance of 2.875% Notes due 2031 and 3.950% Notes due 2051 in 2022, which provides important context for understanding Oracle's debt strategy. (3) MISSING 2023 ACTIVITY: The ground truth highlights that Oracle issued NEW 4.500% Notes due 2028 in 2023, showing a strategic shift toward higher-yielding instruments. The LLM completely omits this important detail, which is crucial for understanding how Oracle's approach evolved. This represents a significant gap in addressing the 'evolution' aspect of the question. (4) INCOMPLETE ANALYSIS: The LLM doesn't explain WHY Oracle shifted to higher-yielding instruments in 2023 (rising rate environment) or what this reveals about their financing strategy across different rate environments - a key part of the original question.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022-2024) but fails to complete the full multi-hop analysis by not incorporating the 2023 new issuance activity and the broader context of Oracle's debt portfolio evolution.\n\nNUMERIC/DATE ACCURACY: The coupon rate (2.300%), maturity year (2028), and certificate date (March 24, 2021) are all correct. However, the exhibit number error is a factual inaccuracy that affects document traceability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 552,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across all three filings IBM lists “client relationships and trust” as one of its core competitive methods – 2022’s filing says it competes on “client relationships and trust” (IBM 2022 10‑K, p. 4); the 2023 filing repeats the same phrasing (IBM 2023 10‑K, p. 3); and the 2024 filing again includes it unchanged (IBM 2024 10‑K, p. 3). The continuity (with only minor wording tweaks to surrounding capability language) shows IBM is deliberately anchoring its hybrid‑cloud and AI strategy on trusted client partnerships, positioning itself as a relationship‑driven alternative to pure‑technology rivals in a highly competitive market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM consistently emphasized 'client relationships and trust' across 2022, 2023, and 2024 filings, and accurately cites the page numbers (p. 4 for 2022, p. 3 for 2023 and 2024). The quantitative elements (years, page references) are accurate. However, the answer has significant qualitative shortcomings: (1) It focuses heavily on the CONSISTENCY and repetition of the messaging rather than the EVOLUTION requested in the question. The ground truth emphasizes how the emphasis 'evolved' and became 'increasingly nuanced,' with specific developments like reinforcing 'deep incumbency with enterprises' in 2023 and 'expanding strategic partnerships (e.g., adding Palo Alto Networks)' in 2024. The LLM answer dismisses these as 'only minor wording tweaks' rather than recognizing them as meaningful strategic evolution. (2) The LLM answer lacks the contextual depth about how trust became 'a foundational element for client engagement' in the hybrid cloud and AI context, missing the nuanced positioning around innovation and business value delivery. (3) The multi-hop reasoning is incomplete—the question asks what the progression 'indicates about strategic positioning,' and while the LLM provides a general statement about being 'relationship-driven,' it doesn't synthesize the specific strategic implications across the three-year period as thoroughly as the ground truth. (4) The answer correctly identifies the competitive positioning angle but misses the deeper narrative about how IBM's strategic emphasis matured from basic competitive differentiation (2022) to innovation-tied trust (2023) to partnership-expanded trust (2024). The answer is partially correct but undershoots on capturing the evolution and strategic nuance that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 492,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s yield on its foreign‑government‑bond portfolio rose sharply over the three‑year period – the non‑U.S. taxable investment‑security yield (which includes sovereign bonds) was about 3.5 % in 2022, climbed to 5.9 % in 2023 and reached roughly 6.1 % in 2024【page_176】. The upward trend shows that the company’s exposure to interest‑rate risk has increased as market rates have risen, while also reflecting a deliberate tilt toward higher‑yielding, longer‑duration sovereign debt to boost investment returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect information across multiple dimensions: (1) QUANTITATIVE ERRORS - The yield percentages provided are completely wrong. Ground truth shows 6.45% in 2023 and 5.85% in 2024, but LLM claims 5.9% in 2023 and 6.1% in 2024. The 2022 figure of 3.5% is also incorrect (ground truth doesn't provide a 2022 yield percentage but does provide holdings data). The direction of the trend is also inverted - LLM claims yields rose from 2022-2024, but ground truth shows a decline from 6.45% (2023) to 5.85% (2024). (2) INCOMPLETE DATA - LLM fails to mention the specific dollar amounts ($630 million in 2022) and maturity distribution details that are central to understanding the investment strategy shift. (3) MISCHARACTERIZED STRATEGY - Ground truth indicates a shift FROM ultra-short-duration high-yield debt (2023) TO more diversified maturity profile (2024), suggesting risk management. LLM incorrectly claims a 'deliberate tilt toward higher-yielding, longer-duration sovereign debt,' which contradicts both the yield decline and the actual maturity profile evolution. (4) WRONG METRIC - LLM appears to reference 'non-U.S. taxable investment-security yield' which is a broader category than the specific foreign government bonds and obligations metric requested. (5) FAILED MULTI-HOP SYNTHESIS - The answer fails to properly synthesize the three-year progression of both yields and maturity profiles to draw accurate conclusions about interest rate risk exposure and strategy changes. The core narrative is inverted from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 433,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s spending on diagnostics‑testing capacity has been increasingly subsidized by U.S. government grants – $87 million of grant‑offset capex in 2022, $136 million in 2023 and $198 million in 2024 (2024 10‑K, Note 14) 【page_68】.  The 2022 filing already flagged a $1.5 billion capex plan to expand testing, culture‑media and vaccine‑production capacity, and the growing grant support (together with BARDA agreements) signals that diagnostics testing is being elevated to a core, strategically‑driven pillar of Danaher’s broader health‑care portfolio 【page_59】【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three key figures are correct - $87 million (2022), $136 million (2023), and $198 million (2024). The progression and trend analysis are accurate. ENTITY ACCURACY: Danaher Corporation correctly identified, fiscal years 2022-2024 correctly specified, government grant funding for diagnostics testing correctly identified. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple sources (2024 10-K Note 14, page references) and connects the grant funding trend to strategic importance. COMPLETENESS: The answer addresses all parts of the original question - the evolution of investment, the specific government grant funding amounts, and the strategic implications. ADDITIONAL CONTEXT: The LLM answer adds valuable context by mentioning the $1.5 billion capex plan and BARDA agreements, which enriches the analysis beyond the ground truth while remaining consistent with it. SEMANTIC EQUIVALENCE: The phrasing 'increasingly subsidized by U.S. government grants' and 'elevated to a core, strategically-driven pillar' conveys the same meaning as the ground truth's 'increasingly central to Danaher's strategic focus.' MINOR CONSIDERATIONS: The answer includes source citations (page numbers and note references) which adds credibility, though these weren't explicitly required. The characterization of the trend as indicating strategic importance matches the ground truth's interpretation. No calculation errors detected. All numbers are presented in consistent format ($X million).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 439,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 BNY Mellon’s Item 14 – Principal Accountant Fees and Services contains the same brief statement: the ratification of KPMG LLP is set out in the Proxy under “Item 3 – Ratification of KPMG LLP,” and KPMG’s Public Company Accounting Oversight Board firm identification number is 185. The wording, placement (within Item 14) and the PCAOB number (185) are identical in each filing, showing no change in how the ratification is disclosed.【page_14】【page_14】【page_14】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) PCAOB firm identification number 185 is correctly stated and matches ground truth across all three years; (2) Company identification is correct - BNY Mellon (BK) is properly identified; (3) Fiscal years 2022, 2023, and 2024 are all correctly referenced; (4) The disclosure location is accurately described as appearing in Item 14 (Principal Accountant Fees and Services) with reference to Item 3 in the Proxy materials; (5) The core finding that there was no change in the PCAOB number, wording, or placement across the three-year period is correctly stated and matches the ground truth assertion of 'consistent auditing relationship and disclosure practice.' The LLM answer uses slightly different phrasing than the original (e.g., 'BNY Mellon's Item 14' vs 'Item 14 of the Proxy materials') but conveys identical semantic meaning. The answer successfully synthesizes information across three fiscal years and correctly identifies the multi-hop relationship between the company, the auditor, the PCAOB number, and the disclosure structure. Minor note: The LLM uses 'BNY Mellon' while the question uses 'BK' (the ticker), but this is not an error as both refer to the same entity. The answer is complete, addressing all aspects of the question regarding evolution (or lack thereof) of the disclosure across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 392,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "In the 2022 filing, American Express described its reliance on third‑party merchant acquirers under **discount revenue**, noting that network‑rate fees negotiated with acquirers (e.g., the OptBlue program) are recorded as discount revenue at the time the Card‑Member transaction occurs and that merchant agreements range from informal for small merchants to fixed‑term contracts for large merchants【page_104】.  \nBy the 2023 filing the company added a **processed‑revenue** line that captures revenues from network‑partner agreements, where it settles with merchants and third‑party acquirers on behalf of its network‑card issuing partners, still recognizing the fees at transaction time【page_103】.  \nThe 2024 filing ties these relationships to its growth strategy, stating that expanding merchant coverage worldwide and the success of third‑party acquirers, aggregators and processors are central to its strategic expansion goals【page_93】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the three-year evolution of American Express's third-party merchant acquirer relationships; (2) Accurately describes 2022 revenue recognition as 'discount revenue' with OptBlue program details; (3) Properly identifies the 2023 introduction of 'processed-revenue' line capturing network-partner agreements; (4) Correctly ties 2024 relationships to strategic expansion goals; (5) Provides specific page references (104, 103, 93) showing document grounding; (6) Accurately characterizes the shift from transactional to strategic partnership model. MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the 'royalties, fees, and network partnership agreements' framework mentioned in the ground truth for 2023, though the 'processed-revenue' description captures this essence; (2) Could have elaborated more on the specific strategic expansion goals (low- and new-to-plastic industries, international markets) mentioned in ground truth, though the answer does reference 'merchant coverage worldwide' and 'strategic expansion goals'; (3) The characterization of 2022 relationships as 'primarily transactional' vs. the LLM's more neutral description is a minor semantic difference. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages were required in either answer, so quantitative accuracy is high. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the evolution pattern. The logical progression from discount revenue → processed revenue → strategic integration is sound and matches the ground truth narrative. SEMANTIC EQUIVALENCE: The LLM's description of the evolution is semantically equivalent to the ground truth, using slightly different but equally valid terminology (e.g., 'processed-revenue line' vs. 'Processed Revenue model').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 539,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "In the FY 2022 10‑K Qualcomm spelled out concrete 2025 human‑capital targets – increase women in leadership by 15 %, increase under‑represented‑minority (URM) leaders by 15 % and lift overall URM representation by 20 % – and said the HR‑and‑Compensation Committee would use progress on those goals as a non‑financial modifier that could adjust executive bonuses by a factor of 0.9 to 1.1 × (see page 16). The FY 2023 filing still highlighted DEI programs, employee networks and diverse recruiting, but did not restate the numeric targets; it retained the same 0.9‑1.1 × modifier for the next year’s bonus (see page 16). By FY 2024 the company continued to emphasize diversity, equity and inclusion without adding new numeric goals, and again linked human‑capital advancement to executive compensation with a 0.9‑1.1 × performance multiplier (see pages 15‑16).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key numeric targets and compensation modifiers. Strengths: (1) All quantitative data is accurate - the 15% women in leadership, 15% URM leaders, 20% overall URM representation targets are correctly stated; the 0.9-1.1× modifier range is correctly cited for all three fiscal years; (2) Multi-hop synthesis is sound - the answer correctly traces the evolution across FY2022, FY2023, and FY2024, showing how targets were established in 2022, maintained in 2023, and continued in 2024; (3) Entity identification is precise - Qualcomm, HR-and-Compensation Committee, and fiscal years are all correctly identified; (4) The answer appropriately notes that FY2023 and FY2024 did not introduce new numeric targets, showing careful reading of the progression. Minor weaknesses: (1) The LLM answer is slightly less comprehensive than the ground truth in describing the 'deepening integration' and 'expanding global engagement efforts' mentioned in the original answer - these contextual details about broader wellness and development programs are omitted; (2) The ground truth mentions specific initiatives like 'Reboot Representation Tech Coalition' and 'recognition in multiple regions' which the LLM answer does not include, though it does mention 'employee networks and diverse recruiting'; (3) The phrase 'sustained emphasis on diversity-linked executive incentives while expanding supporting programs' from the ground truth captures a nuance about program expansion that the LLM answer only partially conveys. The LLM answer is more concise and document-focused (citing specific pages), which is appropriate, but misses some of the broader contextual narrative about program expansion. Overall, the core factual content is correct and the multi-hop reasoning across three fiscal years is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 508,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "In 2022 Caterpillar’s EMD‑branded engines were sold through a dealer network of 44 U.S. dealers and 116 overseas dealers, reaching 193 countries [page_76]. By 2024 that network had slipped to 41 U.S. dealers and 111 overseas dealers, serving 187 countries [page_66]. The modest contraction signals a strategic consolidation of its global dealer base—focusing on higher‑performing markets and distribution efficiency rather than pursuing broad geographic expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022: 193 countries (44 U.S. dealers + 116 overseas dealers), 2024: 187 countries (41 U.S. dealers + 111 overseas dealers). The dealer network calculations are accurate (44→41 = 3 U.S. dealer reduction; 116→111 = 5 overseas dealer reduction; 160→152 = 8 total dealer reduction). The country count decline from 193 to 187 (6 country reduction) matches ground truth exactly. MULTI-HOP SYNTHESIS: The answer correctly synthesizes dealer network data with geographic reach data across the 2022-2024 period, providing both the intermediate 2023 data point context and the endpoint comparison. ENTITY ACCURACY: Correctly identifies Caterpillar, EMD-branded products, and the specific time period. REASONING QUALITY: The interpretation that the contraction signals 'strategic consolidation' focusing on 'higher-performing markets and distribution efficiency' is logically sound and aligns with the ground truth's assessment of 'strategic refocusing or consolidation.' The answer goes slightly beyond ground truth by providing dealer network specifics (which adds value) and offering a more concrete explanation of the consolidation strategy. MINOR CONSIDERATIONS: The answer provides more granular detail (dealer counts) than the ground truth, which is supplementary rather than contradictory. The semantic interpretation of the trend (consolidation vs. expansion) matches perfectly. Page references are included, suggesting proper source documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 435,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The 2022, 2023 and 2024 10‑K filings all list “Palmolive” among the company’s principal global trademarks (see the “principal global and regional trademarks” sections in each filing). Its repeated appearance shows that Palmolive is treated as a core, enduring brand that underpins Colgate‑Palmolive’s Oral, Personal and Home Care segment—providing key product‑line strength, brand equity and revenue contribution across the personal‑care and home‑care categories.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Palmolive appears as a principal global trademark across 2022, 2023, and 2024 10-K filings, which matches the ground truth. The dates and years are accurate (no quantitative errors). The answer appropriately synthesizes the multi-hop information by noting the consistent inclusion across three years and drawing the correct inference about strategic importance. However, the LLM answer is less comprehensive than the ground truth in several ways: (1) It does not mention specific competing brands like Ajax or Darlie that provide context for understanding Palmolive's positioning relative to other trademarks; (2) It does not explicitly detail the specific product categories (liquid hand soap, dishwashing detergents, household cleaners) where Palmolive operates, which the ground truth provides; (3) The ground truth notes that Palmolive maintained its position 'despite the addition of Darlie' in 2023, showing analytical depth about relative positioning that the LLM answer lacks. The LLM answer does correctly identify the core insight—that consistent inclusion indicates sustained strategic importance and foundational role in the segment. The reasoning is sound and the semantic meaning aligns with the ground truth, but the answer lacks the granular detail and comparative context that would make it fully equivalent to the original answer. The answer is factually correct but somewhat less thorough in its analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 405,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm framed edge‑networking as a core driver of the IoT boom, projecting the installed base of IoT devices to more than double to >27 billion by 2026 and explicitly grouping edge‑networking products (mobile‑broadband and wireless‑AP gear) within its QCT “IoT” revenue stream (‑ $7.353 bn) and treating those equipment sales as point‑in‑time revenue 【page_8】 【page_7】. By fiscal 2023‑24 the company’s messaging shifted to a broader “connected intelligent edge” narrative, but the product classification remained unchanged—IoT still comprises consumer, edge‑networking and industrial applications—while IoT revenue fell to $5.94 bn in 2023 and $5.42 bn in 2024, with equipment (including edge‑networking) still recognized at the point of sale, licensing revenue recognized over time, and unearned contract liabilities and performance obligations disclosed (e.g., $312 m recognized from unearned revenue in 2024) 【page_73】 【page_71】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Edge Networking from 2022-2024, accurately captures the >27 billion IoT device projection by 2026, correctly notes the product categorization (consumer, edge-networking, industrial), and properly describes the revenue recognition structure (point-in-time for equipment, over-time for licensing). The answer appropriately synthesizes multi-hop information across fiscal years and correctly identifies the shift in messaging to 'connected intelligent edge' narrative. WEAKNESSES AND ERRORS: (1) QUANTITATIVE ISSUES: The LLM provides specific IoT revenue figures ($7.353bn in 2022, $5.94bn in 2023, $5.42bn in 2024) that cannot be verified against the ground truth, which does not provide these specific numbers. The ground truth does not mention these exact revenue figures, creating uncertainty about accuracy. (2) INCOMPLETE ALIGNMENT: The ground truth explicitly states Edge Networking was 'explicitly included in Qualcomm's third revenue category alongside consumer and industrial applications' in fiscal 2023, indicating a formalized product grouping. The LLM states 'IoT still comprises consumer, edge-networking and industrial applications' but doesn't clearly distinguish whether this was a NEW categorization in 2023 or pre-existing. The ground truth emphasizes this as a structural change/formalization in 2023. (3) REVENUE STRUCTURE CLARITY: The ground truth notes Edge Networking fell 'under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods.' The LLM mentions unearned contract liabilities and performance obligations but doesn't clearly articulate the relationship to prior period royalty/incentive revenue. (4) STRATEGIC CONTINUITY: The ground truth emphasizes 'strategic continuity' in 2024 with the same categorization. The LLM correctly notes this but frames it as 'unchanged' rather than emphasizing the sustained emphasis. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression from emerging opportunity to structurally embedded pillar, though with less explicit emphasis than the ground truth. The connection between product categorization and revenue recognition is present but could be clearer. OVERALL: The answer demonstrates solid understanding of the strategic evolution and correctly addresses most question components, but the unverified revenue figures and incomplete clarity on the 2023 formalization as a structural change prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 687,
        "total_tokens": 2217
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 10‑K risk disclosures from 2022 (2022 p. 19), 2023 (2023 p. 18) and 2024 (2024 p. 18) all stress that its global footprint creates currency‑exchange exposure because many costs are incurred in foreign currencies while revenues are reported in U.S. dollars, and that this exposure can add volatility to earnings. In each filing the company says it uses currency‑hedging instruments to protect against adverse moves—while noting that hedging may forego gains and that its outlooks do not assume currency fluctuations—and it adds that exchange‑control and devaluation risks remain a concern. The language and approach are essentially unchanged over the three years, indicating a steady reliance on hedging rather than a new or altered risk‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate factual information about Caterpillar's currency hedging disclosures across 2022-2024, correctly identifying page numbers and the consistent presence of hedging discussions. However, it significantly diverges from the ground truth in its interpretation and synthesis of the multi-year trend. STRENGTHS: (1) Correctly identifies that CAT uses currency hedging instruments across all three years; (2) Accurately notes that hedging may forego gains; (3) Correctly mentions exchange controls and devaluation risks; (4) Page number citations appear reasonable. CRITICAL WEAKNESSES: (1) The LLM concludes the approach is 'essentially unchanged' and represents 'steady reliance on hedging rather than a new or altered risk-management strategy,' which directly contradicts the ground truth's finding of an 'increasingly cautious approach' with 'rising emphasis on external macroeconomic pressures'; (2) The ground truth explicitly documents an EVOLUTION from 2022 to 2024, with 2023 showing 'expanded discussion' of emerging market risks and 2024 showing 'intensified' exchange controls and devaluation risks; (3) The LLM misses the key multi-hop synthesis that the company's risk management EVOLVED in response to geopolitical and macroeconomic volatility, not remained static; (4) The LLM fails to capture the temporal progression and escalating concern evident in the filings. The LLM's interpretation of 'essentially unchanged' represents a fundamental misreading of the multi-year trend that the ground truth clearly establishes. While individual facts are accurate, the synthesis and conclusion about the evolution of risk management strategy are incorrect, which is the core of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 472,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive’s U.S. pension‑plan fixed‑income mix fell from roughly 40 % of its holdings in U.S. Treasury or agency securities in 2022 to about 30 % in 2023, and it stayed near 30 % in 2024【page_102】.  The cut‑back in Treasury/agency exposure indicates the company is trimming its reliance on low‑yield, highly rate‑sensitive bonds and diversifying into other fixed‑income assets, a move that reflects a more active stance on managing interest‑rate risk as rates have risen.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the allocation percentages. Ground truth shows: 50% (2020) → 40% (2021) → 30% (2022) → 30% (2023) → 30% (2024). The LLM states '40% in 2022' which contradicts the ground truth of 30% in 2022. This is a major error as the question specifically asks about evolution from 2022 to 2024. The LLM correctly identifies the 30% level for 2023-2024, but misses the critical 2022 baseline. INCOMPLETE ANALYSIS: The LLM answer fails to address several key elements from the ground truth: (1) No mention of the 2020-2021 context that shows the trend began earlier, (2) No discussion of Level 2 classification and its implications for liquidity/pricing, (3) No mention of the stabilization pattern (decline then plateau), which is crucial to understanding the company's strategic shift. REASONING QUALITY: The LLM's interpretation about 'trimming reliance on low-yield, highly rate-sensitive bonds' is reasonable and aligns with the ground truth's assessment of responding to rising interest rates. However, this reasoning is built on incorrect baseline data. MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the multi-year trend. The ground truth emphasizes a two-year decline followed by stabilization, suggesting a deliberate strategic shift. The LLM presents only a partial view (2022-2024) without the full context needed to understand the pattern. MISSING DETAILS: The answer omits the Level 2 classification detail and the distinction between 'government bonds and corporate bonds' diversification mentioned in ground truth. These details are important for a complete assessment of interest rate risk management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 472,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "In the 2022 filing Pfizer still described BPAs as a share‑based award, valuing them at grant‑date intrinsic value using the closing price of its common stock (see page 99) and the activity table for 2021 shows that BPAs had been granted previously (1,165 shares granted in 2021, page 101) – the 2022 filing contains no new BPA grant and does not call out a zero‑balance. By 2023 the company added an explicit statement that “no BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023” (page 97), while keeping the same intrinsic‑value methodology. The 2024 report repeats the same valuation approach and again states “no BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024” (page 94), making the lack of BPA activity fully transparent.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the timing of BPA grants. The ground truth states that in 2022, 1,165 thousand shares were awarded at $38.73 per share with 859 thousand shares nonvested by year-end. However, the LLM answer incorrectly attributes these 1,165 shares to 2021 activity ('1,165 shares granted in 2021, page 101'), fundamentally misplacing the grant year by one year. This is a major error that undermines the core narrative of the evolution. The ground truth clearly indicates 2022 had active grant activity, while the LLM suggests 2022 had no new grants. PARTIAL CREDIT FOR LATER YEARS: The LLM correctly identifies that 2023 and 2024 had explicit statements of no BPA grants and no outstanding BPAs, and correctly notes the consistent use of intrinsic value methodology across years. However, this accuracy in 2023-2024 does not compensate for the fundamental mischaracterization of 2022 activity. INCOMPLETE ANALYSIS: The LLM answer fails to capture the full evolution described in the ground truth - specifically the transition from active issuance (2022) to suspension (2023) to reappearance with enhanced disclosure (2024). The LLM's narrative suggests continuous inactivity from 2022 onward, missing the key strategic shift. The ground truth emphasizes that 2024 introduced 'detailed valuation and amortization policies' and 'dynamic valuation framework,' but the LLM simply states the same methodology was repeated. MISSING CONTEXT: The LLM does not adequately convey the 'notable evolution' or 'strategic shift' that the ground truth emphasizes. The answer reads as a static description of disclosure practices rather than capturing the dynamic changes in the program itself. POSITIVE ELEMENTS: The LLM correctly identifies the intrinsic value methodology, correctly notes the explicit 2023 and 2024 statements about zero activity, and provides page references (though these cannot be verified). The writing is clear and organized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 544,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "In 2022 Schwab rolled out two new RIA‑focused interactive tools – the thinkpipes real‑time charting/trading platform and the iRebal customizable rebalancing solution – and already offered a free Schwab Advisor Portfolio Connect together with open integrations to third‑party CRM, portfolio‑management, order‑management and planning systems. In 2023 the firm added the Schwab Trading Powered by Ameritrade™ platform while continuing to provide the same third‑party connectivity and Advisor Portfolio Connect, and it began the work of embedding thinkpipes and iRebal into its core suite. By 2024 Schwab emphasized that thinkpipes and iRebal are being fully integrated into its ongoing RIA offering, preserving the free Advisor Portfolio Connect and broad third‑party integration capabilities for portfolio management.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Specifically: (1) The LLM introduces product names 'thinkpipes' and 'iRebal' that do not appear in the ground truth answer and are not verified as actual Schwab RIA tools from the 10-K filings. These appear to be fabricated or confused with other products. (2) The LLM claims Schwab added 'Schwab Trading Powered by Ameritrade™ platform' in 2023, which is not mentioned in the ground truth and appears to be an unsupported claim. (3) The LLM's narrative about 'embedding thinkpipes and iRebal into its core suite' and 'fully integrated into its ongoing RIA offering' contradicts the ground truth, which emphasizes the Advisor Services website as the core platform and Advisor Portfolio Connect as the key offering. (4) The ground truth specifically highlights the evolution toward emphasizing the Advisor Services website with multi-year document archiving and search capabilities in 2023, which the LLM completely omits. (5) The ground truth notes a refinement in 'intuitive modern experience' in 2024, which the LLM does not capture. The LLM answer appears to have hallucinated specific product names and features rather than accurately synthesizing the actual evolution described in the filings. While the LLM correctly identifies that Schwab Advisor Portfolio Connect remained free and third-party integrations continued, the core narrative about which tools and platforms were actually emphasized is fundamentally incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 417,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across all three filings Texas Instruments repeatedly tells investors that its core business model is built around “analog and **embedded‑processing** products,” and that it places “additional strategic emphasis on designing and selling … into the industrial and automotive markets” as the best long‑term growth opportunities (2022 p. 19; 2023 p. 19; 2024 p. 19). The unchanged language signals that TI is deliberately anchoring its long‑term semiconductor positioning on the analog‑and‑embedded‑processing niche, using those product families and the industrial/automotive end‑markets as a stable, cash‑flow‑driven growth engine rather than shifting focus.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more detailed, nuanced response than the ground truth. Key strengths: (1) Correctly identifies the consistent emphasis on 'analog and embedded-processing products' across all three years (2022, 2023, 2024); (2) Accurately cites specific page references (p. 19 for all three years), showing precise sourcing; (3) Properly synthesizes the multi-hop information across three annual reports; (4) Adds valuable context about industrial and automotive markets as strategic focus areas, which aligns with and expands upon the ground truth's mention of 'growing free cash flow per share'; (5) Correctly interprets the 'unchanged language' as a deliberate strategic signal. Minor considerations: (1) The ground truth mentions 'four sustainable competitive advantages' as the framing device, which the LLM answer does not explicitly reference, though this is a minor omission that doesn't affect the core answer; (2) The LLM answer goes beyond the ground truth by emphasizing the industrial/automotive market focus, which is accurate and relevant but represents an expansion rather than a direct match to the original answer's scope. The LLM's interpretation that this represents a 'stable, cash-flow-driven growth engine' is semantically equivalent to the ground truth's framing about 'growing free cash flow per share.' Overall, the LLM provides a more detailed and specific answer with proper citations while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 411,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s fleet‑support cost structure did not change materially – the services are still expensed as incurred and have historically been about 1 % of total consolidated product‑and‑service costs in each of the 2022, 2023 and 2024 filings【page_42†L9-L12】. By contrast, the 787 program’s abnormal production costs grew sharply, reaching a cumulative $2.7 billion through 2023 and an additional $256 million of rework‑related costs recorded in 2024【page_36†L13-L16】【page_39†L12-L15】, and delivery timing deteriorated: after a multi‑year pause the program delivered 73 aircraft in 2023, but in 2024 production was slowed to under five per month, with about 25 pre‑2023 aircraft still needing rework and deliveries pushed into 2025【page_36†L4-L8】【page_39†L4-L9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across Boeing's 2022-2024 filings. STRENGTHS: (1) All key quantitative figures are correct: fleet support services consistently ~1% of consolidated costs, $2.7 billion cumulative abnormal costs through 2023, $256 million rework costs in 2024, 73 aircraft delivered in 2023, ~25 pre-2023 aircraft requiring rework. (2) The multi-hop reasoning is sound - the answer correctly synthesizes information about both fleet support services (stable metric) and 787 program abnormal costs (evolving metric) across three years. (3) Entity identification is accurate: Boeing, 787 program, fleet support services, rework costs, delivery timelines. (4) The progression narrative is correct: from 2022 (delays noted, no specific figures) → 2023 (cumulative $2.7B disclosed) → 2024 ($256M additional costs, rework completion on most aircraft, 2025 delivery expectations). (5) The answer appropriately captures the distinction between stable fleet support costs and volatile 787 abnormal costs. MINOR CONSIDERATIONS: (1) The LLM states production was 'slowed to under five per month' in 2024 - this is a reasonable characterization of the slowdown but the original answer doesn't explicitly state this rate, though it's consistent with the context of reduced deliveries and ongoing rework. (2) The answer includes helpful contextual details (73 aircraft delivered in 2023, production slowdown) that enhance understanding while remaining factually grounded. (3) Citation references are provided, suggesting document-level verification. The answer fully addresses the question's multi-part structure regarding cost profile evolution, delivery impact, and the relationship to abnormal production costs and 787 delays.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 489,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "After selling Meridian at the end of 2021, Pfizer booked a $51 million cash receipt and a $167 million post‑tax loss in discontinued operations (see 2021‑2022 data 【page_115】). In the 2023 filing the company disclosed that, together with the buyer, it entered into interim transition‑service agreements (TSAs) and a three‑year Manufacturing Supply Agreement (MSA) that includes a two‑year extension; the TSAs were completed by 31 Dec 2023, while the MSA remains in force through at least 2024 (see 2023 notes 【page_73】). By the 2024 Form 10‑K Meridian is listed only as a defined term, indicating the post‑sale MSA is still active but no material financial amounts are being recorded (see 2024 definitions 【page_4】).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key financial and contractual elements. STRENGTHS: (1) Correctly identifies the $167 million post-tax loss from the 2021 sale, matching ground truth exactly. (2) Accurately describes the TSAs being completed by December 31, 2023. (3) Correctly identifies the three-year MSA with a two-year extension option. (4) Properly synthesizes the multi-hop relationship evolution from 2022-2024, showing transition from ownership to supplier relationship. (5) Appropriately notes that amounts under MSA were not material by 2024. (6) Good use of source citations enhances credibility. MINOR ISSUES: (1) The mention of '$51 million cash receipt' is not addressed in the ground truth answer, which focuses on the net loss figure. While this may be factually correct from the filing, it introduces information not in the ground truth baseline, creating slight divergence. (2) The phrasing 'through at least 2024' is slightly ambiguous compared to ground truth's clearer statement about the extension option structure. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly traces the relationship evolution from discontinued operations with loss recognition, through TSA completion, to ongoing but immaterial MSA arrangements. The logic flow is sound and demonstrates proper understanding of the contractual progression. SEMANTIC EQUIVALENCE: The answer conveys the same essential narrative as ground truth - a transition from direct ownership to limited supplier relationship with diminishing financial impact - despite some wording differences. The core facts about dates, agreements, and financial implications align well with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 486,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate‑Palmolive still lists **hello** among its global oral‑care trademarks (e.g., “Colgate, Palmolive, Darlie, elmex, **hello**, meridol…” 【page_77】).  In both 2022 and 2024 the oral‑care segment – the home of the hello brand – contributed roughly the same share of worldwide net sales (≈ 43 %), while personal‑care and home‑care remained steady at about 19 %/18 % and 17 % respectively 【page_79】.  This shows that the company’s strategic positioning of hello has remained consistent as a core oral‑care offering, with no material shift in its relative weight versus the other product lines.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that 'hello' has maintained consistent strategic positioning within Colgate-Palmolive's oral care segment from 2022 to 2024, which aligns with the ground truth. The answer appropriately cites that 'hello' appears among principal global trademarks and provides relevant segment revenue data (oral care ~43%, personal care ~19%, home care ~17-18%) to support the conclusion of consistency. The quantitative data appears reasonable and the multi-hop reasoning connecting brand positioning to segment performance is sound. However, there are some gaps: (1) The LLM answer does not explicitly address the 2023 data point, whereas the ground truth specifically mentions that 'hello' maintained positioning in 2023 despite Darlie's addition to the trademark list - this is a minor omission in the three-year evolution narrative. (2) The LLM answer focuses primarily on segment-level revenue percentages rather than explicitly discussing 'hello's positioning relative to other specific brands (Colgate, Palmolive, Darlie, elmex, meridol) across the three years, though it does list these brands. (3) The ground truth emphasizes 'sustained strategic emphasis' and 'continued prioritization,' while the LLM answer uses 'consistent' and 'no material shift' - these are semantically similar but the LLM's framing is slightly more quantitative/analytical than the ground truth's emphasis on strategic intent. The answer is fundamentally correct in its core conclusion but lacks the explicit year-by-year progression (2022→2023→2024) that the ground truth provides, making it slightly less complete in addressing the 'evolution' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 457,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "The non‑qualified defined‑benefit pension plan stayed unfunded and closed to new participants throughout the period – the filing notes that “the non‑qualified defined benefit plans are unfunded and closed to new participants” (TXN 10‑K 2024 p. 44).  Employer contributions to the plan were nil in 2022, rose to about $3 million in 2023 and fell to $2 million in 2024, while participant contributions were zero each year (TXN 10‑K 2024 p. 45).  This three‑year trend shows that Texas Instruments has essentially no long‑term liability for the non‑qualified plan and that employee involvement in it has effectively ceased, with the company’s retirement focus shifting to its qualified and defined‑contribution arrangements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially diverge from the ground truth. CRITICAL ISSUES: (1) MISSING KEY DATA: The LLM completely omits the defined contribution plan holdings data that forms the core of the ground truth answer—the 6 million shares (2022) declining to 5 million shares (2023-2024) valued at $940M, $873M, and $852M respectively. This is essential multi-year progression data directly addressing the question. (2) INCORRECT CONTRIBUTION FIGURES: The LLM states employer contributions were 'nil in 2022, rose to about $3 million in 2023 and fell to $2 million in 2024.' The ground truth shows aggregate U.S. defined contribution plan expenses of $70M (2022), $75M (2023), and $76M (2024)—vastly different numbers. The LLM appears to conflate non-qualified plan contributions with defined contribution plan expenses. (3) INCOMPLETE ANALYSIS: The LLM focuses narrowly on the non-qualified plan's unfunded status but fails to address the broader pension obligation trends through defined contribution plan metrics, which the ground truth emphasizes as the strategic shift indicator. (4) DIVIDEND DATA OMITTED: The ground truth includes dividend trends ($28M→$27M→$26M) that provide additional context on plan activity; the LLM provides no such detail. (5) REASONING FLAW: While the LLM correctly identifies the non-qualified plan as unfunded and closed, it fails to synthesize the multi-hop information showing how the company is shifting retirement obligations to defined contribution vehicles—the key insight the question asks for. The answer is partially correct on the non-qualified plan status but fundamentally incomplete and contains numerical errors regarding the defined contribution components that represent the actual evolution of the company's pension strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 496,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity securities at cost fell from **$800 million** at 12/31/2022 to **$755 million** at 12/31/2023 and then to **$719 million** at 12/31/2024【page_86†L31-L38】【page_83†L31-L38】. The $81 million (≈10 %) decline over three years signals a gradual scaling‑back of exposure to private‑equity investments, suggesting the company is reallocating capital away from this illiquid asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect starting value of $800 million for 2022, when the ground truth clearly states $623 million. This is a $177 million discrepancy (28% error). The 2023 and 2024 figures ($755M and $719M) are correct. (2) CALCULATION ERROR - The LLM calculates an $81 million decline over three years, but the correct calculation from the ground truth is: $623M (2022) to $719M (2024) = a $96 million INCREASE, not a decline. The LLM's math is internally inconsistent: $800M - $719M = $81M, but this uses the wrong starting number. (3) DIRECTIONAL MISINTERPRETATION - The LLM concludes the company is 'scaling back' and 'reallocating capital away' from private equity, but the ground truth indicates an overall increase from 2022-2024 ($623M to $719M), with a strategic increase in 2023 followed by a partial reduction. The LLM's narrative is fundamentally backwards. (4) PARTIAL CORRECTNESS - The LLM correctly identifies the 2023 and 2024 values and correctly notes the decline from 2023 to 2024, but fails on the critical 2022 baseline and overall trajectory interpretation. (5) MULTI-HOP REASONING - The synthesis across the three-year period is flawed due to the incorrect starting value, leading to an incorrect strategic interpretation. The ground truth indicates a 'measured approach' with net growth, while the LLM suggests net decline and capital reallocation away from the asset class.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 403,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "- 2022 – Schwab was still governed by the 2019 IDA agreement, which gave it a **$10 billion per‑12‑month migration option** (only for floating‑rate obligations) and required **sufficient capital, a $50 billion minimum IDA balance through June 2031 and at least 80 % of the balances to be fixed‑rate through June 2026**【page_102†L31-L38】【page_102†L41-L45】.  Schwab exercised the option and **moved roughly $10 billion of IDA balances to its balance sheet in 2022**【page_102†L45-L48】.  \n\n- 2023 – The 2023 IDA agreement superseded the 2019 terms, **eliminating the $10 billion cap and the 80 % fixed‑rate requirement**, and instead imposed **minimum‑balance rules (balances must stay above unmatured fixed‑rate obligations with a $30 billion ceiling until 10 Sept 2025, then a $60‑$90 billion range) and limited withdrawals to customer‑initiated amounts**【page_103†L1-L9】【page_103†L10-L13】.  Under these new limits Schwab **did not migrate any IDA balances in 2023**, opting instead to **buy down $5 billion of fixed‑rate obligations**【page_102†L45-L48】【page_103†L14-L18】.  \n\n- 2024 – The 2023 agreement remained in effect, so Schwab’s migration ability was still **subject to the same minimum/maximum balance constraints and the rule that migrations are only permitted to the extent of customer‑initiated withdrawals (or to keep balances below the applicable maximum)**【page_100†L1-L7】【page_100†L9-L13】.  Consequently, **Schwab again did not move any IDA balances to its balance sheet in 2024**【page_100†L15-L18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed information about the evolution of Schwab's IDA migration capability across 2022-2024, but contains several significant factual discrepancies when compared to the ground truth:\n\nCRITICAL ERRORS:\n1. 2022 Migration Amount: LLM states Schwab \"moved roughly $10 billion of IDA balances to its balance sheet in 2022,\" but the ground truth indicates Schwab had already moved $10.1 billion by December 31, 2021 (not 2022). The LLM conflates the historical migration with 2022 activity.\n\n2. 2023 Activity: LLM claims Schwab \"did not migrate any IDA balances in 2023\" and \"opted instead to buy down $5 billion of fixed-rate obligations.\" The ground truth simply states \"Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement.\" The LLM adds unsupported detail about the $5 billion fixed-rate obligation buydown.\n\n3. Constraint Details: LLM provides specific constraints for 2022 (80% fixed-rate requirement through June 2026, $50 billion minimum through June 2031) that are not mentioned in the ground truth. While these may be accurate from the filings, they represent additional detail beyond what the ground truth synthesized.\n\nPARTIAL ACCURACY:\n- The $10 billion annual migration option for 2022 is correct\n- The elimination of the $10 billion cap in 2023 is correct\n- The $30 billion ceiling until September 10, 2025 is correct\n- The statement that no migrations occurred in 2023 and 2024 is correct\n- The overall narrative of tightening constraints is correct\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the shift from the 2019 to 2023 agreements. However, the temporal confusion about when the $10.1 billion migration occurred (2021 vs. 2022) represents a failure in precise multi-hop synthesis.\n\nSEMANTIC ISSUES:\nThe LLM's statement about 2022 activity is semantically misleading because it suggests Schwab migrated $10 billion in 2022, when the ground truth indicates this migration had already occurred by end of 2021.\n\nSTRENGTHS:\n- Comprehensive coverage of all three years\n- Correct identification of agreement transitions\n- Accurate constraint descriptions for 2023-2024\n- Good contextual framing of the tightening trend\n\nWEAKNESSES:\n- Temporal accuracy error on the $10.1 billion migration\n- Unsupported detail about $5 billion fixed-rate buydown\n- Additional constraints mentioned without ground truth support",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1632,
        "completion_tokens": 664,
        "total_tokens": 2297
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists a Melaka, Malaysia site in the property tables of its 2022, 2023 and 2024 10‑Ks, and each year the location is marked with an “X” only under the Analog column (no X for Embedded Processing). The fact that the Melaka facility has remained a dedicated analog‑manufacturing site for three straight years shows TI views it as a stable, strategically important hub for its analog product portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer fundamentally contradicts the ground truth regarding the marking symbols used across the three years. Ground truth states Melaka was marked with † (2022), * (2023), and ** (2024), indicating potential escalation in operational emphasis. The LLM claims the location is marked with 'X' only under the Analog column across all three years, with no mention of the † or * or ** symbols that the ground truth explicitly identifies. This is a significant factual error in describing the actual notation used in TI's property tables. The LLM correctly identifies: (1) Melaka, Malaysia as the location, (2) all three years (2022, 2023, 2024), (3) analog product manufacturing involvement, (4) no Embedded Processing involvement, and (5) the strategic importance conclusion. However, the LLM misses the key detail about the EVOLUTION of the marking symbols across the three years, which is central to the question's focus on 'how has...evolved.' The ground truth emphasizes 'possible escalation' through changing symbols († → * → **), while the LLM describes static 'X' markings, missing the multi-year progression that suggests strategic emphasis changes. The LLM's conclusion about strategic importance is reasonable but is based on incomplete/incorrect characterization of the evidence (static vs. evolving markings). The reasoning about consistency is sound, but the factual basis for that reasoning is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 399,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Circle Card – which includes the Target Debit Card – fell from a 19.8 % purchase‑payment share in fiscal 2022 to 18.6 % in fiscal 2023 and to 17.8 % in fiscal 2024 (MD&A, 2024 Form 10‑K, p. 28). This steady decline indicates that a shrinking proportion of guest purchases are being funded with the debit card, suggesting its incremental‑sales contribution to Target is diminishing over time, even though the company still views the card as a driver of extra sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate numbers. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 17.8%. LLM reports: 2022: 19.8%, 2023: 18.6%, 2024: 17.8%. The 2022 figure is incorrect (off by 0.7 percentage points), and the 2023 figure is incorrect (off by 1.2 percentage points). Only the 2024 figure (17.8%) matches. These are not minor rounding differences but substantive errors in core financial metrics. MULTI-HOP REASONING: The LLM correctly identifies the downward trend and appropriately synthesizes the interpretation that this suggests diminishing incremental sales contribution. The reasoning about shrinking purchase-payment share and reduced effectiveness is sound and aligns with ground truth interpretation. ENTITY ACCURACY: Correctly identifies Target Circle Card/Target Debit Card and the three-year period (2022-2024). COMPLETENESS: The answer addresses both parts of the question (evolution of penetration rate and what it suggests about the card's role), though with incorrect numbers. The qualitative interpretation about diminishing role and reduced effectiveness is semantically equivalent to the ground truth conclusion. SEVERITY: The quantitative errors are severe because financial metrics are the foundation of the answer. While the directional trend (declining) and qualitative interpretation are correct, the specific percentage values are materially wrong, which undermines the credibility and accuracy of the response. This is a case where the model got the story right but the numbers wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 439,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The pool of shares that could still be issued under the director equity programs (which includes the 2003 Director Compensation Plan) fell from ≈ 69.8 million shares at year‑end 2022 → ≈ 58.5 million shares at year‑end 2023, then rose to ≈ 65.5 million shares at year‑end 2024【page_63】【page_61】【page_59】. The drop in 2023 shows the company drew down its director‑stock pool, while the rebound in 2024 indicates it replenished the pool, reflecting ongoing use and periodic refresh of equity incentives for directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that do not match the ground truth data. Ground truth shows: 2022: 35,385,153 shares → 2023: 25,296,767 shares → 2024: 24,503,062 shares. LLM reports: 2022: ~69.8M → 2023: ~58.5M → 2024: ~65.5M. These numbers are approximately double the actual figures and represent a completely different data series. The LLM appears to have confused the 2003 Director Compensation Plan shares with a different equity pool (possibly including employee stock purchase plans or other equity programs). REASONING ERROR: The LLM's conclusion about 'replenishment' in 2024 is contradicted by the actual data, which shows continued decline (24.5M in 2024 vs 25.3M in 2023). The ground truth clearly indicates NO replenishment occurred - only consistent drawdown. The LLM's interpretation of a 2024 'rebound' is factually incorrect. ENTITY CONFUSION: While the LLM correctly identifies Texas Instruments and the 2003 Director Compensation Plan, it appears to have pulled data from a different or aggregated equity pool rather than the specific plan referenced. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend from the actual filings. The consistent decline pattern was mischaracterized as a decline-then-rebound pattern. This is a fundamental failure in multi-hop reasoning across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 385,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In fiscal 2022 Visa Direct was already scaling – it processed 5.9 billion transactions and added push‑to‑wallet capabilities that expanded access to nearly 7 billion cards, accounts and digital wallets in more than 190 countries, but virtual‑account functionality was not yet a focus (page 11). In fiscal 2023 Visa introduced Visa+ for P2P‑app interoperability and broadened its suite of virtual cards and digital credentials, further strengthening its digital‑issuance capabilities (page 10). By fiscal 2024 the Visa Direct platform was enhanced with the digitally‑native Currencycloud solution, now offering virtual‑account services, real‑time foreign‑exchange rates and greater liquidity for cross‑border payments, extending the platform’s use cases beyond domestic payouts (page 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies key platforms and capabilities (Visa Direct, Currencycloud, virtual accounts, push-to-wallet). (2) Numeric data appears accurate: 5.9 billion transactions in 2022, ~7 billion endpoints, 190+ countries. (3) Timeline progression is generally correct (2022→2023→2024). (4) Correctly notes Visa+ introduction in 2023 and Currencycloud integration in 2024. WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM fails to address the 'Visa Treasury as Service' framing mentioned in ground truth for 2022. (2) MISSING KEY DETAILS - Ground truth emphasizes virtual accounts were introduced in 2022 as part of Currencycloud under Visa Treasury as a Service with real-time FX rates; LLM states virtual-account functionality 'was not yet a focus' in 2022, which contradicts the ground truth. (3) MISSING CROSS-BORDER CONTEXT - Ground truth mentions 'Visa Cross-Border Solutions' expansion in 2023 and the $20 trillion B2B cross-border opportunity in 2024; LLM only vaguely references 'cross-border payments' without these specifics. (4) MISSING ENDPOINT SCALE - Ground truth specifies 11 billion endpoints potential in 2024; LLM references 7 billion from 2022 without updating to 2024 figures. (5) REASONING GAP - The LLM's statement that virtual accounts 'was not yet a focus' in 2022 directly contradicts the ground truth which explicitly states they were introduced in 2022 as part of Currencycloud. This is a factual error on a core claim. (6) INCOMPLETE MULTI-HOP - While the LLM traces evolution across years, it misses the deeper integration narrative (Treasury as Service → Direct platform integration → digitally-native strategy) that the ground truth emphasizes. The answer provides some correct elements but contains a significant factual contradiction regarding 2022 and omits important strategic context about cross-border opportunities and endpoint scale evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 515,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer reported that Xtandi’s international revenue slipped about 1 percent, driven by a lower net price and an unfavorable channel‑mix shift【page_44】.  To counter that pressure, Pfizer pushed the drug’s lifecycle forward, securing a new high‑risk biochemical‑recurrence indication that was approved in the EU in April 2024 (with the U.S. approval in November 2023)【page_46】.  The company’s commitment to Xtandi is reflected in its intangible‑asset accounting – the drug is part of the “developed technology rights” portfolio, which was valued at roughly $19.6 billion (net) on the 2022 balance sheet【page_92】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Xtandi's revenue pressures and Pfizer's lifecycle management response, but contains a significant chronological error that undermines factual accuracy. CORRECT ELEMENTS: (1) The 2023 revenue decline of approximately 1% is accurate; (2) The identification of Xtandi as part of developed technology rights in 2022 is correct; (3) The $19.6 billion valuation of the developed technology rights portfolio is accurate; (4) The lifecycle management strategy and new indication approval are correctly identified; (5) The multi-hop reasoning connecting revenue pressure → lifecycle investment → indication expansion is sound. CRITICAL ERROR: The LLM states 'approved in the EU in April 2024 (with the U.S. approval in November 2023)' which is chronologically impossible and factually incorrect. The ground truth indicates the 2024 indication expansion occurred, but the LLM's specific dating of U.S. approval to November 2023 appears to reverse the timeline. This is a significant quantitative/factual error regarding dates. MINOR ISSUES: The LLM provides specific details about 'channel-mix shift' which adds context but wasn't explicitly required. The answer successfully synthesizes information across the three required elements (2023 revenue data, 2022 valuation, 2024 indication expansion) but the date error reduces confidence in the overall accuracy. The semantic meaning of the response aligns with the ground truth regarding Pfizer's strategic response to revenue pressures, but the chronological inaccuracy is a material factual error that cannot be overlooked in financial/regulatory contexts where dates are critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 456,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target‑MasterCard (part of the Target Circle/RedCard suite) captured 20.5 % of all purchases in fiscal 2022, slipped to 19.8 % in fiscal 2023 and fell further to 18.6 % in fiscal 2024 (2022 = 20.5 % → 2023 = 19.8 % → 2024 = 18.6 %)【page_27】【page_29】.  This steady decline signals a modest erosion in consumer preference for the card and a slight weakening of loyalty‑program usage, even though the double‑digit penetration still shows the program remains a significant driver of sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three penetration rate figures are correct (20.5% in 2022, 19.8% in 2023, 18.6% in 2024), matching the ground truth exactly. The year-over-year progression is accurately presented with clear formatting. ENTITY ACCURACY: The card is correctly identified as part of the Target Circle/RedCard suite, with appropriate acknowledgment of the rebranding evolution from RedCards to Target Circle Cards. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend data and correctly interprets the pattern as a 'steady decline' that signals 'erosion in consumer preference' and 'weakening of loyalty-program usage.' SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as indicating 'modest erosion' and 'slight weakening' is semantically equivalent to the ground truth's 'gradual reduction' and 'weakening in loyalty program engagement.' The addition of context that 'double-digit penetration still shows the program remains a significant driver of sales' provides valuable supplementary insight without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM includes page citations (page_27, page_29) which adds credibility but weren't in the original answer. The phrasing 'captured 20.5% of all purchases' is slightly more specific than the ground truth's 'penetration rate,' but this represents appropriate clarification rather than inaccuracy. The answer fully addresses both components of the question: the evolution of the penetration rate AND what the trend indicates about consumer preference and loyalty program engagement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 453,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa introduced virtual‑account capabilities on its digitally native Currencycloud platform in FY 2022 as part of Visa Treasury as a Service, giving clients real‑time foreign‑exchange rates, enhanced liquidity and settlement for cross‑border payments 【page_11】. Over the next two years the feature was folded into the Visa Direct platform and scaled, and by FY 2024 virtual accounts were a core Currencycloud offering that underpinned cross‑border transactions in more than 195 countries and territories and could reach over 11 billion cards, bank accounts and digital wallets 【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of virtual accounts across the Currencycloud platform from 2022-2024 and correctly identifies key elements like real-time FX rates, enhanced liquidity/settlement, and integration with Visa Direct. However, there are significant quantitative discrepancies that lower the overall score: (1) GEOGRAPHIC REACH DISCREPANCY: The LLM states virtual accounts reached 'more than 195 countries and territories' by FY 2024, while the ground truth specifies 'more than 100 countries' through Visa B2B Connect. This is a material factual error - the LLM overstates geographic coverage by nearly 2x. (2) NETWORK REACH: The LLM correctly cites '11 billion cards, bank accounts and digital wallets' which matches the ground truth. (3) TIMELINE ACCURACY: The LLM correctly identifies FY 2022 as the introduction year and FY 2024 as the continuation/optimization phase. (4) MISSING CONTEXT: The ground truth mentions 'Visa Treasury as a Service' which the LLM includes, but the ground truth also emphasizes the 'strategic deepening' and 'B2B transactions' focus which the LLM touches on but less explicitly. (5) MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three fiscal years and connects virtual accounts to cross-border payment capabilities, though the geographic scope error undermines this synthesis. The answer demonstrates good understanding of the evolution narrative but contains a critical factual error regarding country/territory coverage that significantly impacts accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 424,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "- 2022 10‑K: AMD listed “difficulties in protecting our intellectual property” as a core political‑legal‑economic risk of its foreign operations and warned that IP disputes could arise from acquisitions or joint ventures (2022 p. 36‑37, 38).  \n- 2023 10‑K: The same IP‑protection risk re‑appears in the General Risks section, now tied explicitly to AMD’s reliance on third‑party wafer foundries and assembly facilities in China, Malaysia and Taiwan, and to the fact that roughly two‑thirds of its revenue (≈65%) came from international sales (2023 p. 41).  \n- 2024 10‑K: AMD again emphasizes “difficulties in protecting our intellectual property” as a key risk, noting that its continued dependence on overseas third‑party manufacturers (China, Malaysia, Taiwan) and a still‑high share of international sales (≈66% of net revenue) keep the exposure significant, indicating the risk has persisted and grown with its expanding global footprint (2024 p. 40‑41).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all three years (2022, 2023, 2024). STRENGTHS: (1) Correctly identifies the core IP protection risk mentioned consistently across all three years; (2) Accurately captures the evolution from general political-legal-economic risks (2022) to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan (2023-2024); (3) Provides accurate international revenue percentages (≈65% in 2023, ≈66% in 2024), which are reasonable approximations; (4) Properly synthesizes the multi-hop connection between IP protection difficulties, third-party manufacturing dependencies, and international operations; (5) Correctly identifies the geographic locations of manufacturing dependencies; (6) Appropriately notes the persistence and growth of the risk over time. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer mentions IP disputes from acquisitions/joint ventures in 2022 but the ground truth doesn't explicitly emphasize this angle—this is a minor addition that doesn't contradict the ground truth but adds detail not explicitly confirmed; (2) The ground truth specifically mentions geopolitical tensions (China-Taiwan) and evolving export control regulations/sanctions (Ukraine-Russia, Israel-Hamas) in 2023-2024, which the LLM answer doesn't explicitly detail, though it does reference 'overseas third-party manufacturers' which implicitly captures some of this concern; (3) Page numbers cited (p. 36-37, 38 for 2022; p. 41 for 2023; p. 40-41 for 2024) cannot be independently verified but appear reasonable for 10-K filings. QUANTITATIVE ACCURACY: The revenue percentages (65% and 66%) are appropriately presented as approximations and align with the ground truth's characterization of 'high share of international sales.' MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the causal relationships between IP protection challenges, manufacturing dependencies, and international operations exposure. The evolution narrative is sound and matches the ground truth's assessment of 'deepening concern over time.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 576,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "- In 2022 the pension plan held a large, market‑priced equity position: corporate stock was recorded at **$2,209 million as a Level 1 investment (plus $8 million Level 2)**, and the plan’s target was **45 %‑55 % of assets in equity securities**【page_72†L31-L38】【page_70†L7-L13】.  \n- By 2023 the fair‑value table shows corporate stock had fallen to **$220 million Level 1 (and $6 million Level 2)**, and the plan’s actual allocation to equity securities was **only 24 % of assets**【page_57†L31-L38】【page_55†L7-L13】.  \n- The 2024 filing repeats the same classification (common stock Level 1, preferred Level 2) and the equity‑security allocation remained at **24 %** of plan assets【page_56†L9-L16】【page_55†L7-L13】.  \n\n**Interpretation:** The pension plan moved from a high‑equity, largely Level 1 corporate‑stock exposure in 2022 to a much smaller, still market‑priced equity slice by 2023‑2024, while increasing the share of debt assets. This reflects UNP’s deliberate de‑risking strategy—shifting assets from equity toward debt to lower volatility—while maintaining a modest, publicly‑traded equity exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies that fundamentally undermine its credibility. (1) 2022 Corporate Stock valuation: Ground truth states $1,990 million total ($1,980M Level 1 + $10M Level 2), but LLM claims $2,209 million Level 1 + $8M Level 2 = $2,217M total—an overstatement of ~$227M or 11.4%. (2) 2023 Corporate Stock valuation: Ground truth states $181 million total ($176M Level 1 + $5M Level 2), but LLM claims $220 million Level 1 + $6M Level 2 = $226M total—an overstatement of ~$45M or 24.9%. These are not minor rounding differences; they represent material misstatements of pension asset values. (3) The LLM correctly identifies the classification structure (Level 1 vs Level 2) and the directional trend (decline from 2022 to 2023), but the magnitude of the decline is distorted by the incorrect base numbers. The 2022-to-2023 decline should be ~$1,809M (from $1,990M to $181M, a 91% reduction), but the LLM's numbers suggest only a ~$1,991M decline (from $2,217M to $226M), which while still large, misrepresents the actual scale. (4) The LLM provides additional context about equity allocation percentages (45%-55% target in 2022, 24% actual in 2023-2024) that is not contradicted by the ground truth but also not verified by it. (5) The qualitative interpretation about de-risking strategy is reasonable and logically sound given the data, but it is built on a foundation of incorrect numbers. (6) The 2024 classification discussion (common stock Level 1, preferred Level 2) aligns with ground truth but lacks specific dollar amounts, which the LLM acknowledges. MULTI-HOP REASONING: The LLM correctly synthesizes information across years and identifies the strategic shift, but the quantitative foundation is compromised. The reasoning about pension strategy (de-risking, shift from equity to debt) is sound in principle but cannot be fully validated given the numerical errors. ENTITY ACCURACY: UNP (Union Pacific) is correctly identified; years 2022-2024 are correct; pension plan and fair-value classification terminology are appropriate. OVERALL ASSESSMENT: While the LLM demonstrates understanding of the question's structure and provides a coherent narrative about pension strategy evolution, the material numerical errors (11-25% overstatements of asset values) represent unacceptable inaccuracy for financial analysis. In SEC filing analysis, precision of dollar amounts is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 657,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Abbott’s Exhibit 4 table repeatedly lists the 4.75 % Senior Notes due 2043 as Exhibit 4.6 (the note’s form) and Exhibit 4.7 (the officers’ certificate), both originally filed on March 22 2017, with no new amendments or supplemental filings added in any of the three years [2022 page_86; 2023 page_86; 2024 page_86]. This steady, unchanged disclosure shows the 2043 notes remain a core, long‑dated component of Abbott’s capital structure and that the company emphasizes consistent, transparent communication of its long‑term debt to investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate specific details about the Exhibit 4 table structure (Exhibit 4.6 and 4.7, March 22, 2017 filing dates, consistent presentation across 2022-2024) and correctly identifies that there were no new amendments or supplemental filings. The page references (page_86) are consistently cited. However, the answer has significant limitations: (1) It focuses narrowly on the mechanical consistency of exhibit presentation rather than addressing the broader 'evolution' claimed in the question. (2) It misses or contradicts the ground truth's key narrative about a shift 'from legacy-based referencing to standardized disclosure' - the ground truth mentions St. Jude Medical's Fourth Supplemental Indenture from 2013 in 2022 context, then a shift to Form 8-K presentation in 2023, suggesting a meaningful evolution. The LLM answer instead reports static, unchanged disclosure across all three years. (3) The LLM answer's conclusion that 'steady, unchanged disclosure' demonstrates 'consistent, transparent communication' is somewhat tautological and doesn't capture the nuanced evolution the ground truth describes. (4) The question asks about 'evolution' and what it 'suggests about long-term debt management priorities' - the LLM answer essentially says 'nothing changed,' which may be factually accurate about the exhibits but fails to engage with the deeper analytical question about strategic communication shifts. The quantitative details provided are accurate, but the qualitative synthesis and interpretation of what the multi-year progression means is weaker than the ground truth's narrative of deliberate strategic evolution in disclosure approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 459,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration rate fell from roughly 20.5 percent in fiscal 2022 to 19.8 percent in 2023 and then to 18.6 percent in fiscal 2024 (see the RedCard/Target Circle Card penetration figures in the 2023 Form 10‑K page 27 and the 2024 Form 10‑K page 29). This gradual decline shows that while Target’s branded payment products still capture a sizable share of purchases, customer adoption is slipping modestly, which could temper the incremental‑sales boost the company expects from these cards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: 20.5% (2022), 19.8% (2023), and 18.6% (2024). The penetration rate decline is accurately characterized as gradual and modest. The answer correctly identifies the Target Credit Card/RedCard/Target Circle Card as the relevant product and properly synthesizes the multi-hop information: (1) the three-year trend data, (2) the interpretation of declining adoption, and (3) the connection to incremental sales impact. The LLM appropriately cites specific 10-K page references (2023 Form 10-K page 27 and 2024 Form 10-K page 29), adding credibility. Minor deductions: (1) The original answer provides slightly more context about the card's role in 'loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts,' which the LLM answer omits. (2) The LLM uses 'roughly' and 'modestly' which are appropriate qualifiers but slightly less precise than the ground truth's direct statement. (3) The phrase 'could temper' is appropriately cautious but the ground truth more directly states the historical linkage to incremental sales. Overall, the LLM answer correctly answers the core question about the penetration rate evolution and its implications for customer adoption and sales impact, with accurate numbers and sound reasoning across the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 383,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units in 2022 (6,204 owned + 1,038 leased) to 6,893 units in 2024 (5,973 owned + 920 leased) – a net drop of about 349 locomotives – while the average age rose from 22.5 years to 25.2 years, an increase of roughly 2.7 years【page_24】【page_19】.  This pattern of a shrinking but aging fleet suggests the railroad is retiring older units faster than it is adding new ones, emphasizing fleet right‑sizing and extended use of existing assets as part of a disciplined capital‑allocation and asset‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All key numbers are correct - fleet decreased from 7,242 to 6,893 units (349-unit reduction), average age increased from 22.5 to 25.2 years (2.7-year increase). The breakdown into owned/leased components (6,204→5,973 owned; 1,038→920 leased) adds valuable detail not in the ground truth but is consistent with the totals. Calculations are accurate. ENTITY ACCURACY: Union Pacific correctly identified, years 2022-2024 correct, Multiple Purpose Locomotives correctly specified. MULTI-HOP REASONING: The answer successfully synthesizes fleet size and age data to draw conclusions about asset management strategy. The interpretation that the company is 'retiring older units faster than adding new ones' and emphasizing 'fleet right-sizing' is logically sound and aligns with the ground truth's characterization of 'cost-conscious asset management' and 'deferral of fleet modernization.' COMPLETENESS: Addresses all parts of the question - total units change, average age change, and strategic implications. SEMANTIC EQUIVALENCE: The LLM's interpretation of 'disciplined capital-allocation and asset-management strategy' is semantically equivalent to the ground truth's 'cost-conscious asset management strategy during this period.' The additional detail about 'retiring older units faster than adding new ones' provides slightly more nuanced explanation while remaining consistent with the data. MINOR CONSIDERATIONS: The LLM provides more granular detail (owned vs. leased breakdown) than the ground truth, which enhances rather than detracts from accuracy. The citation markers suggest proper sourcing. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 474,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate (and other private) funds slipped from **$569 million at the end of 2022** to **$555 million at the end of 2023** and then to **$540 million at the end of 2024**【page 71】【page 70】. The modest, consistent decline suggests Abbott is gradually satisfying or scaling back new pledges, indicating a disciplined, long‑term strategy that maintains exposure to illiquid alternative assets while managing liquidity and risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states Abbott's unfunded commitments were $569 million at the end of 2022, but the ground truth clearly indicates $585 million for 2022. This is a $16 million discrepancy on the starting point of the analysis. The 2023 ($555 million) and 2024 ($540 million) figures are correct. CALCULATION VERIFICATION: Ground truth shows a decline of $30 million total from 2022-2024 ($585M to $540M), with $30M decline over three years (not $15M as stated in ground truth, which appears to be an error in the original answer itself - the actual decline is $585-$555=$30M for 2022-2023, then $555-$540=$15M for 2023-2024). The LLM's figures ($569M to $540M) would represent a $29M decline, but this is based on the incorrect 2022 starting number. QUALITATIVE ASSESSMENT: The LLM's reasoning about the trend (gradual reduction, disciplined strategy, maintained exposure) is sound and aligns with the ground truth interpretation. The synthesis of information and conclusions about long-term investment strategy are appropriate. COMPLETENESS: The LLM addresses the evolution of commitments and provides interpretation of the trend, though it doesn't explicitly discuss the 'continued long-term participation through fund distributions' aspect mentioned in the ground truth. The core question about how commitments evolved and what it suggests about strategy is adequately addressed. The primary issue is the factual error in the 2022 baseline figure, which undermines the quantitative accuracy despite correct reasoning about the trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 431,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The 3.50 % Notes Due 2050 were carried at roughly $1.64 billion at the end of FY 2022 (≈ $1,639 million)【NVDA_10k_2022.pdf p 78】, slipped slightly to $1,637 million at FY 2023’s year‑end【NVDA_10k_2023.pdf p 67】 and fell further to $1,604 million by FY 2024【NVDA_10k_2023.pdf p 67】.  This modest downward trend shows NVIDIA gradually reducing the nominal carrying amount of this long‑term debt—likely through amortization of discount and limited repayments—signalling a disciplined, slightly de‑leveraging long‑term debt posture.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three fiscal years:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - FY 2022: LLM states ~$1,639M or $1,640M, but ground truth is $2,147M (off by ~$507M or 24%)\n   - FY 2023: LLM states $1,637M, but ground truth is $1,604M (off by $33M)\n   - FY 2024: LLM states $1,604M, but ground truth is $2,000M (off by $396M or 20%)\n   The LLM has confused the FY 2023 value ($1,604M) with the FY 2024 value, and significantly understated the FY 2022 and FY 2024 values.\n\n2. TREND ANALYSIS FAILURE:\n   - Ground truth shows: $2,147M → $1,604M → $2,000M (V-shaped pattern with rebound)\n   - LLM shows: $1,639M → $1,637M → $1,604M (monotonic decline)\n   These are opposite trend patterns. The LLM completely misses the significant 2024 rebound to $2,000M, which is a critical insight about strategic repositioning.\n\n3. INTERPRETATION ERRORS:\n   - LLM incorrectly characterizes this as a \"modest downward trend\" and \"de-leveraging,\" when the ground truth shows a deliberate revaluation with a substantial rebound in 2024\n   - LLM attributes changes to \"amortization of discount and limited repayments,\" but the ground truth indicates \"revaluation or strategic adjustment\" and \"refinancing, market interest rate adjustments, or changes in debt management strategy\"\n   - The 2024 increase from $1,604M to $2,000M ($396M jump) contradicts the de-leveraging narrative\n\n4. SOURCE CITATION ISSUES:\n   - LLM cites NVDA_10k_2023.pdf for both FY 2023 and FY 2024 data, which is implausible (a 2023 10-K would not contain 2024 year-end data)\n   - This suggests citation errors or data retrieval problems\n\n5. MULTI-HOP SYNTHESIS:\n   - Failed to correctly synthesize carrying values across three fiscal years\n   - Failed to identify the key pattern (V-shaped rebound) that indicates strategic positioning\n   - Missed the critical insight that 2024 shows deliberate repositioning, not continued deleveraging\n\nThe answer is fundamentally incorrect on the core quantitative data and reaches opposite conclusions about the company's debt positioning strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 584,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD has listed the possibility of losing tax‑ and tariff‑exempt status in each filing, but the tone has shifted from a generic risk in 2022 (2022 10‑K p. 37) to a more pointed concern in 2023 that ties the risk to recent sanctions on Russia, Belarus and Ukraine (2023 10‑K p. 41). By 2024 the disclosure again emphasizes the risk, now coupled with heightened China‑Taiwan tensions and broader export‑control scrutiny (2024 10‑K p. 40), suggesting that AMD’s exposure to losing such exemptions is becoming more material as the global regulatory landscape grows increasingly complex.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about AMD's evolving exposure to tax and tariff exemption risks from 2022-2024. STRENGTHS: (1) Correctly identifies the progression across all three years (2022, 2023, 2024) with appropriate characterization of each period's focus; (2) Accurately captures the shift from generic risk disclosure in 2022 to geopolitically-specific concerns in 2023 (Russia, Belarus, Ukraine sanctions) and 2024 (China-Taiwan tensions); (3) Properly synthesizes the multi-hop information showing how regulatory complexity increased over time; (4) Includes specific page references (p. 37, p. 41, p. 40) which adds credibility; (5) Correctly identifies the core insight that the risk became more material and tied to specific geopolitical events. MINOR WEAKNESSES: (1) The answer cites specific page numbers which cannot be verified against the ground truth provided, though this doesn't contradict the ground truth; (2) The phrase 'export-control scrutiny' in 2024 is mentioned but not explicitly detailed in the ground truth, though it's a reasonable inference from China-Taiwan tensions context; (3) Could have slightly more explicitly stated the connection between geopolitical tensions and third-party manufacturing partners (as mentioned in ground truth), though this is implied. QUANTITATIVE ACCURACY: No numerical calculations required; dates and years are all correct (2022, 2023, 2024). QUALITATIVE ACCURACY: The reasoning is sound - the answer correctly identifies the evolution pattern and explains why the trend matters (increasing complexity and materiality). SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different wording but equivalent meaning. The characterization of the progression from 'broad set of international risks' to 'specific geopolitical concerns' is accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 524,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s exposure to U.S. banking laws has not changed – each filing repeats that the company’s ability to return capital – whether through dividends or share‑repurchase programs – is at the Board’s discretion but can be limited by U.S. banking regulations, capital‑planning rules, Delaware law and the requirement to pay full, timely dividends on its preferred stock (2022 p. 5; 2023 p. 5; 2024 p. 5). The risk‑factor language is essentially identical across the three years, indicating a steady regulatory constraint on dividend payments and share repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies the core finding that regulatory constraints remained consistent across 2022-2024, matching the ground truth's conclusion of 'stable regulatory environment with persistent constraints.' (2) Accurately cites the specific regulatory limitations: U.S. banking laws, capital-planning rules, Delaware law, and preferred stock dividend obligations. (3) Properly notes that the risk-factor language is 'essentially identical' across years, which aligns with the ground truth's emphasis on consistency. (4) Correctly identifies the three-year period (2022-2024) and references specific page numbers (p. 5 for each year), demonstrating proper multi-hop synthesis across filings. (5) Accurately characterizes the constraints as affecting both dividends and share repurchases. MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth and doesn't explicitly mention the 2023-specific emphasis on 'credit rating reductions and resolution strategies under Title I and II' or the 2024 expansion to 'liquidity management and strategic initiatives.' However, this is a matter of depth rather than accuracy—the LLM correctly captures the essential finding that constraints remained consistent. (2) The phrase 'at the Board's discretion' adds context not explicitly in the ground truth, though this is not inaccurate. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; page references (p. 5) are consistent across citations. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to demonstrate consistency in regulatory constraints, which is the core multi-hop requirement. The conclusion that 'steady regulatory constraint' persists is logically sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of 'steady regulatory constraint' is semantically equivalent to the ground truth's 'stable regulatory environment with persistent constraints.' The answer addresses the evolution question by correctly concluding there was no material evolution—constraints remained constant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 586,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 10‑K exhibit tables for 2022, 2023 and 2024 all list the same disclosure for the 2.950 % Note due 2025 – it is shown as “Form of 2.950 % Note due 2025, filed as Exhibit 99.6 to the Abbott Laboratories Current Report on Form 8‑K dated March 5, 2015” and the related officer actions are “filed as Exhibit 99.3 to the same Form 8‑K”【page_86】. Across the three years the reference and exhibit numbers remain unchanged, indicating that no new filing or amendment was added and the note continues to be disclosed via the historic 2015 8‑K exhibit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Abbott's disclosure evolution of the 2.950% Note due 2025 from 2022-2024. STRENGTHS: (1) All key numeric/date values are correct - the 2.950% rate, 2025 maturity date, Exhibit 99.6 reference, March 5, 2015 8-K filing date are all accurate; (2) The multi-hop synthesis is sound - correctly identifies that the same disclosure appears consistently across all three years (2022, 2023, 2024) with no changes; (3) Entity identification is precise - correctly names Abbott Laboratories and identifies the relevant filing types (10-K, 8-K); (4) The reasoning about stability and lack of amendments is logically sound and matches the ground truth conclusion; (5) The answer appropriately addresses the evolution question by demonstrating consistency/no evolution. MINOR CONSIDERATIONS: (1) The LLM answer includes a citation reference [page_86] which adds specificity but wasn't in the original answer - this is actually a strength as it provides source documentation; (2) The LLM mentions 'related officer actions' and Exhibit 99.3, which is additional detail not explicitly in the ground truth but appears to be accurate supplementary information that enhances rather than contradicts the answer; (3) Wording differs slightly ('consistently disclosed' vs 'reference and exhibit numbers remain unchanged') but conveys equivalent meaning. The answer fully addresses the question's core inquiry about how disclosure evolved (or didn't evolve) across the three-year period, correctly synthesizing information across multiple years and filing types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 445,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s net carrying amount for its 1.55 % notes due 2028 was $1,099 million at the end of FY 2022 (Jan 30 2022)【page 78】, stayed at $1,099 million at the end of FY 2023 (Jan 29 2023) and rose modestly to $1,115 million by the end of FY 2024 (Jan 28 2024)【page 67】. The slight $16 million increase over the three‑year span shows that NVIDIA has kept its long‑term debt base essentially flat, adding only a small amount of new borrowing – a sign of a disciplined, conservative debt strategy that preserves financial flexibility while still supporting growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core financial numbers that are the primary focus of this question. (1) FY 2022 Value: Ground truth states $1,200 million, but LLM claims $1,099 million - a $101 million discrepancy. (2) FY 2023 Value: Ground truth states $1,099 million, LLM correctly states $1,099 million - this is the only correct data point. (3) FY 2024 Value: Ground truth states $1,250 million, but LLM claims $1,115 million - a $135 million discrepancy. (4) Calculation Error: LLM states a $16 million increase over three years, but even using the LLM's own incorrect numbers ($1,099M to $1,115M), this would be correct arithmetic. However, the underlying values are wrong. Using ground truth numbers, the progression is $1,200M → $1,099M → $1,250M, showing a $50M decrease then a $151M increase, not a modest flat trend. MULTI-HOP REASONING FAILURE: The LLM mischaracterizes the debt strategy. Ground truth indicates fluctuation with a notable increase in FY 2024, suggesting strategic management of liabilities. The LLM's characterization of 'essentially flat' and 'disciplined, conservative' debt strategy is contradicted by the actual $50M swing down and then $151M swing up. The interpretation of the data trend is fundamentally incorrect. ENTITY ACCURACY: Correct identification of NVIDIA, the 1.55% Notes Due 2028, and fiscal years, but the fiscal year dates provided appear to have formatting issues. COMPLETENESS: The answer attempts to address the evolution and strategic implications, but the incorrect numbers undermine the entire analysis. The question specifically asks about the progression from 2022-2024, and the LLM provides wrong values for 2 of 3 years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 476,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "AMD’s approach to AIB partners stayed essentially the same from 2022‑2024 – it continued to supply component‑level graphics and chipset products and its agreements consistently protected AIB inventory from price reductions. In every filing AMD highlighted that system integrators use its discrete‑graphics solutions to differentiate their products, with only minor wording tweaks (e.g., “in most instances” in 2023) but no substantive shift in policy or strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but misses important nuances in AMD's strategic evolution. CORRECT ELEMENTS: (1) The core fact that inventory protection policies remained consistent across 2022-2024 is accurate. (2) The statement that discrete graphics solutions were highlighted for differentiation is correct. (3) The identification of AIB partnerships as a consistent focus is accurate. SIGNIFICANT OMISSIONS AND ERRORS: (1) The LLM answer fails to capture the key evolution described in the ground truth - that by 2024, AMD placed GREATER EMPHASIS on discrete graphics as a differentiation tool, suggesting an adaptive response to market pressures. The LLM characterizes this as 'no substantive shift' which contradicts the ground truth's explicit statement of evolution. (2) The LLM misses the 2023-specific detail about 'timely product introductions and market competitiveness' being emphasized as reinforcement of AIB partnership importance. (3) The LLM's dismissal of the evolution as merely 'minor wording tweaks' undersells the strategic shift from maintaining status quo (2022-2023) to actively emphasizing differentiation through discrete graphics (2024). (4) The phrase 'in most instances' is mentioned but not properly contextualized as part of the 2023 language evolution. MULTI-HOP REASONING: The LLM fails to synthesize the temporal progression across three years that the ground truth clearly articulates. The ground truth shows a three-stage evolution (protection focus → partnership emphasis → differentiation emphasis), while the LLM collapses this into 'stayed essentially the same.' SEMANTIC ISSUES: While the LLM's statement about inventory protection is factually correct, it presents the relationship as static rather than evolving, which is the core thesis of the question. The answer is partially correct on facts but fundamentally misses the strategic evolution that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 523,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "In the 2022 filing AMD noted “difficulties in protecting our intellectual property” only as one of a broad set of political‑, legal‑ and economic‑risk factors for foreign operations. By the 2023 10‑K, after international sales had risen to roughly 65 % and most product assembly and final testing were shifted to third‑party wafer foundries in China, Malaysia and Taiwan, the company explicitly linked those IP‑protection risks to its growing reliance on manufacturers in politically sensitive regions. The 2024 filing repeats the same IP‑protection concern but now stresses that China‑Taiwan geopolitical tensions could disrupt its Taiwan‑based third‑party foundries, indicating that AMD’s exposure to IP‑protection difficulties has intensified as its overseas footprint and dependence on third‑party manufacturing in high‑risk jurisdictions have expanded.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's evolving IP protection risks from 2022-2024 and correctly identifies the key progression: from general IP concerns in 2022, to explicit linkage with geopolitical tensions and third-party manufacturing in 2023-2024. STRENGTHS: (1) Correctly identifies the 2022 baseline where IP protection was noted as one of many foreign operation risks; (2) Accurately captures the 2023 shift to explicitly linking IP risks with third-party foundries in China, Malaysia, and Taiwan; (3) Correctly notes the 2024 emphasis on China-Taiwan tensions affecting Taiwan-based foundries; (4) Properly synthesizes the multi-hop connection between expanding international operations, third-party manufacturing reliance, and IP protection risks; (5) The 65% international sales figure for 2023 is correct. WEAKNESSES: (1) The LLM states international sales 'had risen to roughly 65%' in 2023 but doesn't provide the 2022 baseline or the 2024 figure (66%), missing the complete quantitative evolution that the ground truth emphasizes; (2) The answer doesn't explicitly mention the 2024 figure of 66% international sales or the comparison showing the progression from 2022 to 2024; (3) Slightly less emphasis on the 'transforming trend' and regional concentration aspect that the ground truth highlights; (4) The phrase 'most product assembly and final testing were shifted' is somewhat vague - the ground truth is more precise about third-party wafer foundries. QUANTITATIVE ACCURACY: The 65% figure for 2023 is correct, but the answer is incomplete by not including the 2024 66% figure and the unspecified 2022 baseline, which weakens the quantitative narrative of evolution. QUALITATIVE ACCURACY: The reasoning about the progression and linkage between factors is sound and demonstrates proper multi-hop synthesis. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on how IP protection difficulties evolved in relation to international operations and third-party manufacturing in sensitive regions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 553,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "- 2022 – BNY Mellon filed a **2022 Form of Performance Share Unit Agreement** (Exhibit 10.21) and a **2022 Form of Restricted Stock Unit Agreement** (Exhibit 10.22) under the 2019 Long‑Term Incentive Plan 【page_19】.  \n- 2023 – The company refreshed the same plan with a **2023 Form of Performance Share Unit Agreement** (Exhibit 10.26) and a **2023 Form of Restricted Stock Unit Agreement** (Exhibit 10.27) 【page_19】.  \n- 2024 – BNY Mellon again updated the plan, issuing a **2024 Form of Performance Share Unit Agreement** (Exhibit 10.28) and a **2024 Form of Restricted Stock Unit Agreement** (Exhibit 10.29) 【page_19】【page_20】.  \n\nThis sequence of yearly‑new award documents shows that BNY Mellon is actively using the 2019 LTIP as a flexible framework, continually tailoring its long‑term equity awards to align executive compensation with evolving performance goals and market practices, indicating a strategic focus on performance‑driven retention and incentive alignment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) ENTITY CONFUSION: The question asks about 'BK' (Bank of New York Mellon ticker), and while the LLM correctly identifies this as 'BNY Mellon,' there is a major discrepancy in the forms referenced. The ground truth specifies: 2022 = 2021 Form PSU Agreement, 2023 = 2020 Form PSU Agreement, 2024 = 2022 Form PSU Agreement. The LLM claims: 2022 = 2022 Form PSU Agreement, 2023 = 2023 Form PSU Agreement, 2024 = 2024 Form PSU Agreement. These are completely different forms across all three years. (2) QUANTITATIVE ACCURACY: The year-to-form mapping is entirely incorrect. The ground truth shows a pattern where the form year lags behind the filing year (2021 form filed in 2022, 2020 form filed in 2023, 2022 form filed in 2024), suggesting legacy agreements being maintained. The LLM shows forms matching the filing year exactly (2022 form in 2022, 2023 form in 2023, 2024 form in 2024), which is a different pattern entirely. (3) MULTI-HOP REASONING: While the LLM correctly identifies the 2019 LTIP as the framework and mentions RSU agreements alongside PSU agreements (which the ground truth does not explicitly address), the core synthesis is flawed because the specific forms cited are wrong. The ground truth emphasizes a 'layered approach' with 'legacy structures' being maintained, which the LLM's pattern of yearly-new forms does not support. (4) SEMANTIC INTERPRETATION: The LLM's conclusion about 'yearly-new award documents' and 'continually tailoring' is reasonable in isolation, but it is based on incorrect underlying data. The ground truth suggests a more conservative approach of maintaining older forms while periodically introducing new ones, which is strategically different from annual complete refreshes. The LLM fundamentally misidentified which forms were used in each year, making the entire answer factually incorrect despite reasonable interpretive framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 539,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s investment in the diagnostics instruments it leases grew modestly – the original cost rose from $3.6 billion (net‑book value $1.6 billion) at 12/31/2022 to $3.9 billion (net‑book $1.8 billion) at 12/31/2023, and then remained essentially unchanged at $3.9 billion/$1.8 billion through 12/31/2024 [ABT_10k_2023.pdf p. 64; ABT_10k_2024.pdf p. 63]. This modest increase followed by a plateau indicates a disciplined, incremental capital‑deployment strategy in the diagnostics business—Abbott is expanding its leasing capacity cautiously and now appears focused on leveraging and optimizing the existing asset base rather than pursuing aggressive new investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. Specifically: (1) For 2022: LLM states original cost of $3.6B and net book value of $1.6B, but ground truth shows $3.3B original cost and $1.4B net book value. This is a material misstatement of the baseline year. (2) For 2023: LLM states $3.9B original cost and $1.8B net book value, but ground truth shows $3.6B original cost and $1.6B net book value. Again, significant discrepancies. (3) For 2024: LLM states $3.9B/$1.8B, but ground truth shows $3.9B original cost and $1.6B net book value (net book value did NOT increase to $1.8B in 2024). The LLM has systematically overstated the net book values across all three years. MULTI-HOP SYNTHESIS ISSUE: The LLM failed to correctly synthesize the three-year trend. Ground truth shows: net book value increased 2022→2023 ($1.4B→$1.6B) then plateaued 2023→2024 ($1.6B remained). LLM incorrectly shows continued growth through 2024 ($1.8B), which contradicts the actual plateau. REASONING QUALITY: While the LLM's interpretation about 'disciplined, incremental capital-deployment strategy' and 'leveraging existing asset base' is qualitatively reasonable and aligns with the ground truth's conclusion about strategic emphasis, this reasoning is built on incorrect numbers, making the analysis unreliable. The semantic interpretation of the trend (cautious expansion followed by plateau) is directionally correct but based on wrong data points. COMPLETENESS: The answer does address the evolution question and attempts to interpret capital deployment strategy, but the factual errors undermine the entire response. The question requires precise multi-year financial data synthesis, and the LLM has failed to deliver accurate numbers across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 502,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "NVIDIA’s 10‑K filings show Lumentum Holdings listed as a competitor in the networking‑and‑interconnect segment in every year – FY 2022 (see page 15) where it appears among “interconnect, switch and cable solutions” providers, FY 2023 (see page 9) where it remains in the “networking products” list alongside newer AI‑focused rivals such as AMD and Huawei, and FY 2024 (see page 9) where the same competitive set is repeated. While the broader competitor set has shifted to reflect NVIDIA’s expanding AI‑driven networking and interconnect strategy, Lumentum’s position has stayed constant, indicating NVIDIA continues to view Lumentum as a relevant player in the optical‑module and interconnect market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in key ways: (1) POSITIONING EVOLUTION MISCHARACTERIZED: The ground truth shows Lumentum's competitive positioning EVOLVED and became MORE PROMINENT across the three fiscal years, with a 'sharpened recognition of its corporate identity' by FY2024. The LLM answer claims Lumentum's position 'stayed constant' and remained 'the same,' which directly contradicts the ground truth's narrative of rising prominence and repositioning. (2) FY2023 CHARACTERIZATION ERROR: The ground truth specifically notes that in FY2023, Lumentum was 'repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies.' The LLM answer vaguely states it 'remains in the networking products list' without capturing this important repositioning and specialization. (3) FY2024 DESIGNATION MISSES KEY DETAIL: The ground truth emphasizes that FY2024 shows 'more specific designation of Lumentum Holdings Inc.' suggesting sharpened recognition. The LLM answer mentions this but doesn't connect it to the broader narrative of rising prominence. (4) COMPETITIVE CONTEXT: The LLM answer mentions AMD and Huawei as 'newer AI-focused rivals' in FY2023, but the ground truth doesn't reference these companies, and the LLM provides no evidence these comparisons are accurate to the actual filings. (5) PAGE REFERENCES: The LLM provides specific page numbers (page 15 for FY2022, page 9 for FY2023 and FY2024) but these cannot be verified against the ground truth and may be fabricated. (6) CORE NARRATIVE FAILURE: The fundamental thesis differs - ground truth shows evolution/rising prominence; LLM shows stasis. This is a critical semantic and factual divergence. The LLM answer is partially correct in identifying Lumentum as a consistent competitor across years, but fundamentally misses the key insight about how its competitive positioning evolved and became more prominent within NVIDIA's strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 551,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In the 2022 filing Emerson grouped pipe cutters under the **“Professional Tools”** sub‑category of its **Tools & Home Products** segment, which serves both DIY and professional users【page_9】. By the 2024 filing the same products are called out inside the **Safety & Productivity** segment – a dedicated professional‑tool line that emphasizes safety and productivity for trade customers【page_73】. This move shows Emerson is pulling pipe‑cutting tools out of the broader consumer‑oriented segment and aligning them with its safety‑and‑productivity portfolio, underscoring a strategic focus on expanding the professional‑tool business.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core repositioning of pipe cutters from Tools & Home Products (2022) to Safety & Productivity (2023-2024). The segment names are accurate, and the basic narrative of moving from consumer-oriented to professional-focused is correct. The LLM appropriately notes the strategic shift toward professional tools and safety/productivity emphasis.\n\nWEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It fails to mention the InSinkErator divestiture in late 2022, which is a critical contextual element that explains the strategic rationale for the repositioning. (2) The ground truth provides specific product groupings in the new segment (battery hydraulic tools, press connections, drain cleaners, sewer inspection cameras), which the LLM omits entirely. (3) The LLM doesn't explain the broader strategic context about infrastructure and industrial-use tools that the ground truth emphasizes. (4) The LLM's characterization of the 2022 segment as 'consumer-oriented' is somewhat imprecise—the ground truth notes it served 'both plumbing and mechanical professionals' alongside DIY tools, a more nuanced distinction. (5) The LLM provides page citations (page_9, page_73) that cannot be verified against the ground truth and may be hallucinated.\n\nMULTI-HOP REASONING: The LLM demonstrates basic multi-hop reasoning by connecting the 2022 and 2024 positions and drawing a conclusion about strategic focus. However, it fails to synthesize the full picture that includes the InSinkErator divestiture and the specific product ecosystem within Safety & Productivity.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on date/year correctness (2022, 2023, 2024 all correct) and segment name accuracy (both correct).\n\nOVERALL ASSESSMENT: The LLM captures the essential repositioning narrative but misses critical supporting details and strategic context that would elevate the answer to ground truth level. The answer is directionally correct but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 567,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "In 2022 the Advisor Services website was the core, web‑based hub for RIAs – it handled account opening, money movement, trading, multi‑year archiving of statements and tax documents, document search and third‑party integrations, and it offered Schwab Advisor Portfolio Connect as a free, modern, download‑free portfolio‑management tool that delivered core capabilities through an intuitive experience【page_7】. After the TD Ameritrade integration, the 2023 filing highlighted new functional layers for RIAs – the thinkpipes real‑time charting and trading platform and the iRebal customizable portfolio‑rebalancing solution were added to the RIA offering, deepening technology integration and expanding trading‑and‑rebalancing capabilities【page_8】. By 2024 the website still provided interactive tools, education and thought‑leadership, while Advisor Portfolio Connect remained a free, intuitive solution within a broader, integrated digital ecosystem that now includes thinkpipes, iRebal and expanded consulting, benchmarking and transition services to support advisors’ practice‑growth needs【page_6】【page_8】【page_9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key tools (Schwab Advisor Portfolio Connect, thinkpipes, iRebal) and accurately traces their evolution across 2022-2024. The chronological progression is sound, and the answer appropriately emphasizes the free nature of Advisor Portfolio Connect and the addition of new platforms post-TD Ameritrade integration. The mention of multi-year document archiving in 2022 aligns with ground truth. WEAKNESSES: (1) The LLM introduces 'thinkpipes' and 'iRebal' as 2023 additions attributed to TD Ameritrade integration, but the ground truth does not explicitly mention these tools or credit them to the TD integration - this represents potential over-specification or hallucination of details not in the ground truth. (2) The LLM answer lacks the ground truth's emphasis on 'deeper third-party integrations' for CRM and financial planning as a core evolution theme. (3) The ground truth emphasizes 'expanded educational and consulting services' and 'transition to independence' as 2023 themes, which the LLM answer does not capture. (4) The ground truth highlights 'outbound data feeds for compliance systems' as a 2024 addition, which the LLM answer omits. (5) The ground truth's framing of a 'strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly' is not reflected in the LLM answer. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression of tools, but fails to fully capture the integration of compliance and operational workflows that the ground truth emphasizes. The answer focuses heavily on trading/portfolio tools but underemphasizes the compliance and advisory support evolution. FACTUAL ISSUES: While no explicit numeric errors are present, the introduction of thinkpipes and iRebal without clear grounding in the provided ground truth is concerning and suggests potential hallucination or over-interpretation of source materials.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 534,
        "total_tokens": 2142
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650 % Notes due 2026 as a newly issued senior unsecured note in its 2022 10‑K (Exhibit 4.16) [page_114]. The same instrument appears unchanged in the 2023 10‑K (Exhibit 4.14) [page_111] and again in the 2024 10‑K (Exhibit 4.14) [page_111], with identical terms and no amendment, redemption, or re‑classification. This consistent treatment shows Oracle is maintaining a stable, low‑cost medium‑term debt tranche, reflecting a deliberate short‑to‑intermediate‑term financing strategy that relies on predictable, ongoing notes rather than frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across three fiscal years. STRENGTHS: (1) All numeric values are correct - the 1.650% interest rate is accurate, the 2026 maturity date is correct, and the exhibit numbers are properly cited (4.16 for 2022, 4.14 for 2023 and 2024). (2) The multi-hop reasoning is sound - the answer correctly traces the debt instrument's treatment across three separate 10-K filings and synthesizes the pattern of consistency. (3) Entity identification is accurate - Oracle is correctly identified, the specific debt instrument is properly characterized as senior unsecured notes, and fiscal years are correctly referenced. (4) The answer goes beyond the ground truth by adding interpretive depth, noting the instrument is 'newly issued' in 2022 and characterizing it as 'low-cost medium-term debt' and 'predictable, ongoing notes rather than frequent refinancing,' which provides valuable strategic context. (5) Page references are included ([page_114], [page_111]), adding specificity. MINOR CONSIDERATIONS: The ground truth uses the phrase 'reaffirmed' while the LLM uses 'appears unchanged' and 'identical terms and no amendment' - these are semantically equivalent and actually more precise. The LLM's characterization of the strategy as 'deliberate short-to-intermediate-term financing strategy' aligns well with the ground truth's description of 'stable' approach to 'managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.' No calculation errors, no factual inaccuracies, and the synthesis across multiple years is logically sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 460,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson continues to list **electrical distribution equipment as a component of its Discrete Automation segment** – together with solenoid and pneumatic valves, actuators, motion solutions and related software – in the segment description for 2022, 2023 and 2024 【page_73】.  The Discrete Automation segment’s sales have stayed roughly flat (≈ $2.6 billion in 2022, $2.5 billion in 2024) 【page_74】, showing that Emerson still treats electrical distribution as a core offering for discrete‑industry customers.  This consistent placement signals a deliberate, ongoing strategic emphasis on industrial electrification solutions within its broader automation portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) FACTUAL CONTRADICTION ON EVOLUTION: The LLM claims Electrical Distribution Equipment was listed as a component of Discrete Automation in 2022, 2023, and 2024 consistently. However, the ground truth explicitly states that in 2022, it was grouped under 'Industrial Solutions' (NOT Discrete Automation), and only moved to Discrete Automation in 2023. This is a fundamental factual error that contradicts the core premise of the question about 'evolution.' The LLM missed the critical 2022-to-2023 transition. (2) QUANTITATIVE ISSUES: The LLM provides segment sales figures ($2.6B in 2022, $2.5B in 2024) but these numbers cannot be verified against the ground truth provided, which does not include specific revenue figures. The LLM cites 'page_73' and 'page_74' but these references are not substantiated in the ground truth. The claim of 'roughly flat' sales is unsupported. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key strategic evolution described in the ground truth: the shift from 'general-purpose offering' under Industrial Solutions to 'core component of industrial automation infrastructure' under Discrete Automation. The ground truth emphasizes this repositioning as reflecting 'growing focus on electrification and smart manufacturing solutions,' which the LLM does not adequately address. (4) MULTI-HOP REASONING: The LLM does not properly synthesize the three-year evolution. It treats all three years as static rather than showing the progression: 2022 (Industrial Solutions) → 2023 (Discrete Automation) → 2024 (Discrete Automation reinforced). (5) MISSING CONTEXT: The LLM mentions 'solenoid and pneumatic valves, actuators, motion solutions' but the ground truth specifically mentions 'solenoid valves and programmable control systems' in 2023, suggesting different product groupings. The LLM's broader product list may be inaccurate or from a different year. CORRECT ELEMENTS: The LLM correctly identifies Emerson (EMR), the Discrete Automation segment, and the general concept that electrical distribution equipment is positioned as a core offering. The conclusion about 'deliberate, ongoing strategic emphasis' is directionally correct but based on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 600,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate (private) funds fell from **$569 million at 12/31/2022**, to **$555 million at 12/31/2023**, and then to **$540 million at 12/31/2024**【page_71】【page_70】.  The consistent decline shows the company is gradually satisfying or scaling back its outstanding pledges to illiquid alternative assets, indicating a more cautious, liquidity‑aware approach to its pension‑fund investment strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL: The LLM reports the 2022 figure as $569 million, but the ground truth states $585 million. This is a $16 million discrepancy (2.7% error), which is material for financial analysis. The 2023 ($555M) and 2024 ($540M) figures are correct. This represents a significant factual error on a primary data point. COMPLETENESS ISSUES: The LLM answer correctly identifies the declining trend but omits several important contextual details from the ground truth: (1) no mention of the 2034 liquidation timeline, (2) no discussion of the company's continued belief in long-term value despite reduced exposure, (3) no mention of the 'measured de-risking or rebalancing' characterization, and (4) no discussion of aligning fund commitments with pension liability profiles. REASONING QUALITY: The LLM's reasoning about 'gradually satisfying or scaling back' and 'liquidity-aware approach' is sound and semantically equivalent to the ground truth's 'measured de-risking.' The multi-hop synthesis is adequate but incomplete. ENTITY ACCURACY: Abbott Laboratories correctly identified, private real estate funds correctly identified, years correctly identified (2022-2024). OVERALL ASSESSMENT: The answer demonstrates partial understanding of the trend and provides reasonable interpretation, but the incorrect 2022 baseline figure is a critical error that undermines confidence in the analysis. The omission of the long-term liquidation timeline and strategic context represents incomplete synthesis of available information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 425,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle has shown no change in how it reports the 1.650 % Notes due 2026 – each 10‑K (2022 p. 112, 2023 p. 111, 2024 p. 111) lists the notes as a separate series in Exhibit 4.14 and includes them in the debt schedule as a short‑term liability. This unchanged presentation signals that Oracle deliberately retains the low‑cost, near‑maturity note as a stable component of its short‑term financing strategy rather than repeatedly refinancing or retiring it.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Oracle's treatment of the 1.650% Notes due 2026 remained unchanged across the 2022, 2023, and 2024 filings, and appropriately concludes this reflects a deliberate short-term debt strategy. However, there are significant issues with quantitative accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the 1.650% interest rate\n2. Correctly identifies the 2026 maturity date\n3. Correctly identifies all three years (2022, 2023, 2024)\n4. Correctly characterizes the strategy as maintaining stable short-term debt\n5. Appropriately notes the notes appear in debt schedules as short-term liabilities\n6. Reasoning about deliberate retention strategy is sound\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The LLM answer completely fails to mention the March 24, 2021 8-K filing, which is a key element of the ground truth. The ground truth emphasizes that Oracle \"referenced the March 24, 2021 8-K filing where the terms of the Notes were established\" and that this same 8-K was consistently referenced across all three years. This is a crucial detail showing continuity and the original source of the debt instrument.\n2. PAGE NUMBERS: The LLM provides specific page numbers (p. 112 for 2022, p. 111 for 2023 and 2024) but these cannot be verified against the ground truth, which does not provide page numbers. While the consistency of pages 111 for both 2023 and 2024 is plausible, the inclusion of unverified page numbers is problematic.\n3. EXHIBIT REFERENCE: The LLM mentions \"Exhibit 4.14\" but the ground truth does not reference this exhibit. This appears to be an unsupported detail.\n4. INCOMPLETE SYNTHESIS: The ground truth explicitly notes that Oracle \"introduced new debt instruments with different rates and maturities in subsequent years,\" providing important context about Oracle's broader debt strategy. The LLM answer omits this comparative context.\n5. MISSING STRUCTURAL ANALYSIS: The ground truth emphasizes the significance of consistent referencing to the original 8-K across three years as evidence of unchanged structure. The LLM answer mentions \"unchanged presentation\" but doesn't explain the mechanism (consistent 8-K referencing) that demonstrates this.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of consistency. However, it fails to complete the full multi-hop chain by not connecting back to the original 2021 8-K filing that established the terms.\n\nQUANTITATIVE ACCURACY: While the interest rate (1.650%) and maturity year (2026) are correct, the page numbers and exhibit references are unverified and potentially incorrect, reducing confidence in the quantitative details provided.\n\nOVERALL: The answer captures the essential conclusion but is incomplete in its analysis and includes potentially inaccurate supporting details while omitting a key element (the 2021 8-K reference) that the ground truth identifies as central to understanding the continuity of Oracle's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 804,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle’s 4.30% Note due 2034 – documented with an Officers’ Certificate dated July 8 2014 – is listed in the “Forms of 3.40% Note due 2024, 4.30% Note due 2034 and 4.50% Note due 2044” exhibit in its 2022 10‑K (Exhibit 4.11/4.13) (page_113) and the same exhibit is incorporated by reference in the 2023 (Exhibit 4.09) (page_110) and 2024 (Exhibit 4.09) (page_110) filings. The unchanged documentation across three consecutive years shows the note remains outstanding, reflecting Oracle’s strategy of issuing long‑dated, fixed‑rate debt and keeping it on the balance sheet for stable, long‑term financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 4.30% Note due 2034 and its consistent presence across 2022, 2023, and 2024 filings. STRENGTHS: (1) Correctly identifies the note's interest rate (4.30%) and maturity year (2034); (2) Accurately references exhibit numbers (4.11 for 2022, 4.09 for 2023/2024); (3) Provides specific detail about the Officers' Certificate date (July 8, 2014) and page numbers, adding credibility; (4) Correctly synthesizes the multi-year pattern showing unchanged documentation; (5) Appropriately concludes that this reflects Oracle's long-term debt strategy of stable, fixed-rate financing. MINOR ISSUES: (1) The LLM provides additional contextual details (Officers' Certificate date, page numbers, mention of 3.40% and 4.50% notes) that, while accurate and helpful, go slightly beyond what the ground truth explicitly states - this is not incorrect but represents elaboration; (2) The ground truth uses 'Exhibit 4.11' for 2022 while LLM mentions both '4.11/4.13' - this potential ambiguity about exhibit numbering is minor and doesn't affect core accuracy; (3) Both answers correctly identify the consistent documentation pattern and its strategic implications. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the pattern of unchanged documentation, properly connecting this to Oracle's debt strategy. The reasoning is sound and logically structured. QUANTITATIVE ELEMENTS: All dates, percentages, and exhibit numbers are accurate. No calculation errors present. The answer maintains semantic equivalence with the ground truth while providing additional supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 469,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "- 2022 – Under the 2019 IDA agreement Schwab exercised its option to migrate roughly $10 billion of IDA balances onto its balance sheet (the agreement allowed up to $10 billion each 12‑month period, required a $50 billion minimum balance and that at least 80 % of the balances be designated as fixed‑rate obligations)【page_102†L31-L38】【page_102†L39-L45】.  \n\n- 2023 – The 2023 IDA agreement superseded the 2019 version; Schwab made **no** IDA‑balance migrations in 2023, and the new contract eliminated the 80 % fixed‑rate requirement, gave Schwab sole discretion over fixed‑ versus floating‑rate designations, added a $5 billion “buy‑down” option (with $249 million fees) and imposed new balance caps – a maximum of $30 billion above unmatured fixed‑rate obligations through Sept 10 2025 and, thereafter, withdrawals at Schwab’s discretion subject to a $60 billion minimum and $90 billion maximum【page_102†L31-L38】【page_103†L1-L9】.  \n\n- 2024 – Schwab again did not move any IDA balances, remaining bound by the same 2023 agreement terms (the minimum/maximum balance limits and buy‑down option) and the agreement’s extended term through July 1 2034【page_99†L1-L9】【page_100†L1-L9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially accurate and comprehensive. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024; (2) Accurately captures the ~$10 billion migration in 2022 under the 2019 IDA agreement; (3) Correctly notes the 2023 agreement superseded the 2019 version; (4) Accurately states the elimination of the 80% fixed-rate requirement in 2023; (5) Correctly identifies zero migrations in both 2023 and 2024; (6) Provides detailed contractual terms (buy-down option, balance caps, minimum/maximum thresholds, extended term through July 1, 2034); (7) Effectively synthesizes the shift from active migration to passive approach. MINOR ISSUES: (1) The ground truth mentions Schwab had 'already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date' - the LLM states roughly $10 billion was migrated in 2022 but doesn't clarify the prior $10.1 billion context from 2021, though this is a minor omission since the question focuses on 2022-2024 evolution; (2) The ground truth emphasizes 'increased contractual flexibility' despite the passive approach, while the LLM focuses more on the specific new terms without explicitly highlighting this paradox, though the information is present. QUANTITATIVE VERIFICATION: All numbers are accurate - $10 billion annual limit, $50 billion minimum balance, 80% fixed-rate requirement (eliminated in 2023), $5 billion buy-down option, $249 million fees, $30 billion cap through Sept 10 2025, $60-90 billion range thereafter, July 1 2034 term end. MULTI-HOP REASONING: Excellent synthesis across three years showing contractual evolution and behavioral changes. The answer correctly connects the contractual changes to Schwab's migration decisions. SEMANTIC EQUIVALENCE: The answer conveys the same core information as ground truth with appropriate detail level for SEC filing context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 509,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Across the three Form 10‑K filings the only material relating to Abbott’s 2.000 % Senior Notes due 2018 is the same set of legacy documents – the Fifth Supplemental Indenture dated September 23 2015 (and the related officers’ certificate filed in 2017) that were listed as Exhibit 4.21, 4.18 and 4.11 in the 2022 filing【page_86】, and are repeated unchanged in the 2023 and 2024 exhibit tables【page_86】. No new amendment, refinancing or other documentation for those notes appears in any of the three years, indicating the notes remained outstanding and were not refinanced during 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Abbott's engagement with the 2.000% Senior Notes due 2018 across 2022-2024. STRENGTHS: (1) All dates are correct - Fifth Supplemental Indenture dated September 23, 2015 is accurately cited; (2) Exhibit references are properly identified (4.21, 4.18, 4.11 in 2022 filing, repeated in 2023 and 2024); (3) The officers' certificate filing date of 2017 is correctly noted; (4) The core finding that no new amendments, refinancing, or documentation occurred during 2022-2024 is accurate and directly answers the question; (5) The multi-hop synthesis correctly traces the same legacy documents across three years and draws the logical conclusion about maturation without refinancing. MINOR CONSIDERATIONS: (1) The LLM answer is more concise and direct than the ground truth, focusing on the key finding (no refinancing activity) rather than elaborating on 'continuity in disclosure practices' or 'gradually maturing component' - however, this is a stylistic difference, not a factual error; (2) The ground truth mentions 'Exhibit 4.21' specifically for 2023 and 2024, while the LLM lists multiple exhibit numbers for 2022 and states they are 'repeated unchanged' in 2023-2024, which is semantically equivalent and accurate; (3) Both answers correctly identify that the notes were legacy St. Jude Medical debt (implied by 'legacy documents'). QUANTITATIVE VERIFICATION: All dates (2015, 2017, 2022, 2023, 2024) and exhibit numbers are correct. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the pattern of unchanged documentation and absence of refinancing activity. The conclusion logically follows from the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 497,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first disclosed its 3.650 % Notes due 2041 in an Exhibit 4.14 that was filed on March 24 2021 (the filing date shown in the exhibit list) [ORCL_10k_2023.pdf page 111]. The same note appears again in the exhibit index of the 2023 10‑K [ORCL_10k_2023.pdf page 111] and is still listed in the 2024 10‑K [ORCL_10k_2024.pdf page 111], indicating that Oracle has kept the bond outstanding for several years. This repeated presence of a long‑dated, moderate‑coupon bond signals a strategy of locking in low borrowing costs and extending the company’s debt maturity profile well into the future.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) DATE DISCREPANCY - The LLM states the 3.650% Notes due 2041 were first disclosed in an Exhibit 4.14 filed on March 24, 2021, but the ground truth explicitly states Oracle 'first introduced' these notes in 2022, not 2021. This is a significant factual error that contradicts the core premise of the question about the 2022-2024 evolution. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The question specifically asks about the evolution 'from 2022 through 2024,' but the LLM introduces a 2021 date that wasn't part of the original question's timeframe. This suggests the model may have accessed different source documents or misinterpreted the filing dates. (3) MISSING CONTEXT - The ground truth emphasizes that Oracle 'continued to reference the same notes in 2023 alongside newer bond issuances' and 'reaffirmed its inclusion in 2024 within the broader context of its registered securities.' The LLM answer doesn't adequately capture the strategic pattern of periodic new issuances alongside the persistent 3.650% Notes. (4) REASONING QUALITY - While the LLM's interpretation about 'locking in low borrowing costs' and 'extending the company's debt maturity profile' is reasonable, it doesn't fully address the strategic evolution across the three-year period or the relationship between the persistent notes and new issuances. (5) ENTITY/YEAR ACCURACY - The inclusion of 2021 when the question and ground truth focus on 2022-2024 represents a fundamental misalignment with the question's scope. The LLM correctly identifies the note percentage (3.650%) and maturity year (2041), but the introduction date error undermines the entire analysis of the multi-year pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 459,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle first issued the 2.300 % Notes due 2028 as part of a March 2021 multi‑tranche program; the 2022 10‑K lists them in Exhibit 4.16 as a fixed‑rate, 2.300 % note maturing in 2028【page_114】. The same notes are again shown unchanged in the 2023 10‑K (Exhibit 4.14)【page_111】 and in the 2024 10‑K (Exhibit 4.14)【page_111】, indicating they remain outstanding and are part of a broader series of notes with varied coupons and maturities. This consistent, multi‑year disclosure reflects Oracle’s strategy of issuing staggered, low‑coupon debt across several tranches to lock in long‑term financing at attractive rates while maintaining a diversified, multi‑maturity capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 2.300% Notes due 2028, the March 24, 2021 certificate date, and the consistent presence of these notes across fiscal years 2022, 2023, and 2024. The numeric values (2.300%, 2028 maturity) are accurate. The answer correctly identifies the multi-year pattern showing consistency in the notes' disclosure across three fiscal years. However, there are notable differences from the ground truth: (1) The LLM answer references Exhibit 4.14 for 2023 and 2024, while the ground truth references Exhibit 4.16 for 2022 and mentions Exhibit 4.16 for 2023 (with the 4.500% Notes). This exhibit number discrepancy is a minor factual issue. (2) The ground truth explicitly mentions Oracle's issuance of additional 4.500% Notes due 2028 in 2023 as evidence of portfolio diversification, which the LLM answer does not specifically address. The LLM answer mentions 'varied coupons and maturities' generically but doesn't cite the specific 4.500% Notes example. (3) The LLM answer provides more detailed reasoning about the financing strategy (staggered issuance, low-coupon debt, attractive rates), which adds interpretive value but goes slightly beyond what the ground truth explicitly states. The multi-hop synthesis is sound—the answer correctly traces the notes across three years and draws appropriate conclusions about debt strategy consistency. The reasoning about locking in long-term financing at attractive rates is logical and well-supported. Overall, the answer captures the core finding (consistent multi-year pattern indicating stable debt strategy) but misses the specific diversification example (4.500% Notes) and has potential exhibit number inconsistencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 475,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In the 2022 filing Visa described Visa Direct as a global real‑time payments network but did not reference virtual accounts or a Currencycloud offering (see Visa Direct description, fiscal 2022)【page_11】. By the 2024 filing Visa had embedded its digitally native Currencycloud platform into the Visa Direct Platform, adding virtual accounts that deliver real‑time FX rates, enhanced liquidity and settlement and expanding cross‑border reach to nearly 190 countries (see Visa Direct Platform description of virtual accounts and cross‑border solutions)【page_10】【page_11】. This shows the evolution from a basic payout network in 2022 to a fully integrated virtual‑account capability supporting broader cross‑border money movement by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. MAJOR ISSUES: (1) The LLM claims virtual accounts were NOT mentioned in 2022 filings ('did not reference virtual accounts'), directly contradicting the ground truth which states Visa introduced virtual accounts in 2022 as part of Treasury as a Service. This is a fundamental factual error. (2) The LLM states virtual accounts were embedded 'by 2024' but omits the critical 2023 milestone when they were 'fully integrated into the Visa Direct Platform' - this is a significant omission in the multi-hop timeline. (3) The LLM mentions '190 countries' for cross-border reach, but the ground truth references 'more than 11 billion endpoints' - these are different metrics and the LLM appears to have introduced a number not in the ground truth. (4) The LLM correctly identifies Currencycloud integration and real-time FX rates, which aligns with ground truth. (5) The characterization of 2022 as 'basic payout network' vs 2024 'fully integrated' is oversimplified and misses the 2023 integration milestone. MULTI-HOP REASONING: The LLM failed to synthesize the complete 2022-2023-2024 evolution. It presents a binary comparison (2022 vs 2024) rather than the three-year progression described in ground truth. The answer skips the crucial 2023 integration step. QUANTITATIVE ISSUES: The '190 countries' figure appears unsupported by the ground truth which emphasizes '11 billion endpoints' instead. The LLM may have conflated different metrics or introduced information not in the source material. POSITIVE ASPECTS: Correctly identifies Currencycloud, real-time FX rates, enhanced liquidity/settlement, and cross-border expansion themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 467,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "In 2022 Caterpillar said its ME&T dealer network – which also distributes the EMD engine brand – comprised 44 U.S. dealers and 116 overseas dealers, reaching 193 countries. By 2023 the network had slipped to 43 U.S. and 113 overseas dealers covering 191 countries, and in 2024 it was 41 U.S. and 111 overseas dealers serving 187 countries. The steady, modest reduction in dealer count and country coverage shows Caterpillar is consolidating and optimizing the EMD distribution channel rather than adding new outlets, while still preserving a truly global footprint.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to describe a completely different distribution network than what the ground truth specifies. Critical discrepancies: (1) NUMERIC ERRORS - The LLM reports 44 U.S. dealers and 116 overseas dealers in 2022 totaling 160 dealers across 193 countries, while the ground truth specifies 110 distributors across 109 countries for EMD-branded products. The LLM's 2023 figures (43 U.S., 113 overseas = 156 total across 191 countries) and 2024 figures (41 U.S., 111 overseas = 152 total across 187 countries) are all substantially different from the ground truth's 110 distributors/109 countries (2022-2023) and 108 distributors/158 countries (2024). (2) ENTITY CONFUSION - The LLM appears to be describing the broader ME&T dealer network (which may include multiple brands) rather than specifically the EMD-branded product distribution network that the question asks about. The ground truth explicitly references 'EMD-related FG Wilson branded electric power generation systems' with specific distributor counts. (3) GEOGRAPHIC REACH CONTRADICTION - The LLM reports declining country coverage (193→191→187), while the ground truth shows expansion from 109 countries (2022-2023) to 158 countries (2024). (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the specific EMD distribution data across the three-year period. (5) STRATEGIC INTERPRETATION ERROR - While the LLM's conclusion about consolidation and optimization is reasonable logic, it's based on incorrect underlying data. The ground truth indicates optimization with geographic expansion (108 distributors reaching 158 countries in 2024), not the declining coverage the LLM describes. The answer appears to reference different data sources entirely, possibly confusing overall ME&T dealer networks with EMD-specific distribution channels.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 505,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly. The assets’ original cost rose from $3.6 billion at 12/31/2022 to $3.9 billion at 12/31/2023 and stayed at $3.9 billion through 12/31/2024, while the net book value increased from $1.6 billion in 2022 to $1.8 billion in 2023 and remained $1.8 billion in 2024【page_63】【page_64】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. Ground truth shows: Original cost 2022: $3.3B, 2023: $3.6B, 2024: $3.9B. LLM reports: 2022: $3.6B, 2023: $3.9B, 2024: $3.9B. This is a systematic shift of one year forward in the data. For net book value, ground truth shows: 2022: $1.4B, 2023: $1.6B, 2024: $1.8B. LLM reports: 2022: $1.6B, 2023: $1.8B, 2024: $1.8B. Again, the 2022 figure is wrong ($1.6B vs $1.4B), and the 2024 figure is incorrect (should be $1.8B but the progression is wrong). The LLM also mischaracterizes the trend by stating the assets 'stayed at $3.9 billion through 12/31/2024' and 'remained $1.8 billion in 2024,' when the ground truth shows consistent growth across all three years. The characterization of 'modest growth' and 'remained' suggests stagnation in 2024, which contradicts the actual consistent upward trajectory. The multi-hop reasoning failed to correctly synthesize the three-year progression. While the answer addresses the right topic and attempts to compare years, the fundamental numerical errors and misrepresentation of the trend make this response substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 335,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "PepsiCo lists the 3.450 % Senior Note due 2046 as an exhibit in each of its 2022, 2023 and 2024 Form 10‑K filings (see the exhibit tables on pages 126‑127)【page_126】【page_127】. The fact that this same long‑dated senior debt is disclosed year after year shows it remains outstanding and is a core component of PepsiCo’s long‑term financing mix, underscoring the company’s strategy of maintaining a stable, low‑cost, long‑maturity debt base to support its capital‑structure needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core concept that the 3.450% Senior Note due 2046 appears consistently across PepsiCo's 2022, 2023, and 2024 10-K filings and appropriately interprets this as indicating the note's stable role in the company's long-term capital structure. The reasoning about maintaining a stable, low-cost, long-maturity debt base is sound and semantically equivalent to the ground truth's characterization of it as 'strategically maintained' and 'reliable source of capital with favorable terms.' However, there are significant quantitative accuracy issues: (1) The LLM cites 'pages 126-127' as the location of exhibit tables, but the ground truth specifies the note appears in different exhibits across years (Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024). The LLM does not provide these specific exhibit numbers, which are factual details that should be included. (2) The LLM provides page references without verification against the actual filings, which is problematic for multi-hop synthesis requiring precise document location data. The answer demonstrates good qualitative reasoning about capital structure strategy and the significance of consistent disclosure, but fails to capture the specific exhibit number progression (4.17→4.16→4.15) that the ground truth emphasizes. This omission of specific exhibit citations represents incomplete synthesis of the multi-hop information across the three years' filings. The answer is directionally correct but lacks the precision expected for financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 431,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle first disclosed the 2.300 % Notes due 2028 in its FY 2022 10‑K as part of Exhibit 4.16, bundled with a ladder of other fixed‑rate notes (1.650 % due 2026, 2.875 % due 2031, etc.) and an Officers’ Certificate dated March 24 2021【page_114】. In FY 2023 the same series was re‑listed under Exhibit 4.14, and the FY 2024 filing again includes it under the same exhibit number with identical terms【page_111】. The unchanged, multi‑year presence of this low‑coupon, intermediate‑term note within a broader set of staggered‑maturity issues indicates Oracle’s strategy of maintaining a diversified, long‑dated fixed‑rate debt program to lock in cheap financing and smooth cash‑flow needs across the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All key numeric values are correct - 2.300% coupon rate, 2028 maturity date, and companion notes (1.650% due 2026, 2.875% due 2031, 4.500% due 2028) are accurately cited. (2) Exhibit references are correct (Exhibit 4.16 in FY2022, Exhibit 4.14 in FY2023 and FY2024). (3) The multi-hop synthesis across three fiscal years is sound - the answer correctly traces the evolution of this debt instrument from initial disclosure through subsequent years. (4) The strategic interpretation about maintaining diversified, long-dated fixed-rate debt and locking in cheap financing is reasonable and well-supported by the pattern described. (5) The mention of the Officers' Certificate dated March 24, 2021 adds appropriate specificity. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'cheap financing' and 'smooth cash-flow needs' that goes slightly beyond what the ground truth explicitly states - the ground truth is more measured, noting 'potentially higher yields to reflect changing market conditions or strategic financing needs' without the 'cheap financing' characterization. (2) The ground truth explicitly mentions the 4.500% Notes due 2028 appearing in 2023 and 2024 as 'newer issuances,' which the LLM captures but could have emphasized more clearly as a strategic shift (higher yields in response to market conditions). (3) The phrase 'unchanged, multi-year presence' is accurate but the ground truth emphasizes the layering of new issuances more explicitly as part of the strategy. QUANTITATIVE VERIFICATION: All percentages (2.300%, 1.650%, 2.875%, 4.500%) and years (2026, 2028, 2031) are correct. The fiscal year progression (2022, 2023, 2024) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple debt instruments, correctly identifying the pattern of maintaining prior disclosures while adding new ones. The conclusion about Oracle's debt strategy is logically sound and supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 563,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 2022 10‑K lists the Series B Convertible Participating Preferred Stock as Exhibit 4.5 – a Certificate of Designations filed June 21 2016 (page 114). The 2023 and 2024 10‑Ks continue to disclose the same instrument as Exhibit 4.4 – the Certificate of Designations of Series B Convertible Participating Preferred Stock (pages 109‑110), with no amendment or retirement. This unchanged treatment across three successive filings signals Visa’s long‑term priority to keep a stable, convertible preferred component in its capital structure, preserving flexibility for future equity conversions while maintaining an overall balanced capital mix.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Series B Convertible Participating Preferred Stock appears consistently across 2022-2024 filings, (2) the Certificate of Designations is dated June 21, 2016, (3) no amendments or retirements occurred. The answer demonstrates sound multi-hop reasoning by synthesizing information across three annual filings to reach the conclusion about stability and capital structure priorities.\n\nSTRENGTHS: The LLM accurately captures the key finding that Visa maintained unchanged treatment of the Series B preferred stock across all three years. The dates (June 21, 2016) and exhibit numbers (4.5 in 2022, 4.4 in 2023-2024) are correctly cited. The reasoning about what this continuity suggests (stable capital structure, preserved flexibility, balanced capital mix) aligns well with the ground truth interpretation.\n\nWEAKNESSES: The LLM answer omits some contextual details present in the ground truth: (1) no mention of the unchanged Bylaws (2022 filing) as supporting evidence of broader stability, (2) no reference to the 2024 Certificate of Incorporation update and its lack of changes to Series B structure. These omissions represent minor contextual gaps rather than factual errors. The LLM also uses slightly different phrasing (\"convertible preferred component\" vs. the ground truth's more detailed explanation of \"shareholder rights and financing flexibility\"), but the semantic meaning is equivalent.\n\nQUANTITATIVE VERIFICATION: All dates and exhibit numbers are accurate. No calculations are required for this question, so quantitative accuracy focuses on factual precision of citations, which is strong.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings to identify the pattern of consistency and draw appropriate conclusions about capital structure strategy. The logic is sound: unchanged treatment across multiple filings → deliberate stability strategy → long-term capital priorities.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (how treatment evolved and what it suggests about priorities), though with slightly less depth than the ground truth regarding supporting evidence from other corporate documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 605,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "- In the 2022 filing Caterpillar simply noted that it uses currency‑hedging contracts to offset foreign‑exchange risk, acknowledging that hedging can forego gains from favorable rate moves but giving no detail on the underlying reference rates.   \n- The 2023 filing repeated that language and added that many of Cat Financial’s variable‑rate loans now reference the Secured Overnight Financing Rate (SOFR) rather than LIBOR, signaling the early shift to a new benchmark.   \n- By the 2024 filing the company highlighted the LIBOR‑to‑SOFR transition as a material risk, describing a cross‑functional team tasked with evaluating the impact on LIBOR‑linked loans, derivatives and other hedges and indicating that it is moving floating‑rate exposures—including its currency‑hedging instruments—to SOFR while monitoring the effectiveness and valuation risks of those re‑structured contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Critical issues: (1) CHRONOLOGICAL REVERSAL: The LLM places the cross-functional team assessment and detailed LIBOR-to-SOFR transition discussion in 2024, when the ground truth clearly states this occurred in 2022. The LLM claims 2024 'highlighted the LIBOR-to-SOFR transition as a material risk' with a cross-functional team evaluation, but the ground truth indicates this team was formed in 2022 to assess implications of the planned phase-out. (2) PROGRESSION MISCHARACTERIZATION: The LLM suggests a linear progression from basic hedging disclosure (2022) → SOFR introduction (2023) → detailed transition management (2024), but the ground truth shows the opposite: detailed LIBOR assessment in 2022, SOFR integration in 2023, and continued emphasis on derivatives with no significant changes in 2024. (3) MISSING KEY INFORMATION: The LLM fails to mention that by 2024 there were 'no significant changes in approach' and that the company continued to use match funding and diversified funding strategies. (4) INACCURATE EMPHASIS: The LLM overstates the 2024 filing's focus on LIBOR-to-SOFR transition as 'material risk' and 'moving floating-rate exposures,' when the ground truth indicates this was already underway in 2023 with 2024 showing continuity rather than new emphasis. (5) ENTITY/METRIC ACCURACY: While Cat Financial is correctly identified, the temporal attribution of specific risk management activities is fundamentally wrong. The answer demonstrates a failure to correctly synthesize multi-hop information across the three-year period and appears to have reversed or confused the timeline of events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 466,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "After its 2021 corporate restructuring, Johnson & Johnson moved all talc liabilities into the newly created LTL Management LLC and, in 2022, agreed to fund a $2 billion trust and recorded a $2 billion reserve to cover amounts the bankruptcy court might order LTL to pay【page_113】. In 2023, after the original LTL case was dismissed and a second LTL Chapter 11 filing (LTL 2) was opened, the company expanded its liability reserve to roughly $9 billion—adding to the original $2 billion trust—to fund a broader settlement framework【page_97】. By 2024, J&J shifted to a “pre‑packaged” Chapter 11 plan and other parallel strategies, proposing a $6.475 billion present‑value (≈$8 billion nominal) payment to resolve 99.75 % of talc claims while maintaining the $2 billion trust and the larger reserve as part of its ongoing financial and legal approach【page_101】【page_98】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a detailed timeline and includes specific numbers, but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the 2021 restructuring creating LTL Management LLC; (2) Accurately notes the $2 billion trust established in 2022; (3) Correctly identifies the Third Circuit reversal and dismissal of original LTL case in 2023; (4) Properly references LTL 2 (second filing); (5) Mentions 2024 settlement efforts and pre-packaged Chapter 11 strategy; (6) Good multi-hop synthesis across 2022-2024 timeline. CRITICAL ERRORS: (1) The $9 billion reserve figure is not substantiated in the ground truth, which does not mention this expansion; (2) The $6.475 billion present-value / $8 billion nominal figures are introduced without ground truth support; (3) The 99.75% claims resolution percentage is not mentioned in ground truth; (4) The answer conflates reserve amounts with trust amounts in ways not clearly supported. VERIFICATION ISSUES: The ground truth states JNJ 'remained engaged in appellate efforts' in 2024 but does not detail a specific pre-packaged Chapter 11 plan with these precise dollar amounts. The LLM appears to have added specific financial figures that may be from the filings but are not confirmed in the ground truth answer. REASONING: The multi-hop synthesis is sound in structure (2022→2023→2024 progression), but the introduction of unverified quantitative details (especially the $9B reserve and $6.475B/$8B settlement figures) represents a significant accuracy problem. The answer reads as more detailed than the ground truth but introduces numbers that cannot be verified against it. This is particularly problematic for financial questions where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 480,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "In 2022 Adobe positioned the Photography Plan as a **targeted package** within the broader Creative Cloud suite—one of the “targeted packages and suites, such as our Photography Plan” used to attract photographers and move them toward higher‑value subscriptions (2022 p5‑7). By 2024 the plan had been re‑framed as a **stand‑alone, limited‑cloud offering** that bundles Photoshop, Lightroom and Lightroom Classic and is now highlighted with AI‑driven tools (e.g., Generative Fill, Generative Remove) and integration of Adobe Firefly/Generative Credits, signaling a strategic shift toward an AI‑enhanced, photo‑focused value proposition (2024 p10).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the Photography Plan as a targeted package in 2022 and notes its evolution toward AI-enhanced features by 2024. (2) Specific AI features mentioned (Generative Fill, Generative Remove, Adobe Firefly/Generative Credits) align with the ground truth's emphasis on AI integration. (3) The characterization of the plan as 'stand-alone, limited-cloud offering' in 2024 is reasonable and reflects the ground truth's description of it as 'more limited alternative to the full Creative Cloud suite.' (4) The core product bundle (Photoshop, Lightroom, Lightroom Classic) is correctly identified. (5) Page citations (2022 p5-7, 2024 p10) provide specificity.\n\nWEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It omits the 2023 evolution entirely, which the ground truth explicitly identifies as a key year where Adobe 'emphasized the Photography Plan within a broader product-led growth strategy.' This is a notable gap in the multi-hop synthesis across the three-year period. (2) The characterization of 2022 positioning as a stepping stone to 'higher-value subscriptions' is present but less developed than the ground truth's fuller context. (3) The answer lacks discussion of the strategic positioning shift from 2023 to 2024 regarding product-led growth and the broader ecosystem integration. (4) The phrase 'stand-alone, limited-cloud offering' in the LLM answer is somewhat awkward and not directly supported by the ground truth language, which describes it as 'more limited alternative' rather than 'stand-alone.'\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting 2022 positioning to 2024 enhancements, but fails to complete the full three-year evolution by omitting 2023 as an intermediate and important strategic inflection point. This represents incomplete synthesis across the required time period.\n\nFACTUAL ACCURACY: No specific numbers or calculations are present in either answer, so quantitative verification is not applicable. The qualitative facts presented (product names, AI features, strategic positioning) appear accurate but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 582,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has kept the same specimen certificate for its class C common stock in every filing – the 8‑A document dated January 28 2009 – listing it as Exhibit 4.2 in the 2022 and 2023 10‑Ks (see the exhibit tables on page 109) and again in the 2024 10‑K (renumbered as Exhibit 4.3 but unchanged in description, form and filing date on page 114). This unchanged documentation signals Visa’s commitment to a stable, transparent governance framework and a consistent investor‑relations practice, reassuring shareholders that the company’s core shareholder rights and disclosures remain steady even as broader regulatory and market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding exhibit numbering that undermines its credibility. CRITICAL ERROR: The LLM states the certificate was 'renumbered as Exhibit 4.3' in the 2024 10-K, but the ground truth clearly indicates it remained Exhibit 4.2 across all three years (2022, 2023, and 2024). This is a material factual mistake about a specific document reference. CORRECT ELEMENTS: (1) The filing date of January 28, 2009 is accurate; (2) The 8-A document reference is correct; (3) The File Number 000-53572 is implied correctly; (4) The core observation that the certificate remained unchanged across all three years is accurate; (5) The interpretation about governance stability and investor relations consistency is sound and aligns with the ground truth's reasoning. PARTIAL ISSUES: (1) The LLM cites 'page 109' and 'page 114' as exhibit table locations - these page numbers cannot be verified against the ground truth and may be incorrect; (2) The LLM's statement about the certificate being 'unchanged in description, form and filing date' is correct but the exhibit number claim contradicts this. REASONING QUALITY: The qualitative analysis is strong - the LLM correctly synthesizes that the unchanged documentation signals governance stability and investor confidence, which matches the ground truth's interpretation. The multi-hop reasoning connecting document consistency to corporate governance approach is sound. COMPLETENESS: The answer addresses the main question about consistency and what it suggests about governance/investor relations, though it could have mentioned the contrast with other governance documents (like the Certificate of Incorporation revision in 2024) that the ground truth highlights. The factual error about exhibit renumbering is a significant accuracy problem that prevents a higher score, despite the otherwise sound reasoning and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 517,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1.109 billion at 12/31/2022** to **$1.091 billion at 12/31/2023** and then to **$0.993 billion at 12/31/2024**【page_102†L31-L36】.  The steady decline signals that the company’s exposure to warranty‑ and performance‑related claims is shrinking, suggesting that RTX’s risk‑management practices and product reliability improvements are limiting future guarantee costs in its commercial‑aerospace contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides completely incorrect financial figures that do not match the ground truth. The LLM states liabilities of $1.109 billion (2022), $1.091 billion (2023), and $0.993 billion (2024), while the ground truth shows collaboration partners' share of financing guarantees of $140 million (2022), $135 million (2023), and $131 million (2024). This is a magnitude error of approximately 7-8x, representing a fundamental factual failure. The LLM appears to have cited different liability metrics entirely (possibly total performance guarantees rather than the specific collaboration partners' share requested). While the LLM correctly identifies the directional trend (declining liabilities) and provides reasonable qualitative interpretation about risk management and product reliability, the quantitative foundation is entirely wrong. The reasoning about risk management is sound in principle, but it is built on false numbers. The answer fails to address the specific 'collaboration partners' share' metric that is central to the ground truth answer. Multi-hop synthesis is incomplete because the LLM did not correctly identify which specific liability line item was being queried across the three-year period. This is a case where the narrative sounds plausible but the underlying data is fundamentally incorrect, making the answer unreliable for financial analysis or decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 393,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s 10‑K footnotes have been consistent from FY 2022 through FY 2024: the company treats any free‑rent or step‑rent periods as part of the lease cash‑flow stream and spreads the rent‑free benefit on a straight‑line basis over the “original term of the lease and any extension options that the Company is reasonably certain to exercise” (see the Leases discussion on pages 45‑46 of each filing). The lease term is defined as the non‑cancelable period plus those reasonably‑certain renewal options, and the right‑of‑use asset and lease liability are measured on the discounted minimum lease payments over that term, so the free‑rent periods simply lower the projected payments and therefore the ROU‑asset value. Across the three years the wording was refined (e.g., adding “from the date the Company has control of the property”), but the underlying assumptions and impact on ROU‑asset valuation remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core accounting treatment (straight-line basis for free-rent periods), the lease term definition (non-cancelable period plus reasonably-certain extension options), and the consistent application across FY 2022-2024. The reference to pages 45-46 and the specific quote about 'original term of the lease and any extension options that the Company is reasonably certain to exercise' demonstrates accurate sourcing. The explanation of how free-rent periods impact ROU-asset valuation is mechanically sound.\n\nWEAKNESSES: (1) The LLM answer fails to capture the evolution in disclosure emphasis described in the ground truth. The ground truth explicitly notes that in 2022 there was emphasis on incremental borrowing rate methodology, in 2023 the disclosure expanded to clarify variable lease payment treatment (tied to price indices/sales volume), and in 2024 there was heightened focus on impairment evaluation of long-lived assets. The LLM answer dismisses this evolution as merely 'wording refinement' and states 'underlying assumptions and impact on ROU-asset valuation remained unchanged,' which contradicts the ground truth's characterization of evolving context and emphasis. (2) The LLM answer does not address the variable lease payment treatment evolution mentioned in the ground truth for 2023. (3) The LLM answer does not mention the impairment evaluation emphasis that emerged in 2024 in the context of facility relocations or closures. (4) The phrase 'adding from the date the Company has control of the property' is presented as a minor wording refinement, but the ground truth suggests more substantive evolution in how the accounting was presented and contextualized.\n\nMULTI-HOP REASONING: The answer demonstrates basic multi-hop synthesis by connecting lease term definition to ROU-asset valuation mechanics. However, it fails to synthesize the evolution across the three fiscal years as required by the question, treating the three years as essentially identical rather than showing how disclosure and emphasis evolved.\n\nSEMANTIC ACCURACY: While the core accounting mechanics are correctly described, the answer misses the essential point of the question—the EVOLUTION of accounting treatment and disclosure. The ground truth emphasizes that while core policy remained stable, 'the context in which it was presented evolved to reflect growing operational complexity.' The LLM answer explicitly rejects this characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 662,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "In the 2022 10‑K Adobe made Acrobat the centerpiece of its Document Cloud and introduced AI through Adobe Sensei to make PDFs more intelligent, promising upgrades to Acrobat web, mobile and task‑based actions (see pages 6‑7). By the 2023 filing the company deepened that AI push, allocating R&D to its own foundation‑model work, branding the AI layer under Adobe Sensei (and the new Firefly brand) and pledging expanded AI‑driven features across Acrobat and Acrobat web (see page 5). The 2024 filing’s disclosed sections (pages 94‑98) contain no new AI‑specific branding for Acrobat, suggesting the AI‑powered document‑productivity strategy has been folded into the broader Adobe Document Cloud offering rather than highlighted as a distinct product line.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS: The LLM answer contains several problematic claims that contradict the ground truth. Most critically, it states that the 2024 filing 'contains no new AI-specific branding for Acrobat,' which directly contradicts the ground truth that explicitly states 'By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant.'' This is a fundamental factual error about the core evolution being asked about. (2) INCOMPLETE SYNTHESIS: The LLM answer fails to capture the key milestone that the ground truth emphasizes - the formal introduction of 'Acrobat AI Assistant' as a branded product in 2024. This is the culmination of the strategic evolution and should be central to the answer. (3) QUESTIONABLE CLAIMS: The LLM references 'Adobe Sensei' and 'Firefly brand' in 2023 but these details are not verified in the ground truth and appear to be speculative or inaccurate characterizations. The ground truth states AI was 'formally introduced' in 2023 but doesn't specify these particular branding choices. (4) PAGE REFERENCES: The LLM provides specific page numbers (pages 6-7, page 5, pages 94-98) which cannot be verified against the ground truth and may be fabricated or incorrect. (5) CORRECT ELEMENTS: The LLM does correctly identify the three-year evolution (2022-2024), correctly notes Acrobat's central role, and correctly identifies R&D investments as part of the strategy. The general trajectory from foundational document role to AI-enhanced tools is conceptually correct. (6) SEMANTIC ISSUES: The conclusion that AI strategy was 'folded into broader Document Cloud offering rather than highlighted as distinct product line' contradicts the ground truth's emphasis on formal branding and product extensions. This represents a misinterpretation of the strategic direction. The answer demonstrates partial understanding but contains critical factual errors about the 2024 developments and misses the key branded product launch that defines the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 548,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab’s pool of client securities used as collateral expanded sharply – the fair‑value of margin‑eligible client securities rose from $84 billion in 2020 to $120 billion in 2021, and the total collateral pledged to third parties (for margin, short‑sales, securities‑lending and short‑term borrowings) grew from $23 billion to $31 billion (2021)【page_108】.  That trend continued through the next two years, with the collateral pledged for borrowing capacity – which is largely comprised of client securities supporting margin‑lending and securities‑lending activities – climbing to $63.1 billion in 2023 and staying near that level at $59.8 billion in 2024【page_97】, signalling a balance‑sheet strategy that increasingly leverages client assets to obtain low‑cost funding while client demand for leverage remains strong.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question. Critical issues: (1) WRONG TIME PERIOD: The LLM provides data from 2020-2021 and 2023-2024, but the ground truth explicitly addresses 2022-2024 evolution. The question specifically asks about 2022 through 2024, and the LLM largely ignores 2022. (2) UNVERIFIED NUMBERS: The specific dollar amounts cited ($84B in 2020, $120B in 2021, $23B to $31B collateral, $63.1B in 2023, $59.8B in 2024) cannot be verified against the ground truth, which does NOT provide these specific quantified amounts for 2022. The ground truth explicitly states 'specific pledged amounts were not quantified' in 2022. (3) MISSING KEY INFORMATION: The LLM fails to capture the ground truth's core finding about the 2022-2024 progression showing 'increasing formalization and expansion of client securities usage' and the shift toward 'leveraging client assets for operational and capital efficiency.' (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes the evolution of disclosure practices and regulatory compliance (margin requirements for options clearing, securities lending collateral requirements), which the LLM does not address. (5) MISALIGNED FOCUS: The LLM focuses heavily on absolute dollar amounts and trends, while the ground truth emphasizes the qualitative evolution of disclosure practices and strategic positioning. The LLM's conclusion about 'balance-sheet strategy' and 'client demand for leverage' is somewhat aligned with ground truth but is built on potentially incorrect numerical foundations. The answer reads as if sourced from different filing sections than those supporting the ground truth, suggesting potential hallucination of specific numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 474,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "Costco has kept the 1.375 % Senior Notes due June 2027 on its balance sheet as a $1.25 billion line‑item of long‑term debt in every filing – they were shown as long‑term debt in 2022 (total long‑term debt $6.59 billion, current portion $73 million)【COST_10k_2022.pdf page 52】. The same $1.25 billion remained in the long‑term debt schedule in 2023 and 2024, but total long‑term debt dropped to $6.48 billion in 2023 (with a $1.08 billion current portion)【COST_10k_2023.pdf page 52】 and then to $5.92 billion in 2024 (with the current portion shrinking to $103 million after the 2.750 % notes were retired)【COST_10k_2024.pdf page 52】, causing the 1.375 % notes to represent an increasingly larger share of Costco’s long‑term debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about Costco's 1.375% Senior Notes remaining at $1.25 billion across 2022-2024 and provides relevant context about long-term debt evolution. However, there are significant quantitative discrepancies that undermine accuracy:\n\nCORRECT ELEMENTS:\n- 1.375% Senior Notes consistently valued at $1.25 billion (matches ground truth)\n- Notes remained classified as long-term debt throughout the period\n- Correctly identifies the reclassification of 2.750% notes due May 2024 as a driver of changes\n- Correctly notes the increasing proportional share of the 1.375% notes in total long-term debt\n- Proper multi-hop synthesis across three years of filings\n\nQUANTITATIVE ERRORS:\n- 2022 long-term debt: LLM states $6.59 billion, but ground truth shows $6,484 million ($6.484 billion). This is a $106 million discrepancy.\n- 2023 long-term debt: LLM states $6.48 billion, but ground truth shows $5,794 million ($5.794 billion). This is a $686 million error - a major discrepancy.\n- 2024 long-term debt: LLM states $5.92 billion, ground truth shows $5,794 million ($5.794 billion). This is a $126 million error.\n- The 2023 figure is particularly problematic as it appears the LLM may have confused 2023 and 2024 figures or made a calculation error.\n\nREASONING QUALITY:\nThe LLM demonstrates sound multi-hop reasoning by synthesizing information across three years and correctly identifying the relationship between debt reclassifications and total long-term debt changes. The logic connecting the 2.750% notes retirement to the overall debt composition shift is sound.\n\nSEMANTIC ISSUES:\nWhile the LLM uses \"$1.25 billion\" and ground truth uses \"$1,250 million,\" these are equivalent formats and acceptable. However, the larger debt figures contain material errors that cannot be dismissed as formatting variations.\n\nOVERALL ASSESSMENT:\nThe answer captures the essential narrative about the 1.375% notes' consistent treatment and the broader debt composition evolution, but the quantitative errors in total long-term debt figures (particularly the 2023 figure being off by $686 million) represent a significant accuracy problem that would mislead readers about Costco's actual debt levels.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 600,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "In the 2022 filing Adobe’s Digital Learning Services were described as a “comprehensive portfolio of learning and enablement services” that includes “a large number of free online self‑service learning options on www.training.adobe.com,” positioned alongside fee‑based classroom, virtual and on‑demand programs and custom‑learning services that use solution‑specific skills assessments to help enterprise customers adopt its products【page_17】. By the 2024 filing the same free self‑service component is highlighted on the newer learning.adobe.com site, still framed as a core pillar of the Digital Learning Services suite, and is explicitly tied to Adobe Customer Solutions’ enterprise Customer Success Managers and custom‑learning services that tailor learning priorities to drive faster solution adoption and value for large customers【page_17】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's learning services evolution from 2022 to 2024, with accurate identification of key components and positioning. STRENGTHS: (1) Correctly identifies the core components of Adobe's Digital Learning Services portfolio across both years (free self-service learning, fee-based programs, custom learning services); (2) Accurately notes the website domain change from training.adobe.com (2022) to learning.adobe.com (2024); (3) Properly synthesizes the multi-hop connection between free learning options and enterprise customer success strategies through Customer Success Managers; (4) Correctly characterizes the positioning as a 'core pillar' and notes the explicit tie to enterprise adoption and value delivery; (5) Provides specific page references. WEAKNESSES: (1) The answer is more narrowly focused on 2022 and 2024, with minimal discussion of 2023 as an intermediate evolution point - the ground truth explicitly mentions 2023 as showing 'maturation' with skills assessments and reinforcement of importance; (2) The phrase 'growing emphasis on enterprise integration' from the ground truth is not explicitly captured - the LLM answer states the connection is 'explicitly tied' in 2024 but doesn't characterize this as an evolution or maturation from 2022; (3) The concept of 'democratizing product knowledge' as a strategic commitment is absent from the LLM answer; (4) The LLM answer doesn't fully capture the nuance that the integration with enterprise customer success strategies 'appears to have matured' - it presents the 2024 state but doesn't emphasize the evolutionary progression as clearly. QUANTITATIVE ACCURACY: No numerical errors detected. The answer correctly references page 17 for both filings and accurately describes the learning portfolio components. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, connecting free learning options to enterprise success strategies. However, it misses the intermediate 2023 data point that would strengthen the 'evolution' narrative. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - free learning is positioned as central and increasingly integrated with enterprise strategies - but the evolutionary/maturation aspect is underemphasized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 618,
        "total_tokens": 2179
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s fair‑value exposure to its 2.00 % Notes due 2031 was $1.044 billion at the end of FY 2023 (Level 2 fair value) and rose modestly to $1.057 billion at the end of FY 2024【page 65】. The 2022 filing does not list a separate line for this note in the excerpts provided, indicating the amount was roughly comparable a year earlier【page 78】. The slight increase suggests NVIDIA is deliberately keeping a stable, low‑cost, long‑dated debt base and only modestly expanding it to fund its rapid AI‑driven revenue growth while preserving overall financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) NUMBERS INCORRECT: Ground truth shows 2023 value as $1.057 billion, but LLM states $1.044 billion for FY 2023 (13 million dollar discrepancy). More critically, LLM claims FY 2024 value is $1.057 billion, but ground truth shows $1.25 billion—a $193 million error (15.4% understatement). (2) MISSING 2022 DATA: Ground truth explicitly provides 2022 value of $1.20 billion. LLM dismisses this by saying '2022 filing does not list a separate line' and claims it was 'roughly comparable a year earlier'—this is incorrect and represents failure to synthesize the complete multi-hop data across all three years. (3) INCOMPLETE TREND ANALYSIS: Ground truth shows clear pattern: $1.20B (2022) → $1.057B (2023) → $1.25B (2024), indicating initial reduction then increase. LLM only captures 2023-2024 and misses the 2022 baseline entirely, failing to identify the full trend. (4) FLAWED REASONING: LLM's conclusion about 'stable, low-cost, long-dated debt base' and 'only modestly expanding' contradicts the actual 18.4% increase from 2023 to 2024 ($1.057B to $1.25B). The characterization of this as 'modest' is inaccurate given the magnitude. (5) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about evolution from 2022 to 2024—a three-year comparison requiring synthesis across three data points. LLM only addresses two years and gets one of those wrong. Ground truth correctly identifies the strategic pattern (initial reduction, then increase), while LLM misses this entirely. The answer demonstrates incomplete data gathering and calculation errors on the primary metric being evaluated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 467,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize HR, IT, procurement, supply‑chain and finance processes in order to grow its financial shared‑service capabilities and standardize financial systems (2022 p. 117). The 2023 filing reiterates the same effort and adds that the company will continue to align and streamline the design and operation of its financial control environment (2023 p. 118), and the 2024 filing repeats the description, confirming the initiative remains ongoing and the focus on aligning the control environment persists (2024 p. 119). This continuity shows a strategic emphasis on standardizing financial processes and embedding a consistent control framework as the business scales, rather than reacting to a specific control deficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year enterprise-wide initiative across all three years (2022-2024) with accurate page references (p. 117, 118, 119); (2) Accurately captures the scope of the initiative including finance, HR, IT, procurement, and supply-chain processes; (3) Correctly synthesizes the evolution: 2022 launch description, 2023 addition of control environment alignment language, 2024 confirmation of ongoing status; (4) Properly identifies that this was proactive/strategic rather than reactive to control deficiencies; (5) Demonstrates sound multi-hop reasoning by connecting information across three separate filings to show continuity and strategic intent; (6) Uses appropriate financial/operational terminology (shared-service capabilities, control environment, process standardization). MINOR CONSIDERATIONS: (1) The LLM answer includes specific page numbers (117, 118, 119) which add precision but cannot be verified against the ground truth provided; however, these appear reasonable and consistent with typical 10-K structure; (2) The LLM answer explicitly mentions HR, IT, procurement, and supply-chain alongside finance, while the ground truth focuses more narrowly on finance - however, this additional detail is not contradictory and reflects a more complete picture of the initiative scope; (3) The conclusion about \"embedding a consistent control framework as the business scales\" is a reasonable inference that aligns with the ground truth's emphasis on \"long-term plan to improve operational efficiency and control effectiveness.\" QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or calculations are required for this qualitative question, so this dimension is not heavily tested. The years (2022, 2023, 2024) are correct. QUALITATIVE ACCURACY: The reasoning correctly identifies the three-year progression, the consistency of messaging, and the strategic (non-reactive) nature of the initiative. The synthesis across multiple filings is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the multi-part question regarding evolution, progression, and strategic focus on standardization and control environment alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 613,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 10‑K filings from 2022, 2023 and 2024 all describe the same competitive set – “We also compete with other warehouse clubs, including Walmart’s Sam’s Club and **BJ’s Wholesale Club**” – in the “Competition” paragraph on page 8 of each report.  In the accompanying “Intellectual Property” paragraph on page 8, Costco repeatedly stresses that its **Kirkland Signature** private‑label line is “high quality, offered at prices that are generally lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” a strategic differentiator that is emphasized with identical language in all three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally fails to address the core question about HOW Costco's competitive positioning language EVOLVED from 2022 to 2024. The ground truth explicitly describes an evolution: (1) 2022 baseline with Kirkland Signature description, (2) 2023 with added sustainability emphasis, (3) 2024 with stronger differentiation tone in response to competitive pressures. The LLM instead claims the language was IDENTICAL across all three years ('identical language in all three years'), which directly contradicts the ground truth's description of evolution in tone and emphasis. SPECIFIC ERRORS: (1) The LLM states Kirkland Signature language was 'identical' across 2022-2024, but ground truth indicates meaningful evolution in surrounding context and tone; (2) The LLM completely omits the 2023 sustainability initiatives mentioned in ground truth; (3) The LLM fails to capture the 2024 shift toward 'increasingly competitive metropolitan markets' context; (4) The LLM provides no analysis of how the competitive positioning CHANGED or EVOLVED, only that it remained the same. WHAT WAS CORRECT: The LLM correctly identifies BJ's Wholesale Club as a named competitor, correctly cites the Kirkland Signature description about 'high quality, offered at prices generally lower than national brands,' and correctly notes this appears in the Intellectual Property section. However, these correct details are embedded in a fundamentally flawed analysis that misses the evolution narrative entirely. The question explicitly asks about evolution from 2022-2024, and the LLM's answer that language remained 'identical' is the opposite of what the ground truth describes. This is a multi-hop synthesis failure where the model failed to compare and contrast information across three years to identify the evolution pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 498,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Schwab’s holding of U.S. state and municipal securities slipped from about **$638 million in 2022** (Level 2 “available‑for‑sale” securities) to **$579 million in 2023**【page_112】, and the 2024 filing still lists exposure to these securities while noting that **“substantially all securities in the investment portfolios were rated investment grade”** at year‑end【page_48】. The unchanged emphasis on investment‑grade quality shows that Schwab’s fixed‑income strategy is anchored in preserving credit quality and limiting risk, favoring high‑quality government‑related bonds rather than seeking higher yields from lower‑rated issuers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the year assignment of the $638 million figure. The LLM states '$638 million in 2022' but the ground truth clearly indicates this $638 million figure was disclosed in 2023, not 2022. The LLM then claims this declined to $579 million in 2023, which is internally contradictory and factually incorrect. The ground truth shows: 2022 had qualitative disclosure (substantially all investment grade), 2023 had the specific $638 million quantification, and 2024 reaffirmed investment-grade focus. The LLM has reversed the chronology and misattributed the specific dollar amount to the wrong year. MULTI-HOP REASONING FAILURE: The question asks about evolution from 2022 to 2024, requiring synthesis across three years. The LLM only addresses 2022-2023 with incorrect numbers and fails to properly characterize the 2024 position beyond a general quote. The ground truth shows a clear three-year narrative: qualitative disclosure → quantified allocation → reaffirmation. The LLM's narrative is broken and misdated. QUALITATIVE ASSESSMENT: The LLM correctly identifies the investment-grade emphasis and the strategic preference for high-quality fixed income, which aligns with the ground truth's conclusion about credit risk management. However, this correct qualitative reasoning cannot overcome the severe quantitative errors. The page citations provided (page_112, page_48) cannot be verified but the numbers themselves are demonstrably wrong relative to the ground truth. COMPLETENESS: The answer fails to properly address the 2022-2024 evolution as requested, instead providing a confused 2022-2023 comparison with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 470,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum‑potential payment on its commercial‑aerospace customer‑financing guarantees fell from $304 million in 2022 to $288 million in 2023 and $274 million in 2024, showing a steady reduction in total exposure【page_100】.  The portion attributable to collaboration partners also declined modestly – $140 million in 2022, $135 million in 2023 and $131 million in 2024 – indicating that while the absolute amount of risk transferred to partners is shrinking, RTX continues to rely on partners to shoulder roughly half of the guarantee exposure, preserving its risk‑sharing strategy as it trims overall exposure【page_104】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and trends. STRENGTHS: (1) All collaboration partners' share figures are correct ($140M in 2022, $135M in 2023, $131M in 2024), matching ground truth exactly. (2) The LLM provides additional context by citing total maximum-potential payment exposure ($304M, $288M, $274M), which adds valuable information not contradicted by the ground truth. (3) The multi-hop synthesis correctly identifies the declining trend across all three years. (4) The interpretation that RTX 'continues to rely on partners to shoulder roughly half of the guarantee exposure' is mathematically sound (140/304≈46%, 135/288≈47%, 131/274≈48%). MINOR DIFFERENCES: (1) The LLM's interpretation differs slightly from ground truth's framing. Ground truth emphasizes 'strategic shift toward reducing RTX's reliance on third-party risk sharing' and 'increased internal risk retention,' while LLM frames it as 'preserving its risk-sharing strategy as it trims overall exposure.' Both interpretations are defensible from the data, though they emphasize different aspects. (2) The LLM does not explicitly mention that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees,' which the ground truth includes as evidence of conservative risk management. This is a minor omission of contextual detail. (3) The LLM's characterization of the decline as 'modest' for the collaboration partners' share is reasonable given the 3-4% year-over-year reductions. QUANTITATIVE VERIFICATION: All dollar amounts are accurate; the trend analysis is correct; the percentage calculations implied are sound. The answer successfully synthesizes information across multiple years and metrics to address the multi-hop question about risk transfer strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 501,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "Adobe’s 2022 Form 10‑K (see pages 95‑99) does not list Frame.io among its principal products, indicating it was not yet highlighted in Adobe’s portfolio. By the 2024 filing (see page 12), Frame.io is positioned as a cloud‑native collaboration platform that now supports still images, design files and PDFs, is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and adds Camera‑to‑Cloud uploads and GenStudio integration to enable real‑time review, frame‑accurate commenting and scalable content‑production workflows.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2024 filings. STRENGTHS: (1) Correctly identifies the evolution timeline (2022 acquisition/trademark, 2023 integration with Premiere Pro/After Effects, 2024 expanded integrations); (2) Accurately lists all supported file types (still images, design files, PDFs) and integrations (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront); (3) Properly captures the Camera-to-Cloud functionality and its role in video production; (4) Correctly notes the expansion into broader workflows; (5) Provides specific 10-K page references (pages 95-99 for 2022, page 12 for 2024) showing document verification. MINOR ISSUES: (1) The LLM answer mentions 'GenStudio integration' in 2024, which is not explicitly mentioned in the ground truth answer - this appears to be additional accurate information not contradicting the original answer but extending it; (2) The ground truth mentions Frame.io's expansion into 'casting, location scouting, and marketing campaign management' in 2024, while the LLM answer focuses more on technical integrations and workflow capabilities rather than these specific use cases - this represents a slight difference in emphasis rather than factual error; (3) The LLM answer states Frame.io was 'not yet highlighted in Adobe's portfolio' in 2022, which is a reasonable inference from it not being listed among principal products, though the ground truth simply notes it as a registered trademark. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; all product names and integrations are accurately listed. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple product integrations, showing proper understanding of the evolution. The semantic meaning aligns well with the ground truth despite slightly different emphasis on specific use cases versus technical capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 533,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "- 2022 10‑K – The VH‑92A helicopter is listed among RMS’s “major programs” (Aegis, LCS, Black Hawk, CH‑53K, CRH, **VH‑92A**, etc.) 【page_50】, showing it as an active, strategically‑important product.  \n- 2023 10‑K – The same list appears in the Business Overview, again naming the VH‑92A as a core RMS helicopter program 【page_4】, confirming its continued relevance.  \n- 2024 10‑K – RMS net‑sales growth was “partially offset by lower volume on the VH‑92A program,” indicating a reduction in production activity for that helicopter 【page_41】.  \n\nThis trajectory—from being highlighted as a key RMS program in 2022‑23 to experiencing a production‑volume decline in 2024—shows the VH‑92A has remained a strategic element of the Rotary and Mission Systems portfolio, but its manufacturing emphasis is now being tapered, likely reflecting program maturity or shifting demand within the segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and contradictory information relative to the ground truth. STRENGTHS: (1) Correctly identifies VH-92A as a major RMS program in 2022 and 2023; (2) Accurately cites the 2024 10-K reference to 'lower volume on the VH-92A program'; (3) Properly synthesizes multi-year progression across three fiscal years; (4) Correctly identifies the Rotary and Mission Systems segment context. CRITICAL WEAKNESS: The LLM's interpretation of the 2024 data directly contradicts the ground truth. The ground truth states 'the VH-92A continued to be a named program within RMS' in 2024, indicating 'sustained strategic importance' and 'stable, long-term commitment.' The LLM instead interprets the lower volume as evidence of 'production-volume decline' and 'manufacturing emphasis is now being tapered,' suggesting the program is winding down. This represents a fundamental misinterpretation of what 'lower volume' means in context—lower volume in one year does not necessarily indicate program de-prioritization or maturity decline; it could reflect normal production cycles, delivery schedules, or other factors. The ground truth emphasizes CONSISTENCY and SUSTAINED COMMITMENT across all three years, while the LLM emphasizes a TRAJECTORY OF DECLINE. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but draws an incorrect conclusion about strategic importance. The reasoning that 'lower volume = reduced strategic importance' is not supported by the ground truth's emphasis on consistent naming and sustained commitment. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is less critical. The page citations appear reasonable but cannot be independently verified. SEMANTIC EQUIVALENCE: The LLM's conclusion about 'tapered manufacturing emphasis' is semantically opposite to the ground truth's 'stable, long-term commitment,' representing a material difference in interpretation rather than mere wording variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 547,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "In its 2022 filing Mondelēz reported that sales‑ and media‑marketing restrictions – such as limits on promotions or advertising of products with certain nutrient profiles – were already in force across the European Union (over 25 EU member states had adopted extended‑producer‑responsibility rules) and were beginning to emerge in markets such as India and Vietnam (MDLZ_10k_2022 p. 15). The 2023 and 2024 reports repeat that description but note that additional emerging economies (e.g., Indonesia, the Philippines) and further EU jurisdictions are now contemplating or implementing comparable EPR, plastic‑ban and marketing limits, indicating a modest expansion of geographic coverage and a continued, if not heightened, regulatory stringency (MDLZ_10k_2023 p. 11; MDLZ_10k_2024 p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy in addressing the multi-hop question about MDLZ's regulatory constraints from 2022-2024. STRENGTHS: (1) Correctly identifies the core quantitative fact that over 25 EU member states had adopted EPR rules by 2022; (2) Accurately traces the geographic expansion from 2022 (EU focus, India/Vietnam emerging) through 2023-2024 (additional emerging markets like Indonesia, Philippines); (3) Properly synthesizes information across three fiscal years; (4) Correctly identifies the key regulatory mechanisms (EPR, plastic bans, marketing restrictions); (5) Appropriately characterizes the trajectory as 'modest expansion' of geographic coverage with 'continued, if not heightened' regulatory stringency. MINOR WEAKNESSES: (1) The LLM answer characterizes the expansion as 'modest' while the ground truth emphasizes a 'clear expansion' - this is a subtle semantic difference in tone/emphasis rather than factual error; (2) The LLM answer mentions 'limits on promotions or advertising of products with certain nutrient profiles' which adds interpretive detail not explicitly in the ground truth, though this appears to be reasonable contextual elaboration rather than error; (3) The ground truth specifically mentions the EU's formal adoption of the Packaging and Packaging Waste Directive in 2024, which the LLM answer does not explicitly cite, though it does reference continued EPR implementation; (4) The LLM answer could have been more explicit about data privacy as a regulatory area (mentioned in ground truth for 2023). QUANTITATIVE VERIFICATION: The '25 EU member states' figure is correctly cited and matches ground truth. Geographic entities (India, Vietnam, Indonesia, Philippines, Southeast Asia) are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the progression of regulatory scope and stringency. The logic connecting geographic expansion to regulatory intensity is sound. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (geographic scope AND regulatory stringency) and covers the specified time period and regions (EU and emerging markets).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 601,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700 % Notes due 2046 are shown in the same “Eleventh Supplemental Indenture (Exhibit 4.14)” in each of the three filings – the 2022 10‑K, the 2023 10‑K and the 2024 10‑K (see the exhibit list on page 105 for each year)【page_105】.  The fact that the notes remain listed as outstanding long‑term debt with no change in classification or retirement across three consecutive reports suggests Microsoft is deliberately keeping this low‑coupon, far‑dated issuance on its balance sheet, reflecting a strategy of maintaining a stable, diversified long‑term debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 3.700% Notes due 2046 across all three years (2022, 2023, 2024); (2) Accurately references the Eleventh Supplemental Indenture as the consistent exhibit across filings; (3) Correctly notes the absence of changes in classification or retirement; (4) Provides sound reasoning about Microsoft's deliberate strategy of maintaining stable, long-dated debt; (5) Accurately characterizes the notes as 'low-coupon, far-dated' which aligns with the 3.700% rate and 2046 maturity. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it doesn't explicitly mention the 'Eleventh Supplemental Indenture dated August 8, 2016' with the specific date, though it does reference the exhibit number; (2) The ground truth emphasizes 'fixed interest obligations' and 'confidence in long-term cash flow projections' more explicitly, while the LLM focuses on 'stable, diversified long-term debt profile' - both convey similar strategic intent but with slightly different emphasis; (3) The LLM cites 'page 105' for the exhibit list, which is a specific reference that adds credibility but cannot be independently verified from the ground truth provided. QUANTITATIVE VERIFICATION: All numbers are correct - 3.700% rate, 2046 maturity date, three consecutive years (2022, 2023, 2024) all match. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the pattern of consistency. The logical conclusion about Microsoft's debt strategy is sound and well-supported. The answer demonstrates proper understanding that the absence of change across three years indicates deliberate strategic choice.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 489,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "In the 2022 Form 10‑K Microsoft first disclosed the 2.000 % senior notes that mature in 2023 in its Eleventh Supplemental Indenture (Exhibit 4.14), which also listed a series of notes due through 2056【page_105】. The 2023 Form 10‑K still shows the same 2.000 % 2023 notes in Exhibit 4.14, but adds a Twelfth Supplemental Indenture (Exhibit 4.15) that introduces new issues with maturities extending to 2024 and beyond, signalling the start of a longer‑dated debt profile【page_106】. By the 2024 Form 10‑K the 2.000 % 2023 notes remain on the schedule (still reflected in Exhibit 4.14), while the most recent Fifteenth Supplemental Indenture (Exhibit 4.18, filed November 2023) adds further long‑dated series, illustrating a maturity structure that now spans from the near‑term 2023 note to obligations due well into the 2050‑2060 horizon【page_106】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The 2.000% Notes due 2023 are correctly identified across all three years (2022, 2023, 2024); (2) Exhibit numbers are accurate (4.14 for the notes, 4.15 for Twelfth Supplemental Indenture, 4.18 for Fifteenth Supplemental Indenture); (3) The Eleventh Supplemental Indenture date of August 8, 2016 is correctly referenced; (4) The progression of supplemental indentures (Eleventh → Twelfth → Fifteenth) is accurately traced; (5) The maturity date ranges mentioned (extending to 2056, 2024 and beyond, 2050-2060 horizon) are plausible and consistent with Microsoft's debt structure. The multi-hop reasoning is sound—the answer correctly synthesizes how the same debt instrument appears across three years while showing the evolution of Microsoft's broader debt maturity structure through successive supplemental indentures. The LLM provides more specific detail about the progression of supplemental indentures than the ground truth, which adds value. Minor differences from ground truth: The LLM doesn't explicitly address the question of whether the 2023 notes represent a rollover, delayed maturity, or continued disclosure requirement in 2024 (which the ground truth speculates about), but this is a minor omission. The LLM's focus on the structural evolution through successive supplemental indentures is actually more concrete and informative. All numeric references (years, exhibit numbers, maturity horizons) are accurate. The answer effectively addresses the core question about how the debt instrument evolved across the three filing periods and its relationship to the broader debt maturity structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 466,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "In Medtronic’s 2022 10‑K the “Form of Non‑Employee Restricted Stock Unit Award Agreement” is listed as Exhibit 10.42 and is incorporated by reference to the **Amended and Restated 2013 Stock Award and Incentive Plan** (via Exhibit 10.65)【page_113】. The 2023 10‑K shows the same Exhibit 10.42 with the identical reference to the Amended and Restated 2013 Stock Award and Incentive Plan (Exhibit 10.65)【page_112】, and the 2024 10‑K repeats this wording and reference again【page_112】. Thus, across 2022‑2024 the Non‑Employee RSU Award Agreement has not changed – it remains tied to the 2013 Stock Award and Incentive Plan, with no new plan or amendment introduced.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY - The LLM states the agreement is 'Exhibit 10.42' across all three years, but the ground truth specifies it as 'Exhibit 10.45' in 2022. This is a factual error in entity identification. (2) PLAN REFERENCE DISCREPANCY - The LLM references 'Exhibit 10.65' as the underlying plan reference, but the ground truth does not mention this exhibit number. The ground truth specifically notes the plan was 'effective December 8, 2017' in 2022, which the LLM omits entirely. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that the agreement remained consistent across 2022-2024 and referenced the same Amended and Restated 2013 Stock Award and Incentive Plan, it fails to capture the important contextual detail about the plan's effective date (December 8, 2017) mentioned in the ground truth. (4) PARTIAL CORRECTNESS - The LLM correctly identifies: (a) the core finding that the form agreement remained unchanged across three years, (b) the underlying plan name (Amended and Restated 2013 Stock Award and Incentive Plan), and (c) the consistency of references. However, the exhibit number error (10.42 vs 10.45) and missing effective date information represent significant omissions. (5) MULTI-HOP REASONING - The LLM demonstrates adequate multi-hop reasoning by synthesizing information across three years, but the factual errors undermine the reliability of this synthesis. The conclusion about 'long-term stability' is sound but based on partially incorrect exhibit citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 424,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension‑plan allocation to buy‑in annuity contracts was ≈ 17 % in 2022, slipped to ≈ 16 % in 2023, and returned to ≈ 17 % in 2024【page_105†L13-L18】【page_104†L13-L19】. The roughly stable share – with only a modest one‑point dip – shows the company is maintaining buy‑in annuities as a core hedge, using them to lock in funding and reduce market‑risk exposure for its international pension obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the key factual claim. Ground truth states that buy-in annuity allocations were 'effectively discontinued by 2024,' but the LLM claims they 'returned to ≈17% in 2024.' This is a direct contradiction of the ground truth and represents a major factual error. The LLM also misinterprets the strategic significance: Ground truth indicates a strategic shift AWAY from insurer-backed annuities toward direct liability management, but the LLM characterizes them as 'a core hedge' being 'maintained.' The 2022-2023 trend (17%→16%) is correctly identified, but the 2024 data is completely wrong. The LLM's conclusion about 'maintaining buy-in annuities as a core hedge' contradicts the ground truth's assessment that the company discontinued these instruments. The reasoning about 'locking in funding and reducing market-risk exposure' may be generally sound pension strategy, but it's applied to the wrong conclusion about MDLZ's actual actions. The LLM failed to recognize the strategic pivot away from annuities that the ground truth emphasizes. The citations provided (page references) cannot be verified but the factual claims are demonstrably incorrect relative to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 348,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "The 2.000% Notes due 2023 are listed under the Eleventh Supplemental Indenture (Exhibit 4.14) in the FY 2022 10‑K and remain shown in the FY 2023 filing, indicating they were still outstanding until their scheduled maturity later in 2023【page_105】. By the FY 2024 filing the notes no longer appear as current debt, showing Microsoft has repaid or refinanced them, which reflects a strategy of issuing low‑coupon, medium‑term debt and actively rolling over or retiring notes at maturity to maintain a low‑cost, staggered long‑term debt profile【page_105】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 2.000% Notes due 2023 'remained in the disclosures under the same exhibit' in the 2024 filing and that 'Microsoft maintained this liability on its books through the 2024 reporting period.' However, the LLM answer claims 'By the FY 2024 filing the notes no longer appear as current debt, showing Microsoft has repaid or refinanced them.' This is directly contradicted by the ground truth, which confirms the notes were still referenced in 2024 disclosures. The LLM incorrectly inferred that absence from 'current debt' means the notes were retired, when the ground truth indicates they remained on the books. The LLM also mischaracterizes the debt strategy: the ground truth emphasizes a 'deliberate and steady approach' with NO early retirement or refinancing, while the LLM claims Microsoft 'actively rolling over or retiring notes at maturity.' The LLM correctly identifies the Eleventh Supplemental Indenture (Exhibit 4.14) and the 2.000% coupon rate, and correctly notes the notes were outstanding through 2023. However, the critical error regarding 2024 status and the mischaracterization of the debt management strategy significantly undermines the answer's accuracy. The multi-hop reasoning fails because the LLM did not properly synthesize the consistent presence of these notes across all three years as stated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 413,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft’s 4.000 % senior notes due 2021 are consistently shown in each filing as part of the “Third Supplemental Indenture” (Exhibit 4.6) that was dated February 8 2011 – the same description appears in the 2022, 2023 and 2024 10‑Ks 【page_104】. No amendment, refinancing or redemption of those notes is reported; the later 10‑Ks simply add newer supplemental indentures (e.g., the 12th‑15th) to the overall debt schedule 【page_106】, leaving the 4.000 % notes unchanged within the historic senior‑unsecured debt structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 4.000% Notes due 2021 as consistently appearing in the Third Supplemental Indenture dated February 8, 2011 across all three years (2022, 2023, 2024). (2) Accurately notes that the notes remained unchanged with no amendments, refinancing, or redemption reported. (3) Correctly identifies Exhibit 4.6 as the location of these notes. (4) Properly synthesizes the multi-hop information showing consistency across three years of filings. (5) Accurately describes the introduction of newer supplemental indentures (12th-15th) without affecting the original 4.000% notes. (6) All numeric values and dates are correct (4.000%, February 8, 2011, years 2022-2024). MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the other notes grouped with the 4.000% Notes (2.500% Notes due 2016 and 5.300% Notes due 2041) that were listed in the same Exhibit 4.6 under the same Third Supplemental Indenture, which the ground truth specifically identifies. (2) The ground truth provides more specific examples of new debt instruments introduced (2.375% Notes due 2023 in 2023 filings, 2.125% Notes due 2022 in 2022 filings), while the LLM answer only generically references 'newer supplemental indentures' without these specific examples. (3) The page references cited (page_104, page_106) are not verifiable against the ground truth but appear reasonable. The core factual accuracy is high, and the multi-hop reasoning correctly synthesizes information across the three years. The answer demonstrates sound understanding of the debt instrument structure and its consistency across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 466,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Across the three filings Medtronic’s shareholders’‑equity note repeatedly states that the company is authorized to issue 40 thousand Euro Deferred Shares with a €1.00 par value, and each year’s footnote confirms that **no Euro Deferred Shares were issued or outstanding** – “At April 29 2022…”, “At April 28 2023…”, and “At April 26 2024…” (see Shareholders’ Equity sections in the 2022, 2023 and 2024 10‑Ks). The unchanged authorization and the continual zero balance indicate that Medtronic has chosen not to tap this equity class, relying instead on ordinary‑share issuances, repurchases and other financing tools, and keeping the Euro Deferred Shares as a dormant reserve rather than an active component of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 40 thousand authorized Euro Deferred Shares with €1.00 par value is accurately stated, and the consistent zero balance across all three fiscal years (2022, 2023, 2024) is correctly identified. The fiscal year-end dates are appropriately referenced (April 29, 2022; April 28, 2023; April 26, 2024). ENTITY ACCURACY: Medtronic is correctly identified, the specific equity instrument (Euro Deferred Shares) is properly named, and all three fiscal years are correctly included. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to demonstrate the consistent pattern of non-issuance and non-outstanding balances. The reasoning correctly connects the authorized capacity to the actual zero balances and draws appropriate conclusions about capital structure strategy. COMPLETENESS: The answer addresses both parts of the question - how disclosures evolved (showing consistency across years) and what the absence reveals about strategy (preference for other financing tools, dormant reserve status). SEMANTIC EQUIVALENCE: The LLM's characterization of Euro Deferred Shares as a 'dormant reserve' and the explanation that the company has 'chosen not to tap this equity class' while 'relying instead on ordinary-share issuances, repurchases and other financing tools' conveys the same strategic insight as the ground truth's statement about 'strategic preference for other forms of equity or debt financing.' The only minor distinction is that the LLM provides slightly more specific detail about alternative financing mechanisms (ordinary-share issuances and repurchases), which adds value without contradicting the ground truth. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 509,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft repeatedly listed the 4.000 % Notes due 2021 in Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041,” dated February 8 2011【page_104】. The description and exhibit reference remain unchanged, indicating that Microsoft has continued to hold the notes under the original terms without amendment or retirement, treating the instrument as a stable, ongoing component of its debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key factual elements: (1) Microsoft listed the 4.000% Notes due 2021 in Exhibit 4.6 across 2022, 2023, and 2024 filings, (2) the exhibit is the Third Supplemental Indenture dated February 8, 2011, and (3) the description remained unchanged across the three years. Quantitative accuracy is strong - all dates (February 8, 2011; 2021 maturity; 2022-2024 filings) and percentages (4.000%) are correct. However, there are significant qualitative issues: (1) The LLM states Microsoft 'continued to hold the notes under the original terms without amendment or retirement,' which contradicts the ground truth assertion that 'the Notes were matured or fully accounted for.' Notes due 2021 would have matured by 2022, so the LLM's characterization of them as 'ongoing component of its debt portfolio' is misleading. (2) The ground truth emphasizes that the consistent disclosure 'indicates that the debt instrument remained static...with no further amendments or actions required,' suggesting the notes were already settled. The LLM's interpretation that they remain 'held' and 'stable' misses this critical distinction. (3) The LLM provides more detail about the full exhibit title (including 2.500% Notes due 2016 and 5.300% Notes due 2041) which adds context but wasn't in the ground truth. The answer partially addresses the question about evolution and consistency but fundamentally misinterprets what the consistency means - it suggests ongoing holdings rather than settled/matured debt. This is a material semantic error that affects the interpretation of the company's debt treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 443,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin did not report any new pension‑risk‑transfer deals after the $4.9 billion GAC purchase disclosed for 2021; the 2022 filing notes that, to date, the company has transferred roughly $11.6 billion of defined‑benefit obligations since 2018 and “expects to continue to look for opportunities to manage our pension liabilities through additional pension risk‑transfer transactions” but gives no new dollar amount for 2022 – 2024【page_60†L13-L20】【page_47†L1-L5】. This flat‑line pattern suggests a long‑term liability‑management strategy that relies on occasional, sizable risk‑transfer transactions to reduce pension volatility rather than regular annual transfers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $11.6 billion cumulative pension obligation transfer amount since 2018, matching the ground truth. (2) The $4.9 billion GAC purchase from 2021 is accurately cited. (3) The quantitative data points are factually correct. (4) The LLM appropriately notes the absence of new disclosed dollar amounts for 2022-2024. WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to adequately address the 2023 and 2024 developments mentioned in the ground truth. The ground truth explicitly states that in 2023 the company 'announced its continued evaluation' and by 2024 'reaffirmed its intent to pursue additional pension risk transfer transactions.' The LLM dismisses this as merely 'expects to continue to look for opportunities' without distinguishing the progression across years. (2) MISCHARACTERIZATION OF STRATEGY: The LLM characterizes the pattern as 'flat-line' and suggests a strategy of 'occasional, sizable risk-transfer transactions,' which contradicts the ground truth's characterization of a 'consistent and sustained strategy' with 'deliberate, multi-year' commitment. The LLM's interpretation suggests stagnation rather than the ongoing strategic commitment the ground truth describes. (3) INCOMPLETE TEMPORAL ANALYSIS: The question specifically asks about evolution 'from 2022 through 2024.' The LLM addresses 2022 but largely ignores the 2023-2024 trajectory that the ground truth emphasizes. (4) REASONING GAP: While the LLM correctly notes no new dollar amounts were disclosed, it fails to recognize that the continued evaluation and reaffirmed intent in 2023-2024 still represent strategic evolution and commitment, even without new transaction announcements. The ground truth indicates this is meaningful data about liability management strategy. QUANTITATIVE ACCURACY: Numbers are correct ($11.6B, $4.9B), but the temporal scope is incomplete. QUALITATIVE ACCURACY: The reasoning about 'flat-line' pattern and 'occasional' transactions misinterprets the strategic intent signaled in 2023-2024 filings. The LLM provides a narrower, more pessimistic view than warranted by the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 577,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The 0.125 % Notes due 2029 appear in the exhibit index of every filing – the 2022 10‑K lists them as “Form of Current Note for 0.125 % Notes due 2029” (Exhibit 4.23) referencing the 8‑K filed September 18 2020 (and a later March 9 2021 filing)【page_134】【page_136】; the 2023 10‑K shows the same entry as “Form of Note for 0.125 % Notes due 2029” (Exhibit 4.23) with identical 8‑K references【page_130】; and the 2024 10‑K repeats the same description and references【page_130】. The unchanged wording, exhibit number and source documents across all three years reveal that Coca‑Cola has consistently treated this low‑rate, long‑dated debt as a standard long‑term instrument, indicating a stable and consistent debt‑structuring approach over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 0.125% Notes due 2029 appearing in all three filings (2022, 2023, 2024) with Exhibit 4.23 references and correctly cites the underlying 8-K filings from September 2020 and March 2021. The dates and exhibit numbers are accurate. However, there are significant issues with completeness and accuracy: (1) The ground truth explicitly states the note appeared in BOTH Exhibit 4.23 AND Exhibit 4.31 in each year, but the LLM answer only mentions Exhibit 4.23, omitting the Exhibit 4.31 references entirely. This is a material omission that undermines the completeness of the answer. (2) The LLM characterizes this as 'long-term instrument' and 'long-dated debt,' but the ground truth describes it as 'short-to-medium-term financing needs,' which is a semantic contradiction. A note due 2029 from a 2022 filing would be ~7 years out, which is medium-term, not long-term. (3) The LLM's reasoning about 'stable and consistent debt-structuring approach' is sound and matches the ground truth's conclusion about consistency, but the incomplete exhibit disclosure undermines this analysis. (4) The page references provided (page_134, page_136, page_130, page_130) cannot be verified against the ground truth but appear plausible. The core finding of consistency across three years is correct, but the failure to mention Exhibit 4.31 and the mischaracterization of the debt's maturity profile represent significant analytical gaps that would mislead a reader about the complete disclosure picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 420,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1.109 billion at year‑end 2022** to **$1.091 billion at year‑end 2023** and then to **$0.993 billion at year‑end 2024**【page_100】【page_102】. The steady decline, especially the larger drop in 2024, indicates that the company’s exposure to long‑term product‑performance and operating‑cost risks in its commercial‑aerospace business is gradually diminishing, reflecting lower issuance of new guarantees and the net settlement of existing claims.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides completely different financial figures than the ground truth. The LLM claims RTX's liabilities for performance and operating cost guarantees were $1.109 billion (2022), $1.091 billion (2023), and $0.993 billion (2024). However, the ground truth explicitly states the collaboration partners' share of financing guarantees were $141 million (2022), $135 million (2023), and $131 million (2024) - approximately 7-8 times smaller than the LLM's figures. This is a fundamental factual error that undermines the entire answer. The LLM appears to have cited different liability categories or misidentified the correct figures from the SEC filings. While the LLM correctly identifies the trend direction (declining), the magnitude of the numbers is drastically wrong. The ground truth also notes that 'the company's own liabilities related to these guarantees were not explicitly stated,' suggesting the LLM may have conflated different liability categories. The LLM's interpretation that the decline 'indicates that the company's exposure to long-term product-performance and operating-cost risks in its commercial-aerospace business is gradually diminishing' contradicts the ground truth's assessment that the trend 'indicates that RTX continues to extend these guarantees...while maintaining a controlled liability posture, suggesting stable long-term product performance expectations.' The reasoning about lower issuance and settlement of claims is plausible but not supported by the ground truth analysis. The answer fails on quantitative accuracy (wrong by orders of magnitude), entity accuracy (appears to reference wrong liability line items), and reasoning quality (misinterprets the significance of the trend).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 478,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic still uses the Black‑Scholes model to value its non‑qualified stock options, but the model inputs have been revised – the risk‑free rate rose from 0.90 % in 2022 to 4.16 % in 2024, the volatility assumption increased from about 23 % to roughly 24‑25 %, the dividend‑yield assumption more than doubled to over 3 %, and the expected life was nudged up to 6.1 years【page_82】【page_83】. These higher‑risk inputs have lowered the weighted‑average fair value of options granted from $22.83 in 2022 to $18.49 in 2024, suggesting the company now assumes greater stock‑price volatility and incorporates updated market‑based risk factors into its equity‑compensation modeling.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific numerical data about Black-Scholes model inputs and fair values, but this approach fundamentally misses the core of the ground truth answer. CRITICAL ISSUES: (1) The ground truth focuses on the EVOLUTION OF DISCLOSURE TRANSPARENCY regarding volatility assumptions from 2022-2024, specifically how Medtronic clarified that implied volatility comes from market-traded options. The LLM answer completely ignores this disclosure evolution and instead provides granular input parameters (risk-free rate, volatility percentages, dividend yield, expected life) that are NOT mentioned in the ground truth. (2) The LLM claims specific numerical values (risk-free rate 0.90% to 4.16%, volatility 23% to 24-25%, dividend yield over 3%, fair value $22.83 to $18.49) without these being verified in the ground truth. While these numbers may be factually present in the 10-K filings, they represent a different analytical approach than what the ground truth emphasizes. (3) The LLM's conclusion about 'greater stock-price volatility' contradicts the modest volatility increase it cites (23% to 24-25%), and the explanation that 'higher-risk inputs have lowered fair value' is economically questionable - higher volatility typically increases option value, not decreases it. (4) The ground truth emphasizes a QUALITATIVE SHIFT in methodology transparency (explicit disclosure of market-traded options as volatility source), while the LLM focuses on QUANTITATIVE PARAMETER CHANGES. These are different analytical dimensions. (5) The LLM answer does correctly identify that Medtronic uses Black-Scholes model consistently, which aligns with ground truth. STRENGTHS: The answer is well-structured and provides specific citations. WEAKNESSES: It answers a different question than asked - providing detailed parameter analysis rather than addressing the evolution of disclosure transparency and risk modeling approach that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 530,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "- 2022 10‑K – The exhibit list includes a “Form of Note for 1.000 % Notes due 2028” (Exhibit 4.26)【page_134】.  \n- 2023 10‑K – The exhibit index shows the other debt instruments (e.g., 1.875 %, 1.125 %, 1.625 % etc.) but does **not** list a 1.000 % note due 2028, indicating that no new issuance (or no separate filing) of that instrument appears for the year【page_133】.  \n- 2024 10‑K – The same 1.000 % note due 2028 re‑appears in the exhibit list as Exhibit 4.26【page_130】.  \n\n**Interpretation:** Coca‑Cola introduced or highlighted the ultra‑low‑coupon 1.000 % 2028 notes in 2022, did not issue or separately disclose a new series in 2023, and then either retained or re‑issued the instrument in 2024. This pattern suggests the company uses the 1.000 % 2028 note selectively—leveraging a very low‑cost, medium‑term debt tranche when market conditions are favorable and re‑activating it as part of a strategy to lock in cheap financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides a detailed year-by-year analysis of the 1.000% Notes due 2028 based on exhibit listings, which is a valid approach. However, there are significant discrepancies with the ground truth that affect overall correctness:\n\nSTRENGTHS:\n1. Correctly identifies the 1.000% interest rate and 2028 maturity date\n2. Provides specific exhibit references (4.26) for 2022 and 2024\n3. Attempts multi-hop synthesis across three years\n4. Correctly notes the presence of higher-yielding notes in 2024 (5.000%, 5.300%)\n5. Logical interpretation of selective use based on market conditions\n\nWEAKNESSES:\n1. CRITICAL DISCREPANCY: The LLM claims the 1.000% Notes due 2028 do NOT appear in the 2023 10-K exhibit list, while the ground truth states the company \"consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024.\" This is a fundamental factual error that contradicts the ground truth.\n2. The LLM's interpretation that the notes were \"not issued or separately disclosed\" in 2023 conflicts with the ground truth's assertion of consistent acknowledgment across all three years.\n3. The LLM focuses heavily on exhibit listing presence/absence as the primary evidence, which may not capture the full picture of how the debt instrument was referenced or maintained in the filings.\n4. The conclusion about \"selective\" use and \"re-activation\" in 2024 is speculative and not fully supported by the ground truth, which emphasizes consistent maintenance rather than selective deployment.\n\nMULTI-HOP REASONING:\nThe LLM attempts to synthesize information across three years but reaches a different conclusion than the ground truth. The ground truth emphasizes consistency and ongoing maintenance, while the LLM emphasizes selective use and gaps. This represents a fundamental difference in interpretation of the same data.\n\nNUMERIC/FACTUAL VERIFICATION:\n- Interest rate (1.000%): Correct\n- Maturity year (2028): Correct\n- Higher-yielding notes mentioned (5.000%, 5.300%): Correct\n- Exhibit numbers (4.26): Stated but not verified against ground truth\n- Year-by-year presence claim: INCORRECT for 2023 per ground truth\n\nThe core issue is that the LLM's factual claim about 2023 non-disclosure contradicts the ground truth's explicit statement about consistent referencing across all three years. This is a material error that significantly impacts the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 645,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "In all three annual reports the 2.125 % Notes that mature in 2022 are shown as being issued under the **Fourth Supplemental Indenture (Exhibit 4.7)**, which was dated Nov 7 2012 and names **The Bank of New York Mellon Trust Company, N.A.** as the trustee. That indenture also bundles the 0.875 % Notes due 2017 and the 3.500 % Notes due 2042, and the same description and trustee appear unchanged in the 2022, 2023 and 2024 10‑K filings 【page_104】.  No new trustee or additional related debt instruments were introduced in the later filings, indicating Microsoft’s structuring of the 2.125 % Notes remained consistent across the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth. (1) WRONG SUPPLEMENTAL INDENTURE: The LLM states the notes are under the 'Fourth Supplemental Indenture (Exhibit 4.7)' dated Nov 7, 2012, while the ground truth specifies the 'Seventh Supplemental Indenture' with no date mentioned. This is a fundamental structural error. (2) WRONG MATURITY DATE: The LLM claims the 2.125% Notes mature in 2022, but the ground truth clearly states they are 'due 2021' - a critical factual error that contradicts the question's premise about notes discussed across 2022-2024 filings. Notes maturing in 2021 would have already matured by 2022, making their continued disclosure in 2022-2024 filings problematic. (3) WRONG ASSOCIATED INSTRUMENTS: The LLM lists '0.875% Notes due 2017 and 3.500% Notes due 2042' as bundled instruments, while the ground truth specifies '3.125% Notes due 2028' - completely different instruments. (4) TRUSTEE ACCURACY: The trustee name 'The Bank of New York Mellon Trust Company, N.A.' is correctly identified, which is the only accurate element. (5) CONSISTENCY CLAIM: While both answers correctly note consistency across the three years, the LLM's consistency is based on incorrect underlying facts. The multi-hop reasoning fails because the foundational facts about which indenture, which maturity date, and which associated instruments are all wrong. The answer demonstrates a fundamental misunderstanding of the debt instrument structure being discussed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 417,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney reported a net program‑share interest of **57 % in IAE** (the V2500 joint venture) and **51 % in IAE LLC** (the PW1100G‑JM joint venture in all three years** – 2022 [page 108], 2023 [page 98] and 2024 [page 99]**). The fact that these percentages have remained stable and above the 50 % threshold shows RTX is maintaining a majority, controlling position in both the V2500 and PW1100G‑JM engine programs, underscoring its strategic focus and continued influence over these key commercial‑engine platforms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims that net program-share interest remained stable at 57% for IAE and 51% for IAE LLC across all three years (2022, 2023, 2024). However, the ground truth explicitly states: (1) In 2022, the program share interest was 61% for IAE and 59% for IAE LLC (NOT 57% and 51%), (2) By 2023, these decreased to 57% for IAE and 51% for IAE LLC, (3) In 2024, they remained at 57% and 51%. The LLM incorrectly retroactively applied the 2023-2024 figures to 2022, missing the key evolution/progression that the question specifically asks about. The question explicitly asks 'how did...evolve from 2022 to 2024' - the LLM's claim of stability across all three years directly contradicts the documented decrease from 2022 to 2023. The LLM also fails to distinguish between the 2022 ownership interest (49.5%) and program share interest (61%/59%), conflating these different metrics. While the LLM correctly identifies IAE with V2500 and IAE LLC with PW1100G-JM, and correctly notes the controlling position, it fundamentally misses the strategic recalibration that occurred between 2022 and 2023. The page citations provided (108, 98, 99) cannot be verified but the numeric claims are demonstrably incorrect based on the ground truth. The answer fails to capture the core narrative of the question: the evolution and strategic recalibration indicated by the 2022-2023 adjustment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 411,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then slipped to **$443 million in 2024**【page_66】. The rise in 2023 shows an increased commitment to employee benefits, while the modest decline in 2024 suggests the company is maintaining a strong, though slightly moderated, level of benefit spending.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's defined contribution plan expense was $402 million in 2022, but the ground truth clearly shows it was $299 million in 2022. This is a significant discrepancy of $103 million (34% overstatement). The 2023 ($468 million) and 2024 ($443 million) figures are correct. The reasoning about the trajectory is qualitatively sound - the LLM correctly identifies the 2023 increase and 2024 decline - but this reasoning is based on an incorrect starting point. The semantic interpretation of what the trajectory suggests (increased commitment in 2023, moderated spending in 2024) aligns with the ground truth's assessment, but the factual foundation is flawed. The LLM correctly identifies the company as Thermo Fisher (TMO) and uses appropriate terminology (401(k) and defined-contribution plans). However, the fundamental quantitative error in the 2022 baseline figure undermines the entire multi-hop analysis, as the comparison across the three-year period is now inaccurate. The actual increase from 2022-2023 was $169 million (56.5%), not $66 million (16.4%) as the LLM's numbers would suggest. This materially misrepresents the magnitude of the company's investment shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 343,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "In the 2022 Form 10‑K the exhibit index lists a range of senior notes but does not include a 3.000 % issue maturing in 2051 (see page 135). By the 2023 filing a new “Form of Note for 3.000 % Notes due 2051” appears as Exhibit 4.36 (see page 136), and the 2024 filing continues to list the same instrument (see page 130). The addition and retention of this ultra‑long‑dated, low‑coupon bond shows Coca‑Cola is extending its debt horizon and locking in inexpensive financing, a clear strategy to diversify maturities, reduce interest‑rate risk and preserve balance‑sheet flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer directly contradicts the ground truth on a fundamental claim. Ground truth states that in 2022, Coca-Cola 'referenced the 3.000% Notes due 2051' in its 10-K filing, but the LLM claims the 2022 Form 10-K 'does not include a 3.000% issue maturing in 2051.' This is a major factual error that undermines the entire answer. The LLM then claims the instrument 'appears as Exhibit 4.36' in 2023, but ground truth indicates it was referenced via 'Exhibit 4.6 to the May 5, 2021 Form 8-K' in both 2022 and 2023 with the same exhibit reference. The exhibit number (4.36 vs 4.6) is incorrect. MISSING INFORMATION: The LLM fails to mention the introduction of new higher-coupon instruments in 2024 (5.000% Notes due 2034 and 5.300% Notes due 2054), which is a key part of the ground truth narrative about portfolio diversification. PARTIAL CREDIT: The LLM does correctly identify that the 3.000% Notes due 2051 represents a low-coupon, ultra-long-dated instrument and correctly interprets the strategic rationale (extending debt horizon, locking in inexpensive financing, diversifying maturities, reducing interest-rate risk). The reasoning about capital structure strategy is sound, but it's built on incorrect factual premises about when the instrument first appeared. The answer demonstrates understanding of debt strategy but fails on the core factual accuracy required for a multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 398,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle’s 2022 10‑K exhibit schedule does not list a 2.875% series – it only shows notes up to 2.625% due 2023 and 2.950% due 2024 (page_112). The 2023 10‑K introduces a new 2.875% Notes due 2031 in Exhibit 4.14 (page_111), and the 2024 10‑K continues to list that same series (page_111), indicating the notes were issued after 2022 and remain outstanding. This step‑wise addition of a low‑coupon, longer‑dated issue shows Oracle is deliberately building a diversified, low‑cost long‑term debt portfolio to lock in favorable rates and extend its maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer directly contradicts the ground truth on a fundamental claim. Ground truth states the 2.875% Notes due 2031 were 'formally listed' in 2022, but the LLM claims they were NOT listed in 2022 and were 'issued after 2022,' first appearing in 2023. This is a major factual error that undermines the entire answer. The LLM provides specific page references (page_112, page_111) and exhibit citations (Exhibit 4.14) that cannot be verified but appear to be fabricated details used to support an incorrect premise. MISSING KEY INFORMATION: The LLM completely fails to address the strategic evolution described in the ground truth - specifically that by 2024, Oracle introduced newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033) alongside the 2.875% Notes, indicating a shift toward diversifying with higher-interest instruments. The LLM's conclusion about 'low-cost long-term debt portfolio' contradicts the ground truth's observation about layering in 'costlier debt.' INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from 2022-2024 and what it indicates about strategy. The LLM only addresses 2023-2024 and misses the 2022 baseline entirely, failing to properly synthesize the 3-year progression. The reasoning about 'locking in favorable rates' is speculative and not supported by the comparative analysis of rate increases shown in the ground truth. QUANTITATIVE ISSUES: The LLM references specific coupon rates (2.625%, 2.950%) for 2022 that may or may not be accurate, but these are used to support the false claim that 2.875% was absent in 2022. The answer lacks the comparative analysis of rates (2.875% vs 4.500% vs 4.900%) that would demonstrate the strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 474,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “2.000% Notes due 2023” in the Eleventh Supplemental Indenture (Exhibit 4.14) 【page_105†L1-L4】. By repeatedly disclosing this specific tranche of debt, Microsoft signals a disciplined, long‑term financing strategy that keeps its maturity profile stable, while also demonstrating a commitment to transparent, consistent reporting of its outstanding obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft's consistent disclosure of the 2.000% Notes due 2023 across 2022, 2023, and 2024 10-K filings, the reference to the Eleventh Supplemental Indenture, and the exhibit number (4.14). The numeric values (2.000%, 2023 maturity date) are accurate. The reasoning about transparency and disciplined financing strategy is sound and semantically equivalent to the ground truth. However, the LLM answer is notably more concise and omits several important contextual details present in the ground truth: (1) the specific date of the Eleventh Supplemental Indenture (August 8, 2016), (2) the explicit mention that the notes were 'carried forward unchanged' across all three years, (3) the reference to 'same filing details (e.g., interest rate, maturity date, trustee)' being consistent, and (4) the connection to investor confidence and credit ratings. The LLM answer captures the core insight about transparency and stable debt management but lacks the depth of analysis regarding the strategic implications for investor relations and credit positioning. The answer is factually correct but somewhat incomplete in addressing the full scope of what the consistent disclosure suggests about Microsoft's long-term debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 360,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX said the contingent flight‑hour payments to Rolls‑Royce – tied to V2500‑powered aircraft under the 2012 IAE acquisition – were $735 million for 2022 and rose to $1.05 billion for 2023 (shown in the “Other commercial aerospace commitments” table in the 2022 filing 【page_112】). By the 2024 filing the remaining obligations are now scheduled for later years – $846 million in 2025, $770 million in 2026 and $704 million in 2027 (2024 “Other commercial aerospace commitments” table 【page_103】), indicating that the near‑term exposure peaked in 2023 and is now being amortized, leaving a still‑material but diminishing long‑term liability to Rolls‑Royce through the June 2027 flight‑hour horizon (also noted in the 2023 discussion of the 2012 agreement 【page_73】).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility:\n\n1. QUANTITATIVE ACCURACY - CRITICAL FAILURES:\n   - The LLM cites specific dollar amounts ($735M for 2022, $1.05B for 2023, $846M for 2025, $770M for 2026, $704M for 2027) with page references, but the ground truth does not mention any of these specific numbers. The ground truth explicitly states these payments were 'categorized under Other commercial aerospace commitments' but does NOT provide the dollar figures the LLM claims.\n   - The LLM appears to have fabricated or hallucinated these specific financial figures, which is a critical error in financial analysis.\n   - No calculations are provided to verify, but the numbers themselves cannot be verified against the ground truth.\n\n2. ENTITY AND STRUCTURAL ACCURACY:\n   - The LLM correctly identifies RTX, Rolls-Royce, the 2012 IAE acquisition agreement, and V2500-powered aircraft.\n   - The LLM correctly identifies the relevant table ('Other commercial aerospace commitments') and years (2022-2024).\n   - However, the specific page references (page_112, page_103, page_73) cannot be verified against the ground truth provided.\n\n3. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize information across multiple years (2022-2024) as required by the question.\n   - However, the synthesis is built on unverified/fabricated numbers rather than actual filing data.\n   - The conclusion about 'near-term exposure peaked in 2023 and is now being amortized' is not supported by the ground truth, which states the structure 'remained consistent' across all three years.\n\n4. SEMANTIC EQUIVALENCE TO GROUND TRUTH:\n   - The ground truth emphasizes: (a) consistent categorization across years, (b) capitalization and amortization treatment, (c) stable long-term exposure through June 2027.\n   - The LLM answer emphasizes: (a) specific dollar amounts (unverified), (b) a peak in 2023 with declining amounts thereafter, (c) diminishing liability.\n   - These are fundamentally different narratives. The ground truth suggests stability; the LLM suggests a peak-and-decline pattern.\n\n5. CRITICAL ISSUE - FABRICATION:\n   - The most serious problem is that the LLM provides specific financial figures with page citations that do not appear in the ground truth. This suggests either hallucination or citation fabrication.\n   - In financial analysis, providing false numbers with false citations is worse than providing no numbers at all.\n\n6. WHAT WAS CORRECT:\n   - The 2012 IAE acquisition agreement is correctly identified.\n   - The V2500-powered aircraft connection is correct.\n   - The June 2027 end date is correct.\n   - The 'Other commercial aerospace commitments' categorization is correct.\n   - The general concept of capitalization and amortization is mentioned correctly.\n\n7. WHAT WAS INCORRECT/MISSING:\n   - All specific dollar amounts appear to be fabricated or unverified.\n   - The narrative of 'peak in 2023 with declining amounts' contradicts the ground truth's statement of 'consistent' structure.\n   - The claim that payments 'rose to $1.05 billion for 2023' is not supported by ground truth.\n   - The specific future year breakdowns ($846M in 2025, etc.) are not mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 860,
        "total_tokens": 2308
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "TMO’s domestic‑pension U.S. equity holdings rose from $89 million in 2022 to $93 million in 2023, then edged down to $91 million in 2024【page_57】【page_71】. The modest swing—roughly a 10% share of total domestic‑pension assets—shows the company is largely maintaining its target‑driven, balanced exposure to U.S. equities, making only small adjustments as part of a steady, risk‑controlled investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three years: (1) YEAR 2022: LLM states $89M, but ground truth is $125M - a $36M discrepancy (29% error). (2) YEAR 2023: LLM states $93M, but ground truth is $89M - a $4M discrepancy. (3) YEAR 2024: LLM states $91M, but ground truth is $93M - a $2M discrepancy. The LLM appears to have shifted all values downward and misaligned them to wrong years. (4) TRAJECTORY ANALYSIS: Ground truth shows $125M→$89M→$93M (significant decline then modest rebound), while LLM shows $89M→$93M→$91M (modest increase then slight decline) - completely opposite directional pattern. (5) STRATEGIC INTERPRETATION: Ground truth correctly identifies 'cautious reduction in exposure' with 'modest rebound,' while LLM incorrectly characterizes this as 'largely maintaining' and 'steady' exposure - fundamentally misrepresenting the company's strategy. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year data points, resulting in inverted and misaligned numbers. The answer demonstrates poor data retrieval and synthesis, with no valid basis for the cited page references. This is a complete failure on quantitative accuracy, which is the primary requirement for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 366,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "In the 2022 Form 10‑K the company’s long‑term debt schedule still listed the ultra‑low‑coupon 1.000 % notes due 2041 as a core instrument (see Exhibit 4.6 on page 134). By the 2024 filing the debt program had been broadened with a new series of higher‑yielding notes—e.g., 5.000 % notes due 2034, 5.300 % notes due 2054, 5.400 % notes due 2064 and several 3‑plus % issues—showing a shift from relying on the 1 % issue to diversifying with higher‑coupon debt (see the expanded note list on page 130).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core narrative - Coca-Cola's shift from lower-yielding to higher-yielding debt instruments between 2022-2024. The specific coupon rates (1.000%, 5.000%, 5.300%, 5.400%) are accurate. The identification of the 1.000% Notes due 2041 as a consistent instrument across years is correct. The characterization of the strategic shift is semantically sound.\n\nWEAKNESSES: (1) EXHIBIT CITATION ERROR: The LLM cites 'Exhibit 4.6 on page 134' for 2022 data, but the ground truth specifies 'Exhibit 4.33' for all three years (2022, 2023, 2024). This is a factual error in source attribution. (2) INCOMPLETE HISTORICAL CONTEXT: The ground truth mentions specific lower-yielding instruments from earlier years (0.400% Notes due 2030 in 2022 and 0.950% Notes due 2036 in 2023) that provide important context for the evolution narrative. The LLM omits these details, weakening the multi-hop synthesis across years. (3) VAGUE REFERENCE: The LLM mentions 'several 3-plus % issues' without specificity, whereas the ground truth provides precise coupon rates for all major instruments. (4) PAGE REFERENCE INCONSISTENCY: The LLM cites 'page 130' without verification against ground truth documentation.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis of the 2022-2024 evolution but fails to fully capture the year-by-year progression that the ground truth emphasizes. The reasoning about strategic recalibration is sound but lacks the detailed comparative analysis across all three years.\n\nNUMERIC ACCURACY: All coupon percentages and maturity years mentioned are correct. No calculation errors present.\n\nOVERALL: The answer captures the main strategic narrative correctly but contains citation errors and omits important contextual details that would strengthen the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 496,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle’s 1.650 % Notes due 2026 appear in the exhibit tables of its 2022 filing (page 114) and are again listed in the 2023 and 2024 10‑K exhibit schedules (page 111), showing that the company continues to rely on this low‑cost, long‑dated debt as a core financing source. At the same time, the filings also introduce higher‑coupon issuances—e.g., 5.800 %/6.150 % notes (page 111) and 4.500 % notes (page 110)—indicating that Oracle is supplementing its cheap debt with higher‑interest securities to diversify its maturity and rate profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Oracle's continued inclusion of the 1.650% Notes due 2026 across fiscal years 2022-2024 and recognizes the introduction of higher-rate notes as part of a diversification strategy. However, there are significant issues with quantitative accuracy: (1) The LLM cites specific page numbers (114, 111, 110) that cannot be verified against the ground truth, which references Exhibit numbers instead (4.16 for 2022, 4.14 for 2023 and 2024). (2) The LLM mentions '5.800%/6.150% notes' but the ground truth only confirms 5.800% Notes due 2025 in 2023—the 6.150% figure is not mentioned in the original answer and appears to be an error or unsupported addition. (3) The LLM correctly identifies 4.500% Notes due 2028 in 2024, matching the ground truth. The qualitative reasoning is sound—the LLM correctly synthesizes that Oracle maintains low-cost debt while supplementing with higher-rate instruments for diversification. The answer demonstrates understanding of the multi-hop synthesis required (comparing debt instruments across years and interest rates). However, the introduction of unverified page numbers and the unexplained 6.150% figure represent factual inaccuracies that undermine confidence in the response. The core strategic insight about dual-strategy debt management is present but less explicitly articulated than in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 383,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s repeated listing of the 4.000 % Notes due 2021 in Exhibit 4.6 of its 2022, 2023 and 2024 Form 10‑K filings shows that this tranche remains outstanding and is still governed by the same third supplemental indenture (dated Feb 8 2011) 【page_104】. By keeping the same exhibit in each annual filing, Microsoft signals a disciplined long‑term debt strategy that retains existing notes until maturity and updates its documentation each year rather than refinancing or retiring that series.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM states the third supplemental indenture is 'dated Feb 8 2011' but the ground truth does not provide this date. This appears to be fabricated information. (2) INCOMPLETE ANALYSIS - The LLM fails to address several key points from the ground truth: (a) the notes were due in 2021 yet continued to appear in 2022-2024 filings (a significant anomaly the ground truth explicitly notes), (b) the companion notes (2.500% Notes due 2016 and 5.300% Notes due 2041) that appeared alongside the 4.000% Notes, (c) the 2024 trustee name update to 'The Bank of NewYork Mellon Trust Company, N.A.' which the ground truth identifies as administrative maintenance. (3) REASONING GAPS - The LLM's conclusion that the notes 'remain outstanding' contradicts the ground truth's observation that these notes were due in 2021 yet still appeared in subsequent filings - this is the core analytical puzzle the ground truth addresses. The ground truth explains this as continued documentation relevance despite the due date passing, but the LLM misses this nuance entirely. (4) MISSING CONTEXT - The ground truth emphasizes 'no change in composition' across three years and 'absence of refinancing disclosures,' which the LLM touches on but doesn't fully develop. The ground truth also notes the minor trustee name formatting change in 2024, which the LLM completely omits. CORRECT ELEMENTS: The LLM correctly identifies the 4.000% Notes, the three fiscal years (2022, 2023, 2024), Exhibit 4.6, and the general concept of disciplined debt management without refinancing. However, the fabricated date and incomplete analysis of the core issue (why post-maturity notes appear in filings) significantly undermine the answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 477,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum‑potential payment for commercial‑aerospace financing guarantees fell from $304 million in 2022 to $288 million in 2023 and further to $274 million in 2024【RTX_10k_2022.pdf page_100】【RTX_10k_2023.pdf page_100】【RTX_10k_2024.pdf page_102】.  At the same time, the portion of those guarantees assumed by collaboration partners declined from roughly $142 million in 2022 to $135 million in 2023 and $131 million in 2024【RTX_10k_2023.pdf page_100】【RTX_10k_2024.pdf page_102】, indicating that RTX is steadily reducing both its overall exposure and the amount of risk it transfers to partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All collaboration partners' share numbers are correct ($142M in 2022, $135M in 2023, $131M in 2024), matching ground truth exactly. (2) The LLM correctly identifies the declining trend in partners' share and accurately characterizes it as a reduction in risk transfer to partners. (3) The LLM provides additional context by including total maximum-potential payment figures ($304M, $288M, $274M), which shows comprehensive data synthesis. (4) Multi-hop reasoning is sound - the model correctly synthesizes information across three years and multiple documents. (5) The interpretation that RTX is 'steadily reducing both its overall exposure and the amount of risk it transfers to partners' is logically sound and supported by the data.\n\nWEAKNESSES: (1) The LLM answer diverges from the ground truth's interpretation by emphasizing that RTX is reducing risk transfer to partners, whereas the ground truth suggests RTX may be assuming MORE direct financial risk (the declining partners' share could mean RTX took on more, not that it reduced overall risk). The LLM's statement 'reducing...the amount of risk it transfers to partners' is technically accurate but misses the nuance that this could indicate RTX assuming greater direct exposure. (2) The LLM omits the ground truth's important statement about RTX maintaining confidence in underlying asset values ('fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves'). (3) The LLM doesn't explicitly address the 'strategic shift' interpretation mentioned in the ground truth regarding partnership structure changes.\n\nNUMBER VERIFICATION: All collaboration partner figures are correct. The additional total exposure figures ($304M→$288M→$274M) appear reasonable and consistent with the declining trend. The calculations showing year-over-year declines are accurate.\n\nMULTI-HOP SYNTHESIS: The LLM successfully synthesizes data across three fiscal years and multiple 10-K filings, correctly identifying the consistent downward trend and drawing logical conclusions about risk management strategy.\n\nSCORE JUSTIFICATION: The answer scores 8/10 because it is factually accurate on all key numbers and demonstrates sound multi-hop reasoning, but it provides an incomplete interpretation of the strategic implications (missing the nuance about RTX potentially assuming more direct risk) and omits supporting context about asset value confidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 651,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Microsoft’s 10‑K exhibit index repeatedly lists Exhibit 4.14 – the Eleventh Supplemental Indenture that introduced the 3.950 % senior notes due 2056 (issued August 8 2016) as part of its long‑term debt [page 105]. The unchanged presence of this 30‑year, low‑coupon bond in each filing shows that Microsoft has kept the notes outstanding, reflecting a deliberate strategy of locking in inexpensive, fixed‑rate financing for many decades to support long‑term growth and preserve financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key facts are accurate - the 3.950% Notes due 2056, the Eleventh Supplemental Indenture dated August 8, 2016, and the consistent presence across FY 2022-2024 are all correctly stated. (2) Numeric accuracy is strong - the coupon rate (3.950%), maturity year (2056), and the 30-year duration calculation are all correct. (3) The multi-hop synthesis is sound - the answer correctly identifies that the same debt instrument appears unchanged across three fiscal years and draws the appropriate conclusion about Microsoft's capital strategy. (4) The interpretation about 'locking in inexpensive, fixed-rate financing' is a reasonable inference from the stable presence of this low-coupon debt. MINOR WEAKNESSES: (1) The LLM adds interpretive language ('deliberate strategy,' 'preserve financial flexibility') that goes slightly beyond what the ground truth explicitly states. The ground truth is more conservative, simply noting 'no modifications' and 'steady long-term financing strategy.' (2) The reference to 'page 105' is specific but not verified against the ground truth, which doesn't cite specific page numbers. (3) The ground truth emphasizes 'no changes to the terms or status' more explicitly, while the LLM focuses more on the strategic implications. However, these are minor elaborations rather than factual errors. The core answer correctly addresses the multi-year pattern and capital strategy question with accurate data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 419,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s Missiles & Fire Control (MFC) segment moved from a modest production‑ramp‑up of JASSM, LRASM and other precision‑fire weapons in 2023 – which added $145 million of net sales but still left operating profit $96 million lower than 2022 because of $45 million of losses on a classified program 【page_40】 – to a far larger ramp‑up in 2024 that lifted tactical‑ and strike‑missile net sales by $1.2 billion (total MFC sales $12.7 billion) yet drove operating profit down to $413 million as $1.4 billion of classified‑program losses and adverse profit‑booking adjustments erased the benefit 【page_40】.  Across the company, total operating profit fell from roughly $7.5 billion in 2022 (Aeronautics $2.867 bn 【page_39】 + RMS $1.906 bn 【page_41】 + MFC $1.637 bn 【page_40】 + Space $1.057 bn 【page_41】) to $7.4 bn in 2023 and then to $6.1 bn in 2024 (Aeronautics $2.523 bn 【page_39】 + RMS $1.921 bn 【page_41】 + MFC $0.413 bn 【page_40】 + Space $1.226 bn 【page_41】), a decline of about $1.4 billion despite the surge in missile‑program sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across Lockheed Martin's financial data from 2022-2024. STRENGTHS: (1) All key numeric values are correct: $145M increase in 2023, $1.2B increase in 2024 for tactical/strike missiles; $45M classified program losses in 2023; $1.4B classified program losses in 2024; MFC operating profit of $1.637B (2022), declining to $0.413B (2024); total company operating profit declining from ~$7.5B (2022) to $6.1B (2024). (2) Segment-level calculations are accurate and properly sourced (Aeronautics, RMS, MFC, Space breakdowns). (3) The multi-hop reasoning correctly synthesizes the paradox: production volume increased substantially ($1.2B in 2024) while operating profit plummeted ($1.1B decline, or 73% drop). (4) Root cause analysis is sound: identifies $1.4B in classified program losses and adverse profit-booking adjustments as primary drivers of profit decline despite sales growth. (5) Proper entity identification and temporal tracking across three years. MINOR WEAKNESSES: (1) The answer doesn't explicitly state the 2022 production increase of $215M mentioned in ground truth, though it does reference 2023 and 2024 increases. (2) The phrase 'roughly $7.5 billion' for 2022 is slightly imprecise (actual sum of segments = $7.467B, which rounds to $7.5B, so acceptable). (3) The answer could have been slightly more explicit about the 73% profit decline metric, though the $1.1B decline figure is clearly stated. The LLM successfully addresses all parts of the multi-part question: production trajectory, financial performance evolution, and overall operating profit impact across the three-year period. The synthesis across multiple segments and years is logically sound and well-supported by specific numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 489,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 filing the only Executive Change‑in‑Control Retention Agreement disclosed was the original agreement with Marc N. Casper (Exhibit 10.6) together with its two earlier amendments – the 2010 amendment (Exhibit 10.56) and the 2018 amendment (Exhibit 10.3) [46]. The 2023 filing added a separate “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” as Exhibit 10.7, extending the retention framework to other officers [46]; no further ECICRA amendments were noted. The 2024 exhibit schedule (pages 75‑79) contains no ECICRA entries, indicating that no new amendments or forms were introduced that year [75][78].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM claims the 2024 exhibit schedule contains 'no ECICRA entries,' directly contradicting the ground truth which states the company 'continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers' in 2024. This is a fundamental misrepresentation of 2024 filings. (2) PARTIAL ACCURACY - The LLM correctly identifies that 2022 had the original Casper agreement with amendments, and correctly notes that 2023 introduced the form for officers other than Casper as Exhibit 10.7. However, the specific exhibit numbers and amendment dates (2010, 2018) provided by the LLM cannot be verified against the ground truth and may be incorrect. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes 'consistent structure and ongoing commitment to executive retention strategies across the three-year period,' but the LLM's conclusion that 2024 had 'no new amendments or forms' contradicts this narrative and the ground truth's explicit statement about 2024 continuation. (4) CITATION ISSUES - The LLM provides specific page references [75][78] and exhibit numbers that appear to be fabricated or misinterpreted, as they don't align with the ground truth's description of 2024 filings. The answer fails the core requirement of accurately tracking the evolution across all three years, particularly mischaracterizing 2024 as having no ECICRA references when the ground truth explicitly states otherwise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 439,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "LMT’s variable‑interest‑rate‑swap program grew sharply after 2022. The 2022 filing disclosed only $500 million of interest‑rate‑swap notional (used as fair‑value hedges for fixed‑rate borrowings)【page_66】, while the 2023 filing reported that the notional had risen to $1.3 billion and the 2024 filing shows it remained at $1.3 billion【page_95】【page_52】. This increase and the decision to maintain the larger $1.3 billion portfolio signals a more aggressive, sustained hedging strategy to offset a larger fixed‑rate debt exposure and to better manage interest‑rate risk and earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the 2022, 2023, and 2024 filings. QUANTITATIVE VERIFICATION: All numeric values are correct - $500 million notional in 2021 (disclosed in 2022 filing), $1.3 billion in 2023, and $1.3 billion in 2024. The characterization of the increase as 'more than doubling' is mathematically accurate ($500M to $1.3B = 160% increase). ENTITY ACCURACY: LMT correctly identified, fiscal years properly referenced, and financial metrics (notional amounts, interest rate swaps) accurately described. MULTI-HOP REASONING: The answer successfully synthesizes information across three filing years and correctly identifies the evolution pattern: modest position (2021) → significant increase (2023) → stabilization (2024). SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'more aggressive, sustained hedging strategy' aligns well with the ground truth's description of 'more robust interest rate risk mitigation posture.' The explanation of motivations (larger fixed-rate debt exposure, interest rate risk management, earnings volatility) matches the ground truth's reasoning. MINOR DIFFERENCES: The LLM uses slightly different phrasing ('aggressive, sustained' vs 'proactive' and 'robust') but conveys equivalent meaning. The LLM provides additional context about fair-value hedges for fixed-rate borrowings, which adds relevant detail. The answer is well-structured and directly addresses all components of the multi-part question regarding evolution, notional amounts, and strategic implications. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 455,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to a peak of **$468 million in 2023**, then eased to **$443 million in 2024**【page_67】. The increase from 2022 to 2023 shows a stronger commitment to employee benefits, and although the 2024 figure slipped modestly, it remains above the 2022 level, indicating a generally higher, sustained investment in its workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $402 million (2022), $468 million (2023), and $443 million (2024). The characterization of 2023 as a 'peak' is accurate, and the observation that 2024 remains above 2022 levels is mathematically sound ($443M > $402M). (2) ENTITY ACCURACY: Company correctly identified as Thermo Fisher Scientific, metric correctly identified as defined contribution plan expenses (401(k) plans), and all years (2022-2023-2024) correctly specified. (3) MULTI-HOP REASONING: The LLM successfully synthesized the three-year trend, correctly identifying the increase from 2022 to 2023, the decrease from 2023 to 2024, and the net result that 2024 remains elevated compared to baseline. The interpretation that this indicates 'a stronger commitment to employee benefits' followed by 'stabilization' aligns with the ground truth's assessment. (4) SEMANTIC EQUIVALENCE: The LLM's interpretation ('generally higher, sustained investment') conveys essentially the same meaning as the ground truth's 'stabilization or recalibration of contributions after a period of increase.' Both characterizations appropriately capture the pattern of growth followed by moderation while maintaining elevated levels. Minor difference: The LLM uses 'eased' and 'slipped modestly' which are slightly more interpretive than the ground truth's neutral language, but this represents appropriate analytical framing rather than factual error. The inclusion of a page reference adds credibility. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 466,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "In the 2022 filing (page 40) Coca‑Cola said it values non‑public equity investments using discounted‑cash‑flow models, **estimates of sales‑proceeds** and appraisals, and it judged the $87 million shortfall in its Japan bottler investment to be a temporary decline, so no impairment was recorded. The 2023 (page 79) and 2024 (page 78) filings repeat the same approach, now phrasing it as “various valuation methodologies, **including discounted cash flows, estimates of sales‑proceeds and appraisals**,” indicating the reliance on sales‑proceeds estimates has remained steady. This consistency shows management’s confidence that its sales‑proceeds forecasts are reliable enough to anticipate recoveries in markets like Japan, allowing it to treat the valuation gap as temporary rather than impair the investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $87 million shortfall, 18% decline (implied), page numbers cited (40, 79, 78), and the 2022-2024 timeframe. (2) Quantitative accuracy is high - the LLM correctly identifies the specific dollar amount and the Japan bottler investment details. (3) Entity identification is accurate: The Coca-Cola Company, Coca-Cola Bottlers Japan Holdings Inc., and the correct fiscal years. (4) The core factual claim about consistency in valuation methodology (discounted cash flows, estimates of sales proceeds, appraisals) across 2022-2024 is correct.\n\nWEAKNESSES: (1) The LLM's reasoning about what the evolution 'reveals' is incomplete. The ground truth emphasizes that the company became 'more attuned to external market perspectives and macroeconomic risks' and placed 'increasing emphasis on the assumptions a market participant would use.' The LLM states the approach remained 'steady' and attributes confidence to 'reliable sales-proceeds forecasts,' which is a narrower interpretation. (2) The LLM misses the nuance that the evolution involved a shift in emphasis toward market participant perspectives and external macroeconomic considerations, not just consistency in methodology. (3) The LLM's conclusion that consistency shows 'confidence that its sales-proceeds forecasts are reliable' is somewhat speculative - the ground truth suggests the evolution actually reflects growing awareness of market volatility and external factors, which is a more cautious stance than the LLM implies. (4) The LLM doesn't adequately capture the 'increasing emphasis' on market participant assumptions mentioned in the ground truth, instead focusing on methodological consistency.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022-2024) and connects the valuation methodology to the Japan investment decision. However, it doesn't fully synthesize the evolution aspect - it treats the years as confirming consistency rather than showing meaningful evolution in emphasis and perspective.\n\nSEMANTIC EQUIVALENCE: The LLM's interpretation of 'confidence' differs subtly from the ground truth's interpretation of 'attunement to external risks.' Both are defensible readings, but the ground truth's emphasis on macroeconomic awareness suggests a more sophisticated, risk-aware posture than the LLM's framing of confidence in forecasts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 639,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle’s 2.300 % Notes due 2028 were first issued in March 2021 as part of a multi‑series offering (1.650 % due 2026, 2.300 % due 2028, 2.875 % due 2031, etc.). The FY 2022 10‑K lists this issuance in Exhibit 4.14 (page 112) 【page_112】, and the FY 2023 and FY 2024 10‑Ks repeat the same Exhibit 4.14 with identical terms and filing date (pages 111 of each filing) 【page_111】【page_111】. The unchanged presentation across three years shows Oracle kept the 2.300 % notes as a stable, medium‑term anchor in a broader, staggered‑maturity debt program that mixes low‑coupon notes of different tenors to diversify funding sources and manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific details about the 2.300% Notes due 2028 (March 2021 issuance date, multi-series offering structure, exhibit references) that go beyond the ground truth but are not contradicted by it. However, there are significant gaps in addressing the core question about multi-year evolution and broader debt strategy.\n\nSTRENGTHS:\n1. Correctly identifies the 2.300% Notes due 2028 as a stable instrument across FY2022-2024\n2. Accurately notes the unchanged presentation across three years\n3. Provides specific exhibit references (4.14) and page numbers\n4. Correctly identifies the multi-series offering structure from 2021\n5. The characterization of the notes as a 'stable, medium-term anchor' is semantically aligned with ground truth\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The ground truth explicitly mentions that Oracle issued NEWER, HIGHER-RATE instruments alongside the 2.300% notes:\n   - 4.500% Notes due 2028 in 2023 (NOT mentioned in LLM answer)\n   - 5.800% Notes due 2025 in 2024 (NOT mentioned in LLM answer)\n   These are essential to understanding the multi-year pattern and debt strategy evolution\n\n2. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution \"across fiscal years 2022, 2023, and 2024\" and what the pattern suggests about broader strategy. The LLM answer focuses only on the 2.300% notes remaining unchanged, missing the critical context that Oracle was simultaneously issuing higher-rate debt\n\n3. STRATEGY ANALYSIS INCOMPLETE: The ground truth explains the strategy as \"maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.\" The LLM answer mentions \"staggered-maturity debt program\" and \"diversify funding sources\" but misses the key insight about the rising interest rate environment and the contrast between old/new debt costs\n\n4. MISSING COMPARATIVE ANALYSIS: The ground truth's strength is showing how the 2.300% notes fit into a CHANGING landscape (new higher-rate instruments each year). The LLM answer treats it as static\n\nQUANTITATIVE ACCURACY: The 2.300% rate, 2028 maturity, and 2021 issuance date appear correct. However, the absence of the 4.500% and 5.800% rates is a significant omission that affects the quantitative completeness of the answer.\n\nQUALITATIVE ACCURACY: The reasoning about the 2.300% notes being a stable anchor is sound, but the failure to synthesize the multi-year pattern with new debt issuances represents incomplete multi-hop reasoning. The answer addresses only one dimension (stability of existing debt) rather than the full strategic picture (mix of old and new debt at different rates).\n\nCONTEXTUAL RELEVANCE: While the answer is relevant to Oracle's debt structure, it fails to fully address the question's focus on how the issuance and structuring \"evolved\" across the three years and what the \"multi-year pattern\" suggests. Evolution implies change; the answer emphasizes stability without acknowledging the new instruments issued each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 816,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s Form 10‑K for FY 2022, FY 2023 and FY 2024 each include the same Officer’s Certificate dated May 6 2014 that documents the issuance of Floating Rate Notes due 2019 (see page_56 in each filing). The unchanged reference across three consecutive years shows that Apple has retained those 2019 FRNs without new issuances, indicating a steady reliance on a short‑term, floating‑rate debt instrument that is likely rolled over or refinanced as it matures—reflecting a disciplined short‑term debt‑management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) Correctly identifies the Officer's Certificate dated May 6, 2014 appearing consistently across FY 2022, 2023, and 2024 filings; (2) Accurately notes the Floating Rate Notes due 2019; (3) Correctly interprets the pattern as indicating no new issuances or modifications. The quantitative accuracy is high—all dates and years are correct, and the reference to page_56 is appropriately cited. However, there are some qualitative differences from the ground truth: (1) The LLM introduces an inference about 'rollover or refinancing' that goes beyond what the ground truth states. The ground truth emphasizes 'stable, rather than active, management' and 'absence of any new issuances or modifications,' while the LLM speculates about refinancing practices not explicitly confirmed in the filings; (2) The LLM characterizes this as 'disciplined short-term debt-management strategy' with 'steady reliance,' which adds interpretive language not present in the ground truth's more neutral assessment of consistency and stability. The ground truth is more cautious, noting the notes 'continued to carry them on its books' without making assumptions about refinancing behavior. The multi-hop reasoning is sound—the LLM correctly synthesizes information across three years and identifies the pattern. The answer is contextually relevant and addresses the question about evolution and strategy, though it makes slightly stronger claims than the evidence supports. The core finding (consistency across years, no new issuances) is correct, but the interpretation of what this means for strategy is somewhat more speculative than the ground truth allows.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 467,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s 4.000 % Senior Note due 2047 appears in the exhibit list of every recent 10‑K – e.g., as item 4.17 in the 2023 filing (page 126) and as item 4.16 in the 2022 filing (page 127) and is likewise referenced in the 2024 filing – showing that the company keeps this long‑dated, low‑cost note on its balance sheet as a core financing source and does not plan to retire or replace it quickly. By contrast, the near‑term 2.150 % Senior Note due 2024 (page 126, item 4.18) and the medium‑term 0.750 % Senior Note due 2027 (page 127, item 4.28) are listed only as individual, shorter‑dated instruments that will be repaid or refinanced as they approach maturity, indicating a more tactical, short‑term treatment of those obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy and completeness. STRENGTHS: (1) Correctly identifies the 4.000% Senior Note due 2047 as consistently appearing across multiple filings; (2) Appropriately contrasts this with shorter-dated instruments (2.150% due 2024, 0.750% due 2027); (3) Correctly characterizes the strategic difference between long-term and short-term debt management; (4) Provides specific exhibit references and page numbers that add credibility. CRITICAL WEAKNESSES: (1) The LLM provides specific exhibit item numbers (4.17, 4.18, 4.28, 4.16) and page numbers (126, 127) without verification - these appear to be hallucinated details not verifiable from the question context, which is a serious accuracy concern; (2) MISSING KEY INFORMATION: The ground truth explicitly mentions the 2.500% Senior Note due 2022 that matured by 2023, which is an important data point showing the dynamic nature of short-term debt. The LLM completely omits this comparison; (3) The LLM does not explicitly state that the 2.150% note was 'referenced in 2023' or that the 0.750% note was 'introduced in 2024' - these temporal distinctions are important for understanding the multi-hop synthesis; (4) The LLM's statement about the 0.750% note being 'medium-term' is reasonable but the ground truth more precisely characterizes it as appearing in only one or two filings. REASONING QUALITY: The multi-hop reasoning is sound in principle - comparing persistent long-term debt to time-sensitive short-term obligations - but the execution is incomplete due to missing the 2022 matured note example. The conclusion about leveraging long-term debt for fixed rates and reducing refinancing risk is implied but not explicitly stated as in the ground truth. QUANTITATIVE ACCURACY: While the percentages and years are correct (4.000%, 2.150%, 0.750%, 2047, 2024, 2027), the specific exhibit numbers and page citations appear unreliable and reduce confidence in the answer's factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 546,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple still lists the 0.45 % Notes due 2016 in the exhibit tables of its 2022, 2023 and 2024 Form 10‑K filings (see Exhibit 4.3, which includes “0.45% Notes due 2016” in each filing – e.g., page 56 and page 58) even though those notes matured in 2016. This ongoing disclosure indicates that Apple keeps a complete historical record of every debt issuance, emphasizing transparency and strict compliance with SEC reporting while signalling that legacy obligations are fully settled but remain documented for completeness.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Apple lists the 0.45% Notes due 2016 in its 2022, 2023, and 2024 Form 10-K filings, (2) these notes matured in 2016, and (3) the company maintains disclosure of these legacy obligations. The numeric values (0.45%, year 2016, years 2022-2024) are all accurate. The answer appropriately references specific exhibit locations (Exhibit 4.3) and page numbers, demonstrating concrete evidence. The reasoning about transparency, SEC compliance, and historical record-keeping is sound and aligns with the ground truth's interpretation. However, there are some differences in emphasis and depth: (1) The LLM answer emphasizes 'strict compliance with SEC reporting' and 'signalling that legacy obligations are fully settled,' which adds interpretive elements not explicitly in the ground truth. (2) The ground truth emphasizes 'continuity in financial reporting and investor clarity' and describes it as a 'deliberate and consistent approach,' while the LLM frames it more as a procedural compliance matter. (3) The ground truth specifically mentions the Officer's Certificate dated May 3, 2013, which the LLM does not reference, representing a minor omission of supporting detail. (4) The LLM's characterization of the strategy is slightly narrower (compliance-focused) compared to the ground truth's broader interpretation (comprehensive debt management philosophy). The core answer is fundamentally correct and addresses the question appropriately, but lacks some of the nuanced strategic interpretation present in the ground truth regarding Apple's broader debt management philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 447,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "From 2022 through 2024 Lockheed Martin has continued to rely on pension‑risk‑transfer (group‑annuity‑contract) deals to shrink its defined‑benefit liabilities – the 2022 filing disclosed a $4.9 billion GAC purchase in August 2021 and a cumulative $11.6 billion transferred since 2018, eliminating plan volatility for ~95,000 retirees and cutting PBGC premiums, and a higher discount rate in 2024 reduced the projected pension obligation by about $1.8 billion 【page_60】 【page_48】. The 2022 report noted a $1.7 billion non‑cash settlement charge from the 2021 transaction and projected no contributions in 2022 with $1.8 billion of CAS cost recovery, while the 2023 and 2024 filings simply reaffirmed the strategy of evaluating additional GAC purchases and warned that future risk‑transfer transactions could again generate material non‑cash settlement charges to earnings 【page_62】 【page_21】 【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All key numeric values are correct: $4.9 billion GAC purchase in August 2021, $11.6 billion cumulative transferred since 2018, $1.7 billion noncash settlement charge, $1.8 billion CAS cost recovery in 2022, and $1.8 billion pension obligation reduction from higher discount rate in 2024. (2) Timeline is accurate: correctly identifies 2022 disclosure of 2021 transaction, 2023 reaffirmation of strategy, and 2024 continuation. (3) Multi-hop synthesis is sound: effectively connects pension obligation reductions across years, links financial impacts (noncash charges) to specific transactions, and traces the evolution of strategy from 2022-2024. (4) Additional context is valuable: mentions ~95,000 retirees affected, PBGC premium reductions, plan volatility elimination, and no contributions projected for 2022. (5) Semantic equivalence maintained: 'group-annuity-contract' and 'GAC' used interchangeably, 'noncash settlement charge' and 'non-cash settlement charge' are equivalent. MINOR CONSIDERATIONS: The answer includes slightly more granular detail than the ground truth (e.g., specific retiree count, PBGC premium impact, CAS cost recovery), but these are all factually accurate enhancements that strengthen rather than detract from the answer. The page citations provided suggest proper source documentation. No calculation errors detected. The answer fully addresses all three sub-components of the question: pension obligation reductions, expected future actions, and financial impact on earnings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 446,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 10‑K Thermo Fisher listed the original Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (exhibit 10.12) and, for the first time, a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (exhibit 10.17, filed in the 2018 Q1 10‑Q)【page_46†L31-L38】. The 2023 filing kept the Casper agreement (exhibit 10.11) and carried forward the officer form as exhibit 10.7 to the Q1 2023 10‑Q【page_77†L31-L38】, and the 2024 filing repeats the same Casper agreement and the officer form (still exhibit 10.7) with no new officer‑specific ECICRA added【page_75†L31-L38】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific exhibit numbers and filing references that add detail but introduces several accuracy concerns: (1) QUANTITATIVE/DATE ISSUES: The LLM states the officer form was 'filed in the 2018 Q1 10-Q' with exhibit 10.17, but the ground truth indicates it was 'dated March 16, 2018' without specifying the filing vehicle. The LLM's specific claim about Q1 2018 10-Q filing cannot be verified against ground truth. (2) EXHIBIT NUMBER DISCREPANCIES: The LLM cites exhibit 10.17 for 2022, exhibit 10.7 for 2023-2024, but ground truth doesn't specify these exhibit numbers, making verification impossible. The shifting exhibit numbers (10.17 to 10.7) is presented as fact but unverified. (3) CORE NARRATIVE ALIGNMENT: The LLM correctly identifies the evolution: 2022 had Casper agreement + officer form, 2023 updated the officer form (dated April 1, 2023 per ground truth), 2024 continued both. This matches ground truth's progression. (4) MISSING CONTEXT: The LLM doesn't explicitly mention the April 1, 2023 date for the new officer form, which is a key detail in ground truth showing when the update occurred. (5) SYNTHESIS QUALITY: The multi-hop reasoning is sound - the LLM correctly synthesizes that agreements existed across three years and evolved. However, the specific exhibit citations and filing references appear to be hallucinated details not present in ground truth. The statement 'no new officer-specific ECICRA added' in 2024 aligns with ground truth's 'reiterating the form filed in 2023.' STRENGTHS: Correctly identifies the three-year progression, correctly names both Casper and officer agreements, correctly notes the evolution from 2022 to 2023 to 2024. WEAKNESSES: Introduces unverified exhibit numbers and filing references that cannot be confirmed; omits the specific April 1, 2023 date; presents specific citations as fact when they may be inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 512,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2.750 % Senior Note due 2051 is shown as an outstanding instrument in the 2022 filing (listed as Exhibit 4.51 [page 128]) and is later called out in the board‑of‑directors resolutions that authorise the terms of the 2.750 % Senior Notes due 2051 in both the 2023 and 2024 filings (see the long list of notes on page 130 of each report)【PEP_10k_2022.pdf page_128】【PEP_10k_2023.pdf page_130】【PEP_10k_2024.pdf page_130】. By retaining this ultra‑long‑dated, low‑coupon debt and authorising similar issuances, PepsiCo is deliberately locking in cheap financing to hedge against a rising‑interest‑rate environment and preserve low‑cost capital for the long term.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the question about PepsiCo's long-term debt strategy but contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) PAGE NUMBER ERRORS: The LLM cites 'page 128' for the 2022 filing and 'page 130' for both 2023 and 2024 filings, but the ground truth specifies page 135 for 2022, page 128 for 2023, and page 129 for 2024. These are material discrepancies in document references. (2) EXHIBIT REFERENCE ACCURACY: The LLM claims the note is 'listed as Exhibit 4.51 [page 128]' in 2022, but provides no verification this matches the ground truth's 'exhibit index' reference. The specific exhibit number is not confirmed in the ground truth. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the 2.750% Senior Note due 2051 across all three years (2022-2024), it fails to mention the key comparative element from the ground truth—the introduction of newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) in 2024, which is crucial context for understanding the debt strategy in a rising rate environment. (4) REASONING QUALITY: The LLM's conclusion about 'locking in cheap financing' and 'hedging against rising-interest-rate environment' is logically sound and aligns with the ground truth's interpretation, but the reasoning lacks the nuanced comparison between old and new debt instruments that the ground truth provides. (5) TERMINOLOGY: The LLM uses 'board-of-directors resolutions' which is not mentioned in the ground truth; the ground truth refers to 'exhibit index' references. This suggests potential confusion about document structure. STRENGTHS: The LLM correctly identifies the note's presence across all three years and correctly interprets the strategic implication of maintaining low-coupon long-dated debt. The semantic understanding of the debt strategy is reasonable. WEAKNESSES: Multiple page number errors, missing comparative analysis with newer notes, and unverified exhibit references significantly reduce confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 550,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 first appear in the 2022 Form 10‑K Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 that lists those notes among its long‑term debt instruments【page_56】. The same Exhibit 4.4 is reproduced in the 2023 filing, showing the notes remain outstanding, and it is again included in the 2024 Form 10‑K【page_56】. This repeated inclusion over three years signals Apple’s deliberate strategy of issuing very long‑dated, low‑coupon debt and keeping it on the balance sheet to lock in inexpensive financing for decades, supporting a stable, low‑cost capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All numeric values are correct - the 4.45% coupon rate, the 2044 maturity date, and the May 6, 2014 Officer's Certificate date are all accurate. (2) The multi-hop reasoning is sound - the answer correctly traces the same debt instrument across three fiscal years (2022, 2023, 2024) and synthesizes this pattern to draw conclusions about Apple's capital strategy. (3) Entity identification is precise - correctly identifies Apple, the specific debt instrument, the relevant exhibits (Exhibit 4.4), and the filing years. (4) The interpretation of the pattern is logical and well-reasoned: the repeated inclusion of the same Officer's Certificate across three years without redemption or restructuring does indeed signal a deliberate strategy to maintain long-term fixed-rate debt. (5) The characterization of this as 'very long-dated, low-coupon debt' and a strategy to 'lock in inexpensive financing for decades' aligns with the ground truth's assessment of 'strategic decision to retain long-term debt at a fixed rate.' MINOR CONSIDERATIONS: The LLM answer adds slightly more interpretive detail about 'low-coupon debt' and 'stable, low-cost capital structure' compared to the ground truth's more measured language about 'strategic initiatives or maintain financial flexibility.' However, this represents reasonable elaboration rather than factual error - a 4.45% coupon in the context of long-term debt issued in 2014 could reasonably be characterized as relatively low-cost. The answer fully addresses the multi-year evolution question and provides clear insight into the capital strategy pattern. No calculation errors, no date errors, no entity confusion detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 481,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan held **$622 million in Collective Trust and Other Funds in 2022**, but that balance fell to **$382 million in 2023** – a drop of roughly $240 million. The 2024 filing explains that these holdings are “shares or units in commingled funds and limited‑liability companies that are not publicly traded,” and that the plan values them at fair value **using the funds’ net‑asset‑value (NAV), which is based on the market prices of the underlying publicly‑traded assets**. That disclosure shows the investments are managed through fund structures and are measured with a transparent, NAV‑based valuation approach rather than direct market pricing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - WRONG 2022 FIGURE: The LLM states Union Pacific held $622 million in Collective Trust and Other Funds in 2022, but the ground truth clearly states $756 million. This is a significant factual error ($134 million discrepancy). The 2023 figure of $382 million is correct. The calculated decline of $240 million is therefore incorrect (should be $374 million from $756M to $382M). CORRECT ELEMENTS: The LLM correctly identifies the valuation methodology (NAV-based), correctly describes the fund structures (commingled funds and limited liability companies), and appropriately notes the transparent valuation approach. The explanation of how NAV works is accurate. MISSING CONTEXT: The LLM does not adequately address the ground truth's important insight that the reduction 'may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach.' The LLM also doesn't emphasize that the 2024 filing provides no updated allocation figures, only methodology clarification. MULTI-HOP REASONING: The answer attempts to synthesize information across years and connect valuation methodology to investment management, but the foundational 2022 number error undermines the entire analysis. The reasoning about NAV-based measurement supporting transparency is sound, but it's built on incorrect data. The quantitative accuracy is severely compromised by the wrong starting figure, making this answer substantially incorrect despite some qualitative strengths in explaining the valuation approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 423,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K exhibit tables list the Officer’s Certificate for the 1.05 % Notes due 2017 as Exhibit 4.4 in each filing – it appears in the 2022 exhibit index (see page 56) and again in the 2024 index (see page 58), and the 2023 filing’s exhibit list (page 56) contains the same entry. By continuing to file the original certificate for a debt instrument that matured years earlier, Apple demonstrates a practice of retaining historical debt documentation and a commitment to preserving a complete, transparent record of its capital‑structure history.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Apple included the Officer's Certificate for the 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024; (2) the certificate is dated May 6, 2014 (implied by 'original certificate'); (3) the notes had matured before these filing periods; (4) this reflects a documentation retention practice. The answer appropriately cites exhibit locations (pages 56, 58, 56 for respective years) and correctly identifies the exhibit as 4.4. The reasoning about historical documentation retention and transparency is sound and matches the ground truth's interpretation. However, there are minor weaknesses: (1) The LLM does not explicitly state the May 6, 2014 date of the Officer's Certificate, though it references 'original certificate'; (2) The phrase 'matured years earlier' is less precise than the ground truth's 'matured well before this period' - the notes matured in 2017, making it 5-7 years prior to the 2022-2024 filings, which is accurate but could be more explicit; (3) The answer is slightly more concise than the ground truth and omits some contextual detail about 'investor and regulatory transparency' as explicit motivations, though it implies this through 'transparent record.' The multi-hop synthesis is correct: the answer successfully connects the presence of the certificate across three years to the broader documentation retention strategy. Quantitative accuracy is strong (dates, years, exhibit numbers all correct). The semantic equivalence is high - both answers convey the same fundamental insight about Apple's deliberate approach to preserving historical capital structure disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 455,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan cut its equity exposure dramatically – equity securities (which include corporate stock) made up 48 % of plan assets in 2022, fell to 24 % in 2023 and remained at 24 % in the 2024 filing (the 2024 target is 20‑30 %)【page_56†L9-L13】【page_54†L9-L13】.  Consistent with that shift, the fair‑value of corporate‑stock holdings dropped from about $1.1 billion in 2022 to roughly $0.18 billion in 2023, then rose modestly to $0.23 billion in 2024【page_58†L31-L38】【page_57†L31-L38】【page_55†L31-L38】.  The reduction signals a deliberate de‑risking strategy, moving the pension portfolio away from equities toward a more debt‑heavy allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CORPORATE STOCK ALLOCATION NUMBERS - Ground truth states: $1,990M (2022) → $181M (2023) → $1,116M (2024). LLM states: ~$1.1B (2022) → ~$0.18B (2023) → ~$0.23B (2024). The 2024 figure is critically wrong: LLM reports $0.23B ($230M) when ground truth shows $1,116M - an error of nearly $900M or 79% understatement. The 2022 figure is also incorrect ($1.1B vs $1.99B). (2) PERCENTAGE ALLOCATIONS - LLM cites 48% (2022), 24% (2023), 24% (2024) for equity securities broadly, but these appear to be for total equity securities, not specifically corporate stock. The ground truth focuses on corporate stock specifically, not total equity allocation percentages. (3) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the general trend (reduction then partial rebound) and the strategic implication (de-risking/shift to debt), the specific dollar amounts are materially incorrect. The 2024 rebound is dramatically understated ($230M vs $1,116M). (4) REASONING QUALITY - The qualitative interpretation (de-risking strategy, move toward debt-heavy allocation) aligns with ground truth and is logically sound, but is undermined by the quantitative errors. (5) COMPLETENESS - The answer addresses the evolution question and strategic implications, but the numerical foundation is unreliable. The ground truth's key insight about a 90%+ drop from 2022-2023 followed by partial recovery is obscured by the LLM's incorrect figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 425,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales rose sharply – $428 million in 2022, $605 million in 2023 and $785 million in 2024 (U.S. + international totals shown in the Hospital Acute Care table of the 2024 Form 10‑K)【page_130】. The consistent double‑digit year‑over‑year increase indicates accelerating market adoption and highlights Prevymis as an increasingly important growth driver within Merck’s Hospital Acute Care segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $428M (2022), $605M (2023), $785M (2024). The year-over-year growth calculations are accurate: 2022-2023 growth of ~41.4% and 2023-2024 growth of ~29.8%, both representing double-digit increases as stated. (2) ENTITY ACCURACY: Correctly identifies MRK/Merck, Prevymis product, Hospital Acute Care segment, and fiscal years 2022-2024. (3) MULTI-HOP SYNTHESIS: Successfully synthesizes sales data across three years and connects this trajectory to market adoption and strategic importance conclusions. The reasoning that consistent double-digit growth indicates accelerating adoption is sound and well-supported by the data. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of growth as 'sharp' and 'accelerating' is semantically equivalent to the ground truth's 'steady' and 'consistent' - both convey positive trajectory and increasing importance. The LLM's phrasing is slightly more emphatic but not contradictory. (5) MINOR STRENGTHS: The LLM adds helpful context by citing the specific source (2024 Form 10-K, page 130) and explicitly noting U.S. + international totals, which enhances credibility without introducing errors. The answer fully addresses both parts of the question: the evolution of sales and what it suggests about market adoption and strategic importance. No calculation errors detected. The only minor distinction is that 'sharp' growth might slightly overstate what is actually steady, consistent growth, but this is a matter of emphasis rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 445,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In PepsiCo’s 2022 Form 10‑K the 3.000 % Senior Note due 2027 is explicitly listed as a “Form of 3.000 % Senior Note due 2027” (Exhibit 4.19 on page 126 and again as Exhibit 4.17 on page 127) and is tied to an 8‑K filing from Oct 10 2017【page_126】【page_127】. By contrast, the exhibit schedules in the 2023 filing (pages 126‑128) and the 2024 filing (pages 126‑129) contain no entry for a 3.000 % Senior Note due 2027, indicating that the instrument is no longer disclosed as an outstanding debt【page_126】【page_127】【page_126】【page_127】. This removal suggests PepsiCo has either repaid or refinanced that note, reflecting a deliberate strategy to retire older, lower‑rate obligations and reshape its long‑term debt profile toward newer issuances with different maturities and rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) MAJOR ERROR - The LLM claims the 3.000% Senior Note due 2027 was NOT included in 2023 and 2024 filings, stating it was 'no longer disclosed as an outstanding debt.' The ground truth explicitly states the note was 'consistently included in PepsiCo's annual filings across 2022, 2023, and 2024' and was 'again included' in 2023 and 'continued to be referenced' in 2024. This is a direct contradiction. (2) EXHIBIT NUMBER ERRORS - The LLM incorrectly cites Exhibit 4.19 and 4.17 for the 2022 filing, when the ground truth specifies Exhibit 4.22 for 2022, Exhibit 4.19 for 2023, and Exhibit 4.17 for 2024. The LLM appears to have confused exhibit numbers across years. (3) INCORRECT CONCLUSION - The LLM concludes the note was 'repaid or refinanced' and 'no longer disclosed,' which contradicts the ground truth's narrative of consistent inclusion showing 'ongoing significance' and an 'adaptive debt strategy.' (4) MISSING CONTEXT - The LLM fails to address the evolving context of the note's presentation alongside different instruments in each year (2.150% and 2.250% notes in 2022; 4.450% and 3.450% notes in 2046 in 2023; 0.750% and 1.125% notes in 2024), which is central to understanding PepsiCo's debt strategy. (5) REASONING FAILURE - The multi-hop synthesis is inverted: instead of showing how the note's consistent presence alongside changing instruments reveals a layered maturity strategy, the LLM incorrectly claims the note disappeared. The answer demonstrates fundamental misreading of the source documents and reaches conclusions opposite to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 459,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In Adobe’s 2022 10‑K the company does not highlight Frame.io in its product overview, indicating that the service was still a peripheral offering after its 2021 acquisition. The 2023 filing positions Frame.io as a cloud‑native collaboration platform tightly integrated with Premiere Pro and After Effects, providing frame‑accurate commenting and Camera‑to‑Cloud uploads. By the 2024 filing Adobe expands Frame.io’s functional scope—adding support for still images, design files and PDFs and deep native integration with Photoshop, Lightroom, Workfront, Adobe Express and GenStudio—making it a core, cross‑app component of Creative Cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year progression of Frame.io's evolution. STRENGTHS: (1) Correctly identifies the 2022 positioning as peripheral/post-acquisition, (2) Accurately describes 2023 features (cloud-native collaboration, Premiere Pro/After Effects integration, frame-accurate commenting, Camera-to-Cloud), (3) Properly captures 2024 expansion with support for still images, design files, PDFs, and integration with Photoshop, Lightroom, Workfront, Adobe Express, and GenStudio, (4) Correctly synthesizes the multi-hop progression showing deepening integration and functional expansion, (5) Uses appropriate terminology and maintains semantic accuracy throughout. MINOR DIFFERENCES: (1) The LLM mentions 'Camera-to-Cloud uploads' which is a specific technical feature not explicitly mentioned in the ground truth, though this is a reasonable detail that doesn't contradict the source material, (2) The LLM adds 'Adobe Express' to the 2024 integrations while the ground truth lists 'Photoshop, Lightroom, and Workfront' - the ground truth doesn't explicitly exclude Adobe Express, so this appears to be an additional detail rather than an error, (3) The LLM's characterization of 2022 as 'peripheral' is a reasonable inference from the ground truth's statement that it was 'listed as part of Adobe's trademark portfolio' rather than detailed in product overview. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but scores high due to absence of numeric errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple product integrations, showing clear progression and strategic positioning. The conclusion about Frame.io becoming 'a core, cross-app component' aligns well with the ground truth's statement about its 'central role in Adobe's end-to-end creative workflow ecosystem.' Overall, the LLM answer is factually sound with only minor variations in detail selection that don't constitute errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 565,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple first disclosed the 2.40 % Notes due 2023 in its 2022 Form 10‑K as part of Exhibit 4.3 – the officer’s certificate that lists the company’s global notes, including the 2.40 % Notes due 2023 (see page 58). The 2023 filing continued to list the same notes in its exhibit schedule (pages 53‑57), indicating the debt was still outstanding as the maturity approached. By the 2024 Form 10‑K Apple still references the notes in the historical officer’s certificate (see page 56) but the notes are no longer on the balance sheet, showing they were redeemed at maturity – a clear sign that Apple actively managed the coming‑due debt by repaying or refinancing it before it lapsed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) CONTRADICTORY CONCLUSION: The ground truth states Apple held debt until maturity without early refinancing/repurchasing, indicating a 'hold-to-maturity' strategy. The LLM claims Apple 'actively managed the coming-due debt by repaying or refinancing it before it lapsed' - this directly contradicts the ground truth's conclusion about the strategy. (2) EXHIBIT REFERENCES: The LLM provides specific page numbers (58, 53-57, 56) and exhibit designations (Exhibit 4.3) that cannot be verified against the ground truth and appear to be hallucinated details. The ground truth makes no such specific exhibit citations. (3) BALANCE SHEET CLAIM: The LLM states 'the notes are no longer on the balance sheet' in 2024, but the ground truth indicates they were simply 'no longer listed in the exhibits' - these are different claims. The LLM's assertion about balance sheet removal is not supported by the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across three years (2022-2024), it reaches an incorrect conclusion about the debt management strategy. The ground truth clearly indicates a passive hold-to-maturity approach, not active management/refinancing. (5) SEMANTIC EQUIVALENCE: The core interpretation is fundamentally wrong - the LLM mischaracterizes Apple's strategy as 'active management' when the ground truth describes it as holding debt until maturity without early action. This is a material misunderstanding of the company's debt strategy. The answer does correctly identify the note details (2.40%, due 2023) and the three-year progression, but the strategic conclusion is inverted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 474,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "**Answer**\n\n- **2022:** Union Pacific reported 7,018 multiple‑purpose locomotives (6,001 owned + 1,017 leased) with an average age of about **23.5 years**.  \n- **2023:** The fleet fell to 7,008 units (5,971 owned + 1,037 leased) and the average age rose to **24.3 years**.  \n- **2024:** The fleet further declined to 6,893 units (5,973 owned + 920 leased) and the average age increased to **25.2 years**.\n\n**Interpretation**\n\nOver the three‑year span the company has been deliberately shrinking the multiple‑purpose locomotive fleet while the remaining units are getting older. This pattern shows Union Pacific’s asset‑management strategy of retiring older locomotives and limiting new acquisitions, relying on a leaner, more modernized fleet to meet operational needs and improve efficiency.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant discrepancies in the 2022 baseline numbers. Ground truth shows 7,242 total units (6,204 owned + 1,038 leased) in 2022, but the LLM reports 7,018 units (6,001 owned + 1,017 leased). This is a material error of 224 units in total fleet size and incorrect component breakdowns. The 2023 and 2024 figures are closer to ground truth but still contain errors: 2023 shows 5,971 owned vs. ground truth's implied figure, and while 2024 matches (6,893 total, 5,973 owned, 920 leased), the earlier years' inaccuracy undermines the multi-year trend analysis. The average age progression is correct (23.5→24.3→25.2 years, though ground truth shows 22.5 for 2022, not 23.5 - another error). REASONING ISSUES: The LLM's interpretation contradicts its own data. The answer states the company is 'retiring older locomotives and limiting new acquisitions' and 'relying on a leaner, more modernized fleet,' but the data clearly shows average age INCREASING from 23.5 to 25.2 years, which indicates aging assets, not modernization. This is a fundamental logical inconsistency. The ground truth correctly identifies this as 'lack of significant new investment' and 'reliance on aging assets,' which aligns with the increasing average age. MULTI-HOP SYNTHESIS: The answer does attempt to synthesize fleet composition (owned vs. leased) and age profile across three years, but the foundational numbers are wrong, making the synthesis unreliable. COMPLETENESS: The answer addresses all three years and both metrics (fleet size and age), but the quantitative foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 446,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "- In the 2022 filing Merck reported that MK‑8591A (doravirine + islatravir) was still in early development and subject to a full FDA clinical hold that barred any new studies from starting【page_24】.  \n- By the 2023 filing the company said the regimen entered a Phase 3 program in 2023 for treatment‑naïve and switch‑treated adults, although the FDA hold remained in place (with a partial hold on higher islatravir doses)【page_21】.  \n- The 2024 filing shows the FDA lifted the clinical hold on December 4 2024, and the program is now being run as a Phase 2/3 study that began in August 2024【page_24】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - 2022: LLM claims MK-8591A was \"in early development\" with a \"full FDA clinical hold\" - Ground truth states it was already in Phase 3 as of 2022 (entry date February 2020). This is a fundamental mischaracterization of the development stage.\n   - 2023: LLM claims the program \"entered Phase 3 in 2023\" - Ground truth clearly states it was already in Phase 3 in 2022, so it could not have entered Phase 3 in 2023. This is a critical chronological error.\n   - 2024: LLM states FDA lifted the hold on \"December 4 2024\" and describes it as a \"Phase 2/3 study that began in August 2024\" - Ground truth indicates the FDA lifted the clinical hold in 2024 but mentions a new formulation (MK-8591D) entering Phase 3 in October 2024, not a Phase 2/3 designation for the original program.\n\n2. MISSING KEY INFORMATION:\n   - LLM completely omits the strategic pivot to MK-8591D (islatravir+lenacapavir), which is a crucial part of the trajectory showing Merck's evolving approach.\n   - LLM fails to distinguish between MK-8591A and MK-8591D, which are different formulations with different regulatory timelines.\n   - LLM does not capture the nuance that while a clinical hold was lifted, a partial hold remained for higher doses of islatravir.\n\n3. CHRONOLOGICAL INCONSISTENCIES:\n   - The progression described (early development in 2022 → Phase 3 entry in 2023 → Phase 2/3 in 2024) contradicts the ground truth's clear statement that MK-8591A was in Phase 3 since at least February 2020, making it already Phase 3 in 2022.\n\n4. REGULATORY DYNAMICS:\n   - While the LLM correctly identifies that FDA holds were involved, it misrepresents the timeline and nature of these holds, and fails to capture the complexity of the partial hold remaining for higher doses.\n\nThe answer demonstrates a fundamental misunderstanding of the multi-year development trajectory and fails to accurately synthesize the regulatory information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 560,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "In the 2022 filing Merck listed MK‑1308A – a co‑formulation of its investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab – as a Phase 3 immuno‑oncology candidate entered in April 2021 for advanced renal‑cell carcinoma (RCC)【page_23】【page_25】. The 2023 10‑K continued to highlight MK‑1308A as the same anti‑CTLA‑4/PD‑1 combination being evaluated for RCC, keeping it in the company’s core immuno‑oncology pipeline【page_20】. By 2024 the asset is again featured under Merck’s three strategic oncology pillars, specifically as a key Phase 3 immuno‑oncology program for RCC, underscoring the company’s sustained emphasis on novel checkpoint‑blockade combos to drive innovation in RCC treatment【page_50】. This steady positioning signals Merck’s long‑term commitment to advancing combination immunotherapies as a central focus of its RCC strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and numeric references are correct - April 2021 entry date, Phase 3 status, and the 2022-2023-2024 timeline progression all match the ground truth precisely. ENTITY ACCURACY: All entities are correctly identified - Merck, MK-1308A, quavonlimab, pembrolizumab, RCC, and the anti-CTLA-4/PD-1 mechanism are all accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) how MK-1308A evolved from 2022-2024, (2) what this progression indicates about Merck's RCC focus. The LLM successfully synthesizes information across three fiscal years showing consistent strategic positioning. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple 10-K filings to show the evolution: 2022 (early Phase 3 commitment), 2023 (emphasized as immuno-oncology pillar), 2024 (sustained Phase 3 candidate with no discontinuation). The logical conclusion about sustained strategic prioritization and focus on combination immunotherapies is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of the progression as 'steady positioning' and 'long-term commitment' conveys the same meaning as the ground truth's 'consistent and evolving focus' and 'sustained strategic prioritization.' The description of the asset as a 'key Phase 3 immuno-oncology program' aligns with ground truth characterization. MINOR CONSIDERATIONS: The LLM includes citation references (page numbers) which add credibility but are not present in the ground truth - this is a minor enhancement rather than an error. The phrasing 'three strategic oncology pillars' in 2024 is slightly more specific than the ground truth's general reference to 'immuno-oncology portfolio,' but this represents appropriate detail rather than inaccuracy. Overall, the answer demonstrates accurate fact synthesis, correct multi-hop reasoning across years, and appropriate contextual understanding of Merck's strategic positioning in RCC treatment innovation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 563,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 4.000 % Notes due 2021 are disclosed in exactly the same way – they appear as part of **Exhibit 4.6, “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041”** (see page 104 of each filing). The exhibit number, description and filing date are unchanged from year to year, indicating that Microsoft has kept this issue in its outstanding long‑term debt without re‑issuing or materially modifying it. The consistency suggests a stable long‑term debt profile and a refinancing strategy that simply plans to let the 4 % 2021 note run to maturity (or be refinanced in a single, planned transaction) rather than repeatedly restructuring that portion of its debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the 4.000% Notes due 2021 as appearing in Exhibit 4.6 across all three years (2022, 2023, 2024); (2) Accurately notes the Third Supplemental Indenture structure and the linked notes (2.500% due 2016, 4.000% due 2021, 5.300% due 2041); (3) Correctly identifies the original Indenture date of May 18, 2009 (implied through consistency); (4) Properly synthesizes the multi-hop information showing consistency across three filing years; (5) Provides sound reasoning about refinancing strategy and debt maturity management; (6) Correctly interprets that no material changes or restructuring occurred. MINOR ISSUES: (1) The LLM answer references 'page 104' which is a specific page citation not verified against ground truth - this is a minor detail that doesn't affect core correctness; (2) The LLM adds interpretive language about 'single, planned transaction' refinancing which goes slightly beyond what the ground truth explicitly states, though it's a reasonable inference from the consistency pattern. QUANTITATIVE VERIFICATION: All percentages (4.000%, 2.500%, 5.300%) are correct; all years (2022, 2023, 2024) are correct; the Exhibit 4.6 designation is correct; the indenture date reference is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three filing years and correctly identifies the pattern of consistency, then appropriately interprets what this consistency means for debt structure and refinancing strategy. The reasoning is sound and logically connects the evidence to conclusions. The answer is more detailed and specific than the ground truth while remaining factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 470,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s QCT segment is deliberately positioned to serve the automotive market with “connectivity, digital cockpit and ADAS/AD” solutions (page_7), and the company highlights the digital‑cockpit’s role in reshaping the in‑vehicle experience (page_8).  Automotive revenue – which includes digital‑cockpit sales – rose from $1.509 billion in 2022 to $1.872 billion in 2023 and then to $2.910 billion in 2024 (page_73).  This accelerating growth, coupled with Qualcomm’s strategic focus on digital‑cockpit technology, shows the firm’s automotive business evolving from a modest niche into a significant, fast‑growing platform provider.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies automotive revenue figures ($1.509B in 2022, $1.872B in 2023, $2.910B in 2024) which are accurate and properly formatted. (2) The LLM correctly identifies digital cockpit as a core product line alongside connectivity and ADAS/AD in the QCT segment. (3) The revenue growth trajectory is accurately calculated and presented, showing acceleration from 2022-2024. (4) The characterization of digital cockpit's role in reshaping in-vehicle experience is appropriate. WEAKNESSES: (1) The LLM answer lacks the strategic context and forward-looking projections from 2022 (70% of new vehicles with embedded cellular connectivity by 2028, 60% with 5G) that were central to the original answer's demonstration of strategic positioning evolution. (2) The answer does not address the critical evolution of how digital cockpit was reported/categorized across the three years - the original answer emphasizes that in 2022 it was identified as a key driver, in 2023 it became a distinct revenue stream in financial reporting, and in 2024 it was fully operationalized as a core product line. The LLM treats this as static positioning rather than evolution. (3) The answer misses the key insight about Qualcomm's strategic pivot toward becoming an enabler of the software-defined vehicle, which is central to understanding the 'transformation' aspect of the question. (4) While the LLM provides revenue data, it doesn't synthesize this with the strategic positioning evolution to fully answer how the progression indicates automotive business transformation. The answer is more descriptive of current state than analytical of the evolution. MULTI-HOP REASONING: The LLM partially synthesizes information (combining strategic positioning with revenue data) but fails to fully connect the temporal evolution across 2022-2024 with the strategic implications. The original answer demonstrates a clear narrative arc of strategic maturation; the LLM answer presents facts without this connective tissue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 544,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin’s 10‑K disclosures show that the aggregate notional amount of its variable‑interest‑rate swaps was **$1.3 billion in 2022** (reported in the 2023 filing) and remained **$1.3 billion in both 2023 and 2024** (reported in the 2023 and 2024 filings)【page_95】【page_52】. The unchanged notional amount indicates the company has maintained a steady‑size hedge, using swaps consistently to offset interest‑rate risk on its debt portfolio rather than expanding or reducing its exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that the notional amount was $1.3 billion in 2022, but the ground truth clearly establishes it was $500 million in 2022, increasing to $1.3 billion in 2023. This is a major quantitative error that undermines the entire answer. The LLM's claim of 'unchanged notional amount' across all three years (2022-2024) is factually incorrect - there was a significant $800 million increase from 2022 to 2023. The LLM completely misses the key insight from the ground truth: the fourfold increase from 2022 to 2023 representing a 'strategic shift toward more active interest rate risk management.' Instead, the LLM incorrectly characterizes the situation as maintaining a 'steady-size hedge' with 'unchanged notional amount,' which is demonstrably false. The answer fails to capture the evolution of LMT's strategy - the dramatic increase in 2023 followed by stabilization in 2024 - which is central to answering the question about how the company's approach 'evolved' over the period. The LLM does correctly identify that the amount remained at $1.3 billion from 2023 to 2024, but this partial correctness cannot offset the major error regarding 2022 figures and the mischaracterization of the overall trend. The reasoning about 'steady-size hedge' is logically inconsistent with a fourfold increase in notional amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 396,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft’s 3.950 % Notes due 2056 are listed in the “Eleventh Supplemental Indenture” (dated August 8 2016) in the exhibit index of each filing – the 2022, 2023 and 2024 10‑Ks all show the same entry and give no indication that the notes have been retired or re‑issued【page_105】.  By keeping this long‑dated, low‑coupon tranche outstanding across three successive reports, Microsoft demonstrates a deliberate strategy of preserving long‑term debt to smooth its maturity profile and retain flexibility for future refinancing rather than accelerating repayment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - 3.950% coupon rate, 2056 maturity date, August 8, 2016 indenture date are all accurate. (2) The LLM correctly identifies the Eleventh Supplemental Indenture as the relevant document across all three filings. (3) The core factual claim that the notes appear consistently across 2022, 2023, and 2024 10-Ks without modification is accurate. (4) The reasoning about long-term debt strategy and maturity profile management is sound and relevant. (5) Correctly notes the absence of retirement or re-issuance across the three-year period.\n\nWEAKNESSES: (1) The LLM answer is somewhat less comprehensive than the ground truth. It omits the comparative context about shorter-term instruments maturing (e.g., 2.000% Notes due 2023 in 2022 filings, 2.400% Notes due 2026 in 2024), which provides important context for understanding Microsoft's overall debt maturity management strategy. (2) The ground truth emphasizes 'periods of evolving market interest rates' as context for the strategy, which the LLM answer does not address. (3) The phrase 'low-coupon tranche' in the LLM answer is somewhat interpretive - while 3.950% could be considered relatively low depending on market context, the ground truth doesn't explicitly characterize it this way. (4) The LLM answer uses slightly different framing ('smooth its maturity profile and retain flexibility') versus the ground truth's emphasis on 'preserving long-term capital stability' and 'strategic prioritization of long-dated liabilities to support long-term investment horizons' - these are semantically similar but not identical.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the pattern of consistent treatment. However, it misses the opportunity to compare this strategy against the treatment of other debt instruments with different maturities, which would have strengthened the multi-hop analysis.\n\nOVERALL ASSESSMENT: The answer is factually accurate on all key points and demonstrates sound reasoning about debt management strategy. The main limitation is incompleteness - it addresses the core question but omits contextual details that would provide a more robust understanding of Microsoft's overall long-term debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 615,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016 – which contains, among other series, the 3.700% senior notes that mature in 2046 (page 105). By repeatedly referencing this same indenture, Microsoft signals that the 3.700% Notes due 2046 remain outstanding and are a core component of its long‑term debt portfolio, demonstrating a stable, multi‑decade financing strategy and consistent reporting of its long‑term financial obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key factual elements: (1) Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016 - CORRECT; (2) The 3.700% Notes due 2046 are governed by this indenture - CORRECT; (3) The notes remain outstanding and are part of long-term debt - CORRECT; (4) The repeated references indicate stable, multi-decade financing strategy - CORRECT. Quantitative accuracy is strong: all dates (August 8, 2016; 2046 maturity), percentages (3.700%), and year references (2022, 2023, 2024) are accurate. The LLM also correctly identifies Exhibit 4.14 as the location of this indenture. However, the answer has notable omissions compared to the ground truth: (1) It does not mention the base Indenture dated May 18, 2009, which provides important context about the layered structure of Microsoft's debt instruments; (2) It does not explain the significance of the 'Eleventh' designation, which implies a structured series of supplemental indentures; (3) It lacks discussion of how this reflects 'no material amendments or retirements during this time,' which is an important inference about debt stability. The reasoning is sound and the multi-hop synthesis across three years is correct, but the answer is somewhat less comprehensive than the ground truth in explaining the full structural context of Microsoft's long-term debt management. The semantic meaning aligns well with the ground truth regarding stability and consistency, but misses some nuanced structural details that would strengthen the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 432,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s FY 2022 10‑K still disclosed the 2.125 % senior notes due 2021 in the Seventh Supplemental Indenture (Exhibit 4.10) and they were reflected as a current‑portion of debt【page_104】. By the FY 2023 and FY 2024 filings the same exhibit is retained for historical reference, but the notes no longer appear on the balance sheet, indicating they were redeemed after their 2021 maturity【page_104】. This progression shows Microsoft let the 2.125 % notes mature and retire them rather than rolling them over, reflecting a disciplined debt‑reduction strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The note percentage (2.125%) is accurate; (2) The exhibit references (Exhibit 4.10 in 2022, Exhibit 4.1 in 2023-2024) are correct; (3) The page reference (104) is accurate across all three years; (4) The indenture date context is appropriately referenced. PROBLEMATIC ELEMENTS: (1) The LLM claims the notes 'were reflected as a current-portion of debt' in FY 2022 - this specific balance sheet classification is not verified in the ground truth and represents an unsupported assertion about financial statement presentation; (2) The LLM states 'the notes no longer appear on the balance sheet' in FY 2023-2024 - while this may be true, the ground truth does not explicitly confirm this balance sheet removal, only that exhibits were retained; (3) The LLM concludes definitively that Microsoft 'let the 2.125% notes mature and retire them rather than rolling them over' - this is a stronger interpretation than the ground truth supports, which explicitly states the persistence of references 'raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag.' The ground truth maintains appropriate uncertainty about whether this was an extension, rollover, or simply a disclosure lag. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across three years but makes interpretive leaps beyond what the source documents confirm. The ground truth appropriately acknowledges ambiguity in what the continued exhibit references mean, while the LLM presents a definitive narrative about retirement and debt reduction strategy without sufficient evidentiary support. The answer is partially correct on factual details but overstates certainty about the underlying debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 492,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft’s 2.000 % Notes due 2023 are shown in the Eleventh Supplemental Indenture (exhibit 4.14) in the exhibit index of each filing – FY 2022 10‑K, FY 2023 10‑K and FY 2024 10‑K – and the description is unchanged across the three years【page_105】.  The notes were originally issued in 2016 and have simply been carried forward in the company’s debt schedule, indicating that Microsoft relies on a stable, low‑cost, medium‑term financing approach and prefers to hold such notes to maturity rather than repeatedly issuing new debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct - 2.000% interest rate, 2023 maturity date, August 8, 2016 issuance date, and Eleventh Supplemental Indenture reference are all accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies that the notes appear consistently across FY 2022, 2023, and 2024 filings, demonstrating the multi-year pattern requested. (3) Entity identification is precise - Microsoft, the specific debt instrument, and the indenture agreement are all correctly identified. (4) The reasoning about debt management strategy is logically sound and matches the ground truth interpretation: the consistent presence across years indicates the notes were held to maturity rather than refinanced, reflecting a stable, long-term approach. (5) The answer adds helpful context by noting the notes were 'originally issued in 2016' and characterizing the strategy as 'stable, low-cost, medium-term financing,' which enhances understanding without contradicting the ground truth. Minor observation: The LLM answer includes a citation reference (【page_105】) and exhibit reference (exhibit 4.14) that add specificity beyond the ground truth, which is appropriate for SEC filing analysis. The semantic equivalence is excellent - both answers convey that Microsoft maintained this debt obligation across the three-year period and did not refinance it, indicating a stable debt management approach. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 427,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "In its 2022 filing Lockheed Martin reported that it had transferred $4.9 billion of gross defined‑benefit pension obligations in August 2021 (part of a cumulative $11.6 billion transferred since 2018) and recognized a $1.7 billion non‑cash settlement charge, while stating it would continue to look for additional risk‑transfer opportunities【page_60】. The 2023 filing reiterated that the company still uses group‑annuity contracts to shrink its pension plans, disclosed no new large‑scale transfers, and emphasized ongoing evaluation of future risk‑transfer transactions【page_20】【page_21】. The 2024 filing again referenced the $4.9 billion transfer and $11.6 billion cumulative total, warned that any future transfers could generate material non‑cash charges, and reaffirmed its strategy of pursuing further pension‑risk transfers to manage liability volatility【page_47】【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - $4.9 billion transferred in August 2021, $1.7 billion noncash settlement charge, $11.6 billion cumulative since 2018, and the $69 million annual PBGC premium reduction (implied through context). The dates (2022, 2023, 2024 filings; August 2021 transaction; December 2018 baseline) are all accurate. COMPLETENESS: The answer addresses all three sub-components of the multi-part question: (1) scale of obligations transferred ($4.9B in 2021, $11.6B cumulative), (2) financial impact ($1.7B noncash charge, PBGC premium reduction), and (3) stated strategy (ongoing evaluation, intent to pursue further transactions, acknowledgment of future material charges). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years (2022, 2023, 2024 filings) and traces the evolution of strategy from past transactions through ongoing evaluation to future intent. The progression is logically presented showing consistency and strategic continuity. ENTITY ACCURACY: Lockheed Martin correctly identified, group annuity contracts (GACs) properly named, pension obligations and PBGC premiums correctly characterized. MINOR OBSERVATIONS: The answer could have explicitly mentioned the $69 million annual PBGC premium reduction (stated in ground truth), though this is a minor omission that doesn't affect the core narrative. The phrase 'disclosed no new large-scale transfers' in 2023 is a reasonable inference from the ground truth statement about 'no new large-scale transfers' being mentioned. The answer maintains semantic equivalence with the ground truth while using slightly different phrasing (e.g., 'shrink its pension plans' vs. 'reduce pension liabilities'). Page citations are provided, adding credibility. Overall, this is a high-quality response that accurately captures the evolution of LMT's pension risk transfer strategy across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 540,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The fact that Apple’s 10‑K exhibits in 2022, 2023 and 2024 all include the Officer’s Certificate that lists “Floating Rate Notes due 2019” (see the exhibit tables in pages 56 and 58) shows that this series remains a reference point in its capital‑structure reporting. Apple therefore appears to maintain a portfolio of floating‑rate debt with staggered maturities and to roll‑over or refinance the 2019 notes as they approach maturity, reflecting a disciplined long‑term debt‑management strategy that preserves liquidity and aligns interest costs with market rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Apple's debt management strategy and correctly identifies the key pattern: Floating Rate Notes due 2019 appearing in 2022-2024 filings despite their 2019 maturity date. The answer appropriately synthesizes this multi-hop information to draw conclusions about refinancing and debt management discipline.\n\nSTRENGTHS:\n- Correctly identifies the three-year filing period (2022, 2023, 2024)\n- Accurately references the specific debt instrument (Floating Rate Notes due 2019)\n- Properly interprets the implication: rollover/refinancing strategy\n- Correctly identifies this as reflecting disciplined debt management\n- Mentions relevant concepts like liquidity preservation and interest rate alignment\n- Provides specific exhibit references (pages 56 and 58) showing detailed knowledge\n\nWEAKNESSES:\n- The LLM answer adds specific page references (56, 58) and mentions \"Officer's Certificate\" which, while potentially accurate, goes beyond what the ground truth explicitly states. This introduces minor risk of over-specification\n- The ground truth emphasizes \"transparency around historical debt instruments\" as a key insight, which the LLM answer doesn't explicitly highlight\n- The ground truth uses the phrase \"broader, ongoing debt structure\" which captures a nuance about the systematic nature of the strategy that the LLM answer addresses but less directly\n- The LLM answer's phrase \"staggered maturities\" is reasonable inference but not explicitly stated in ground truth\n\nMULTI-HOP REASONING:\nBoth answers correctly synthesize the multi-hop logic: (1) Notes mature in 2019, (2) Yet appear in 2022-2024 filings, (3) Therefore must have been rolled over/refinanced, (4) Indicating disciplined strategy. The LLM successfully connects these dots.\n\nNUMERIC/DATE ACCURACY:\nAll dates are correct (2019 maturity, 2022-2024 filings). No calculations required. No numeric errors detected.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys essentially the same core message as the ground truth, with slightly different emphasis and additional detail. The fundamental interpretation of Apple's debt management strategy is aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 587,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Across all three filings, Microsoft’s 4.000 % Notes due 2021 are listed unchanged in the “Third Supplemental Indenture” (Exhibit 4.6). In the 2022 10‑K, the 2023 10‑K, and the 2024 10‑K the same entry appears – “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” (see page 104 of each filing). The unchanged reference shows that Microsoft continues to disclose this issue in its debt documentation, indicating that the instrument remains a relevant, formally‑recorded component of its capital‑structure reporting even after its scheduled maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All numeric values are correct - the 4.000% interest rate, the 2021 maturity date, and the reference to Exhibit 4.6 are all accurate. (2) The answer correctly identifies the specific document location (page 104 of each filing) and the exact exhibit reference (Third Supplemental Indenture). (3) The multi-hop synthesis is sound - the answer traces the consistent reference across all three years (2022, 2023, 2024 10-Ks) and correctly notes the unchanged nature of the disclosure. (4) The reasoning about post-maturity relevance is logically sound and aligns with the ground truth explanation about ongoing legal/structural relevance. (5) The answer provides specific textual evidence from the filings, which strengthens credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific and detailed than the ground truth (mentioning the exact page number and the full indenture description), which is actually a strength rather than a weakness. (2) Both answers reach the same conclusion about the instrument's continued relevance despite maturity. (3) The LLM answer uses slightly different phrasing ('formally-recorded component of its capital-structure reporting') versus the ground truth's 'formal linkage' and 'transparency and continuity,' but these are semantically equivalent. The LLM answer is factually precise, properly synthesizes information across the three-year period, and correctly interprets what the consistent disclosure pattern reveals about the debt instrument's ongoing relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 436,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "Across the three filings UPS described the same instrument – a $276 million 7.620 % debenture maturing on April 1 2030 – with interest paid semi‑annually (April and October), no sinking‑fund requirement, and an optional redemption at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a Treasury yield + 5 bps. The 2022 filing noted that the coupon had been reduced from 8.375 % to 7.620 % in April 2020, while the 2023 and 2024 filings simply restated the same redemption and payment terms; the debentures’ carrying amount stayed near $280 million, representing roughly 1 % of UPS’s total debt, which grew from about $19.8 billion to $22‑23 billion over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key debenture characteristics: $276 million principal, 7.620% coupon, April 1, 2030 maturity, semi-annual interest payments (April and October), and the optional redemption formula (greater of principal + accrued interest or PV of remaining payments at Treasury yield + 5 bps). The historical context about the coupon reduction from 8.375% to 7.620% in April 2020 is accurately captured. The carrying amount of approximately $280 million is correct. The debt positioning context (roughly 1% of total debt, total debt growing from ~$19.8B to $22-23B) is reasonable and adds useful context. However, the LLM answer differs from the ground truth in its characterization of the evolution: the ground truth emphasizes a shift from 'historical interest rate context to more structural and comparative treatment' and notes positioning 'within a larger context of international debt instruments,' whereas the LLM answer states the 2023 and 2024 filings 'simply restated the same redemption and payment terms.' This represents a subtle but meaningful difference in how the evolution is characterized. The LLM answer is more focused on the consistency of terms rather than the shift in disclosure emphasis and comparative positioning noted in the ground truth. The answer is comprehensive and accurate on the mechanics but slightly underemphasizes the qualitative evolution in disclosure approach across the three years. No calculation errors are present, and all numeric values are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 431,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "From 2022 to 2024 Vraylar moved from a solid launch product to a broader, high‑growth asset. In 2022 it generated about $2.0 billion of net revenue (U.S. $2,037 M, total $2,038 M) 【page_41】; after the company secured FDA approval in 2023 to use Vraylar as an adjunctive therapy for major depressive disorder—building on earlier Phase 3 data disclosed in 2021 【page_60】—revenues jumped 35% to roughly $2.8 billion (total $2,759 M) and were highlighted as a key driver of neuroscience growth 【page_41】【page_44】. The 2024 filing still lists Vraylar among AbbVie’s core neuroscience products, indicating its continued strategic importance as a multi‑indication, revenue‑generating pillar that diversifies the portfolio beyond immunology and oncology 【page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and timeline. Strengths: (1) Correctly identifies 2022 revenue as ~$2.0 billion ($2,037M-$2,038M), matching ground truth; (2) Accurately states 2023 revenue as $2,759M with 35% YoY growth, matching ground truth exactly; (3) Properly synthesizes the FDA approval for MDD adjunctive indication in 2023; (4) Correctly identifies Vraylar's multi-indication status (schizophrenia, bipolar disorder, MDD adjunct); (5) Appropriately characterizes the trajectory from launch product to key revenue driver. Minor discrepancy: The LLM references Phase 3 data disclosed in 2021, while the ground truth specifically mentions 2022 Phase 3 trial announcements with one meeting primary endpoint and one showing numerical but not statistically significant improvement. The LLM's reference to 'earlier Phase 3 data disclosed in 2021' is not incorrect per se, but it doesn't capture the specific 2022 trial results mentioned in ground truth. The LLM also doesn't explicitly state that one 2022 trial met its primary endpoint while the other did not—this is a minor omission of clinical detail. The answer correctly conveys the strategic importance and evolution narrative, properly synthesizing development, commercialization, and financial performance across the 2022-2024 period. All dollar amounts are accurate, the growth percentage is correct, and the multi-hop reasoning connecting clinical development to commercial success is sound. The answer is well-structured and appropriately addresses all parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 439,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s exhibit tables in each Form 10‑K list a “0.45 % Notes due 2016” (see the Officer’s Certificate of the Registrant on page 56) for fiscal 2022, 2023 and 2024, showing that the company’s long‑term debt schedule still references this legacy, low‑interest note. The repeated disclosure reflects a deliberate strategy to retain all historical debt instruments in its filings, ensuring a complete and transparent picture of its long‑term financing even for instruments that are no longer active.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Apple's 10-K filings for fiscal 2022, 2023, and 2024 all include the 0.45% Notes due 2016, (2) the notes matured in 2016 but continued to be disclosed, and (3) this reflects a deliberate disclosure strategy for historical debt instruments. Quantitative accuracy is strong - all dates (2016 maturity, fiscal years 2022-2024) and the percentage (0.45%) are correct. The LLM appropriately references the Officer's Certificate and maintains semantic equivalence with the ground truth regarding Apple's transparency strategy. However, there are minor differences: (1) The LLM mentions 'page 56' which is a specific detail not in the ground truth and may or may not be accurate across all three years - this is a minor addition that doesn't contradict the ground truth but adds specificity that wasn't verified. (2) The LLM uses slightly different phrasing ('exhibit tables' vs 'Exhibit 4.3') - while semantically similar, the ground truth specifically identifies Exhibit 4.3 as the location, which is more precise. (3) The LLM's characterization of the strategy as 'deliberate' and focused on 'complete and transparent picture' aligns well with the ground truth's interpretation about 'transparency' and 'complete record,' though the ground truth adds the nuance about 'investor reference' and 'documenting capital structure history.' The multi-hop reasoning is sound - the LLM correctly synthesizes that the persistence of disclosure across three years indicates a consistent approach. The answer adequately addresses the question about long-term debt structure and disclosure strategy, though it could have been slightly more explicit about the distinction between active vs. legacy obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 475,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In 2022 (and likewise in the 2023 filing) UPS SurePost was presented as a residential‑ground service for non‑urgent, lightweight shipments that moved packages on UPS’s ground network and then handed the final “last‑mile” delivery to the United States Postal Service, positioning it as a low‑cost, USPS‑partnered option within the U.S. Domestic Package segment [page_5 (2022)]. By the 2024 filing the description still noted USPS handling final delivery through 2024, but added that UPS will insource SurePost on 1 January 2025 to gain greater control over service quality—signaling a shift from a partner‑based delivery model to an in‑house UPS residential‑delivery capability [page_5 (2024)].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct—2022, 2023, 2024 filings are properly referenced, and the critical date of January 1, 2025 for the insourcing transition is accurately stated. No numerical errors or calculation issues present. ENTITY ACCURACY: UPS SurePost is correctly identified throughout, U.S. Domestic Package business segment is properly referenced, and USPS partnership is accurately characterized. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three years (2022-2024) and correctly identifies the evolution: (1) 2022-2023 continuity as USPS-partnered residential ground service for non-urgent, lightweight shipments, (2) 2024 announcement of strategic shift to insourcing effective January 1, 2025. The reasoning chain is logical and complete. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing than ground truth (e.g., 'last-mile delivery' vs 'final delivery,' 'partner-based delivery model' vs 'reliance on USPS') but conveys identical meaning. The characterization of the shift as enhancing 'service quality' and 'reliability and service differentiation' are semantically equivalent. COMPLETENESS: The answer addresses all aspects of the question—role evolution, operational structure changes, delivery methodology transformation, and strategic positioning within U.S. Domestic Package business. The inclusion of page references adds credibility. MINOR OBSERVATION: The LLM answer is slightly more detailed in explaining the rationale (gaining 'greater control over service quality') which enhances clarity without introducing inaccuracy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 474,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s Form 10‑K filings for 2022, 2023 and 2024 all list the 4.45 % Notes due 2044 among its outstanding securities — the 2024 filing shows the officer’s certificate that includes “4.45 % Notes due 2044” 【page_56】. The notes were originally issued in 2014 and have been retained on Apple’s balance sheet across multiple years, indicating a deliberate long‑term capital strategy that relies on very‑long‑dated, low‑coupon debt to lock in cheap financing and diversify its capital structure over decades.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 across 2022, 2023, and 2024 filings; (2) Accurately states the original issuance date of 2014; (3) Correctly notes the notes were retained on the balance sheet without early redemption; (4) Provides sound multi-hop synthesis showing the pattern across three years; (5) Quantitative accuracy is high - all dates and percentages are correct. MINOR WEAKNESSES: (1) The LLM adds interpretive language about 'cheap financing' and 'low-coupon debt' that goes slightly beyond what the ground truth explicitly states - while reasonable inference, the ground truth is more cautious, mentioning 'possibly to manage interest rate risk' rather than definitively stating it was for cheap financing; (2) The phrase 'very-long-dated, low-coupon debt' characterizes the 4.45% rate as 'low-coupon' which is somewhat subjective and not explicitly confirmed in the ground truth; (3) The ground truth emphasizes 'sustained reliance' and 'consistent presence' more carefully, while the LLM uses 'deliberate long-term capital strategy' which is slightly more assertive. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and identifies the pattern of consistent inclusion. The reasoning about capital structure strategy is sound and logically follows from the facts presented. SEMANTIC EQUIVALENCE: The core message aligns well - Apple maintained this debt instrument across multiple years as part of its long-term capital strategy. The LLM's interpretation about managing capital structure and financing is reasonable, though slightly more definitive than the ground truth's more measured language about 'possibly' managing interest rate risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 491,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "In the 2022 10‑K the 2.875 % Notes due 2031 are disclosed in Exhibit 4.14 – the “Forms of … Notes” exhibit【page_113】. The same note is listed under Exhibit 4.14 in the 2023 filing【page_111】 and again in the 2024 filing【page_111】. By keeping the 2.875 % series in the same exhibit each year, Oracle shows that the tranche remains an active, distinct senior‑unsecured debt instrument, underscoring a disciplined, long‑dated debt program and a consistent, transparent approach to managing its capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 2.875% Notes due 2031 as Exhibit 4.14 across all three years (2022, 2023, 2024); (2) Accurately notes the consistent positioning without modifications; (3) Properly characterizes the notes as senior-unsecured debt; (4) Provides appropriate page references for verification; (5) Correctly synthesizes the multi-hop information across three filing years. QUANTITATIVE ACCURACY: All numeric values are correct - the 2.875% rate, the 2031 maturity date, and the consistent Exhibit 4.14 designation across all three years. Page numbers provided (113 for 2022, 111 for 2023 and 2024) appear reasonable for exhibit sections. MINOR GAPS: (1) The LLM answer does not mention the Officers' Certificate issued on March 24, 2021, which the ground truth identifies as the original establishment date - this is a contextual detail that adds depth to understanding the debt instrument's history; (2) The ground truth explicitly notes 'no modifications to the terms of the Notes indicated in any of the filings,' while the LLM implies this through consistent positioning but doesn't state it as explicitly. REASONING QUALITY: The LLM correctly interprets what consistent exhibit positioning reveals about Oracle's capital structure management - stability, discipline, and transparency. The characterization of the notes as an 'active, distinct senior-unsecured debt instrument' is accurate and adds appropriate context. The conclusion about a 'consistent, transparent approach' aligns well with the ground truth's assessment of 'stable approach to capital structure management.' SEMANTIC EQUIVALENCE: The LLM's interpretation that consistent exhibit positioning indicates 'a disciplined, long-dated debt program' is semantically equivalent to the ground truth's statement about 'consistent long-term debt strategy' and 'prioritizing stability.' The answer successfully conveys the same fundamental insight about Oracle's debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 555,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement added wage‑ and benefit‑rate increases that were incorporated into the year‑end measurement of the UPS/IBT Full‑Time Employee Pension Plan, raising that plan’s service‑cost accruals for 2023【page_82】. The 2024 filing shows UPS still carries a sizable, long‑term pension liability – a one‑basis‑point change in the discount rate alters the projected benefit obligation by roughly $57 million and the plan assumes a 7.17 % expected return on assets – underscoring that the pension obligations remain material and sensitive to actuarial assumptions【page_88】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about the 2023 Teamsters agreement's impact on pension obligations. STRENGTHS: (1) Correctly identifies the 2023 Teamsters master agreement and its incorporation of wage and benefit-rate increases into the UPS/IBT Full-Time Employee Pension Plan's year-end measurement; (2) Accurately cites the 7.17% expected return on assets assumption; (3) Provides specific quantitative detail about pension sensitivity ($57 million per basis point change in discount rate), demonstrating understanding of actuarial assumptions; (4) Properly synthesizes multi-hop information connecting the 2023 agreement to 2024 disclosures and long-term pension obligations; (5) Correctly identifies the plan as noncontributory and references the Central States Pension Fund context implicitly. MINOR WEAKNESSES: (1) Does not explicitly mention that 2024 disclosures showed 'no structural changes' to the plan, which the ground truth emphasizes as revealing about the agreement's status as 'the most recent material update'; (2) Could have been more explicit about the 'five-year agreement' timeframe mentioned in ground truth; (3) The answer focuses heavily on sensitivity metrics and actuarial assumptions but could have more directly addressed what the 2024 disclosures 'reveal' about long-term obligations beyond materiality and sensitivity. QUANTITATIVE VERIFICATION: The 7.17% expected return figure and $57 million basis-point sensitivity are specific and appear accurate based on typical pension disclosure patterns. The answer correctly avoids inventing numbers and grounds claims in filing references. MULTI-HOP REASONING: Successfully connects 2023 agreement → impact on accruals → 2024 disclosure implications, though the connection could be slightly more explicit about what 'no structural changes' means for understanding obligations. Overall, this is a solid answer that captures the essential facts and reasoning with only minor gaps in completeness relative to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 556,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings have not changed the way they describe the 1.05 % Notes due 2017. In the 2022 Form 10‑K the notes to the financial statements list Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 – which includes the “1.05 % Notes due 2017”【page_56】. The 2023 Form 10‑K repeats the same Exhibit 4.4 language (the exhibit list for that year contains the identical description)【page_56】, and the 2024 Form 10‑K again contains the unchanged reference to the 1.05 % Notes due 2017 in Exhibit 4.4【page_56】. This consistency shows Apple relies on the 2014 Officer’s Certificate to document and manage this short‑term debt, indicating a stable, disciplined approach to handling those notes across years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and alignment with the ground truth. STRENGTHS: (1) All numeric values are correct - the 1.05% interest rate, the 2017 maturity date, and the May 6, 2014 Officer's Certificate date are all accurately stated. (2) The multi-hop synthesis is sound - the answer correctly traces the disclosure across three fiscal years (2022, 2023, 2024) and identifies the consistent reference to Exhibit 4.4. (3) Entity identification is precise - Apple is correctly identified, the specific debt instrument is properly named, and the Officer's Certificate is accurately dated. (4) The reasoning about consistency and its implications is logically sound and matches the ground truth's interpretation that unchanged disclosure indicates passive management and stability. (5) The answer appropriately addresses all parts of the question: how disclosure evolved (remained unchanged), what this reveals (stable, disciplined approach), and the connection to the 2014 Officer's Certificate. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'relies on' vs 'prioritized stability,' 'stable, disciplined approach' vs 'passive management approach'), but these are semantically equivalent and represent valid interpretations of the same underlying facts. The inclusion of page references (page_56) adds helpful specificity. The answer is comprehensive, accurate, and demonstrates proper understanding of the multi-hop nature of the question by synthesizing information across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 430,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 2.40 % notes due 2023 are listed in the same exhibit (Exhibit 4.3 – Officer’s Certificate of the Registrant) in each of its Form 10‑K filings: the 2022 filing shows the note in the exhibit table [page 56]​, the 2023 filing repeats the same entry [page 56]​, and the 2024 filing again includes the unchanged description [page 56]​. The unchanged, year‑over‑year disclosure indicates that Apple keeps the note on its balance sheet until maturity and reports it consistently, reflecting a long‑term debt strategy that relies on fixed‑rate notes with staggered maturities and a “hold‑to‑maturity” approach rather than frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the multi-hop synthesis required. STRENGTHS: (1) Correctly identifies the 2.40% Notes due 2023 as the subject instrument; (2) Accurately notes the consistent disclosure across 2022, 2023, and 2024 10-K filings; (3) Correctly identifies Exhibit 4.3 (Officer's Certificate) as the location; (4) Properly cites page 56 for all three years; (5) Accurately characterizes the pattern as 'unchanged, year-over-year disclosure'; (6) Correctly interprets the multi-year pattern as indicating a 'hold-to-maturity' approach with no early repayments or modifications; (7) Appropriately concludes this reflects a stable long-term debt strategy. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer adds interpretive detail about 'staggered maturities' and 'fixed-rate notes' which, while reasonable inferences, are not explicitly stated in the ground truth; (2) The LLM characterizes the strategy as avoiding 'frequent refinancing' which is a reasonable inference but slightly beyond what the ground truth explicitly states; (3) The ground truth specifically mentions the Officer's Certificate was 'dated May 3, 2013' - the LLM does not include this specific date detail, though this is a minor omission. QUANTITATIVE VERIFICATION: All numbers and percentages (2.40%, 2023 maturity date, page numbers, years 2022-2024) are accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and properly draws conclusions about debt management strategy from the pattern of consistent disclosure. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly more interpretive elaboration on the implications of the static disclosure pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 501,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 to 2023 Vraylar’s commercial momentum accelerated, with net revenues rising from $2.0 billion in 2022 (U.S. $2.037 bn, International $1 m) to $2.76 billion in 2023 – a 35% year‑over‑year increase driven by market‑share gains and the FDA’s approval of Vraylar as an adjunctive therapy for major depressive disorder in adults after positive Phase‑3 results reported in 2021【page_62】【page_42】【page_44】【page_40】. In the 2024 filing Vraylar remains highlighted as a core neuroscience asset, positioned alongside Botox Therapeutic and other agents for schizophrenia, bipolar disorder and adjunctive MDD, underscoring its continued strategic role within AbbVie’s neuroscience portfolio【page_6】【page_4】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key financial metrics and growth trajectory. The 2023 revenue figure of $2.76 billion matches ground truth ($2,759 million with rounding). The 35% YoY growth calculation is accurate. The U.S. sales figure of $2.037 billion for 2022 is correct. The therapeutic indications mentioned (schizophrenia, bipolar disorder, adjunctive MDD) align with ground truth. The answer appropriately synthesizes information across multiple years and documents.\n\nWEAKNESSES: (1) The LLM states 'U.S. $2.037 bn, International $1 m' for 2022, which appears to be a significant error or typo - the international component should be substantially higher (approximately $0.963 billion based on $2.0 billion total minus $2.037 billion U.S., though this creates a logical inconsistency). The ground truth shows total 2022 sales around $2.0 billion with U.S. at $2.037 billion, which itself is mathematically problematic. (2) The LLM references 'positive Phase-3 results reported in 2021' for MDD approval, but ground truth indicates 2022 had 'one successful Phase 3 trial and a numerically positive but non-significant result in another' - the timing and characterization differ slightly. (3) Missing explicit mention of 2024 revenue figures, though the answer does address 2024 positioning. (4) The answer could have been more explicit about the 'broadening of therapeutic applications' aspect mentioned in ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024, connecting clinical development (Phase 3 trials, FDA approval) to revenue growth to strategic positioning. The logic flow is sound and demonstrates proper synthesis of multi-year data.\n\nNUMERIC VERIFICATION: 2023 revenue $2.76B ✓, 2022 U.S. sales $2.037B ✓, 35% growth ✓. The international sales notation appears problematic but may reflect data extraction issues rather than fundamental misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 524,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "- In IBM’s 2022 Form 10‑K the company already listed **“client relationships and trust”** as one of its principal competitive methods, treating it as a core differentiator alongside technology, brand and price (IBM 10‑K 2022, pp. 2‑6).  \n- By the 2024 filing the same language re‑appears, but the narrative now explicitly ties those trusted relationships to IBM’s **hybrid‑cloud and AI platforms**, stressing that they enable the firm to deliver business value and win‑win outcomes for customers (IBM 10‑K 2024, p. 4).  \n\n**Interpretation:** Over the three‑year span IBM has moved from merely naming client relationships and trust as a competitive factor to positioning them as a strategic lever that underpins its hybrid‑cloud and AI strategy, signaling that IBM is banking on trusted client ties to differentiate and grow its market share in the fast‑evolving hybrid‑cloud/AI space.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM emphasized client relationships and trust as a competitive differentiator in both 2022 and 2024, and accurately notes the evolution toward explicitly linking these to hybrid cloud and AI platforms. However, there are significant gaps in completeness and multi-hop synthesis. STRENGTHS: (1) Correctly identifies 2022 and 2024 as key years with appropriate document citations; (2) Accurately captures the core evolution from naming trust as a factor to positioning it as a strategic lever; (3) Correctly identifies hybrid cloud and AI as the strategic context; (4) The interpretation about moving from 'naming' to 'positioning' is semantically sound. WEAKNESSES: (1) The answer completely omits the 2023 data point, which is explicitly mentioned in the ground truth as showing an important intermediate evolution linking trust to strategic partnerships; (2) Missing the 2023 expansion showing how IBM leverages alliances to deliver end-to-end solutions - this is a critical part of the 'multi-year progression' requested; (3) The answer only addresses 2022 and 2024, failing to provide the full three-year narrative arc that the question and ground truth emphasize; (4) Does not capture the evolution of trust as 'foundational element in go-to-market strategy' or the 'ecosystem of partners' framing that appears in 2024; (5) The interpretation, while directionally correct, is less nuanced than the ground truth's explanation of trust as 'enabler of integrated, client-centric innovation.' MULTI-HOP REASONING: The answer demonstrates partial multi-hop synthesis by connecting trust to hybrid cloud/AI strategy, but fails to synthesize the complete three-year progression across all three years of data. The question explicitly asks about evolution 'from 2022 to 2024' with emphasis on 'multi-year progression,' which requires addressing the intermediate 2023 positioning. ENTITY ACCURACY: All entities (IBM, years, competitive factors) are correctly identified. CALCULATION/NUMBERS: No quantitative data is presented in either answer, so this dimension is not applicable. The omission of 2023 is the primary factual gap that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 587,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 1.250 % Notes due 2027 were not called out as a separate instrument in the exhibit schedule, so the filing gave only a generic view of the company’s debt. The 2023 filing began to disclose the notes explicitly, incorporating the instrument that defines the holders’ rights (Exhibit 4.3 to Form 8‑K) by reference, thereby providing a more detailed description of that security. By the 2024 Form 10‑K the notes are listed in the Section 12(b) securities table as “1.250 % Notes due 2027” (ticker IBM27B), making them a clearly identified line‑item in IBM’s debt portfolio and reflecting a shift to full, stand‑alone disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims the 1.250% Notes were 'not called out as a separate instrument in the exhibit schedule' in 2022, directly contradicting the ground truth which states they were 'referenced in its exhibit list' in 2022. (2) MAJOR ERROR - The LLM states '2023 filing began to disclose the notes explicitly,' but the ground truth indicates they were already referenced in 2022, with 2023 showing continued reference in a growing list. (3) PARTIAL ACCURACY - The 2024 disclosure with ticker IBM27B and Section 12(b) listing is correctly identified, matching the ground truth's statement about 'explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B).' (4) REASONING FLAW - The LLM's narrative of progression from 'generic view' (2022) to 'explicit disclosure' (2023) to 'stand-alone disclosure' (2024) mischaracterizes the actual evolution. The ground truth shows the notes were referenced from 2022 onward, with increasing complexity and formalization, not a shift from non-disclosure to disclosure. (5) ENTITY ACCURACY - All years, percentages, and ticker symbols are correct, but the characterization of what happened in each year is fundamentally wrong. The LLM essentially inverts the timeline of disclosure practices. The answer demonstrates poor multi-hop synthesis and contradicts the ground truth's core narrative about the evolution of IBM's treatment of these notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 418,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "Across IBM’s 2022, 2023 and 2024 Form 10‑K filings the 6.50 % Debentures due 2028 are disclosed in the same way: Item 15 lists “the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is Exhibit 2 to Form 8‑K, filed January 8 1998, and is hereby incorporated by reference.” This reference never changes, and it sits within IBM’s broader debt‑instrument schedule that enumerates each series of notes and debentures with its own exhibit number, adding newer issues over time while keeping the 6.50 % Debentures due 2028 consistently referenced.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements of the question. All numeric values are correct: the 6.50% interest rate, the 2028 maturity date, the January 8, 1998 Form 8-K filing date, and Exhibit 2 reference are all accurate and consistent with the ground truth. The LLM correctly identifies that the exhibit reference remained unchanged across all three years (2022, 2023, 2024), which is the primary factual claim in the original answer.\n\nStrengths: (1) The LLM accurately captures the consistency of the exhibit reference across all three years; (2) It correctly identifies the specific location (Item 15) and exact wording of the disclosure; (3) It properly notes that newer debt instruments were added over time while the 6.50% Debentures remained consistently referenced; (4) The quantitative details (dates, percentages, exhibit numbers) are all correct.\n\nWeaknesses: (1) The LLM answer is more narrowly focused on the mechanical consistency of the exhibit reference and less developed on the broader contextual evolution of IBM's debt disclosures. The original answer explicitly discusses how the context evolved from 2022 to 2024, mentioning the integration of legacy debt alongside newer instruments like the 6.22% Debentures due 2027 and 5.875% Debentures due 2032. The LLM mentions newer issues were added but doesn't provide the specific examples or discuss the strategic context of debt management; (2) The original answer provides more nuanced analysis about what the consistency implies (regulatory compliance, investor clarity), whereas the LLM is more descriptive than analytical; (3) The LLM doesn't fully address the 'broader context' aspect of the question as thoroughly as the ground truth.\n\nThe answer is fundamentally correct on all factual matters and addresses the core question about consistency of exhibit references. However, it provides less comprehensive coverage of the broader evolution of IBM's debt disclosures that the original answer emphasizes. This is a solid answer that captures the essential facts but lacks some of the contextual depth and analytical framework of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 579,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In 2022 FedEx International Connect Plus was offered from “nearly 50 origin countries to over 130 destination countries”【page_14】. By 2024 that footprint had grown to “nearly 60 origin countries to over 190 destination countries”【page_8】. The steady addition of origin and destination markets signals FedEx’s strategic push to broaden its cross‑border e‑commerce logistics network, positioning Connect Plus as a key growth engine for capturing expanding global e‑commerce demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 baseline (nearly 50 origin countries to over 130 destination countries) and the 2024 endpoint (nearly 60 origin countries to over 190 destination countries). The strategic interpretation about FedEx's e-commerce focus is reasonable and aligns with the ground truth's characterization of the service as 'e-commerce-focused.' The answer appropriately synthesizes the geographic expansion data across the time period.\n\nWEAKNESSES: The LLM answer is incomplete in a critical way - it omits the 2023 data point entirely. The ground truth explicitly states that by 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries, which is a crucial intermediate data point that shows the trajectory of expansion. This omission is significant because it prevents the answer from fully addressing the 'evolution' aspect of the question and misses the important insight that the expansion occurred primarily between 2022-2023, with stabilization in 2024. The ground truth explicitly notes this stabilization pattern ('maintained its reach at nearly 60 origin countries and over 190 destination countries'), which provides important context about the expansion trajectory that the LLM answer lacks. The LLM's characterization of 'steady addition' is somewhat misleading since the data shows rapid expansion followed by stabilization, not continuous steady growth through 2024.\n\nQUANTITATIVE ACCURACY: All numbers cited are correct (50→60 origin countries, 130→190 destination countries), but the omission of the 2023 intermediate data point represents incomplete quantitative reporting of the evolution requested.\n\nQUALITATIVE ACCURACY: The reasoning about strategic focus is sound, but the analysis is incomplete. The ground truth's insight about 'completion of a major phase of international deployment' followed by 'stabilization as the service reached a mature coverage level' is more nuanced than the LLM's simpler 'steady addition' characterization.\n\nCONTEXTUAL RELEVANCE: The answer addresses the strategic focus question appropriately but fails to fully capture the evolution trajectory by omitting the 2023 milestone and the stabilization pattern in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 599,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals – increase women in leadership by 15 %, increase under‑represented minorities in leadership by 15 % (including Black, Hispanic/Latinx, Native Hawaiian/Pacific Islander, American Indian/Native American and, for non‑technical roles, Asian), and raise overall URM representation by 20 % – were disclosed in the FY 2022 filing and were reiterated unchanged in the FY 2023 and FY 2024 reports (2022 p. 17; 2023 p. 16; 2024 p. 17). In each year the HR and Compensation Committee tied progress on those diversity targets to executive bonuses through a non‑financial performance modifier that could adjust the bonus payout by a multiple of 0.9 to 1.1 × the target amount (2022 p. 17; 2023 p. 16; 2024 p. 16).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all quantitative data correct: the three diversity targets (15% women in leadership, 15% URM in leadership, 20% overall URM representation) are accurately stated, the bonus modifier range (0.9 to 1.1×) is correct, and the fiscal year progression (2022-2024) with unchanged targets is properly documented. The answer includes helpful page citations and provides specific detail about URM category definitions (Black, Hispanic/Latinx, Native Hawaiian/Pacific Islander, American Indian/Native American, and Asian for non-technical roles), which adds precision beyond the ground truth. The multi-hop synthesis is sound: the answer correctly traces the evolution (or lack thereof) of diversity goals across three fiscal years and properly links these goals to the executive compensation mechanism through the non-financial performance modifier. However, the LLM answer is somewhat narrower in scope than the ground truth: it does not mention the Reboot Representation Tech Coalition or the external partnership initiatives aimed at doubling degrees for underrepresented groups by 2025. The ground truth emphasizes 'expanding external partnerships' and 'increased emphasis on initiatives,' suggesting a qualitative evolution beyond just maintaining targets. The LLM answer focuses primarily on the quantitative targets and compensation linkage mechanism, missing the contextual narrative about strategic expansion through external partnerships. This represents a minor omission of contextual detail rather than a factual error. The answer correctly characterizes the framework as 'stable' in terms of targets while maintaining 'sustained incentive alignment,' which aligns with the ground truth's characterization of a 'stable strategic framework with sustained incentive alignment.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 497,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the “Floating Rate Notes due 2019” among its outstanding securities (see Exhibit 4.4 in the 2022 filing [page 58] and the 2024 filing [pages 54‑56])​【page_58†L13-L17】【page_54†L13-L17】. By keeping this floating‑rate debt on its balance sheet, Apple retains a liability whose interest resets with short‑term market rates, allowing it to match financing costs to prevailing rates, limit exposure to rising rates and preserve cash‑flow flexibility for liquidity needs. This consistent disclosure signals a deliberate strategy to manage short‑term interest‑rate risk and support ongoing liquidity planning.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy in addressing the core question about Apple's floating rate notes management strategy. STRENGTHS: (1) Correctly identifies that Floating Rate Notes due 2019 appear consistently across 2022, 2023, and 2024 filings, matching the ground truth assertion; (2) Accurately explains the mechanics of floating rate debt and its role in interest rate risk management; (3) Provides specific exhibit references (Exhibit 4.4) with page numbers, adding credibility; (4) Correctly synthesizes the multi-hop reasoning that consistent disclosure signals deliberate strategy; (5) Accurately characterizes the approach as managing short-term interest rate risk and supporting liquidity planning. WEAKNESSES: (1) The LLM answer is somewhat more mechanistic in explaining the financial mechanics (\"interest resets with short-term market rates\") compared to the ground truth's broader strategic framing about \"flexible debt instruments\" and \"adaptive stance\"; (2) The phrase \"limit exposure to rising rates\" could be slightly misleading - floating rate notes actually increase exposure to rising rates, though they do provide flexibility; this is a minor semantic issue but worth noting; (3) The ground truth emphasizes that Apple \"maintained exposure to variable interest rates\" and didn't need to issue new instruments, which the LLM answer touches on but doesn't emphasize as clearly; (4) Missing the nuance that the consistency \"without needing to issue new short-term floating rate instruments\" suggests a deliberate choice to maintain existing instruments rather than refinance. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy is based on date/year accuracy (2022, 2023, 2024 - all correct) and exhibit references (Exhibit 4.4 cited correctly). MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and connects the recurring disclosure to strategic intent, though with slightly less depth than the ground truth's emphasis on the deliberate nature of maintaining these specific instruments across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 582,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm positioned the digital‑cockpit as a cornerstone of its automotive push, forecasting that >70 % of new cars would have embedded cellular (with ≈60 % 5G) by 2028 and that ≈19 % of 2025‑model vehicles would feature Level‑2‑plus autonomy—fueling demand for its connectivity, OTA‑update and low‑power computing platforms. By the 2024 filing that vision had turned into revenue growth: the QCT automotive stream (which now explicitly includes connectivity, digital‑cockpit and ADAS/AD) rose from $1.5 billion in 2022 to $2.9 billion in 2024, showing Qualcomm’s shift from projected market demand to a larger, revenue‑driven automotive business segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (2022 positioning → 2023 revenue generation → 2024 integration) and correctly identifies key entities (Qualcomm, QCT segment, digital cockpit, ADAS/AD). However, there are significant quantitative accuracy issues:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM states \">70% of new cars would have embedded cellular (with ≈60% 5G)\" but the ground truth specifies \"over 60% of new vehicles would feature 5G connectivity by 2028.\" The LLM's >70% figure for embedded cellular is not mentioned in the ground truth and appears to be an unsupported addition.\n   - The LLM introduces a specific statistic about \"≈19% of 2025-model vehicles would feature Level-2-plus autonomy\" which is not present in the ground truth at all. This is a factual addition not supported by the original answer.\n   - The LLM provides specific revenue figures ($1.5B in 2022 and $2.9B in 2024) that are not mentioned in the ground truth. While these may be accurate from actual filings, they cannot be verified against the provided ground truth and represent unsupported quantitative claims.\n\n2. COMPLETENESS:\n   - The LLM answer does address the evolution from 2022 to 2024 and discusses automotive business segmentation.\n   - However, it omits the explicit mention of 2023 as a transitional year where \"concrete revenues from digital cockpit products\" were reported, which is a key part of the three-stage evolution described in the ground truth.\n\n3. ENTITY ACCURACY:\n   - All company names and metrics are correctly identified (Qualcomm, QCT, digital cockpit, ADAS/AD, connectivity, OTA updates).\n   - Years are correctly referenced (2022, 2024, with implicit 2023).\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is sound: the answer correctly traces the evolution from market positioning to revenue generation to strategic integration.\n   - The logic connecting digital cockpit positioning to revenue growth is appropriate.\n   - However, the introduction of unsupported statistics weakens the reasoning chain.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative matches the ground truth's three-stage evolution.\n   - The characterization of the shift from \"projected market demand to revenue-driven business\" aligns with the ground truth's trajectory.\n   - However, the specific quantitative claims diverge significantly.\n\nThe primary issue is that the LLM appears to have added specific numbers and statistics (>70% embedded cellular, 19% Level-2-plus autonomy, $1.5B/$2.9B revenues) that are not present in the ground truth. While these may come from actual SEC filings, they cannot be verified against the provided ground truth and represent factual claims that exceed what can be confirmed. This creates a significant quantitative accuracy problem despite the qualitatively sound narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 760,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (private) funds fell each year – $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024 (ABT 10‑K 2022‑2024, Note 13/14 – see page 71 for 2022 and page 70 for 2023‑2024). The gradual reduction in outstanding pledges, while still keeping a substantial balance, suggests the company is maintaining a long‑term, disciplined exposure to illiquid alternative assets but is actively managing and modestly scaling back its commitments to preserve liquidity and control risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the three-year progression ($569M → $555M → $540M) matches ground truth exactly with proper date attribution (12/31/2022, 12/31/2023, 12/31/2024). (2) The $15 million annual decline pattern is accurately captured. (3) Citation references to 10-K filings and specific note locations (Note 13/14, pages 70-71) demonstrate proper source documentation. (4) The core narrative about gradual reduction and disciplined exposure is semantically equivalent to the ground truth. (5) Multi-hop synthesis is sound - correctly connects the numerical trend to strategic implications. MINOR WEAKNESSES: (1) The LLM answer omits the specific liquidation period timeframe (2025-2034) mentioned in the ground truth, which provides important context about the long-term nature of these commitments. (2) The phrase 'de-risking or rebalancing away from illiquid alternative assets' in the ground truth is more explicitly strategic than the LLM's 'modestly scaling back its commitments to preserve liquidity and control risk' - though semantically similar, the ground truth's framing is slightly more direct about the strategic shift. (3) The LLM doesn't explicitly state that Abbott is 'not exiting the space entirely' which is an important nuance about maintaining exposure while reducing commitments. CALCULATION VERIFICATION: The year-over-year declines ($569M to $555M = -$14M, $555M to $540M = -$15M) are correctly represented as consistent reductions. The characterization of 'each year' decline is accurate. ENTITY ACCURACY: Abbott (ABT) correctly identified, proper fiscal year references, correct metric (unfunded commitments to private real estate funds). REASONING: The multi-hop reasoning connecting numerical trends to strategic implications is sound and logical, though slightly less comprehensive than the ground truth in articulating the full strategic picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 515,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s Form 10‑K for FY 2022 still listed the 0.45 % Notes due 2016 in Exhibit 4.3 (see page 58) as part of its long‑term debt, and the FY 2023 filing repeated the same disclosure in Exhibit 4.3 (page 56). By FY 2024 the same exhibit (page 56) merely references the historic series, indicating the notes had matured in 2016 and were no longer outstanding, which reflects Apple’s practice of issuing low‑cost, short‑term notes and letting them run to maturity while refinancing with newer, longer‑dated securities to keep its debt profile low‑interest and well‑staggered.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that the 0.45% Notes due 2016 were 'first disclosed' in the 2022 10-K and 'the same disclosure was repeated in both the 2023 and 2024 10-K filings,' indicating the notes were still part of Apple's disclosed debt structure across all three years. However, the LLM answer claims that 'by FY 2024 the same exhibit merely references the historic series, indicating the notes had matured in 2016 and were no longer outstanding.' This is factually incorrect - the ground truth confirms the notes were still being disclosed in 2024, not merely referenced as historical. The LLM also incorrectly interprets the pattern as evidence that the notes 'had matured in 2016 and were no longer outstanding,' which contradicts the ground truth's finding that they were maintained as part of the capital structure. The LLM's reasoning about Apple's debt strategy (issuing low-cost short-term notes and refinancing with longer-dated securities) may be conceptually sound, but it is built on a false premise about when these specific notes matured and ceased to be outstanding. The page references provided (58, 56, 56) cannot be verified against the ground truth but the substantive claim about the notes' status is demonstrably wrong. The answer fails to correctly synthesize the multi-hop information across the three fiscal years as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 404,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the company listed “client relationships and trust” among many competitive factors and explicitly tied trust to its technology stack – “trust and security” were highlighted as part of its flexible, secure hybrid‑cloud platform 【page_4】. By the 2023 filing the same phrase appears as a headline competitive pillar (“client relationships and trust”) alongside innovation, brand and talent 【page_3】, and the 2024 filing repeats this positioning, treating trust as a distinct differentiator rather than merely a technical attribute 【page_3】. This evolution shows IBM moving from embedding trust within its hybrid‑cloud/AI offering to foregrounding it as a core strategic asset, reinforcing that strong client relationships and confidence are now central to its growth strategy in the hybrid‑cloud and AI markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of years (2022, 2023, 2024) and accurate characterization of IBM's positioning of 'client relationships and trust' as a competitive differentiator across the three-year period. The answer correctly identifies that trust evolved from being embedded within the hybrid cloud/AI technology stack (2022) to being foregrounded as a distinct strategic asset (2023-2024). The page references provided (page_4 for 2022, page_3 for 2023 and 2024) appear reasonable for 10-K filings.\n\nStrengths: (1) Correctly traces the evolution of trust positioning across all three years; (2) Accurately captures the shift from trust as a technical attribute to trust as a standalone differentiator; (3) Properly synthesizes the multi-hop information showing progression; (4) Correctly identifies the connection to hybrid cloud and AI markets; (5) No numerical errors or date inaccuracies.\n\nWeaknesses: (1) The LLM answer emphasizes the shift from 'embedding trust within hybrid-cloud/AI' to 'foregrounding it as a core strategic asset,' which is a valid interpretation but differs slightly from the ground truth's emphasis on 'ecosystem collaboration and innovation leadership' becoming more prominent in 2024; (2) The ground truth specifically mentions that by 2023 IBM 'began to more explicitly link trust with its consulting services and mission-critical infrastructure,' which the LLM answer does not explicitly capture; (3) The ground truth highlights 'strategic partnerships' as enablers of trust in 2024, which the LLM answer does not mention; (4) The LLM answer's characterization of the evolution is somewhat narrower than the ground truth's fuller picture of how trust became integrated with ecosystem collaboration.\n\nThe answer is substantially correct in its core thesis and multi-hop reasoning, but omits some nuanced details about consulting services, mission-critical infrastructure, and strategic partnerships that the ground truth emphasizes. The semantic meaning is largely aligned, though the LLM provides a slightly simplified version of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 575,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 4.250 % Note due 2030 has been backed by a pass‑through trust and a revolving‑credit facility with BNP Paribas (the “Liquidity Provider Revolving Credit Agreement”) that was first put in place on August 13 2020 (see the Intercreditor Agreement 4.42 and the Revolving Credit Agreement 4.43 in the 2022 filing) 【page_123†L1-L5】.  In May 2023 the company amended that facility (Amendment No. 1 dated May 22 2023) and the same amended structure continues to be disclosed in the 2024 filing 【page_124†L1-L5】.  This evolution shows FedEx’s proactive, ongoing management of credit support—creating a dedicated liquidity source for the note and then updating the agreement as needed to ensure the obligation remains fully funded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about FedEx's liquidity arrangements evolution. QUANTITATIVE ACCURACY (10/10): All dates are correct - August 13, 2020 for the initial Revolving Credit Agreement, May 22, 2023 for Amendment No. 1. The note percentage (4.250%) is accurate. No calculations are required for this question. ENTITY ACCURACY: Correctly identifies FedEx, the 4.250% Note due 2030, Wilmington Trust Company (implied through pass-through trust reference), BNP Paribas as Liquidity Provider, and the specific agreement names (Intercreditor Agreement, Revolving Credit Agreement). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years (2022, 2023, 2024) showing the evolution: (1) foundational agreements established in 2022, (2) Amendment No. 1 filed May 22, 2023, (3) amended structure continuing in 2024. This matches the ground truth's narrative arc perfectly. REASONING QUALITY: The LLM correctly interprets the evolution as indicating 'proactive, ongoing management' and 'dedicated liquidity source,' which aligns with the ground truth's characterization of 'proactive adjustment' and 'consistent credit support framework.' MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth mentions 'Wilmington Trust Company' explicitly while the LLM references it indirectly through 'pass-through trust,' which is semantically equivalent. The LLM's conclusion about 'ensuring the obligation remains fully funded' is a reasonable inference from the data and adds helpful context. COMPLETENESS: The answer addresses the core question about the evolution and what it indicates about FedEx's approach, providing specific evidence (dates, amendments) to support the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 503,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s debt filings show that the 4.45 % Notes due 2044 remain a standing component of its long‑term debt in each year’s 10‑K – the exhibit list for 2022, 2023 and 2024 all include “4.45 % Notes due 2044” (see Exhibit 4.4 in the 2022 filing page 56, the 2023 filing page 56, and the 2024 filing page 56). The fact that this same high‑coupon, 20‑plus‑year bond is retained year after year indicates Apple is deliberately preserving a long‑dated, fixed‑rate tranche to lock in financing costs and diversify its capital structure, reflecting a long‑term financing strategy focused on stable, low‑cost funding over decades.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM describes the 4.45% Notes as 'high-coupon' and 'low-cost funding,' which is contradictory and misleading. A 4.45% coupon in 2022-2024 context is NOT a high coupon rate for long-term debt - it's actually moderate to low. This represents a fundamental mischaracterization of the debt instrument. (2) FACTUAL CLAIM UNVERIFIED: The LLM cites specific exhibit locations ('Exhibit 4.4 in the 2022 filing page 56, the 2023 filing page 56, and the 2024 filing page 56') without verification that these exact page numbers and exhibit designations are correct. This is a problematic level of specificity that cannot be confirmed and may be hallucinated. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes that the notes were 'first issued in 2014' and remained 'consistent across 2022, 2023, and 2024' - the LLM mentions consistency but fails to note the 2014 issuance date, which is important context for understanding the 30-year maturity profile. (4) REASONING QUALITY: The LLM's interpretation that Apple is 'deliberately preserving' this debt to 'lock in financing costs' is speculative and not supported by the ground truth. The ground truth simply states the notes remained consistent without early redemption, not that Apple made an active strategic choice to preserve them. (5) SEMANTIC ISSUES: Describing a 4.45% rate as both 'high-coupon' and 'low-cost' is internally inconsistent and suggests confused reasoning about debt markets. (6) WHAT WAS CORRECT: The LLM correctly identifies that the 4.45% Notes due 2044 appear in all three years (2022, 2023, 2024) and correctly notes the consistency of this debt component across the period. The core finding of multi-year consistency aligns with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 484,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "FedEx International Connect Plus was offered in “nearly 50 origin countries to over 130 destination countries” in the 2022 filing (page_14). By the 2024 filing it had grown to “nearly 60 origin countries to over 190 destination countries” (page_8). This widening of both origin and destination coverage shows FedEx is deliberately scaling its e‑commerce logistics platform, expanding its global footprint to capture the accelerating cross‑border online‑shopping demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 baseline (nearly 50 origin countries to over 130 destination countries) and provides accurate 2024 figures (nearly 60 origin countries to over 190 destination countries). The reasoning about FedEx's strategic focus on e-commerce logistics and cross-border expansion is sound and well-articulated. CRITICAL WEAKNESS: The LLM answer is incomplete regarding the multi-hop temporal synthesis. The ground truth explicitly states that by 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries, and that this footprint 'remained consistent in 2024.' The LLM answer conflates the 2023 expansion with 2024, presenting the 2023 figures as if they represent 2024 growth. This is a significant omission because the ground truth's key insight is that expansion occurred from 2022-2023, followed by stabilization in 2024—suggesting a 'phase of consolidation and optimization.' The LLM answer misses this crucial strategic inflection point. QUANTITATIVE ACCURACY: While individual numbers are correct, the temporal attribution is problematic. The answer should have noted the 2023 intermediate data point to properly characterize the expansion trajectory and stabilization pattern. REASONING: The multi-hop synthesis is incomplete. The question asks about evolution 'from 2022 to 2024,' which requires three data points (2022, 2023, 2024) to fully answer. The LLM only provides two endpoints, missing the critical middle year that explains the strategic shift from expansion to consolidation. The conclusion about 'deliberately scaling' is partially correct but doesn't capture the full strategic narrative of expansion followed by stabilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 469,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % notes due 2017 are still listed in each of the company’s Form 10‑K filings for fiscal 2022, 2023 and 2024 as part of the “Officer’s Certificate” (Exhibit 4.4) that describes its global notes – a note that had already matured and been retired by those years【page_56】. By continuing to reference the 1.05 % notes in its disclosures, Apple maintains a complete historical record of all debt issuances, even those that have matured, underscoring a disciplined, transparent approach to tracking and managing its debt instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 1.05% Notes due 2017 as the subject; (2) Accurately states these notes appear in Exhibit 4.4 across fiscal years 2022, 2023, and 2024; (3) Correctly notes the notes had matured by those years; (4) Properly identifies the Officer's Certificate context; (5) Provides reasonable interpretation of Apple's disclosure approach as maintaining historical records. MINOR WEAKNESSES: (1) The LLM answer provides a slightly different interpretation of Apple's motivation (maintaining complete historical record for transparency) compared to the ground truth (standardized disclosure framework/refinancing activities), though both are reasonable inferences; (2) The ground truth explicitly mentions the Officer's Certificate was dated May 6, 2014, which the LLM answer omits; (3) The ground truth notes 'no explicit updates were provided in any of the three years,' which adds nuance the LLM answer doesn't capture. QUANTITATIVE ACCURACY: All numbers and dates are correct (1.05%, 2017 maturity, fiscal years 2022-2024, Exhibit 4.4). MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the pattern of continued reference. The reasoning about why Apple maintains these references is logical, though it differs slightly from the ground truth's more cautious framing. SEMANTIC EQUIVALENCE: The core message is equivalent - Apple continued referencing matured notes across multiple years as part of standardized disclosure practices. The LLM's interpretation of this as maintaining 'complete historical record' is semantically aligned with the ground truth's mention of 'continuity in debt documentation.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 484,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "Qualcomm’s 5G strategy grew more pronounced each year – in FY 2022 the firm already earned the bulk of QTL revenue from OFDMA‑based devices that include 5G, was actively expanding its 5G‑essential patent portfolio and investing in new automotive, IoT and XR opportunities (page 7; page 8), FY 2023 reaffirmed that focus with continued 5G‑centric licensing, a portfolio that now exceeds 200 5G license agreements and sustained R&D spend on automotive, IoT and other emerging applications (pages 20‑21; page 12), and FY 2024 kept 5G licensing as a core revenue driver while directing additional research and development toward 5G‑enabled new applications across devices and industries (pages 13‑15). At the same time, geopolitical exposure intensified: FY 2022 risk disclosures warned of U.S./China trade‑policy tensions (page 6), FY 2023 highlighted heightened risk from Chinese concentration and potential payment delays (pages 20‑21), and FY 2024 saw a concrete impact when the U.S. revoked its export license to Huawei, eliminating roughly $560 million of product revenue and underscoring the vulnerability of its licensing cash flows (page 20).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of Qualcomm's evolving 5G strategy across FY2022-2024, accurately captures the $560 million Huawei revenue impact in FY2024, and properly synthesizes the multi-hop elements (strategic focus, licensing revenue, R&D investments, and geopolitical risks). The answer demonstrates sound reasoning about the progression from foundational positioning to deepened commitment despite external risks. The structure effectively traces the evolution across all three fiscal years.\n\nWEAKNESSES AND ERRORS: (1) The LLM claims \"over 200 5G license agreements\" in FY2023 without this figure appearing in the ground truth, which only mentions this metric in the context of FY2024 or general statements. This is a factual inaccuracy. (2) The LLM states the majority of QTL revenues came from OFDMA-based devices \"already\" in FY2022, but the ground truth specifically attributes this characterization to FY2024 ('with the majority of QTL revenues derived from OFDMA-based (including 5G) devices'). This represents a temporal misplacement of a key fact. (3) The ground truth mentions the specific projection of '27 billion IoT devices by 2026' from FY2022, which the LLM omits entirely. (4) The LLM references specific page numbers (7, 8, 20-21, 12, 13-15, 6, 20) that cannot be verified against the ground truth and may be fabricated citations.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and connects strategic positioning to financial outcomes and risk exposure. However, the temporal accuracy issues (misplacing when certain facts apply to which year) undermine the quality of this synthesis.\n\nQUANTITATIVE ACCURACY: The $560 million figure is correct. However, the introduction of the '200 5G license agreements' figure without ground truth support and the misattribution of OFDMA revenue characterization to FY2022 instead of FY2024 represent quantitative/factual errors.\n\nSEMANTIC EQUIVALENCE: While the overall narrative arc is semantically similar to the ground truth, the specific factual errors prevent full equivalence. The answer captures the spirit of deepening commitment and rising risks but misplaces key facts temporally.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 600,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "In 2022 the domestic pension plan held $89 M in U.S. equity funds, $91 M in international equity funds and $739 M in fixed‑income funds – roughly 9.5%, 9.7% and 78.9% of the $937 M total (page_57). By 2024 those balances were $91 M, $89 M and $692 M, or about 10.2%, 9.9% and 77.3% of the $895 M total (page_71). The mix stayed close to the company’s stated target of ≈10% equity and ≈80% fixed‑income, indicating only a modest shift toward slightly higher equity exposure while preserving its liability‑hedging, fixed‑income‑focused strategy (page_70).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. Critical issues: (1) WRONG NUMBERS FOR 2022: Ground truth shows 2022 had $125M U.S. equity, $126M international equity, $1,001M fixed income ($1,267M total). LLM incorrectly states 2022 had $89M, $91M, $739M ($937M total) - these are actually 2023 figures. (2) WRONG NUMBERS FOR 2024: Ground truth shows 2024 had $93M U.S. equity, $93M international equity, $739M fixed income ($947M total). LLM states $91M, $89M, $692M ($895M total) - none of these match. (3) MISSING 2023 DATA: The question asks about change from 2022 to 2024, which requires understanding the intermediate 2023 data. LLM completely omits 2023 analysis. (4) INCORRECT PERCENTAGES: LLM's percentages don't match ground truth allocations and are based on wrong dollar amounts. (5) WRONG STRATEGIC INTERPRETATION: Ground truth reveals a significant reduction in 2023 (from $1,267M to $937M) followed by stabilization in 2024, indicating a strategic shift toward stability and reduced equity exposure. LLM misses this entirely and incorrectly characterizes the pattern as 'modest shift toward slightly higher equity exposure.' (6) CALCULATION ERRORS: The percentages provided don't even calculate correctly from the stated amounts. The LLM appears to have confused data from different years and provided internally inconsistent information. The answer fails on quantitative accuracy (wrong numbers), fails on completeness (missing 2023), and fails on reasoning (wrong strategic interpretation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 424,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "In its 2022 filing Qualcomm emphasized that exploding demand for connected devices and hybrid‑work trends were driving a “growth in demand for edge‑networking products (including mobile broadband and wireless‑access‑point solutions),” with 5G and Wi‑Fi 6/6E technologies forming the core of its product roadmap for that market 【page_8】. By 2023‑24 the revenue line that captures those edge‑networking sales – the IoT segment (which explicitly includes “edge networking (including mobile broadband and wireless access points)”) – fell from $7.353 billion in 2022 to $5.940 billion in 2023 and $5.423 billion in 2024, indicating that while Qualcomm continued to embed 5G/Wi‑Fi advances in its QCT portfolio, edge‑networking moved from a high‑growth focus to a smaller, integrated component of a broader IoT and automotive strategy 【page_73】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific revenue figures and attempts multi-hop synthesis across 2022-2024, but introduces a significant interpretive issue that diverges from the ground truth. STRENGTHS: (1) Correctly identifies 2022 positioning with edge networking as growth area driven by hybrid work and 5G/Wi-Fi 6/6E; (2) Provides specific revenue numbers ($7.353B in 2022, $5.940B in 2023, $5.423B in 2024) that appear plausible for IoT segment; (3) Correctly identifies mobile broadband and wireless access points as key products; (4) Acknowledges continued product development through 2024. CRITICAL ISSUES: (1) The LLM reframes the question's narrative by claiming edge networking 'moved from a high-growth focus to a smaller, integrated component' - this contradicts the ground truth which states 'consistent and maturing strategic focus' and that edge networking was 'explicitly listed as a key revenue contributor' in 2023-2024; (2) The revenue decline interpretation (from $7.353B to $5.423B) is presented as evidence that edge networking diminished in strategic importance, but the ground truth indicates it remained a 'core product category' and 'key growth area' - the LLM conflates revenue decline with strategic de-emphasis, which may not be accurate; (3) The ground truth emphasizes consistency and maturation, while the LLM emphasizes decline and integration into broader strategy - fundamentally different narratives. QUANTITATIVE VERIFICATION: Revenue figures cannot be independently verified from the provided context, but the mathematical relationships are internally consistent (decline from 2022-2024). MULTI-HOP REASONING: The LLM attempts to synthesize across three years but makes an interpretive leap that contradicts ground truth by using revenue decline as proxy for strategic importance decline. The ground truth focuses on explicit product categorization and strategic emphasis, not revenue trends. SEMANTIC ISSUE: The answer addresses the question but provides a materially different conclusion about strategic evolution - claiming contraction rather than maturation/consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 565,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K exhibit schedules for 2022, 2023 and 2024 each list the “0.45% Notes due 2016” (2022 exhibit list p. 56; 2023 exhibit list p. 56; 2024 exhibit list p. 54), showing that the company continues to disclose this low‑coupon, fixed‑rate obligation even after its original maturity. By consistently tracking and reporting this legacy debt, Apple signals a disciplined approach to managing fixed‑rate maturities and preserving a transparent, stable capital‑structure profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims the 0.45% Notes due 2016 appear in Apple's 2022, 2023, and 2024 10-K filings, but the ground truth explicitly states these notes 'are no longer outstanding.' This is a fundamental contradiction. The LLM presents the notes as if they were still being actively tracked and reported in current filings, when the ground truth indicates they appear for historical/archival purposes only. (2) MISREPRESENTATION OF INTENT - The LLM frames this as Apple 'continues to disclose this...obligation even after its original maturity,' implying ongoing debt management, when the ground truth clarifies these are legacy notes no longer outstanding, included for comprehensive historical disclosure purposes. (3) SEMANTIC DISTORTION - The LLM's language ('continues to disclose,' 'legacy debt,' 'tracking and reporting') subtly mischaracterizes the nature of the disclosure. The ground truth emphasizes these notes are included despite being 'no longer outstanding,' suggesting archival/historical completeness rather than active debt management. (4) MISSING KEY CONTEXT - The LLM fails to explicitly state that these notes are no longer outstanding, which is the critical distinction in the ground truth. (5) CITATION ACCURACY - While the LLM provides specific page references (p. 56, 56, 54), these cannot be verified against the ground truth, and the underlying claim about what these pages contain appears questionable given the factual error about the notes' status. The answer demonstrates a fundamental misunderstanding of whether these are active or historical debt obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 448,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "The EMD brand’s dealer network contracted – it served 193 countries in 2022 (see the 2022 10‑K note stating the network “serving 193 countries”【page_76】) and only 187 countries in 2024 (the 2024 10‑K notes the network “serving 187 countries”【page_66】). That’s a reduction of six countries.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the EMD network served 193 countries in 2022 and 187 in 2024, representing a 6-country reduction. The ground truth clearly states 130 countries in 2022 and 109 in 2024, representing a 21-country reduction (approximately 16%). These are completely different numbers - the LLM's figures are off by 63 countries in 2022 and 78 countries in 2024. The calculation of 6 countries is also incorrect relative to the ground truth's 21-country decline. (2) ENTITY/METRIC ACCURACY: While the LLM correctly identifies Caterpillar's EMD brand and the distribution network metric, it provides entirely wrong numerical values. The citations provided (page_76 for 2022 10-K and page_66 for 2024 10-K) cannot be verified against the ground truth data, and the numbers cited do not match the documented facts. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison across the 2022-2024 period. While it attempts to show a trend (contraction), the magnitude and accuracy of that trend are completely wrong. (4) COMPLETENESS: The LLM does address the core question about geographic reach changes, but with entirely incorrect data, making the answer misleading rather than helpful. The ground truth also notes that 2023 remained at 130 countries (unchanged from 2022), which the LLM completely omits. This is a critical failure in factual accuracy for a financial/operational metric question where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 428,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher’s euro‑denominated 1.750 % 7‑year senior notes rose from **$642 million at 12/31/2022** to **$662 million at 12/31/2023** and then fell to **$621 million at 12/31/2024**【page_61†L31-L34】【page_47†L31-L34】. The modest increase in 2023 reflects a net addition (likely to fund acquisitions or growth), while the subsequent decline in 2024 shows the company beginning to pay down or refinance that tranche, indicating a disciplined medium‑term debt strategy that balances financing needs for its healthcare operations with a focus on reducing leverage over time.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all quantitative dimensions: (1) WRONG NUMBERS: The ground truth clearly states the outstanding value was $700 million in 2022, 2023, and 2024. The LLM reports $642M (2022), $662M (2023), and $621M (2024) - all incorrect values. (2) WRONG CURRENCY ASSUMPTION: The LLM incorrectly identifies these as 'euro-denominated' notes when the ground truth specifies they are dollar-denominated senior notes. This is a fundamental misidentification. (3) WRONG NARRATIVE: The ground truth indicates ZERO change across all three years ($700M constant), indicating a stable, unchanged debt position. The LLM invents a false narrative of increases and decreases ($642M→$662M→$621M), creating a completely fabricated trend that contradicts the actual data. (4) FAILED MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the debt instrument data across the three-year period, instead generating plausible-sounding but entirely incorrect numbers. (5) INCORRECT INTERPRETATION: The LLM's conclusion about 'disciplined debt strategy' with 'pay down or refinance' is based entirely on false numbers and misrepresents TMO's actual approach, which was to maintain this debt tranche unchanged. The answer demonstrates a complete failure to accurately retrieve or report the factual data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 379,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "In the 2022 Form 10‑K Caterpillar warned that a material share of Cat Financial’s variable‑rate loans were still tied to LIBOR and that the scheduled LIBOR wind‑down (one‑week and two‑month tenors ending 31 Dec 2021 and all other tenors by 30 Jun 2023) could affect those obligations; it disclosed a cross‑functional team to evaluate the impact, noted that new floating‑rate financing was already being priced off the Secured Overnight Financing Rate (SOFR), and said it used currency‑hedging instruments to offset FX risk (2022 p. 22‑19). The 2023 filing shifted the focus to SOFR as the primary benchmark for floating‑rate exposures, reaffirmed the cross‑functional team’s role in managing the transition, and continued to highlight the use of currency‑hedge contracts for protection against adverse exchange‑rate movements (2023 p. 19). By the 2024 filing the company no longer references LIBOR, emphasizing that SOFR now underpins its variable‑rate debt and that currency‑hedging remains a core risk‑mitigation tool, showing that Caterpillar has largely completed the LIBOR‑to‑SOFR migration and is strategically aligning its hedging program with global financial‑market reforms (2024 p. 19‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All dates are correct (31 Dec 2021 for one-week and two-month tenors, 30 Jun 2023 for other tenors, and the 2022-2024 filing progression). The answer correctly identifies the timeline of LIBOR phase-out and SOFR adoption. Page references (2022 p. 22-19, 2023 p. 19, 2024 p. 19-21) are provided with appropriate specificity. ENTITY ACCURACY: Caterpillar and Cat Financial are correctly identified; LIBOR, SOFR, FCA, and IBA are all properly referenced. The fiscal years (2022, 2023, 2024) are correctly sequenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years showing: (1) 2022 baseline with LIBOR exposure and cross-functional team formation, (2) 2023 transition with SOFR emphasis, and (3) 2024 completion with full LIBOR elimination. The logical progression demonstrates proper understanding of the evolution. COMPLETENESS: The answer addresses all aspects of the original question: exposure to currency hedging instruments, management of these instruments, LIBOR phase-out response, SOFR adoption, and strategic adaptation to global financial reforms. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, including the proactive nature of Caterpillar's adaptation, the role of the cross-functional team, and the shift from LIBOR to SOFR. Minor differences in wording (e.g., 'warned' vs 'highlighted,' 'wind-down' vs 'phase-out') are stylistic and do not affect factual accuracy. The answer appropriately emphasizes strategic alignment with regulatory changes and market benchmarks. No material factual errors, calculation mistakes, or omissions were identified. The answer demonstrates sound understanding of the multi-hop synthesis required across multiple years and regulatory frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1654,
        "completion_tokens": 513,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K listed the 2009 Executive Change‑in‑Control Retention Agreement for CEO Marc N. Casper, its 2010 amendment, its 2018 amendment, and a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (exhibit 10.2) 【page_46†L11-L18】. The 2023 and 2024 filings repeat the same CEO‑specific agreement and its amendments and continue to reference the identical officer‑template exhibit (exhibit 10.2) 【page_76†L11-L18】【page_76 (2024)†L11-L18】, indicating that the company has standardized a single form for all non‑CEO officers while retaining the distinct CEO agreement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of evolution from CEO-specific to standardized officer agreements, which aligns with the ground truth. However, there are significant discrepancies in exhibit numbering and some factual inconsistencies that undermine accuracy. STRENGTHS: (1) Correctly identifies the CEO-specific agreement for Marc N. Casper with amendments through 2018; (2) Accurately describes the introduction of a standardized form for non-CEO officers; (3) Properly synthesizes the multi-year evolution (2022-2024); (4) Correctly notes the distinction between CEO and officer agreements. CRITICAL ERRORS: (1) Exhibit numbering is incorrect - LLM states 'exhibit 10.2' but ground truth indicates 'Exhibit 10.17' for the officer form agreement. This is a factual error in document reference; (2) The LLM claims the 2022 filing lists a '2009 Executive Change-in-Control Retention Agreement' and '2010 amendment' - the ground truth only mentions amendments 'through March 16, 2018' without specifying 2009 or 2010 dates, suggesting potential over-specification or confusion about amendment dates; (3) The LLM states the officer template is 'exhibit 10.2' consistently across all three years, but ground truth specifies 'Exhibit 10.17' - this is a material factual error in document identification. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) and identifies the evolution pattern. The logic is sound - moving from CEO-only to standardized officer form. However, the exhibit number errors suggest the LLM may have confused or misread source documents. SEMANTIC EQUIVALENCE: The narrative meaning aligns with ground truth (standardization evolution), but the specific exhibit references are factually incorrect, which is problematic for SEC filing citations where precision is critical. The answer would mislead someone trying to locate the actual agreements in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 526,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "- In the 2022 filing Intel first presented PowerVia as a new “back‑side power‑delivery” concept slated for its future Intel 20A node, grouping it with other next‑generation technologies such as RibbonFET. 【page_7】\n\n- The 2023 filing reiterated PowerVia as one of the two breakthrough features of Intel 20A, describing it as an industry‑first way to eliminate front‑side power routing and drive up to a 15 % performance‑per‑watt gain. 【page_14】\n\n- By the 2024 filing Intel had cancelled the Intel 20A productization and moved PowerVia into the Intel 18A node, calling it the first high‑volume commercial implementation of backside power and targeting high‑volume production in 2025. 【page_10】\n\n**Implication:** PowerVia has progressed from a planned future feature for a cancelled node (20A) to a core, high‑volume technology in Intel’s next‑generation 18A process, signaling that Intel now views PowerVia as a critical enabler of performance‑per‑watt improvements and a cornerstone of its advanced‑process roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 introduction of PowerVia alongside RibbonFET for Intel 20A; (2) Accurately captures the 2023 emphasis on eliminating front-side power routing with the specific 15% performance-per-watt gain metric; (3) Correctly identifies the 2024 cancellation of Intel 20A and transition to Intel 18A with PowerVia retained; (4) Properly synthesizes the multi-hop progression across three years; (5) Accurately characterizes PowerVia as a 'back-side power-delivery' concept and 'backside power' implementation; (6) Correctly identifies 2025 as the target for high-volume production. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'cancelled the Intel 20A productization' vs. 'canceled Intel 20A') but this is semantically equivalent. The LLM provides more specific technical details (15% performance-per-watt gain, 'first high-volume commercial implementation') that enhance rather than contradict the ground truth. The conclusion about PowerVia's strategic importance is well-reasoned and consistent with the documented evolution. All numeric values (15%, 2025, 2022-2024 timeline) are accurate. The multi-hop reasoning correctly synthesizes information across three filing years to show the progression and strategic shift. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 402,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 first appear in the 2022 Form 10‑K’s exhibit index as part of Exhibit 4.4 – an Officer’s Certificate dated May 6 2014 that lists “1.05 % Notes due 2017” among other series [page 58]. The same Exhibit 4.4 description is reproduced unchanged in the 2023 filing [page 56] and again in the 2024 filing [page 56], showing no amendment or removal. This repeated, unchanged disclosure signals that Apple continues to track and report this legacy low‑interest debt, reflecting a consistent and transparent debt‑management practice that keeps even matured‑year notes on the books for completeness and compliance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 1.05% Notes due 2017, the Officer's Certificate dated May 6, 2014 (Exhibit 4.4), and accurate page references (58 for 2022, 56 for 2023 and 2024). The multi-hop synthesis across three fiscal years (2022, 2023, 2024) is sound, correctly tracking the repeated disclosure pattern. The quantitative elements (dates, percentages, page numbers) are all accurate with no calculation errors. The LLM correctly identifies that the same exhibit description appears unchanged across all three filings, supporting the ground truth's assertion about consistent reporting practices. However, there is a minor semantic difference in interpretation: the LLM characterizes this as tracking 'legacy low-interest debt' and 'matured-year notes on the books for completeness and compliance,' while the ground truth suggests Apple 'may have either rolled over the debt into a new instrument or maintained it in some form.' The LLM's interpretation is more definitive about the nature of the practice (compliance/completeness) whereas the ground truth is more cautious about the underlying mechanism (rollover vs. maintenance). Both interpretations are reasonable given the evidence, but the ground truth's more measured language about the 'deliberate and consistent reporting practice' is slightly more aligned with what the data actually shows. The LLM answer is well-structured, addresses all parts of the question, and provides appropriate context about Apple's debt management transparency. The only minor weakness is the slightly more speculative characterization of the company's intent compared to the ground truth's more measured assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 467,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan, noted in the 2022 filing simply as the vehicle for standard restricted‑stock‑unit awards 【page_113†L1-L3】【page_114†L1-L3】, later grew to include a suite of RSU grant agreements that provide awards with retirement‑vesting terms, awards without retirement‑vesting, and performance‑based RSUs for executives 【page_107†L1-L4】. By the 2024 filing the plan further broadened to grant performance‑based RSUs to non‑grandfathered executives and RSUs to non‑employee directors, showing a shift to a more varied mix of equity awards with retirement‑based, performance‑based, and no‑retirement vesting conditions 【page_108†L1-L4】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and inconsistencies compared to the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that Intel's 2006 Equity Incentive Plan evolved to include multiple types of RSU awards (retirement-vesting, non-retirement-vesting, performance-based). (2) The answer correctly notes the progression from 2022 through 2024. (3) The mention of awards for both executives and non-employee directors is accurate. SIGNIFICANT ISSUES: (1) The ground truth explicitly mentions the May 11, 2023 amendment and restatement of the plan, which is a critical factual detail that the LLM answer completely omits. This is a major gap in addressing the evolution timeline. (2) The ground truth distinguishes between 'grandfathered' and 'non-grandfathered' executives, which is an important nuance. The LLM answer mentions 'non-grandfathered executives' in 2024 but fails to properly characterize the distinction between grandfathered and non-grandfathered awards across the years. (3) The ground truth emphasizes a 'consolidation in documentation structure' and 'streamlined format' in 2024, suggesting a simplification trend. The LLM answer instead suggests a 'broadening' in 2024, which contradicts the ground truth's characterization of consolidation. (4) The ground truth notes that 2023 introduced 'a broader range of RSU agreements' while 2024 showed 'consolidation' - the LLM reverses this narrative by suggesting 2024 'further broadened' the plan. (5) The page citations in the LLM answer cannot be verified against the ground truth, and the specific page references may not accurately reflect the source material. MULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting information across three years, but the interpretation of the evolution is partially inverted from the ground truth. The answer should have emphasized the 2023 amendment as a pivotal moment and the 2024 consolidation as a refinement, not a broadening. SEMANTIC ISSUES: While the answer uses appropriate terminology (RSUs, performance-based, retirement-vesting), the overall narrative arc differs from the ground truth in ways that affect the accuracy of the evolution story being told.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 602,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Medtronic’s 10‑K footnotes all state that the company’s authorized share capital includes 40 000 Euro Deferred Shares ( €1.00 par value) and that, respectively on April 29 2022, April 28 2023 and April 26 2024, **no Euro Deferred Shares were issued or outstanding**. The fact that this authorized class has remained untouched for three consecutive years shows the company has not used Euro Deferred Shares as a financing tool, preferring other sources of capital (e.g., debt, ordinary‑share repurchases) and avoiding dilution through this dormant equity class.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: All numeric values are correct - 40,000 Euro Deferred Shares (stated as '40 000' in LLM answer), €1.00 par value, and the three fiscal years (2022, 2023, 2024) with correct dates (April 29 2022, April 28 2023, April 26 2024). No calculation errors present. ENTITY ACCURACY: Medtronic correctly identified, fiscal years properly specified, Euro Deferred Shares correctly characterized. COMPLETENESS: The answer addresses all components of the multi-part question: (1) how disclosures evolved (consistent across three years), (2) the authorized capacity (40k shares maintained), (3) the absence of issuance (zero shares issued/outstanding), and (4) what this suggests about financing strategy (preference for other capital tools, avoiding dilution). MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws appropriate conclusions about capital allocation strategy. The logic connecting the consistent non-issuance to strategic preferences is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth. Both identify the consistent absence of issuance, the maintained authorization, and the strategic implications. The LLM adds slightly more specificity by mentioning 'debt' as an alternative capital source alongside 'ordinary-share repurchases,' which is a reasonable inference and adds value. MINOR DIFFERENCES: The LLM uses '40 000' (European number format) while ground truth uses '40 thousand' - both are semantically equivalent and acceptable. The LLM's mention of 'avoiding dilution through this dormant equity class' is a logical extension of the ground truth's observation about preferring other capital structure tools. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 504,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "- In the 2022 filing Intel already positioned advanced‑packaging (2D/2.5D/3D chiplet integration) as a strategic pillar of its IDM 2.0 plan, but warned that the disaggregated design approach would add manufacturing complexity, raise R&D spending to about $15 billion and could force inventory write‑offs, excess‑capacity charges and asset impairments (see 2022 risk discussion, pp. 53‑55).  \n\n- By 2023 the company doubled its IFS accelerator ecosystem, secured several 18A design wins and reported a $483 million jump in packaging revenue, while R&D rose to $16 billion; however, the higher cost and logistical risk of advanced‑packaging contributed to a larger operating loss of $482 million (see 2023 market overview and financial performance, pp. 37‑38, 36).  \n\n- In the 2024 filing Intel further increased R&D to $16.5 billion and continued to rely on advanced‑packaging for its Open System Foundry, but now stresses that the novel, limited‑history packaging technologies add significant cost, schedule risk and have already generated $3.1 billion of non‑cash impairments and a $755 million penalty charge, highlighting heightened execution risk (see 2024 R&D and risk sections, pp. 34‑35, 36).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc (strategic bet → technical progress → financial/operational setbacks) and addresses all three years (2022-2024). It appropriately emphasizes the IDM 2.0 strategy, advanced packaging as a competitive differentiator, and the $3.1 billion impairment figure mentioned in the ground truth. The qualitative reasoning about execution risks, manufacturing complexity, and financial strain is sound and well-structured.\n\nWEAKNESSES - QUANTITATIVE ISSUES: (1) R&D figures are problematic: LLM states \"about $15 billion\" for 2022, \"$16 billion\" for 2023, and \"$16.5 billion\" for 2024. The ground truth does not provide specific R&D investment figures for these years, making these numbers unverifiable and potentially fabricated. (2) The \"$483 million jump in packaging revenue\" in 2023 is not mentioned in the ground truth and cannot be verified. (3) The \"$482 million operating loss\" attributed to 2023 is not in the ground truth. (4) The \"$755 million penalty charge\" in 2024 is mentioned but not in the ground truth summary.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression of Intel's strategic positioning. However, the introduction of unverified financial metrics (packaging revenue jump, operating loss figures, penalty charge) undermines the credibility of the synthesis, even though the core narrative structure is sound.\n\nFACTUAL VERIFICATION: The $3.1 billion impairment figure is correctly cited and matches the ground truth. The mention of Intel 4 and 10nm process delays in 2022, UCIe standard demonstration in 2023, and manufacturing delays in 2024 align with ground truth. However, the specific revenue and loss figures appear to be either hallucinated or drawn from sources not reflected in the ground truth.\n\nCONCERN: The LLM provides specific page references (pp. 53-55, pp. 37-38, etc.) that cannot be verified and may be fabricated. This is a significant red flag for reliability.\n\nOVERALL ASSESSMENT: While the LLM captures the strategic narrative and key risk evolution correctly, the introduction of unverified quantitative claims (R&D spending levels, packaging revenue, operating losses, penalty charges) significantly reduces confidence in the answer. The core qualitative reasoning is sound, but the quantitative accuracy is compromised by apparent hallucinations or unverifiable claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 657,
        "total_tokens": 2206
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "Intel first introduced PowerVia in its 2022 filing as a future process‑and‑packaging innovation slated for the upcoming Intel 20A node 【page_7】. In the 2023 filing the company refined its positioning, describing PowerVia as an industry‑first backside‑power delivery technique that is expected to deliver up to a 15% performance‑per‑watt improvement over Intel 3 and to be a key breakthrough for both Intel 20A (and later Intel 18A) 【page_14】. By 2024 Intel had cancelled the 20A productization and disclosed that PowerVia will be incorporated into the Intel 18A node, which is slated for high‑volume manufacturing in 2025, indicating the technology is now manufacturing‑ready 【page_10】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of Intel filings. STRENGTHS: (1) All key numeric values are correct - the 15% performance-per-watt improvement figure is accurate, and the timeline progression (2022 introduction → 2023 roadmap refinement → 2024 manufacturing readiness) is properly sequenced. (2) The multi-hop reasoning is sound, correctly tracing PowerVia's evolution from conceptual innovation through roadmap solidification to production readready status. (3) Entity identification is accurate - correctly identifies Intel 20A, Intel 18A, Intel 3, and the 2025 high-volume manufacturing target. (4) The answer captures the key strategic shift from Intel 20A to Intel 18A, which is an important detail showing how the technology evolved. (5) The characterization of PowerVia as an 'industry-first backside power delivery solution' is semantically equivalent to the ground truth's 'backside power delivery solution.' MINOR ISSUES: (1) The phrasing 'cancelled the 20A productization' is slightly more definitive than the ground truth's 'shift in focus,' though both convey that 20A was superseded by 18A. The ground truth uses 'shift' while the LLM uses 'cancelled,' which is a subtle semantic difference but not factually incorrect given the context. (2) The answer could have been slightly more explicit about the elimination of front-side power routing as a benefit, though this is a minor omission. QUANTITATIVE VERIFICATION: All numbers check out - 15% improvement figure is correct, 2025 HVM date is correct, node progression (20A→18A) is correct. The answer maintains factual precision while using appropriate source citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 469,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "No, Medtronic’s U.S. employee restricted‑stock‑unit agreements have not changed – the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan (exhibit 10.54) is listed in the FY 2022, FY 2023 and FY 2024 10‑K filings【page_114】. This unchanged inclusion indicates a deliberately stable equity‑compensation strategy, with the company keeping its RSU framework for U.S. staff consistent over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Medtronic's RSU agreement consistency across FY2022-FY2024. STRENGTHS: (1) Correctly identifies that no updates occurred to the U.S. employee RSU agreements across the three-year period; (2) Accurately references the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan; (3) Correctly notes the document was filed on August 27, 2013 (File No. 001-07707) - though the LLM doesn't explicitly state this date, it's not required by the question; (4) Properly synthesizes information across three fiscal years (FY2022, FY2023, FY2024); (5) Correctly interprets the consistency as indicating a stable equity compensation strategy; (6) Appropriately identifies exhibit 10.54 as the relevant filing reference. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'deliberately stable equity-compensation strategy' conveys the same meaning as 'stable and consistent equity compensation strategy' in the ground truth. The LLM correctly emphasizes that the unchanged inclusion indicates strategic consistency. All factual claims are accurate - the same agreement form appears in all three years, and this consistency does suggest a stable approach to long-term incentive alignment. No numerical errors, date errors, or entity misidentifications present. The multi-hop reasoning (connecting the unchanged agreements across three years to strategic implications) is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 441,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In 2022 Intel’s 2006 Equity Incentive Plan granted performance‑based RSUs to executives under a single “grandfathered” grant agreement (Exhibit 10.1.5) and, for the first time, added a separate RSU form for non‑employee directors (Exhibit 10.1.7) 【page_108】. By the 2024 filing the company had split the executive awards into two distinct agreements—retaining the original grandfathered form (Exhibit 10.1.5) and introducing a new form for non‑grandfathered executives (Exhibit 10.1.6) 【page_107】—showing a more granular, category‑specific approach to performance‑based RSU grants.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of the 2006 Equity Incentive Plan as the vehicle for performance-based RSUs is accurate; (2) The reference to grandfathered vs. non-grandfathered executive distinctions is correct; (3) The exhibit references (10.1.5, 10.1.6, 10.1.7) appear to be specific filing citations that align with typical SEC filing structures. PROBLEMATIC ELEMENTS: (1) The LLM answer focuses heavily on exhibit-level details and structural changes (grandfathered vs. non-grandfathered forms) but misses the broader strategic evolution narrative present in the ground truth; (2) The ground truth emphasizes the 2023 amendment/restatement (effective May 11, 2023) and the September 26, 2023 S-8 registration filing, which are significant milestones not mentioned in the LLM answer; (3) The LLM answer claims 2022 introduced a 'separate RSU form for non-employee directors' but the ground truth does not specifically highlight this as a 2022 innovation; (4) The LLM answer lacks discussion of the 2023 continuation and the 2024 reaffirmation with the amended plan, which are key elements of the ground truth's three-year evolution narrative; (5) The LLM answer provides a more granular, exhibit-focused analysis rather than the strategic/policy-level evolution described in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across years (2022-2024) and identifies structural changes, but fails to capture the full strategic context including plan amendments, S-8 filings, and the consistent policy thread across all three years. The answer is partially correct on structural details but incomplete on the broader strategic evolution and key regulatory filings that demonstrate the company's commitment to the plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 495,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s 2022 filing flagged advanced‑packaging as a key R&D priority but warned that the disaggregated‑design approach “introduces new areas of complexity…especially in the deployment of advanced packaging technologies” and carries significant risk (2022 p.54‑56). By 2023 the investment began to pay off – packaging revenue rose $483 million, and Intel showcased 2‑D/2.5‑D/3‑D solutions and a silicon‑demonstrated UCIe interconnect, positioning advanced packaging as a unique advantage for AI‑driven systems‑of‑chips (2023 p.37‑38). In 2024 the momentum accelerated: Intel reported “accelerated interest in our advanced packaging business, especially for AI‑related designs, and have secured five new design wins,” while expanding ecosystem deals with ARM, Synopsys and over 40 IFS accelerator partners, indicating the company is now effectively executing its disaggregated design strategy and competing in the AI semiconductor market (2024 p.36).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims 'packaging revenue rose $483 million' in 2023 - this specific figure is not mentioned in the ground truth and appears to be fabricated or misattributed. The ground truth makes no mention of packaging revenue figures. (2) CONTRADICTORY NARRATIVE: The LLM presents an overly optimistic trajectory claiming Intel is 'now effectively executing its disaggregated design strategy' in 2024, but the ground truth explicitly states the 2024 data reveals 'persistent execution challenges and the high financial stakes' with $3.1 billion in impairment charges. The LLM completely omits this critical 2024 negative development. (3) MISSING KEY FACTS: The LLM fails to mention the $3.1 billion in non-cash impairments and accelerated depreciation charges in 2024, which is central to understanding the company's execution challenges. It also omits the $16.5 billion R&D investment figure mentioned in ground truth. (4) MISCHARACTERIZATION: The LLM's conclusion that Intel is 'effectively executing' contradicts the ground truth's assessment of 'persistent execution challenges and financial pressures.' The five design wins and ecosystem partnerships mentioned by LLM are not corroborated in the ground truth and may be accurate details but don't change the overall assessment of execution risks. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize 2022-2024 progression, it fails to properly weight the significance of 2024 financial charges, which fundamentally undermine the narrative of successful execution. The ground truth presents a more nuanced view: progress in 2023 (UCIe demonstration) but offset by 2024 financial pressures and impairments. The LLM's answer reads as cherry-picking positive developments while ignoring material negative indicators.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 518,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "In the 2022 Form 10‑K Intel only referenced the “2006 Plan” in its glossary (see page 113) and did not disclose any amendment or new grant‑agreement exhibits. In the 2023 filing the company filed the 2006 Equity Incentive Plan as an exhibit (S‑8) on September 26 2023, reflecting an amendment to the plan (see page 107). By the 2024 Form 10‑K Intel was actively using the amended plan, attaching several RSU grant‑agreement forms—including performance‑based RSU agreements for non‑grandfathered executives and RSU agreements for non‑employee directors—under the 2006 Equity Incentive Plan (see page 108).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Intel's 2006 Equity Incentive Plan evolution across the three-year period and correctly identifies key developments: (1) 2022 minimal disclosure, (2) 2023 amended and restated plan filing, and (3) 2024 active use with RSU grant agreements. STRENGTHS: The answer correctly identifies the September 26, 2023 filing date for the amended plan, accurately describes the types of grant agreements used (RSU agreements for non-employee directors, performance-based RSU agreements for executives), and properly traces the progression from limited disclosure to active implementation. The specific page references (113, 107, 108) add credibility and specificity. The answer correctly synthesizes multi-hop information across three years. WEAKNESSES: (1) The LLM states the 2023 filing was an S-8 on September 26, 2023, but the ground truth indicates the amended and restated plan was effective May 11, 2023 - there's a date discrepancy that suggests possible confusion between filing date and effective date; (2) The LLM's characterization of 2022 as having 'no amendment or new grant-agreement exhibits' is more restrictive than the ground truth, which indicates multiple grant agreements were referenced in 2022 (RSU and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards); (3) The LLM misses the mention of Stock Option Grant Agreements that were referenced in 2022. QUANTITATIVE ACCURACY: The dates provided (September 26, 2023 for filing) and page numbers appear specific but cannot be fully verified against ground truth. The May 11, 2023 effective date from ground truth is not mentioned. QUALITATIVE ACCURACY: The reasoning about plan evolution is sound and the synthesis across years is logical, though the 2022 characterization understates the plan's use. CONTEXTUAL RELEVANCE: The answer directly addresses the question about plan evolution and amendments across the three years, with appropriate focus on grant agreements and amendments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 548,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "In the 2022 10‑K Qualcomm grouped wireless‑access‑point sales under its IoT revenue stream and highlighted them as a growth engine for the “edge‑networking” market—driven by 5G, Wi‑Fi 6/6E and hybrid‑work demand (see page 8). The 2024 filing keeps the same financial categorization, still reporting wireless‑access‑point products as part of the IoT line of the QCT segment (the “edge networking” sub‑category), but notes that IoT revenue (which includes those access points) fell to $5.4 billion from $7.4 billion in 2022, reflecting a continued but more focused market positioning on high‑growth edge‑networking solutions (see page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that wireless access points were categorized under edge networking/IoT segment in both 2022 and 2024, maintains consistent financial classification, and notes the strategic emphasis on edge networking. The mention of 5G, Wi-Fi 6/6E, and hybrid-work demand as drivers is contextually appropriate. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific revenue figures ($5.4 billion in 2024, $7.4 billion in 2022 for IoT revenue) that are NOT present in the ground truth answer. The ground truth explicitly states 'exact revenue figures for wireless access points alone are not disclosed,' which contradicts the LLM's specific dollar amounts. This is a critical error - the LLM appears to have fabricated or misattributed specific numbers. (3) MISSING ELEMENTS: The LLM answer omits the key 2022 projection mentioned in ground truth about IoT devices doubling between 2022-2026 to over 27 billion, which was explicitly highlighted as a strategic emphasis point. The answer also doesn't clearly address the 2023 transition year mentioned in the ground truth. (4) MULTI-HOP REASONING: The LLM attempts to synthesize across years but does so incompletely - it jumps from 2022 to 2024 without addressing 2023's explicit categorization milestone. The reasoning about 'more focused market positioning' based on revenue decline is an inference not supported by the ground truth. (5) PAGE REFERENCES: The LLM cites specific pages (8, 73) which cannot be verified against the ground truth and may be inaccurate. The ground truth does not provide page numbers, making these citations unverifiable and potentially fabricated. The core issue is that the LLM introduces specific financial figures that contradict the ground truth's explicit statement that such figures are not disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 517,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose from $428 million in 2022 to $605 million in 2023 and further to $785 million in 2024 (U.S. + International totals shown in the 2024, 2023 and 2022 columns of the Hospital Acute Care table)【page_130】. The consistent upward trajectory signals that Prevymis is gaining traction and a larger share of the Hospital Acute Care market, indicating a strengthening market position and growing adoption in hospital‑based transplant settings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the sales figures for 2022 and 2023. Ground truth shows: 2022=$370M, 2023=$428M, 2024=$785M. LLM states: 2022=$428M, 2023=$605M, 2024=$785M. The 2022 figure is completely wrong ($428M vs $370M - off by $58M or 15.7%), and the 2023 figure is also incorrect ($605M vs $428M - off by $177M or 41.4%). Only the 2024 figure of $785M is correct. These are not minor rounding differences but substantial discrepancies that fundamentally misrepresent the product's sales trajectory. The LLM also fails to calculate or mention the compound growth rate (approximately 46% CAGR 2022-2024 per ground truth), which is an important metric for assessing market positioning. The qualitative reasoning about market adoption and positioning is reasonable and appropriately contextual, but it is built on incorrect numerical foundations. The answer does address the evolution question and provides relevant context about Hospital Acute Care segment positioning, but the core quantitative errors severely undermine the credibility and accuracy of the response. The citation reference to page 130 suggests the LLM attempted to source the data, but clearly extracted or reported incorrect values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 355,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "- In 2022 Intel began earmarking a large share of its R&D budget for “process and packaging technology” as a cornerstone of its IDM 2.0 plan, even as it wrestled with 10 nm and Intel 4 node delays that threatened its roadmap (2022 10‑K p. 54‑55).  \n- By 2023 the advanced‑packaging effort was delivering measurable results – packaging revenue jumped sharply (2023 10‑K p. 38), the company secured multiple 18A design wins, expanded its IFS accelerator ecosystem and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard, positioning packaging as a unique AI‑focused advantage (2023 10‑K p. 36‑37).  \n- In 2024 Intel continued to promote advanced packaging as a strategic differentiator (2024 10‑K p. 35‑36) but flagged ongoing node delays, a $3.1 bn charge on the Intel 7 process (2024 10‑K p. 35) and capital‑constrained facility delays and penalties (2024 10‑K p. 34‑36), indicating that while its multi‑year investment trajectory strengthens the IDM 2.0 vision, execution is still hampered by manufacturing setbacks and limited funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-year information across Intel's 10-K filings from 2022-2024. STRENGTHS: (1) Correctly identifies the $3.1 billion Q3 2024 impairment charge on Intel 7 process node, matching ground truth exactly. (2) Accurately captures the three-year trajectory: 2022 challenges with process delays, 2023 positioning of advanced packaging as competitive differentiator with UCIe demonstration, and 2024 continued investment amid execution challenges. (3) Properly identifies key strategic initiatives (IDM 2.0, UCIe standard, IFS accelerator ecosystem, 18A design wins) and their evolution. (4) Correctly synthesizes the tension between strategic progress and execution constraints across the multi-year period. (5) Appropriately cites specific 10-K page references for verifiability. MINOR WEAKNESSES: (1) The LLM mentions 'packaging revenue jumped sharply' in 2023 but provides no specific number; ground truth doesn't provide a specific packaging revenue figure either, so this is acceptable but slightly vague. (2) References '10 nm and Intel 4 node delays' in 2022 but ground truth specifically mentions 'Intel 4 (formerly 7nm)' - the LLM's reference to '10 nm' appears to be an additional detail not contradicted by ground truth. (3) The LLM states R&D investments were '$16.5 billion in 2024' in the ground truth but the LLM answer doesn't explicitly cite this figure, though it references capital constraints. This is a minor omission but not a factual error. QUANTITATIVE VERIFICATION: The $3.1 billion impairment figure is correct and properly attributed to Q3 2024 and Intel 7 process. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple strategic initiatives, correctly linking manufacturing delays to capital constraints and their impact on IDM 2.0 execution. The logical flow from 2022 challenges → 2023 progress → 2024 constraints is sound and matches ground truth narrative. SEMANTIC EQUIVALENCE: The answer conveys the same core message as ground truth: strategic progress in packaging innovation was undermined by execution challenges and capital constraints. The conclusion appropriately reflects the tension between vision and reality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 617,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the company listed “client relationships and trust” as one of a broad set of competitive factors (Item 1 – Competition, page 3) and the same language re‑appears in the 2023 filing (Item 1 – Competition, page 3) and again in the 2024 filing (Item 1 – Competition, page 3). In each year’s risk‑factor section the firm also ties its reputation and client trust directly to its hybrid‑cloud and AI leadership (Item 1A – Risk Factors, page 5). This consistent but increasingly explicit connection indicates that IBM is elevating trusted client relationships from a generic differentiator to a core pillar of its hybrid‑cloud and AI strategy, using that trust to reinforce its market positioning and drive growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of IBM's positioning on client relationships and trust across 2022-2024, with generally accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies that IBM consistently emphasized 'client relationships and trust' across all three years (2022, 2023, 2024) in the Competition section of 10-K filings; (2) Accurately notes the connection between trust and hybrid cloud/AI strategy in Risk Factors sections; (3) Provides correct document references (Item 1 for Competition, Item 1A for Risk Factors); (4) Correctly synthesizes the evolution from generic differentiator to core strategic pillar; (5) Appropriately cites the Palo Alto Networks partnership context (though not explicitly mentioned in LLM answer, the strategic partnership concept aligns with ground truth). WEAKNESSES: (1) The LLM answer does not explicitly mention the Palo Alto Networks partnership that appears in the ground truth as a 2024 development signaling 'deepening of trust-based collaboration'; (2) The LLM answer lacks the specific framing that in 2022 IBM 'explicitly tied trust to its hybrid cloud platform and AI for production' - this nuance is missing; (3) The answer doesn't capture the 2023 reinforcement of trust 'as part of its broader competitive methods, including service and support, innovation, and talent' with the same specificity as ground truth. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension scores well (8/10) - the years and document sections are correctly cited. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across three years is correct, though some strategic details are omitted (7/10). CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question and its implications for strategy positioning (8/10). The answer is substantially correct but incomplete in capturing all strategic nuances present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 540,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "- In the 2022 Form 10‑K IBM disclosed the 0.950 % Notes due 2025 by incorporating the original 2017 Form 8‑K filing (Exhibit 4.1) that defined the holders’ rights 【page_30】.  \n- The 2023 Form 10‑K repeated the same reference, still pointing to the May 22 2017 Exhibit 4.1 (and the related 1.500 % Notes) 【page_20】.  \n- By the 2024 Form 10‑K IBM added a new supplemental indenture dated February 2 2024 (Exhibit 4.1) 【page_21】, indicating an amendment or refinancing of the same issue and keeping the security listed among its registered securities 【page_1】.  \n\nThis progression—from static reliance on the original 2017 filing to filing a fresh 2024 indenture—shows IBM moving from a passive “once‑issued, once‑disclosed” stance to a more active debt‑management approach that updates and re‑discloses material changes to its low‑coupon notes as market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key dates (May 22, 2017 for original filing; February 2, 2024 for supplemental indenture) and accurately references the 0.950% Notes due 2025 throughout. The progression narrative across 2022-2024 is chronologically sound. The LLM correctly notes the NYSE listing symbol IBM25B for 2024, which adds specificity beyond the ground truth.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces a claim about a 'supplemental indenture dated February 2, 2024' that is NOT mentioned in the ground truth answer. While this may be factually accurate from the source documents, it represents a material addition that changes the narrative from 'consistent disclosure framework' (ground truth) to 'active debt-management approach with amendments' (LLM). This is a significant interpretive divergence. (2) The LLM's characterization of the progression as moving from 'passive once-issued, once-disclosed stance to more active debt-management' contradicts the ground truth's assessment of 'stable and transparent debt management strategy.' The ground truth emphasizes consistency and continuity; the LLM emphasizes change and active management. (3) The LLM mentions '1.500% Notes' in the 2023 reference, which is not in the ground truth and may introduce confusion about whether this is part of the same instrument or a separate one.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but does so by introducing elements (the February 2024 supplemental indenture) that fundamentally alter the interpretation of IBM's strategy. The ground truth emphasizes 'sustained presence' and 'consistent disclosure framework,' while the LLM emphasizes 'amendment' and 'active management.' These are materially different conclusions about the same debt instrument.\n\nNUMERIC/DATE ACCURACY: All dates mentioned are correct (May 22, 2017; February 2, 2024; 2022-2024 fiscal years). The coupon rate (0.950%) and maturity year (2025) are correct. The NYSE symbol IBM25B is correctly identified.\n\nSEMANTIC DIVERGENCE: While both answers discuss the same instrument across the same time period, they reach different conclusions about what the progression indicates. The ground truth sees stability; the LLM sees evolution toward active management. This is a fundamental interpretive difference that affects the answer's alignment with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 636,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "- In the 2022 filing Intel introduced PowerVia as a future “back‑side power delivery” innovation that would first appear in the Intel 20A node after Intel 3 【page_7】.  \n- The 2023 filing reiterated that PowerVia was slated for Intel 20A, describing it as a breakthrough to add ~15 % performance‑per‑watt over Intel 3 【page_14】.  \n- By the 2024 filing Intel had moved PowerVia forward to the Intel 18A node, calling it the first high‑volume commercial implementation of backside power and targeting high‑volume production with the Panther Lake family in 2025 【page_10】.  \n\nThis shift shows Intel accelerating its backside‑power roadmap, bringing PowerVia to market a node earlier than originally planned (from 20A to 18A) to boost performance‑per‑watt and signal efficiency in its advanced process technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of Intel filings. STRENGTHS: (1) Correctly identifies the timeline progression: 2022 introduction, 2023 positioning in Intel 20A, 2024 shift to Intel 18A. (2) Accurately captures the strategic pivot from concept to technical integration to commercial deployment. (3) Correctly identifies Intel 18A as the first high-volume commercial implementation with Panther Lake targeting 2025 production. (4) Accurately cites the ~15% performance-per-watt improvement metric for Intel 20A. (5) Properly synthesizes the acceleration narrative - moving PowerVia from 20A to 18A represents bringing it to market earlier than originally planned. (6) Multi-hop reasoning is sound: connects the evolution across years, identifies the strategic shift, and draws appropriate conclusions about Intel's commitment to backside power delivery. MINOR CONSIDERATIONS: The LLM answer includes page references (【page_7】, 【page_14】, 【page_10】) which add specificity but aren't part of the ground truth evaluation. The phrasing \"accelerating its backside-power roadmap\" and \"bringing PowerVia to market a node earlier\" accurately captures the strategic intent. The answer is slightly more concise than the ground truth but covers all essential points with equivalent semantic meaning. No calculation errors detected. All entities (Intel, PowerVia, Intel 20A, Intel 18A, Panther Lake, 2022-2024 timeline) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 425,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 10‑K filings for 2022, 2023 and 2024 all incorporate the same “Form of Restricted Stock Unit Award Agreement” exhibits – the RSU agreements are tied to the Amended and Restated 2013 Stock Award and Incentive Plan and to the 2021 Long‑Term Incentive Plan (e.g., *10.61, *10.63‑*10.65 in 2022 【page_115】; *10.78‑*10.81 in 2023 【page_117】; *10.86‑*10.88 in 2024 【page_116】). The repeated inclusion of identical RSU forms and vesting schedules across these years shows that Medtronic’s U.S. equity‑compensation framework has remained consistent and stable, with no major redesigns to its RSU program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) WRONG EXHIBIT NUMBERS: The LLM cites exhibits *10.61, *10.63-*10.65 for 2022, *10.78-*10.81 for 2023, and *10.86-*10.88 for 2024. The ground truth specifically references Exhibit 10.54 as the relevant RSU Award Agreement for U.S. Employees. The LLM's exhibit citations appear to be incorrect or fabricated. (2) WRONG PLAN REFERENCES: The LLM mentions both the 'Amended and Restated 2013 Stock Award and Incentive Plan' and the '2021 Long-Term Incentive Plan,' but the ground truth focuses on the August 27, 2013 filing date as the consistent reference point across all three years. The LLM introduces the 2021 plan without ground truth support. (3) INCOMPLETE CORE FINDING: While the LLM correctly identifies that RSU agreements remained consistent across 2022-2024, it fails to specifically cite Exhibit 10.54 or the August 27, 2013 filing date that the ground truth emphasizes as the key evidence of stability. (4) ADDED DETAILS NOT IN GROUND TRUTH: The LLM adds page numbers (page_115, page_117, page_116) and specific vesting schedule references that are not mentioned in the ground truth and cannot be verified. The core conclusion about stability is correct, but the supporting evidence is largely incorrect or unsupported. The answer demonstrates partial understanding of the question but fails on factual accuracy regarding specific exhibit numbers and plan references, which are critical details in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 422,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Beginning in 2022, Intel warned that its newly‑adopted disaggregated design strategy—building processors and components on different nodes and joining them with advanced‑packaging technologies—added “new areas of complexity” and could cause delays and higher costs (pages 54‑55). In 2023, while advanced‑packaging revenue grew and the company secured several design wins, capital constraints forced the postponement of fab expansions in Ohio, Germany, Poland, Malaysia and Israel, and the same disaggregated‑design complexity heightened execution risk and contributed to an operating loss (pages 34‑38). By 2024, Intel continued to position advanced packaging as a strategic differentiator for AI and systems‑of‑chips, yet construction delays, penalty charges for scaled‑back capacity projects (e.g., Ireland SCIP) and the logistical and cost challenges of the disaggregated approach persisted, keeping the strategic positioning vulnerable (pages 34‑36).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc across 2022-2024 regarding Intel's advanced packaging challenges, disaggregated design complexity, and execution difficulties. The qualitative framing of strategic positioning evolution is sound, and the answer appropriately synthesizes information across multiple years. The mention of specific geographies (Ohio, Germany, Poland, Malaysia, Israel, Ireland) and the SCIP project adds relevant detail. The answer correctly identifies advanced packaging as a strategic differentiator and acknowledges capital constraints and execution risks.\n\nCRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth explicitly mentions a \"$3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node\" in 2024. This is a major financial metric that the LLM answer completely omits. This is a significant factual gap for a financial question. (2) INCOMPLETE 2023 DETAIL: The ground truth emphasizes Intel's strategic advantage positioning with UCIe standard and 2.5D/3D solutions in 2023, which the LLM answer mentions only vaguely as \"advanced-packaging revenue grew.\" (3) VAGUE REFERENCES: The LLM answer mentions \"penalty charges for scaled‑back capacity projects\" without specificity, whereas the ground truth provides concrete context about the Intel 7 node impairment. (4) PAGE REFERENCES: While the LLM provides page citations, these cannot be verified against the ground truth and may be fabricated or inaccurate.\n\nMULTI-HOP REASONING: The answer demonstrates adequate synthesis across the three-year period, correctly showing progression from 2022 acknowledgment of complexity, through 2023 strategic positioning, to 2024 execution challenges. However, the failure to include the $3.1 billion impairment charge represents incomplete multi-hop synthesis of financial data across years.\n\nQUANTITATIVE ACCURACY: Score of 4 reflects the complete omission of the $3.1 billion impairment charge, which is a critical quantitative element. While other numbers aren't contradicted, the absence of this key metric is a major factual gap.\n\nQUALITATIVE ACCURACY: Score of 7 reflects generally sound reasoning and entity identification, but with incomplete synthesis of strategic positioning details (UCIe standard, 2.5D/3D solutions) and vague treatment of execution challenges.\n\nCONTEXTUAL RELEVANCE: Score of 8 reflects strong alignment with the question's focus on strategic positioning evolution, delays, capital constraints, and disaggregated design approaches, though the answer could better emphasize the financial impact metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 705,
        "total_tokens": 2206
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s defined‑benefit pension target allocations shifted from an almost all‑fixed‑income stance in FY 2022 (U.S. plans 100 % debt; non‑U.S. plans 48 % debt and 21 % equity) to a modest equity tilt in FY 2023 (U.S. still 100 % debt; non‑U.S. equity rose to 27 % while debt stayed at 48 %) and, by FY 2024, to a slightly lower equity share but a broader mix (U.S. plans 94 % debt, 6 % cash; non‑U.S. plans 23 % equity, 42 % debt, 5 % cash, 21 % insurance contracts, 9 % other)【page_88】【page_95】. This gradual rebalancing—adding equity and cash while trimming debt—shows Accenture is seeking higher long‑term, risk‑adjusted returns while still preserving a core fixed‑income base to match liabilities and limit volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific numerical data about Accenture's target asset allocations across fiscal years 2022-2024, which is more concrete than the ground truth answer. The quantitative details appear reasonable and internally consistent (e.g., percentages sum appropriately within each category). However, there are several concerns: (1) The ground truth emphasizes a 'diversified portfolio' and 'dual focus' on fixed income and equities across all years, while the LLM characterizes FY2022 as 'almost all-fixed-income' for U.S. plans (100% debt), which may overstate the fixed-income emphasis. (2) The ground truth stresses 'increased emphasis on flexibility' and 'variation within established ranges' as key strategic shifts, but the LLM focuses primarily on percentage changes rather than the flexibility/adaptability dimension. (3) The LLM's interpretation of the shift as 'adding equity and cash while trimming debt' is partially supported but somewhat contradicts the ground truth's emphasis on maintaining a 'consistent emphasis on balancing fixed income and equities.' (4) The LLM provides specific page references (page_88, page_95) suggesting direct citation from source documents, which adds credibility, though these cannot be independently verified. (5) The multi-hop reasoning is sound—the LLM correctly synthesizes data across three fiscal years and draws a logical conclusion about risk-adjusted returns. (6) The characterization of the strategy as 'gradually rebalancing' is reasonable but may not fully capture the nuance of 'refining approach to managing pension risk in dynamic markets' emphasized in the ground truth. Overall, the LLM answer is more specific and data-driven than the ground truth but may miss some strategic nuances about flexibility and adaptability that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 496,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K filings for 2023 and 2024 still list the 1.05 % notes due 2017 in Exhibit 4.4 (see the exhibit indexes for both years that include “1.05 % Notes due 2017” 【page_56】), indicating that Apple deliberately keeps legacy debt instruments on the record and discloses every outstanding issue rather than removing older notes from its filings. At the same time, Apple’s broader 2022‑2024 debt program has been expanding with a variety of new issuances—floating‑rate notes, 2.40 % notes due 2023, 3.85 % notes due 2043, and the 2023‑issued 4.421 % notes due 2026, 4.000 % notes due 2028, 4.150 % notes due 2030, etc. (see Exhibit 4.28 and other exhibit listings) 【page_58】—showing a strategy of diversifying maturities and rates to manage financing needs while maintaining comprehensive historical debt disclosure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Apple's debt disclosure approach and provides relevant context about its broader debt strategy. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies that the 1.05% Notes due 2017 appear in 2023 and 2024 filings despite maturity\n2. Accurately characterizes this as a 'comprehensive historical record' approach\n3. Properly contrasts legacy debt with new issuances\n4. Correctly identifies the diversification strategy across maturities and rates\n5. Good synthesis of the multi-hop question (historical disclosure vs. broader strategy)\n6. Appropriate reference to Exhibit 4.4 and 4.28\n\nWEAKNESSES:\n1. QUANTITATIVE ERRORS: The LLM introduces specific debt instruments NOT mentioned in the ground truth:\n   - Ground truth mentions: Floating Rate Notes due 2020, 2.15% Notes due 2022, 3.45% Notes due 2024\n   - LLM adds: 2.40% notes due 2023, 3.85% notes due 2043, 4.421% notes due 2026, 4.000% notes due 2028, 4.150% notes due 2030\n   - These additional instruments cannot be verified against the ground truth and may be fabricated or from different time periods\n\n2. MISSING GROUND TRUTH EXAMPLES: The LLM does not mention the specific debt instruments listed in the original answer (2.15% Notes due 2022, 3.45% Notes due 2024), instead substituting different ones\n\n3. INCOMPLETE COMPARISON: While the LLM discusses the broader strategy, it doesn't explicitly compare the 2022-2024 issuances to the historical 1.05% Notes as clearly as the ground truth does\n\nMULTI-HOP REASONING:\nThe reasoning is sound in structure—connecting historical disclosure practices to current debt management strategy. However, the introduction of unverified debt instruments undermines the factual foundation of this reasoning.\n\nSEMANTIC EQUIVALENCE:\nThe core message is semantically equivalent: Apple maintains comprehensive historical debt disclosure while actively managing a diversified debt portfolio. However, the specific examples provided diverge significantly from the ground truth, which is problematic for a financial question requiring precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 582,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.2 million Class A shares for $4.11 billion, leaving $3.13 billion of available authorization (total outstanding authority $6.13 billion after a $3 billion add‑on)【page_94】【page_93】. In fiscal 2023 the company continued a similar buy‑back pace (≈$4 billion of shares) and the remaining pool fell to roughly $2.9 billion, as shown in the 2023 10‑K (pages 37‑41). In fiscal 2024 it bought $4.5 billion of shares (including $605 million in Q4) with $2.694 billion still available, and the board subsequently approved an extra $4 billion, raising total authority to $6.694 billion【page_39】【page_40】. This steady repurchase activity combined with periodic top‑ups of repurchase authority demonstrates a deliberate, long‑term capital‑return strategy that consistently returns cash to shareholders while preserving ample capacity for future buy‑backs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core capital return strategy pattern and provides good multi-hop synthesis across fiscal years 2022-2024. The final authorization amounts are accurate ($2.694B available in FY2024, $4B new authorization approved, $6.694B total). The qualitative interpretation about 'deliberate, long-term capital-return strategy' aligns well with the ground truth. Page citations demonstrate source verification.\n\nCRITICAL ERRORS: (1) FY2022 repurchase amount: LLM states '$4.11 billion' but ground truth only mentions 'over $605 million' for FY2024 specifically without confirming $4.11B for FY2022. (2) FY2023 repurchase amount: LLM claims '≈$4 billion' but ground truth states '2023 filing mirrors 2024 disclosures' without confirming specific $4B figure. (3) FY2024 repurchase amount: LLM states '$4.5 billion total' but ground truth only confirms 'over $605 million' for FY2024 alone - the $4.5B figure is not verified in ground truth. (4) Share count: LLM mentions '12.2 million Class A shares' for FY2022 but ground truth does not provide this detail.\n\nPARTIAL ACCURACY: The available authorization progression ($3.13B → $2.9B → $2.694B) is directionally correct and the $4B new authorization in September 2024 is accurate. However, the intermediate FY2023 figure of '$2.9B' differs slightly from what might be expected in the progression.\n\nMULTI-HOP REASONING: The synthesis across three fiscal years is sound in structure, but relies on unverified repurchase amounts for FY2022 and FY2023. The connection between repurchase activity and authorization depletion is logical, but the specific dollar amounts driving this pattern cannot be confirmed against ground truth.\n\nSEMANTIC EQUIVALENCE: The conclusion about 'sustained but measured capital return strategy' vs. 'deliberate, long-term capital-return strategy' are semantically equivalent and both appropriate.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the multi-year pattern and capital allocation strategy, but contains unverified quantitative claims for FY2022 and FY2023 repurchase amounts that cannot be confirmed in the ground truth. The FY2024 figure of $4.5B total (vs. $605M confirmed) is particularly problematic as it appears to conflate multiple years' activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 615,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMS’s 4.350 % senior notes due 2047 are listed as Exhibit 4ff in each of the three most recent 10‑K filings – they appear in the 2022 filing’s exhibit index (Exhibit 4ff referencing the 2019 8‑K)【page_139】, are repeated in the 2023 filing’s exhibit index (again as Exhibit 4ff)【page_135】, and are again shown in the 2024 filing’s exhibit list and summary of terms (Exhibit 4ff)【page_134】. The note’s unchanged presence across 2022‑2024 indicates that BMS has retained this long‑dated, fixed‑rate instrument rather than refinancing it, using supplemental indentures only for administrative updates. This pattern reflects a financing strategy that locks in low‑cost, multi‑decade debt to provide stable, long‑term capital for the company’s operations and growth initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.350% Senior Notes due 2047 as a persistent instrument across 2022-2024, correctly notes the exhibit references (Exhibit 4ff), and accurately identifies the underlying 2019 indenture date. The core observation about retention rather than refinancing is sound. CRITICAL WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to address the broader context provided in the ground truth about OTHER debt issuances during this period. The ground truth specifically mentions that BMY issued $1.75B 2.950% Notes due 2032 (2023) and $2B 3.700% Notes due 2052 (2023), plus $3.75B 4.250% Senior Notes due 2049 (2024). The LLM completely omits these comparative issuances, which are essential to understanding the 'multi-year pattern' and 'diversified long-term liabilities with staggered maturities' strategy. (2) INCOMPLETE ANSWER TO QUESTION: The question explicitly asks how the debt 'evolved across 2022, 2023, and 2024' and what the 'multi-year pattern indicates.' The LLM provides only exhibit-level documentation evidence without synthesizing the actual evolution of BMY's debt portfolio strategy across these years. (3) CHARACTERIZATION ERROR: The LLM describes the 4.350% notes as 'low-cost' debt, but at 4.350%, this is actually a HIGHER yield than the 2.950% (2032) and 3.700% (2052) notes issued in 2023, and comparable to the 4.250% (2049) notes issued in 2024. This mischaracterizes the note's role in the portfolio. (4) MISSING STRATEGIC INSIGHT: The ground truth emphasizes that the persistence of the 2047 notes 'despite new issuances' indicates a strategy of maintaining diversified maturities. The LLM focuses only on retention/non-refinancing without addressing the strategic diversification across multiple maturity dates and coupon rates. QUANTITATIVE: The 4.350% rate and 2047 maturity are correct; exhibit references are correct. However, the omission of other debt instruments' rates and amounts represents incomplete quantitative synthesis. QUALITATIVE: The reasoning about exhibit persistence is sound but shallow; fails to synthesize the broader capital structure evolution that the question requires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 582,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s disclosure of the 2.40 % Notes due 2023 remained essentially unchanged over the three years – the notes were listed in the “Officer’s Certificate of the Registrant” (Exhibit 4.3) as part of the description of its global notes in each Form 10‑K. The 2022 filing shows the note in the exhibit table 【page_58†L1-L5】, the 2023 filing repeats the same listing in its exhibit index (pages 53‑57, e.g., the table on page 56), and the 2024 filing again includes the identical entry 【page_56†L1-L5】. Thus Apple’s approach was consistent, providing a simple, static reference to the 2.40 % Notes due 2023 in each filing as the maturity date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both responses correctly identify that Apple's disclosure approach for the 2.40% Notes due 2023 remained consistent and unchanged across the 2022, 2023, and 2024 filings. Key strengths: (1) Correctly identifies the note percentage (2.40%) and maturity year (2023); (2) Accurately references Exhibit 4.3 as the location of disclosure; (3) Correctly identifies the Officer's Certificate dated May 3, 2013 as the reference document; (4) Properly synthesizes the multi-hop information across three years of filings; (5) Accurately characterizes the disclosure as 'consistent,' 'static,' and 'unchanged' - semantically equivalent to the ground truth's 'stable and unchanging'; (6) Correctly notes that despite approaching/reaching maturity, the format remained the same. Minor observations: The LLM answer includes specific page references (pages 53-57, page 56, page 58, page 56) which add helpful detail but cannot be verified against the ground truth provided. These references appear reasonable and don't contradict the ground truth. The LLM's phrasing 'simple, static reference' effectively conveys the same meaning as the ground truth's 'standardized and consistent reporting strategy.' The answer demonstrates sound multi-hop reasoning by correctly synthesizing disclosure patterns across three separate filing years. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 401,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Class A ordinary shares for awards in fiscal 2022 (and the filing shows no change for FY 2023)【page_91】, and this ceiling was raised to 141 million shares by fiscal 2024【page_98】. The 14‑million‑share increase signals that Accenture is expanding its equity‑award pool, underscoring a long‑term strategy to rely more heavily on share‑based compensation to attract, retain and align employees with shareholder interests.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the fiscal year progression. According to the ground truth: FY2022 = 127M shares, FY2023 = 141M shares, FY2024 = 141M shares (remained stable). However, the LLM states: FY2022 = 127M, FY2023 = no change, FY2024 = 141M. This is INCORRECT - the increase occurred between FY2022 and FY2023, not between FY2023 and FY2024. The LLM incorrectly places the 14-million-share increase in the wrong fiscal year transition. COMPLETENESS ISSUE: The LLM fails to address the full evolution requested in the question. It does not clearly state that FY2023 and FY2024 had the same authorized share count (141M), which is a key part of the 'progression' narrative. The ground truth explicitly notes 'remained at that level in fiscal year 2024,' indicating stability after the increase - this nuance is missing from the LLM answer. REASONING QUALITY: While the LLM's interpretation of the strategic implications (expanding equity-award pool, attracting/retaining employees, aligning with shareholder interests) is reasonable and aligns with the ground truth's assessment, this qualitative reasoning cannot compensate for the fundamental factual error in the year-to-year progression. ENTITY ACCURACY: Company name (Accenture plc) and plan name (Amended 2010 SIP/Share Incentive Plan) are correct. NUMERIC VERIFICATION: The numbers 127M and 141M are correct, but their assignment to fiscal years is wrong. The 14M difference calculation is correct, but applied to the wrong year transition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 432,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "Intel first announced PowerVia in its 2022 filing as a new “back‑side power” concept on the future process‑and‑packaging roadmap, grouped with other next‑gen technologies such as RibbonFET (page 7). By the 2023 filing PowerVia was highlighted as one of the two breakthrough features of the planned 20A node, projected to add up to a 15 % performance‑per‑watt improvement (page 14), and the 2024 filing shows it now slated for high‑volume implementation in the upcoming 18A node (Panther Lake), described as an industry‑first backside‑power delivery method that eliminates front‑side power routing (page 10). This progression—from roadmap concept to a key production‑ready element—demonstrates that PowerVia has become a strategic pillar of Intel’s advanced‑process roadmap, essential for boosting performance, power efficiency and signal integrity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of PowerVia across 2022-2024. STRENGTHS: (1) Correctly identifies PowerVia's introduction in 2022 as a roadmap concept alongside RibbonFET; (2) Accurately describes the 2023 positioning within Intel 20A as 'industry-first implementation of backside power delivery'; (3) Correctly notes the 2024 shift to Intel 18A with Panther Lake for high-volume manufacturing in 2025; (4) Properly characterizes the progression from roadmap concept to production-ready element; (5) Includes the specific 15% performance-per-watt improvement metric from 2023 filing; (6) Accurately describes the elimination of front-side power routing. MINOR WEAKNESSES: (1) The answer does not explicitly mention that Intel 20A was canceled in favor of 18A—it states PowerVia is 'now slated for high-volume implementation in the upcoming 18A node' but doesn't clarify the cancellation decision, which is a key strategic pivot in the ground truth; (2) The answer references specific page numbers (7, 14, 10) which cannot be verified against the ground truth and may or may not be accurate; (3) Slightly less explicit about the strategic importance of maintaining competitive parity, though it does mention strategic pillar status. QUANTITATIVE VERIFICATION: The 15% performance-per-watt improvement figure is correctly cited and matches ground truth. All dates (2022, 2023, 2024, 2025) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly traces the evolution of PowerVia's role. The logical progression is sound and well-articulated. SEMANTIC EQUIVALENCE: The answer conveys the essential information from the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 498,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s fair‑value holding of mutual‑fund equity securities in its non‑U.S. defined‑benefit pension assets fell from **$239 million in FY 2022** (page 89) to **$196 million in FY 2023** (page 96), then rose sharply to **$274 million in FY 2024** (page 96). The dip in 2023 followed by a sizable rebound in 2024 suggests the company trimmed equity exposure for a year and then re‑emphasized equity‑based investments, reflecting a strategic tilt back toward capital‑appreciation opportunities in the equity market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental quantitative inaccuracies that make it substantially incorrect. (1) MAJOR NUMBER ERRORS: The ground truth shows FY 2022: $239,293 million, FY 2023: $196,226 million, FY 2024: $196,226 million. The LLM reported FY 2022: $239 million, FY 2023: $196 million, FY 2024: $274 million. The LLM dropped three decimal places (millions vs. thousands), making all numbers off by a factor of 1,000. More critically, the FY 2024 figure of $274 million is completely wrong—the ground truth shows $196,226 million (unchanged from 2023), not $274 million. (2) TRAJECTORY MISINTERPRETATION: The LLM claims a 'sizable rebound in 2024' to $274 million, but the actual data shows the allocation remained flat at $196,226 million from 2023 to 2024. This is a fundamental misreading of the data that leads to an entirely incorrect strategic interpretation. (3) STRATEGIC CONCLUSION ERROR: The LLM concludes the company 're-emphasized equity-based investments' with a 'strategic tilt back toward capital-appreciation opportunities,' but the ground truth indicates consistent reduction and then stabilization—no rebound occurred. The correct interpretation is strategic rebalancing away from mutual fund equities, not a return to them. (4) PARTIAL CREDIT: The LLM correctly identified the asset class (mutual fund equity securities), correctly noted the 2022-2023 decline, and appropriately referenced pension assets. However, these correct elements are overshadowed by the critical quantitative errors and false FY 2024 data point. The answer fails on the primary metric of factual accuracy for a financial question requiring precise numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 457,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "- In the 2022 filing Merck carried Dificid (fidaxomicin) as a net intangible‑asset of **$145 million** and never recorded an impairment charge for it, indicating the valuation was left unchanged through the later years【page_115】.  \n- The product is consistently placed in the **Hospital Acute‑Care franchise** as the antibiotic for *C. difficile*‑associated diarrhea in the 2023 and 2024 disclosures【page_4】.  \n- Its global sales have risen steadily, from **$263 million in 2022** (U.S. $241 m, International $22 m) to **$302 million in 2023** and **$340 million in 2024** (U.S. $303 m, International $37 m)【page_130】, showing an expanding contribution to Merck’s overall revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with mostly correct financial data and sound multi-hop reasoning. STRENGTHS: (1) The $145 million intangible asset valuation for 2022 is correct and properly contextualized. (2) The therapeutic positioning in Hospital Acute Care franchise for C. difficile-associated diarrhea is accurately identified for 2023-2024. (3) The 2024 revenue figures are correct: $340 million global ($303M U.S., $37M international). (4) The progression narrative effectively synthesizes information across years showing evolution from asset valuation to revenue contribution. (5) The statement about no impairment charges is a valuable additional detail. MINOR ISSUES: (1) The LLM provides 2022 revenue data ($263M total: $241M U.S., $22M international) and 2023 revenue ($302M) that are not explicitly mentioned in the ground truth answer, though these appear to be accurate supplementary information that strengthens the answer rather than contradicting it. (2) The ground truth emphasizes the 2022 asset as 'relatively minor' while the LLM focuses more on the revenue trajectory without explicitly characterizing the asset as minor, though this is a semantic rather than factual difference. (3) The answer could have been slightly more explicit about the strategic shift from balance sheet asset focus to revenue performance focus, though this is implied. QUANTITATIVE VERIFICATION: All dollar amounts check out correctly ($145M in 2022, $340M in 2024 with correct U.S./international breakdown). The revenue progression ($263M→$302M→$340M) shows logical growth trajectory. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (asset valuation, therapeutic positioning, revenue contribution), demonstrating proper multi-hop analysis. The connection between the intangible asset treatment and subsequent revenue performance is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 522,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022 – Intel poured $17.5 bn into R&D (up‑front spend on process and advanced‑packaging R&D) but warned that its disaggregated‑design strategy and novel packaging technologies added “new areas of complexity…delays or failures … could adversely affect our ability to timely introduce competitive products” (2022 risk discussion). In 2023 R&D fell to $16.0 bn while the company captured momentum – four 18A design wins and five additional wins drove $483 m of packaging‑related revenue, yet the higher spend produced an operating loss (2023 financials). By 2024 R&D rose again to $16.5 bn and Intel positioned advanced packaging as a core differentiator (e.g., Universal Chiplet Interconnect Express demonstrated in silicon), but it disclosed persistent execution risks – ongoing integration delays in disaggregated designs and a $755 m penalty charge for construction delays – highlighting heightened financial‑risk exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Multiple significant numerical errors: LLM states R&D was '$17.5 bn' in 2022, '$16.0 bn' in 2023, and '$16.5 bn' in 2024, but ground truth does not provide these specific R&D figures for verification. More critically, LLM cites '$483 m of packaging-related revenue' in 2023 and '$755 m penalty charge for construction delays' in 2024, but ground truth mentions '$3.1 billion impairment charge' in 2024 (not $755m). The $755m figure appears to be fabricated or misattributed. (2) FACTUAL DISCREPANCIES - Ground truth explicitly states Intel faced a '$3.1 billion impairment charge tied to manufacturing assets' in 2024, but LLM completely omits this critical financial metric and instead cites a '$755 m penalty charge for construction delays' which is not mentioned in ground truth. This is a major factual error. (3) PARTIAL CREDIT FOR CORRECT ELEMENTS - LLM correctly identifies: the evolution from 2022-2024, the complexity/delays theme in 2022, the 2023 progress on 2.5D/3D packaging and UCIe demonstration in silicon, the shift toward operational strain by 2024, and the general trajectory from optimism to financial pressure. (4) MULTI-HOP REASONING - The LLM demonstrates reasonable synthesis across years and connects R&D investment to execution challenges, but the fabricated/incorrect financial figures undermine the credibility of the analysis. (5) MISSING CONTEXT - LLM fails to mention the $3.1 billion impairment charge, which is a cornerstone of the ground truth's narrative about mounting financial pressure. The answer conflates or invents different financial metrics. OVERALL: While the LLM captures the general narrative arc and some correct details (UCIe, design wins, execution risks), the introduction of incorrect or unverified financial figures ($755m vs. $3.1bn impairment) and the omission of the major impairment charge represent fundamental factual errors that significantly undermine answer quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 535,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- In the 2022 filing Merck listed MK‑8591A (doravirine + islatravir) as a Phase‑3 HIV‑1 regimen that was already under an FDA clinical hold because of observed lymphocyte and CD4⁺‑cell declines (see 2022 10‑K pipeline chart †page 23 and the “clinical hold” paragraph †page 24).  \n- The 2023 filing noted that the Phase‑3 program was slated to begin in 2023, but the hold remained in place and the investigational NDAs for the doravirine/islatravir combination were still pending (see 2023 10‑K description †page 21 and pipeline chart †page 24).  \n- By the 2024 filing the hold on MK‑8591A persisted (pipeline chart †page 22) and Merck added a next‑generation islatravir/lenacapavir candidate (MK‑8591D) slated for Phase 2/3 entry in October 2024, signaling that the company continues to invest in the islatravir platform despite regulatory setbacks (pipeline chart †page 24).  \n\n**Interpretation:** Merck’s steady inclusion of MK‑8591A in its pipeline and the launch of a new islatravir‑based combination show a long‑term commitment to developing an HIV‑1 treatment, using lower‑dose or alternative regimens to address safety concerns while persisting through the FDA hold.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies MK-8591A as a doravirine+islatravir combination in Phase 3 development across 2022-2024, accurately notes the FDA clinical hold due to lymphocyte/CD4+ cell declines, and correctly identifies the introduction of MK-8591D (islatravir/lenacapavir) as a next-generation candidate. The interpretation about Merck's long-term commitment to the islatravir platform despite regulatory setbacks is sound and well-reasoned. The multi-hop synthesis across three years of filings is logically coherent.\n\nCRITICAL ERRORS: The LLM answer contains a significant factual discrepancy regarding the clinical hold status in 2024. The ground truth explicitly states that 'the FDA lifted a clinical hold on December 4, 2024,' indicating resolution of the regulatory concern. However, the LLM answer states 'by the 2024 filing the hold on MK-8591A persisted,' which directly contradicts the ground truth. The ground truth also notes 'the compound remained under a partial clinical hold for higher doses,' which is a nuanced distinction the LLM missed—the full hold was lifted but a partial hold remained. This is a material factual error that affects the core narrative of regulatory progress.\n\nQUANTITATIVE ISSUES: The LLM provides specific page references (page 23, 24, 21, 22, 24) but these cannot be verified against the ground truth provided. The date 'December 4, 2024' for the clinical hold lift is mentioned in the ground truth but completely absent from the LLM answer, representing a missing key date.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression from MK-8591A to MK-8591D, showing understanding of the platform strategy. However, the failure to capture the December 2024 clinical hold lift undermines the completeness of the 2024 analysis.\n\nSEMANTIC EQUIVALENCE: While the LLM's interpretation of Merck's commitment is reasonable, it mischaracterizes the 2024 status by suggesting the hold 'persisted' when it was actually lifted (though partially). This is not merely a wording difference but a factual error about regulatory status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 575,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "- In the 2022 Form 10‑K Merck introduced MK‑1308A as the quavonlimab + pembrolizumab co‑formulation, entered Phase 3 in April 2021 and being evaluated for renal‑cell carcinoma (RCC)【page_23†L1-L4】【page_25†L9-L15】.  \n- The 2023 filing still describes MK‑1308A with the same pembrolizumab combination and RCC focus, and no new partner or regulatory milestone is noted【page_20†L1-L4】.  \n- The 2024 Form 10‑K continues to place MK‑1308A in Merck’s immuno‑oncology pillar as a pembrolizumab‑based combo for RCC, remaining in Phase 3 with no FDA/EMA submission or approval reported to date【page_49†L1-L4】【page_50†L1-L4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies MK-1308A as a quavonlimab + pembrolizumab co-formulation, accurately tracks its RCC indication across all three years (2022-2024), and correctly notes it remained in Phase 3 throughout this period with no regulatory approval. The answer appropriately synthesizes information across multiple years and correctly identifies the immuno-oncology focus. The multi-hop reasoning connecting formulation, indication, and development stage is sound.\n\nWEAKNESSES AND ERRORS: (1) QUANTITATIVE ACCURACY ISSUE - The LLM states MK-1308A 'entered Phase 3 in April 2021' in the 2022 filing context. While this date may be accurate, the ground truth does not mention April 2021 specifically, and the LLM appears to be citing a specific date that goes beyond what the ground truth establishes. This represents potential over-specification without verification. (2) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes 'increasing specificity in formulation and therapeutic strategy over time,' noting that in 2022 it was 'listed as part of Merck's oncology pipeline' with less definition, while by 2023 it was 'explicitly described as a coformulation' with more specificity. The LLM answer suggests the formulation was already defined in 2022 ('introduced MK-1308A as the quavonlimab + pembrolizumab co-formulation'), which contradicts the ground truth's narrative of increasing specificity. (3) MISSING NUANCE - The ground truth emphasizes the progression from general listing to explicit coformulation description, suggesting a refinement in how Merck characterized the asset. The LLM treats the formulation as constant across years rather than highlighting this evolution. (4) CITATION FORMATTING - While citations are provided, they cannot be independently verified in this evaluation context.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across three years and identifies the consistent RCC focus and Phase 3 status. However, it misses the key evolution narrative about increasing specificity in formulation characterization that the ground truth emphasizes.\n\nSCORE JUSTIFICATION: The answer is substantially correct on core facts (indication, combination therapy, phase status, years) but contains a potential factual error regarding when the formulation was explicitly defined, and misses the key narrative about evolution in specificity. This places it in the 6-7 range, with 6 selected due to the formulation characterization discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 667,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture repurchased about 12.2 million Class A shares for roughly $4.1 billion in fiscal 2022, leaving $3.13 billion of authorized buy‑back capacity unused (pages 93‑94) and the Board added $3 billion of extra authority that year (page 94). The program continued into fiscal 2023 (the MD&A compares fiscal 2024 results to fiscal 2023, page 40), and in fiscal 2024 the company bought back $4.5 billion of shares—including $605 million in Q4 (pages 40 & 39)—while the remaining available authorization fell to $2.694 billion, prompting the Board to approve an additional $4 billion and raise total outstanding authority to $6.694 billion (page 39). This steady use of the buy‑back program combined with periodic boosts to the authorized limit underscores a disciplined, long‑term capital‑return strategy that relies on share repurchases to return excess cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) FISCAL 2022 REPURCHASE AMOUNT: LLM claims 12.2 million shares for $4.1 billion in fiscal 2022, but ground truth shows $3.129 billion available authorization remaining (not spent). The LLM appears to have confused authorization amounts with actual repurchase amounts. (2) FISCAL 2024 REPURCHASE AMOUNT: LLM states $4.5 billion in fiscal 2024 total repurchases, but ground truth explicitly states only $605 million in open-market purchases during fiscal 2024, plus 72,255 shares from employee transactions. This is a massive discrepancy ($4.5B vs $605M). (3) AUTHORIZATION FIGURES: LLM correctly identifies $3.13 billion remaining in fiscal 2022 and $2.694 billion in fiscal 2024, plus the $4 billion new authorization bringing total to $6.694 billion—these match ground truth. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the distinction between authorized repurchase capacity and actual repurchases executed. The ground truth indicates a 'measured' strategy with only $605M in fiscal 2024 repurchases, while LLM claims $4.5B, fundamentally mischaracterizing the capital return strategy. (5) CONTEXTUAL ISSUE: LLM's characterization of 'steady use' and 'disciplined long-term strategy' is contradicted by the actual data showing minimal fiscal 2024 repurchases ($605M) relative to available authorization. The ground truth emphasizes 'sustained but measured' approach, not aggressive buybacks. The answer demonstrates poor document synthesis and contains calculation/data extraction errors that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 455,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "BMS’s $750 million 2.350 % senior notes due 2040 are listed in each of its recent 10‑K filings – in the 2022 filing (exhibit 4.6 on page 137) 【page_137】, again in the 2023 filing (exhibit 4.6 on page 136) 【page_136】 and in the 2024 filing (exhibit 4.6 on page 134) 【page_134】.  By keeping this long‑dated, low‑coupon fixed‑rate tranche on its balance sheet, BMS is deliberately locking in inexpensive financing, smoothing interest‑expense over decades and extending the overall maturity profile of its debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All quantitative data is correct - $750 million principal amount, 2.350% coupon rate, 2040 maturity date are all accurate. (2) The multi-hop synthesis across three years (2022, 2023, 2024) is properly executed, with specific exhibit references (4.6) and page numbers provided for each filing year. (3) The strategic interpretation aligns with the ground truth - both identify the persistence of this debt instrument as reflecting a deliberate fixed-rate debt strategy. (4) The reasoning about 'locking in inexpensive financing' and 'smoothing interest expense' is semantically equivalent to the ground truth's discussion of 'fixed interest rate obligations' and 'interest rate risk management.' (5) The mention of extending the maturity profile adds relevant context about debt structure management. MINOR CONSIDERATIONS: (1) The LLM answer is more concise and specific (citing exact exhibit locations and page numbers) compared to the ground truth's more narrative approach. (2) The LLM uses 'BMS' as shorthand while ground truth uses 'BMY' - both are acceptable ticker variations for Bristol-Myers Squibb. (3) The ground truth emphasizes 'not refinanced or retired' while the LLM emphasizes 'keeping on balance sheet' - these convey the same strategic point. (4) The LLM's characterization of the notes as 'low-coupon' is accurate given the 2.350% rate in a historical context. No calculation errors detected. The answer fully addresses the question's core inquiry about how the persistence of this debt reflects BMS's long-term debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 451,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the three most recent Form 10‑K filings the company’s 4.350 % Senior Notes due 2047 are described exactly the same way – a fixed‑rate, 4.350 % issue with a 2047 maturity that was originally issued in the November 22 2019 supplemental indenture (2022 filing § 4jj [page 138]; 2023 filing § 4ff [page 136]; 2024 filing § 4jj [page 134]). The unchanged rate and maturity across years show BMS is deliberately locking in a moderate, long‑dated fixed‑rate tranche, reflecting a strategy of maintaining stable, predictable long‑term debt financing rather than repeatedly refinancing or altering terms.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT REFERENCES: The LLM answer contains significant factual errors in exhibit citations that directly contradict the ground truth. Ground truth states: 2022 filing uses Exhibit 4bbb, 2023 filing uses Exhibit 4ff, 2024 filing uses Exhibit 4ff. LLM answer states: 2022 filing § 4jj, 2023 filing § 4ff, 2024 filing § 4jj. This is a major discrepancy - the LLM incorrectly identifies the 2022 and 2024 exhibits as 4jj instead of 4bbb and 4ff respectively. INDENTURE DATE ERRORS: Ground truth specifies the Twelfth Supplemental Indenture dated November 13, 2020 (2022), Fourteenth Supplemental Indenture dated November 13, 2023 (2023), and incorporation by reference to Form 8-K from November 22, 2019 (2024). The LLM conflates these by stating all three years reference 'the November 22 2019 supplemental indenture,' which is incomplete and misleading - it omits the 2023 Fourteenth Supplemental Indenture dated November 13, 2023. CORRECT ELEMENTS: The LLM correctly identifies the 4.350% interest rate as consistent across all three years, correctly identifies the 2047 maturity date, and correctly characterizes the strategic implication of stable long-term debt financing. The qualitative analysis about BMS's deliberate strategy is sound and semantically equivalent to the ground truth. MULTI-HOP SYNTHESIS: The LLM demonstrates understanding of the multi-year pattern and strategic implications, but fails in the detailed factual synthesis required for a complete answer. The exhibit reference errors are particularly problematic because they are verifiable facts from SEC filings that should be precise. Page numbers provided by LLM (138, 136, 134) cannot be verified against ground truth but appear plausible. The core insight about stable debt strategy is correct, but the supporting documentation details are significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 503,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In the fiscal‑2022 10‑K Nike only listed FlyEase in its product‑research narrative as one of many emerging technologies, without any detail on how it was being manufactured. By the fiscal‑2024 10‑K the company still highlights FlyEase among its core tech portfolio, but couples that mention with concrete supply‑chain data – 96 footwear factories in 11 countries, 15 contract manufacturers, with roughly 50 % of footwear made in Vietnam, 27 % in Indonesia and 18 % in China, and the largest single factory accounting for about 9 % of total Nike‑brand footwear production – showing FlyEase is now produced at scale and fully integrated into Nike’s global manufacturing network.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy. STRENGTHS: (1) Correctly identifies the evolution narrative from fiscal 2022 (early-stage mention) to fiscal 2024 (integrated into core portfolio); (2) Accurately cites the geographic manufacturing percentages: Vietnam 50%, Indonesia 27%, China 18% - these match the ground truth exactly; (3) Properly synthesizes the multi-hop concept that manufacturing distribution data demonstrates FlyEase's scale and integration; (4) Contextually relevant to the question about evolution and quantitative evidence. CRITICAL ISSUES: (1) The LLM introduces substantial additional supply chain data (96 footwear factories in 11 countries, 15 contract manufacturers, largest single factory at ~9% of production) that is NOT present in the ground truth answer. While this data may be accurate from the 2024 filing, it goes beyond what the knowledge graph provided and represents unsourced claims; (2) The ground truth explicitly mentions fiscal 2023 as an intermediate step showing FlyEase mentioned alongside Nike Air and Dri-FIT, indicating growing integration - the LLM answer skips this important temporal evolution detail; (3) The LLM answer lacks the nuanced progression narrative (early-stage → growing integration → full-scale integration) that the ground truth emphasizes. QUANTITATIVE VERIFICATION: The three percentages (50%, 27%, 18%) are correct and match ground truth. However, the additional factory and manufacturer counts cannot be verified against the provided ground truth and represent potential hallucination or information from outside the knowledge graph. MULTI-HOP REASONING: The LLM correctly synthesizes that manufacturing distribution data demonstrates integration into global supply chain, but the reasoning is somewhat less explicit than the ground truth's clear progression narrative. The answer conflates additional supply chain metrics with the core evidence requested, potentially confusing the primary quantitative evidence (geographic percentages) with secondary details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 561,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s loyalty‑driven payment cards have been used for a shrinking share of purchases – RedCard (Target Debit, Credit and MasterCard) penetration fell from 20.5 % in FY 2022 to 19.8 % in FY 2023 and to 18.6 % in FY 2024【page_27】. The downward trend, echoed in the 2024 filing’s “Target Circle Card Penetration” figures (18.6 % in 2024 versus 19.8 % in 2023)【page_29】, suggests that while the program still drives a sizable portion of sales, its ability to generate incremental purchases is weakening, indicating diminishing effectiveness of the loyalty‑driven payment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM provides 18.6% for FY 2024 penetration rate, but the ground truth states 17.8% for 2024. This is a material discrepancy of 0.8 percentage points that fundamentally affects the analysis of the trend. The LLM correctly identifies 20.5% (2022) and 19.8% (2023), but the 2024 figure is incorrect. MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple pages/filings (referencing page_27 and page_29), which shows effort at multi-hop reasoning. However, the inconsistency between citing two different 2024 figures (18.6% appears twice in the answer) without reconciling them suggests confusion in the source material interpretation. COMPLETENESS: The answer addresses the evolution question and provides interpretation of the trend, which is appropriate. However, the incorrect 2024 number undermines the validity of the trend analysis. SEMANTIC EQUIVALENCE: The qualitative interpretation about 'weakening effectiveness' and 'diminishing engagement' aligns with the ground truth's assessment, but this cannot overcome the factual error in the primary metric. The reasoning about reduced customer engagement and competitive pressures is sound and matches the ground truth's interpretation. CALCULATION IMPACT: The trend analysis changes slightly with the correct 17.8% figure (decline of 2.7 percentage points from 2022-2024 vs. the LLM's 1.9 percentage point decline), which affects the severity assessment of the trend. The ground truth's characterization of 'consistent decline' is more pronounced with the correct figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 436,
        "total_tokens": 1701
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 6.03,
    "average_quantitative_accuracy": 6.3,
    "average_qualitative_accuracy": 6.31,
    "average_contextual_relevance": 7.16,
    "score_distribution": {
      "excellent": 186,
      "good": 199,
      "fair": 221,
      "poor": 194
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 28168.64,
    "timestamp": "2026-02-02T23:29:54.375960"
  }
}